<SEC-DOCUMENT>0001628280-21-015891.txt : 20210805
<SEC-HEADER>0001628280-21-015891.hdr.sgml : 20210805
<ACCEPTANCE-DATETIME>20210805163651
ACCESSION NUMBER:		0001628280-21-015891
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		78
CONFORMED PERIOD OF REPORT:	20210630
FILED AS OF DATE:		20210805
DATE AS OF CHANGE:		20210805

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SELECT MEDICAL HOLDINGS CORP
		CENTRAL INDEX KEY:			0001320414
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HOSPITALS [8060]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34465
		FILM NUMBER:		211148963

	BUSINESS ADDRESS:	
		STREET 1:		C/O SELECT MEDICAL CORP
		STREET 2:		4714 GETTYSBURG RD
		CITY:			MECHANICSBURG
		STATE:			PA
		ZIP:			17055
		BUSINESS PHONE:		717-972-1100

	MAIL ADDRESS:	
		STREET 1:		C/O SELECT MEDICAL CORP
		STREET 2:		4714 GETTYSBURG RD
		CITY:			MECHANICSBURG
		STATE:			PA
		ZIP:			17055
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>sem-20210630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:13e6905e-72a0-44f6-9164-f135c900c5bf,g:37e820a7-74f5-4c60-b984-336d3d990bf4,d:2ca4a620761f4048abbeb3b8e6b51d6f--><html xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:sem="http://www.selectmedical.com/20210630" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sem-20210630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80L2ZyYWc6ZjdmNDg2YzQ2NDAzNDk3ZDkyMTljNmE4N2QzMWY1ZWEvdGFibGU6NWYwZGUyNmY0NjJkNDIyOTgzZWU2NWUwMDFhM2E4NzQvdGFibGVyYW5nZTo1ZjBkZTI2ZjQ2MmQ0MjI5ODNlZTY1ZTAwMWEzYTg3NF8yLTEtMS0xLTA_7e288311-ae8b-4fb0-99f2-12900725e184">0001320414</ix:nonNumeric><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80L2ZyYWc6ZjdmNDg2YzQ2NDAzNDk3ZDkyMTljNmE4N2QzMWY1ZWEvdGFibGU6NWYwZGUyNmY0NjJkNDIyOTgzZWU2NWUwMDFhM2E4NzQvdGFibGVyYW5nZTo1ZjBkZTI2ZjQ2MmQ0MjI5ODNlZTY1ZTAwMWEzYTg3NF8zLTEtMS0xLTA_fb422ddb-a7ed-4b3f-a6a5-692420c76ff3">false</ix:nonNumeric><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80L2ZyYWc6ZjdmNDg2YzQ2NDAzNDk3ZDkyMTljNmE4N2QzMWY1ZWEvdGFibGU6NWYwZGUyNmY0NjJkNDIyOTgzZWU2NWUwMDFhM2E4NzQvdGFibGVyYW5nZTo1ZjBkZTI2ZjQ2MmQ0MjI5ODNlZTY1ZTAwMWEzYTg3NF80LTEtMS0xLTA_5820f1be-fed9-415e-a832-8e0c7b350ec2">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80L2ZyYWc6ZjdmNDg2YzQ2NDAzNDk3ZDkyMTljNmE4N2QzMWY1ZWEvdGFibGU6NWYwZGUyNmY0NjJkNDIyOTgzZWU2NWUwMDFhM2E4NzQvdGFibGVyYW5nZTo1ZjBkZTI2ZjQ2MmQ0MjI5ODNlZTY1ZTAwMWEzYTg3NF81LTEtMS0xLTA_e2632f9e-91bb-435b-a595-080d44a1f28d">2021</ix:nonNumeric><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80L2ZyYWc6ZjdmNDg2YzQ2NDAzNDk3ZDkyMTljNmE4N2QzMWY1ZWEvdGFibGU6NWYwZGUyNmY0NjJkNDIyOTgzZWU2NWUwMDFhM2E4NzQvdGFibGVyYW5nZTo1ZjBkZTI2ZjQ2MmQ0MjI5ODNlZTY1ZTAwMWEzYTg3NF82LTEtMS0xLTA_dd5a9197-d15f-41aa-a44c-d437ecd4ab37">Q2</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="sem-20210630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ib7edbe299d2e4cef8af2828feb10a42e_I20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ib27967ed4eaf45369238e20d447ab83e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i632267a60f314ae3bccec20a793b8465_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdefa3d6cdb34858b7e182fc46afa080_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45d9d93694034373837c3f573d2d7ecb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5bfd431ead745a5a4f73a79e9a90180_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e6a554b8f8b45e8990535f027a788ff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if240d4208ad5471cb7b4b597c1a3ca8f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2806b7f400f4487e923e629b54913b07_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99b36c5b771943a6b90df106ee6a8bdb_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae8baa77c8704ff2859751da1e6a993f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73ab481852c04d249b8c95efbb1484d3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a7594d5c1e845f08d5c0cfb7e2dd9be_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8442ecf8486d42759fe367c2de8b4c85_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91c3a6aa3d9d463fb2244dc55d06fda9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4eaf841b3bc54e8887fcaab6cc4ba423_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73199de2eb734a1aa6d9d339b39814ea_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic13effada5f24e1dad9e29d7a8d0c5fb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1a6dc4d8592426aab6aeb9d0584fc06_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if551e4794f2b45c9a16a1f7ed95b3aae_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb9ee276a38c43b39dc4a7f012322150_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia25336bcc81845369b7acc4ef55a0c51_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16c67f9004aa4dfc83ced10a10230d97_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89986053f5394ec4bd4e69b2d52aa4e5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fbafc1a282f4ad88e8b769cba297e21_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cbdf661e9ee48f8a93652e5f73c501d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbb0e9e9121e4076a912834a8c0a2178_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i878a9c337abc406cbfa8912be660cfd9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d78995f73114fd9a07a5844ce1ebb86_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia507842de06c463cab8ad4f320a68bc7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06ac0cf032dc44e1baa12c616a1ab18f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29a8b026887f4d80b776c2643d660e67_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c472725691f4294afa81232749b2c38_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i748a28affcd7487d875035c464368d05_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c17c8cd7cac4115a14753f94ab8ab6c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i452ed919b2244df887431ff7b2c2d508_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f1d1941a2d54dd682218923f73f78e5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3996149e08774457b7cf81521fc7a46f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e001ee24b8d4e398bb154b6b74d75a6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80fc7da8ac2f44c1a89ba81702a6efef_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fcf10033def4edc8873b5e817d0b994_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98dbdae0901944a8bb7a4850bf5db8e1_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4d382e1e08d4eb1ba65b7ff2dc29af0_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc6557fef505437581efa07d7b365cb0_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f9c8016c7f342c79de1144a230d1612_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i757df6705cb74d08b9e53d576ac2c1f7_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07ef9561e63c46ecbfdf268105880ec9_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ab6f6ed4c5c40c785bf0ec5a56f7a7f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8979c36c27b948e7a75318aa470eb1c5_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b4a592cf00044548cc38f91879e81fa_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e12f979c9064796bbcd7735451cbf07_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i228ce0ec788848459a6778243cdfe2f9_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfaaf0f42d9042e7b77d153a10a8eeb5_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if41275a882144f35838503cdd9e3b9d8_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i072109b8da604643af13c0729800e1df_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6fcb443a0464cef95544365b85db50b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55f4763f21f4479ba3089c7486346215_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i150a45bd54dd4d4fa4ee7374f6bc72d3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ca9e03469c34d19aa6464835674249e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2386c06e6394e9192e485e15d848c39_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i966afdef72fe4d53ac2ff6217e8e9793_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3c7dc108fdc4209adb112435c46e453_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic33ba2829aad4672a382563462592dcf_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i139e861ba4e7472982269ee17ca2c68b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2126fcb95b794e1d9f9873202b50af46_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i54986ecc7fc44b8686d9e92cd152643d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">sem:MedicareReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cd99a1029914dfba302e3c8d1747dc9_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">sem:MedicareReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i419b57ae7aed4416a0c64ed51064c3f9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47ca05e15f9b40f489ce514ca61c046e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i700401d3c9d145e5a4af74e91aa63697_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72f4a9b9828d4a3b943644bbd290287b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94d49e31dfc5481b83733fba9533f7e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fb9c18f057d4a6cac88d6653d9ec800_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied45fa8b01774a98b132e46124b37c0a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia19667dc075545788618f5c66316f37a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i097daf64265140a892929bd7dac3e0fd_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e821cac29074fc185f5771945e60d79_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2eb84cd5898941968056ee90d2e078ac_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5447d034988f4dba82554eb01fc5e2a2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cee8f7161ea4a8a92cd3e773a1e4ece_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cc51a7a4bbb48fd82bfef91f2d58ed8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2722863174014f129b2ae71613b5e3ef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie50961b97f5d4e09a5947761afae9b15_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d92202a78304997b52107c3a7f606b2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">sem:CertificatesOfNeedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50009e4e14044151932827ba2b1bbb8f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">sem:CertificatesOfNeedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice892a1481a14854bded5d410c627ea7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">sem:AccreditationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i330f8d443bf84101a754a226814bfe6c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">sem:AccreditationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i602fead3b8954e80b8ecfba7f8e331a4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib04ddc4871e84537b195da0e20d46573_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i008b3ba5aedd4b238f380f5108ca88c2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if929eb1eca084fde8793ca88f272572d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i302b948d2285436d8d4925ae04d98b18_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48c41d6695124d31993223ed4735ed45_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f259df1c9c14a91877a5d8ddebfe895_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">sem:AccreditationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c8e70e09d574bd5bf50455cec27484e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i230304098a504f6e8bb8d87b3c8ff168_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25db1c92c0d94c90a36f23378754f459_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if091ae9541ec4cc8b5912d42e54eaf33_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i857a4ce6f52d4c159052310deeec6c7a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idac118b21fb34cc0987c43b0e5069eca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a6556d47b534c46b69474e970b014e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6837d0c7f474574b480bbb7ab422f4a_I20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04dc07ecbc4842379f1b38ab30b5eba8_I20210602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08f710aa7b9e476e9cfe1eb202bb9575_I20210602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80ee1121b7294df28e95de1abb339e57_D20210602-20210602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sem:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:ConcentraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-02</xbrli:startDate><xbrli:endDate>2021-06-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1a2d014fb1e4ad28dd4c378b19640ec_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6032142566484e849a1c5d74fc32c36c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8bac61b83244def99333977ca6bc8dd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c19072c8de04863a294aa039b4d4f1c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if569ced9cfba4b40a89af8439239b76d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id57e27efd97745c990ac963fa61e26b6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id110289f580b4bf99ef20d4061298d26_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7224211964a0414eb6d46f88101082e5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i318011501b1440e589143c06cf03d2a6_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i583e60e6ec66438ca44ad0bd1c978df3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7536a90c020479993c3e239213bd5b9_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6547976a10ee43418548a025bba5b82a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83e6ab5f1d91457a8c4e1283a5492962_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b2a61478b0140669828a01db0126a67_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i394d4e4cc11347d6bbe4d04a5195d6fa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sem:OtherAccruedLiabilitiesCurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide56b585b96145e2a275a4c246014f7a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sem:OtherAccruedLiabilitiesCurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e07cda8fc2f4dfbb5b2dd986ade2878_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17c6a45ecdbf4d0f95f5f9be53712a5c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i902a144fb9c24c4c9a915b36772f9aa3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i101b81566dfb4f6083f1433734385dd6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81a4a93b5710486380910f66202cea4c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i698e8ca3bbf14329ad97debd8fc5d02d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e1d48a74eba45399c9304871d02e6ac_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d9eaba867e94987bae380499ef0dea5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83fa48e193ef409091a5469b91556348_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i842ce964455440c8bf019b096558985c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i153dba6636544126b8b590e3eceb746a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie40b7ae534f84659b72f603832026b2c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7fe7ee2784746f5af6d2429cd8a2219_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8083b69f958c4c0f8dbe5292758beec8_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4101982ebb88440ab0a78e005d9ac883_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51d714fd1694458d8c8a2740933d72d8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae89f2bc1bb34c1c88b6b97eb1162a82_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1f26863a74d46b3807377370b9f5c71_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaed2d25f9da44d15a8e75aa82e738f7c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8878162e48ac455b871924e5a7f16043_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffb407c8a9fd406bbddf4aaba0a22fbf_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1d773ec12ea468d884922f6a9c624ab_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78b5037d6f24467bb284a7f3daadf67d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i593f37f6bebf4b5c8147fc667686329b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a46c953c7a44137882933b2fccefa90_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9da22e6ac16b4906870e768509e1fb6f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fe3df84cda8454c8ffd79d805543ebf_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i197ea75654664fa7a7dd48b4a0515835_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i699f8bdade4a44e29271a7ea09f9b932_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if588fc73933845bbb155e472e99ba08e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i232ac557a5c14113bafaf53b25c2801d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfa155817d6141a5af84386d83aa6d7d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71ae59b24b3143e89410ddfca8316817_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4876618fa9e49bfae481558c3925540_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c27e0254b2645b0bdf18d8599991191_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98da6697f91448bfa929dfa3d12ec44d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2445574d08d460aadb6cb824e13b57b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17a8bda6aa364b458b46c6989204116a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08f65e64fc704e26b6d0c36a9b3e98cc_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ad499a02f004e11a55a3d20c113db01_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6157d64fab14d1f866ca5d716c12912_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51ff975211194a639c5584cea74d9cb5_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5664ca3bf1834ed1b346b6f980fe1645_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1932c1a031b842f497c5e4232f3f980c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia82ee7626c034379a7ef163f2061e2bf_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb2712f735bf4472b74c12c452e1727d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9163058a56849f4b1b6ebd3958a1728_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43209435be314fa6a83374c8722c58a5_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2eb9a05c181e4145a86c46192acc8653_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5dc54ed53b94d6eabdf4d733168a430_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5110b434e804f27b249daa0ac18bd3d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1301e820f4e544f99fea1fdaef7b153a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia49b80360ab44d889a87b1c6f86dba3d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6e87f49cddf4c0993fcc9475663950b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d3595ddefe5469b964256337e3fb034_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a40e1e8ef2b4a6ca0e3d8215ef692c7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae9d25c4a62e4670a396e7b6215efe42_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddb712476dc64adeae838bf8e4757e71_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32cc5b0f0da748fa964f8bee8c8e5eab_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i424eb507e0b64cc39d53cf96c199d2c3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2f065968f664f51a97a9c4c8a8f6786_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedc923ca54a245aa839e41b3bd36de0e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97ccae97127f42ec84a3a9dd4735f5cd_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i091aa3c41eb94571a18e7d780ed4b261_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77d3137a60484a139d63c1c58d70fceb_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42b3c528abf945e9859cc7f7f223fceb_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd3ac5b6dbc749ff8ee6bfd8cf0ca211_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddc4d97079e3443eba00958c5b46559d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76832d2c4ca64519914f4773ca5655bc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbd9fe5a16a7443b8f6b7fb4c8339e17_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18f495ab15c4472ea5245942bf95dbc0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic066865053b14c43b32c73b1cbc2a459_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe618caa2cdd41b493cccea11ad44386_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb0e1422e48941919179e0c5e60cc063_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21b8f9d9710f4d46bba3b4cd219bcae3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i116e543b7d364332a96e426369913e91_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ce5d7ae1f3b480f9d278936f6173744_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4d10e3e03a54b60a9d607bc62d66b9d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c16ab56e4cf48229de650aa8e6455b3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i473b076cbb2248cda45ee5fecdf6c6d9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22bf8e5a71a74e0ab969fc88fc9d25f9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31fd5c81c9e74201ae6e106c98ca01c6_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02680b33aed34a55a6fe418edcde45ed_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fcbd9d03f874759a798ba9dfa435489_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6f011f7031b41769857679e22ff5b33_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25ea57bf51c745e29ae8656720141e04_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4602a266daee48acb939fda3366b3e59_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52fcf8fa0e7f407ca9b2a0421d3c01b8_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b1c9f6d7cde4d229d84a29158db43c5_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb336581b1ab46dabf7a10b846ee714d_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cf7cf902b774976a354f108a49e122b_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09e5085e732d4d6fb28c986bae301d35_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c5c1a4ea8b1455f8ea9b309f782aed0_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabcbf2354ad849b5a607f2c23acf92b6_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f1e3f7f1bd3482cb8ed258cb9ada854_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30d728f258204b97bb72e03b6261514d_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i059d076681264fbfb89b79347f63c29a_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f1cf5853d5f4c45936b37bfbdffa0db_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i063dc8bb9c604cb991c0938ed63900c1_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e73da1de31a46198a088e1a579b197e_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i013ac78a834a4a17a349b46fff225ede_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i241f967097904b2e90e2c1981d5bfb2f_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i606bd30a10194d7c92111ec05dd70ef2_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14aff568d487484d955b6414e353d276_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f5bf5cc569148f08c2f756e392e095a_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i513bb2ed05384cf0b367f1a1f2df60cd_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ae7544550d341458079a0f82f73a2f8_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1343d1d64ee546f4b3bc8de894d6a417_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i446969a89bf54833b066ad6cadf438aa_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35be1d23264d4ef8900b083084bae9b1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i228091dd94e94a2fb65278d548b96136_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84a37576ff314681abd2c231a24ffea5_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibef36a70c20e4c0e98c28b191ddfb97b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bd1eaf1ae624135ac4bc8d0d22d46d6_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8c4a3d34c3f41908312ed9c79fa8fd3_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie29532d76e2d4dee8c6c7b7b1be770c1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45fee6050b8a4216a0f668de2e12e95b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i982e0b3f126040f69ce41b2c2252c0bc_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1882e5c4817847d286a5e4ee18cd8c03_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89fb0d7ade4b445bbe6adb3867b94148_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39ec355699c047d88cd0a6ed1979c79b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaee340f3a6b64cbdbe9dbc79ba2744d6_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e316619ee3b482d9c7fae4209c447ad_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27949e6e57514846a097e4475475890d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i101f8dba1cbb472ab5d1e292ca9ad014_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67f288ba5c84408f889c40613f2a07b4_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1950866dbcfb4c3e96407bec7d05b210_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e70dfbd95e342bd9f7d99e607af7d63_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4760aa7fcf714911a502ad44e9ed68ac_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic39be75c367b45e1a92d762771bc3eec_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71dc8bf60a54443290451e38ffa4cbb0_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf91d28d1f7f4831a5c56411e190d606_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bd31c72edeb45d9b4601581e31a0e89_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis">us-gaap:ProfessionalMalpracticeLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia491adcb999943c481f80ad4aaeebcae_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if67ed923fb524d7e88c6828d4a0c423a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis">us-gaap:ProfessionalMalpracticeLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied10c49f8e374623bcde2e89b5b25289_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis">us-gaap:ProfessionalMalpracticeLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i465d9175e18d4165b2f6834e5d9e0b7a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis">us-gaap:ProfessionalMalpracticeLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i760d525b19534ec8bf2275b1a4759394_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69380e325f114ea89df7916749073905_D20200327-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-27</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e1fc4e7b10d4564ae73da8aaf8268ca_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0cd8e5fc1d2451fa507e01087b5e757_I20210804"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001320414</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-04</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjI3_59fa01a8-66ce-40ae-ab49-f5547e2ea23d">10-Q</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.150%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGFibGU6ZjhmNjQ0NWFkYzg3NDZmODg2OTUyZjlhNjMyMTk2NzQvdGFibGVyYW5nZTpmOGY2NDQ1YWRjODc0NmY4ODY5NTJmOWE2MzIxOTY3NF8wLTAtMS0xLTA_f34bf8a5-f145-464e-a79f-d89bd779b253">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 or 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Quarterly Period Ended <ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8xMzg_1b023975-bce6-4e3f-8e78-8967077ed38a">June&#160;30, 2021</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGFibGU6ZjgyOTg1MTg3MmZjNDUyNzg4OWI0MzZlMzAyZmI4MjQvdGFibGVyYW5nZTpmODI5ODUxODcyZmM0NTI3ODg5YjQzNmUzMDJmYjgyNF8wLTAtMS0xLTA_9ec2549a-f3f2-4176-be08-e012240e0a6d">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 or 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF&#160;1934</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission file numbers: <ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjMy_706705ad-90de-4891-bcff-3696423f3e73">001-34465</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjMz_77c71a19-f83f-43aa-9d72-a2c1fe6d174e">SELECT MEDICAL HOLDINGS CORP</ix:nonNumeric>ORATION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Exact name of Registrant as specified in its Charter)</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.166%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.167%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGFibGU6ZmY5MWM2MTAyMzY2NDdkOTgwMzU1ZGU1YWYwNjczNWMvdGFibGVyYW5nZTpmZjkxYzYxMDIzNjY0N2Q5ODAzNTVkZTVhZjA2NzM1Y18wLTAtMS0xLTA_4b056974-152a-414c-8eaa-db2dae08a226">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGFibGU6ZmY5MWM2MTAyMzY2NDdkOTgwMzU1ZGU1YWYwNjczNWMvdGFibGVyYW5nZTpmZjkxYzYxMDIzNjY0N2Q5ODAzNTVkZTVhZjA2NzM1Y18wLTItMS0xLTA_e311d890-8f2c-4d5f-9a56-77a8f57ca889">20-1764048</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation or Organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification Number)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjM0_7e893baa-a670-4f5b-b98e-f95ae96974d7">4714 Gettysburg Road</ix:nonNumeric>, <ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjI4_0b2a6c29-dec3-471a-bb3e-1bf00943f5bc">P.O.&#160;Box&#160;2034</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjI5_5f1bbd55-112a-4ae5-afde-ed05b8c465c1">Mechanicsburg</ix:nonNumeric>, <ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjM1_eb8bec23-3762-40a9-8c35-e10668b85e29">PA</ix:nonNumeric> <ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjM2_b44881e5-3e4a-42d3-a43d-e8c593c3a95a">17055</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices and Zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjMw_a2601d22-5e43-405d-937c-903c60ad2412">717</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjM3_44022ec6-a88f-463a-9fe0-6fe7bf37ea73">972-1100</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGFibGU6ZGNhMjExZTczN2Y4NDQwMWIzMjRjMDdiODNiNzM2ZDYvdGFibGVyYW5nZTpkY2EyMTFlNzM3Zjg0NDAxYjMyNGMwN2I4M2I3MzZkNl8xLTAtMS0xLTA_63349353-0bda-4d6d-b7f9-ad626f7bba69">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGFibGU6ZGNhMjExZTczN2Y4NDQwMWIzMjRjMDdiODNiNzM2ZDYvdGFibGVyYW5nZTpkY2EyMTFlNzM3Zjg0NDAxYjMyNGMwN2I4M2I3MzZkNl8xLTEtMS0xLTA_c60ee474-1b76-42d6-8cb5-a2dc6f65938b">SEM</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGFibGU6ZGNhMjExZTczN2Y4NDQwMWIzMjRjMDdiODNiNzM2ZDYvdGFibGVyYW5nZTpkY2EyMTFlNzM3Zjg0NDAxYjMyNGMwN2I4M2I3MzZkNl8xLTItMS0xLTA_f9fcf529-23f0-41ec-aa06-8a34cd47284f">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(NYSE)</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods as such Registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160; <ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjM4_d027717c-49a9-49e3-89e3-419c852a27a5">Yes</ix:nonNumeric>&#160; &#9746;&#160; No&#160;&#9744; </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).&#160;&#160; <ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjMx_8a840003-a953-4d12-8ada-9699793e9c47">Yes</ix:nonNumeric> &#9746; No&#160;&#9744; </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act. (Check one):</span></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.440%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGFibGU6MmMxNTA4ODg3YjBjNGY5Mzk1N2JlODg1NmU0MTc2M2QvdGFibGVyYW5nZToyYzE1MDg4ODdiMGM0ZjkzOTU3YmU4ODU2ZTQxNzYzZF8wLTAtMS0xLTA_e7cb627c-1a34-4e6d-a0c6-aa7587fd9da4">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGFibGU6MmMxNTA4ODg3YjBjNGY5Mzk1N2JlODg1NmU0MTc2M2QvdGFibGVyYW5nZToyYzE1MDg4ODdiMGM0ZjkzOTU3YmU4ODU2ZTQxNzYzZF8xLTMtMS0xLTA_cc8b9fe9-0690-42bd-b6b9-76b9109fea4d">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGFibGU6MmMxNTA4ODg3YjBjNGY5Mzk1N2JlODg1NmU0MTc2M2QvdGFibGVyYW5nZToyYzE1MDg4ODdiMGM0ZjkzOTU3YmU4ODU2ZTQxNzYzZF8yLTMtMS0xLTA_c4f8ad5c-0be3-46c7-97f1-a3de86a08b92">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.&#160; &#9744; </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160; Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjM5_bf215d61-9fd1-4eec-807a-320671803c4e">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160; No&#160;&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of July&#160;31, 2021, Select Medical Holdings Corporation had outstanding <ix:nonFraction unitRef="shares" contextRef="ib7edbe299d2e4cef8af2828feb10a42e_I20210731" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yMDU1_f2140d7d-2d50-40f1-8530-0ff4db465d74">134,576,139</ix:nonFraction> shares of common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unless the context indicates otherwise, any reference in this report to &#8220;Holdings&#8221; refers to Select Medical Holdings Corporation and any reference to &#8220;Select&#8221; refers to Select Medical Corporation, the wholly owned operating subsidiary of Holdings, and any of Select&#8217;s subsidiaries. Any reference to &#8220;Concentra&#8221; refers to Concentra Group Holdings Parent,&#160;LLC (&#8220;Concentra Group Holdings Parent&#8221;) and its subsidiaries, including Concentra Inc. References to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer collectively to Holdings, Select, and Concentra.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:216pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.344%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_10">PART&#160;I</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_10">FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_10">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_13">ITEM 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_13">CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_16">Condensed consolidated balance sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_19">Condensed consolidated statements of operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_25">Condensed consolidated statements of comprehensive income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_25">5</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_28">Condensed consolidated statements of changes in equity and income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_28">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_31">Condensed consolidated statements of cash flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_31">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_34">Notes to condensed consolidated financial statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_34">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_100">ITEM 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_100">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_100">23</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_142">ITEM 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_142">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_142">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_145">ITEM 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_145">CONTROLS AND PROCEDURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_145">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_148">PART&#160;II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_148">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_148">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_151">ITEM 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_151">LEGAL PROCEEDINGS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_151">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_154">ITEM 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_154">RISK FACTORS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_154">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_157">ITEM 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_157">UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_157">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_163">ITEM 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_163">DEFAULTS UPON SENIOR SECURITIES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_163">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_166">ITEM 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_166">MINE SAFETY DISCLOSURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_166">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_169">ITEM 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_169">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_169">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_172">ITEM 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_172">EXHIBITS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_172">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_175">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:216pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;I: FINANCIAL INFORMATION</span></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> ITEM 1.     CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Select Medical Holdings Corporation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-bottom:15pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in thousands, except share and per share amounts)</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:58.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMy0xLTEtMS0w_e5eb0d23-1a5d-4c0c-b19e-77efd7e430c6">577,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMy0zLTEtMS0w_8df53029-0272-4672-a8c8-debd6e16a755">803,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNC0xLTEtMS0w_8aa31406-d4e1-4e28-a01c-ed6628a79b1a">896,763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNC0zLTEtMS0w_7a1164ea-bd9f-4ea5-9013-5f28cddc9aa6">931,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNS0xLTEtMS0w_16b85a4c-1476-45f1-b3ed-5ee71c418085">5,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNS0zLTEtMS0w_6b8bc16d-fced-4c1d-a589-a60fca666e90">5,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNi0xLTEtMS0w_957d3e47-05d4-4530-b17f-0e18dac0dc93">114,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNi0zLTEtMS0w_acff1a66-c861-4ff5-9ee7-28d3035bed66">128,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Current Assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNy0xLTEtMS0w_6de70e18-d3ac-4723-8186-4383e8027941">1,594,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNy0zLTEtMS0w_bb6a201b-8123-4f17-bf25-90f72d2bb422">1,868,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfOC0xLTEtMS0w_a5a6c0f2-1584-44b4-82f0-fb805af3d68a">1,032,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfOC0zLTEtMS0w_bc54db35-29cb-4fc0-8fa2-8ddc20c3843a">1,053,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfOS0xLTEtMS0w_3abddb5c-44a4-4edd-a49c-3b213db1979a">943,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfOS0zLTEtMS0w_90d3bf3d-179f-4fa0-9acb-e033c4e8fd86">928,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTAtMS0xLTEtMA_a7359be4-cd35-45f7-9930-471fe1987209">3,379,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTAtMy0xLTEtMA_3aa2dc5f-0e5a-4233-b7a6-c408c7d10c55">3,391,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Identifiable intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTEtMS0xLTEtMA_b19a4009-d221-4663-92c0-ce0ecc3d237b">387,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTEtMy0xLTEtMA_08993796-e16b-4c6b-a4ac-fdbf61f68711">380,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTItMS0xLTEtMA_da54d785-c7ee-4cf8-82fe-6da383529d6f">319,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTItMy0xLTEtMA_b8354370-86ca-473c-9325-ab18e636cc5b">335,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTMtMS0xLTEtMA_a170ac76-c4e6-459e-b56e-ff0f5124eb77">7,655,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTMtMy0xLTEtMA_cd34b8db-7a80-4cc7-96f4-50e541d00624">7,956,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTctMS0xLTEtMA_8a5559ed-b88a-48dc-8918-fecff7bb7dde">220,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTctMy0xLTEtMA_b864be02-3fb6-41e5-b77c-c030f11ecb30">224,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of long-term debt and notes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTgtMS0xLTEtMA_4ab9212a-2283-443c-b47e-46a960537881">12,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTgtMy0xLTEtMA_370d4ee1-1dda-4623-a1ac-0d743cbad972">11,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTktMS0xLTEtMA_bb050a24-f830-4480-b037-d3723d2b8d9f">177,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTktMy0xLTEtMA_efaab3d8-6872-4f10-8559-67fb8e3c0711">187,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued payroll</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="sem:AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjAtMS0xLTEtMA_8101b440-f473-433c-bbfb-89ec08be20b9">224,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjAtMy0xLTEtMA_5c29fe0d-d42d-49ba-b995-8db7327abf19">246,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued vacation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedVacationCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjEtMS0xLTEtMA_94a602a9-b574-4e6e-af75-29b57f84dc0f">132,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedVacationCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjEtMy0xLTEtMA_9225aee2-65b7-4b37-9ed4-28aac43348ca">146,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjItMS0xLTEtMA_7fbe273d-ba58-442d-b95c-3dc658f8a634">29,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjItMy0xLTEtMA_2fe306ef-3529-4378-97e5-40c2e00cded1">28,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjMtMS0xLTEtMA_b2b98773-565e-4536-91c3-2e4f393a02eb">228,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjMtMy0xLTEtMA_96b4c8b7-a2b8-4b31-82c9-2f3b54b22287">256,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Government advances (Note 15)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="sem:GovernmentAdvancesCARESAct" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjQtMS0xLTEtMA_949a8fdb-5f2f-49e5-878c-94709f4d4325">321,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:GovernmentAdvancesCARESAct" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjQtMy0xLTEtMA_d29dba24-2146-4542-9f33-8c6108532788">251,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unearned government assistance (Note 15)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="sem:UnearnedGovernmentAssistanceCARESAct" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjUtMS0xLTEtMA_14103402-dd23-4697-964e-758464f68725">82,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:UnearnedGovernmentAssistanceCARESAct" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjUtMy0xLTEtMA_66cda929-1bea-4b05-9db0-6f9a09d94e2a">4,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjctMS0xLTEtMA_84fd72a7-6156-445f-86aa-f7dbe3cff54b">7,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjctMy0xLTEtMA_b9880ac9-4c4a-4b66-a40b-fc0cc3d490f5">50,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Current Liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjgtMS0xLTEtMA_147575cf-2a36-4493-aaa3-a9d4a064796d">1,438,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjgtMy0xLTEtMA_fb9ce31f-ac8c-4ad1-a501-7f44ba954bf4">1,409,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-current operating lease liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjktMS0xLTEtMA_c6d2a619-ba04-4b31-b559-9ec8d5ff5c1c">875,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjktMy0xLTEtMA_f0d8f6bd-3c2f-4ffd-bd52-865429785da9">893,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzAtMS0xLTEtMA_e721de50-5d51-4118-89ad-d00b09300af2">3,389,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzAtMy0xLTEtMA_a3cc097f-55ec-4605-b262-629f4dbaeaf7">3,386,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-current deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzEtMS0xLTEtMA_155352d7-8586-4443-8bdf-f1879c1dbc8b">132,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzEtMy0xLTEtMA_09e11995-750c-43cf-8c2d-26d8cec60a9d">123,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzItMS0xLTEtMA_ea4f6ef3-e8bb-4e5c-b2d1-1bb56fe35267">168,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzItMy0xLTEtMA_fdfa59b0-62a6-407f-92b7-871c4be25c80">172,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzMtMS0xLTEtMA_f6c8fcb0-29ec-4cde-aefc-bcee3d02a6ba">6,004,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzMtMy0xLTEtMA_dff11d37-086e-494c-9d74-cd8df141fe7e">5,984,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 14)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzQtMS0xLTEtMA_4bb85344-c7f3-4cfc-93da-9d40cef152e2"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzQtMy0xLTEtMA_6f6eab80-21b9-403f-8609-92847f53b6e8"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzUtMS0xLTEtMA_21d59ba7-2c0a-434c-9046-8c2f2065b57f">398,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzUtMy0xLTEtMA_3a0bd9ea-80da-4312-84b4-364c821d5f14">521,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stockholders&#8217; Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjkyOGU1ZTc0YWVmNDRkMzg5Njg4NTI1M2I3NjQ1N2VlXzE4_332b79e9-dbae-42d9-b95f-c49410ee6aaf"><ix:nonFraction unitRef="usdPerShare" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjkyOGU1ZTc0YWVmNDRkMzg5Njg4NTI1M2I3NjQ1N2VlXzE4_861ba9cd-8d51-4f2e-b7ec-de2c6a9047f3">0.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjkyOGU1ZTc0YWVmNDRkMzg5Njg4NTI1M2I3NjQ1N2VlXzMy_22494d95-cfc3-43a3-b5eb-4d451f5085ef"><ix:nonFraction unitRef="shares" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjkyOGU1ZTc0YWVmNDRkMzg5Njg4NTI1M2I3NjQ1N2VlXzMy_4dc7a78a-ef54-4d29-bd26-fdde39ead2cb">700,000,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjkyOGU1ZTc0YWVmNDRkMzg5Njg4NTI1M2I3NjQ1N2VlXzU0_8f303d2f-c6c6-4326-9563-5bf223a68d57"><ix:nonFraction unitRef="shares" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjkyOGU1ZTc0YWVmNDRkMzg5Njg4NTI1M2I3NjQ1N2VlXzU0_e46e0d69-af0e-45fb-af35-03bf84e3e6fb">134,850,735</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjkyOGU1ZTc0YWVmNDRkMzg5Njg4NTI1M2I3NjQ1N2VlXzYx_205a0edd-a3b8-4cd1-a690-2f9ba0cdc178"><ix:nonFraction unitRef="shares" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjkyOGU1ZTc0YWVmNDRkMzg5Njg4NTI1M2I3NjQ1N2VlXzYx_adea7643-1c10-4acf-9baf-a21c51c2638f">135,005,369</ix:nonFraction></ix:nonFraction> shares issued and outstanding at 2020 and 2021, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzctMS0xLTEtMA_18fce4ac-d559-4aaf-9ef6-f1c4b3854ea0">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzctMy0xLTEtMA_c8e9d597-7e5b-4a69-9a8a-6126af05f81d">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capital in excess of par</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzgtMS0xLTEtMA_c1ef6530-682b-44aa-90da-7994d8611eec">509,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzgtMy0xLTEtMA_3ba45421-2c60-4083-8693-c78ba513b296">516,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzktMS0xLTEtMA_5dbb9d8f-1090-48ec-9f02-b02fe96af42a">553,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzktMy0xLTEtMA_ed8032d8-3552-465a-86d7-91d4ec2fdf66">713,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNDAtMS0xLTEtMA_bcad5f55-ea2b-409f-9cfe-c0f5b93ef7d5">2,027</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNDAtMy0xLTEtMA_fa39c45d-ef64-4846-b976-4e44f0abd204">4,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Stockholders&#8217; Equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNDEtMS0xLTEtMA_fa600c6f-b18f-4e71-a28a-305d2ae1c8af">1,060,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNDEtMy0xLTEtMA_d947d38f-45ee-47f5-8dad-d003f7ef7cb3">1,234,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNDItMS0xLTEtMA_89c9b41e-2609-4387-b5b0-ffc134c0ae81">192,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNDItMy0xLTEtMA_bebf7eff-a3a6-4924-981d-91d117bde9b2">215,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNDMtMS0xLTEtMA_daa32da2-b5bd-4977-9601-39e799a7c34f">1,252,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNDMtMy0xLTEtMA_7786c03c-14a5-422f-bcd1-972e3738b6d2">1,449,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Liabilities and Equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNDQtMS0xLTEtMA_40800c2d-9de2-4d0d-a0d4-0e38c2fd0e84">7,655,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNDQtMy0xLTEtMA_45837ca3-d064-4ffd-aa88-768d3bd1c1ac">7,956,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Select Medical Holdings Corporation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in thousands, except per share amounts)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMi0xLTEtMS03OTA_ccbf0263-4768-4de3-b7e3-82e7610550c4">1,232,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMi0zLTEtMS03OTA_9ac2da6a-bc35-4393-8865-1ea99e30c097">1,564,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMi0xLTEtMS0w_e4fdd68a-896f-41b1-897a-a758986d6b6f">2,647,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMi0zLTEtMS0w_a9b74e5a-cbca-4eb1-89b1-66b7cec84cd6">3,110,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of services, exclusive of depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNC0xLTEtMS03OTA_7a51112c-5723-4bc9-8914-7382b4181c52">1,082,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNC0zLTEtMS03OTA_f0ed8b41-912f-4d9d-8a1a-5af9e5db7026">1,291,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNC0xLTEtMS0w_bd259109-6442-46f4-ab47-9d6db0c0428e">2,282,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNC0zLTEtMS0w_6826d89d-b760-42f1-95af-120b6256a8ea">2,584,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNS0xLTEtMS03OTA_8aa16b1e-9169-487b-949f-8c6431c42020">33,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNS0zLTEtMS03OTA_a7d9f313-e658-4a74-9434-e776869aefd4">35,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNS0xLTEtMS0w_524ba628-c173-4739-9289-146c60837534">67,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNS0zLTEtMS0w_58785d20-0d6c-40f1-bd57-1910af8d9ca1">71,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNi0xLTEtMS03OTA_2180dece-4c1c-4b50-a482-20bd8a364fe3">52,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNi0zLTEtMS03OTA_2e6d270c-bd52-4d90-96ad-b5ce1bf67e5c">50,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNi0xLTEtMS0w_ffa3d312-813a-4479-b37c-69812ea25fe5">104,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNi0zLTEtMS0w_0da8753a-1904-4896-906a-d93acf05e623">100,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNy0xLTEtMS03OTA_63171a17-44db-46b9-aaba-bb88d5c5caaa">1,168,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNy0zLTEtMS03OTA_f596f393-80cb-4c7d-8827-667272b38375">1,378,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNy0xLTEtMS0w_4f60336d-2f3a-4084-bb77-294895d56ad7">2,454,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNy0zLTEtMS0w_151f4f24-0939-4881-bbe7-50f76b6a32e7">2,756,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfOC0xLTEtMS03OTA_90fe16a4-238d-436b-8a16-b0a18d4a0eed">54,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfOC0zLTEtMS03OTA_4e7d016c-98cb-4f21-8f7f-0748b54cd3a9">98,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfOC0xLTEtMS0w_2afab8c0-143e-4c4d-bfa5-ee3a0d77871e"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfOC0xLTEtMS0w_64d3bdf5-51fe-4937-b243-1e0cd4bf7964">54,988</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfOC0zLTEtMS0w_f98ae8c8-23b7-4554-8008-5db63b8de0e0">132,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfOS0xLTEtMS03OTA_2b6ab58b-d497-45c0-954a-f57cd6f696e3">119,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfOS0zLTEtMS03OTA_0841b466-1243-4715-aeb9-7003790ef200">283,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfOS0xLTEtMS0w_93273f01-8b37-40da-9e70-8c26bfb530e5">248,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfOS0zLTEtMS0w_42e70b0e-f8b5-43bd-b7e5-e2fde33b5fe2">485,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income and expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTItMS0xLTEtNzkw_be5e2bec-eb28-478e-8096-c3af6b578629">8,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTItMy0xLTEtNzkw_a515021a-f923-4d40-a30a-8c257ca64970">11,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTItMS0xLTEtMA_d6512f0e-9cc1-49e1-ac25-0af904c3d24b">10,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTItMy0xLTEtMA_aff10776-bc34-4e81-a816-9dd878435476">21,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on sale of businesses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTMtMS0xLTEtNzkw_a0547508-f3b4-4fce-b022-a6cde5aa53ae">346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTMtMy0xLTEtNzkw_3d613e50-d8bf-4306-9457-b62ebab4ca9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTMtMS0xLTEtMA_30920f22-4616-48c6-a011-e5ab33004903">7,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTMtMy0xLTEtMA_bc3154b8-c06c-4259-b51b-d45d761667dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:LitigationSettlementInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTQtMS0xLTEtNzkw_203f6e03-ff1c-45ce-8af2-a9bbf66bb4a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LitigationSettlementInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTQtMy0xLTEtNzkw_0138ddc7-6d30-488d-a8d8-272f502c7490">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:LitigationSettlementInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTQtMS0xLTEtMA_29d08a63-574d-463b-9906-a2430969e4d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTQtMy0xLTEtMA_d7c30e00-71fd-4774-8ba5-7daf3138327d">4,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTUtMS0xLTEtNzkw_84475845-6461-4b69-be3c-bb074edb0d07">37,366</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTUtMy0xLTEtNzkw_b176745e-de66-491b-b7ff-328c0d7e120b">33,888</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTUtMS0xLTEtMA_84170ae5-834f-4d5b-9887-c6df5adacf84">83,473</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTUtMy0xLTEtMA_c18c29af-35dd-4e2a-8ff1-335bbe375785">68,290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTYtMS0xLTEtNzkw_f037e50f-e6ab-4aec-ba25-ab983dc8b61f">90,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTYtMy0xLTEtNzkw_288edd8d-7299-40c1-876d-2a6db84e6097">261,889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTYtMS0xLTEtMA_cfdae4cf-9c57-4c43-813e-6286db0ac907">183,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTYtMy0xLTEtMA_0811f256-11de-4127-81e7-45cf33f1db46">444,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTctMS0xLTEtNzkw_8c58409e-c99b-48fa-9e9f-018bde2bf4f5">23,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTctMy0xLTEtNzkw_f71451c9-9533-4c3b-94b7-913434cfc6f7">65,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTctMS0xLTEtMA_f8d4249c-359c-47fe-aadf-7005ddcca824">45,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTctMy0xLTEtMA_c7d392a5-0865-4135-8de6-d1b2640db3c1">110,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTgtMS0xLTEtNzkw_91326bc0-55b2-4385-8d85-4ca4a2d896f9">67,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTgtMy0xLTEtNzkw_ef3b8a02-cbe4-40bc-9daa-c790714059c8">196,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTgtMS0xLTEtMA_e690abae-d247-415d-be1a-69a36ae81c13">137,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTgtMy0xLTEtMA_6cd6400d-3615-4f2a-812f-530aee92fd40">333,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Net income attributable to non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTktMS0xLTEtNzkw_e3400c37-a4d9-4ed7-ae57-ace4c30cafa4">15,836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTktMy0xLTEtNzkw_9a059b87-e98f-4e91-8946-bdf65cc69757">31,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTktMS0xLTEtMA_cf3c7816-51cc-4ea1-a28b-5fbc4bf3122a">33,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTktMy0xLTEtMA_948fd0a0-9352-4f9b-8b3a-b972491c8790">57,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to Select Medical Holdings Corporation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjAtMS0xLTEtNzkw_16557c47-757b-4df3-b97e-3d0f5c0711fa">51,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjAtMy0xLTEtNzkw_25ee18a5-ee76-4bf3-ba6e-dc80d559e4a4">164,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjAtMS0xLTEtMA_bf144b6c-8364-4c38-82a5-1c7e36c94444">104,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjAtMy0xLTEtMA_2b9fe718-fe35-4778-8151-2f22db9fdac5">275,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Earnings per common share (Note 13):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjItMS0xLTEtNzkw_791ff8e9-e4d1-434a-b3ea-9be3b10de37e"><ix:nonFraction unitRef="usdPerShare" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjItMS0xLTEtNzkw_7c2caddf-8264-4743-8953-ad4dc1f9e6c3">0.39</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjItMy0xLTEtNzkw_05bb455e-1dd4-4bc7-a629-f5ce1823ae1e"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjItMy0xLTEtNzkw_c15f3d1a-56f8-4f4d-818a-072a8a792f4d">1.22</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjItMS0xLTEtMA_544a41fe-0485-4f50-8182-7ca8ad4f5421"><ix:nonFraction unitRef="usdPerShare" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjItMS0xLTEtMA_c29dd232-fa30-4471-b148-aa18ab911e06">0.78</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjItMy0xLTEtMA_754ca5a9-335e-41c4-977d-092385232238"><ix:nonFraction unitRef="usdPerShare" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjItMy0xLTEtMA_f3eed5d9-e397-4829-a6a1-754c100ae96d">2.04</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Select Medical Holdings Corporation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Income</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.070%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.923%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.923%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">For the Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfMi0xLTEtMS04NTM_4fab6bd7-099e-44e7-86bd-50b067b74a4e">67,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfMi0zLTEtMS04NTM_36b54f1b-bff0-4dc0-9264-f3246b6e678e">196,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfMi0xLTEtMS0w_5ca0d6f5-3e6a-4087-b027-8a9aaad0b091">137,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfMi0zLTEtMS0w_7725064e-45de-42a7-91fb-584354ab8933">333,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) on interest rate cap cash flow hedge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNC0xLTEtMS00NDQ1_aa55fd51-8016-4452-8611-7c237db4b740">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNC0zLTEtMS00NDQ1_6504035c-77e4-448d-941d-78048e33425b">1,403</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNC01LTEtMS00NDQ1_1033adcb-ba4e-49cb-877a-8a9f63abe63b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNC03LTEtMS00NDQ1_38308db4-28ba-4030-8e39-08e6bda1fd0f">6,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification adjustment for (gains) losses included in net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNC0xLTEtMS04NTg_ec9373d8-9807-4200-8b75-bf4f122878ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNC0zLTEtMS04NTg_491289b8-1bc0-4514-8d93-9e0b8ecbfabf">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNC0xLTEtMS0w_73007707-13d3-4c10-ae91-951be509c15f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNC0zLTEtMS0w_6c6721cd-cf55-4298-b9e2-18b60af8b67d">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net change, net of tax benefit (expense) of $<ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi0wLTEtMS00NTA3L3RleHRyZWdpb246Mjk0MjkzNDI5YjczNDk0ODk5ODQwODUyNTVlMTZkZmNfMjc0ODc3OTA2OTUxOA_0e4ab380-2896-44f2-9899-8fa0c7b093f9">&#8212;</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi0wLTEtMS00NTA3L3RleHRyZWdpb246Mjk0MjkzNDI5YjczNDk0ODk5ODQwODUyNTVlMTZkZmNfMjc0ODc3OTA2OTQ5Mw_02e4098e-1168-4e0d-a1ac-6c4606f72303">486</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi0wLTEtMS00NTA3L3RleHRyZWdpb246Mjk0MjkzNDI5YjczNDk0ODk5ODQwODUyNTVlMTZkZmNfMjc0ODc3OTA2OTQ5OA_c4a88c93-80c1-462d-a1eb-94f736e9aa72">&#8212;</ix:nonFraction>, and $(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi0wLTEtMS00NTA3L3RleHRyZWdpb246Mjk0MjkzNDI5YjczNDk0ODk5ODQwODUyNTVlMTZkZmNfMjc0ODc3OTA2OTUwNw_169328da-fcbb-49a7-b137-b168d7c24114">2,348</ix:nonFraction>)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi0xLTEtMS00NTAx_c34d9351-aa97-4f25-96c4-082488932b44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi0zLTEtMS01MTEw_68729bd2-55eb-438d-b0bd-b6c62f38af5b">1,397</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi01LTEtMS01MTEw_0ae48a1b-f90b-43cf-a9da-a282a1cfbce4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi03LTEtMS01MTEw_2f87b697-9f2e-4b5e-ab37-0d8394572a75">6,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi0xLTEtMS04ODM_6a1068db-cf9e-43b4-9193-e64495c7a0b9">67,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi0zLTEtMS04ODM_ac00428a-ab6d-4dce-a025-d71319fae5aa">194,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi0xLTEtMS0w_2fc6389a-d1e7-4760-9cc3-3814e1d349c2">137,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi0zLTEtMS0w_cb3c652e-8e4a-4f57-9816-7c3b8ca706f9">340,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Comprehensive income attributable to non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNy0xLTEtMS04NjI_450949a8-a600-476b-a3e9-ccf480170310">15,836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNy0zLTEtMS04NjI_8931942c-eac9-4ae4-a5ea-67fa288080ed">31,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNy0xLTEtMS0w_422e6e03-fe8e-4df8-92dc-d7b2d9b6709e">33,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNy0zLTEtMS0w_334f40d6-7e38-4f32-ba53-c970a564ff57">57,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Comprehensive income attributable to Select Medical Holdings Corporation</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfOC0xLTEtMS04ODM_e84d6303-d96d-4d36-abeb-cfee59fe4dbe">51,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfOC0zLTEtMS04ODM_2eff6375-1242-4cf3-bd95-1f54ef066f83">163,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfOC0xLTEtMS0w_e93ef35c-00ea-4bab-b2c3-5a2490f5ce47">104,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfOC0zLTEtMS0w_8829c734-76a3-42b6-bebf-9bec2977369e">282,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Select Medical Holdings Corporation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Changes in Equity and Income</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">For the Six Months Ended June 30, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total&#160;Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock<br/>Issued</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock<br/>Par&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capital in<br/>Excess<br/>of&#160;Par</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifdefa3d6cdb34858b7e182fc46afa080_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNC0xLTEtMS0w_1fc0f834-f557-40e9-a312-e3a2e1167636">134,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdefa3d6cdb34858b7e182fc46afa080_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNC0zLTEtMS0w_57917cd7-e535-4931-a1fe-6be123755fa0">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45d9d93694034373837c3f573d2d7ecb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNC01LTEtMS0w_577820da-6327-44dd-abc6-ae74bbb03caa">509,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5bfd431ead745a5a4f73a79e9a90180_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNC03LTEtMS0w_7ab97d76-81c6-4558-a812-5df8aa74320d">553,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e6a554b8f8b45e8990535f027a788ff_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNC05LTEtMS0w_5c4b65cc-7378-4f2e-aff4-6b702e07ce33">2,027</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if240d4208ad5471cb7b4b597c1a3ca8f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNC0xMS0xLTEtMA_15295ecd-734e-4bca-a4fe-5a593759084b">1,060,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2806b7f400f4487e923e629b54913b07_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNC0xMy0xLTEtMA_78cbe167-3b34-4ac9-b5c5-b7cc20fc4a44">192,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNC0xNS0xLTEtMA_6a8ab140-ebc0-4800-8e75-84891d30089e">1,252,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to Select Medical Holdings Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99b36c5b771943a6b90df106ee6a8bdb_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNS03LTEtMS0w_63981dfa-316d-4d5b-bb5a-f80cf61536fd">110,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae8baa77c8704ff2859751da1e6a993f_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNS0xMS0xLTEtMA_bf25313d-501c-4200-9482-86ed4bf07bd2">110,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNS0xNS0xLTEtMA_9864f513-53aa-463f-89e9-f6fbbaabe90d">110,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73ab481852c04d249b8c95efbb1484d3_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNi0xMy0xLTEtMA_9f10b20b-0807-4be3-a57e-18545a3cb690">17,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNi0xNS0xLTEtMA_7b4d7604-0b4d-4b0e-bfad-39e8a1aaa0cd">17,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3a7594d5c1e845f08d5c0cfb7e2dd9be_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNy0xLTEtMS0w_36359f78-5d1b-4e2e-8c45-448fa48e2f7d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7594d5c1e845f08d5c0cfb7e2dd9be_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNy0zLTEtMS0w_e40b847c-0ae1-4148-841e-4f82ba3200b0">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8442ecf8486d42759fe367c2de8b4c85_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNy01LTEtMS0w_4aca02d8-4392-4045-a56c-e3b0569d504d">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNy0xNS0xLTEtNTE5Mg_c34f2152-b483-43ff-9266-0d3228950adf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Forfeitures of unvested restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3a7594d5c1e845f08d5c0cfb7e2dd9be_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfOC0xLTEtMS0w_8513316b-e1ef-4090-9a49-b35b20b66b0b">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7594d5c1e845f08d5c0cfb7e2dd9be_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfOC0zLTEtMS0w_fe253e61-e6bf-4fc1-a348-97e848b0fc86">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8442ecf8486d42759fe367c2de8b4c85_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfOC01LTEtMS0w_2f6ce454-10e1-4467-8485-ed898a4fb251">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfOC0xNS0xLTEtNTE5Mg_77442032-0650-4eae-b966-514eb71b86ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vesting of restricted stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8442ecf8486d42759fe367c2de8b4c85_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfOS01LTEtMS0w_01b43042-2c2a-44f6-a51c-aff4685df8fd">6,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae8baa77c8704ff2859751da1e6a993f_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfOS0xMS0xLTEtMA_925e3ea7-9f5f-4948-a9eb-d96cb280c29f">6,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfOS0xNS0xLTEtMA_c087e882-b233-490c-8f97-c35e6aa5f18a">6,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-controlling interests acquired in business combination</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73ab481852c04d249b8c95efbb1484d3_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTItMTMtMS0xLTA_61a2396f-fdca-4300-81b0-673e91014f70">8,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTItMTUtMS0xLTA_7349425f-49c7-499d-aab5-eb7b89d24214">8,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions to and purchases of non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8442ecf8486d42759fe367c2de8b4c85_D20210101-20210331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTMtNS0xLTEtMA_ab456684-1356-41ce-a13c-7e1ba0de4bf1">787</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae8baa77c8704ff2859751da1e6a993f_D20210101-20210331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTMtMTEtMS0xLTA_ee5f5a32-a6c6-4512-8c53-234f3447e7cd">787</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73ab481852c04d249b8c95efbb1484d3_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTMtMTMtMS0xLTA_fe738154-5324-40eb-8fad-fdd46a7d62e0">13,458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTMtMTUtMS0xLTA_3682eb55-f700-42bb-a202-5770168e1e93">14,245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Redemption value adjustment on non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99b36c5b771943a6b90df106ee6a8bdb_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTQtNy0xLTEtMA_f76b124b-4cf6-4b3d-9989-c86b1bb09bc5">38,405</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae8baa77c8704ff2859751da1e6a993f_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTQtMTEtMS0xLTA_20789dc6-41a6-4a45-8d32-81c46af82177">38,405</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTQtMTUtMS0xLTA_21cf2633-82f6-4355-b7c4-911820e027b3">38,405</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c3a6aa3d9d463fb2244dc55d06fda9_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTUtOS0xLTEtMA_ce796ab0-a21e-4bf3-b74d-91806f595168">8,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae8baa77c8704ff2859751da1e6a993f_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTUtMTEtMS0xLTA_11f3278f-0cc1-4e9c-a9f0-761b6ccfd8d1">8,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTUtMTUtMS0xLTA_73c0fa9f-af86-4abb-b02a-453213d86d58">8,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8442ecf8486d42759fe367c2de8b4c85_D20210101-20210331" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTYtNS0xLTEtMA_545bb45e-0cac-4a38-9864-43de403a636a">178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99b36c5b771943a6b90df106ee6a8bdb_D20210101-20210331" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTYtNy0xLTEtMA_adeaa735-74f8-44cb-af88-ddbff4f8fee4">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae8baa77c8704ff2859751da1e6a993f_D20210101-20210331" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTYtMTEtMS0xLTA_357223cb-72c8-4ab9-9efc-aaac73979fd1">182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73ab481852c04d249b8c95efbb1484d3_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTYtMTMtMS0xLTA_b250aecd-2073-4d18-a859-929de074bba2">371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTYtMTUtMS0xLTA_8a9a6ebf-d16b-4075-91c0-7279f0afadad">189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4eaf841b3bc54e8887fcaab6cc4ba423_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTctMS0xLTEtMA_dfe4e488-c402-4e71-8c12-1fc3b082d403">134,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eaf841b3bc54e8887fcaab6cc4ba423_I20210331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTctMy0xLTEtMA_d437dccd-6505-4020-82ab-9b12edf44ced">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73199de2eb734a1aa6d9d339b39814ea_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTctNS0xLTEtMA_83ab60cc-a317-4962-a073-ae20b4226cb0">514,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic13effada5f24e1dad9e29d7a8d0c5fb_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTctNy0xLTEtMA_7610f863-7e97-4622-81a2-b7111e97fbd1">625,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a6dc4d8592426aab6aeb9d0584fc06_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTctOS0xLTEtMA_eb187a99-86e4-4f75-a6a9-5e79ce0297dd">6,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if551e4794f2b45c9a16a1f7ed95b3aae_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTctMTEtMS0xLTA_13f501e2-b750-4211-9c94-663242a66a0a">1,145,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb9ee276a38c43b39dc4a7f012322150_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTctMTMtMS0xLTA_2737d14f-392c-4b40-b394-f333f406d235">204,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia25336bcc81845369b7acc4ef55a0c51_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTctMTUtMS0xLTA_c4fa8e67-7887-46a6-9449-f893f29026b4">1,350,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to Select Medical Holdings Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16c67f9004aa4dfc83ced10a10230d97_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTgtNy0xLTEtMA_d6f527a8-aece-48d7-93f7-e62487572908">164,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89986053f5394ec4bd4e69b2d52aa4e5_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTgtMTEtMS0xLTA_3562516d-c57f-46f8-82db-d1beb3cb70d7">164,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTgtMTUtMS0xLTA_6d6f3ba4-4ae4-4470-b60e-b9067893d3e1">164,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fbafc1a282f4ad88e8b769cba297e21_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTktMTMtMS0xLTA_9a03c61e-d971-42a8-914e-41855858566e">13,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTktMTUtMS0xLTA_07812cb4-adde-4223-95c2-6783db891a4a">13,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared for common stockholders ($<ix:nonFraction unitRef="usdPerShare" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjAtMC0xLTEtOTQ0L3RleHRyZWdpb246ZjUyNjZhYWZjNjE5NDQzN2IyN2MzNDI3NmU1YjZiNGZfMjc0ODc3OTA2OTQ4Nw_54cb17a6-2b67-49e5-83c3-f32b3f2b2659">0.125</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16c67f9004aa4dfc83ced10a10230d97_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjAtNy0xLTEtOTI5_195ffcf2-739d-4cd7-ad5c-3d077776de1c">16,876</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89986053f5394ec4bd4e69b2d52aa4e5_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjAtMTEtMS0xLTc1NjQ_400fa24e-549e-41df-bb2f-84d66e8c749a">16,876</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjAtMTUtMS0xLTUxMjY_ccd4d844-ca0b-4565-9580-bdd430e83efd">16,876</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5cbdf661e9ee48f8a93652e5f73c501d_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjAtMS0xLTEtMA_9b1286ed-a83e-4b87-a9f1-9045ff360aa5">211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cbdf661e9ee48f8a93652e5f73c501d_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjAtMy0xLTEtMA_19081fc4-6e4b-4581-82dc-6849d9e7a3ef">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbb0e9e9121e4076a912834a8c0a2178_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjAtNS0xLTEtMA_ca9aad44-b9e4-4405-8ab5-168311e334b1">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjAtMTUtMS0xLTA_fb3efa73-8f1c-4208-9851-ba82b35462f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Forfeitures of unvested restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5cbdf661e9ee48f8a93652e5f73c501d_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjEtMS0xLTEtMA_6c2ee68f-99cc-49ee-9110-abe7b7f387a2">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cbdf661e9ee48f8a93652e5f73c501d_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjEtMy0xLTEtMA_9c17a40e-9b07-48b2-9b89-94100d435d4c">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbb0e9e9121e4076a912834a8c0a2178_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjEtNS0xLTEtMA_094acf88-010b-4075-8a65-32525d04dc36">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjEtMTUtMS0xLTA_e27f2b20-f7c0-47b1-a673-a81d2e60b64a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vesting of restricted stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbb0e9e9121e4076a912834a8c0a2178_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjItNS0xLTEtMA_b68fb5c9-49c5-4ec1-b6b2-a91c55694f5f">6,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89986053f5394ec4bd4e69b2d52aa4e5_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjItMTEtMS0xLTA_14eff136-0941-49ff-9c6a-be7efe5a1f5d">6,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjItMTUtMS0xLTA_74260dae-5368-4b89-ad24-53accb575f7f">6,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repurchase of common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5cbdf661e9ee48f8a93652e5f73c501d_D20210401-20210630" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjMtMS0xLTEtMA_123b4065-f56a-4dad-8d6b-ad1b73b335d0">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cbdf661e9ee48f8a93652e5f73c501d_D20210401-20210630" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjMtMy0xLTEtMA_fc27cdc7-8fdf-46dc-99f4-305892fd8a26">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbb0e9e9121e4076a912834a8c0a2178_D20210401-20210630" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjMtNS0xLTEtMA_b6e1ea49-e236-40fc-bf6e-78ff7f444309">707</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16c67f9004aa4dfc83ced10a10230d97_D20210401-20210630" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjMtNy0xLTEtMA_0160d493-6896-4e6e-a238-1635d3d6513d">903</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89986053f5394ec4bd4e69b2d52aa4e5_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjMtMTEtMS0xLTA_b0eaf59f-1294-4292-8e30-cc79f1e2acb5">1,610</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjMtMTUtMS0xLTA_74f86817-4c9d-42c8-b1d8-136857544653">1,610</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbb0e9e9121e4076a912834a8c0a2178_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjUtNS0xLTEtNTQ0OQ_a1f49c47-d0db-4af2-a4cb-8580c95e21cc">1,051</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89986053f5394ec4bd4e69b2d52aa4e5_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjUtMTEtMS0xLTc1NjE_16d742f8-ccb7-4dc6-ad24-4d74f4b35278">1,051</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fbafc1a282f4ad88e8b769cba297e21_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjQtMTMtMS0xLTA_9baed192-1c07-41ef-bc8e-4f4ce375ffe0">6,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjQtMTUtMS0xLTA_0a2fdd8c-05e0-4db6-95fc-20fe597935d7">5,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions to and purchases of non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbb0e9e9121e4076a912834a8c0a2178_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjUtNS0xLTEtMA_00d2f68a-f3aa-4088-89ef-1eca92c7c17a">2,970</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89986053f5394ec4bd4e69b2d52aa4e5_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjUtMTEtMS0xLTA_7b6dd211-0e6f-4e55-80fc-2a2e8de252ea">2,970</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fbafc1a282f4ad88e8b769cba297e21_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjUtMTMtMS0xLTA_144df745-f67b-4956-8003-bc6798f15ba0">9,324</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjUtMTUtMS0xLTA_743f8c60-4c2b-43eb-adb1-54924dc53c02">12,294</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Redemption value adjustment on non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16c67f9004aa4dfc83ced10a10230d97_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjYtNy0xLTEtMA_6bce18cf-7cce-40f8-b8a3-a2fe8556fc44">59,370</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89986053f5394ec4bd4e69b2d52aa4e5_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjYtMTEtMS0xLTA_b0277a2c-d012-40dc-ba0f-8a76ca9432fd">59,370</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjYtMTUtMS0xLTA_b8c4ab59-fc13-4cb7-abdf-7e3631e752e5">59,370</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i878a9c337abc406cbfa8912be660cfd9_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjgtOS0xLTEtMTA2MQ_91fccdba-4d66-4269-a5b3-e96e1ed95995">1,397</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89986053f5394ec4bd4e69b2d52aa4e5_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjgtMTEtMS0xLTc1Njg_9de42a06-7e9c-44fc-8682-47d9b3ffb358">1,397</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjgtMTUtMS0xLTU0MDk_ec2de41e-7568-49a3-87e1-f25cf11245be">1,397</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ifbb0e9e9121e4076a912834a8c0a2178_D20210401-20210630" sign="-" xsi:nil="true" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjctNS0xLTEtMA_202967fb-5ce3-4040-ab05-33b1886d66e7"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16c67f9004aa4dfc83ced10a10230d97_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjctNy0xLTEtMA_db5f5847-0608-4b03-ab12-dc5f50848f87">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89986053f5394ec4bd4e69b2d52aa4e5_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjctMTEtMS0xLTA_d2e058f1-a5a6-44e7-afe2-68b50b93482f">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fbafc1a282f4ad88e8b769cba297e21_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjctMTMtMS0xLTA_c0f61900-e972-4f41-b0a6-58f178324875">370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjctMTUtMS0xLTA_e0692a31-4675-4f34-8aed-58514ae03b2b">435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d78995f73114fd9a07a5844ce1ebb86_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjgtMS0xLTEtMA_7bbc0a63-1dd6-46df-8430-ab658d540274">135,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d78995f73114fd9a07a5844ce1ebb86_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjgtMy0xLTEtMA_43770855-d77f-43ca-9624-60b21836fecf">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia507842de06c463cab8ad4f320a68bc7_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjgtNS0xLTEtMA_d63b6375-be2d-45cc-ab95-87758a1544b9">516,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06ac0cf032dc44e1baa12c616a1ab18f_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjgtNy0xLTEtMA_12da5081-163b-40ad-ac41-4161c35fff1c">713,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29a8b026887f4d80b776c2643d660e67_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMzAtOS0xLTEtNTE2NQ_62de3439-8d62-4344-8f93-ccff4861ad7a">4,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c472725691f4294afa81232749b2c38_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjgtMTEtMS0xLTA_606f675e-79e9-4935-a3a1-44d837d8de8d">1,234,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748a28affcd7487d875035c464368d05_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjgtMTMtMS0xLTA_10286cae-f8bb-43e5-8f63-9e7f89824421">215,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjgtMTUtMS0xLTA_06415e33-b7c0-40b6-bf14-a8be8b12af95">1,449,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">For the Six Months Ended June 30, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock<br/>Issued</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common<br/>Stock<br/>Par&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Capital in<br/>Excess<br/>of&#160;Par</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6c17c8cd7cac4115a14753f94ab8ab6c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNC0xLTEtMS0w_66d67462-0085-4499-8b81-52cd96919277">134,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c17c8cd7cac4115a14753f94ab8ab6c_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNC0zLTEtMS0w_89e7dab7-3149-4316-9444-e497f6162886">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i452ed919b2244df887431ff7b2c2d508_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNC01LTEtMS0w_ce41be6f-cb05-493f-93ca-100c4405729c">491,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f1d1941a2d54dd682218923f73f78e5_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNC03LTEtMS0w_34a234ac-e420-4831-b959-d24430c8cfa8">279,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3996149e08774457b7cf81521fc7a46f_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNC05LTEtMS0w_702c5520-306f-4abc-a31f-03b216a54a70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e001ee24b8d4e398bb154b6b74d75a6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNC0xMS0xLTEtMA_35d6b1f5-954d-445e-9781-f0ab10464579">770,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80fc7da8ac2f44c1a89ba81702a6efef_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNC0xMy0xLTEtMA_c3a94acd-df1f-42f4-915e-d50d5aa53989">158,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fcf10033def4edc8873b5e817d0b994_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNC0xNS0xLTEtMA_0197b41b-157b-4950-879a-635d251d5114">929,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to Select Medical Holdings Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98dbdae0901944a8bb7a4850bf5db8e1_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNS03LTEtMS0w_69bfa152-80e8-4f8d-8abd-0c437b532922">53,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d382e1e08d4eb1ba65b7ff2dc29af0_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNS0xMS0xLTEtMA_73f21d05-ae89-49ee-8e16-d90e0661f597">53,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNS0xNS0xLTEtMA_48eb8921-a7a0-4bc4-ab8b-955f8cea0d45">53,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc6557fef505437581efa07d7b365cb0_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNi0xMy0xLTEtMA_b979f4f3-12c1-410f-9460-78f3d890fe0f">10,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNi0xNS0xLTEtMA_9caa9470-88b5-4466-90a4-a649583b0a00">10,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f9c8016c7f342c79de1144a230d1612_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNy0xLTEtMS0w_fe621cbf-9ba0-4737-aca8-ad29b19a65c5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f9c8016c7f342c79de1144a230d1612_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNy0zLTEtMS0w_e77ab3d4-db5b-4e54-ada1-2d264728beda">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i757df6705cb74d08b9e53d576ac2c1f7_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNy01LTEtMS0w_ab87182e-f235-438d-92d7-a48dc20ecb38">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNy0xNS0xLTEtMA_73022523-eed7-475d-990e-5a1ada07fa79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Forfeitures of unvested restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0f9c8016c7f342c79de1144a230d1612_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfOC0xLTEtMS0w_d8d536a8-99bf-49a9-99e5-726c9f10a039">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f9c8016c7f342c79de1144a230d1612_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfOC0zLTEtMS0w_53375d6b-7aa9-4e63-b644-f9b0521c625d">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i757df6705cb74d08b9e53d576ac2c1f7_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfOC01LTEtMS0w_86dba23b-ca92-4ee0-9d15-0bc82c678940">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfOC0xNS0xLTEtMA_ff46cc4a-5295-4c51-827b-1347b0813498">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vesting of restricted stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i757df6705cb74d08b9e53d576ac2c1f7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfOS01LTEtMS0w_e9d198cc-8cf2-4209-bea4-98f86a75786c">6,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d382e1e08d4eb1ba65b7ff2dc29af0_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfOS0xMS0xLTEtMA_fc53e458-fcb4-4f15-b881-03b5c82e288d">6,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfOS0xNS0xLTEtMA_07ff4b49-4119-48fc-88db-4eb709a03075">6,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repurchase of common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0f9c8016c7f342c79de1144a230d1612_D20200101-20200331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTAtMS0xLTEtMA_80360559-117b-4c87-b53c-be3e13e7024d">492</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f9c8016c7f342c79de1144a230d1612_D20200101-20200331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTAtMy0xLTEtMA_2efd8a4f-c082-4b30-a9e5-3153284429eb">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i757df6705cb74d08b9e53d576ac2c1f7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTAtNS0xLTEtMA_bef1f9a6-3c09-454c-847e-75d7aba94004">5,350</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98dbdae0901944a8bb7a4850bf5db8e1_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTAtNy0xLTEtMA_74704757-554b-4fcf-ac22-934c177b832e">3,341</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4d382e1e08d4eb1ba65b7ff2dc29af0_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTAtMTEtMS0xLTA_e5ef7971-63d4-4c11-b563-933584fc4bbd">8,691</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTAtMTUtMS0xLTA_1f6aeff7-a686-45f9-b5cb-d300b0ac1233">8,691</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc6557fef505437581efa07d7b365cb0_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTEtMTMtMS0xLTA_9dd0fb00-d685-4882-9840-6d6e7271509d">1,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTEtMTUtMS0xLTA_19cc7e7f-b67a-4d97-965d-aa4677236f53">1,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions to and purchases of non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98dbdae0901944a8bb7a4850bf5db8e1_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTItNy0xLTEtMA_08e4a2d3-8869-4c35-96ef-657c07693cc9">2,726</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4d382e1e08d4eb1ba65b7ff2dc29af0_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTItMTEtMS0xLTA_d0342d53-f533-47bc-a0a8-700b905d927a">2,726</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc6557fef505437581efa07d7b365cb0_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTItMTMtMS0xLTA_bfdaf31a-410a-4244-b4fc-a9d96ef57753">4,048</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTItMTUtMS0xLTA_c4db6783-b7a1-41ee-9216-0b85a52b12c4">6,774</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Redemption value adjustment on non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98dbdae0901944a8bb7a4850bf5db8e1_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTMtNy0xLTEtMA_ae62e29f-1a2c-4876-9453-f77e5c4904a6">10,123</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4d382e1e08d4eb1ba65b7ff2dc29af0_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTMtMTEtMS0xLTA_b0ab224d-d5c2-401f-8d38-b282079f81ae">10,123</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTMtMTUtMS0xLTA_c990771f-e83a-404b-9872-910a603e91b7">10,123</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98dbdae0901944a8bb7a4850bf5db8e1_D20200101-20200331" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTQtNy0xLTEtMA_af910dde-d4f7-42c0-b651-d5aecb1bea60">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4d382e1e08d4eb1ba65b7ff2dc29af0_D20200101-20200331" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTQtMTEtMS0xLTA_bb7bac23-0816-4fb5-a152-06dd6ebfc4b7">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc6557fef505437581efa07d7b365cb0_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTQtMTMtMS0xLTA_3e066c7d-5eb5-42ea-b88f-048f315e72b3">420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTQtMTUtMS0xLTA_0268b5ea-737a-4347-8d40-b8419a1a3476">365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i07ef9561e63c46ecbfdf268105880ec9_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTUtMS0xLTEtMA_17d6806c-8dd5-4ad0-8fc5-48d903b2e9a2">133,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07ef9561e63c46ecbfdf268105880ec9_I20200331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTUtMy0xLTEtMA_fd3f7922-3f31-4db0-b969-b173876f01e7">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab6f6ed4c5c40c785bf0ec5a56f7a7f_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTUtNS0xLTEtMA_0fa07383-8312-4cd1-beec-10d3990e0a5d">491,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8979c36c27b948e7a75318aa470eb1c5_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTUtNy0xLTEtMA_b66279a2-7559-47e2-94f1-175c247e2cec">316,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b4a592cf00044548cc38f91879e81fa_I20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTUtOS0xLTEtMA_5a69696b-608d-4e09-a691-cd6e86839b3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e12f979c9064796bbcd7735451cbf07_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTUtMTEtMS0xLTA_e1dc52ea-9a6b-4a82-a2ea-ebbf91ec60bb">808,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228ce0ec788848459a6778243cdfe2f9_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTUtMTMtMS0xLTA_2bdccd42-0558-4234-8254-2dc01f83558f">166,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfaaf0f42d9042e7b77d153a10a8eeb5_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTUtMTUtMS0xLTA_cdf591dd-5f1a-42e5-a36e-967600199a45">974,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to Select Medical Holdings Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if41275a882144f35838503cdd9e3b9d8_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTYtNy0xLTEtMA_48efd554-ea94-430b-86dc-2762408058ec">51,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i072109b8da604643af13c0729800e1df_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTYtMTEtMS0xLTA_764a7ffa-b1b6-46bd-9f2c-18b5b095ad22">51,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTYtMTUtMS0xLTA_72a16338-1707-47a2-ba71-5a64a2d74d54">51,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6fcb443a0464cef95544365b85db50b_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTctMTMtMS0xLTA_2c30f6c1-1a2e-4120-acd8-a92ffea3ec8f">12,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTctMTUtMS0xLTA_2ffa6099-673b-4b18-976d-7eda442cc478">12,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i55f4763f21f4479ba3089c7486346215_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTgtMS0xLTEtMA_77914127-b6e1-43b0-ab1e-99f3e7a151d7">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55f4763f21f4479ba3089c7486346215_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTgtMy0xLTEtMA_3a5f502c-4689-4310-81be-b7b0395632ba">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150a45bd54dd4d4fa4ee7374f6bc72d3_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTgtNS0xLTEtMA_200cd2f0-ef8d-4737-9120-9edf48052d34">0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTgtMTUtMS0xLTA_ae0cb0b5-d77a-405a-bb0e-819b7bb3e1f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Forfeitures of unvested restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i55f4763f21f4479ba3089c7486346215_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTktMS0xLTEtMA_48e7812a-b18d-46af-ab89-ccb30d41c904">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55f4763f21f4479ba3089c7486346215_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTktMy0xLTEtMA_b2d4129e-9e18-4c8e-b016-304d739c9c1b">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150a45bd54dd4d4fa4ee7374f6bc72d3_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTktNS0xLTEtMA_1a3b53cc-6705-4bfd-955f-e87929ce843e">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTktMTUtMS0xLTA_1f2168f2-b0d1-4a58-9f5c-64042aaa939c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vesting of restricted stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150a45bd54dd4d4fa4ee7374f6bc72d3_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjAtNS0xLTEtMA_c2c6d202-1551-486f-9eef-e533c806e8b1">6,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i072109b8da604643af13c0729800e1df_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjAtMTEtMS0xLTA_5d073b2e-6f78-4ec6-b146-b2248d6b17f4">6,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjAtMTUtMS0xLTA_1fa04255-3c30-4fc1-b561-77f941e3f9e4">6,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repurchase of common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i55f4763f21f4479ba3089c7486346215_D20200401-20200630" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjEtMS0xLTEtMA_f9bec19f-d33c-4b5e-a8fa-a9a8c720ab5b">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55f4763f21f4479ba3089c7486346215_D20200401-20200630" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjEtMy0xLTEtMA_c31c79ae-fb2d-430e-a5e7-cd66f4a4a6c5">0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i150a45bd54dd4d4fa4ee7374f6bc72d3_D20200401-20200630" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjEtNS0xLTEtMA_0295ec95-15c1-422d-badc-32134eeb5171">441</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if41275a882144f35838503cdd9e3b9d8_D20200401-20200630" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjEtNy0xLTEtMA_66d90ef0-067f-4fef-a280-5537fecbadc8">283</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i072109b8da604643af13c0729800e1df_D20200401-20200630" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjEtMTEtMS0xLTA_5d3c4902-e6d3-400a-980f-5a7283454dff">724</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjEtMTUtMS0xLTA_f03ac2a6-e392-45dd-a210-1eb138a129c6">724</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i150a45bd54dd4d4fa4ee7374f6bc72d3_D20200401-20200630" xsi:nil="true" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjMtNS0xLTEtMA_1ad6c666-9d05-423a-af7e-9bbb1327bc89"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i072109b8da604643af13c0729800e1df_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjMtMTEtMS0xLTA_0723d702-9576-46f7-9ec4-fae76dfe5993">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6fcb443a0464cef95544365b85db50b_D20200401-20200630" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjMtMTMtMS0xLTA_55960f22-bfb0-4aa4-bce5-fe9e22956583">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjMtMTUtMS0xLTA_0fa3935f-f0f5-4bc0-82ee-bf4f31ca5ec9">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions to and purchases of non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i150a45bd54dd4d4fa4ee7374f6bc72d3_D20200401-20200630" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjQtNS0xLTEtMA_3549db3b-e537-4143-b4c3-036d9257e38b">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i072109b8da604643af13c0729800e1df_D20200401-20200630" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjQtMTEtMS0xLTA_ac7fcf4a-f41e-4469-a68b-369596bad99e">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6fcb443a0464cef95544365b85db50b_D20200401-20200630" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjQtMTMtMS0xLTA_bd09e230-a1d6-4c3a-9bb5-8516ee0ace00">418</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjQtMTUtMS0xLTA_21753c58-c684-40a8-89a3-8bda785d2cd7">483</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Redemption value adjustment on non-controlling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if41275a882144f35838503cdd9e3b9d8_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjUtNy0xLTEtMA_19a2de3c-e7b6-4730-8644-619ea8129e13">127,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i072109b8da604643af13c0729800e1df_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjUtMTEtMS0xLTA_e9e4c0ac-2fb4-4469-8a46-3cae3b42b081">127,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjUtMTUtMS0xLTA_b1b6e042-82b8-4d20-85f6-22c897ca3228">127,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i150a45bd54dd4d4fa4ee7374f6bc72d3_D20200401-20200630" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjYtNS0xLTEtMA_3d76140d-f77b-4775-9aed-da81d3d1cc20">795</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if41275a882144f35838503cdd9e3b9d8_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjYtNy0xLTEtMA_98da3d36-46e5-4e81-a92f-973496f4b211">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i072109b8da604643af13c0729800e1df_D20200401-20200630" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjYtMTEtMS0xLTA_ab5ffc7e-8b78-49b9-a35a-3c7b85c5ddb5">794</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6fcb443a0464cef95544365b85db50b_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjYtMTMtMS0xLTA_849919e3-76e4-429d-a05e-7eb15a024aad">1,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjYtMTUtMS0xLTA_557e10c3-986e-4d0c-80b5-efd49e67235c">411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ca9e03469c34d19aa6464835674249e_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjctMS0xLTEtMA_23eca9e8-770c-43e9-994e-210cbf548dbb">133,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ca9e03469c34d19aa6464835674249e_I20200630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjctMy0xLTEtMA_25edb57a-9070-409e-8db8-23afaf942ba5">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2386c06e6394e9192e485e15d848c39_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjctNS0xLTEtMA_6e72349b-184c-48d4-8a05-eb0c19c4f026">496,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i966afdef72fe4d53ac2ff6217e8e9793_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjctNy0xLTEtMA_42f78a9d-54aa-43cf-98bf-b441cd39918d">495,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c7dc108fdc4209adb112435c46e453_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjctOS0xLTEtNTE5NA_6ffdb529-8ffb-4c99-b9ec-cf9bc7928253">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic33ba2829aad4672a382563462592dcf_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjctMTEtMS0xLTA_27c26280-b24d-457c-b84c-832d62d1b88f">992,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i139e861ba4e7472982269ee17ca2c68b_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjctMTMtMS0xLTA_dcaca6a0-eaab-45a4-941a-9c7d58f9abbf">179,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2126fcb95b794e1d9f9873202b50af46_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjctMTUtMS0xLTA_00def69b-271d-457f-878a-3db7ebee6d30">1,172,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Select Medical Holdings Corporation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(unaudited) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:58.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.574%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">For the Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMy0xLTEtMS0w_5ca0d6f5-3e6a-4087-b027-8a9aaad0b091">137,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMy0zLTEtMS0w_7725064e-45de-42a7-91fb-584354ab8933">333,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions from unconsolidated subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNS0xLTEtMS0w_9eeabab6-a522-4f58-80ee-9ab220a03129">11,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNS0zLTEtMS0w_827fd25b-2a0c-4aaa-8eb6-f02dc5158bbb">19,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNi0xLTEtMS0w_b3e9151e-51a3-4a8a-a5a4-dbf6f2a4e25d">104,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNi0zLTEtMS0w_9cc4097f-1b45-4be9-908f-e2aa11aa2180">100,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for expected credit losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNy0xLTEtMS0w_5f1c81be-0d13-4d78-9d0a-5523fd4e49db">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNy0zLTEtMS0w_8ca77750-5de5-4d97-a8eb-2b4f73252e1e">212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfOC0xLTEtMS0w_88d4efcc-9bf2-47ef-9b80-3f369c1ac419">10,912</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfOC0zLTEtMS0w_a4c8554f-70ef-4c6a-a280-dc05eb6b80f7">21,728</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss (gain) on sale or disposal of assets and businesses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTAtMS0xLTEtMA_47fd2d54-f77e-4c63-aeeb-ee2eff319a0d">7,881</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTAtMy0xLTEtMA_155a39db-de03-4f1d-bd1d-b7e4a37f4de3">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTEtMS0xLTEtMA_297ae879-a497-4973-9274-1e0a402133e3">13,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTEtMy0xLTEtMA_4cf50f6c-8261-49cc-a13b-09a587b70fa8">13,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of debt discount, premium and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTItMS0xLTEtMA_4e57b306-075b-4987-aa90-9ee90d61b76e">1,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTItMy0xLTEtMA_0d3a872c-6aaf-4288-976e-8e8aca7e97ef">1,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTMtMS0xLTEtMA_ee452e6d-ea6c-4c26-81dc-e0eedeaa21a7">3,416</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTMtMy0xLTEtMA_1aa17f9e-6ce2-455d-9e9f-c61e1ed83274">8,323</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of effects of business combinations:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTUtMS0xLTEtMA_c66153d4-f0a7-45d5-9a4b-52d22f835b5b">13,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTUtMy0xLTEtMA_7de9544b-f519-45b2-ab8f-23a5e247954d">31,751</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTYtMS0xLTEtMA_87f995ce-afc5-4713-98f9-ba537c4d737d">713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTYtMy0xLTEtMA_30c9f474-ddd7-4373-bad6-887f8d97fc2e">12,856</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTctMS0xLTEtMA_1e442230-60e7-4cb3-b898-4389d4b42035">11,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTctMy0xLTEtMA_7d9cc051-0334-4ff5-90a6-4be6f441d8e9">11,984</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTgtMS0xLTEtMA_f35691c9-b0cc-4268-9b15-a5a74edd0974">4,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTgtMy0xLTEtMA_7f501873-22fe-4819-b0c0-10b73160daeb">18,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTktMS0xLTEtMA_f0688cb7-a1ed-4900-96fe-7361a1e6a5f0">4,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTktMy0xLTEtMA_72110424-129b-43bf-b763-35b217500e7c">71,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Government advances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjAtMS0xLTEtMA_df6d1391-0591-480c-83c5-1f3930161984">316,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="sem:ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjAtMy0xLTEtMA_d25f2d68-768c-4536-8785-cd0ae2b258f9">73,703</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unearned government assistance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjEtMS0xLTEtMA_de73483e-b44e-4023-b3ed-eb55b3f64da4">45,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="sem:IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjEtMy0xLTEtMA_9dbcfed8-fba7-4498-828c-217c84af978b">78,509</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjMtMS0xLTEtMA_1615c9e4-57ab-4bb2-b46e-b5b7bf645c2a">43,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjMtMy0xLTEtMA_bd9a7116-16df-4ed9-8966-d05b746a6909">42,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjQtMS0xLTEtMA_4bea3c0a-ff8a-47dd-bae1-faec12e61ea2">686,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjQtMy0xLTEtMA_26350be0-64e3-43b0-a2e4-1b871db08ffd">363,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Business combinations, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjYtMS0xLTEtMA_a613c4f8-6d8b-45f0-9f35-52e9c1562552">6,961</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjYtMy0xLTEtMA_1436d724-7c7d-4dff-8032-f4c01f5c5508">10,081</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjctMS0xLTEtMA_e45aec73-77c1-46a4-b653-d47cf282b492">71,253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjctMy0xLTEtMA_2e701706-4d83-480c-9965-b4161c86dfc7">76,442</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in businesses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjgtMS0xLTEtMA_a7255fa4-109c-4e75-b404-8f4e9d5298c8">14,749</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjgtMy0xLTEtMA_26653562-d7f6-49f6-a044-82e67d8757e3">11,185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of assets and businesses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjktMS0xLTEtMA_bea19d7e-b1f0-4d30-b702-ab4a9c705140">12,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjktMy0xLTEtMA_2ea8a3c1-a87c-49b1-8086-060187dbbb1a">9,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMzAtMS0xLTEtMA_fe6303b5-324f-44fb-803b-18cf4edb9cf6">80,562</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMzAtMy0xLTEtMA_a40ff8cd-e32d-453f-8e0e-2cc4f27b4553">88,245</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Borrowings on revolving facilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMzItMS0xLTEtMA_533a9912-aab6-44f3-88fb-1319ba578193">470,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMzItMy0xLTEtMA_801e72fd-9cd0-47dc-b8cc-a029462c5fa3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on revolving facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMzMtMS0xLTEtMA_37f0acd9-1e77-4e7a-80a5-47a60d17cf8e">470,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMzMtMy0xLTEtMA_509278e9-5b0d-4774-95ff-1d078d263c61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on term loans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMzUtMS0xLTEtMA_541c178c-4ab6-4eb4-888b-735313f094b9">39,843</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RepaymentsOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMzUtMy0xLTEtMA_38b22bff-2413-4626-9d59-871486fd59ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Borrowings of other debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromOtherDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMzktMS0xLTEtMA_2c6adbb4-abfb-4af5-bd5f-d68f7d55902c">31,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromOtherDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMzktMy0xLTEtMA_241c823f-e43d-4ba0-9b7c-72b00f9692ed">8,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Principal payments on other debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDAtMS0xLTEtMA_1121305a-5819-4cc1-9d06-6ecbc4d027f2">35,733</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDAtMy0xLTEtMA_655f4e53-7e27-4480-840e-a1d5500e95b8">15,314</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends paid to common stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsOfDividendsCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDEtMS0xLTEtOTU0_6fc9ec72-5047-435e-a11b-c6ffa649b02a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividendsCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDEtMy0xLTEtOTU0_592fba68-3bdf-4db6-b751-8adbbefb53d8">16,876</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDEtMS0xLTEtMA_e93ed33c-2192-49b5-8ca0-667c4788a4e1">9,415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDEtMy0xLTEtMA_0a10ddf9-1108-4b91-bfcb-507f3c1169dc">1,610</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDQtMS0xLTEtMA_292f8240-6ae6-4e64-b817-4eff6887d12c">1,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDQtMy0xLTEtMA_f42457d2-6a5c-4c4d-9e4f-079912825031">5,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to and purchases of non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDUtMS0xLTEtMA_7ae698a8-a219-4d56-9231-29bc75f951d5">13,660</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDUtMy0xLTEtMA_c972df5f-6a4a-41c3-97f4-5b17ad47254e">29,152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of membership interests of Concentra Group Holdings Parent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDYtMS0xLTEtMA_5c03a286-79fc-4b57-866f-7bf2aa19241f">366,203</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDYtMy0xLTEtMA_fe21dc67-b324-494f-b46c-3eb7d8347a94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDctMS0xLTEtMA_ca9c7e12-cc06-49f5-a6d7-2ce4fd7cdbf0">431,681</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDctMy0xLTEtMA_c3594d61-9b3e-40af-a045-f367bfa4347a">48,349</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDgtMS0xLTEtMA_84a1fa77-1e3d-415c-8536-a07334b60ff3">173,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDgtMy0xLTEtMA_9a8e714c-d29a-49d6-aac5-23b757f5f34a">226,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fcf10033def4edc8873b5e817d0b994_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDktMS0xLTEtMA_e3306c2b-7b20-4409-a1ec-1e31ccb0a9c0">335,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDktMy0xLTEtMA_686ace5b-b9c5-4bd1-a833-aed50d8788d2">577,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2126fcb95b794e1d9f9873202b50af46_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNTAtMS0xLTEtMA_400fe19b-72cb-42bb-bdbd-6edc32ac9840">509,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNTAtMy0xLTEtMA_78c57c3f-e308-4604-910f-6e958b022027">803,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental Information</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNTItMS0xLTEtMA_af3c55f2-f103-4388-ad9a-0ca8c1ca09b0">86,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNTItMy0xLTEtMA_c9d94ced-30ae-4ce6-bf66-1006219516b3">66,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNTMtMS0xLTEtMA_bea3743a-c384-42e5-ba09-2271d82fdee7">4,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNTMtMy0xLTEtMA_7028ec1c-7ec9-47f0-a1a4-8edb7887c171">76,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SELECT MEDICAL HOLDINGS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</span></div><div><span><br/></span></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_37"></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zNy9mcmFnOmU5ZjIzNGY3ZTdmNjRjN2RiY2I4ZDAwMmNmZmM3MzA3L3RleHRyZWdpb246ZTlmMjM0ZjdlN2Y2NGM3ZGJjYjhkMDAyY2ZmYzczMDdfMTgxNA_9b32b194-1494-4ff3-88d2-344e164b7383" continuedAt="i6200c6d8c3c04fe289a5b5f3580b3f3b" escape="true">Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="i6200c6d8c3c04fe289a5b5f3580b3f3b"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements of Select Medical Holdings Corporation (&#8220;Holdings&#8221;) include the accounts of its wholly owned subsidiary, Select Medical Corporation (&#8220;Select&#8221;). Holdings conducts substantially all of its business through Select and its subsidiaries. Holdings and Select and its subsidiaries are collectively referred to as the &#8220;Company.&#8221; The unaudited condensed consolidated financial statements of the Company as of June&#160;30, 2021, and for the three and six month periods ended June&#160;30, 2020 and 2021, have been prepared pursuant to the rules&#160;and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;) for interim reporting and the accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). Accordingly, certain information and disclosures required by GAAP, which are normally included in the notes to the consolidated financial statements, have been condensed or omitted pursuant to those rules&#160;and regulations, although the Company believes the disclosure is adequate to make the information presented not misleading. In the opinion of management, such information contains all adjustments, which are normal and recurring in nature, necessary for a fair statement of the financial position, results of operations and cash flow for such periods. All significant intercompany transactions and balances have been eliminated.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three and six months ended June&#160;30, 2021, are not necessarily indicative of the results to be expected for the full fiscal year ending December&#160;31, 2021. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December&#160;31, 2020, contained in the Company&#8217;s Annual Report on Form&#160;10-K filed with the SEC on February 25, 2021.</span></div></ix:continuation><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_40"></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80MC9mcmFnOmU2YzFlYmE4MDAzZDQyZTNiNDY5ZmViYWJjMmVmYjI0L3RleHRyZWdpb246ZTZjMWViYTgwMDNkNDJlM2I0NjlmZWJhYmMyZWZiMjRfMjkz_aafc19af-54b0-47d8-8841-7c5c450797d0" continuedAt="i007c5306f9184cc09131040bb310ef65" escape="true">Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i007c5306f9184cc09131040bb310ef65" continuedAt="i29d0f8f74ee844a4b3a96b11779e27e6"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80MC9mcmFnOmU2YzFlYmE4MDAzZDQyZTNiNDY5ZmViYWJjMmVmYjI0L3RleHRyZWdpb246ZTZjMWViYTgwMDNkNDJlM2I0NjlmZWJhYmMyZWZiMjRfMjk0_191e4c0a-c0ec-4ffa-b2a4-562a6fa53b40" escape="true"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Actual results could differ from those estimates.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80MC9mcmFnOmU2YzFlYmE4MDAzZDQyZTNiNDY5ZmViYWJjMmVmYjI0L3RleHRyZWdpb246ZTZjMWViYTgwMDNkNDJlM2I0NjlmZWJhYmMyZWZiMjRfNjU5NzA2OTc2OTEwNA_aea74f1e-6c09-4182-874d-d6373188eb89" continuedAt="iedb1f193e96f4298b20a4d88dd3ed919" escape="true"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Instruments and Contracts on an Entity&#8217;s Own Equity</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ASU simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. As part of this update, convertible instruments are to be included in diluted earnings per share using the if-converted method, rather than the treasury stock method. Further, contracts which can be settled in cash or shares, excluding liability-classified share-based payment awards, are to be included in diluted earnings per share on an if-converted basis if the effect is dilutive, regardless of whether the entity or the counterparty can choose between cash and share settlement. The share-settlement presumption may not be rebutted based on past experience or a stated policy. This pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2021. The Company plans to adopt this pronouncement as of January 1, 2022. The use of either the modified retrospective or fully retrospective method of transition is permitted.</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i29d0f8f74ee844a4b3a96b11779e27e6"><ix:continuation id="iedb1f193e96f4298b20a4d88dd3ed919">Under the terms of the Amended and Restated Limited Liability Company Agreement of Concentra Group Holdings Parent, certain members of Concentra Group Holdings Parent have put rights that obligate the Company to purchase certain of such members&#8217; equity interests in Concentra Group Holdings Parent when exercised. The Company can elect to pay the purchase price for those equity interests in cash or in shares of Holdings&#8217; common stock. Under ASU 2020-06, the Company is no longer able to rebut the share-settlement presumption based on its past experience. Accordingly, if any of the put rights provided for under the Amended and Restated Limited Liability Company Agreement of Concentra Group Holdings Parent are outstanding upon adoption of ASU 2020-06, the shares which are potentially issuable will be included in diluted earnings per share, on an if-converted basis. At this time, the Company cannot reasonably estimate the impact that the adoption of ASU 2020-06 will have on its financial statements.</ix:continuation></ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80My9mcmFnOjBiNzg2ZTBlNjgzNjQ0M2I5NDFhOGI0MDVmMDhmMzQxL3RleHRyZWdpb246MGI3ODZlMGU2ODM2NDQzYjk0MWE4YjQwNWYwOGYzNDFfNzk2_a8166d89-6460-444d-8d77-355a3ae7b6dc" continuedAt="ia773edc96e9549888a2220b89d9a7b27" escape="true"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80My9mcmFnOjBiNzg2ZTBlNjgzNjQ0M2I5NDFhOGI0MDVmMDhmMzQxL3RleHRyZWdpb246MGI3ODZlMGU2ODM2NDQzYjk0MWE4YjQwNWYwOGYzNDFfNzk3_f3eb7a88-7cef-4b72-8d77-af3e6f206b82" continuedAt="i3e6a1d1162cd448bb34790ccc545c5b2" escape="true">Credit Risk Concentrations</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i3e6a1d1162cd448bb34790ccc545c5b2"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia773edc96e9549888a2220b89d9a7b27" continuedAt="ib02292e551f74d1aad6b4f8f375bb422">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash balances and accounts receivable. The Company&#8217;s excess cash is held with large financial institutions. The Company grants unsecured credit to its patients, most of whom reside in the service area of the Company&#8217;s facilities and are insured under third-party payor agreements.</ix:continuation></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib02292e551f74d1aad6b4f8f375bb422">Because of the diversity in the Company&#8217;s non-governmental third-party payor base, as well as their geographic dispersion, accounts receivable due from the Medicare program represent the Company&#8217;s only significant concentration of credit risk.</ix:continuation> Approximately <ix:nonFraction unitRef="number" contextRef="i54986ecc7fc44b8686d9e92cd152643d_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80My9mcmFnOjBiNzg2ZTBlNjgzNjQ0M2I5NDFhOGI0MDVmMDhmMzQxL3RleHRyZWdpb246MGI3ODZlMGU2ODM2NDQzYjk0MWE4YjQwNWYwOGYzNDFfNjg4_96a9387f-5cdc-4dd0-9ad8-59de5b7b6d16">18</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i6cd99a1029914dfba302e3c8d1747dc9_D20210101-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80My9mcmFnOjBiNzg2ZTBlNjgzNjQ0M2I5NDFhOGI0MDVmMDhmMzQxL3RleHRyZWdpb246MGI3ODZlMGU2ODM2NDQzYjk0MWE4YjQwNWYwOGYzNDFfNjk1_4ce48ccb-663f-42b9-902c-948c780700f9">15</ix:nonFraction>% of the Company&#8217;s accounts receivable is due from Medicare at December&#160;31, 2020, and June&#160;30, 2021, respectively.</span></div></ix:continuation><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_46"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RleHRyZWdpb246YmUzYTdmZTlkNTVhNGExZWJmNThjZDMxMGIxMWMxZDRfOTky_78ca6e07-7149-49f0-b6ce-b2ee561c829d" continuedAt="i47fd2d3013b64639af38909f1e6dc58c" escape="true"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:MinorityInterestDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RleHRyZWdpb246YmUzYTdmZTlkNTVhNGExZWJmNThjZDMxMGIxMWMxZDRfOTk1_85d093b8-67ce-472a-a9e3-2533ffaaccc7" continuedAt="i3de746a49e9040b0bb84a892258edcf2" escape="true">Redeemable Non-Controlling Interests</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i3de746a49e9040b0bb84a892258edcf2"><ix:continuation id="i47fd2d3013b64639af38909f1e6dc58c"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ownership interests held by outside parties in subsidiaries, which include limited liability companies and limited partnerships, controlled by the Company are classified as non-controlling interests. Some of the Company&#8217;s non-controlling ownership interests consist of outside parties that have certain redemption rights that, if exercised, require the Company to purchase the parties&#8217; ownership interests. These interests are classified and reported as redeemable non-controlling interests and have been adjusted to their approximate redemption values, after the attribution of net income or loss.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s redeemable non-controlling interests are comprised primarily of the voting membership interests owned by outside members of Concentra Group Holdings Parent, each of which have put rights with respect to their interests in Concentra Group Holdings Parent.</span></div></ix:continuation><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:RedeemableNoncontrollingInterestTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RleHRyZWdpb246YmUzYTdmZTlkNTVhNGExZWJmNThjZDMxMGIxMWMxZDRfOTk3_a93e8ace-41d7-469d-b9ee-789dad24aed7" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in redeemable non-controlling interests were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.737%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fcf10033def4edc8873b5e817d0b994_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMy0xLTEtMS0w_d19d6ed2-67d9-4814-a05f-b67bd675ca80">974,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMy0zLTEtMS0w_dfcab369-7104-490f-a957-3a986ca9aeb0">398,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfNC0xLTEtMS0w_e1acc91e-3cc2-4512-90f0-ffd0bafa7aff">7,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfNC0zLTEtMS0w_129d40eb-656a-4a12-b32a-8f85eb2934d4">9,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to and purchases of redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="sem:NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfNi0xLTEtMS0w_dc4fafdd-1584-477b-b9aa-3d44f61dd24b">5,687</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331" decimals="-3" name="sem:NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfNi0zLTEtMS0w_117755f2-eabc-422d-b9ef-7b0c1af2a0f9">614</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of membership interests of Concentra Group Holdings Parent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfNy0xLTEtMS0w_68268e07-70a2-4299-8857-0d2639ba9f50">366,203</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfNy0zLTEtMS0w_7951417f-594e-4e15-9b6c-79f81cad23dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redemption value adjustment on redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfOC0xLTEtMS0w_9b8cd7bb-45c7-4b51-938a-a1574715d707">10,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfOC0zLTEtMS0w_15785f17-b9b2-486c-b1a0-b99e4018b8f6">38,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331" decimals="-3" name="us-gaap:TemporaryEquityOtherChanges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfOS0xLTEtMS0w_58ec3911-3c4d-4cef-9431-9a69b264a0cc">347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331" decimals="-3" name="us-gaap:TemporaryEquityOtherChanges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfOS0zLTEtMS0w_3b13cf56-296c-4509-adf3-c612fe1ff52b">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfaaf0f42d9042e7b77d153a10a8eeb5_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTAtMS0xLTEtMA_fe860ae6-fb58-4f1e-b6ad-8033706a44bf">620,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia25336bcc81845369b7acc4ef55a0c51_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTAtMy0xLTEtMA_034a249f-7f73-4e3d-9a9a-707d97c4b275">445,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTEtMS0xLTEtMA_d485e242-61a6-4354-99aa-a836623f50bc">3,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTEtMy0xLTEtMA_57b621c9-97be-447f-8071-3aba67992c6c">18,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to and purchases of redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" name="sem:NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTItMS0xLTEtMA_fe0e9eb3-f701-475c-b3f4-db8462e59a11">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTItMy0xLTEtMA_b39fa787-5e89-4bb5-8f1b-43e9d54258bb">1,987</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redemption value adjustment on redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTMtMS0xLTEtMA_9f85cb2b-917c-41bc-91f2-fbdd269e8c12">127,916</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestChangeInRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTMtMy0xLTEtMA_5f2467ed-744d-45b1-ba7a-366931818896">59,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" name="us-gaap:TemporaryEquityOtherChanges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTQtMS0xLTEtMA_a8272457-fb35-42d0-a26b-fc42b50b770a">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" name="us-gaap:TemporaryEquityOtherChanges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTQtMy0xLTEtMA_ac4bb106-6a93-417c-ac87-1119d3b4603b">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of June 30</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2126fcb95b794e1d9f9873202b50af46_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTUtMS0xLTEtMA_36345e6d-d8ee-4875-86d3-c95ede26724f">495,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTUtMy0xLTEtMA_1aaccec2-3aa8-4084-a960-927bd80f8448">521,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_49"></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:VariableInterestEntityDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80OS9mcmFnOjM1M2EzZjE2M2UzMDQ2YjJhYmVmMjY3ZTIwYjFlODY4L3RleHRyZWdpb246MzUzYTNmMTYzZTMwNDZiMmFiZWYyNjdlMjBiMWU4NjhfMTQwOA_73602305-9519-4fee-a712-16d959dd9d0c" continuedAt="icb95b6289ab3406ea6a3b92e5e2372fc" escape="true"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80OS9mcmFnOjM1M2EzZjE2M2UzMDQ2YjJhYmVmMjY3ZTIwYjFlODY4L3RleHRyZWdpb246MzUzYTNmMTYzZTMwNDZiMmFiZWYyNjdlMjBiMWU4NjhfMTQwOQ_905aef61-8548-4c7f-9d8a-7d927f39fa5d" continuedAt="iddf7ff0dee9f4fedb76d354cd8d17488" escape="true">Variable Interest Entities</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="icb95b6289ab3406ea6a3b92e5e2372fc"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iddf7ff0dee9f4fedb76d354cd8d17488">Certain states prohibit the &#8220;corporate practice of medicine,&#8221; which restricts the Company from owning medical practices which directly employ physicians and from exercising control over medical decisions by physicians. In these states, the Company enters into long-term management agreements with medical practices that are owned by licensed physicians, which, in turn, employ or contract with physicians who provide professional medical services. The management agreements provide for the Company to direct the transfer of ownership of the medical practices to new licensed physicians at any time. Based on the provisions of the management agreements, the medical practices are variable interest entities for which the Company is the primary beneficiary.</ix:continuation></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020 and June&#160;30, 2021, the total assets of the Company&#8217;s variable interest entities were $<ix:nonFraction unitRef="usd" contextRef="i419b57ae7aed4416a0c64ed51064c3f9_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80OS9mcmFnOjM1M2EzZjE2M2UzMDQ2YjJhYmVmMjY3ZTIwYjFlODY4L3RleHRyZWdpb246MzUzYTNmMTYzZTMwNDZiMmFiZWYyNjdlMjBiMWU4NjhfODg4_f5d520f1-111d-42e9-817c-94680ecc214d">208.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i47ca05e15f9b40f489ce514ca61c046e_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80OS9mcmFnOjM1M2EzZjE2M2UzMDQ2YjJhYmVmMjY3ZTIwYjFlODY4L3RleHRyZWdpb246MzUzYTNmMTYzZTMwNDZiMmFiZWYyNjdlMjBiMWU4NjhfODk1_170b5843-95c0-40b9-9142-1e022dd4bc76">242.3</ix:nonFraction> million, respectively, and are principally comprised of accounts receivable. As of December 31, 2020 and June&#160;30, 2021, the total liabilities of these variable interest entities were $<ix:nonFraction unitRef="usd" contextRef="i419b57ae7aed4416a0c64ed51064c3f9_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80OS9mcmFnOjM1M2EzZjE2M2UzMDQ2YjJhYmVmMjY3ZTIwYjFlODY4L3RleHRyZWdpb246MzUzYTNmMTYzZTMwNDZiMmFiZWYyNjdlMjBiMWU4NjhfMTA2MA_a89957cc-3704-4f06-bc6a-93e5611aac79">55.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i47ca05e15f9b40f489ce514ca61c046e_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80OS9mcmFnOjM1M2EzZjE2M2UzMDQ2YjJhYmVmMjY3ZTIwYjFlODY4L3RleHRyZWdpb246MzUzYTNmMTYzZTMwNDZiMmFiZWYyNjdlMjBiMWU4NjhfMTA2Nw_e725950f-e376-438a-ae82-f2661a4601b1">58.8</ix:nonFraction> million, respectively, and are principally comprised of accounts payable and accrued expenses. The Company&#8217;s variable interest entities have obligations payable for services received under the aforementioned management agreements of $<ix:nonFraction unitRef="usd" contextRef="i419b57ae7aed4416a0c64ed51064c3f9_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DueToAffiliateCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80OS9mcmFnOjM1M2EzZjE2M2UzMDQ2YjJhYmVmMjY3ZTIwYjFlODY4L3RleHRyZWdpb246MzUzYTNmMTYzZTMwNDZiMmFiZWYyNjdlMjBiMWU4NjhfMTI5NQ_ebb2aae5-fe60-482b-88d8-a3f9dc251de0">151.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i47ca05e15f9b40f489ce514ca61c046e_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DueToAffiliateCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80OS9mcmFnOjM1M2EzZjE2M2UzMDQ2YjJhYmVmMjY3ZTIwYjFlODY4L3RleHRyZWdpb246MzUzYTNmMTYzZTMwNDZiMmFiZWYyNjdlMjBiMWU4NjhfMTMwMg_0181eb96-668d-46d4-8433-59c186b94d6d">182.1</ix:nonFraction> million as of December 31, 2020 and June&#160;30, 2021, respectively; these intercompany balances are eliminated in consolidation.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RleHRyZWdpb246YTM1NjBiOGFmMmU0NGY4ZmE3YjBlY2JjY2MyMjJiOTVfNTMy_dd924755-8c2c-443b-974a-0c6887286435" continuedAt="i9828ba6a348e40c480f7161a3fc67367" escape="true"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RleHRyZWdpb246YTM1NjBiOGFmMmU0NGY4ZmE3YjBlY2JjY2MyMjJiOTVfNTMy_f28d70cc-b760-4b31-adaf-f8de94436033" continuedAt="i4779f2abbcc244bd959e82f119c6fdcd" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i9828ba6a348e40c480f7161a3fc67367" continuedAt="ic06cfba159d34103bb2a0e83972f3cc4"><ix:continuation id="i4779f2abbcc244bd959e82f119c6fdcd" continuedAt="if16919a4b4744a9491576763066226a4"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating and finance leases for its facilities. The Company leases its corporate office space from related parties. </span></div><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RleHRyZWdpb246YTM1NjBiOGFmMmU0NGY4ZmE3YjBlY2JjY2MyMjJiOTVfNTM5_37b1d5e3-da1e-451b-8722-53b5aafacc84" continuedAt="i1d32d26918cb4e408ce399dca6c5875a" escape="true"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s total lease cost was as follows:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.285%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease cost</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseCostUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfMi0xLTEtMS03MTA_d34c5a0b-ca6b-4115-826b-ca8b96652301">69,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseCostRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfMi0zLTEtMS03MTA_80ac8eee-2ea8-4755-8abd-8d92917c808d">1,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfMi01LTEtMS03MTU_a49a500b-2802-4461-ad09-47ab86121d69">71,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseCostUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfMi03LTEtMS03MTA_c4e67874-321f-4bf9-9feb-6e97375f46e2">70,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseCostRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfMi05LTEtMS03MTA_a172bc53-d1f3-4dd3-afef-c294ba1a36fa">1,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfMi0xMS0xLTEtNzE3_f6f6361c-4bb7-4da9-9621-8d2c7c20e460">72,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease cost:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" name="sem:FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNC0xLTEtMS03MTA_5c20243c-41d3-4186-bfbe-8bf1da8b2860">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="sem:FinanceLeaseRightOfUseAssetAmortizationRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNC0zLTEtMS03MTA_a5d2e8c4-2895-477a-8afa-f59652ae9f54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNC01LTEtMS03MTU_d58df1fd-ca1b-4312-a3aa-0faad9751f23">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" name="sem:FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNC03LTEtMS03MTA_90b85a5f-85c1-4bd7-a327-8ae225b3cdbb">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="sem:FinanceLeaseRightOfUseAssetAmortizationRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNC05LTEtMS03MTA_129d5b5e-81f0-476c-b971-a00255261578">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNC0xMS0xLTEtNzE3_c336e7ce-cf37-4f2a-8a38-5786531ad8dd">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" name="sem:FinanceLeaseInterestExpenseUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNS0xLTEtMS03MTA_929a7346-734d-47e5-a9ec-b418db02941c">231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="sem:FinanceLeaseInterestExpenseRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNS0zLTEtMS03MTA_4be44689-4ba1-4d26-a687-b23af1410406">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNS01LTEtMS03MTU_9d282282-66f8-4799-b825-fcc9bb415cb4">231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" name="sem:FinanceLeaseInterestExpenseUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNS03LTEtMS03MTA_ced04936-6faf-4ea9-a688-848a960a98af">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="sem:FinanceLeaseInterestExpenseRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNS05LTEtMS03MTA_71afc7a7-5557-410d-a15d-72e46b3ef737">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNS0xMS0xLTEtNzE3_44f5c918-b42d-4444-8009-eb55726df4af">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:VariableLeaseCostUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNy0xLTEtMS03MTA_a9cc5eba-38f0-4aaf-8db1-5d619b698ffb">11,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" name="sem:VariableLeaseCostRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNy0zLTEtMS03MTA_efc426d9-18ab-445d-b9b4-c3ee4e0a8725">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNy01LTEtMS03MTU_ab9a8e8f-77ac-4233-bbc9-2cb09dbdd1cd">11,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:VariableLeaseCostUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNy03LTEtMS03MTA_5b729ad7-6c5f-4b29-98e1-8627bd66d621">13,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" name="sem:VariableLeaseCostRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNy05LTEtMS03MTA_7567a3bc-6b84-4907-8253-b65907e14dfa">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNy0xMS0xLTEtNzE3_42b92bec-8072-44d5-b9aa-2e04e66a6b4f">13,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:SubleaseIncomeUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOC0xLTEtMS03MTA_b57c0001-f482-4373-b389-b7faa22e9cab">2,621</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="sem:SubleaseIncomeRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOC0zLTEtMS03MTA_a20ff5a2-1a60-4ab5-843d-6258eefa4112">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOC01LTEtMS03MTU_f9bec3e8-749e-4532-959b-806c99ccd1d2">2,621</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:SubleaseIncomeUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOC03LTEtMS03MTA_bca2f871-d8f6-4bde-9679-17f5ec3c6ef8">2,229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="sem:SubleaseIncomeRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOC05LTEtMS03MTA_e0aa7949-828c-4c9f-8ef6-acc9f138566d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOC0xMS0xLTEtNzE3_c5275c33-1238-42f6-b3bc-7895b4944786">2,229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:LeaseCostUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOS0xLTEtMS03MTk_1df3c351-b606-40ba-ad17-75a36c3aea5d">78,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:LeaseCostRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOS0zLTEtMS03MTk_2e1e839a-ecb4-4aae-a007-becc3a72f967">1,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOS01LTEtMS03MTU_27cf4236-15c1-47ac-99ff-191f04b91701">80,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LeaseCostUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOS03LTEtMS03MTk_3c56dd78-ccf9-4abb-b445-4bffc5b4b3dc">81,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LeaseCostRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOS05LTEtMS03MTk_cbde8809-818b-496d-95a6-6b29de43024b">1,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOS0xMS0xLTEtNzE3_eae9d9e2-126a-4435-a0b2-815f0ba56062">83,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.285%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease cost</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseCostUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMy0xLTEtMS0w_5b67fe35-b55d-4867-ac97-102beec4426b">139,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseCostRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMy0zLTEtMS0w_b57025a4-5f0b-46be-950b-fd5397685b5c">3,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMy01LTEtMS0w_d3161de3-d112-4fbe-aeca-99b3a4c48f16">142,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseCostUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMy03LTEtMS0w_5b2f658d-0e03-46e2-841b-31b16355c3b4">140,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseCostRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMy05LTEtMS0w_dd4604d7-0ac1-4c07-ba24-b98b450da34f">3,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMy0xMS0xLTEtMA_06a31924-6205-42c6-8243-1f57297e5712">144,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease cost:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" name="sem:FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNS0xLTEtMS0w_541507a1-833d-4a19-873a-89d1ff3a09ad">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="sem:FinanceLeaseRightOfUseAssetAmortizationRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNS0zLTEtMS0w_b92320d9-abe5-4a6d-8bf1-46a5c2388ae5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNS01LTEtMS0w_89450b07-3066-4582-89d6-47cb4dfc6ca2">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" name="sem:FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNS03LTEtMS0w_30220f98-7e03-4dfc-8aab-6146edf25799">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="sem:FinanceLeaseRightOfUseAssetAmortizationRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNS05LTEtMS0w_a4fa30b2-c186-4dfb-8b72-77e3892b65d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNS0xMS0xLTEtMA_a611c5eb-9933-4d51-b171-dc4aaf0b0ac5">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" name="sem:FinanceLeaseInterestExpenseUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNi0xLTEtMS0w_9e99b984-c7e9-459f-8c53-5f46ced0f4de">487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="sem:FinanceLeaseInterestExpenseRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNi0zLTEtMS0w_b7af220c-32ab-4af0-9be5-073a8ee24a36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNi01LTEtMS0w_df7759af-930e-4f41-afb7-7549976c5bcf">487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" name="sem:FinanceLeaseInterestExpenseUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNi03LTEtMS0w_1cfb404c-f095-48f2-a7a3-dc045354bf9a">505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="sem:FinanceLeaseInterestExpenseRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNi05LTEtMS0w_d2a602fa-b7a3-42e2-ac5e-5ccd7dccd4e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNi0xMS0xLTEtMA_06ee1424-3eac-4166-bd89-d04b45201fcc">505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:VariableLeaseCostUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOC0xLTEtMS0w_2125e5f0-ba3b-4a8c-9743-fa6aeeeef080">24,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" name="sem:VariableLeaseCostRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOC0zLTEtMS0w_a2a18cf4-76c0-4132-8b2f-9d165d45d8b6">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOC01LTEtMS0w_5c461e14-bbc5-462e-a1ee-fb0ad29887a8">24,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:VariableLeaseCostUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOC03LTEtMS0w_f1866691-224b-4a06-907c-ad904d8d9357">26,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" name="sem:VariableLeaseCostRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOC05LTEtMS0w_1770ad8f-84cf-41c9-96a9-aa49619f7b85">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOC0xMS0xLTEtMA_124a688a-7c70-4feb-8703-5202a4cb1b84">26,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:SubleaseIncomeUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOS0xLTEtMS0w_c4caeffe-0e1b-4445-85f1-6304c6690d6e">5,176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="sem:SubleaseIncomeRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOS0zLTEtMS0w_92f83d05-da73-469b-b734-021ad96b70df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOS01LTEtMS0w_119b5974-2549-47d7-a1e0-3a6d8ea806ed">5,176</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:SubleaseIncomeUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOS03LTEtMS0w_80b6e376-611f-48b9-b059-0d5c3de835ab">4,463</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="sem:SubleaseIncomeRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOS05LTEtMS0w_f870efcc-0836-4338-9923-b1fa97f288fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOS0xMS0xLTEtMA_4e6b4823-557d-4a6d-a0ca-37a18ece692c">4,463</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:LeaseCostUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMTAtMS0xLTEtMA_1e572497-8119-4d9b-864b-93ec1abfef97">158,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:LeaseCostRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMTAtMy0xLTEtMA_0760bc98-6d85-4c53-b799-5a8704bcb82a">3,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMTAtNS0xLTEtMA_f8adcd19-f7b0-4eb6-b119-bfebec7431b3">162,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LeaseCostUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMTAtNy0xLTEtMA_9188ae2f-2f8e-46ad-88db-83e93ef59b69">163,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LeaseCostRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMTAtOS0xLTEtMA_8ec3311a-ee4a-4234-8111-470ef0d008ad">3,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMTAtMTEtMS0xLTA_e88dc042-3fc4-4c4d-911e-aee2d5e8ff58">166,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RleHRyZWdpb246YTM1NjBiOGFmMmU0NGY4ZmE3YjBlY2JjY2MyMjJiOTVfNTI2_f01893d3-1318-491f-80fa-eb21fa85041f" escape="true"><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOmU4NDQzMzM0NmFlNjQyZWRhMGVjNTE1ZjM2OGFiZjE1L3RhYmxlcmFuZ2U6ZTg0NDMzMzQ2YWU2NDJlZGEwZWM1MTVmMzY4YWJmMTVfNC0xLTEtMS0w_e8355191-916c-4a44-860c-b1a53484b406">140,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOmU4NDQzMzM0NmFlNjQyZWRhMGVjNTE1ZjM2OGFiZjE1L3RhYmxlcmFuZ2U6ZTg0NDMzMzQ2YWU2NDJlZGEwZWM1MTVmMzY4YWJmMTVfNC0zLTEtMS0w_7c841671-d50f-49cd-a4a4-b66233bb3a52">145,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOmU4NDQzMzM0NmFlNjQyZWRhMGVjNTE1ZjM2OGFiZjE1L3RhYmxlcmFuZ2U6ZTg0NDMzMzQ2YWU2NDJlZGEwZWM1MTVmMzY4YWJmMTVfNS0xLTEtMS0w_0db8fa69-0941-48dc-8c89-559277eb0161">487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOmU4NDQzMzM0NmFlNjQyZWRhMGVjNTE1ZjM2OGFiZjE1L3RhYmxlcmFuZ2U6ZTg0NDMzMzQ2YWU2NDJlZGEwZWM1MTVmMzY4YWJmMTVfNS0zLTEtMS0w_490dace7-795f-4be4-bc95-a05208c3c1de">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOmU4NDQzMzM0NmFlNjQyZWRhMGVjNTE1ZjM2OGFiZjE1L3RhYmxlcmFuZ2U6ZTg0NDMzMzQ2YWU2NDJlZGEwZWM1MTVmMzY4YWJmMTVfNi0xLTEtMS0w_c2766077-329c-4a04-befc-5fbd41c16bcf">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOmU4NDQzMzM0NmFlNjQyZWRhMGVjNTE1ZjM2OGFiZjE1L3RhYmxlcmFuZ2U6ZTg0NDMzMzQ2YWU2NDJlZGEwZWM1MTVmMzY4YWJmMTVfNi0zLTEtMS0w_9ef2e678-0ac3-480a-8a3b-df6bdf58949d">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOmU4NDQzMzM0NmFlNjQyZWRhMGVjNTE1ZjM2OGFiZjE1L3RhYmxlcmFuZ2U6ZTg0NDMzMzQ2YWU2NDJlZGEwZWM1MTVmMzY4YWJmMTVfOC0xLTEtMS0w_c6b469bf-3c5f-4f37-873f-6f3cd979f4e6">132,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOmU4NDQzMzM0NmFlNjQyZWRhMGVjNTE1ZjM2OGFiZjE1L3RhYmxlcmFuZ2U6ZTg0NDMzMzQ2YWU2NDJlZGEwZWM1MTVmMzY4YWJmMTVfOC0zLTEtMS0w_f8c7c589-869c-4d00-9aeb-1f4d9fbe1da0">138,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOmU4NDQzMzM0NmFlNjQyZWRhMGVjNTE1ZjM2OGFiZjE1L3RhYmxlcmFuZ2U6ZTg0NDMzMzQ2YWU2NDJlZGEwZWM1MTVmMzY4YWJmMTVfOS0xLTEtMS0w_3c80f5af-3af1-47c4-ac71-9d60e77981de">989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOmU4NDQzMzM0NmFlNjQyZWRhMGVjNTE1ZjM2OGFiZjE1L3RhYmxlcmFuZ2U6ZTg0NDMzMzQ2YWU2NDJlZGEwZWM1MTVmMzY4YWJmMTVfOS0zLTEtMS0w_e0f9318f-8abf-4d83-8f7e-27e6add1ca92">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="sem:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RleHRyZWdpb246YTM1NjBiOGFmMmU0NGY4ZmE3YjBlY2JjY2MyMjJiOTVfNTUy_04e8a8e8-27b2-40ed-8c23-3355efbe2999" continuedAt="if757fadad2be45a1b5020fc34cbb9052" escape="true"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.285%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseRightOfUseAssetUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNC0xLTEtMS0w_61d23520-7e0b-4846-84d3-95c5c3f2deaf">1,002,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseRightOfUseAssetRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNC0zLTEtMS0w_d3b6cdce-cbaa-4442-b7cb-86763da4138d">30,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNC01LTEtMS0w_196cf0dd-054c-4fa5-b11d-206797504dc7">1,032,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseRightOfUseAssetUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNC03LTEtMS0w_7eb4b22f-7ac4-4e9b-8e92-05df4d73418d">1,026,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseRightOfUseAssetRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNC05LTEtMS0w_0af237a7-b35e-4106-a2a4-aa31cf48c1b9">27,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNC0xMS0xLTEtMA_f0f7d816-bb56-4183-bf76-68d514fedc2a">1,053,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseLiabilityCurrentUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNi0xLTEtMS0w_f5e529d7-f785-406d-ac1e-b1a3b9866e54">214,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseLiabilityCurrentRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNi0zLTEtMS0w_e1715248-2b8f-48a3-bb2d-2fc7e118d9af">6,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNi01LTEtMS0w_3e237f2f-0997-44f0-827b-7b12877b9a1c">220,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseLiabilityCurrentUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNi03LTEtMS0w_2dc52cbb-7f2d-4652-a0e0-1e96d9201daa">218,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseLiabilityCurrentRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNi05LTEtMS0w_2101a581-9779-4ea3-b730-91c4f3e79fb7">6,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNi0xMS0xLTEtMA_82dee6ea-7cd9-4ff4-82c8-2dd8d693c24f">224,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-current operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseLiabilityNoncurrentUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNy0xLTEtMS0w_894d5703-8539-4963-9180-7852e5663f47">848,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseLiabilityNoncurrentRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNy0zLTEtMS0w_117a5d1b-89f4-47ae-8843-3946abd2b23e">27,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNy01LTEtMS0w_c546f06c-a575-434a-8b30-358ea2d0e4c5">875,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseLiabilityNoncurrentUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNy03LTEtMS0w_4493a426-8470-494a-ae45-98f6a9fb9d68">869,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseLiabilityNoncurrentRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNy05LTEtMS0w_0bad650a-f795-40b3-bd59-9abb72e46bf3">24,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNy0xMS0xLTEtMA_419c16d4-a151-4d61-8811-982aec83338f">893,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseLiabilityUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfOC0xLTEtMS0w_b663cf1d-f38f-46ee-acbe-450473f80ba0">1,062,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseLiabilityRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfOC0zLTEtMS0w_5d4bb6ee-27d6-4d73-a264-38b9fc468f27">33,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfOC01LTEtMS0w_7ec1c715-be35-482e-a8e6-18b28a6ef186">1,095,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseLiabilityUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfOC03LTEtMS0w_5b83a2fe-6785-4428-b938-141cf0c9d8ab">1,088,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:OperatingLeaseLiabilityRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfOC05LTEtMS0w_8c5285b9-9435-4555-8096-5f00f16b70f6">30,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfOC0xMS0xLTEtMA_03621a94-8e70-4e46-b8d1-f1fb2e1c73ab">1,118,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><ix:continuation id="ic06cfba159d34103bb2a0e83972f3cc4"><ix:continuation id="if16919a4b4744a9491576763066226a4"><div style="text-align:justify"><ix:continuation id="if757fadad2be45a1b5020fc34cbb9052"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.285%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="sem:FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfNi0xLTEtMS0w_e8332188-c2f7-4788-a660-855da8d63181">5,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:zerodash" name="sem:FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfNi0zLTEtMS0w_770ebb7d-39f1-4536-ba76-d16a323ffdd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfNi01LTEtMS0w_09c0d654-bb95-44d1-bb4f-eaf91138422b">5,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfNi03LTEtMS0w_07e4f8a8-0b76-4816-8c70-e47c09e277ea">5,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:zerodash" name="sem:FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfNi05LTEtMS0w_285fbded-5d60-4740-894b-415aafa036c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfNi0xMS0xLTEtMA_c13700e0-b907-4c3f-9628-4dad563bb080">5,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of long-term debt and notes payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" name="sem:FinanceLeaseLiabilityCurrentUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOC0xLTEtMS0w_1685f899-005f-4ac5-bd42-b78bb5354a00">663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:zerodash" name="sem:FinanceLeaseLiabilityCurrentRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOC0zLTEtMS0w_45d1cba9-0b2e-4b71-bc15-dfd694b4b179">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOC01LTEtMS0w_cf332086-56a4-47ac-97c4-ce580f1ba0b2">663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" name="sem:FinanceLeaseLiabilityCurrentUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOC03LTEtMS0w_3a00a64b-dfee-49cd-b553-3996889f7378">638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:zerodash" name="sem:FinanceLeaseLiabilityCurrentRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOC05LTEtMS0w_f98f86bd-b920-4694-af20-7a94c6148eaf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOC0xMS0xLTEtMA_8363d6d7-d589-4a5f-9061-652d172dedad">638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="sem:FinanceLeaseLiabilityNoncurrentUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOS0xLTEtMS0w_a1c349b2-a286-4926-afda-4442ab9415ff">13,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:zerodash" name="sem:FinanceLeaseLiabilityNoncurrentRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOS0zLTEtMS0w_070aa1c9-312f-4cac-9d68-aacbb6d1c1d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOS01LTEtMS0w_cdb32974-47ba-4ba2-a9a8-d446e82a2829">13,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:FinanceLeaseLiabilityNoncurrentUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOS03LTEtMS0w_2bf696bc-b0a7-498a-96a2-3d580b12a10c">13,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:zerodash" name="sem:FinanceLeaseLiabilityNoncurrentRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOS05LTEtMS0w_12b0e3ce-7f30-4888-b448-0199a57ed080">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOS0xMS0xLTEtMA_317cf9ee-5a5e-4a81-a5f2-376ff3ff8bcc">13,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="sem:FinanceLeaseLiabilityUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfMTAtMS0xLTEtMA_d7d60167-3625-48d5-997a-5f19e49dba5b">14,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:zerodash" name="sem:FinanceLeaseLiabilityRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfMTAtMy0xLTEtMA_2bd273cc-3c19-4b68-be1d-78e039c3853d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfMTAtNS0xLTEtMA_5a5a920c-aa76-4142-a88b-df678fe44443">14,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:FinanceLeaseLiabilityUnrelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfMTAtNy0xLTEtMA_697033e2-4128-489c-a0b6-eb7744aa54a7">14,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:zerodash" name="sem:FinanceLeaseLiabilityRelatedParties" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfMTAtOS0xLTEtMA_5cf43e26-ed92-45b3-bcf7-95e369106837">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfMTAtMTEtMS0xLTA_31de00de-c971-4717-baf8-be62aa6b7cf1">14,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:continuation id="i1d32d26918cb4e408ce399dca6c5875a"><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease terms and discount rates were as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years):</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjRjNTUxYzcyNWUzZDQwYTU5MGIyMDQ1ZjQ3ZTdjMmJkL3RhYmxlcmFuZ2U6NGM1NTFjNzI1ZTNkNDBhNTkwYjIwNDVmNDdlN2MyYmRfMi0xLTEtMS0w_ad85779b-ac05-4e30-8d55-5d326cb735f4">7.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjRjNTUxYzcyNWUzZDQwYTU5MGIyMDQ1ZjQ3ZTdjMmJkL3RhYmxlcmFuZ2U6NGM1NTFjNzI1ZTNkNDBhNTkwYjIwNDVmNDdlN2MyYmRfMi0zLTEtMS0w_2687eb8d-6e30-428e-a4f3-cf24c8aa7928">7.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjRjNTUxYzcyNWUzZDQwYTU5MGIyMDQ1ZjQ3ZTdjMmJkL3RhYmxlcmFuZ2U6NGM1NTFjNzI1ZTNkNDBhNTkwYjIwNDVmNDdlN2MyYmRfMy0xLTEtMS0w_4848ac39-2b15-4364-af61-9f36774265d3">31.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjRjNTUxYzcyNWUzZDQwYTU5MGIyMDQ1ZjQ3ZTdjMmJkL3RhYmxlcmFuZ2U6NGM1NTFjNzI1ZTNkNDBhNTkwYjIwNDVmNDdlN2MyYmRfMy0zLTEtMS0w_13e37779-468a-4e69-995b-a09bc41832ff">30.6</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjRjNTUxYzcyNWUzZDQwYTU5MGIyMDQ1ZjQ3ZTdjMmJkL3RhYmxlcmFuZ2U6NGM1NTFjNzI1ZTNkNDBhNTkwYjIwNDVmNDdlN2MyYmRfNS0xLTEtMS0w_7be77971-d31c-4c8e-9925-1e91dfa0be79">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjRjNTUxYzcyNWUzZDQwYTU5MGIyMDQ1ZjQ3ZTdjMmJkL3RhYmxlcmFuZ2U6NGM1NTFjNzI1ZTNkNDBhNTkwYjIwNDVmNDdlN2MyYmRfNS0zLTEtMS0w_5f66b426-06dd-4a6d-9144-ab3bf5e7cc1f">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjRjNTUxYzcyNWUzZDQwYTU5MGIyMDQ1ZjQ3ZTdjMmJkL3RhYmxlcmFuZ2U6NGM1NTFjNzI1ZTNkNDBhNTkwYjIwNDVmNDdlN2MyYmRfNi0xLTEtMS0w_70f2342f-eae3-4ca7-a92d-dd42623c514c">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjRjNTUxYzcyNWUzZDQwYTU5MGIyMDQ1ZjQ3ZTdjMmJkL3RhYmxlcmFuZ2U6NGM1NTFjNzI1ZTNkNDBhNTkwYjIwNDVmNDdlN2MyYmRfNi0zLTEtMS0w_317f30fa-98a4-490a-9b61-e86442e2624d">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RleHRyZWdpb246YTM1NjBiOGFmMmU0NGY4ZmE3YjBlY2JjY2MyMjJiOTVfNTQ4_01eff225-dc28-4bd1-8ffa-45f700616e10" escape="true"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RleHRyZWdpb246YTM1NjBiOGFmMmU0NGY4ZmE3YjBlY2JjY2MyMjJiOTVfNTQ4_4cf1c011-692a-449c-be98-4322b5f337b3" escape="true"><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, maturities of lease liabilities were approximately as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021 (remainder of year)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfMi0xLTEtMS0w_dc78803d-b123-49f0-8406-a995464b83a2">143,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfMi0zLTEtMS0w_ac6ab71e-088f-4600-b4fd-6b335e65b4d9">790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfMy0xLTEtMS0w_225e5d7b-7655-41cd-a380-7e8dec2c414f">258,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfMy0zLTEtMS0w_d7bf2377-d8ec-4ac8-b2bf-4108eaabd40e">1,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfNC0xLTEtMS0w_9df71d00-ee21-4ee0-a30f-e781fa01350c">211,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfNC0zLTEtMS0w_7ed88beb-29db-4e4b-b8c1-7200c377f979">1,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfNS0xLTEtMS0w_6c3d5c81-0685-4c27-ad95-68f71f43ceb4">172,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfNS0zLTEtMS0w_54abb1d1-9394-4966-b947-ea816a98cabb">1,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfNi0xLTEtMS0w_4dabd00d-c001-4b58-b527-f0eccedb7574">138,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfNi0zLTEtMS0w_8cbd1b95-38d4-4f72-93cb-0887098d4d95">1,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfNy0xLTEtMS0w_84c52fa7-9cca-4f42-a6b7-9cf7aa0933eb">533,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:FinanceLeaseLiabilityPaymentsDueAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfNy0zLTEtMS0w_a45f9a7a-6698-44c8-84ec-8638d14de513">29,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total undiscounted cash flows</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfOC0xLTEtMS0w_065f89ee-41e8-42f0-8755-cd7b7e3c117e">1,457,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfOC0zLTEtMS0w_63b720c4-c6f6-4a4a-9066-fbab582f768b">35,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfOS0xLTEtMS0w_57499aff-cfc5-4a3e-aa1d-327ddd3d2c4a">339,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfOS0zLTEtMS0w_d564b462-a071-4507-a786-c63412b4b9f2">21,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total discounted lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfMTAtMS0xLTEtMA_23cd47ed-26b7-4cad-adaa-81a841a5c6c5">1,118,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfMTAtMy0xLTEtMA_5288dae6-50e0-455f-af19-75b36010f9ef">14,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation></ix:continuation><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_58"></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RleHRyZWdpb246NWIxNTVkMWZiYTM5NGJjOGI4YWFmNDA2N2M1NjVkYTJfNzc2_d4fd591a-3dd6-4bc4-bdff-9d8b35b6f04c" continuedAt="i8e88484b3cc2465aa98f9abc866d239d" escape="true">Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="i8e88484b3cc2465aa98f9abc866d239d" continuedAt="iecbeee1b4a9a4177b3f45215fecfca03"><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RleHRyZWdpb246NWIxNTVkMWZiYTM5NGJjOGI4YWFmNDA2N2M1NjVkYTJfNzcy_4b4c0460-1e5d-4ddd-af85-38fb13e73a57" escape="true"><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows changes in the carrying amounts of goodwill by reporting unit for the six months ended June&#160;30, 2021:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:26.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i700401d3c9d145e5a4af74e91aa63697_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfMi0xLTEtMS0w_3a859e35-b0a9-4eae-ac50-e89dbe2e06e4">1,084,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72f4a9b9828d4a3b943644bbd290287b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfMi0zLTEtMS0w_68c5e037-0b15-476a-8f96-9f9327988a19">432,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d49e31dfc5481b83733fba9533f7e5_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfMi01LTEtMS0w_cc45d983-226c-48d8-9ea7-37df4707eaf0">646,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fb9c18f057d4a6cac88d6653d9ec800_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfMi03LTEtMS0w_f8c4c61a-96e5-4bcd-bda9-f77f5627038d">1,215,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfMi05LTEtMS0w_6568f4c6-5a76-41bc-a7c0-c17cfd0c6497">3,379,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition of businesses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied45fa8b01774a98b132e46124b37c0a_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfMy0xLTEtMS0w_d34c6c77-08e2-45aa-a4c0-abec54f1447b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia19667dc075545788618f5c66316f37a_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfMy0zLTEtMS0w_70dc60e3-575b-41f9-ae28-aba0cad231cc">9,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i097daf64265140a892929bd7dac3e0fd_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfMy01LTEtMS0w_8207886c-2a7d-40f4-a506-ea461b424145">1,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e821cac29074fc185f5771945e60d79_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfMy03LTEtMS0w_77078490-4251-4bf1-9669-53b44fc32f37">1,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfMy05LTEtMS0w_15eeab14-6f7e-42a6-8542-3874427b337d">12,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eb84cd5898941968056ee90d2e078ac_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfNi0xLTEtMS0w_51f82e0d-f80e-4168-9d1f-58822e63f197">1,084,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5447d034988f4dba82554eb01fc5e2a2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfNi0zLTEtMS0w_230c3a9f-4642-4bd3-b856-afa0043eb271">442,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cee8f7161ea4a8a92cd3e773a1e4ece_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfNi01LTEtMS0w_81d4632d-a046-487e-a970-57cac1918b8b">647,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cc51a7a4bbb48fd82bfef91f2d58ed8_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfNi03LTEtMS0w_80170be5-a3dd-4024-816f-6a425c44c91e">1,216,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfNi05LTEtMS0w_106e691b-f2ba-4baa-81ba-a95b39cd7f92">3,391,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><ix:continuation id="iecbeee1b4a9a4177b3f45215fecfca03"><div style="margin-bottom:12pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Identifiable Intangible Assets</span></div><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RleHRyZWdpb246NWIxNTVkMWZiYTM5NGJjOGI4YWFmNDA2N2M1NjVkYTJfNzg2_447a44fd-3905-4bee-b174-110bb4f4cb1c" escape="true"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the gross carrying amounts, accumulated amortization, and net carrying amounts for the Company&#8217;s identifiable intangible assets:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:23.053%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.833%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2722863174014f129b2ae71613b5e3ef_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNC0yLTEtMS0w_06dc8d9e-b8e7-48ae-ba56-4446085927dc">166,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2722863174014f129b2ae71613b5e3ef_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNC02LTEtMS0w_188cdba3-18a1-44e1-a6a6-c8d116a4f05c">166,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie50961b97f5d4e09a5947761afae9b15_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNC04LTEtMS0w_008a22f1-1134-4721-899f-2ee6d07b98e0">166,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie50961b97f5d4e09a5947761afae9b15_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNC0xMi0xLTEtMA_43caac3b-6676-4de2-ac51-5ea90b24240a">166,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certificates of need</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d92202a78304997b52107c3a7f606b2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNS0yLTEtMS0w_18b86e30-bd4b-48b9-8cf9-c1617e95a125">18,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d92202a78304997b52107c3a7f606b2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNS02LTEtMS0w_9ea2fa6a-a4cf-46a4-b700-9812ab8617d9">18,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50009e4e14044151932827ba2b1bbb8f_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNS04LTEtMS0w_0782afe7-ca4a-4132-825d-83329490eb51">18,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50009e4e14044151932827ba2b1bbb8f_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNS0xMi0xLTEtMA_a118ce4c-44e5-4280-8101-0cdc9b5bfe23">18,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accreditations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice892a1481a14854bded5d410c627ea7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNi0yLTEtMS0w_6d485c1a-7fe0-4434-bf9c-0575b8a47488">1,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice892a1481a14854bded5d410c627ea7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNi02LTEtMS0w_3dec94d7-a1f1-4f82-b2ad-beadea9c676c">1,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i330f8d443bf84101a754a226814bfe6c_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNi04LTEtMS0w_c651d174-ad99-43d7-aea1-3bb859bce420">1,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i330f8d443bf84101a754a226814bfe6c_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNi0xMi0xLTEtMA_47aca6ad-08b7-49ca-ac54-3f7817e8eb60">1,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finite-lived intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i602fead3b8954e80b8ecfba7f8e331a4_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOC0yLTEtMS0w_f260dd93-9468-4c4e-8abd-2ee97aca23be">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i602fead3b8954e80b8ecfba7f8e331a4_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOC00LTEtMS0w_4a894b8f-3272-4ed0-a40e-abe9c5b30fe5">5,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i602fead3b8954e80b8ecfba7f8e331a4_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOC02LTEtMS0w_c86038fb-0e51-4322-866b-02b83080d095">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib04ddc4871e84537b195da0e20d46573_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOC04LTEtMS0w_26b6b779-7cf6-4bb3-8a5b-cef4cd4be400">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib04ddc4871e84537b195da0e20d46573_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOC0xMC0xLTEtMA_d835fc5e-c970-438e-9d0e-671bb6dd016e">5,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib04ddc4871e84537b195da0e20d46573_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOC0xMi0xLTEtMA_15651753-3e15-4ec7-bb3f-17b48ec87c57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i008b3ba5aedd4b238f380f5108ca88c2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOS0yLTEtMS0w_ab12bbd2-acf7-4070-b91d-2a1d8a56b0cb">291,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i008b3ba5aedd4b238f380f5108ca88c2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOS00LTEtMS0w_c6593f18-a9b3-4c0e-b7aa-65d958337cb3">113,346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i008b3ba5aedd4b238f380f5108ca88c2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOS02LTEtMS0w_7092c331-05a2-45cc-99ee-d79591ee3d65">178,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if929eb1eca084fde8793ca88f272572d_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOS04LTEtMS0w_45003ac9-7480-46dd-9b25-ef20f28669b2">298,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if929eb1eca084fde8793ca88f272572d_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOS0xMC0xLTEtMA_1cb7194f-25e9-45f8-b93c-16d57b5e087d">126,843</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if929eb1eca084fde8793ca88f272572d_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOS0xMi0xLTEtMA_95614ba9-000d-4317-8605-348d226dfb6c">171,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i302b948d2285436d8d4925ae04d98b18_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTAtMi0xLTEtMA_925faf7b-228d-4877-ab52-ab36fc788284">33,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i302b948d2285436d8d4925ae04d98b18_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTAtNC0xLTEtMA_bfddbaf6-fdd8-4a78-b611-282b1b9e6067">11,771</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i302b948d2285436d8d4925ae04d98b18_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTAtNi0xLTEtMA_474535a2-4fcc-40f7-9df2-f3ab5335d81c">22,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48c41d6695124d31993223ed4735ed45_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTAtOC0xLTEtMA_e53a99f4-d281-41ea-a94a-c345174414d7">35,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48c41d6695124d31993223ed4735ed45_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTAtMTAtMS0xLTA_85343341-7249-4a39-be58-a1995901834c">13,365</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48c41d6695124d31993223ed4735ed45_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTAtMTItMS0xLTA_5c8efae7-26ad-4e2e-9f29-74e8749e406b">21,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total identifiable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTEtMi0xLTEtMA_d09e7285-fd00-4ba7-8ecf-e2db1d412c52">517,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTEtNC0xLTEtMA_a2374b91-1514-4690-af18-a6f872df19a6">130,117</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTEtNi0xLTEtMA_9df716d3-494a-4fee-b63a-b1c6e49e2a32">387,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTEtOC0xLTEtMA_49091265-e4a1-487d-9487-65792e27f60e">525,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTEtMTAtMS0xLTA_e7717f87-b3af-4ec2-8b95-dfa89a10011e">145,208</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTEtMTItMS0xLTA_d30554df-da90-4875-a9e3-fc52490e09c9">380,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:4pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accreditations and trademarks have renewal terms and the costs to renew these intangible assets are expensed as incurred. At June&#160;30, 2021, the accreditations and trademarks have a weighted average time until next renewal of <ix:nonNumeric contextRef="i9f259df1c9c14a91877a5d8ddebfe895_D20210101-20210630" format="ixt-sec:duryear" name="sem:IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RleHRyZWdpb246NWIxNTVkMWZiYTM5NGJjOGI4YWFmNDA2N2M1NjVkYTJfNTc1_e9beced6-af5c-4b41-ba61-2d138531588c">1.5</ix:nonNumeric> years and <ix:nonNumeric contextRef="i1c8e70e09d574bd5bf50455cec27484e_D20210101-20210630" format="ixt-sec:duryear" name="sem:IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RleHRyZWdpb246NWIxNTVkMWZiYTM5NGJjOGI4YWFmNDA2N2M1NjVkYTJfNTgy_47a55ea2-8279-4992-8d58-b59126225e0c">8.2</ix:nonNumeric> years, respectively.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s finite-lived intangible assets amortize over their estimated useful lives. Amortization expense was $<ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RleHRyZWdpb246NWIxNTVkMWZiYTM5NGJjOGI4YWFmNDA2N2M1NjVkYTJfMTA5OTUxMTYyODYwNw_1dcd6b20-78af-4ce0-ac01-56de9d099031">6.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RleHRyZWdpb246NWIxNTVkMWZiYTM5NGJjOGI4YWFmNDA2N2M1NjVkYTJfMTA5OTUxMTYyODYxNg_f610a48b-94e1-4e8c-abbe-4557afb8f566">7.3</ix:nonFraction> million for the three months ended June&#160;30, 2020 and 2021, respectively. Amortization expense was $<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RleHRyZWdpb246NWIxNTVkMWZiYTM5NGJjOGI4YWFmNDA2N2M1NjVkYTJfNzE0_c5dacefd-34b6-439f-bd9b-cde985b5abd8">13.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RleHRyZWdpb246NWIxNTVkMWZiYTM5NGJjOGI4YWFmNDA2N2M1NjVkYTJfNzIx_b87a8fa6-a12c-48cb-8f01-ec7b70c7bd25">14.4</ix:nonFraction> million for the six months ended June&#160;30, 2020 and 2021, respectively.</span></div></ix:continuation><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_64"></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RleHRyZWdpb246N2U1NDIyNDE4N2RkNGZkMTgyN2RkZThkZDgxYmY5MmFfMzA0_7df735f6-f6a9-49ee-9a9e-b119a1370e97" continuedAt="i13d846003c27467b85c92f258ed2b281" escape="true">Long-Term Debt and Notes Payable</ix:nonNumeric></span></div><ix:continuation id="i13d846003c27467b85c92f258ed2b281" continuedAt="i2233d9af45134635afd0c1e5d79f45ca"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RleHRyZWdpb246N2U1NDIyNDE4N2RkNGZkMTgyN2RkZThkZDgxYmY5MmFfMzA3_94a68c45-1572-429c-9213-a493e4b1911d" continuedAt="i9fb629a989ce4baba731afff19105146" escape="true"><div style="margin-bottom:15pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company&#8217;s long-term debt and notes payable were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:25.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.811%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized Premium (Discount)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized<br/>Issuance Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select <ix:nonFraction unitRef="number" contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfMi0wLTEtMS0wL3RleHRyZWdpb246ODg3YjhkN2NhOGQyNDUwM2E2ODYwZDMyMGQ3ZDUxOGNfMTE_bd820632-c1a2-47c9-8199-6e79bfdd216a">6.250</ix:nonFraction>% senior notes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfMi0xLTEtMS0w_aa50d8b7-f982-4bf4-862c-e08aabe32d64">1,225,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfMi0zLTEtMS0w_f7e0da3a-76ac-4bd7-a530-9d091ef8c2d5">30,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfMi01LTEtMS0w_f7fd14ac-3f0a-4b56-ac4f-c9e31f890696">15,463</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfMi03LTEtMS0w_e1f4c12d-05af-445e-b728-3344df46d672">1,240,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfMi0xMC0xLTEtMA_4647f3de-e925-441b-8f6c-085ace583320">1,304,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select credit facilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNS0xLTEtMS0w_ece8db95-c00b-4bb1-86eb-c1d347496950">2,103,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNS0zLTEtMS0w_d5927321-b7df-486e-9bc3-1e7877401574">7,398</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNS01LTEtMS0w_5296af72-a92e-478c-b927-b7656830540c">8,064</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNS03LTEtMS0w_20813784-9d25-4cd3-8d73-b468707ec1de">2,087,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNS0xMC0xLTEtMA_d2ebcf93-21b3-4bf6-9635-873928eaafa5">2,077,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other debt, including finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtGrossAndFinanceLeaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNi0xLTEtMS0w_7e359313-1382-49b4-bd2c-7acaa7314fa1">69,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNi0zLTEtMS0w_b02cd569-4a0f-4db7-b106-4f64ffc33449">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNi01LTEtMS0w_8369a05e-7b6f-49ad-a5a1-fb8382f3d269">258</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtAndFinanceLeaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNi03LTEtMS0w_66235e7f-76e5-45f4-89b9-d63ad2b65e74">69,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNi0xMC0xLTEtMA_11374a3e-bee7-49b9-8243-3a763727c751">69,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtGrossAndFinanceLeaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNy0xLTEtMS0w_cc1d239f-7c55-4419-a07c-fe3dca32c871">3,398,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNy0zLTEtMS0w_4923642f-0a1c-4bbe-beb4-bf16d89d6984">23,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNy01LTEtMS0w_c4e5c24b-c916-48be-99cc-573dfdb1da4d">23,785</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtAndFinanceLeaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNy03LTEtMS0w_416b8f2f-a507-4c9a-958a-d9b8991ef618">3,397,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNy0xMC0xLTEtMA_8dff42a8-67bd-4e12-b19d-ef0ecef58a75">3,451,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RleHRyZWdpb246N2U1NDIyNDE4N2RkNGZkMTgyN2RkZThkZDgxYmY5MmFfMzAy_5ad75260-d47a-4930-9e40-b37d967861e8" escape="true"><div style="margin-bottom:9pt;margin-top:7pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal maturities of the Company&#8217;s long-term debt and notes payable were approximately as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:25.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select <ix:nonFraction unitRef="number" contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfMi0wLTEtMS0wL3RleHRyZWdpb246OTg2NTA4ZmRjZGE2NGJjNTgyNjYyY2M1OTk3NTNjN2VfMTE_bd820632-c1a2-47c9-8199-6e79bfdd216a">6.250</ix:nonFraction>% senior notes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfMi0xLTEtMS0w_26236ace-1f36-4550-98bb-0f98fa2dec1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfMi0zLTEtMS0w_a52ceb4c-2248-4b5b-9b48-8d092ab51039">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfMi01LTEtMS0w_3775cf67-7632-4ccc-a3cc-3acf6be86b46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfMi03LTEtMS0w_04788564-47c9-45ed-8f9e-91ba8d92257d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfMi05LTEtMS0w_208b0e9b-c1cc-4acd-b38b-a8edf34b998e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfMi0xMS0xLTEtMA_3eeb5826-4f62-4fae-8cbf-550cf0340927">1,225,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfMi0xMy0xLTEtMA_fdb268e0-7eab-481f-8fbc-cdb32225c671">1,225,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select credit facilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNS0xLTEtMS0w_6a5d0f0c-5193-41ab-bbc7-cbf0ea1e9d73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNS0zLTEtMS0w_395e0242-8228-49b3-a792-eb133b8c8f6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNS01LTEtMS0w_0668ba5a-a915-4a10-8c91-8c63d2d056f8">4,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNS03LTEtMS0w_3f1c666d-91dc-4481-8872-a8bc6dd8d6de">11,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNS05LTEtMS0w_9ec754bf-fc74-4304-b11b-f2f7efee3563">2,087,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630" decimals="-3" format="ixt:zerodash" name="sem:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNS0xMS0xLTEtMA_cbf11cad-b657-484b-ae74-fb40da6a5a9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNS0xMy0xLTEtMA_b4007e4a-7f38-4937-8ad9-de5de8927e5e">2,103,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other debt, including finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNi0xLTEtMS0w_a9a31b53-64fa-421c-bcdc-b07a273596b6">9,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNi0zLTEtMS0w_4437c923-a451-4e4d-9632-142e3f86cdaa">4,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNi01LTEtMS0w_761bfd73-4158-450d-8a53-e2888a796946">20,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNi03LTEtMS0w_ce365975-f7bf-49b2-b437-59835d4e87dc">23,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630" decimals="-3" name="sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNi05LTEtMS0w_513fd55f-8473-45d8-82cb-8903ff0f1428">334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNi0xMS0xLTEtMA_5158f2a7-2875-4904-8d2e-a0f53e3fb821">11,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtGrossAndFinanceLeaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNi0xMy0xLTEtMA_c846e559-6cf0-4d35-8482-a6490fd6b4be">69,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNy0xLTEtMS0w_474b4467-20f2-4fa8-845f-b384cca6e17b">9,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNy0zLTEtMS0w_47cf7460-5ea5-467a-a8c3-d98206d27e3f">4,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNy01LTEtMS0w_c1100759-4dc2-4c04-98dd-e872d10ad762">25,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNy03LTEtMS0w_16e0cb71-b7de-4908-9cf8-7ac14688ef3d">34,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNy05LTEtMS0w_ba145458-7c95-47f7-a720-2aafd5a52a78">2,087,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNy0xMS0xLTEtMA_febef1d0-463f-40d2-916d-d8369565c92e">1,236,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtGrossAndFinanceLeaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNy0xMy0xLTEtMA_8e8dc77c-7121-42c4-a8ec-598a0ad8f85a">3,398,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt;margin-top:7pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:7pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:7pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:7pt;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><ix:continuation id="i2233d9af45134635afd0c1e5d79f45ca" continuedAt="ie97f6bcfbd8e4288941b374999665cac"><ix:continuation id="i9fb629a989ce4baba731afff19105146"><div style="margin-bottom:9pt;margin-top:7pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company&#8217;s long-term debt and notes payable were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:25.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.811%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized Premium (Discount)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized<br/>Issuance Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="30" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select <ix:nonFraction unitRef="number" contextRef="i857a4ce6f52d4c159052310deeec6c7a_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfMi0wLTEtMS0wL3RleHRyZWdpb246N2VkNjRkMDEwMGFjNDNjODlmMWFjZTZiMTQ2NWI0MDZfMTE_ba10e455-54f7-4574-8e87-c6a387d8baa6">6.250</ix:nonFraction>% senior notes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i857a4ce6f52d4c159052310deeec6c7a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfMi0xLTEtMS0w_0eb492e8-1b20-4918-8ba1-a2eeec285932">1,225,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i857a4ce6f52d4c159052310deeec6c7a_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfMi0zLTEtMS0w_f8ede078-0023-4459-b347-3709164e773e">33,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i857a4ce6f52d4c159052310deeec6c7a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfMi01LTEtMS0w_b3b823c9-cbc2-4145-8a17-cdddbefc9a21">16,953</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i857a4ce6f52d4c159052310deeec6c7a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfMi03LTEtMS0w_352550a7-ef58-4738-ab02-5ddec92ca544">1,241,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i857a4ce6f52d4c159052310deeec6c7a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfMi0xMC0xLTEtMA_90805979-7252-415f-a87c-4e19a6b3d8b5">1,316,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select credit facilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac118b21fb34cc0987c43b0e5069eca_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNS0xLTEtMS0w_96511609-7131-4988-b5c6-96c59e65d51b">2,103,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idac118b21fb34cc0987c43b0e5069eca_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNS0zLTEtMS0w_869d037d-9438-4578-8455-eaae8dbcfb29">8,393</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idac118b21fb34cc0987c43b0e5069eca_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNS01LTEtMS0w_dcfd66db-62df-444e-a2fa-1271026aff9d">9,149</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac118b21fb34cc0987c43b0e5069eca_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNS03LTEtMS0w_1b51b532-ad8b-4ed1-9008-479c5e183a79">2,085,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac118b21fb34cc0987c43b0e5069eca_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNS0xMC0xLTEtMA_45594e84-87dd-46d3-813d-c22d78ebbcc5">2,082,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other debt, including finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a6556d47b534c46b69474e970b014e3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtGrossAndFinanceLeaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNi0xLTEtMS0w_4cd44e03-60a6-4121-adba-1cafd13b93d5">74,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a6556d47b534c46b69474e970b014e3_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNi0zLTEtMS0w_1f089388-f7f8-4d22-845b-14a5be85e727">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a6556d47b534c46b69474e970b014e3_I20201231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNi01LTEtMS0w_f0ce44c6-9bbe-495f-a36d-4b1f322241b5">302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a6556d47b534c46b69474e970b014e3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtAndFinanceLeaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNi03LTEtMS0w_2f4a4f2e-af1d-4301-898d-4813b6ff23b2">74,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a6556d47b534c46b69474e970b014e3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNi0xMC0xLTEtMA_3e5fa9be-bfbf-4af2-9ae7-2ce2d393efa3">74,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtGrossAndFinanceLeaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNy0xLTEtMS0w_e8ad9fcb-89d6-4bfc-a516-387744a4ba3a">3,403,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNy0zLTEtMS0w_2a1b97e8-3a6d-45ff-b8b7-5a88e08f32ed">25,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNy01LTEtMS0w_26ceff6f-37c9-4d1f-88ce-fe648585a983">26,404</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="sem:LongTermDebtAndFinanceLeaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNy03LTEtMS0w_5776b5aa-e659-42d8-b12e-a159d604b5b5">3,402,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNy0xMC0xLTEtMA_f4493a4f-d71f-4c9c-82e3-329d25d68ff5">3,473,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:1pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Select Credit Facilities</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 2, 2021, Select entered into Amendment No. 5 to its senior secured credit agreement (the &#8220;Select credit agreement&#8221;) which, among other things, increased the aggregate commitments available under its revolving credit facility (the &#8220;Select revolving facility&#8221;) from $<ix:nonFraction unitRef="usd" contextRef="ie6837d0c7f474574b480bbb7ab422f4a_I20210601" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RleHRyZWdpb246N2U1NDIyNDE4N2RkNGZkMTgyN2RkZThkZDgxYmY5MmFfMjc0ODc3OTA3MTI3Nw_ad4e6969-ca9e-4d78-a6a1-d96eaeccd3b1">450.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i04dc07ecbc4842379f1b38ab30b5eba8_I20210602" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RleHRyZWdpb246N2U1NDIyNDE4N2RkNGZkMTgyN2RkZThkZDgxYmY5MmFfMjc0ODc3OTA3MTI5Ng_6fcc5752-a75a-4732-9d8c-af71c69315c8">650.0</ix:nonFraction> million, including a $<ix:nonFraction unitRef="usd" contextRef="i08f710aa7b9e476e9cfe1eb202bb9575_I20210602" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RleHRyZWdpb246N2U1NDIyNDE4N2RkNGZkMTgyN2RkZThkZDgxYmY5MmFfMjc0ODc3OTA3MTMxNw_8a4664b5-5742-4502-bce6-1b0e8f5dc098">125.0</ix:nonFraction> million sublimit for the issuance of standby letters of credit.</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentra-JPM Revolving Facility</span></div></ix:continuation><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie97f6bcfbd8e4288941b374999665cac">On June 2, 2021, Concentra Inc. terminated its obligations under its first lien credit agreement (the &#8220;Concentra-JPM first lien credit agreement&#8221;). The Concentra-JPM first lien credit agreement provided for commitments of $<ix:nonFraction unitRef="usd" contextRef="i80ee1121b7294df28e95de1abb339e57_D20210602-20210602" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RleHRyZWdpb246N2U1NDIyNDE4N2RkNGZkMTgyN2RkZThkZDgxYmY5MmFfNjU5NzA2OTc3MTk5Mw_c7fcd4f2-b4ba-473e-8808-06aeadfe7cce">100.0</ix:nonFraction>&#160;million under a revolving credit facility (the &#8220;Concentra-JPM revolving facility&#8221;), which was set to mature on March 1, 2022.</ix:continuation> </span></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_67"></div><div style="margin-top:9pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RleHRyZWdpb246YjYxYmE0YWEyMmY3NGI3NDg4OTExMzhiZjM2NmQyYzZfMTg0Ng_6caf7967-5c6f-4eca-bd0f-c31ffa4d9ce1" continuedAt="i5ff7ae94997d4ab8896066b03483f0d5" escape="true">Interest Rate Cap </ix:nonNumeric></span></div><ix:continuation id="i5ff7ae94997d4ab8896066b03483f0d5" continuedAt="ia8a21ca8e1db4d90af1f79182c4006ae"><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to market risk exposure arising from changes in interest rates on the Select term loan, which bears interest at a variable interest rate. The Company&#8217;s objective in using an interest rate derivative is to mitigate its exposure to increases in interest rates. The interest rate cap limits the Company&#8217;s exposure to increases in the reference rate to <ix:nonFraction unitRef="number" contextRef="if1a2d014fb1e4ad28dd4c378b19640ec_I20210630" decimals="INF" name="us-gaap:DerivativeCapInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RleHRyZWdpb246YjYxYmE0YWEyMmY3NGI3NDg4OTExMzhiZjM2NmQyYzZfNDAw_80fc3589-d44b-4627-8650-07a4f218508f">1.0</ix:nonFraction>% on $<ix:nonFraction unitRef="usd" contextRef="if1a2d014fb1e4ad28dd4c378b19640ec_I20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RleHRyZWdpb246YjYxYmE0YWEyMmY3NGI3NDg4OTExMzhiZjM2NmQyYzZfNDA2_8b552423-e914-4517-bb13-e9171a670355">2.0</ix:nonFraction>&#160;billion of principal outstanding under the Select term loan. The interest rate cap became effective March 31, 2021 for the monthly periods from and including April 30, 2021 through September 30, 2024. The Company will pay a premium for the interest rate cap over the term of the agreement. The annual premium is equal to <ix:nonFraction unitRef="number" contextRef="i6032142566484e849a1c5d74fc32c36c_D20210101-20210630" decimals="INF" name="sem:DerivativeCostOfHedgeAnnualPremiumPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RleHRyZWdpb246YjYxYmE0YWEyMmY3NGI3NDg4OTExMzhiZjM2NmQyYzZfNzI2_81f78dc7-9d90-41b6-9aef-606e1e450e23">0.0916</ix:nonFraction>% of the notional amount.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate cap has been designated as a cash flow hedge and is highly effective at offsetting the changes in cash outflows when the reference rate exceeds <ix:nonFraction unitRef="number" contextRef="if1a2d014fb1e4ad28dd4c378b19640ec_I20210630" decimals="INF" name="us-gaap:DerivativeCapInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RleHRyZWdpb246YjYxYmE0YWEyMmY3NGI3NDg4OTExMzhiZjM2NmQyYzZfOTE1_ae2b5cf3-464b-4947-87ff-1144beec345b">1.0</ix:nonFraction>%. Changes in the fair value of the interest rate cap, net of tax, are recognized in other comprehensive income and are reclassified out of accumulated other comprehensive income (&#8220;AOCI&#8221;) and into interest expense when the hedged interest obligations affect earnings.</span></div><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RleHRyZWdpb246YjYxYmE0YWEyMmY3NGI3NDg4OTExMzhiZjM2NmQyYzZfNjU5NzA2OTc3MTUyNw_64aacecf-5837-4013-aa59-35022a713297" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table outlines the changes in AOCI:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.668%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8bac61b83244def99333977ca6bc8dd_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfMy0yLTEtMS0xMzM1_039828c1-16f0-4b6f-a6bf-c57e4d6488f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c19072c8de04863a294aa039b4d4f1c_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfMy00LTEtMS0xMzM1_4e744282-c034-4f29-8395-b9182362734f">2,027</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on interest rate cap cash flow hedge</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if569ced9cfba4b40a89af8439239b76d_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfNC0yLTEtMS0xMzM1_5fa8be7b-0267-4438-bad8-1e1408adbdcc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id57e27efd97745c990ac963fa61e26b6_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfNC00LTEtMS0xMzM1_f537cdf3-cbfe-496c-b3f5-9403627c13bf">8,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id110289f580b4bf99ef20d4061298d26_I20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfNi0yLTEtMS01MTM4_35820c85-d76f-4156-917b-ce8444f883b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7224211964a0414eb6d46f88101082e5_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfNi00LTEtMS01MTM4_aded8e2d-7e5b-40a2-b184-a68f9b34e856">6,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on interest rate cap cash flow hedge</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i318011501b1440e589143c06cf03d2a6_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfNy0yLTEtMS0xMzQw_264d4c84-aed3-4607-b466-7e09d68be791">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i583e60e6ec66438ca44ad0bd1c978df3_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfNy00LTEtMS0xMzQw_646819c0-5e13-40c7-82ce-58a4f72777eb">1,403</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i318011501b1440e589143c06cf03d2a6_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfOC0yLTEtMS0xMzQw_64ea67a2-9461-4b19-94a5-2d8c1b6cff7d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i583e60e6ec66438ca44ad0bd1c978df3_D20210401-20210630" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfOC00LTEtMS0xMzQw_bc579cf9-9330-4a1b-ba79-0aa48a729fd2">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of June 30</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7536a90c020479993c3e239213bd5b9_I20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfOS0yLTEtMS01MTM4_9d152a36-2f97-416a-8617-f7b2206e23f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6547976a10ee43418548a025bba5b82a_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfOS00LTEtMS01MTM4_7a5794cc-ef53-4aa3-8157-d7765cb0aee6">4,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated pre-tax losses expected to be reclassified from AOCI into interest expense within the next twelve months are approximately $<ix:nonFraction unitRef="usd" contextRef="i6032142566484e849a1c5d74fc32c36c_D20210101-20210630" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RleHRyZWdpb246YjYxYmE0YWEyMmY3NGI3NDg4OTExMzhiZjM2NmQyYzZfMTg0NA_4277cef6-47b3-44a1-bd40-45d7875537c2">0.2</ix:nonFraction>&#160;million.  </span></div></ix:continuation><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia8a21ca8e1db4d90af1f79182c4006ae">Refer to Note 10 &#8211; Fair Value of Financial Instruments for information on the fair value of the Company&#8217;s interest rate cap contract and its balance sheet classification.</ix:continuation> </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RleHRyZWdpb246NDkyMWQ5YmEzOGNhNDY1ODllYjc5OTU4MTdhZWZiYTVfMTgyMQ_194c62ea-a1c8-4b53-85cc-f3797015f3a7" continuedAt="i1258d248fa2e4fc48191ed915666366b" escape="true">Fair Value of Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="i1258d248fa2e4fc48191ed915666366b" continuedAt="id62f5921db434675a768c82c7a6f54b8"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which are measured at fair value, or for which a fair value is disclosed, are classified in the fair value hierarchy, as outlined below, on the basis of the observability of the inputs used in the fair value measurement:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Level 1 &#8211; inputs are based upon quoted prices for identical instruments in active markets. </span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Level 2 &#8211; inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant inputs are observable in the market or can be corroborated by observable market data. </span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Level 3 &#8211; inputs are generally unobservable and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the instrument.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s interest rate cap contract is recorded at its fair value on a recurring basis. The fair value of the interest rate cap contract is based upon a model-derived valuation using observable market inputs, such as interest rates and interest rate volatility, and the strike price. </span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RleHRyZWdpb246NDkyMWQ5YmEzOGNhNDY1ODllYjc5OTU4MTdhZWZiYTVfMTgyMg_f46a42c8-d573-43b7-ab7c-3b449526c611" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.683%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.397%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instrument</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap contract, non-current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83e6ab5f1d91457a8c4e1283a5492962_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOjY4ZDAwN2IwNzZlNjRhMzM4N2Q5MmMxZTdhMWRmNDgzL3RhYmxlcmFuZ2U6NjhkMDA3YjA3NmU2NGEzMzg3ZDkyYzFlN2ExZGY0ODNfMi02LTEtMS0w_161b7f2e-aeb0-437e-8aab-cdd97cc235c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b2a61478b0140669828a01db0126a67_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOjY4ZDAwN2IwNzZlNjRhMzM4N2Q5MmMxZTdhMWRmNDgzL3RhYmxlcmFuZ2U6NjhkMDA3YjA3NmU2NGEzMzg3ZDkyYzFlN2ExZGY0ODNfMi04LTEtMS0w_8bff4056-0b06-4b92-863f-feae3651a129">8,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap contract, current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394d4e4cc11347d6bbe4d04a5195d6fa_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOjY4ZDAwN2IwNzZlNjRhMzM4N2Q5MmMxZTdhMWRmNDgzL3RhYmxlcmFuZ2U6NjhkMDA3YjA3NmU2NGEzMzg3ZDkyYzFlN2ExZGY0ODNfNC02LTEtMS0w_d4c1636e-1ffa-4f78-823d-8541d95f84a4">1,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide56b585b96145e2a275a4c246014f7a_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOjY4ZDAwN2IwNzZlNjRhMzM4N2Q5MmMxZTdhMWRmNDgzL3RhYmxlcmFuZ2U6NjhkMDA3YjA3NmU2NGEzMzg3ZDkyYzFlN2ExZGY0ODNfNC04LTEtMS0w_717e245a-7f98-4c51-8d37-f57fe402339b">1,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap contract, non-current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e07cda8fc2f4dfbb5b2dd986ade2878_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOjY4ZDAwN2IwNzZlNjRhMzM4N2Q5MmMxZTdhMWRmNDgzL3RhYmxlcmFuZ2U6NjhkMDA3YjA3NmU2NGEzMzg3ZDkyYzFlN2ExZGY0ODNfNS02LTEtMS0w_ca2348c7-2298-4c23-8053-5b2f33b7c4d7">1,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17c6a45ecdbf4d0f95f5f9be53712a5c_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOjY4ZDAwN2IwNzZlNjRhMzM4N2Q5MmMxZTdhMWRmNDgzL3RhYmxlcmFuZ2U6NjhkMDA3YjA3NmU2NGEzMzg3ZDkyYzFlN2ExZGY0ODNfNS04LTEtMS0w_88d9fe61-897e-405b-a3f3-efc4181a2ca1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:9pt;margin-top:4pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not measure its indebtedness at fair value in its condensed consolidated balance sheets. The fair value of the Select credit facilities is based on quoted market prices for this debt in the syndicated loan market. The fair value of the senior notes is based on quoted market prices. The carrying value of the Company&#8217;s other debt, as disclosed in Note 8 &#8211; Long-Term Debt and Notes Payable, approximates fair value. </span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RleHRyZWdpb246NDkyMWQ5YmEzOGNhNDY1ODllYjc5OTU4MTdhZWZiYTVfMTgyMw_7b05ee43-5354-49ce-9e39-8c5f44c71211" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instrument</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select <ix:nonFraction unitRef="number" contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOmFmMWM1MGUxMDYyMTQ3ODA5NjE4OGU3YWVjMDYyZDhkL3RhYmxlcmFuZ2U6YWYxYzUwZTEwNjIxNDc4MDk2MTg4ZTdhZWMwNjJkOGRfMy0wLTEtMS0wL3RleHRyZWdpb246YTA2ZmI4MzFkMDU0NDUyZGI3ZTdmNmMwZWVmMGNkMzBfMTE_bd820632-c1a2-47c9-8199-6e79bfdd216a">6.250</ix:nonFraction>% senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902a144fb9c24c4c9a915b36772f9aa3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOmFmMWM1MGUxMDYyMTQ3ODA5NjE4OGU3YWVjMDYyZDhkL3RhYmxlcmFuZ2U6YWYxYzUwZTEwNjIxNDc4MDk2MTg4ZTdhZWMwNjJkOGRfMy00LTEtMS0w_ac8a2c40-c395-4663-88a9-36288146b163">1,241,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i902a144fb9c24c4c9a915b36772f9aa3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOmFmMWM1MGUxMDYyMTQ3ODA5NjE4OGU3YWVjMDYyZDhkL3RhYmxlcmFuZ2U6YWYxYzUwZTEwNjIxNDc4MDk2MTg4ZTdhZWMwNjJkOGRfMy02LTEtMS0w_4ce3ed79-88c9-4903-80ca-494b59ce8c23">1,316,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101b81566dfb4f6083f1433734385dd6_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOmFmMWM1MGUxMDYyMTQ3ODA5NjE4OGU3YWVjMDYyZDhkL3RhYmxlcmFuZ2U6YWYxYzUwZTEwNjIxNDc4MDk2MTg4ZTdhZWMwNjJkOGRfMy04LTEtMS0w_d9e3c9d3-ad74-43ce-a77a-6963a445ced2">1,240,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101b81566dfb4f6083f1433734385dd6_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOmFmMWM1MGUxMDYyMTQ3ODA5NjE4OGU3YWVjMDYyZDhkL3RhYmxlcmFuZ2U6YWYxYzUwZTEwNjIxNDc4MDk2MTg4ZTdhZWMwNjJkOGRfMy0xMC0xLTEtMA_6ade93f7-95d6-4dd8-99c0-fecc563034d2">1,304,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select credit facilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select term loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a4a93b5710486380910f66202cea4c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOmFmMWM1MGUxMDYyMTQ3ODA5NjE4OGU3YWVjMDYyZDhkL3RhYmxlcmFuZ2U6YWYxYzUwZTEwNjIxNDc4MDk2MTg4ZTdhZWMwNjJkOGRfNi00LTEtMS0w_b6e12765-4b6d-4874-a91c-d4f28826649a">2,085,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a4a93b5710486380910f66202cea4c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOmFmMWM1MGUxMDYyMTQ3ODA5NjE4OGU3YWVjMDYyZDhkL3RhYmxlcmFuZ2U6YWYxYzUwZTEwNjIxNDc4MDk2MTg4ZTdhZWMwNjJkOGRfNi02LTEtMS0w_518c8802-3246-4740-b377-83e7964dfaf1">2,082,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i698e8ca3bbf14329ad97debd8fc5d02d_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOmFmMWM1MGUxMDYyMTQ3ODA5NjE4OGU3YWVjMDYyZDhkL3RhYmxlcmFuZ2U6YWYxYzUwZTEwNjIxNDc4MDk2MTg4ZTdhZWMwNjJkOGRfNi04LTEtMS0w_75c6ab37-7e85-490a-bf92-f87ead25e11d">2,087,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i698e8ca3bbf14329ad97debd8fc5d02d_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOmFmMWM1MGUxMDYyMTQ3ODA5NjE4OGU3YWVjMDYyZDhkL3RhYmxlcmFuZ2U6YWYxYzUwZTEwNjIxNDc4MDk2MTg4ZTdhZWMwNjJkOGRfNi0xMC0xLTEtMA_967a66d0-86e7-406d-a8e5-b96592ef81d1">2,077,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="margin-bottom:9pt;margin-top:4pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id62f5921db434675a768c82c7a6f54b8">The Company&#8217;s other financial instruments, which primarily consist of cash and cash equivalents, accounts receivable, and accounts payable, approximate fair value because of the short-term maturities of these instruments.</ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RleHRyZWdpb246ZjBiZDlhMTQ3YWRiNGFjMTk3MmIwYzIxMGFiNmRlZGFfMTUwMA_0ee2acc5-4eca-421d-a0cf-57415d524bca" continuedAt="i99a6100360f84050b31251fc9268ea2b" escape="true">Segment Information</ix:nonNumeric></span></div><ix:continuation id="i99a6100360f84050b31251fc9268ea2b" continuedAt="id17be70952a841b68ff114da97f64dc7"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reportable segments consist of the critical illness recovery hospital segment, rehabilitation hospital segment, outpatient rehabilitation segment, and Concentra segment. Other activities include the Company&#8217;s corporate shared services, certain investments, and employee leasing services with non-consolidating subsidiaries. The Company&#8217;s other activities also include other operating income related to the recognition of payments received under the Provider Relief Fund for health care related expenses and loss of revenue attributable to the coronavirus disease 2019 (&#8220;COVID-19&#8221;). Refer to Note 15 &#8211; CARES Act for further information. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the performance of its segments based on Adjusted EBITDA. Adjusted EBITDA is defined as earnings excluding interest, income taxes, depreciation and amortization, gain (loss) on early retirement of debt, stock compensation expense, gain (loss) on sale of businesses, and equity in earnings (losses) of unconsolidated subsidiaries. The Company has provided additional information regarding its reportable segments, such as total assets, which contributes to the understanding of the Company and provides useful information to the users of the consolidated financial statements. </span></div><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RleHRyZWdpb246ZjBiZDlhMTQ3YWRiNGFjMTk3MmIwYzIxMGFiNmRlZGFfMTUwNw_a8ad3d19-6efe-4d43-8a27-a804816cad2e" escape="true"><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize selected financial data for the Company&#8217;s reportable segments. </span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.694%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Critical illness recovery hospital</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e1d48a74eba45399c9304871d02e6ac_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNC0xLTEtMS0w_f04512e0-ab50-4a36-810b-e2d0e8983c67">519,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9eaba867e94987bae380499ef0dea5_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNC0zLTEtMS0w_67f643b0-07a9-4aae-ac5b-4963f6799465">544,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83fa48e193ef409091a5469b91556348_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNC01LTEtMS0w_cda420a6-8cb1-41b9-841c-bece2f2e8ba6">1,020,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i842ce964455440c8bf019b096558985c_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNC03LTEtMS0w_b1c5f152-7675-4316-a495-2058e7dcc6b8">1,138,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rehabilitation hospital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i153dba6636544126b8b590e3eceb746a_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNS0xLTEtMS0w_a6b2553a-4435-431d-bfad-39b0de5edfeb">168,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie40b7ae534f84659b72f603832026b2c_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNS0zLTEtMS0w_d42ffc98-b535-4302-a41c-119f9e8e4bbe">212,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7fe7ee2784746f5af6d2429cd8a2219_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNS01LTEtMS0w_21056a7d-0fc7-43e7-a9a3-38142196fb49">350,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8083b69f958c4c0f8dbe5292758beec8_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNS03LTEtMS0w_27a86827-da0b-4fe5-a700-80623c913133">420,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outpatient rehabilitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4101982ebb88440ab0a78e005d9ac883_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNi0xLTEtMS0w_694d978f-0ea8-4107-851c-fc342a836d7b">167,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51d714fd1694458d8c8a2740933d72d8_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNi0zLTEtMS0w_ba3504df-204f-47f2-a455-7142485e2d7e">280,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89f2bc1bb34c1c88b6b97eb1162a82_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNi01LTEtMS0w_b18b0d4d-b672-4535-a499-7b6018209b77">422,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f26863a74d46b3807377370b9f5c71_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNi03LTEtMS0w_e0fb891f-4daf-487c-b6f3-56e107b79769">532,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Concentra</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed2d25f9da44d15a8e75aa82e738f7c_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNy0xLTEtMS0w_a856743e-fad3-4f50-b65b-2b9fdcfd3b86">312,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8878162e48ac455b871924e5a7f16043_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNy0zLTEtMS0w_467f0ee1-04c1-4336-b82f-87b7494a0277">456,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb407c8a9fd406bbddf4aaba0a22fbf_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNy01LTEtMS0w_1b38acd1-f8b5-4af3-aa1c-529b03fbcf1e">710,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d773ec12ea468d884922f6a9c624ab_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNy03LTEtMS0w_d4776907-e311-4223-ae4b-f22636c8e9ca">879,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78b5037d6f24467bb284a7f3daadf67d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfOC0xLTEtMS0w_d46947d9-e498-4834-9728-030d5f383288">64,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i593f37f6bebf4b5c8147fc667686329b_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfOC0zLTEtMS0w_87d963b1-9ec4-456b-bc30-e615cbaa2701">70,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a46c953c7a44137882933b2fccefa90_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfOC01LTEtMS0w_cbd834f9-dfd8-451f-99b8-215886a3d650">143,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9da22e6ac16b4906870e768509e1fb6f_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfOC03LTEtMS0w_fa39a373-adea-4d4f-a8e9-c8f2f7f4feb5">139,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfOS0xLTEtMS0w_be091096-0a64-465f-8082-a14aca6051b7">1,232,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfOS0zLTEtMS0w_6aa2b8f4-4f6e-4105-a58c-60f87b1dc200">1,564,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfOS01LTEtMS0w_8be95aeb-d50f-4d34-bc1a-926e762f84d2">2,647,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfOS03LTEtMS0w_64a44998-4a14-4b6f-9b81-449dea8c6f65">3,110,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Critical illness recovery hospital</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e1d48a74eba45399c9304871d02e6ac_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTEtMS0xLTEtMA_b7617adb-62ea-4e29-a6be-3e963d360056">89,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9eaba867e94987bae380499ef0dea5_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTEtMy0xLTEtMA_5f5a07ce-adb8-447b-9f29-375ab9b60e8e">72,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83fa48e193ef409091a5469b91556348_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTEtNS0xLTEtMA_92be97f0-6a90-454e-9e8b-44f0e87c3f24">178,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i842ce964455440c8bf019b096558985c_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTEtNy0xLTEtMA_bbc121c7-ae9e-4cd7-906b-71cae37ca3aa">186,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rehabilitation hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i153dba6636544126b8b590e3eceb746a_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTItMS0xLTEtMA_9eb87af0-7934-44ca-a6c0-74c7e1482951">27,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie40b7ae534f84659b72f603832026b2c_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTItMy0xLTEtMA_6b585eb3-f583-4230-bd97-64bd29c73c3f">50,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7fe7ee2784746f5af6d2429cd8a2219_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTItNS0xLTEtMA_083fe61e-c135-4cf3-99fa-bb054f80ad6e">66,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8083b69f958c4c0f8dbe5292758beec8_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTItNy0xLTEtMA_64e216c7-b58d-400e-b873-0d8100a9904c">101,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outpatient rehabilitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4101982ebb88440ab0a78e005d9ac883_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTMtMS0xLTEtMA_5c17c787-947c-4c42-b6ed-49fd95c674a9">6,282</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51d714fd1694458d8c8a2740933d72d8_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTMtMy0xLTEtMA_d0250b54-437e-42f6-84d9-32039362a1a9">45,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89f2bc1bb34c1c88b6b97eb1162a82_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTMtNS0xLTEtMA_2e4a84df-2ee9-498d-8a79-7b9d095bca55">20,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f26863a74d46b3807377370b9f5c71_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTMtNy0xLTEtMA_dcc93ba9-8fd2-47a9-a06b-68092ad7a5ef">71,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Concentra</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed2d25f9da44d15a8e75aa82e738f7c_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTQtMS0xLTEtMA_5124afaf-1886-4718-a720-607e1bd10d81">41,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8878162e48ac455b871924e5a7f16043_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTQtMy0xLTEtMA_4c42ebd2-73a9-475a-8259-8afb8bf441e2">137,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb407c8a9fd406bbddf4aaba0a22fbf_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTQtNS0xLTEtMA_cdf7a753-2929-411d-97d0-18039a1139f7">102,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d773ec12ea468d884922f6a9c624ab_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTQtNy0xLTEtMA_5977fc70-4204-4e3b-981f-f33a8fb65d51">219,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78b5037d6f24467bb284a7f3daadf67d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTUtMS0xLTEtMA_fe9a6285-4531-4d61-a859-239a3390d241">26,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i593f37f6bebf4b5c8147fc667686329b_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTUtMy0xLTEtMA_cafa0a21-3ecb-4009-a2ed-31ffbcc79539">35,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a46c953c7a44137882933b2fccefa90_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTUtNS0xLTEtMA_b80dd22f-08ad-41e7-a7c7-78e6023aa9e8">2,205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9da22e6ac16b4906870e768509e1fb6f_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTUtNy0xLTEtMA_c12ecfef-3072-474c-bbe6-0c72d83d4e88">21,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTYtMS0xLTEtMA_ce0cbd8c-360e-46f0-837e-fafb263e895f">178,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTYtMy0xLTEtMA_bc4d7b3e-c960-43c0-9060-5b7cf64c418b">342,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTYtNS0xLTEtMA_1810c9f6-2b18-4633-9b93-3beae85202c0">366,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTYtNy0xLTEtMA_83149e5b-8f23-4231-8a41-5c44c8eeee60">600,362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Critical illness recovery hospital</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe3df84cda8454c8ffd79d805543ebf_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTgtMS0xLTEtMA_45967455-8eb6-496c-b10b-1166d5149480">2,115,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i197ea75654664fa7a7dd48b4a0515835_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTgtMy0xLTEtMA_49d61ce6-c50e-49e3-8710-73b4377028e6">2,187,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fe3df84cda8454c8ffd79d805543ebf_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTgtNS0xLTEtMA_70312b38-cc59-49db-a40a-36c593dae4e3">2,115,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i197ea75654664fa7a7dd48b4a0515835_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTgtNy0xLTEtMA_34588731-1c3b-4af3-924f-22e8c676ee80">2,187,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rehabilitation hospital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i699f8bdade4a44e29271a7ea09f9b932_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTktMS0xLTEtMA_b2516915-2ac9-4223-8196-5ebe2c0bbff4">1,135,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if588fc73933845bbb155e472e99ba08e_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTktMy0xLTEtMA_fb426b77-3389-4ee1-9953-5ba4e649cd3f">1,186,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i699f8bdade4a44e29271a7ea09f9b932_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTktNS0xLTEtMA_78c8ffe2-fb00-40ab-a12c-9f94b64c6660">1,135,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if588fc73933845bbb155e472e99ba08e_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTktNy0xLTEtMA_ee4db283-17a1-41f7-81a1-b0b1fcaf66a7">1,186,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outpatient rehabilitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i232ac557a5c14113bafaf53b25c2801d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjAtMS0xLTEtMA_b990d5d5-8a2d-4532-82ef-1f606e3dfe9e">1,267,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa155817d6141a5af84386d83aa6d7d_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjAtMy0xLTEtMA_5d9f7c23-ca2d-474a-a217-c8059569dd4c">1,333,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i232ac557a5c14113bafaf53b25c2801d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjAtNS0xLTEtMA_42560918-da6c-4cee-895a-28fb8a4b1ca6">1,267,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa155817d6141a5af84386d83aa6d7d_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjAtNy0xLTEtMA_ed704b2b-ffb3-44dd-a43b-2b20adf6a725">1,333,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Concentra</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71ae59b24b3143e89410ddfca8316817_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjEtMS0xLTEtMA_4502434f-9348-42ad-b9aa-33417a1a94d6">2,351,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4876618fa9e49bfae481558c3925540_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjEtMy0xLTEtMA_16fb128a-90c3-4573-b12d-ca99f1c7f836">2,518,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71ae59b24b3143e89410ddfca8316817_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjEtNS0xLTEtMA_78edd237-6de8-42fc-aa7d-c3a1b5a1f2bd">2,351,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4876618fa9e49bfae481558c3925540_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjEtNy0xLTEtMA_00e05b61-3052-44f4-bade-aca2b7a26805">2,518,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c27e0254b2645b0bdf18d8599991191_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjItMS0xLTEtMA_dce5227c-b2c6-4c18-b4cf-0e2a9a5ebac1">598,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98da6697f91448bfa929dfa3d12ec44d_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjItMy0xLTEtMA_a52949aa-424e-42fc-b7e7-bcc809e7c8d9">730,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c27e0254b2645b0bdf18d8599991191_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjItNS0xLTEtMA_0d4ab62e-ac50-4a8a-bb09-fba519f8d0f7">598,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98da6697f91448bfa929dfa3d12ec44d_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjItNy0xLTEtMA_249aa996-18fb-49a2-9786-8751eba44691">730,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2126fcb95b794e1d9f9873202b50af46_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjMtMS0xLTEtMA_7ddd41ef-ed5c-43bf-8f31-bac3c7470f9a">7,468,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjMtMy0xLTEtMA_56e274ec-22c1-4cdb-8e07-7a988eee57c5">7,956,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2126fcb95b794e1d9f9873202b50af46_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjMtNS0xLTEtMA_fb94acbe-2195-496b-a346-f7ed199acce2">7,468,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjMtNy0xLTEtMA_466bf221-652a-4b6e-9622-b07ff9e55d0e">7,956,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Critical illness recovery hospital</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e1d48a74eba45399c9304871d02e6ac_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjUtMS0xLTEtMA_a4a0f01c-42c3-4ccf-b241-b76f46dc10c7">14,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9eaba867e94987bae380499ef0dea5_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjUtMy0xLTEtMA_253357c9-75f0-4c3c-adc0-34b9e4080b22">16,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83fa48e193ef409091a5469b91556348_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjUtNS0xLTEtMA_d592908e-3ce4-4288-b3b6-8995dac65ef4">23,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i842ce964455440c8bf019b096558985c_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjUtNy0xLTEtMA_4f500071-211c-4966-84a9-46ad7141e765">30,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rehabilitation hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i153dba6636544126b8b590e3eceb746a_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjYtMS0xLTEtMA_ee2fd664-427c-4ff4-a1b6-78cb48d3923c">1,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie40b7ae534f84659b72f603832026b2c_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjYtMy0xLTEtMA_9ea0b572-fb50-4c01-9f16-cb81015783b2">3,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7fe7ee2784746f5af6d2429cd8a2219_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjYtNS0xLTEtMA_6cc8c7f2-4356-4421-b975-799a19c30c62">5,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8083b69f958c4c0f8dbe5292758beec8_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjYtNy0xLTEtMA_a7705a6c-a7fd-4abd-9d83-1acbda63b97a">3,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outpatient rehabilitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4101982ebb88440ab0a78e005d9ac883_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjctMS0xLTEtMA_772f2e4b-ba8e-4802-a293-a78ec083f76c">6,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51d714fd1694458d8c8a2740933d72d8_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjctMy0xLTEtMA_c9af6224-59ba-4f6d-9c96-fd16732f9f7b">7,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89f2bc1bb34c1c88b6b97eb1162a82_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjctNS0xLTEtMA_a176696a-1b14-4655-947c-82ac77ae8ee2">14,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f26863a74d46b3807377370b9f5c71_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjctNy0xLTEtMA_5c2cdfec-a1ba-4081-af09-b264453b78a4">14,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Concentra</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed2d25f9da44d15a8e75aa82e738f7c_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjgtMS0xLTEtMA_804acc2a-ca58-42da-a4d3-02cb8a7d479e">6,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8878162e48ac455b871924e5a7f16043_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjgtMy0xLTEtMA_8a8e3834-c438-4a7a-9deb-17e2c8b6f4ff">7,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb407c8a9fd406bbddf4aaba0a22fbf_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjgtNS0xLTEtMA_caf7c2ad-7ad6-4075-b84c-1f806d78acb2">22,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d773ec12ea468d884922f6a9c624ab_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjgtNy0xLTEtMA_d5e8176e-e5dd-41d6-aab4-d239a7489434">20,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78b5037d6f24467bb284a7f3daadf67d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjktMS0xLTEtMA_75ff3ad4-229a-496d-b2ba-53a46f50e0ab">1,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i593f37f6bebf4b5c8147fc667686329b_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjktMy0xLTEtMA_b7025177-8ca2-4572-95dd-4e1644b0a7b2">1,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a46c953c7a44137882933b2fccefa90_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjktNS0xLTEtMA_e6ac2f50-255f-490c-a819-7a39203d909b">4,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9da22e6ac16b4906870e768509e1fb6f_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjktNy0xLTEtMA_eef50b73-37ee-41e1-9f84-6ba52cb951ce">6,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMzAtMS0xLTEtMA_d6fab3fd-63cf-4c76-81a0-4cf79f7d2cf6">32,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMzAtMy0xLTEtMA_fab7b41d-6986-4844-bbcb-d17ca69707e0">36,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMzAtNS0xLTEtMA_0866ea91-c807-4ab8-bddc-adaac238b071">71,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMzAtNy0xLTEtMA_5c0aa2a5-901b-40d2-b513-25a5033d1543">76,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt;margin-top:4pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><ix:continuation id="id17be70952a841b68ff114da97f64dc7"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RleHRyZWdpb246ZjBiZDlhMTQ3YWRiNGFjMTk3MmIwYzIxMGFiNmRlZGFfMTQ5OA_1a3b0d8e-e3f0-4aa7-baeb-b62abc194682" escape="true"><div style="margin-bottom:12pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of Adjusted EBITDA to income before income taxes is as follows:</span></div><div style="margin-bottom:12pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.704%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e1d48a74eba45399c9304871d02e6ac_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfMy0xLTEtMS0xNTAx_34987edc-0615-4477-a479-9edda1942717">89,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i153dba6636544126b8b590e3eceb746a_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfMy0zLTEtMS0xNTAx_292534ea-da0f-47fd-bdfe-2eb253d6bb01">27,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4101982ebb88440ab0a78e005d9ac883_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfMy01LTEtMS0xNTAx_e4a23e6d-f789-40e4-8142-c49b2a4bf46f">6,282</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed2d25f9da44d15a8e75aa82e738f7c_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfMy03LTEtMS0xNTAx_9581a879-622e-46f4-9232-9d3be0d76a5a">41,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78b5037d6f24467bb284a7f3daadf67d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfMy05LTEtMS0xNTAx_3ee08f17-a1f6-4b45-b6c9-59faaef47cc4">26,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e1d48a74eba45399c9304871d02e6ac_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNC0xLTEtMS0xNTAx_e6ab7679-a67f-46b5-b7f3-c1a8d2f25d1d">13,892</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i153dba6636544126b8b590e3eceb746a_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNC0zLTEtMS0xNTAx_14c1e970-2854-4137-be9f-1376d5d4f508">6,907</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4101982ebb88440ab0a78e005d9ac883_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNC01LTEtMS0xNTAx_0590548c-0b33-4fa2-af71-1cf7536315eb">7,194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaed2d25f9da44d15a8e75aa82e738f7c_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNC03LTEtMS0xNTAx_06592af6-81f2-4c1a-9676-911bc772d9fa">21,857</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78b5037d6f24467bb284a7f3daadf67d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNC05LTEtMS0xNTAx_5ef24939-9715-477c-973e-f9976e10d353">2,421</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e1d48a74eba45399c9304871d02e6ac_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNS0xLTEtMS0xNTAx_768c5f74-64f1-48bd-a816-f941edac0ab6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i153dba6636544126b8b590e3eceb746a_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNS0zLTEtMS0xNTAx_ee14f21b-2a84-48e8-bdf3-4e28bd121809">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4101982ebb88440ab0a78e005d9ac883_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNS01LTEtMS0xNTAx_2d461683-ae5d-46f6-a22f-90e830f2f9f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaed2d25f9da44d15a8e75aa82e738f7c_D20200401-20200630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNS03LTEtMS0xNTAx_c1301970-db05-49a6-aa83-0bc829fa52d5">701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78b5037d6f24467bb284a7f3daadf67d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNS05LTEtMS0xNTAx_4f4dfa2e-c497-4b74-bd1b-8628aff4fc0c">6,262</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e1d48a74eba45399c9304871d02e6ac_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNi0xLTEtMS0xNTIy_c6a2a781-a344-4f71-9df4-2fed8322dabc">75,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i153dba6636544126b8b590e3eceb746a_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNi0zLTEtMS0xNTIy_2bcb7fd1-fd36-42ea-9596-7982e2b16f5e">20,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4101982ebb88440ab0a78e005d9ac883_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNi01LTEtMS0xNTIy_f659d289-75f7-4d5d-9e0b-a267e0247d25">13,476</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed2d25f9da44d15a8e75aa82e738f7c_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNi03LTEtMS0xNTIy_9307b4fb-9abe-4ef3-9137-0ee87dd9b4bc">18,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78b5037d6f24467bb284a7f3daadf67d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNi05LTEtMS0xNTIy_3897bd06-94df-467e-af99-ade2afe3531d">17,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNi0xMS0xLTEtMTUyMg_2bda2a43-9be4-4ef4-a0db-e9c31d093f15">119,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfOC0xMS0xLTEtMTUwMQ_d7bdb352-f776-4126-94b7-6fd8a47b109c">8,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on sale of businesses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfOS0xMS0xLTEtMTUwMQ_84833055-e873-4206-8c15-7fa07ade2cd8">346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfMTEtMTEtMS0xLTE1MDE_0e104543-922e-4a46-a3eb-8586c3e1f393">37,366</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfMTItMTEtMS0xLTE1MjI_d02c9778-f9cd-49ec-a200-73aaa9c5e44a">90,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.704%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9eaba867e94987bae380499ef0dea5_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfMy0xLTEtMS0xNTAx_15d8826a-c1f6-46a0-b6df-6118790d53f8">72,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie40b7ae534f84659b72f603832026b2c_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfMy0zLTEtMS0xNTAx_e10a48fb-830f-49f1-8e0b-6e6d342e5709">50,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51d714fd1694458d8c8a2740933d72d8_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfMy01LTEtMS0xNTAx_d757e2de-e870-45ca-9df6-a94c3b16b086">45,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8878162e48ac455b871924e5a7f16043_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfMy03LTEtMS0xNTAx_9ad3f352-e488-4662-9c54-bb0f37c3278a">137,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i593f37f6bebf4b5c8147fc667686329b_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfMy05LTEtMS0xNTAx_3034ce89-5f2e-4ca4-b6f9-f5dc728695a7">35,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d9eaba867e94987bae380499ef0dea5_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNC0xLTEtMS0xNTAx_076b7bf5-be69-4ca0-956a-ae14b5e2fc46">12,936</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie40b7ae534f84659b72f603832026b2c_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNC0zLTEtMS0xNTAx_d0cebeaa-0312-4905-abbe-76ff415a40aa">6,939</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51d714fd1694458d8c8a2740933d72d8_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNC01LTEtMS0xNTAx_0e483222-3245-4012-9a69-0fa5f615ba12">7,345</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8878162e48ac455b871924e5a7f16043_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNC03LTEtMS0xNTAx_814b62a8-ceb0-4b3c-9c58-595b80eaab14">21,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i593f37f6bebf4b5c8147fc667686329b_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNC05LTEtMS0xNTAx_b23271e9-9e6b-4209-8633-3532c34d3cde">2,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9eaba867e94987bae380499ef0dea5_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNS0xLTEtMS0xNTAx_506e25be-5fd7-4a39-af87-2406b6bed5e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie40b7ae534f84659b72f603832026b2c_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNS0zLTEtMS0xNTAx_d596876f-886b-4002-8a99-86fd04d23c58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51d714fd1694458d8c8a2740933d72d8_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNS01LTEtMS0xNTAx_9351cb64-75b3-4fde-a6d3-059eadd9714b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8878162e48ac455b871924e5a7f16043_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNS03LTEtMS0xNTAx_5c60aa81-0b3b-4a73-9ae0-2aa4df19ae70">535</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i593f37f6bebf4b5c8147fc667686329b_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNS05LTEtMS0xNTAx_f1e4fa79-bf63-4045-bce2-0aea1da66e4d">6,564</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9eaba867e94987bae380499ef0dea5_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNi0xLTEtMS0xNTIw_bd65e164-0ba3-4b13-bc09-abeb0c6cbc00">59,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie40b7ae534f84659b72f603832026b2c_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNi0zLTEtMS0xNTIw_df631075-ced7-4c30-afb9-014bb01ad53a">43,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51d714fd1694458d8c8a2740933d72d8_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNi01LTEtMS0xNTIw_835abdc7-dc4b-45f7-8543-bf6d1f2e323f">38,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8878162e48ac455b871924e5a7f16043_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNi03LTEtMS0xNTIw_e7ad85c5-245c-455a-9146-90ee45305056">115,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i593f37f6bebf4b5c8147fc667686329b_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNi05LTEtMS0xNTIw_35eadc74-73b4-474c-aab8-c95dd51e6ed0">26,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNi0xMS0xLTEtMTUyMA_bd0fba15-a477-47dd-8707-50ebd586bb30">283,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfOC0xMS0xLTEtMTUwMQ_ae9f0ee1-5ed8-4577-9605-cf97b9558ead">11,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfMTEtMTEtMS0xLTE1MDE_8e0ab5f7-7d99-41d9-abcf-491bb36c636b">33,888</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfMTItMTEtMS0xLTE1MjA_6fb22e9f-072f-4747-a7a2-7bd6d5efb918">261,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.704%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83fa48e193ef409091a5469b91556348_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfMy0xLTEtMS0w_4db94e08-7b2f-4cac-97c4-91d27390e1b6">178,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7fe7ee2784746f5af6d2429cd8a2219_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfMy0zLTEtMS0w_6568a889-ff06-46e7-9e79-179a52ad1643">66,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89f2bc1bb34c1c88b6b97eb1162a82_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfMy01LTEtMS0w_c8b71781-70c5-4f2f-a654-bd659d90b7e6">20,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb407c8a9fd406bbddf4aaba0a22fbf_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfMy03LTEtMS0w_3ace622e-2f7d-4ba5-ae1b-414272c37fbf">102,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a46c953c7a44137882933b2fccefa90_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfMy05LTEtMS0w_06b786cb-6a74-466e-bac0-f373e2393355">2,205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83fa48e193ef409091a5469b91556348_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNC0xLTEtMS0w_9d6dae09-86fb-4351-ab34-70b43dae1158">26,228</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7fe7ee2784746f5af6d2429cd8a2219_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNC0zLTEtMS0w_cf119e67-4651-459e-89a2-0602ec4eb268">13,794</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae89f2bc1bb34c1c88b6b97eb1162a82_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNC01LTEtMS0w_c455a40d-e0d3-4f2c-b0e4-e65a97bd3588">14,412</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffb407c8a9fd406bbddf4aaba0a22fbf_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNC03LTEtMS0w_31cffee1-3f88-4fb7-889f-f592318962ca">44,744</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a46c953c7a44137882933b2fccefa90_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNC05LTEtMS0w_5988d726-3e70-42f3-9a49-e8ba5c50d349">4,845</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83fa48e193ef409091a5469b91556348_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNS0xLTEtMS0w_f940dc9d-7f4a-4cf4-b2f7-e97dffbc729d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7fe7ee2784746f5af6d2429cd8a2219_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNS0zLTEtMS0w_3ace75d1-7abf-4868-be5c-57cf3330cf45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89f2bc1bb34c1c88b6b97eb1162a82_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNS01LTEtMS0w_ff6faaeb-2b8e-465e-bd86-fdb94aa1d7f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffb407c8a9fd406bbddf4aaba0a22fbf_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNS03LTEtMS0w_4f3eee90-e420-4058-8192-6be054364ad9">1,468</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a46c953c7a44137882933b2fccefa90_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNS05LTEtMS0w_4e30e59c-2fbd-437d-8fed-96a0f7b5bf43">12,398</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83fa48e193ef409091a5469b91556348_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNi0xLTEtMS0w_89bb4e5a-9ba1-49fa-bb63-fe9f47baea56">152,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7fe7ee2784746f5af6d2429cd8a2219_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNi0zLTEtMS0w_da6e8cca-3011-42f7-a9a9-202dc679a13e">52,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89f2bc1bb34c1c88b6b97eb1162a82_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNi01LTEtMS0w_1ce940a6-9fe7-4ebd-a607-80e8988e2c1b">6,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb407c8a9fd406bbddf4aaba0a22fbf_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNi03LTEtMS0w_f8f0927f-3081-4a6e-a3ff-e03a870af1aa">56,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a46c953c7a44137882933b2fccefa90_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNi05LTEtMS0w_c29a56a0-fba2-4441-878f-35a46a38aa50">19,448</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNi0xMS0xLTEtMA_c643da78-9781-4be4-a36c-60499ff48732">248,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfOC0xMS0xLTEtMA_7ac5332a-cb6a-4d56-8198-2ea1b9e1e44a">10,912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on sale of businesses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfOS0xMS0xLTEtMA_44c1472b-fba3-42b4-bf18-383f132906a1">7,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfMTEtMTEtMS0xLTA_7ba3fd7f-207e-4d59-b742-19ba348dae83">83,473</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfMTItMTEtMS0xLTA_01a6f180-4646-400a-9e72-4ec87587c177">183,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.704%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i842ce964455440c8bf019b096558985c_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfMy0xLTEtMS0w_cb3e40d7-298e-4538-a629-597b85a3da77">186,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8083b69f958c4c0f8dbe5292758beec8_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfMy0zLTEtMS0w_f5bf31a6-8bb9-4c92-8797-5b969977de25">101,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f26863a74d46b3807377370b9f5c71_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfMy01LTEtMS0w_d232b91b-eaa1-43e6-a52a-a616f424a6ab">71,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d773ec12ea468d884922f6a9c624ab_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfMy03LTEtMS0w_b5a3ae51-7287-491d-9b06-742fd64f1b48">219,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9da22e6ac16b4906870e768509e1fb6f_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="sem:AdjustedEbitda" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfMy05LTEtMS0w_f162573a-0ada-402f-b31a-046457a1c1fb">21,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i842ce964455440c8bf019b096558985c_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNC0xLTEtMS0w_7faf3798-b1d7-4b05-85d3-a4dc5945bb45">25,986</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8083b69f958c4c0f8dbe5292758beec8_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNC0zLTEtMS0w_d77b7ce7-1a36-411e-a609-44400c6a8266">13,999</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1f26863a74d46b3807377370b9f5c71_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNC01LTEtMS0w_3307bfc0-3ee8-4a09-9ebc-b880f2518eaa">14,536</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1d773ec12ea468d884922f6a9c624ab_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNC03LTEtMS0w_aa2a7536-14f2-4551-840a-cab4579cd3d0">41,128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9da22e6ac16b4906870e768509e1fb6f_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNC05LTEtMS0w_d4139b96-d4be-44c2-b9cc-3fc610562456">4,925</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i842ce964455440c8bf019b096558985c_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNS0xLTEtMS0w_9545e4dd-f6f3-40f8-a3e6-d2b9b522d30e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8083b69f958c4c0f8dbe5292758beec8_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNS0zLTEtMS0w_4aa3bddb-4476-4958-a21b-1934e74b68ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f26863a74d46b3807377370b9f5c71_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNS01LTEtMS0w_ab7f85a5-0fcc-420b-b3c3-52d412ddcf7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1d773ec12ea468d884922f6a9c624ab_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNS03LTEtMS0w_e994202b-56df-4651-817e-351bb0c425ac">1,071</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9da22e6ac16b4906870e768509e1fb6f_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNS05LTEtMS0w_dca2572e-3ef3-4941-9e6c-ae167c880b9a">12,737</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i842ce964455440c8bf019b096558985c_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNi0xLTEtMS0w_64390600-c860-4c7d-adf8-cb1f73dcf2da">160,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8083b69f958c4c0f8dbe5292758beec8_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNi0zLTEtMS0w_643eba1d-f9be-4fe2-9fcc-bff90329b4df">87,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f26863a74d46b3807377370b9f5c71_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNi01LTEtMS0w_05485dfb-f913-4c2a-847a-be98caebf0d9">57,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d773ec12ea468d884922f6a9c624ab_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNi03LTEtMS0w_edd3eeaf-d844-412c-834f-e13703cafca8">176,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9da22e6ac16b4906870e768509e1fb6f_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNi05LTEtMS0w_573dd910-27f7-4364-9475-fdc954489de6">4,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNi0xMS0xLTEtMA_90cf3adb-4f75-4857-86fc-7202fc5c5bc5">485,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfOC0xMS0xLTEtMA_997fd60e-d37f-4a5b-ac39-b9a7d992f59f">21,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfMTAtMTEtMS0xLTA_cf5fb8d5-7233-408d-8317-26cc5c924830">4,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfMTEtMTEtMS0xLTA_e9bb841f-10e2-42ba-9546-6d2d93ab8edb">68,290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfMTItMTEtMS0xLTA_e2248ec3-7a85-41a6-8832-04338bdc7f6d">444,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.   &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RleHRyZWdpb246YWViZDE3ZWI2OGQ1NGY0NDg2MGI2NzU5NjNiMDZkOGFfMTQ4_1cc95d92-ae82-4d63-9c37-9884008af83f" continuedAt="i93e6e20fcbfb43ff90f68858fcf55d4e" escape="true">Revenue from Contracts with Customers</ix:nonNumeric></span></div><ix:continuation id="i93e6e20fcbfb43ff90f68858fcf55d4e"><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RleHRyZWdpb246YWViZDE3ZWI2OGQ1NGY0NDg2MGI2NzU5NjNiMDZkOGFfMTU0_17b7f0ce-e5f9-4dec-ad74-50c70238a42e" escape="true"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate the Company&#8217;s revenue for the three and six months ended June&#160;30, 2020 and 2021: </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:23.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.854%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patient service revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2445574d08d460aadb6cb824e13b57b_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNC0xLTEtMS0xNTUy_5726d1c3-7c79-442a-b23b-126ece029156">215,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a8bda6aa364b458b46c6989204116a_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNC0zLTEtMS0xNTUy_cae7c3f5-115d-4a30-94db-dceb2ad94c05">71,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f65e64fc704e26b6d0c36a9b3e98cc_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNC01LTEtMS0xNTUy_eccedc38-3f85-41e9-bc4c-3973e93dfa2f">20,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ad499a02f004e11a55a3d20c113db01_D20200401-20200630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNC03LTEtMS0xNTUy_141884d3-9101-404d-b50c-64613d87a849">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6157d64fab14d1f866ca5d716c12912_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNC05LTEtMS0xNTUy_696c57ef-b847-41db-82af-0608548b6c40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51ff975211194a639c5584cea74d9cb5_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNC0xMS0xLTEtMTU1OQ_e081314b-f524-424c-9cc0-9b1eb2c6059f">307,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-Medicare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5664ca3bf1834ed1b346b6f980fe1645_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNS0xLTEtMS0xNTUy_e0bd33a4-dd72-4a32-bd78-d475ef102474">301,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1932c1a031b842f497c5e4232f3f980c_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNS0zLTEtMS0xNTUy_0c361177-b013-4df8-b9aa-b3c498901478">87,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia82ee7626c034379a7ef163f2061e2bf_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNS01LTEtMS0xNTUy_a07e1088-0220-473d-b651-314246711d47">135,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2712f735bf4472b74c12c452e1727d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNS03LTEtMS0xNTUy_e81aa1cd-def3-4805-be7b-558297b83370">309,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9163058a56849f4b1b6ebd3958a1728_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNS05LTEtMS0xNTUy_f2c4b27a-6825-48ef-b564-aa475554d808">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43209435be314fa6a83374c8722c58a5_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNS0xMS0xLTEtMTU1OQ_8d811ce2-e112-4c75-b5c5-5a58a6ed6ba2">833,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total patient services revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eb9a05c181e4145a86c46192acc8653_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNi0xLTEtMS0xNTU5_f8339dda-0579-419f-b635-e211e3ddad80">516,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5dc54ed53b94d6eabdf4d733168a430_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNi0zLTEtMS0xNTU5_53b3efbe-df50-4d27-a0d1-69d7ffcbda84">159,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5110b434e804f27b249daa0ac18bd3d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNi01LTEtMS0xNTU5_0f035835-5c59-4143-9c39-2f0efbc06ce7">155,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1301e820f4e544f99fea1fdaef7b153a_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNi03LTEtMS0xNTU5_38bb232c-f29f-4482-88a8-42255e6a556f">309,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia49b80360ab44d889a87b1c6f86dba3d_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNi05LTEtMS0xNTU5_4a40bb93-5f12-4fee-bd24-6321152d1191">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6e87f49cddf4c0993fcc9475663950b_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNi0xMS0xLTEtMTU1OQ_224d24eb-cb1e-442c-9e1a-6e46a60f67c7">1,140,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3595ddefe5469b964256337e3fb034_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNy0xLTEtMS0xNTUy_0f67eb20-8949-47f3-9476-72d9c850da62">3,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a40e1e8ef2b4a6ca0e3d8215ef692c7_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNy0zLTEtMS0xNTUy_c3e67732-88fe-45ff-8b57-eaf92560c477">9,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae9d25c4a62e4670a396e7b6215efe42_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNy01LTEtMS0xNTUy_7592bec5-dc7d-4731-99af-d38ffd36d7db">11,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddb712476dc64adeae838bf8e4757e71_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNy03LTEtMS0xNTUy_cba56e5d-4536-418a-9a5a-b52fdcca742a">2,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32cc5b0f0da748fa964f8bee8c8e5eab_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNy05LTEtMS0xNTUy_032ed4c4-43e1-4de6-a8c5-8b3de2876255">64,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i424eb507e0b64cc39d53cf96c199d2c3_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNy0xMS0xLTEtMTU1OQ_b6c002f6-af47-4453-9c4d-738096241e6c">92,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e1d48a74eba45399c9304871d02e6ac_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfOC0xLTEtMS0xNTU5_213f3e9f-a8f9-4a51-bfbd-ca7d8d480eb4">519,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i153dba6636544126b8b590e3eceb746a_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfOC0zLTEtMS0xNTU5_98a5f6d9-7445-41d9-ac9c-272f99d793bc">168,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4101982ebb88440ab0a78e005d9ac883_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfOC01LTEtMS0xNTU5_eda27160-5ac3-47c5-b447-5e70026b7edf">167,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaed2d25f9da44d15a8e75aa82e738f7c_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfOC03LTEtMS0xNTU5_7d09d9c6-ccef-4d5a-b9fe-7f21bd979934">312,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78b5037d6f24467bb284a7f3daadf67d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfOC05LTEtMS0xNTU5_00e188be-6b63-469c-8d47-c7976a4828f5">64,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfOC0xMS0xLTEtMTU1OQ_36322c57-4ce4-4ec6-8484-f03cc22f7fdb">1,232,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:23.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.854%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patient service revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2f065968f664f51a97a9c4c8a8f6786_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNC0xLTEtMS0xNTUy_edecdf54-97b0-4216-a28d-f94b321992c4">201,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedc923ca54a245aa839e41b3bd36de0e_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNC0zLTEtMS0xNTUy_e8838a3c-9460-4a15-89fd-d1d70865e48a">103,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97ccae97127f42ec84a3a9dd4735f5cd_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNC01LTEtMS0xNTUy_98a126f5-4c46-492c-9127-2f2072bba4e2">45,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i091aa3c41eb94571a18e7d780ed4b261_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNC03LTEtMS0xNTUy_1190882d-fe82-4789-a471-8aa462530c02">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77d3137a60484a139d63c1c58d70fceb_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNC05LTEtMS0xNTUy_553c5653-083f-479d-a0b9-5e56c72e075f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42b3c528abf945e9859cc7f7f223fceb_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNC0xMS0xLTEtMTU2MQ_d6f51d70-04b7-4c40-90e7-a17f67d0fe2f">350,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-Medicare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd3ac5b6dbc749ff8ee6bfd8cf0ca211_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNS0xLTEtMS0xNTUy_dc6de541-018c-46aa-86b8-f3b60e60069e">340,929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddc4d97079e3443eba00958c5b46559d_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNS0zLTEtMS0xNTUy_0360466a-5345-4d13-8401-373cb07d15bd">98,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76832d2c4ca64519914f4773ca5655bc_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNS01LTEtMS0xNTUy_6b17122d-c8a4-4721-9787-baf8a422e3fe">217,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbd9fe5a16a7443b8f6b7fb4c8339e17_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNS03LTEtMS0xNTUy_1b9f2d9f-d1d2-41f3-80fa-0fe0cc247a37">454,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f495ab15c4472ea5245942bf95dbc0_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNS05LTEtMS0xNTUy_73fc8f3c-5eab-4de7-873f-6093ba245d86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic066865053b14c43b32c73b1cbc2a459_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNS0xMS0xLTEtMTU2MQ_2f29f1cd-9036-4c29-b9b5-0ab64b22bf0a">1,111,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total patient services revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe618caa2cdd41b493cccea11ad44386_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNi0xLTEtMS0xNTYx_dfeb9c97-06fe-4739-987c-4a2593bded4e">542,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb0e1422e48941919179e0c5e60cc063_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNi0zLTEtMS0xNTYx_6e3b1bb7-3c03-47b2-946c-057ccb879b3e">202,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b8f9d9710f4d46bba3b4cd219bcae3_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNi01LTEtMS0xNTYx_70c17504-e802-48d4-818c-584f805e92f5">263,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i116e543b7d364332a96e426369913e91_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNi03LTEtMS0xNTYx_b6d68334-e547-4b17-8dda-773463b2b3e7">454,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ce5d7ae1f3b480f9d278936f6173744_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNi05LTEtMS0xNTYx_22b4fc78-38f4-4f33-a0e5-727c1e7345b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4d10e3e03a54b60a9d607bc62d66b9d_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNi0xMS0xLTEtMTU2MQ_bebbfca2-6e81-4a25-9a10-b7d2404e6b4f">1,462,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c16ab56e4cf48229de650aa8e6455b3_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNy0xLTEtMS0xNTUy_3974955d-ec54-4e3f-a08b-0153e8ed19fd">1,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i473b076cbb2248cda45ee5fecdf6c6d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNy0zLTEtMS0xNTUy_e58c613d-3db4-4ee5-89bd-11a7bedd1d4f">10,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22bf8e5a71a74e0ab969fc88fc9d25f9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNy01LTEtMS0xNTUy_c694e363-9e08-496a-bf04-7ec660c5a65e">17,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31fd5c81c9e74201ae6e106c98ca01c6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNy03LTEtMS0xNTUy_9fff1e0f-004c-43fa-a6be-fb961d99bc49">1,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02680b33aed34a55a6fe418edcde45ed_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNy05LTEtMS0xNTUy_3eff4132-245f-4a62-8239-8e58a9b0de0e">70,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fcbd9d03f874759a798ba9dfa435489_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNy0xMS0xLTEtMTU2MQ_c116312b-aa74-4951-8e87-022dfa53391d">101,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d9eaba867e94987bae380499ef0dea5_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfOC0xLTEtMS0xNTYx_53f38683-c992-49cd-8405-8dedbdf4a855">544,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie40b7ae534f84659b72f603832026b2c_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfOC0zLTEtMS0xNTYx_c4eae5a8-f669-4d7f-afa1-b0a5bb947d7c">212,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51d714fd1694458d8c8a2740933d72d8_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfOC01LTEtMS0xNTYx_df65927d-1057-494b-87dc-4688fb10e8c1">280,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8878162e48ac455b871924e5a7f16043_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfOC03LTEtMS0xNTYx_29fda258-2694-4aff-90d2-27b1d9d40cce">456,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i593f37f6bebf4b5c8147fc667686329b_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfOC05LTEtMS0xNTYx_f92194df-10c1-4a04-bea3-c2f253e8c790">70,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfOC0xMS0xLTEtMTU2MQ_86cdba08-7f20-4587-8033-9d238f207312">1,564,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:23.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.854%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patient service revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6f011f7031b41769857679e22ff5b33_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNC0xLTEtMS0w_5b0139e7-c949-4a32-aeec-b0aa692488c8">457,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25ea57bf51c745e29ae8656720141e04_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNC0zLTEtMS0w_fe54914c-0481-483f-a973-4836997c3dd5">162,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4602a266daee48acb939fda3366b3e59_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNC01LTEtMS0w_b1ffc60e-35d0-4d4a-a287-39ddb7a80f39">60,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52fcf8fa0e7f407ca9b2a0421d3c01b8_D20200101-20200630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNC03LTEtMS0w_b77e31cc-3605-490d-ab31-c4eed03b9109">729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b1c9f6d7cde4d229d84a29158db43c5_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNC05LTEtMS0w_de9b8610-f810-4d6c-8820-49321f995be7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb336581b1ab46dabf7a10b846ee714d_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNC0xMS0xLTEtMA_9e67df56-046e-4557-9aef-176c8d5220b4">680,889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-Medicare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cf7cf902b774976a354f108a49e122b_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNS0xLTEtMS0w_9e96c581-e247-431b-be41-07228cc26d9e">557,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e5085e732d4d6fb28c986bae301d35_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNS0zLTEtMS0w_005e6b87-54fd-4435-9ca3-1d2aebf0d87a">169,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c5c1a4ea8b1455f8ea9b309f782aed0_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNS01LTEtMS0w_c399480c-b5c4-4fd0-9963-619a9ebefbf8">331,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabcbf2354ad849b5a607f2c23acf92b6_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNS03LTEtMS0w_7060ca97-094e-4953-b498-361de83895a0">704,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f1e3f7f1bd3482cb8ed258cb9ada854_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNS05LTEtMS0w_972e5923-fec3-4691-aee8-f2bc30f5b543">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30d728f258204b97bb72e03b6261514d_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNS0xMS0xLTEtMA_10871f10-35ce-40ed-8bd5-1cae3a459c05">1,762,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total patient services revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059d076681264fbfb89b79347f63c29a_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNi0xLTEtMS0w_bbbe7437-c3fb-4dfe-86ac-340ce14d82bd">1,014,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f1cf5853d5f4c45936b37bfbdffa0db_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNi0zLTEtMS0w_c09075ed-2831-4074-a634-a09cc2122247">331,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i063dc8bb9c604cb991c0938ed63900c1_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNi01LTEtMS0w_71da70a6-2bd1-433d-be02-7e983e530e71">392,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e73da1de31a46198a088e1a579b197e_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNi03LTEtMS0w_006d0c52-c084-4986-bcc0-dd720e08172e">705,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i013ac78a834a4a17a349b46fff225ede_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNi05LTEtMS0w_8d653c75-165f-43f4-a0fb-be0d05ec3390">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i241f967097904b2e90e2c1981d5bfb2f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNi0xMS0xLTEtMA_4e528dea-19be-4f9f-b5e0-0a904fa2178b">2,443,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i606bd30a10194d7c92111ec05dd70ef2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNy0xLTEtMS0w_dbc19cc7-d61e-483d-afa5-71a930ebe123">6,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14aff568d487484d955b6414e353d276_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNy0zLTEtMS0w_fa60521f-8d63-4b26-859f-05528de1ce62">19,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f5bf5cc569148f08c2f756e392e095a_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNy01LTEtMS0w_2267b545-84e9-4a63-8ad7-e266ce36ec8e">29,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i513bb2ed05384cf0b367f1a1f2df60cd_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNy03LTEtMS0w_9c03ba3c-01d7-4420-aaa5-a97253769594">5,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ae7544550d341458079a0f82f73a2f8_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNy05LTEtMS0w_aca93d63-27da-431d-98d3-c3d30831a0d8">143,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1343d1d64ee546f4b3bc8de894d6a417_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNy0xMS0xLTEtMA_f8416c52-8d47-47ea-bbd7-69ff07f95be3">203,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83fa48e193ef409091a5469b91556348_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfOC0xLTEtMS0w_ed0c55ad-b4b7-47bc-ba5a-aa6d9efd28b8">1,020,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7fe7ee2784746f5af6d2429cd8a2219_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfOC0zLTEtMS0w_f6f7a25c-05f4-496b-b35f-553654b8bf35">350,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89f2bc1bb34c1c88b6b97eb1162a82_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfOC01LTEtMS0w_bd956b34-f5ec-4c24-8dd8-728ae8a7c2ea">422,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb407c8a9fd406bbddf4aaba0a22fbf_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfOC03LTEtMS0w_f30e0cdb-826b-49ac-85be-5d6ad1a2026b">710,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a46c953c7a44137882933b2fccefa90_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfOC05LTEtMS0w_70da29cd-b2dc-49e4-934e-c6ba7d4a48e7">143,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfOC0xMS0xLTEtMA_0b437221-5961-40ee-af77-d87a43478956">2,647,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:23.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.854%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patient service revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i446969a89bf54833b066ad6cadf438aa_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNC0xLTEtMS0w_74474164-bd07-411f-8cdd-1288d3aa183b">433,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35be1d23264d4ef8900b083084bae9b1_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNC0zLTEtMS0w_20728bbe-5251-469a-a392-de5661c7bc27">206,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i228091dd94e94a2fb65278d548b96136_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNC01LTEtMS0w_4da4d391-48c5-4ca3-b3ea-a3d0717f9bc1">81,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84a37576ff314681abd2c231a24ffea5_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNC03LTEtMS0w_6f3b1090-4824-46d8-886c-5a56322f5c46">525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibef36a70c20e4c0e98c28b191ddfb97b_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNC05LTEtMS0w_438e91e9-c296-45f9-8b17-fd978454fccd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bd1eaf1ae624135ac4bc8d0d22d46d6_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNC0xMS0xLTEtMA_eec56441-cf0e-40d2-91c3-af43881c9f5a">721,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-Medicare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8c4a3d34c3f41908312ed9c79fa8fd3_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNS0xLTEtMS0w_49f1901a-5239-4ea6-a748-235c361795d8">702,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie29532d76e2d4dee8c6c7b7b1be770c1_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNS0zLTEtMS0w_ad4c63b7-fc88-4e30-871b-c3087795149e">193,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45fee6050b8a4216a0f668de2e12e95b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNS01LTEtMS0w_9ce5192d-931e-450b-982e-1c52436dd166">418,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i982e0b3f126040f69ce41b2c2252c0bc_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNS03LTEtMS0w_a43553a0-9ca2-41d4-bf01-0fe0c07700df">874,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1882e5c4817847d286a5e4ee18cd8c03_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNS05LTEtMS0w_472756dd-5437-40e0-8ee3-a64df44e8fa5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89fb0d7ade4b445bbe6adb3867b94148_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNS0xMS0xLTEtMA_760a80a3-57aa-4d0e-ad32-47266a8bccef">2,189,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total patient services revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ec355699c047d88cd0a6ed1979c79b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNi0xLTEtMS0w_25f7a1c4-cc08-465f-95ed-853d51322a96">1,135,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaee340f3a6b64cbdbe9dbc79ba2744d6_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNi0zLTEtMS0w_6c43f5ec-2fa8-486b-b986-6aea99fec7e5">400,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e316619ee3b482d9c7fae4209c447ad_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNi01LTEtMS0w_007dc11d-5d97-45e8-a2ee-147f8f6c8c22">500,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27949e6e57514846a097e4475475890d_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNi03LTEtMS0w_a0be5f93-4e44-4199-98cd-e1763e042e6a">875,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i101f8dba1cbb472ab5d1e292ca9ad014_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNi05LTEtMS0w_e318737a-8e12-4593-a8a1-f0c30af0c47d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67f288ba5c84408f889c40613f2a07b4_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNi0xMS0xLTEtMA_a7d8ae53-0eec-4a88-9003-a0addb53f42e">2,911,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1950866dbcfb4c3e96407bec7d05b210_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNy0xLTEtMS0w_b1ea1ed4-99db-4c07-a2e3-4292dd0014e7">3,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e70dfbd95e342bd9f7d99e607af7d63_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNy0zLTEtMS0w_606419d6-d8e0-438a-9453-36913115d684">20,445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4760aa7fcf714911a502ad44e9ed68ac_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNy01LTEtMS0w_a9c97934-6c98-465c-8f6a-b63acbdea132">32,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic39be75c367b45e1a92d762771bc3eec_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNy03LTEtMS0w_dad12120-6d10-45ee-bba3-f7d6fb1f03ab">3,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71dc8bf60a54443290451e38ffa4cbb0_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNy05LTEtMS0w_7c66e09a-62c5-47f0-a9dc-6a2ee0400982">139,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf91d28d1f7f4831a5c56411e190d606_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNy0xMS0xLTEtMA_4d5eeec4-72d3-4e9d-b6a3-39d5f90c7bda">199,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i842ce964455440c8bf019b096558985c_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfOC0xLTEtMS0w_cc35e649-99b8-4777-bf56-ed184992c42b">1,138,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8083b69f958c4c0f8dbe5292758beec8_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfOC0zLTEtMS0w_d1a86286-e6b9-4437-b848-a0560f13ef5d">420,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f26863a74d46b3807377370b9f5c71_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfOC01LTEtMS0w_0772660b-891a-413d-be0d-10c001d581ac">532,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d773ec12ea468d884922f6a9c624ab_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfOC03LTEtMS0w_5ad07e98-4f2c-4a02-8310-ec2b23134353">879,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9da22e6ac16b4906870e768509e1fb6f_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfOC05LTEtMS0w_98dfa20b-7067-4e28-87c3-a03a99bdb813">139,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfOC0xMS0xLTEtMA_c1425991-e262-47c3-88be-f21892eb5833">3,110,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:9pt;margin-top:9pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RleHRyZWdpb246NTgzYmNkMDUzZjE0NGEwNjkyMTNjM2VjZGM2ZjdhZGRfMTgwNQ_4986b233-4429-4198-a32c-e3f6186531c8" continuedAt="i008d450f6acd4d9baf3510e75c440134" escape="true">Earnings per Share</ix:nonNumeric></span></div><ix:continuation id="i008d450f6acd4d9baf3510e75c440134"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s capital structure includes common stock and unvested restricted stock awards. To compute earnings per share (&#8220;EPS&#8221;), the Company applies the two-class method because the Company&#8217;s unvested restricted stock awards are participating securities which are entitled to participate equally with the Company&#8217;s common stock in undistributed earnings. Application of the Company&#8217;s two-class method is as follows:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.82pt">Net income attributable to the Company is reduced by the amount of dividends declared and by the contractual amount of dividends that must be paid for the current period for each class of stock. There were <ix:nonFraction unitRef="usdPerShare" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="2" format="ixt-sec:numwordsen" name="us-gaap:EarningsPerShareDilutedDistributed" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RleHRyZWdpb246NTgzYmNkMDUzZjE0NGEwNjkyMTNjM2VjZGM2ZjdhZGRfNjUz_10dadca4-5ba9-42d3-b9e7-ce6306a21d4c"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="2" format="ixt-sec:numwordsen" name="us-gaap:EarningsPerShareDilutedDistributed" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RleHRyZWdpb246NTgzYmNkMDUzZjE0NGEwNjkyMTNjM2VjZGM2ZjdhZGRfNjUz_2139889d-5cf1-410c-92e9-0ebff3695f29"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="2" format="ixt-sec:numwordsen" name="us-gaap:EarningsPerShareBasicDistributed" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RleHRyZWdpb246NTgzYmNkMDUzZjE0NGEwNjkyMTNjM2VjZGM2ZjdhZGRfNjUz_39641ffc-80b0-47a2-9a0d-818445d81572"><ix:nonFraction unitRef="usdPerShare" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="2" format="ixt-sec:numwordsen" name="us-gaap:EarningsPerShareDilutedDistributed" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RleHRyZWdpb246NTgzYmNkMDUzZjE0NGEwNjkyMTNjM2VjZGM2ZjdhZGRfNjUz_55202914-857e-4447-a4d0-b3cf7eec887e"><ix:nonFraction unitRef="usdPerShare" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="2" format="ixt-sec:numwordsen" name="us-gaap:EarningsPerShareBasicDistributed" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RleHRyZWdpb246NTgzYmNkMDUzZjE0NGEwNjkyMTNjM2VjZGM2ZjdhZGRfNjUz_6e086e3c-c93e-45d8-963b-1a9f58bb8564"><ix:nonFraction unitRef="usdPerShare" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="2" format="ixt-sec:numwordsen" name="us-gaap:EarningsPerShareBasicDistributed" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RleHRyZWdpb246NTgzYmNkMDUzZjE0NGEwNjkyMTNjM2VjZGM2ZjdhZGRfNjUz_84e5fcdc-3cfb-4905-bb92-d8af8c63b23b"><ix:nonFraction unitRef="usdPerShare" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="2" format="ixt-sec:numwordsen" name="us-gaap:EarningsPerShareDilutedDistributed" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RleHRyZWdpb246NTgzYmNkMDUzZjE0NGEwNjkyMTNjM2VjZGM2ZjdhZGRfNjUz_8502984c-5c10-42e0-a085-5fcae9a39ca9"><ix:nonFraction unitRef="usdPerShare" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="2" format="ixt-sec:numwordsen" name="us-gaap:EarningsPerShareBasicDistributed" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RleHRyZWdpb246NTgzYmNkMDUzZjE0NGEwNjkyMTNjM2VjZGM2ZjdhZGRfNjUz_af90e3a3-f22b-42d6-82e7-9df6289c9c12">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> contractual dividends paid for the three and six months ended June&#160;30, 2020 and 2021.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.05pt">The remaining undistributed net income of the Company is then equally allocated to its common stock and unvested restricted stock awards, as if all of the earnings for the period had been distributed. The total net income allocated to each security is determined by adding both distributed and undistributed net income for the period. </span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.28pt">The net income allocated to each security is then divided by the weighted average number of outstanding shares for the period to determine the EPS for each security considered in the two-class method.</span></div><ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RleHRyZWdpb246NTgzYmNkMDUzZjE0NGEwNjkyMTNjM2VjZGM2ZjdhZGRfMTgxNA_bad45875-890b-40fd-bdce-f90f4e389ab3" escape="true"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the net income attributable to the Company, its common shares outstanding, and its participating securities outstanding. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNC0yLTEtMS0w_4fab6bd7-099e-44e7-86bd-50b067b74a4e">67,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNC00LTEtMS0w_36b54f1b-bff0-4dc0-9264-f3246b6e678e">196,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNC02LTEtMS0w_5ca0d6f5-3e6a-4087-b027-8a9aaad0b091">137,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNC04LTEtMS0w_7725064e-45de-42a7-91fb-584354ab8933">333,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNS0yLTEtMS0w_e3400c37-a4d9-4ed7-ae57-ace4c30cafa4">15,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNS00LTEtMS0w_9a059b87-e98f-4e91-8946-bdf65cc69757">31,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNS02LTEtMS0w_cf3c7816-51cc-4ea1-a28b-5fbc4bf3122a">33,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNS04LTEtMS0w_948fd0a0-9352-4f9b-8b3a-b972491c8790">57,982</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to the Company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNi0yLTEtMS0w_bc31a35b-6e00-4dc8-9aed-5f8c3bae5f14">51,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNi00LTEtMS0w_71d505cf-1b8b-4ac6-87d0-bb8303239e26">164,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNi02LTEtMS0w_63e517e1-78b3-4b8f-9210-de4b9f271d0b">104,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNi04LTEtMS0w_b55561fa-39ca-489d-b8ca-08d83f579630">275,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Distributed and undistributed income attributable to participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNy0yLTEtMS0w_3be30c60-7c56-4742-80dd-3b0edca4d396"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNy0yLTEtMS0w_8e87a52d-9401-4cf6-961c-506264c6fa84">1,778</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNy00LTEtMS0w_21422369-78ea-415f-b951-2867cdf05b7a"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNy00LTEtMS0w_f2f63858-f5f9-4132-882e-d73b531abc30">5,560</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNy02LTEtMS0w_7a93cd36-c644-4cca-8396-1d18a836a9b1"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNy02LTEtMS0w_b2014949-83c7-45c8-83c9-3b6488a21445">3,596</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNy04LTEtMS0w_3d112dac-8f9e-41a5-bcf9-6bb7e3425bcc"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNy04LTEtMS0w_4b30987e-552a-4f82-80f0-b40b422a9ff7">9,250</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributed and undistributed income attributable to common shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfOC0yLTEtMS0w_6dd0666f-ed01-47ba-a10e-cdb35875d584"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfOC0yLTEtMS0w_fe9f17a9-3fc6-4fb7-9e07-e1fbdefadb1f">49,872</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfOC00LTEtMS0w_08d5428c-6427-4bb6-80d1-9259ad039e5e"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfOC00LTEtMS0w_cb133351-627c-4dab-ad1c-2999f5432449">159,334</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfOC02LTEtMS0w_0c320909-7b3e-47d9-83b9-ad9d6d2118b6"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfOC02LTEtMS0w_ba777ff9-a6e8-4b73-a00e-da18fb9babc7">101,179</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfOC04LTEtMS0w_1396eab5-7852-4217-a1ea-54fd1906d3bd"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfOC04LTEtMS0w_d0ab700d-56fc-443e-a4a2-3a6faa36638d">266,190</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the computation of EPS under the two-class method:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:31.300%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="36" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Allocation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Allocation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="36" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except for per share amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC0yLTEtMS01NTY_2ae4a6d1-d5c3-4193-b7b1-ef5429fae7cb"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC0yLTEtMS01NTY_475f76bb-e86d-497c-8689-20b66415d9cf">49,872</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC00LTEtMS01NTY_7ed97e91-6861-491d-be3c-43341da6cf35"><ix:nonFraction unitRef="shares" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC00LTEtMS01NTY_cd6f1708-6a66-4e29-a423-745e6bf40baf">129,319</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC02LTEtMS02MDQ_8b33aa84-ed6a-44ba-99cc-0804bd299fb0"><ix:nonFraction unitRef="usdPerShare" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC02LTEtMS02MDQ_a7465f37-6c0d-4084-ba2d-be20686b73fd">0.39</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC05LTEtMS01NTY_1c8fa848-c6b6-4805-83cb-7262e008a195"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC05LTEtMS01NTY_3104abb1-84d5-4fac-bdb7-9ef7283cce8e">159,334</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC0xMS0xLTEtNTU2_1e93e7f2-684c-483b-9108-5703c8b9ecfa"><ix:nonFraction unitRef="shares" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC0xMS0xLTEtNTU2_27bfe71e-2ea0-4e79-996f-a97107cdc6a6">130,396</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC0xMy0xLTEtNjA2_08a6d9bb-53f4-45e6-9316-28b6dd32c255"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC0xMy0xLTEtNjA2_5a107905-c886-44af-99c0-7a2d7959baba">1.22</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNS0yLTEtMS01NTY_3be30c60-7c56-4742-80dd-3b0edca4d396"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNS0yLTEtMS01NTY_8e87a52d-9401-4cf6-961c-506264c6fa84">1,778</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNS00LTEtMS01NTY_827609c3-78ef-49ff-b579-9b96c313213e">4,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNS02LTEtMS02MDQ_4658f215-a732-415a-b382-0e09544ed0c1"><ix:nonFraction unitRef="usdPerShare" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNS02LTEtMS02MDQ_84ec6e78-8eae-4bc3-b808-9425573b80fa">0.39</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNS05LTEtMS01NTY_21422369-78ea-415f-b951-2867cdf05b7a"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNS05LTEtMS01NTY_f2f63858-f5f9-4132-882e-d73b531abc30">5,560</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNS0xMS0xLTEtNTU2_726ee58d-d5c0-4b41-ab28-eaa208fa8956">4,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNS0xMy0xLTEtNjA2_87c4050b-de9b-48e6-8860-7f8e3165f0f3"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNS0xMy0xLTEtNjA2_fa00e817-7180-4e02-97ae-cb67d904e6bb">1.22</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNi0yLTEtMS02MDg_9ce8f6e2-59f5-4e5f-962d-c22e9980b1e5">51,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNi05LTEtMS02MTA_da00df3b-fa00-4e37-8047-a293869c7603">164,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:31.300%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="36" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Allocation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Allocation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="36" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except for per share amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC0yLTEtMS0w_32bc83e3-1cf4-4951-b067-a5f0a80850d9"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC0yLTEtMS0w_527057f5-f791-43e1-8a39-3e92dfce1dfd">101,179</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC00LTEtMS0w_4baed145-012e-4482-ac0f-a24f478d082e"><ix:nonFraction unitRef="shares" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC00LTEtMS0w_86d9ef53-a7c5-425f-a836-7a88ef8d8570">129,479</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC02LTEtMS0w_161ae3f1-069e-4639-a6cb-7cd59908532d"><ix:nonFraction unitRef="usdPerShare" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC02LTEtMS0w_ec5613aa-0648-49b0-b1de-4e41f1f20652">0.78</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC05LTEtMS0w_92d36281-bcb1-46a8-8102-836f362017ec"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC05LTEtMS0w_c99f431e-5241-40d9-bdb9-d0edcaf0f28c">266,190</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC0xMS0xLTEtMA_2cd27020-ec74-43c8-9cab-d119faffb677"><ix:nonFraction unitRef="shares" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC0xMS0xLTEtMA_90f1df1f-78ea-4e00-ad0f-de4be69d4e40">130,362</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC0xMy0xLTEtMA_83f3bd06-4afb-4143-9949-2e1ae532069e"><ix:nonFraction unitRef="usdPerShare" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC0xMy0xLTEtMA_f623fa30-d899-4df6-b7ce-e2b1ac7fee6a">2.04</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNS0yLTEtMS0w_7a93cd36-c644-4cca-8396-1d18a836a9b1"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNS0yLTEtMS0w_b2014949-83c7-45c8-83c9-3b6488a21445">3,596</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNS00LTEtMS0w_49c1c006-1964-4893-ac97-dc7dc9ccce5c">4,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNS02LTEtMS0w_01f0027c-5233-49ee-8591-90996a001730"><ix:nonFraction unitRef="usdPerShare" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNS02LTEtMS0w_1d93acc2-621d-4f4a-b13a-e9b9a359c933">0.78</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNS05LTEtMS0w_3d112dac-8f9e-41a5-bcf9-6bb7e3425bcc"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNS05LTEtMS0w_4b30987e-552a-4f82-80f0-b40b422a9ff7">9,250</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNS0xMS0xLTEtMA_988e7e9a-8b40-4d58-8237-f21c88d52969">4,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNS0xMy0xLTEtMA_08621c40-5deb-4490-9641-7bbc377d83c0"><ix:nonFraction unitRef="usdPerShare" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNS0xMy0xLTEtMA_a73784da-65f3-4eb9-b27a-daee1c8cfb53">2.04</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNi0yLTEtMS0w_59c26e44-3508-4636-aabf-04b3e39c039a">104,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNi05LTEtMS0w_3c97207e-e4c1-4a02-91ee-34c4e9be90ee">275,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Represents the weighted average share count outstanding during the period.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85MS9mcmFnOmM5YTZkZWNmNjZjYzRjMmY5MTlhMGVjMDg3NWMwYmE1L3RleHRyZWdpb246YzlhNmRlY2Y2NmNjNGMyZjkxOWEwZWMwODc1YzBiYTVfODYzOA_c5ae9fba-c954-40eb-adf4-5ee5411ff675" continuedAt="i10fa53bd303846d4813773cee7f6ab95" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i10fa53bd303846d4813773cee7f6ab95" continuedAt="if781303ea596426ab5cb903e9d76831f"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various legal actions, proceedings, and claims (some of which are not insured), and regulatory and other governmental audits and investigations in the ordinary course of its business. The Company cannot predict the ultimate outcome of pending litigation, proceedings, and regulatory and other governmental audits and investigations. These matters could potentially subject the Company to sanctions, damages, recoupments, fines, and other penalties. The Department of Justice, Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;), or other federal and state enforcement and regulatory agencies may conduct additional investigations related to the Company&#8217;s businesses in the future that may, either individually or in the aggregate, have a material adverse effect on the Company&#8217;s business, financial position, results of operations, and liquidity.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To address claims arising out of the Company&#8217;s operations, the Company maintains professional malpractice liability insurance and general liability insurance coverages through a number of different programs that are dependent upon such factors as the state where the Company is operating and whether the operations are wholly owned or are operated through a joint venture.  For the Company&#8217;s wholly owned operations, the Company currently maintains insurance coverages under a combination of policies with a total annual aggregate limit of up to $<ix:nonFraction unitRef="usd" contextRef="i6bd31c72edeb45d9b4601581e31a0e89_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MalpracticeInsuranceAnnualCoverageLimit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85MS9mcmFnOmM5YTZkZWNmNjZjYzRjMmY5MTlhMGVjMDg3NWMwYmE1L3RleHRyZWdpb246YzlhNmRlY2Y2NmNjNGMyZjkxOWEwZWMwODc1YzBiYTVfMTQ2Ng_2821bb56-18be-4d05-97e9-16a9aa4907d6">37.0</ix:nonFraction> million for professional malpractice liability insurance and $<ix:nonFraction unitRef="usd" contextRef="ia491adcb999943c481f80ad4aaeebcae_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MalpracticeInsuranceAnnualCoverageLimit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85MS9mcmFnOmM5YTZkZWNmNjZjYzRjMmY5MTlhMGVjMDg3NWMwYmE1L3RleHRyZWdpb246YzlhNmRlY2Y2NmNjNGMyZjkxOWEwZWMwODc1YzBiYTVfMTUyMg_e124014f-ce8f-4175-94d9-cd1d9875a703">40.0</ix:nonFraction> million for general liability insurance. The Company&#8217;s insurance for the professional liability coverage is written on a &#8220;claims-made&#8221; basis, and its commercial general liability coverage is maintained on an &#8220;occurrence&#8221; basis. These coverages apply after a self-insured retention limit is exceeded. For the Company&#8217;s joint venture operations, the Company has designed a separate insurance program that responds to the risks of specific joint ventures. Most of the Company&#8217;s joint ventures are insured under a master program with an annual aggregate limit of up to $<ix:nonFraction unitRef="usd" contextRef="if67ed923fb524d7e88c6828d4a0c423a_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MalpracticeInsuranceAnnualCoverageLimit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85MS9mcmFnOmM5YTZkZWNmNjZjYzRjMmY5MTlhMGVjMDg3NWMwYmE1L3RleHRyZWdpb246YzlhNmRlY2Y2NmNjNGMyZjkxOWEwZWMwODc1YzBiYTVfMjA4Mg_c3aedb4c-744f-4386-af04-5f9a7c3758a6">80.0</ix:nonFraction> million, subject to a sublimit aggregate ranging from $<ix:nonFraction unitRef="usd" contextRef="ied10c49f8e374623bcde2e89b5b25289_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MalpracticeInsuranceAnnualCoverageLimit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85MS9mcmFnOmM5YTZkZWNmNjZjYzRjMmY5MTlhMGVjMDg3NWMwYmE1L3RleHRyZWdpb246YzlhNmRlY2Y2NmNjNGMyZjkxOWEwZWMwODc1YzBiYTVfMjEzMQ_1d685aa6-7b05-4c5c-b82b-be0ca614ce87">23.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i465d9175e18d4165b2f6834e5d9e0b7a_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MalpracticeInsuranceAnnualCoverageLimit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85MS9mcmFnOmM5YTZkZWNmNjZjYzRjMmY5MTlhMGVjMDg3NWMwYmE1L3RleHRyZWdpb246YzlhNmRlY2Y2NmNjNGMyZjkxOWEwZWMwODc1YzBiYTVfMjEzNw_8f7ddccd-4aea-488c-8348-dbf1ada135fd">33.0</ix:nonFraction> million for most joint ventures. The policies are generally written on a &#8220;claims-made&#8221; basis. Each of these programs has either a deductible or self-insured retention limit. The Company reviews its insurance program annually and may make adjustments to the amount of insurance coverage and self-insured retentions in future years. The Company also maintains umbrella liability insurance covering claims which, due to their nature or amount, are not covered by or not fully covered by the Company&#8217;s other insurance policies. These insurance policies also do not generally cover punitive damages and are subject to various deductibles and policy limits. Significant legal actions, as well as the cost and possible lack of available insurance, could subject the Company to substantial uninsured liabilities. In the Company&#8217;s opinion, the outcome of these actions, individually or in the aggregate, will not have a material adverse effect on its financial position, results of operations, or cash flows.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare providers are subject to lawsuits under the qui tam provisions of the federal False Claims Act. Qui tam lawsuits typically remain under seal (hence, usually unknown to the defendant) for some time while the government decides whether or not to intervene on behalf of a private qui tam plaintiff (known as a relator) and take the lead in the litigation. These lawsuits can involve significant monetary damages and penalties and award bounties to private plaintiffs who successfully bring the suits. The Company is and has been a defendant in these cases in the past, and may be named as a defendant in similar cases from time to time in the future.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Therapy Subpoena.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In May 2017, the Company received a subpoena from the U.S. Attorney&#8217;s Office for the District of New Jersey seeking various documents principally relating to the Company&#8217;s contract therapy division, which contracted to furnish rehabilitation therapy services to residents of skilled nursing facilities (&#8220;SNFs&#8221;) and other providers. The Company operated its contract therapy division through a subsidiary until March 31, 2016, when the Company sold the stock of the subsidiary. The subpoena seeks documents that appear to be aimed at assessing whether therapy services were furnished and billed in compliance with Medicare SNF billing requirements, including whether therapy services were coded at inappropriate levels and whether excessive or unnecessary therapy was furnished to justify coding at higher paying levels. The U.S. Attorney&#8217;s Office indicated that the subpoena was issued in connection with a qui tam lawsuit. The Company produced documents in response to the subpoena and fully cooperated with this investigation. In July 2021, the Company entered into a settlement agreement with the United States government, the plaintiff-relator who filed the qui tam lawsuit, and the purchaser of the Company&#8217;s contract therapy division in March 2016. In satisfaction of its indemnity obligations under the purchase agreement signed in March 2016, the Company agreed to make payments related to the settlement that will not exceed the amount of a liability accrued, and a non-operating loss incurred, during the nine months ended September 30, 2020. Such payments, in the aggregate, are immaterial to the Company&#8217;s financial statements. In the settlement agreement, the government and the plaintiff-relator released the Company from liability for all conduct alleged in the complaint, and the Company admitted no liability or wrongdoing.</span></div></ix:continuation><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><ix:continuation id="if781303ea596426ab5cb903e9d76831f" continuedAt="i85cef0b9e8b043b4ad331de9c84a00d6"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oklahoma City Subpoena.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On August 24, 2020, the Company and Select Specialty Hospital &#8211; Oklahoma City, Inc. (&#8220;SSH&#8211;Oklahoma City&#8221;) received Civil Investigative Demands from the U.S. Attorney&#8217;s Office for the Western District of Oklahoma seeking responses to interrogatories and the production of various documents principally relating to the documentation, billing and reviews of medical services furnished to patients at SSH-Oklahoma City. The Company does not know whether the subpoena has been issued in connection with a qui tam lawsuit or in connection with possible civil, criminal or administrative proceedings by the government. The Company is producing documents in response to the subpoena and intends to fully cooperate with this investigation. At this time, the Company is unable to predict the timing and outcome of this matter. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Jersey Litigation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the United States District Court for the District of New Jersey unsealed a qui tam complaint in United States of America and State of New Jersey ex rel. Keith A. DiLello, Sr. v. Hackensack Meridian Health, Jersey Shore University Medical Center, Ocean Medical Center, Seaview Orthopaedics, Shrewsbury Surgery Center, Kessler Rehabilitation, Dr. Halambros Demetriades, Dr. Theodore Kutzan, Dr. Adam Myers, Dr. Hoan-Vu Nguyen, Dr. Frederick De Paola, ABC Corporations 1-10, and John/Jane Does 1-10, Case 3:20-cv-02949-FLW-ZNQ. The complaint was filed under seal in March 2020 and was unsealed after the United States and State of New Jersey declined to intervene in the case. In the complaint, the plaintiff-relator, an automobile accident victim and former patient of the defendant providers, alleges that they routinely billed both personal injury protection (&#8220;PIP&#8221;) carriers and CMS. He alleges that they violated federal and state law by billing CMS when other insurance is available and failing to return payment to CMS after payment was made by the PIP carriers. In March 2021, defendant Kessler Rehabilitation waived service of process of the complaint. The Company intends to vigorously defend this action, but at this time the Company is unable to predict the timing and outcome of this matter.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare Dual-Eligible Litigation</span></div></ix:continuation><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i85cef0b9e8b043b4ad331de9c84a00d6">The Company&#8217;s critical illness recovery hospitals have pursued claims against CMS involving denied Medicare bad debt reimbursement for copayments and deductibles of dual-eligible Medicaid beneficiaries for cost reporting periods ending in 2005 through 2010. A U.S. District Court ruled in favor of the Company and ordered CMS to determine and pay the Medicare bad debt reimbursement plus interest and, in February 2021, the Company received reimbursement proceeds of $<ix:nonFraction unitRef="usd" contextRef="i760d525b19534ec8bf2275b1a4759394_D20210201-20210228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85MS9mcmFnOmM5YTZkZWNmNjZjYzRjMmY5MTlhMGVjMDg3NWMwYmE1L3RleHRyZWdpb246YzlhNmRlY2Y2NmNjNGMyZjkxOWEwZWMwODc1YzBiYTVfODI5Ng_6b6d5b5c-c4d0-4dab-9be6-9340679e60d4">17.9</ix:nonFraction> million plus accrued interest of $<ix:nonFraction unitRef="usd" contextRef="i760d525b19534ec8bf2275b1a4759394_D20210201-20210228" decimals="-5" format="ixt:numdotdecimal" name="sem:ProceedsFromLegalSettlementsAccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85MS9mcmFnOmM5YTZkZWNmNjZjYzRjMmY5MTlhMGVjMDg3NWMwYmE1L3RleHRyZWdpb246YzlhNmRlY2Y2NmNjNGMyZjkxOWEwZWMwODc1YzBiYTVfODMyNA_bc0257c3-5ed2-4002-90ec-7b3e5da0f870">4.7</ix:nonFraction> million. These amounts were recognized as other operating income and interest income, respectively, during the six months ended June&#160;30, 2021.</ix:continuation> </span></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_94"></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfNDIxMA_a1226f85-daef-42fa-8b3d-33ea64a8a5e8" continuedAt="i2b05aafd71364af39dd18ec547bd9ee8" escape="true">CARES Act</ix:nonNumeric></span></div><ix:continuation id="i2b05aafd71364af39dd18ec547bd9ee8" continuedAt="i3f33874c4bf74e9b927fdad793840775"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provider Relief Funds</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) was enacted. Since the enactment of the CARES Act, the Company&#8217;s consolidated subsidiaries have received approximately $<ix:nonFraction unitRef="usd" contextRef="i69380e325f114ea89df7916749073905_D20200327-20210630" decimals="-5" format="ixt:numdotdecimal" name="sem:ProceedsFromGovernmentAssistanceCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfMjQ5_408d4fb0-d748-465a-b97e-07ac2811fecd">208.4</ix:nonFraction> million of payments from the Public Health and Social Services Emergency Fund, also referred to as the Provider Relief Fund. The Company is able to use payments received under the Provider Relief Fund for &#8220;health care related expenses or lost revenues that are attributable to coronavirus.&#8221; The Provider Relief Fund payments must first be applied against health care related expenses attributable to COVID-19. Provider Relief Fund payments not fully expended on healthcare related expenses attributable to COVID-19 are then applied to lost revenues. The provisions of the Provider Relief Fund payments permit a parent organization to allocate all or a portion of its general and targeted distributions among its subsidiaries which are eligible health care providers. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the CARES Act was enacted, the Department of Health and Human Services (&#8220;HHS&#8221;) has issued a series of post-payment notices of reporting requirements and other guidance which, in some instances, have significantly altered the terms and conditions surrounding the Provider Relief Fund payments. Additionally, certain provisions and reporting requirements associated with the Provider Relief Fund payments were signed into law as part of the Coronavirus Response and Relief Supplemental Appropriations Act of 2021 (&#8220;CRRSA Act&#8221;) on December 27, 2020. On June 11, 2021, HHS released an updated post-payment notice of reporting requirements and new and modified responses to its Frequently Asked Questions regarding the Provider Relief Fund payments. Among other things, HHS updated the period of time in which recipients must use the Provider Relief Fund payments. Under the revised guidance, the deadlines for utilizing the payments are based on the date in which the payments were received, rather than requiring all payments be used by June 30, 2021. The deadlines to use the Provider Relief Fund payments are now as follows: (i) payments received between April 10, 2020 and June 30, 2020 must have been used by June 30, 2021, (ii) payments received between July 1, 2020 and December 31, 2020 must be used by December 31, 2021, (iii)  payments received between January 1, 2021 and June 30, 2021 must be used by June 30, 2022, and (iv) payments received between July 1, 2021 and December 31, 2021 must be used by December 31, 2022.</span></div></ix:continuation><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><ix:continuation id="i3f33874c4bf74e9b927fdad793840775" continuedAt="i8c3b6c6e855942f092476ba6a1ed7518"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Company&#8217;s accounting policy, payments are recognized as other operating income when it is probable that it has complied with the terms and conditions of the payments. The Company evaluated its eligibility to utilize certain Provider Relief Fund payments and whether those payments were used in accordance with the terms and conditions set forth within the CRRSA Act and by HHS as of June 30, 2021. The Company&#8217;s assessment of uncertainties surrounding its ability to utilize certain of its Provider Relief Fund payments, including its ability to allocate general distributions among the Company&#8217;s subsidiaries, was updated for additional information obtained during the period. Based on this updated assessment, the Company believes it is probable that it has complied with the terms and conditions associated with the Provider Relief Fund payments as of June 30, 2021. During the three and six months ended June&#160;30, 2021, the Company determined that it was eligible to recognize approximately $<ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="sem:GovernmentAssistanceRecognizedInEarningsCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfMjc0ODc3OTA5MzAyNw_bf2661ed-4562-4164-972d-8646ee17962a">98.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="sem:GovernmentAssistanceRecognizedInEarningsCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfMjc0ODc3OTA5MzAzNw_dc5b79af-1df9-43ee-ba07-3e2499e26e30">114.1</ix:nonFraction> million, respectively, of Provider Relief Fund payments as other operating income on the accompanying condensed consolidated statement of operations. The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630" decimals="-5" format="ixt:numdotdecimal" name="sem:GovernmentAssistanceRecognizedInEarningsCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfMjc0ODc3OTExNzgyMQ_7bb505b1-e95e-4223-bfd9-e5ec745b92ed"><ix:nonFraction unitRef="usd" contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="sem:GovernmentAssistanceRecognizedInEarningsCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfMjc0ODc3OTExNzgyMQ_9b571b8f-a4e2-4696-b4d5-ac08a4ab957b">55.0</ix:nonFraction></ix:nonFraction> million of other operating income during both the three and six months ended June&#160;30, 2020. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, $<ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-5" format="ixt:numdotdecimal" name="sem:UnearnedGovernmentAssistanceCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfMjY0NA_87dd574d-f591-4df3-81cf-66411fcddddd">4.1</ix:nonFraction> million of Provider Relief Fund payments have not yet been utilized by the Company in accordance with the regulations promulgated by HHS and the CRRSA Act and are reported as unearned government assistance on the accompanying condensed consolidated balance sheet. Of this amount, $<ix:nonFraction unitRef="usd" contextRef="i632267a60f314ae3bccec20a793b8465_I20210630" decimals="-5" format="ixt:numdotdecimal" name="sem:UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfMzI5ODUzNDkzMTEwNQ_f10cbb29-b3b7-422c-8c46-828f69096ca1">1.7</ix:nonFraction>&#160;million will be repaid to the government because the payments could not be utilized by the deadlines specified by HHS. The remaining Provider Relief Fund payments may need to be repaid to the extent they cannot be utilized in accordance with the terms and conditions set forth within the CRRSA Act and by HHS. Further changes to the regulations surrounding the Provider Relief Fund payments or amended interpretations of existing guidance may change the Company&#8217;s assessment of whether it is probable that is has complied with the terms of conditions of the Provider Relief Fund payments. These changes may result in the Company being unable to recognize additional Provider Relief Fund payments as other operating income or the reversal of amounts previously recognized.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare Accelerated and Advance Payments Program</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s consolidated subsidiaries received approximately $<ix:nonFraction unitRef="usd" contextRef="i1e1fc4e7b10d4564ae73da8aaf8268ca_I20200430" decimals="-5" format="ixt:numdotdecimal" name="sem:GovernmentAdvancesCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfMTA5OTUxMTY3MzU0MA_f9083a52-644e-4976-a0aa-6d8201dfb1aa">325.0</ix:nonFraction> million of advance payments under CMS&#8217;s Accelerated and Advance Payment Program, which was temporarily expanded by the CARES Act. Repayment of the advance payments begins one year from the issuance date of the payment. After that first year, the Medicare program automatically recoups 25.0% of the Medicare payments otherwise owed to the provider or supplier for eleven months. At the end of the eleven-month period, recoupment increases to 50.0% for another six months. Any amounts that remain unpaid after 29 months are subject to a 4.0% interest rate. </span></div></ix:continuation><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8c3b6c6e855942f092476ba6a1ed7518">The Company received the majority of its advance payments in April 2020. Accordingly, CMS began recouping a portion of the Medicare payments due to the Company beginning in April 2021. CMS recouped $<ix:nonFraction unitRef="usd" contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="sem:GovernmentAdvancesRecoupedCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfMjc0ODc3OTA4ODI1Mw_002a8c21-3f06-426d-9c3e-b2a5dbb4f860"><ix:nonFraction unitRef="usd" contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="sem:GovernmentAdvancesRecoupedCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfMjc0ODc3OTA4ODI1Mw_761bffd4-3fed-4c25-85c8-0d8d6221c238">73.7</ix:nonFraction></ix:nonFraction> million of Medicare payments during the three and six months ended June&#160;30, 2021. The remaining amounts owed to CMS under the Accelerated and Advance Payment Program are reflected as government advances on the accompanying condensed consolidated balance sheets</ix:continuation>.</span></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_97"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85Ny9mcmFnOjM1ZjY1Nzc0YmU0MzQ5ZGU5NmE5MWM3OTQyZjc0YjIxL3RleHRyZWdpb246MzVmNjU3NzRiZTQzNDlkZTk2YTkxYzc5NDJmNzRiMjFfMjQ0_5adc96d3-609d-4777-be0e-490360adfeec" continuedAt="i0d638cb04c6a45658d98ce855f01ec9d" escape="true">Subsequent Event </ix:nonNumeric></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0d638cb04c6a45658d98ce855f01ec9d">On August 4, 2021, the Company&#8217;s board of directors declared a cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib0cd8e5fc1d2451fa507e01087b5e757_I20210804" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85Ny9mcmFnOjM1ZjY1Nzc0YmU0MzQ5ZGU5NmE5MWM3OTQyZjc0YjIxL3RleHRyZWdpb246MzVmNjU3NzRiZTQzNDlkZTk2YTkxYzc5NDJmNzRiMjFfMTA1_e13560c0-4419-411b-b19c-529c2f10c19a">0.125</ix:nonFraction> per share. The dividend will be payable on or about August 30, 2021 to stockholders of record as of the close of business on August 18, 2021.</ix:continuation></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:58.5pt;text-align:justify;text-indent:-58.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;                    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read this discussion together with our unaudited condensed consolidated financial statements and accompanying notes.</span></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_103"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report on Form&#160;10-Q contains forward-looking statements within the meaning of the federal securities laws. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. Forward-looking statements include statements preceded by, followed by or that include the words &#8220;may,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;plan,&#8221; &#8220;target,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;intend,&#8221; and similar expressions. These statements include, among others, statements regarding our expected business outlook, anticipated financial and operating results, including the potential impact of the COVID-19 pandemic on those financial and operating results, our business strategy and means to implement our strategy, our objectives, the amount and timing of capital expenditures, the likelihood of our success in expanding our business, financing plans, budgets, working capital needs, and sources of liquidity.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are only predictions and are not guarantees of performance. These statements are based on our management&#8217;s beliefs and assumptions, which in turn are based on currently available information. Important assumptions relating to the forward-looking statements include, among others, assumptions regarding our services, the expansion of our services, competitive conditions, and general economic conditions. These assumptions could prove inaccurate. Forward-looking statements also involve known and unknown risks and uncertainties, which could cause actual results to differ materially from those contained in any forward-looking statement. Many of these factors are beyond our ability to control or predict. Such factors include, but are not limited to, the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments related to the COVID-19 pandemic including, but not limited to, the duration and severity of the pandemic, additional measures taken by government authorities and the private sector to limit the spread of COVID-19, and further legislative and regulatory actions which impact healthcare providers, including actions that may impact the Medicare program;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in government reimbursement for our services and/or new payment policies may result in a reduction in revenue, an increase in costs, and a reduction in profitability;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the failure of our Medicare-certified long term care hospitals or inpatient rehabilitation facilities to maintain their Medicare certifications may cause our revenue and profitability to decline;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the failure of our Medicare-certified long term care hospitals and inpatient rehabilitation facilities</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operated as &#8220;hospitals within hospitals&#8221; to qualify as hospitals separate from their host hospitals may cause our revenue and profitability to decline;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a government investigation or assertion that we have violated applicable regulations may result in sanctions or reputational harm and increased costs;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquisitions or joint ventures may prove difficult or unsuccessful, use significant resources, or expose us to unforeseen liabilities;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our plans and expectations related to our acquisitions and our ability to realize anticipated synergies;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">private third-party payors for our services may adopt payment policies that could limit our future revenue and profitability;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the failure to maintain established relationships with the physicians in the areas we serve could reduce our revenue and profitability;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">shortages in qualified nurses, therapists, physicians, or other licensed providers, or the inability to attract or retain healthcare professionals due to the heightened risk of infection related to the COVID-19 pandemic, could increase our operating costs significantly or limit our ability to staff our facilities; </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition may limit our ability to grow and result in a decrease in our revenue and profitability;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the loss of key members of our management team could significantly disrupt our operations;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of claims asserted against us could subject us to substantial uninsured liabilities; </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a security breach of our or our third-party vendors&#8217; information technology systems may subject us to potential legal and reputational harm and may result in a violation of the Health Insurance Portability and Accountability Act of 1996 or the Health Information Technology for Economic and Clinical Health Act; and</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other factors discussed from time to time in our filings with the SEC, including factors discussed under the heading &#8220;Risk Factors&#8221; in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2020 and in our Quarterly Report on Form 10-Q for the three months ended March 31, 2021, as such risk factors may be updated from time to time in our periodic filings with the SEC.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the SEC, we are under no obligation to publicly update or revise any forward-looking statements, whether as a result of any new information, future events, or otherwise. You should not place undue reliance on our forward-looking statements. Although we believe that the expectations reflected in forward-looking statements are reasonable, we cannot guarantee future results or performance.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investors should also be aware that while we do, from time to time, communicate with securities analysts, it is against our policy to disclose to securities analysts any material non-public information or other confidential commercial information. Accordingly, stockholders should not assume that we agree with any statement or report issued by any securities analyst irrespective of the content of the statement or report. Thus, to the extent that reports issued by securities analysts contain any projections, forecasts or opinions, such reports are not the responsibility of the Company.</span></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_106"></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We began operations in 1997 and, based on number of facilities, are one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. As of June&#160;30, 2021, we had operations in 46 states and the District of Columbia. We operated 99 critical illness recovery hospitals in 28 states, 30 rehabilitation hospitals in 12 states, and 1,833 outpatient rehabilitation clinics in 38 states and the District of Columbia. Concentra, a joint venture subsidiary, operated 518 occupational health centers in 41 states as of June&#160;30, 2021. Concentra also provides contract services at employer worksites. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reportable segments include the critical illness recovery hospital segment, the rehabilitation hospital segment, the outpatient rehabilitation segment, and the Concentra segment. We had revenue of $3,110.5 million&#160;for the six months ended June&#160;30, 2021. Of this total, we earned approximately 37% of our revenue from our critical illness recovery hospital segment, approximately 14% from our rehabilitation hospital segment, approximately 17% from our outpatient rehabilitation segment, and approximately 28% from our Concentra segment. Our critical illness recovery hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs, and our rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to our critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. Our outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. Our Concentra segment consists of occupational health centers that provide workers&#8217; compensation injury care, physical therapy, and consumer health services as well as onsite clinics located at employer worksites that deliver occupational medicine services.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Measure </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the presentation of Adjusted EBITDA, as defined below, is important to investors because Adjusted EBITDA is commonly used as an analytical indicator of performance by investors within the healthcare industry. Adjusted EBITDA is used by management to evaluate financial performance and determine resource allocation for each of our operating segments. Adjusted EBITDA is not a measure of financial performance under GAAP. Items excluded from Adjusted EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA should not be considered in isolation or as an alternative to, or substitute for, net income, income from operations, cash flows generated by operations, investing or financing activities, or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because Adjusted EBITDA is not a measurement determined in accordance with GAAP and is thus susceptible to varying definitions, Adjusted EBITDA as presented may not be comparable to other similarly titled measures of other companies.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define Adjusted EBITDA as earnings excluding interest, income taxes, depreciation and amortization, gain (loss) on early retirement of debt, stock compensation expense, gain (loss) on sale of businesses, and equity in earnings (losses) of unconsolidated subsidiaries. We will refer to Adjusted EBITDA throughout the remainder of Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reconciles net income and income from operations to Adjusted EBITDA and should be referenced when we discuss Adjusted EBITDA:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.549%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">196,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,934&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">110,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83,473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,749)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on sale of businesses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,547)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated subsidiaries</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,809)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10,912)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21,728)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">119,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">283,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">248,196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">485,980&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Included in general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Included in cost of services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,954&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,752&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">342,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">366,085&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">600,362&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_112"></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effects of the COVID-19 Pandemic on our Results of Operations during the Three and Six Months Ended June 30, 2020 and 2021</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in March 2020, state governments placed significant restrictions on businesses and mandated closures of non-essential or non-life sustaining businesses, causing many employers to furlough their workforce and temporarily cease or significantly reduce their operations. State governments also implemented restrictions on travel and individual activities outside of the home, closed schools, and mandated other social distancing measures. At the same time, hospitals and other facilities began suspending elective surgeries. In an effort to ensure hospitals and health systems had the capacity to absorb and effectively manage surges of COVID-19 patients, a number of waivers and modifications of certain requirements under the Medicare, Medicaid and CHIP programs were authorized in March 2020, including certain regulations under the Medicare program which govern admissions into our critical illness recovery hospitals and rehabilitation hospitals. Specifically, our critical illness recovery hospitals which are certified as LTCHs became exempt from the greater-than-25-day average length of stay requirement for all cost reporting periods that include the COVID-19 public health emergency period. Our rehabilitation hospitals which are certified as IRFs could exclude patients admitted solely to respond to the emergency from the calculation of the &#8220;60 percent rule&#8221; thresholds to receive payment as an IRF. The COVID-19 public health emergency period has been extended and is currently in effect through October 17, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adverse effects of the COVID-19 pandemic, along with the actions of governmental authorities and those in the private sector to limit the spread of COVID-19, caused disruptions in each of our segments; these disruptions were most significant within our outpatient rehabilitation and Concentra segments. By mid-March 2020, our outpatient rehabilitation clinics began experiencing significantly less patient visit volume due to declines in patient referrals from physicians, a reduction in workers&#8217; compensation injury visits resulting from the temporary closure of businesses, and the suspension of elective surgeries which would have required outpatient rehabilitation services. Our Concentra centers experienced similar declines in patient visit volume due to businesses furloughing their workforce and temporarily ceasing or significantly reducing their operations. Since March 2021, our outpatient rehabilitation clinics and Concentra centers have experienced patient visit volumes which approximate or exceed the levels experienced in the months prior to the widespread emergence of COVID-19 in the United States. Although they have experienced temporary disruptions in their core businesses as a result of the COVID-19 pandemic, our outpatient rehabilitation and Concentra segments have been able to expand their services to provide COVID-19 screening and testing.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our critical illness recovery hospitals have played a critical role in caring for patients during the COVID-19 pandemic, and the relaxation of certain admission restrictions have contributed to volume increases in certain of our hospitals. The revenue of our critical illness recovery hospitals and rehabilitation hospitals has also benefited from the temporary suspension of the 2.0% cut to Medicare payments due to sequestration, which began May 1, 2020 following the enactment of the CARES Act, and has been extended through December 31, 2021. Certain of our rehabilitation hospitals experienced temporary declines in patient volume, beginning in March 2020, in areas more significantly impacted by the spread of COVID-19, and as a result of the suspension of elective surgeries at hospitals and other facilities, which consequently reduced the demand for inpatient rehabilitation services. Additionally, some of our rehabilitation hospitals temporarily restricted admissions as a result of the COVID-19 pandemic. Beginning at the onset of the COVID-19 pandemic, both our critical illness recovery hospitals and rehabilitation hospitals modified certain of their protocols in order to follow the guidelines and recommendations for patient treatment and for the protection of our patients and staff members. This has resulted in increased labor costs, including increased contracted labor usage, as well as additional costs resulting from the purchase of personal protective equipment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unpredictable effects of the COVID-19 pandemic, including the duration and extent of disruption on our operations, creates uncertainties about our future operating results and financial condition. We have provided revenue and certain operating statistics below for each of our segments for each of the periods presented. Please refer to our risk factors previously reported in our Annual Report on Form 10-K for the year ended December 31, 2020 for further discussion.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.015%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="78" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Patient Days</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Occupancy Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of Hospitals Owned</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">149,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">199,611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">February</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">190,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">92,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">171,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204,558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Three Months Ended March 31</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">457,534&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500,521&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">594,872&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">258,129&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">270,458&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">293,118&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">156,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">171,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">185,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">156,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">183,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">93,708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">148,490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169,958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">174,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Three Months Ended June 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">461,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">519,626&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">544,059&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">262,860&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">276,889&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">272,981&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Six Months Ended June 30</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">918,677&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,020,147&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,138,931&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt 0 7pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">520,989&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">547,347&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">566,099&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.015%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="78" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Patient Days</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Occupancy Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of Hospitals Owned</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61,673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">February</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60,690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Three Months Ended March 31</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">154,558&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">182,019&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">207,804&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82,816&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">94,568&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102,439&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Three Months Ended June 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">160,374&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168,667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212,666&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86,525&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84,081&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Six Months Ended June 30</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">314,932&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">350,686&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">420,470&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169,341&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,649&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">207,387&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:19.194%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.790%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outpatient Rehabilitation</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Visits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Working Days</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">687,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">757,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">625,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">February</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">658,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">739,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">641,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">708,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">626,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">832,248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Three Months Ended March 31</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">246,905&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">255,249&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">251,961&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,054,483&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,122,665&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,100,154&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95,251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">762,914&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">386,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">810,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">759,829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">409,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">758,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">680,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">546,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">835,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Three Months Ended June 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">261,891&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">167,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,203,505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,342,267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,404,861&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Six Months Ended June 30</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">508,796&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">422,387&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">532,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt 0 7pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,257,988&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,464,932&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,505,015&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt 0 7pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.075%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Visits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Working Days</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">January</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">141,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">127,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">985,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,032,069&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">867,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">February</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133,690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132,349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">919,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">965,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">869,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">136,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">123,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,006,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">879,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,057,871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Three Months Ended March 31</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">396,321&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">398,535&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">422,840&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,911,607&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,877,395&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,795,574&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91,178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,040,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">610,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">999,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99,228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">142,228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,073,763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">674,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">956,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">121,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">988,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">865,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,074,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Three Months Ended June 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">413,451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">456,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,103,089&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,151,080&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,030,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Six Months Ended June 30</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">809,772&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">710,873&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">879,212&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,014,696&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,028,475&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,825,652&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Represents the number of hospitals owned at the end of each period presented.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Represents the number of days in which normal business operations were conducted during the periods presented. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary Financial Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for further discussion of our segment performance measures for the three and six months ended June&#160;30, 2020 and 2021. Please refer to &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Statistic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s&#8221; for further discussion regarding the uses and calculations of the metrics provided above, as well as the operating statistics data for each segment for the three and six months ended June&#160;30, 2020 and 2021.</span></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_115"></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Significant Events</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Payments</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 5, 2021, our board of directors declared a cash dividend of $0.125 per share. The dividend, totaling $16.9 million was paid on June 1, 2021 to stockholders of record as of the close of business on May 19, 2021.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Transactions</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 2, 2021, Select entered into Amendment No. 5 to the Select credit agreement which, among other things, increased the aggregate commitments available under the Select revolving facility from $450.0 million to $650.0 million, including a $125.0 million sublimit for the issuance of standby letters of credit.</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 2, 2021, Concentra Inc. terminated its obligations under the Concentra-JPM first lien credit agreement. The Concentra-JPM first lien credit agreement provided for commitments of $100.0 million under the Concentra-JPM revolving facility, which was set to mature on March 1, 2022. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary Financial Results</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended June 30, 2021 </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, our revenue increased 26.9% to $1,564.0 million, compared to $1,232.7 million for the three months ended June&#160;30, 2020. Income from operations increased 137.6% to $284.0 million for the three months ended June&#160;30, 2021, compared to $119.5 million for the three months ended June&#160;30, 2020. Income from operations included other operating income of $98.1 million and $55.0 million for the three months ended June&#160;30, 2021 and 2020, respectively.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income increased 190.7% to $196.2 million for the three months ended June&#160;30, 2021, compared to $67.5 million for the three months ended June&#160;30, 2020. Net income included a pre-tax gain on sale of businesses of $0.3 million for the three months ended June&#160;30, 2020.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA increased 91.3% to $342.0 million for the three months ended June&#160;30, 2021, compared to $178.8 million for the three months ended June&#160;30, 2020. Our Adjusted EBITDA margin was 21.9% for the three months ended June&#160;30, 2021, compared to 14.5% for the three months ended June&#160;30, 2020.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables reconcile our segment performance measures to our consolidated operating results: </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">544,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">456,372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,564,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(471,155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(161,898)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(234,776)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(352,163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(107,193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,327,185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12,936)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,939)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21,230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,504)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(50,954)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65,771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43,829&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">115,295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,588&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">283,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72,904&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,768&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,633&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,060&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,656&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">342,021&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30.0&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.458%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">519,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">167,138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,232,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(429,883)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(141,062)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(173,420)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(272,331)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(99,221)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,115,917)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,892)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,907)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21,857)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,421)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(52,271)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,851&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,476)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,506&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">119,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,892&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89,743&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,605&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,282)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,497&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,189&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,752&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in segment performance measures for the three months ended June&#160;30, 2021, compared to the three months ended June&#160;30, 2020:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:25.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in income from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">111.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">384.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">508.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in Adjusted EBITDA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">826.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">230.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">N/M &#8212; &#160;&#160;&#160;&#160;Not meaningful.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Six Months Ended June 30, 2021 </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2021, our revenue increased 17.5% to $3,110.5 million, compared to $2,647.4 million for the six months ended June&#160;30, 2020. Income from operations increased 95.8% to $486.0 million for the six months ended June&#160;30, 2021, compared to $248.2 million for the six months ended June&#160;30, 2020. Income from operations included other operating income of $132.1 million and $55.0 million for the six months ended June&#160;30, 2021 and 2020, respectively.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income increased 141.7% to $333.4 million for the six months ended June&#160;30, 2021, compared to $137.9 million for the six months ended June&#160;30, 2020. Net income included a pre-tax gain on sale of businesses of $7.5 million for the six months ended June&#160;30, 2020.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA increased 64.0% to $600.4 million for the six months ended June&#160;30, 2021, compared to $366.1 million for the six months ended June&#160;30, 2020. Our Adjusted EBITDA margin was 19.3% for the six months ended June&#160;30, 2021, compared to 13.8% for the six months ended June&#160;30, 2020.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables reconcile our segment performance measures to our consolidated operating results: </span></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:25.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,138,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">420,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">532,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">879,212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,110,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(970,642)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(319,168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(460,408)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(693,524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(212,295)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,656,037)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25,986)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,999)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14,536)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41,128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,925)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(100,574)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">160,190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87,303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57,426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">176,876&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,185&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">485,980&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,808&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">186,176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101,302&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,962&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">219,075&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,847&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">600,362&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:25.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,020,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">350,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">422,387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">710,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,647,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(841,834)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(284,512)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(401,547)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(610,167)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(212,059)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,350,119)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(26,228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,794)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14,412)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(44,744)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,845)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(104,023)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,085&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,380&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,428&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,751&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19,448)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">248,196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,313&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66,174&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,840&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102,963&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,205)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">366,085&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in segment performance measures for the six months ended June&#160;30, 2021, compared to the six months ended June&#160;30, 2020: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:25.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in income from operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">793.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">211.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in Adjusted EBITDA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">245.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">N/M &#8212; &#160;&#160;&#160;&#160;Not meaningful.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Changes</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2020, filed with the SEC on February 25, 2021, contains a detailed discussion of the regulations that affect our business in Part&#160;I &#8212; Business &#8212; Government Regulations. The following is a discussion of some of the more significant healthcare regulatory changes that have affected our financial performance in the periods covered by this report or are likely to affect our financial performance and financial condition in the future. The information below should be read in conjunction with the more detailed discussion of regulations contained in our Form&#160;10-K.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare Reimbursement</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicare program reimburses healthcare providers for services furnished to Medicare beneficiaries, which are generally persons age 65 and older, those who are chronically disabled, and those suffering from end stage renal disease. The program is governed by the Social Security Act of 1965 and is administered primarily by the HHS and CMS. Revenue generated directly from the Medicare program represented approximately 23% of our revenue for the six months ended June&#160;30, 2021, and 25% of our revenue for the year ended December&#160;31, 2020.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal Health Care Program Changes in Response to the COVID-19 Pandemic</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2020, HHS declared a public health emergency under section 319 of the Public Health Service Act, 42 U.S.C. &#167; 247d, in response to the COVID-19 outbreak in the United States. The HHS Secretary renewed the public health emergency determination for 90-day periods effective on April 26, 2020, July 25, 2020, October 23, 2020, January 21, 2021, April 21, 2021, and July 20, 2021. On March 13, 2020, President Trump declared&#160;a national emergency&#160;due to the COVID-19 pandemic and the HHS Secretary authorized the waiver or modification of certain requirements under the Medicare, Medicaid and Children&#8217;s Health Insurance Program (&#8220;CHIP&#8221;) pursuant to section 1135 of the Social Security Act. Under this authority, CMS issued a number of blanket waivers that excuse health care providers or suppliers from specific program requirements. The following blanket waivers, while in effect, may impact our results of operations:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">Inpatient rehabilitation facilities (&#8220;IRFs&#8221;), IRF units, and hospitals and units applying to be classified as IRFs, can exclude patients admitted solely to respond to the emergency from the calculation of the &#8220;60 percent rule&#8221; thresholds to receive payment as an IRF. </span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">Long-term care hospitals (&#8220;LTCHs&#8221;) are exempt from the greater-than-25-day average length of stay requirement for all cost reporting periods that include the COVID-19 public health emergency period. Hospitals seeking LTCH classification can exclude patient stays from the greater-than-25-day average length of stay requirement where the patient was admitted or discharged to meet the demands of the COVID-19 public health emergency.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.19pt">Medicare expanded the types of health care professionals who can furnish telehealth services to include all those who are eligible to bill Medicare for their professional services. This allows health care professionals who were previously ineligible to furnish and bill for Medicare telehealth services, including physical therapists, occupational therapists, speech language pathologists, and others, to receive payment for Medicare telehealth services.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.73pt">Medicare will not require out-of-state physician and non-physician practitioners to be licensed in the state where they are providing services when they are licensed in another state, subject to certain conditions and state or local licensure requirements.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Many requirements under the hospital conditions of participation (&#8220;CoPs&#8221;) are waived during the emergency period to give hospitals more flexibility in treating COVID-19 patients.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vi.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.73pt">Hospitals can operate temporary expansion locations without meeting the provider-based entity requirements or certain requirements in the physical environment CoP for hospitals during the emergency. This waiver also allows hospitals to change the status of their current provider-based department locations to meet patient needs as part of the state or local pandemic plan.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.96pt">IRFs, LTCHs, and certain other providers did not need to submit quality data to Medicare for October 1, 2019 through June 30, 2020 to comply with the quality reporting programs.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">viii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:2.19pt">The HHS Secretary waived sanctions under the physician self-referral law (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Stark law) for certain types of remuneration and referral arrangements that are related to a COVID-19 purpose. The Office of the Inspector General (&#8220;OIG&#8221;) will also exercise enforcement discretion to not impose administrative sanctions under the federal anti-kickback statute for many payments covered by the Stark law waivers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS also approved section 1135 waivers for 54 state Medicaid programs (including the District of Columbia, Puerto Rico, and other territories), 51 temporary changes to Medicaid or CHIP state plan amendments, 6 traditional changes to Medicaid state plan amendments, and section 1115 waivers for 12 state Medicaid demonstration projects addressing the COVID-19 public health emergency. CMS will consider specific waiver requests from providers and suppliers. We have submitted one or more specific waiver requests to make it easier for our operators or referral partners to treat COVID-19 patients, and we may submit others in the future.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Coronavirus Preparedness and Response Supplemental Appropriations Act, Public Law 116-123, CMS has waived Medicare telehealth payment requirements during the emergency so that beneficiaries in all areas of the country (not just rural areas) can receive telehealth services, including in their homes, beginning on March 6, 2020. CMS issued additional waivers to permit more than 160 additional services to be furnished by telehealth, allow physicians to monitor patient services remotely, and fulfill face-to-face requirements in IRFs.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to these agency actions, the CARES Act was enacted on March 27, 2020. It provides additional waivers, reimbursement, grants and other funds to assist health care providers during the COVID-19 public health emergency. Some of the CARES Act provisions that may impact our operations include:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">$100 billion in appropriations for the Public Health and Social Services Emergency Fund to be used for preventing, preparing, and responding to COVID-19 and for reimbursing &#8220;eligible health care providers for health care related expenses or lost revenues that are attributable to coronavirus.&#8221; The Paycheck Protection Program and Health Care Enhancement Act, Public Law 116-139, added $75 billion to this fund. The Consolidated Appropriations Act, 2021, added another $3 billion to this fund. HHS has allocated three general distributions from the fund for payments to Medicare providers. The Phase 1 General Distribution included $30 billion for health care providers that received Medicare fee-for-service payments in 2019. Another $20 billion was allocated to Medicare providers in a manner that was intended to make the entire $50 billion Phase 1 General Distribution proportional to each provider&#8217;s share of 2018 net patient revenue. Payments from the additional $20 billion allocation were determined based on the lesser of a provider&#8217;s 2018 (or most recent complete tax year) gross receipts or the sum of incurred losses for March and April of 2020. HHS distributed $16 billion from the additional $20 billion allocation. The Phase 2 General Distribution allocated $18 billion for providers in state Medicaid/CHIP programs, Medicaid managed care plans, dentists, and certain Medicare providers who did not receive a Phase 1 General Distribution payment. HHS distributed $5.98 billion from the $18 billion Phase 2 allocation. The Phase 3 General Distribution was projected to include $20 billion for providers to apply for if they suffered financial losses or changes in operating expenses caused by COVID-19 or if they were previously ineligible for a general distribution. HHS made $24.5 billion in payments as part of the Phase 3 General Distribution. The remainder of the COVID-19 related appropriations to the Public Health and Social Services Emergency Fund is for targeted allocations to providers in high impact COVID-19 areas ($20.75 billion), rural providers (approximately $11.09 billion), skilled nursing facilities (approximately $5 billion), nursing home infection control (approximately $2.75 billion), safety net hospitals (approximately $13.07 billion), Indian Health Service and urban health centers ($520 million), children&#8217;s hospitals ($1.06 billion), and unspecified allocations for providers treating uninsured COVID-19 patients. HHS also established a $2.25 billion incentive payment structure for skilled nursing facilities and nursing homes for keeping new COVID-19 infection and mortality rates among residents lower than the communities they serve. Starting on July 1, 2021, recipients of these payments must begin reporting data to HHS on the use of the funds via an online portal. By September 30, 2021, recipients must report to HHS on the use of funds received from April 10, 2020 to June 30, 2020. The deadline to apply these initial payments towards eligible expenses and lost revenue attributable to COVID-19 was June 30, 2021. For payments received from July 1, 2020 to December 31, 2020, recipients must use the funds by December 31, 2021 and will report to HHS regarding the use of the funds during the period of January 1, 2022 to March 31, 2022. Next, any payments received from January 1, 2021 to June 30, 2021 must be used by June 30, 2022 and recipients must report to HHS regarding such payments from July 1, 2022 to September 30, 2022. Finally, if any provider receives payments during the period of July 1, 2021 to December 31, 2021, the provider must use the funds by December 31, 2022 and report to HHS on the use of these funds during the period of January 1, 2023 to March 31, 2023. Any funds that a provider does not apply towards expenses or lost revenue attributable to COVID-19 must be returned to HHS within 30 calendar days after the end of the applicable reporting period. All recipients of funds are subject to audit by HHS, the HHS OIG, or the Pandemic Response Accountability Committee. Audits may include examination of the accuracy of the data providers submitted to HHS in their applications for payments.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">Expansion of the Accelerated and Advance Payment Program to advance three months of payments to Medicare providers. CMS has the ability to recoup the advanced payments through future Medicare claims. Section 2501 of the Continuing Appropriations Act, 2021 and Other Extensions Act, Public Law 116-159, modified the terms of repayment so that a provider can request no recoupment for one year after the advanced payment was issued, followed by a 25% offset the next 11 months, and a 50% offset the last 6 months. Any amounts that remain unpaid after 29 months will be subject to a 4% interest rate (instead of 10.25%). CMS began recouping advance payments on March 30, 2021, but the actual date for each provider is based on the first anniversary of when the provider received the first payment.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.19pt">Temporary suspension of the 2% cut to Medicare payments due to sequestration so that, for the period of May 1, 2020 to December 31, 2020, the Medicare program will be exempt from any sequestration order. The Consolidated Appropriations Act, 2021, extended this temporary suspension of the 2% sequestration cut through March 31, 2021. The Medicare sequester relief bill, which became Public Law 117-7, extended the temporary suspension of the sequestration cut again, through December 31, 2021. To pay for the continued suspension of the sequestration cuts through December 31, 2021, Congress increased the sequester cuts that will apply in fiscal year 2030.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.73pt">Two waivers of Medicare statutory requirements regarding site neutral payment to LTCHs. The first waives the LTCH discharge payment percentage requirement (i.e., 50% rule) for the cost reporting period(s) that include the emergency period. The second waives application of the site neutral payment rate so that all LTCH cases admitted during the emergency period will be paid the LTCH-PPS standard federal rate.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Waiver of the IRF 3-hour rule so that IRF services provided during the public health emergency period do not need to meet the coverage requirement that patients receive at least 3 hours of therapy a day or 15 hours of therapy per week.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vi.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.73pt">Broader waiver authority for HHS under section 1135 of the Social Security Act to issue additional telehealth waivers.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CARES Act also provides for a 20% increase in the payment weight for Medicare payments to hospitals paid under the inpatient hospital prospective payment system (&#8220;IPPS&#8221;) for treating COVID-19 patients. We are monitoring developments related to this provision, in case CMS provides a similar payment add-on for LTCHs and IRFs.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare Reimbursement of LTCH Services</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of significant regulatory changes to the Medicare prospective payment system for our critical illness recovery hospitals, which are certified by Medicare as LTCHs, which have affected our results of operations, as well as the policies and payment rates that may affect our future results of operations. Medicare payments to our critical illness recovery hospitals are made in accordance with the long-term care hospital prospective payment system (&#8220;LTCH-PPS&#8221;). </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fiscal Year 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  On August 16, 2019, CMS published the final rule updating policies and payment rates for the LTCH-PPS for fiscal year 2020 (affecting discharges and cost reporting periods beginning on or after October 1, 2019 through September 30, 2020). Certain errors in the final rule were corrected in a document published October 8, 2019. The standard federal rate was set at $42,678, an increase from the standard federal rate applicable during fiscal year 2019 of $41,559. The update to the standard federal rate for fiscal year 2020 included a market basket increase of 2.9%, less a productivity adjustment of 0.4%. The standard federal rate also included an area wage budget neutrality factor of 1.0020203 and a temporary, one-time budget neutrality adjustment of 0.999858 in connection with the elimination of the 25 Percent Rule. The fixed-loss amount for high cost outlier cases paid under LTCH-PPS was set at $26,778, a decrease from the fixed-loss amount in the 2019 fiscal year of $27,121. The fixed-loss amount for high cost outlier cases paid under the site-neutral payment rate was set at $26,552, an increase from the fixed-loss amount in the 2019 fiscal year of $25,743. For LTCH discharges occurring in cost reporting periods beginning in fiscal year 2020, site neutral payment rate cases will begin to be paid fully on the site neutral payment rate, rather than the transitional blended rate. However, the CARES Act waives the site neutral payment rate for patients admitted during the COVID-19 emergency period and in response to the public health emergency, as discussed above.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fiscal Year 2021.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  On September 18, 2020, CMS published the final rule updating policies and payment rates for the LTCH-PPS for fiscal year 2021 (affecting discharges and cost reporting periods beginning on or after October 1, 2020 through September 30, 2021). Certain errors in the final rule were corrected in a document published December 7, 2020. The standard federal rate was set at $43,755, an increase from the standard federal rate applicable during fiscal year 2020 of $42,678. The update to the standard federal rate for fiscal year 2021 included a market basket increase of 2.3% with no productivity adjustment. The standard federal rate also included an area wage budget neutrality factor of 1.0016837 and a permanent, one-time budget neutrality adjustment of 1.000517 in connection with the elimination of the 25 Percent Rule. As a result of the CARES Act, all LTCH cases are paid at the standard federal rate during the public health emergency. If the public health emergency ends during fiscal year 2021, then CMS will return to using the site-neutral payment rate for reimbursement of cases that do not meet the LTCH patient criteria. The fixed-loss amount for high cost outlier cases paid under LTCH-PPS was set at $27,195, an increase from the fixed-loss amount in the 2020 fiscal year of $26,778. The fixed-loss amount for high cost outlier cases paid under the site-neutral payment rate was set at $29,064, an increase from the fixed-loss amount in the 2020 fiscal year of $26,552.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fiscal Year 2022.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  On August 2, 2021, CMS released a display copy of the final rule updating policies and payment rates for the LTCH-PPS for fiscal year 2022 (affecting discharges and cost reporting periods beginning on or after October 1, 2021 through September 30, 2022). The standard federal rate was set at $44,714, an increase from the standard federal rate applicable during fiscal year 2021 of $43,755. The update to the standard federal rate for fiscal year 2022 included a market basket increase of 2.6%, less a productivity adjustment of 0.7%. The standard federal rate also included an area wage budget neutrality factor of 1.002848. As a result of the CARES Act, all LTCH cases are paid at the standard federal rate during the public health emergency. If the public health emergency ends before or during fiscal year 2022, then CMS will return to using the site-neutral payment rate for reimbursement of cases that do not meet the LTCH patient criteria. The fixed-loss amount for high cost outlier cases paid under LTCH-PPS was set at $33,015, a significant increase from the fixed-loss amount in the 2021 fiscal year of $27,195. The fixed-loss amount for high cost outlier cases paid under the site-neutral payment rate was set at $30,988, an increase from the fixed-loss amount in the 2021 fiscal year of $29,064.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare Reimbursement of IRF Services</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of significant regulatory changes to the Medicare prospective payment system for our rehabilitation hospitals, which are certified by Medicare as IRFs, which have affected our results of operations, as well as the policies and payment rates that may affect our future results of operations. Medicare payments to our rehabilitation hospitals are made in accordance with the inpatient rehabilitation facility prospective payment system (&#8220;IRF-PPS&#8221;).</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fiscal Year 2020.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   On August 8, 2019, CMS published the final rule updating policies and payment rates for the IRF-PPS for fiscal year 2020 (affecting discharges and cost reporting periods beginning on or after October 1, 2019 through September 30, 2020). The standard payment conversion factor for discharges for fiscal year 2020 was set at $16,489, an increase from the standard payment conversion factor applicable during fiscal year 2019 of $16,021. The update to the standard payment conversion factor for fiscal year 2020 included a market basket increase of 2.9%, less a productivity adjustment of 0.4%. CMS decreased the outlier threshold amount for fiscal year 2020 to $9,300 from $9,402 established in the final rule for fiscal year 2019.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fiscal Year 2021.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   On August 10, 2020, CMS published the final rule updating policies and payment rates for the IRF-PPS for fiscal year 2021 (affecting discharges and cost reporting periods beginning on or after October 1, 2020 through September 30, 2021). The standard payment conversion factor for discharges for fiscal year 2021 was set at $16,856, an increase from the standard payment conversion factor applicable during fiscal year 2020 of $16,489. The update to the standard payment conversion factor for fiscal year 2021 included a market basket increase of 2.4% with no productivity adjustment. CMS decreased the outlier threshold amount for fiscal year 2021 to $7,906 from $9,300 established in the final rule for fiscal year 2020.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fiscal Year 2022.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   On August 4, 2021, CMS published the final rule updating policies and payment rates for the IRF-PPS for fiscal year 2022 (affecting discharges and cost reporting periods beginning on or after October 1, 2021 through September 30, 2022). The standard payment conversion factor for discharges for fiscal year 2022 was set at $17,240, an increase from the standard payment conversion factor applicable during fiscal year 2021 of $16,856. The update to the standard payment conversion factor for fiscal year 2022 included a market basket increase of 2.6%, less a productivity adjustment of 0.7%. CMS  increased the outlier threshold amount for fiscal year 2022 to $9,491 from $7,906 established in the final rule for fiscal year 2021.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare Reimbursement of Outpatient Rehabilitation Clinic Services</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outpatient rehabilitation providers enroll in Medicare as a rehabilitation agency, a clinic, or a public health agency. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicare program reimburses outpatient rehabilitation providers based on the Medicare physician fee schedule. For services provided in 2017 through 2019, a 0.5% update was applied each year to the fee schedule payment rates, subject to an adjustment beginning in 2019 under the Merit-Based Incentive Payment System (&#8220;MIPS&#8221;). </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, CMS added physical and occupational therapists to the list of MIPS eligible clinicians. For these therapists in private practice, payments under the fee schedule are subject to adjustment in a later year based on their performance in MIPS according to established performance standards. Calendar year 2021 is the first year that payments are adjusted, based upon t</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he therapist&#8217;s performance under MIPS in 2019. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Providers in facility-based outpatient therapy settings are&#160;excluded&#160;from MIPS eligibility and therefore not subject to this payment adjustment. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For services provided in 2020 through 2025, a 0.0% percent update will be applied each year to the fee schedule payment rates, subject to adjustments under MIPS and the alternative payment models (&#8220;APMs&#8221;). In 2026 and subsequent years, eligible professionals participating in APMs&#160;who meet certain criteria would receive annual updates of 0.75%, while all other professionals would receive annual updates of 0.25%.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each year from 2019 through 2024 eligible clinicians who receive a significant share of their revenues through an advanced APM (such as accountable care organizations or bundled payment arrangements) that involves risk of financial losses and a quality measurement component will receive a 5% bonus. The bonus payment for APM participation is intended to encourage participation and testing of new APMs&#160;and to promote the alignment of incentives across payors. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the 2020 Medicare physician fee schedule final rule, CMS revised coding, documentation guidelines, and increased the valuation for evaluation and management (&#8220;E/M&#8221;) office visit codes, beginning in 2021. Because the Medicare physician fee schedule is budget-neutral, any revaluation of E/M services that will increase spending by more than $20 million will require a budget neutrality adjustment. To increase values for the E/M codes while maintaining budget neutrality under the fee schedule, CMS cut the values of other codes to make up the difference, beginning in 2021. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the 2021 Medicare physician fee schedule final rule, CMS increased the values for the E/M office visit codes and cuts to other specialty codes to maintain budget neutrality. As a result, therapy services provided in our outpatient rehabilitation clinics will receive an estimated 3.6% decrease in payment from Medicare in calendar year 2021. Legislation was introduced in Congress that, if enacted, would waive the budget neutrality requirement with respect to the E/M codes for 2021 in order to avoid or minimize cuts to physical and occupational therapy services and other code values. Separately, the Consolidated Appropriations Act, 2021, provides a one-time 3.75% increase in payments in calendar year 2021 for therapy services and other services paid under the physician fee schedule. This 3.75% increase will expire at the end of calendar year 2021.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the calendar year 2022 physician fee schedule proposed rule, CMS announced its plan to transition the MIPS program to MIPS Value Pathways (&#8220;MVPs&#8221;). CMS proposes to begin the transition to MVPs in 2023 with an initial set of MVPs in which reporting is voluntary. CMS proposes to develop more MVPs from 2024 to 2027 so that MVP reporting would become mandatory in 2028. The first seven proposed MVPs for 2023 align with the following clinical topics: (1) Rheumatology; (2) Stroke Care and Prevention; (3) Heart Disease; (4) Chronic Disease Management; (5) Emergency Medicine; (6) Lower Extremity Joint Repair; and (7) Anesthesia. Each MVP would include population health claims-based measures and require clinicians to report on the Promoting Interoperability performance category measures. In addition, MVP participants would select certain quality measures and improvement activities and then report data for such measures and activities.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Modifiers to Identify Services of Physical Therapy Assistants or Occupational Therapy Assistants</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Medicare physician fee schedule final rule for calendar year 2019, CMS established two new modifiers (CQ and CO) to identify services furnished in whole or in part by physical therapy assistants (&#8220;PTAs&#8221;) or occupational therapy assistants (&#8220;OTAs&#8221;). These modifiers were mandated by the Bipartisan Budget Act of 2018, which requires that claims for outpatient therapy services furnished in whole or part by therapy assistants on or after January 1, 2020 include the appropriate modifier. CMS intends to use these modifiers to implement a payment differential that would reimburse services provided by PTAs and OTAs at 85% of the fee schedule rate beginning on January 1, 2022. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the final </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020 Medicare physician fee schedule rule</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CMS clarified that when the physical therapist is involved for the entire duration of the service and the PTA provides skilled therapy alongside the physical therapist</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the CQ modifier is not required. Also, when the same service (code) is furnished separately by the physical therapist and PTA, CMS will apply the </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de minimis </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">standard to each 15-minute unit of codes, not on the total physical therapist and PTA time of the service, allowing the separate reporting, on t</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">wo different claim lines, of the number of units to which the new modifiers apply and the number of units to which the modifiers do not apply. In the calendar year 2022 physician fee schedule proposed rule, CMS proposes to implement the final part of the requirements in the Bipartisan Budget Act of 2018 regarding PTA and OTA services. For dates of service on and after January 1, 2022, CMS will pay for physical therapy and occupational therapy services provided by PTAs and OTAs at 85% of the otherwise applicable Part B payment amount. CMS also proposes to modify the de minimis standard for calendar year 2022. Specifically, CMS is proposing to allow a timed service to be billed without the CQ or CO modifier when a PTA or OTA participates in providing care, but the physical therapist or occupational therapist meets the Medicare billing requirements without including the PTA&#8217;s or OTA&#8217;s minutes. This occurs when the physical therapist or occupational therapist provides more minutes than the 15-minute midpoint.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IMPACT Act</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2014, President Obama signed into law the Improving Medicare Post-Acute Care Transformation Act of 2014 (the &#8220;IMPACT Act&#8221;). The IMPACT Act made a number of changes and additions to Medicare quality reporting for LTCHs, IRFs, skilled nursing facilities (&#8220;SNFs&#8221;), and home health agencies (&#8220;HHAs&#8221;). In addition, the IMPACT Act requires HHS and the Medicare Payment Advisory Commission (&#8220;MedPAC&#8221;) to develop a technical prototype for a unified post-acute care (&#8220;PAC&#8221;) prospective payment system (&#8220;PPS&#8221;) that could replace the four existing payment systems for LTCHs, IRFs, SNFs, and HHAs.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IMPACT Act directed HHS to begin requiring providers to report certain standardized patient assessment data to CMS. HHS had to adopt this reporting requirement by October 1, 2018, for LTCHs, IRFs, and SNFs, and by January 1, 2019, for HHAs. The IMPACT Act also required CMS to adopt and implement new cross-setting quality measures addressing, at a minimum, the following quality domains: (1) functional status, cognitive function, and changes in function and cognitive function; (2) skin integrity and changes in skin integrity; (3) medication reconciliation; (4) incidence of major falls; and (5) providing for the transfer of health information and treatment preferences of the patient upon transition from a hospital or critical access hospital to another setting, including a PAC provider or the individual&#8217;s home, or upon transition from a PAC provider to another setting including a different PAC provider, hospital, critical access hospital, or the individual&#8217;s home. Next, the IMPACT Act required that by October 1, 2016, for SNFs, IRFs and LTCHs, and by January 1, 2017, for HHAs, CMS specify resource use and other measures for inclusion in the applicable reporting provisions. At a minimum, the resource use measures shall include the following resource use domains: (1) resource use measures, including total estimated Medicare spending per beneficiary; (2) discharge to community; and (3) measures to reflect all-condition risk-adjusted hospitalization rates of potentially preventable readmission rates. CMS began implementing the IMPACT Act&#8217;s data reporting requirements in the FY 2016 rulemakings for LTCHs, IRFs, SNFs, and HHAs.  </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the new reporting requirements, the IMPACT Act outlined a process for the potential development of a unified PAC PPS. The IMPACT Act does not require CMS to adopt a unified PAC PPS, nor does it provide CMS with specific authority to implement a new payment system. However, the IMPACT Act does require HHS and MedPAC to submit a series of reports to Congress with recommendations and a technical prototype for a PAC PPS. These recommendations and prototypes could become the basis of future legislation that would create a unified PAC PPS to replace some or all of the existing Medicare payment systems for LTCHs, IRFs, SNFs, and HHAs. MedPAC submitted the first report to Congress in June 2016.  The report included recommended features for a unified PAC payment system. The Secretary of HHS will submit the next report to Congress with recommendations and a technical prototype. The Secretary&#8217;s report is due no later than two years after CMS has collected two years of data on the quality measures required by the IMPACT Act. After the CMS report, MedPAC is to submit a second report to Congress with recommendations and a technical prototype for a new PAC payment system. The Secretary is expected to issue his report to Congress sometime in 2022. However, a bipartisan bill introduced in the House of Representatives in April 2021 would require the Secretary to first collect eight quarters of IMPACT Act data, including standardized patient assessment data, quality measure data, resource use and claims data, before submitting his report to Congress. The legislation would require that the eight quarters of data could not include any month in which the COVID-19 public health emergency, or a similar nationwide public health emergency, is ongoing. If enacted, the Secretary&#8217;s report would not be submitted before the later of January 1, 2024 or two years after the Secretary collects eight quarters of data.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Price Transparency</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Starting January 1, 2021, new regulations went into effect requiring hospitals to provide clear and accessible pricing information online regarding the items and services they provide. First, a new regulation requires hospitals to provide a machine readable file containing the following standard charges for all items and services provided by the hospital: gross charges, discounted cash prices, payer-specific negotiated charges, and de-identified minimum and maximum negotiated charges. Second, hospitals must provide a consumer-friendly display of standard charges for at least 300 &#8220;shoppable services&#8221; that consumers can schedule in advance. If a hospital does not offer 300 &#8220;shoppable services,&#8221; then the hospital must provide the consumer-friendly display of standard charges for all of the &#8220;shoppable services&#8221; that it does provide. For each &#8220;shoppable service,&#8221; hospitals must provide: discounted cash prices, payer-specific negotiated charges, and de-identified minimum and maximum negotiated charges. For hospitals that do not comply with these requirements, CMS may issue a warning notice, request a corrective action plan, and impose a civil monetary penalty that is publicized on the CMS website. These regulations were promulgated by the Trump administration and, on July 9, 2021, President Biden issued an Executive Order directing HHS to support the new price transparency regulations. On July 19, 2021, CMS issued a proposed rule to increase fines for hospitals that do not comply with the price transparency regulations of at least $300 per day, not to exceed $2,007,500 per hospital per year. CMS is asking for comments on alternative or additional criteria that could be used to scale a penalty, and its proposal that the machine-readable file of hospital charges is accessible to automated searches and direct downloads.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Surprise Billing</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 13, 2021, HHS, the Department of the Treasury, the Department of Labor and the Office of Personnel Management published an interim final rule with comment period to implement certain provisions of the No Surprises Act, which was enacted as part of the Consolidated Appropriations Act, 2021. The interim final rule includes new regulations aimed at limiting surprise medical bills issued by health care providers to consumers. The HHS regulations adopted by this interim final rule are effective January 1, 2022 and apply to hospital emergency departments, freestanding emergency departments, health care providers and facilities, and providers of air ambulance services. The new regulations do not apply to patients covered by Medicare, Medicaid, Indian Health Services, Veterans Affairs health care, or TRICARE because these programs already prohibit balance billing. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Starting January 1, 2022, the interim final rule&#8217;s new regulations will apply to patients with health insurance coverage from a group health plan (including a self-insured group health plan) or from an individual market health insurance issuer. First, if a plan provides coverage for emergency services, the interim final rule requires that emergency services must be covered: (1) without prior authorization; (2) regardless of whether the provider is an in-network provider or an in-network emergency facility; and (3) regardless of any other term or condition of the plan or coverage other than the exclusion or coordination of benefits, or a permitted affiliation or waiting period. Second, the interim final rule includes new limits on patient cost-sharing obligations for out-of-network services. Specifically, patient cost-sharing amounts for emergency services provided by out-of-network emergency facilities and out-of-network providers, and certain non-emergency services furnished by out-of-network providers at certain in-network facilities, must be calculated based on one of the following amounts: (1) an amount determined by an applicable All-Payer Model Agreement under section 1115A of the Social Security Act; (2) a specified state law if there is no such All-Payer Model Agreement; or (3) if neither of the above apply, the lesser amount of either the billed charge or the qualifying payment amount, which is generally the plan or issuer&#8217;s median contracted rate. Third, the interim final rule prohibits non-participating providers, health care facilities, and providers of air ambulance services from balance billing participants, beneficiaries, and enrollees in certain situations. Fourth, the interim final rule establishes that the total amount to be paid to an out-of-network provider or facility, including any cost-sharing, is based on: (1) an amount determined by an applicable All-Payer Model Agreement under section 1115A of the Social Security Act; (2) a specified state law if there is no such All-Payer Model Agreement; or (3) an amount agreed upon by the plan or issuer and the provider or facility if there is no such Agreement or state law. If none of these three circumstances apply, then the amount is determined by an independent dispute resolution (&#8220;IDR&#8221;) entity. Regulations regarding IDR entities and the IDR process will be issued in the future. Fifth, a new regulation requires providers and facilities to make publicly available and provide patients with a one-page notice regarding the requirements and prohibitions applicable to the provider or facility regarding balance billing, any applicable state balance billing prohibitions or limitations, and information on how to contact appropriate state and federal agencies if the patient believes the provider or facility has violated the requirements described in the notice. Finally, the interim final rule establishes a process for HHS to receive and resolve complaints regarding information that any health care provider, provider of air ambulance services, or health care facility may be failing to meet the requirements set forth in the interim final rule. Because these new regulations were adopted through an interim final rule with comment period, they may be modified after CMS reviews public comments.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Statistics</span></div><div style="margin-bottom:9pt;margin-top:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth operating statistics for each of our reportable segments for the periods presented. The operating statistics reflect data for the period of time we managed these operations. Our operating statistics include metrics we believe provide relevant insight about the number of facilities we operate, volume of services we provide to our patients, and average payment rates for services we provide. These metrics are utilized by management to monitor trends and performance in our businesses and therefore may be important to investors because management may assess our performance based in part on such metrics. Other healthcare providers may present similar statistics, and these statistics are susceptible to varying definitions. Our statistics as presented may not be comparable to other similarly titled statistics of other companies.</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical illness recovery hospital data:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of hospitals owned&#8212;start of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of hospitals acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of hospital start-ups</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of hospitals closed/sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of hospitals owned&#8212;end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of hospitals managed&#8212;end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total number of hospitals (all)&#8212;end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available licensed beds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,308&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,322&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,308&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,322&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Admissions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patient days</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">276,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">272,981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">547,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">566,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average length of stay (days)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue per patient day</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Occupancy rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(6)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Percent patient days&#8212;Medicare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(7)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation hospital data:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of hospitals owned&#8212;start of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of hospitals acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of hospital start-ups</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of hospitals closed/sold</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of hospitals owned&#8212;end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of hospitals managed&#8212;end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total number of hospitals (all)&#8212;end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Available licensed beds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,361&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,361&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Admissions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,491&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patient days</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104,948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">207,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Average length of stay (days)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue per patient day</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Occupancy rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Percent patient days&#8212;Medicare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(7)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient rehabilitation data:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of clinics owned&#8212;start of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of clinics acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of clinic start-ups</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of clinics closed/sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of clinics owned&#8212;end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,475&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,475&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of clinics managed&#8212;end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total number of clinics (all)&#8212;end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,757&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,833&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,757&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,833&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of visits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(8)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,342,267&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,404,861&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,464,932&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,505,015&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue per visit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(9)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:1pt;margin-top:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra data:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of centers owned&#8212;start of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of centers acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of center start-ups</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of centers closed/sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of centers owned&#8212;end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of onsite clinics operated&#8212;end of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of CBOCs owned&#8212;end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number of visits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(8)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,151,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,030,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,028,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,825,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue per visit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(9)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Data excludes locations managed by the Company. For purposes of our Concentra segment, onsite clinics and community-based outpatient clinics (&#8220;CBOCs&#8221;) are excluded. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Represents the number of patients admitted to our hospitals during the periods presented. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Each patient day represents one patient occupying one bed for one day during the periods presented. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Represents the average number of days in which patients were admitted to our hospitals. Average length of stay is calculated by dividing the number of patient days, as presented above, by the number of patients discharged from our hospitals during the periods presented. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Represents the average amount of revenue recognized for each patient day. Revenue per patient day is calculated by dividing patient service revenues, excluding revenues from certain other ancillary and outpatient services provided at our hospitals, by the total number of patient days.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Represents the portion of our hospitals being utilized for patient care during the periods presented. Occupancy rate is calculated using the number of patient days, as presented above, divided by the total number of bed days available during the period. Bed days available is derived by adding the daily number of available licensed beds for each of the periods presented. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Represents the portion of our patient days which are paid by Medicare. The Medicare patient day percentage is calculated by dividing the total number of patient days which are paid by Medicare by the total number of patient days, as presented above. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Represents the number of visits in which patients were treated at our outpatient rehabilitation clinics and Concentra centers during the periods presented. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Represents the average amount of revenue recognized for each patient visit. Revenue per visit is calculated by dividing patient service revenue, excluding revenues from certain other ancillary services, by the total number of visits. For purposes of this computation for our Concentra segment, patient service revenue does not include onsite clinics and CBOCs.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_130"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:15pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table outlines selected operating data as a percentage of revenue for the periods indicated:</span></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:41.168%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of services, exclusive of depreciation and amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">94.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">92.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on sale of businesses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to Select Medical Holdings Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Cost of services includes salaries, wages and benefits, operating supplies, lease and rent expense, and other operating costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes selected financial data by segment for the periods indicated:</span></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.069%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Critical illness recovery hospital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">519,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">544,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,020,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,138,931&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rehabilitation hospital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">350,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">420,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outpatient rehabilitation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">167,138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">422,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">532,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Concentra</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">456,372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">710,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">879,212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,232,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,564,020&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,647,350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,110,483&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Critical illness recovery hospital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(20.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">160,190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rehabilitation hospital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">111.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outpatient rehabilitation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,476)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">384.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">793.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Concentra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">115,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">508.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">176,876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">211.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19,448)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/M</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">119,518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">283,968&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">248,196&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">485,980&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">95.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Critical illness recovery hospital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">186,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rehabilitation hospital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outpatient rehabilitation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,282)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">826.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,840&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">245.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Concentra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">230.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">219,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/M</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,752&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">342,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">366,085&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">600,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA margins:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Critical illness recovery hospital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rehabilitation hospital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outpatient rehabilitation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Concentra</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Critical illness recovery hospital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,115,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,187,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,115,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,187,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rehabilitation hospital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,135,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,186,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,135,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,186,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outpatient rehabilitation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,267,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,333,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,267,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,333,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Concentra</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,351,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,518,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,351,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,518,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">598,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">730,282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">598,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">730,282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,468,458&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,956,379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,468,458&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,956,379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Critical illness recovery hospital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rehabilitation hospital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outpatient rehabilitation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Concentra</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,045&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,723&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,253&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76,442&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;Other includes our corporate administration and shared services, as well as employee leasing services with our non-consolidating subsidiaries. Total assets include certain non-consolidating joint ventures and minority investments in other healthcare related businesses.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;During the three months ended June&#160;30, 2021 and 2020, we recognized other operating income of $98.1 million and $55.0 million, respectively. During the six months ended June&#160;30, 2021 and 2020, we recognized other operating income of $132.1 million and $55.0 million, respectively. The impact of this income on the operating results of our critical illness recovery hospital segment, Concentra segment, and other activities is outlined within the tables presented under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary Financial Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for the three and six months ended June&#160;30, 2021 and 2020.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">N/M &#8212; &#160;&#160;&#160;&#160;Not meaningful.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended June&#160;30, 2021, Compared to Three Months Ended June&#160;30, 2020</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the following, we discuss our results of operations related to revenue, operating expenses, other operating income, Adjusted EBITDA, depreciation and amortization, income from operations, equity in earnings of unconsolidated subsidiaries, gain on sale of businesses, interest, income taxes, and net income attributable to non-controlling interests.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effects of the COVID-19 Pandemic on our Results of Operation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">during the Three and Six Months Ended June 30, 2020 and 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; above for further discussion.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue increased 26.9% to $1,564.0 million for the three months ended June&#160;30, 2021, compared to $1,232.7 million for the three months ended June&#160;30, 2020.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Illness Recovery Hospital Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue increased 4.7% to $544.1 million for the three months ended June&#160;30, 2021, compared to $519.6 million&#160;for the three months ended June&#160;30, 2020. The increase in revenue was due to an increase in revenue per patient day during the three months ended June&#160;30, 2021, as compared to the three months ended June&#160;30, 2020. Revenue per patient day increased 6.4% to $1,986 for the three months ended June&#160;30, 2021, compared to $1,867 for the three months ended June&#160;30, 2020. We experienced increases in both our non-Medicare and Medicare revenue per patient day during the three months ended June&#160;30, 2021, as compared to the three months ended June&#160;30, 2020. Occupancy in our critical illness recovery hospitals was 69% during the three months ended June&#160;30, 2021, compared to 72% for the three months ended June&#160;30, 2020. Our patient days were 272,981 for the three months ended June&#160;30, 2021, 276,889 days for the three months ended June&#160;30, 2020, and 262,860 days for the three months ended June 30, 2019. Our critical illness recovery hospitals experienced an increase in patient days during the three months ended June&#160;30, 2020 which was due in part to the effects of the COVID-19 pandemic. Our patient days increased 3.9% to 272,981 days for the three months ended June&#160;30, 2021, compared to 262,860 days for the three months ended June 30, 2019.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rehabilitation Hospital Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue increased 26.1% to $212.7 million for the three months ended June&#160;30, 2021, compared to $168.7 million&#160;for the three months ended June&#160;30, 2020. The increase in revenue resulted primarily from an increase in patient volume during the three months ended June&#160;30, 2021, compared to the three months ended June&#160;30, 2020. Occupancy in our rehabilitation hospitals increased to 85% during the three months ended June&#160;30, 2021, compared to 71% for the three months ended June&#160;30, 2020. Our patient days increased 24.8% to 104,948 days for the three months ended June&#160;30, 2021, compared to 84,081 days for the three months ended June&#160;30, 2020. We experienced a 18.9% increase in patient days in our rehabilitation hospitals which operated during both the three months ended June&#160;30, 2021 and 2020. Our patient volume during the three months ended June&#160;30, 2020 was adversely affected within our rehabilitation hospitals in New Jersey and South Florida that temporarily restricted their admissions as a result of the COVID-19 pandemic. Certain of our rehabilitation hospitals also experienced lower patient volume due to the suspension of elective surgeries at hospitals and other facilities, which consequently reduced the demand for inpatient rehabilitation services during the three months ended June&#160;30, 2020. Since June&#160;30, 2020, we acquired controlling interests in two rehabilitation hospitals; we were previously a minority owner in each of these businesses. These hospitals contributed 6,528 patient days during the three months ended June&#160;30, 2021. Our revenue per patient day increased 1.0% to $1,849 for the three months ended June&#160;30, 2021, compared to $1,831 for the three months ended June&#160;30, 2020. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Outpatient Rehabilitation Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue increased 67.8% to $280.4 million for the three months ended June&#160;30, 2021, compared to $167.1 million for the three months ended June&#160;30, 2020. The increase in revenue was attributable to an increase in visits, which increased 79.2% to 2,404,861 for the three months ended June&#160;30, 2021, compared to 1,342,267 visits for the three months ended June&#160;30, 2020. During the three months ended June&#160;30, 2020, our outpatient rehabilitation clinics experienced significant declines in patient visit volume due to fewer patient referrals from physicians, a reduction in workers&#8217; compensation injury visits due to the closure of businesses, the suspension of elective surgeries at hospitals and other facilities which resulted in less demand for outpatient rehabilitation services, and social distancing practices resulting from the COVID-19 pandemic. Our revenue per visit was $102 for the three months ended June&#160;30, 2021, compared to $106 for the three months ended June&#160;30, 2020. During the three months ended June&#160;30, 2020, we experienced changes in our payor mix as our patient volume declined from the effects of the COVID-19 pandemic. These changes caused our revenue per visit to increase. As our patient volume increased during the three months ended June&#160;30, 2021, as compared to the three months ended June&#160;30, 2020, our payor mix began to normalize and is now more closely aligned with the mix experienced during the months prior to the widespread emergence of COVID-19 in the United States.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentra Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue increased 46.1% to $456.4 million for the three months ended June&#160;30, 2021, compared to $312.3 million for the three months ended June&#160;30, 2020. Our patient visits, which increased 40.9% to 3,030,078 for the three months ended June&#160;30, 2021, compared to 2,151,080 visits for the three months ended June&#160;30, 2020, contributed to the increase in revenue. During the three months ended June&#160;30, 2020, our centers experienced significant declines in patient visit volume due to employers furloughing their workforce and temporarily ceasing or significantly reducing their operations. As a result of the COVID-19 pandemic, we generated revenue from COVID-19 screening and testing services. These services contributed $55.0&#160;million of revenue during the three months ended June&#160;30, 2021, compared to $6.2&#160;million during the three months ended June&#160;30, 2020. During the three months ended June&#160;30, 2021, our revenue per visit increased to $125, compared to $124 for the three months ended June&#160;30, 2020. We experienced a higher revenue per visit due to increases in the reimbursement rates payable pursuant to certain state fee schedules for workers&#8217; compensation visits, as well as increases in our employer services rates during the three months ended June&#160;30, 2021. The increase in revenue per visit was offset partially by a greater percentage of employer services visits, which yield lower per visit rates. Additionally, the revenue of the Concentra segment was impacted by the sale of its Department of Veterans Affairs community-based outpatient clinic business on September 1, 2020. This business contributed $22.0&#160;million of revenue to the Concentra segment during the three months ended June&#160;30, 2020. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating expenses consist principally of cost of services and general and administrative expenses. Our operating expenses were $1,327.2 million, or 84.9% of revenue, for the three months ended June&#160;30, 2021, compared to $1,115.9 million, or 90.5% of revenue, for the three months ended June&#160;30, 2020. Our cost of services, a major component of which is labor expense, was $1,291.4 million, or 82.6% of revenue, for the three months ended June&#160;30, 2021, compared to $1,082.5 million, or 87.8% of revenue, for the three months ended June&#160;30, 2020. The decrease in our operating expenses relative to our revenue was principally due to the improved operating performances of our Concentra, outpatient rehabilitation, and rehabilitation hospital segments. This was driven primarily by an increase in patient volume, as described further within the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; discussions. General and administrative expenses were $35.7 million, or 2.3% of revenue, for the three months ended June&#160;30, 2021, compared to $33.5 million, or 2.7% of revenue, for the three months ended June&#160;30, 2020. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Operating Income</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating income was $98.1 million for the three months ended June&#160;30, 2021, compared to $55.0 million for the three months ended June&#160;30, 2020. The other operating income is primarily related to the recognition of payments received under the Provider Relief Fund for health care related expenses and lost revenues attributable to COVID-19. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating income of $65.8 million and $32.3 million is included within the operating results of our other activities and Concentra segment, respectively, for the three months ended June&#160;30, 2021. Other operating income of $54.2 million and $0.8 million is included within the operating results of our other activities and Concentra segment, respectively, for the three months ended June&#160;30, 2020. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDA</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Illness Recovery Hospital Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160; &#160;Adjusted EBITDA was $72.9 million for the three months ended June&#160;30, 2021, compared to $89.7 million for the three months ended June&#160;30, 2020. Our Adjusted EBITDA margin for the critical illness recovery hospital segment was 13.4% for the three months ended June&#160;30, 2021, compared to 17.3% for the three months ended June&#160;30, 2020. The decreases in Adjusted EBITDA and Adjusted EBITDA margin for our critical illness recovery hospital segment were driven by a decline in patient volume, as discussed above under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and the incurrence of additional operating expenses as a result of the effects of the COVID-19 pandemic. We experienced an increase in these operating expenses during the three months ended June&#160;30, 2021, as compared to the three months ended June&#160;30, 2020. Our critical illness recovery hospitals have experienced increased usage of contract clinical labor during this time and the cost of this labor has risen significantly due to the demand for healthcare professionals. Additionally, our critical illness recovery hospitals have modified certain of their protocols which have resulted in increased costs, including adjusting staffing ratios and purchasing additional personal protective equipment, in order to follow the guidelines and recommendations for patient treatment and for the protection of both our patients and staff members.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rehabilitation Hospital Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160; &#160;Adjusted EBITDA increased 83.9% to $50.8 million for the three months ended June&#160;30, 2021, compared to $27.6 million for the three months ended June&#160;30, 2020. Our Adjusted EBITDA margin for the rehabilitation hospital segment was 23.9% for the three months ended June&#160;30, 2021, compared to 16.4% for the three months ended June&#160;30, 2020. The increases in Adjusted EBITDA and Adjusted EBITDA margin were primarily attributable to an increase in patient volume, as discussed further under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Outpatient Rehabilitation Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Adjusted EBITDA increased to $45.6 million for the three months ended June&#160;30, 2021, compared to Adjusted EBITDA losses of $6.3 million for the three months ended June&#160;30, 2020. Our Adjusted EBITDA margin for the outpatient rehabilitation segment was 16.3% for the three months ended June&#160;30, 2021, compared to (3.8)% for the three months ended June&#160;30, 2020. The increases in Adjusted EBITDA and Adjusted EBITDA margin were driven by increases in patient visit volume. During the three months ended June&#160;30, 2020, our outpatient rehabilitation clinics experienced significant declines in patient visit volume as a result of the effects of the COVID-19 pandemic, as described further above.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentra Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Adjusted EBITDA increased to $137.1 million for the three months ended June&#160;30, 2021, compared to $41.5 million for the three months ended June&#160;30, 2020. Our Adjusted EBITDA margin for the Concentra segment was 30.0% for the three months ended June&#160;30, 2021, compared to 13.3% for the three months ended June&#160;30, 2020. The increase in patient visit volume contributed to the increases in Adjusted EBITDA and Adjusted EBITDA margin. As discussed further above, our Concentra segment experienced significant declines in patient visit volume as a result of the effects of the COVID-19 pandemic during the three months ended June&#160;30, 2020. The increases in Adjusted EBITDA and Adjusted EBITDA margin were also due in part to the COVID-19 screening and testing services provided at our centers and various onsite clinics located at employer worksites, as discussed further under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; We incur lower operating expenses associated with these services as compared to our core services. Our Concentra segment also recognized $32.3 million of other operating income during the three months ended June&#160;30, 2021, as described further above under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Operating Income,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; compared to $0.8 million for the three months ended June&#160;30, 2020.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and Amortization</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense was $51.0 million for the three months ended June&#160;30, 2021, compared to $52.3 million for the three months ended June&#160;30, 2020.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income from Operations</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, we had income from operations of $284.0 million, compared to $119.5 million for the three months ended June&#160;30, 2020. The improved operating performance of our Concentra, outpatient rehabilitation, and rehabilitation hospital segments contributed to the increase in income from operations. We also recognized other operating income of $98.1 million during the three months ended June&#160;30, 2021, as described further under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Operating Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; compared to $55.0 million of other operating income for the three months ended June&#160;30, 2020.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity in Earnings of Unconsolidated Subsidiaries</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, we had equity in earnings of unconsolidated subsidiaries of $11.8 million, compared to $8.3 million for the three months ended June&#160;30, 2020. The increase in equity in earnings is principally due to the improved operating performance of our rehabilitation businesses in which we are a minority owner.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gain on Sale of Businesses</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2020, we recognized a gain of $0.3 million. The gain was attributable to additional proceeds received from the sale of an outpatient rehabilitation business. The sale occurred during the first quarter ended March 31, 2020.  </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense was $33.9 million for the three months ended June&#160;30, 2021, compared to $37.4 million for the three months ended June&#160;30, 2020. The decrease in interest expense was principally due to a decline in variable interest rates.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded income tax expense of $65.7 million for the three months ended June&#160;30, 2021, which represented an effective tax rate of 25.1%. We recorded income tax expense of $23.3 million for the three months ended June&#160;30, 2020, which represented an effective tax rate of 25.7%.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Attributable to Non-Controlling Interests</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to non-controlling interests was $31.3 million for the three months ended June&#160;30, 2021, compared to $15.8 million for the three months ended June&#160;30, 2020. The increase in net income attributable to non-controlling interests was principally due to an increase in the net income of our Concentra segment during the three months ended June&#160;30, 2021. This increase resulted from its improved operating performance and the recognition of $32.3 million of other operating income, as described further above, during the three months ended June&#160;30, 2021. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Six Months Ended June&#160;30, 2021, Compared to Six Months Ended June&#160;30, 2020</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the following, we discuss our results of operations related to revenue, operating expenses, other operating income, Adjusted EBITDA, depreciation and amortization, income from operations, equity in earnings of unconsolidated subsidiaries, gain on sale of businesses, interest, income taxes, and net income attributable to non-controlling interests.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effects of the COVID-19 Pandemic on our Results of Operations during the Three and Six Months Ended June 30, 2020 and 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; above for further discussion. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue increased 17.5% to $3,110.5 million for the six months ended June&#160;30, 2021, compared to $2,647.4 million for the six months ended June&#160;30, 2020.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Illness Recovery Hospital Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Revenue increased 11.6% to $1,138.9 million for the six months ended June&#160;30, 2021, compared to $1,020.1 million&#160;for the six months ended June&#160;30, 2020. The increase in revenue was due to increases in both revenue per patient day and patient volume during the six months ended June&#160;30, 2021, as compared to the six months ended June&#160;30, 2020. Revenue per patient day increased 8.3% to $2,006 for the six months ended June&#160;30, 2021, compared to $1,853 for the six months ended June&#160;30, 2020. We experienced increases in both our non-Medicare and Medicare revenue per patient day during the six months ended June&#160;30, 2021, compared to the six months ended June&#160;30, 2020. Our critical illness recovery hospitals experienced an increase in patient acuity during the six months ended June&#160;30, 2021, which contributed to the increase in Medicare revenue per patient day. We also experienced an increase in revenue per patient day as a result of the temporary suspension of the 2.0% cut to Medicare payments due to sequestration, which is described further under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Change</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s.&#8221; Occupancy in our critical illness recovery hospitals increased to 72% during the six months ended June&#160;30, 2021, compared to 71% for the six months ended June&#160;30, 2020. Our patient days increased 3.4% to 566,099 days for the six months ended June&#160;30, 2021, compared to 547,347 days for the six months ended June&#160;30, 2020. Since June&#160;30, 2020, we reopened our Panama City hospital, which was temporarily closed in October 2018, and acquired a controlling interest in a hospital in which we were previously a minority owner. These hospitals contributed 17,547 patient days during the six months ended June&#160;30, 2021. We also experienced a 1.0% increase in patient days in our critical illness recovery hospitals which operated during both the six months ended June&#160;30, 2021 and 2020. The increase in patient days was due in part to our strengthened referral relationships with general acute care hospitals, as our hospitals continue to demonstrate their ability to care for high acuity patients. The effects of the COVID-19 pandemic and the relaxation of certain admission restrictions also contributed to the increase in volume during the six months ended June&#160;30, 2021, as compared to the six months ended June&#160;30, 2020. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rehabilitation Hospital Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Revenue increased 19.9% to $420.5 million for the six months ended June&#160;30, 2021, compared to $350.7 million&#160;for the six months ended June&#160;30, 2020. The increase in revenue was due to increases in both patient volume and revenue per patient day during the six months ended June&#160;30, 2021, compared to the six months ended June&#160;30, 2020. Occupancy in our rehabilitation hospitals increased to 84% during the six months ended June&#160;30, 2021, compared to 75% for the six months ended June&#160;30, 2020. Our patient days increased 16.1% to 207,387 days for the six months ended June&#160;30, 2021, compared to 178,649 days for the six months ended June&#160;30, 2020. We experienced an increase of 12,851 patient days as a result of acquiring controlling interests in two rehabilitation hospitals since June&#160;30, 2020; we were previously a minority owner in each of these businesses. We also experienced an 11.0% increase in patient days in our rehabilitation hospitals which operated during both the six months ended June&#160;30, 2021 and 2020. Our patient volume during the six months ended June&#160;30, 2020 was adversely affected within our rehabilitation hospitals in New Jersey and South Florida that temporarily restricted their admissions as a result of the COVID-19 pandemic. Certain of our rehabilitation hospitals also experienced lower patient volume due to the suspension of elective surgeries at hospitals and other facilities, which consequently reduced the demand for inpatient rehabilitation services during the six months ended June&#160;30, 2020. Our revenue per patient day increased 4.1% to $1,851 for the six months ended June&#160;30, 2021, compared to $1,778 for the six months ended June&#160;30, 2020. We experienced increases in both our Medicare and non-Medicare revenue per patient day during the six months ended June&#160;30, 2021, compared to the six months ended June&#160;30, 2020. The temporary suspension of the 2.0% cut to Medicare payments due to sequestration, which is described further under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Change</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s,&#8221; contributed to the increase in revenue per patient day.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Outpatient Rehabilitation Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Revenue increased 26.0% to $532.4 million for the six months ended June&#160;30, 2021, compared to $422.4 million for the six months ended June&#160;30, 2020. The increase in revenue was attributable to an increase in visits, which increased 30.0% to 4,505,015 for the six months ended June&#160;30, 2021, compared to 3,464,932 visits for the six months ended June&#160;30, 2020. During the six months ended June&#160;30, 2020, our outpatient rehabilitation clinics experienced significant declines in patient visit volume due to fewer patient referrals from physicians, a reduction in workers&#8217; compensation injury visits due to the closure of businesses, the suspension of elective surgeries at hospitals and other facilities which resulted in less demand for outpatient rehabilitation services, and social distancing practices resulting from the COVID-19 pandemic. Our revenue per visit was $103 for the six months ended June&#160;30, 2021, compared to $105 for the six months ended June&#160;30, 2020. During the six months ended June&#160;30, 2020, we experienced changes in our payor mix as our patient volume declined from the effects of the COVID-19 pandemic. These changes caused our revenue per visit to increase. As our patient volume increased during the six months ended June&#160;30, 2021, as compared to the six months ended June&#160;30, 2020, our payor mix began to normalize and is now more closely aligned with the mix experienced during the months prior to the widespread emergence of COVID-19 in the United States.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentra Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue increased 23.7% to $879.2 million for the six months ended June&#160;30, 2021, compared to $710.9 million for the six months ended June&#160;30, 2020. Our patient visits, which increased 15.9% to 5,825,652 for the six months ended June&#160;30, 2021, compared to 5,028,475 visits for the six months ended June&#160;30, 2020, contributed to the increase in revenue. During the six months ended June&#160;30, 2020, our centers experienced significant declines in patient visit volume due to employers furloughing their workforce and temporarily ceasing or significantly reducing their operations. As a result of the COVID-19 pandemic, we generated revenue from COVID-19 screening and testing services. These services contributed $106.7&#160;million of revenue during the six months ended June&#160;30, 2021, compared to $6.2&#160;million during the six months ended June&#160;30, 2020. During the six months ended June&#160;30, 2021, our revenue per visit increased to $125, compared to $124 for the six months ended June&#160;30, 2020. We experienced a higher revenue per visit due to increases in the reimbursement rates payable pursuant to certain state fee schedules for workers&#8217; compensation visits, as well as increases in our employer services rates during the six months ended June&#160;30, 2021. The increase in revenue per visit was offset partially by a greater percentage of employer services visits, which yield lower per visit rates. Additionally, the revenue of the Concentra segment was impacted by the sale of its Department of Veterans Affairs community-based outpatient clinic business on September 1, 2020. This business contributed $43.5&#160;million of revenue to the Concentra segment during the six months ended June&#160;30, 2020. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating expenses consist principally of cost of services and general and administrative expenses. Our operating expenses were $2,656.0 million, or 85.4% of revenue, for the six months ended June&#160;30, 2021, compared to $2,350.1 million, or 88.7% of revenue, for the six months ended June&#160;30, 2020. Our cost of services, a major component of which is labor expense, was $2,584.9 million, or 83.1% of revenue, for the six months ended June&#160;30, 2021, compared to $2,282.8 million, or 86.2% of revenue, for the six months ended June&#160;30, 2020. The decrease in our operating expenses relative to our revenue was principally due to the improved operating performances of our Concentra, outpatient rehabilitation, and rehabilitation hospital segments. This was driven primarily by an increase in patient volume, as described further within the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; discussions. General and administrative expenses were $71.1 million, or 2.3% of revenue, for the six months ended June&#160;30, 2021, compared to $67.3 million, or 2.5% of revenue, for the six months ended June&#160;30, 2020. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Operating Income</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating income was $132.1 million for the six months ended June&#160;30, 2021, compared to $55.0 million for the six months ended June&#160;30, 2020. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2021, $114.1 million of other operating income is related to the recognition of payments received under the Provider Relief Fund for health care related expenses and lost revenues attributable to COVID-19. $81.9 million and $32.3 million of other operating income is included within the operating results of our other activities and Concentra segment, respectively. The remaining $17.9 million of other operating income is related to the outcome of litigation with CMS and is included in the operating results of our critical illness recovery hospital segment.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2020, the other operating income of $55.0 million is related to the recognition of payments received under the Provider Relief Fund for health care related expenses and lost revenues attributable to COVID-19. $54.2 million and $0.8 million of other operating income is included within the operating results of our other activities and Concentra segment, respectively.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDA</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Illness Recovery Hospital Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Adjusted EBITDA increased 4.4% to $186.2 million for the six months ended June&#160;30, 2021, compared to $178.3 million for the six months ended June&#160;30, 2020. Our Adjusted EBITDA margin for the critical illness recovery hospital segment was 16.3% for the six months ended June&#160;30, 2021, compared to 17.5% for the six months ended June&#160;30, 2020. The increase in Adjusted EBITDA for our critical illness recovery hospital segment was primarily driven by the recognition of $17.9 million of other operating income during the six months ended June&#160;30, 2021, as described further above under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Operating Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221; Our Adjusted EBITDA and Adjusted EBITDA margin were adversely affected by the incurrence of additional operating expenses as a result of the effects of the COVID-19 pandemic. We experienced an increase in these operating expenses during the six months ended June&#160;30, 2021, as compared to the six months ended June&#160;30, 2020. Our critical illness recovery hospitals have experienced increased usage of contract clinical labor during this time and the cost of this labor has risen significantly due to the demand for healthcare professionals. Additionally, our critical illness recovery hospitals have modified certain of their protocols which have resulted in increased costs, including adjusting staffing ratios and purchasing additional personal protective equipment, in order to follow the guidelines and recommendations for patient treatment and for the protection of both our patients and staff members. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rehabilitation Hospital Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Adjusted EBITDA increased 53.1% to $101.3 million for the six months ended June&#160;30, 2021, compared to $66.2 million for the six months ended June&#160;30, 2020. Our Adjusted EBITDA margin for the rehabilitation hospital segment was 24.1% for the six months ended June&#160;30, 2021, compared to 18.9% for the six months ended June&#160;30, 2020. The increases in Adjusted EBITDA and Adjusted EBITDA margin were primarily driven by increases in patient volume and revenue per patient day in our rehabilitation hospitals which operated during both the six months ended June&#160;30, 2021 and 2020, as discussed further under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; Our two newly acquired rehabilitation hospitals also contributed $4.6&#160;million of Adjusted EBITDA during the six months ended June&#160;30, 2021.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Outpatient Rehabilitation Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Adjusted EBITDA increased to $72.0 million for the six months ended June&#160;30, 2021, compared to $20.8 million for the six months ended June&#160;30, 2020. Our Adjusted EBITDA margin for the outpatient rehabilitation segment was 13.5% for the six months ended June&#160;30, 2021, compared to 4.9% for the six months ended June&#160;30, 2020. The increases in Adjusted EBITDA and Adjusted EBITDA margin were driven by increases in patient visit volume. During the six months ended June&#160;30, 2020, our outpatient rehabilitation clinics experienced significant declines in patient visit volume as a result of the effects of the COVID-19 pandemic, as described further above.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentra Segment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Adjusted EBITDA increased to $219.1 million for the six months ended June&#160;30, 2021, compared to $103.0 million for the six months ended June&#160;30, 2020. Our Adjusted EBITDA margin for the Concentra segment was 24.9% for the six months ended June&#160;30, 2021, compared to 14.5% for the six months ended June&#160;30, 2020. The increase in patient visit volume contributed to the increases in Adjusted EBITDA and Adjusted EBITDA margin. As discussed further above, our Concentra segment experienced significant declines in patient visit volume as a result of the effects of the COVID-19 pandemic during the six months ended June&#160;30, 2020. The increases in Adjusted EBITDA and Adjusted EBITDA margin were also due in part to the COVID-19 screening and testing services provided at our centers and various onsite clinics located at employer worksites, as discussed further under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; We incur lower operating expenses associated with these services as compared to our core services. Our Concentra segment also recognized $32.3&#160;million of other operating income during the six months ended June&#160;30, 2021, as described further above under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Operating Income,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; compared to $0.8&#160;million for the six months ended June&#160;30, 2020.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and Amortization</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense was $100.6 million for the six months ended June&#160;30, 2021, compared to $104.0 million for the six months ended June&#160;30, 2020.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income from Operations</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2021, we had income from operations of $486.0 million, compared to $248.2 million for the six months ended June&#160;30, 2020. The improved operating performance of our Concentra, outpatient rehabilitation, and rehabilitation hospital segments contributed to the increase in income from operations. We also recognized other operating income of $132.1 million during the six months ended June&#160;30, 2021, as described further under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Operating Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; compared to $55.0 million of other operating income for the six months ended June&#160;30, 2020.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity in Earnings of Unconsolidated Subsidiaries</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2021, we had equity in earnings of unconsolidated subsidiaries of $21.7 million, compared to $10.9 million for the six months ended June&#160;30, 2020. The increase in equity in earnings is principally due to the improved operating performance of our rehabilitation businesses in which we are a minority owner. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gain on Sale of Businesses</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized a gain of $7.5 million related to the sale of an outpatient rehabilitation business during the six months ended June&#160;30, 2020.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense was $68.3 million for the six months ended June&#160;30, 2021, compared to $83.5 million for the six months ended June&#160;30, 2020. The decrease in interest expense was principally due to a decline in variable interest rates.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June&#160;30, 2021, we recognized interest income of $4.7 million. The interest income is related to the outcome of litigation with CMS.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded income tax expense of $110.7 million for the six months ended June&#160;30, 2021, which represented an effective tax rate of 24.9%. We recorded income tax expense of $45.2 million for the six months ended June&#160;30, 2020, which represented an effective tax rate of 24.7%.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Attributable to Non-Controlling Interests</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to non-controlling interests was $58.0 million for the six months ended June&#160;30, 2021, compared to $33.2 million for the six months ended June&#160;30, 2020. The increase in net income attributable to non-controlling interests was principally due to an increase in the net income of our Concentra segment during the six months ended June&#160;30, 2021. This increase resulted primarily from its improved operating performance and the recognition of $32.3 million of other operating income, as described further above, during the six months ended June&#160;30, 2021. The increase in net income attributable to non-controlling interests also resulted from improvements in the operating performance of our less than wholly owned critical illness recovery hospitals and rehabilitation hospitals.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows for the Six Months Ended June 30, 2021 and Six Months Ended June 30, 2020</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the following, we discuss cash flows from operating activities, investing activities, and financing activities.</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.589%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.323%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flows provided by operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">686,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">363,026&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flows used in investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(80,562)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(88,245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash flows used in financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(431,681)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(48,349)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173,855&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">226,432&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">335,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">577,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">509,737&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">803,493&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:4pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities provided $363.0 million of cash flows for the six months ended June&#160;30, 2021, compared to $686.1 million of cash flows for the six months ended June&#160;30, 2020. During the six months ended June&#160;30, 2020, we experienced an increase in cash flows provided by operating activities as a result of receiving approximately $317.0&#160;million of advanced payments under the Accelerated and Advance Payment Program, as well as approximately $100.5&#160;million of payments under the Provider Relief Fund. During the six months ended June&#160;30, 2021, we received an additional $35.8&#160;million of payments under the Provider Relief Fund. Refer to Note 15 &#8211; CARES Act of the notes to our condensed consolidated financial statements included herein for further information. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our days sales outstanding was 54 days at June&#160;30, 2021 compared to 56 days at December&#160;31, 2020. Our days sales outstanding was 55 days at June&#160;30, 2020, compared to 51 days at December 31, 2019. Our days sales outstanding will fluctuate based upon variability in our collection cycles and patient volumes. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing activities used $88.2 million of cash flows for the six months ended June&#160;30, 2021. The principal uses of cash were $76.4 million for purchases of property and equipment and $21.3 million for investments in and acquisitions of businesses. The cash outflows were offset in part by proceeds received from the sale of assets of $9.5 million. Investing activities used $80.6 million of cash flows for the six months ended June&#160;30, 2020. The principal uses of cash were $71.3 million for purchases of property and equipment and $21.7 million for investments in and acquisitions of businesses. The cash outflows were offset in part by proceeds received from the sale of assets and businesses of $12.4 million.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities used $48.3 million of cash flows for the six months ended June&#160;30, 2021. The principal uses of cash were $29.2 million for distributions to and purchases of non-controlling interests and $16.9 million of dividend payments to common stockholders. Financing activities used $431.7 million of cash flows for the six months ended June&#160;30, 2020. The principal use of cash was $366.2 million for the purchase of additional membership interests of Concentra Group Holdings Parent during the six months ended June&#160;30, 2020. We also used $39.8 million of cash for the mandatory prepayment of term loans under the Select credit facilities. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Resources</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Working capital.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; We had net working capital of $459.1 million at June&#160;30, 2021, compared to $155.6 million at December&#160;31, 2020. The increase in working capital was primarily due to an increase in cash and cash equivalents and decreases in our liabilities related to the payments received under the Accelerated and Advance Payment Program and the Provider Relief Fund. Refer to Note 15 &#8211; CARES Act of the notes to our condensed consolidated financial statements included herein for further information.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Select credit facilities.   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 2, 2021, Select entered into Amendment No. 5 to the Select credit agreement which, among other things, increased the aggregate commitments available under the Select revolving facility from $450.0 million to $650.0 million, including a $125.0 million sublimit for the issuance of standby letters of credit.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021, Select had outstanding borrowings under the Select credit facilities consisting of $2,103.4 million in term loans (excluding unamortized original issue discounts and debt issuance costs of $15.5 million) (the &#8220;Select term loan&#8221;). Select did not have any borrowings outstanding under the Select revolving facility. At June&#160;30, 2021, Select had $594.6 million of availability under the Select revolving facility after giving effect to $55.4 million of outstanding letters of credit.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentra credit facilities.   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 2, 2021, Concentra Inc. terminated its obligations under the Concentra-JPM first lien credit agreement. The Concentra-JPM first lien credit agreement provided for commitments of $100.0 million under the Concentra-JPM revolving facility, which was set to mature on March 1, 2022.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Repurchase Program.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; Holdings&#8217; board of directors has authorized a common stock repurchase program to repurchase up to $500.0&#160;million worth of shares of its common stock. The program has been extended until December&#160;31, 2021, and will remain in effect until then, unless further extended or earlier terminated by the board of directors. Stock repurchases under this program may be made in the open market or through privately negotiated transactions, and at times and in such amounts as Holdings deems appropriate. Holdings funds this program with cash on hand and borrowings under the Select revolving facility. Holdings did not repurchase shares during the three months ended June&#160;30, 2021. Since the inception of the program through June&#160;30, 2021, Holdings has repurchased 38,580,908 shares at a cost of approximately $356.6 million, or $9.24 per share, which includes transaction costs.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; &#160;The duration and extent of the impact from the COVID-19 pandemic on our operations and liquidity depends on future developments that cannot be accurately predicted at this time; however, we believe our internally generated cash flows and borrowing capacity under the Select revolving facility will allow us to finance our operations in both the short and long term. As of June&#160;30, 2021, we had cash and cash equivalents of $803.5 million and availability of $594.6 million under the Select revolving facility after giving effect to $55.4 million of outstanding letters of credit.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may from time to time seek to retire or purchase our outstanding debt through cash purchases and/or exchanges for equity securities, in open market purchases, privately negotiated transactions, tender offers or otherwise. Such repurchases or exchanges, if any, may be funded from operating cash flows or other sources and will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. The amounts involved may be material.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Capital Resources.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; We may from time to time pursue opportunities to develop new joint venture relationships with large, regional health systems and other healthcare providers. We also intend to open new outpatient rehabilitation clinics and occupational health centers in local areas that we currently serve where we can benefit from existing referral relationships and brand awareness to produce incremental growth. In addition to our development activities, we may grow through opportunistic acquisitions.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividend</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 4, 2021, our board of directors declared a cash dividend of $0.125 per share. The dividend will be payable on or about August 30, 2021 to stockholders of record as of the close of business on August 18, 2021.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no assurance that future dividends will be declared. The declaration and payment of dividends in the future are at the discretion of our board of directors after taking into account various factors, including, but not limited to, our financial condition, operating results, available cash and current and anticipated cash needs, the terms of our indebtedness, and other factors our board of directors may deem to be relevant.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 2 &#8211; Accounting Policies of the notes to our condensed consolidated financial statements included herein for information regarding recent accounting pronouncements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160; QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are subject to interest rate risk in connection with our variable rate long-term indebtedness. Our principal interest rate exposure relates to the loans outstanding under the Select credit facilities, which generally bear interest rates that are indexed against LIBOR. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021, Select had outstanding borrowings under the Select credit facilities consisting of the $2,103.4 million Select term loan (excluding unamortized original issue discounts and debt issuance costs of $15.5 million). At June&#160;30, 2021, Select did not have any borrowings outstanding under the Select revolving facility.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to mitigate our exposure to rising interest rates, we entered into an interest rate cap transaction to limit our 1-month LIBOR rate to 1.0% on $2.0 billion of principal outstanding under the Select term loan. The agreement became effective on March 31, 2021 and applies to interest payments from and including April 30, 2021 through September 30, 2024. As of June&#160;30, 2021, the 1-month LIBOR rate was 0.10%. A 0.25% change in market interest rates would impact the interest expense on our variable rate debt by $5.3&#160;million until 1-month LIBOR exceeds 1.0%, at which time the impact of increases in 1-month LIBOR on our interest expense will be mitigated in part by the interest rate cap, as described further in Note 9 &#8211; Interest Rate Cap of the notes to our condensed consolidated financial statements included herein.</span></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_145"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160; CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carried out an evaluation, under the supervision and with the participation of our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule&#160;13a-15(e)&#160;of the Securities Exchange Act of 1934) as of the end of the period covered in this report. Based on this evaluation, as of June&#160;30, 2021, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures, including the accumulation and communication of disclosure to our principal executive officer and principal financial officer as appropriate to allow timely decisions regarding disclosure, are effective to provide reasonable assurance that material information required to be included in our periodic SEC reports is recorded, processed, summarized, and reported within the time periods specified in the relevant SEC rules&#160;and forms.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no change in our internal control over financial reporting (as defined in Rule&#160;13a-15(f)&#160;of the Securities Exchange Act of 1934) identified in connection with the evaluation required by Rule&#160;13a-15(d)&#160;of the Securities Exchange Act of 1934 that occurred during the second quarter ended June&#160;30, 2021, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inherent Limitations on Effectiveness of Controls</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It should be noted that any system of controls, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the system will be met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of future events. Because of these and other inherent limitations of control systems, there is only reasonable assurance that our controls will succeed in achieving their goals under all potential future conditions.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;II: OTHER INFORMATION</span></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_151"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LEGAL PROCEEDINGS</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; section contained within Note 14 &#8211; Commitments and Contingencies of the notes to our condensed consolidated financial statements included herein. </span></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_154"></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISK FACTORS</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes from our risk factors as previously reported in our Annual Report on Form 10-K for the year ended December&#160;31, 2020 and our Quarterly Report on Form 10-Q for the three months ended March 31, 2021.</span></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_157"></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchases of Equity Securities by the Issuer</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holdings&#8217; board of directors has authorized a common stock repurchase program to repurchase up to $500.0&#160;million worth of shares of its common stock. The program, which has been extended until December&#160;31, 2021, will remain in effect until then unless further extended or earlier terminated by the board of directors. Stock repurchases under this program may be made in the open market or through privately negotiated transactions, and at times and in such amounts as Holdings deems appropriate. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information regarding repurchases of our common stock during the three months ended June&#160;30, 2021. </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:30.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of Shares&#160;Purchased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average&#160;Price Paid&#160;Per&#160;Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total&#160;Number of&#160;Shares Purchased&#160;as Part&#160;of&#160;Publicly Announced Plans&#160;or&#160;Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Approximate Dollar&#160;Value&#160;of Shares&#160;that May&#160;Yet&#160;Be Purchased Under&#160;Plans&#160;or Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 1 &#8211; April 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,394,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 1 &#8211; May 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,394,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">June 1 &#8211; June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,394,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42,250&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38.10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,394,863&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Represents common stock surrendered to us to satisfy tax withholding obligations associated with the vesting of restricted shares issued to employees, pursuant to the provisions of our equity incentive plans.</span></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_163"></div><div style="margin-bottom:9pt;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEFAULTS UPON SENIOR SECURITIES</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_166"></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MINE SAFETY DISCLOSURES</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_169"></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_172"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBITS</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1320414/000110465921077043/tm2118508d1_ex10-1.htm">Amendment No. 5, dated June 2, 2021, to the Credit Agreement, dated March 6, 2017, by and among Select Medical Holdings Corporation, Select Medical Corporation, JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent, and the other lenders and issuing banks party thereto, as amended by Amendment No. 1, dated as of March 22, 2018, Amendment No. 2, dated as of October 26, 2018, Amendment No. 3, dated as of August 1, 2019 and Amendment No. 4, dated as of December 10, 2019 (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K, filed on June 4, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sem-630202110qxex311.htm">Certification of Chief Executive Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sem-630202110qxex312.htm">Certification of Executive Vice President and Chief Financial Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sem-630202110qxex321.htm">Certification of Chief Executive Officer, and Executive Vice President and Chief Financial Officer pursuant to 18 U.S.C. Section&#160;1350 as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="i2ca4a620761f4048abbeb3b8e6b51d6f_175"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i2ca4a620761f4048abbeb3b8e6b51d6f_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.898%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.195%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.607%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SELECT MEDICAL HOLDINGS CORPORATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Martin F. Jackson</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Martin F. Jackson</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Duly Authorized Officer)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160; Scott A. Romberger</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott A. Romberger</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Accounting Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated:&#160; August&#160;5, 2021 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>sem-630202110qxex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i8221c4b9ea5c46868f746cda374ad102_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT&#160;31.1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SELECT MEDICAL HOLDINGS CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATIONS PURSUANT TO SECTION&#160;302 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, David S. Chernow, certify that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form&#160;10-Q of Select Medical Holdings Corporation&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.681%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August 5, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; David S. Chernow</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David S. Chernow</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>sem-630202110qxex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ie0fa927c0f9c4dc9a6d95e2ba85bff39_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT&#160;31.2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SELECT MEDICAL HOLDINGS CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATIONS PURSUANT TO SECTION&#160;302 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Martin F. Jackson, certify that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form&#160;10-Q of Select Medical Holdings Corporation&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.681%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; August 5, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Martin F. Jackson</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Martin F. Jackson</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>sem-630202110qxex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ib8e06260471241faae16f65313d5ccbd_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT&#160;32.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form&#160;10-Q of Select Medical Holdings Corporation (the &#8220;Company&#8221;) for the period ended June&#160;30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), we, David S. Chernow and Martin F. Jackson, Chief Executive Officer and Chief Financial Officer, respectively, of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to our knowledge&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;The Report fully complies with the requirements of Section 13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August&#160;5, 2021 </font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; David S. Chernow</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David S. Chernow</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Martin F. Jackson</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Martin F. Jackson</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>sem-20210630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:13e6905e-72a0-44f6-9164-f135c900c5bf,g:37e820a7-74f5-4c60-b984-336d3d990bf4-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sem="http://www.selectmedical.com/20210630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.selectmedical.com/20210630">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sem-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sem-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sem-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sem-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.selectmedical.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsunaudited" roleURI="http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsunauditedParenthetical" roleURI="http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsunaudited" roleURI="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Operations (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeunaudited" roleURI="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical" roleURI="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited" roleURI="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Changes in Equity and Income (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofChangesinEquityandIncomeunauditedParenthetical" roleURI="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunauditedParenthetical">
        <link:definition>1007008 - Statement - Condensed Consolidated Statements of Changes in Equity and Income (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsunaudited" roleURI="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited">
        <link:definition>1008009 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.selectmedical.com/role/BasisofPresentation">
        <link:definition>2101101 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountingPolicies" roleURI="http://www.selectmedical.com/role/AccountingPolicies">
        <link:definition>2102102 - Disclosure - Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountingPoliciesPolicies" roleURI="http://www.selectmedical.com/role/AccountingPoliciesPolicies">
        <link:definition>2203201 - Disclosure - Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditRiskConcentrations" roleURI="http://www.selectmedical.com/role/CreditRiskConcentrations">
        <link:definition>2104103 - Disclosure - Credit Risk Concentrations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditRiskConcentrationsDetails" roleURI="http://www.selectmedical.com/role/CreditRiskConcentrationsDetails">
        <link:definition>2405401 - Disclosure - Credit Risk Concentrations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNonControllingInterests" roleURI="http://www.selectmedical.com/role/RedeemableNonControllingInterests">
        <link:definition>2106104 - Disclosure - Redeemable Non-Controlling Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNonControllingInterestsTables" roleURI="http://www.selectmedical.com/role/RedeemableNonControllingInterestsTables">
        <link:definition>2307301 - Disclosure - Redeemable Non-Controlling Interests (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails" roleURI="http://www.selectmedical.com/role/RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails">
        <link:definition>2408402 - Disclosure - Redeemable Non-Controlling Interests - Schedule of Redeemable Non-Controlling Interests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntities" roleURI="http://www.selectmedical.com/role/VariableInterestEntities">
        <link:definition>2109105 - Disclosure - Variable Interest Entities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesDetails" roleURI="http://www.selectmedical.com/role/VariableInterestEntitiesDetails">
        <link:definition>2410403 - Disclosure - Variable Interest Entities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.selectmedical.com/role/Leases">
        <link:definition>2111106 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.selectmedical.com/role/LeasesTables">
        <link:definition>2312302 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofLeaseCostDetails" roleURI="http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails">
        <link:definition>2413404 - Disclosure - Leases - Schedule of Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalCashFlowInformationDetails" roleURI="http://www.selectmedical.com/role/LeasesSupplementalCashFlowInformationDetails">
        <link:definition>2414405 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>2415406 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails_1" roleURI="http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails_1">
        <link:definition>2415406 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesWeightedAverageLeaseTermsandDiscountRatesDetails" roleURI="http://www.selectmedical.com/role/LeasesWeightedAverageLeaseTermsandDiscountRatesDetails">
        <link:definition>2416407 - Disclosure - Leases - Weighted Average Lease Terms and Discount Rates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" roleURI="http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails">
        <link:definition>2417408 - Disclosure - Leases - Maturities of Operating and Finance Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" roleURI="http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1">
        <link:definition>2417408 - Disclosure - Leases - Maturities of Operating and Finance Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssets" roleURI="http://www.selectmedical.com/role/IntangibleAssets">
        <link:definition>2118107 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsTables" roleURI="http://www.selectmedical.com/role/IntangibleAssetsTables">
        <link:definition>2319303 - Disclosure - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsCarryingAmountofGoodwillDetails" roleURI="http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountofGoodwillDetails">
        <link:definition>2420409 - Disclosure - Intangible Assets - Carrying Amount of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails" roleURI="http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails">
        <link:definition>2421410 - Disclosure - Intangible Assets - Carrying Value and Amortization of Identifiable Intangible Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtandNotesPayable" roleURI="http://www.selectmedical.com/role/LongTermDebtandNotesPayable">
        <link:definition>2122108 - Disclosure - Long-Term Debt and Notes Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtandNotesPayableTables" roleURI="http://www.selectmedical.com/role/LongTermDebtandNotesPayableTables">
        <link:definition>2323304 - Disclosure - Long-Term Debt and Notes Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails" roleURI="http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails">
        <link:definition>2424411 - Disclosure - Long-Term Debt and Notes Payable - Components of Long-Term Debt And Notes Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" roleURI="http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails">
        <link:definition>2425412 - Disclosure - Long-Term Debt and Notes Payable - Principal Maturities Of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtandNotesPayableNarrativeDetails" roleURI="http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails">
        <link:definition>2426413 - Disclosure - Long-Term Debt and Notes Payable - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterestRateCap" roleURI="http://www.selectmedical.com/role/InterestRateCap">
        <link:definition>2127109 - Disclosure - Interest Rate Cap</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterestRateCapTables" roleURI="http://www.selectmedical.com/role/InterestRateCapTables">
        <link:definition>2328305 - Disclosure - Interest Rate Cap (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterestRateCapNarrativeDetails" roleURI="http://www.selectmedical.com/role/InterestRateCapNarrativeDetails">
        <link:definition>2429414 - Disclosure - Interest Rate Cap - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.selectmedical.com/role/InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>2430415 - Disclosure - Interest Rate Cap - Schedule of Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstruments" roleURI="http://www.selectmedical.com/role/FairValueofFinancialInstruments">
        <link:definition>2131110 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsTables" roleURI="http://www.selectmedical.com/role/FairValueofFinancialInstrumentsTables">
        <link:definition>2332306 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails" roleURI="http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails">
        <link:definition>2433416 - Disclosure - Fair Value of Financial Instruments - Schedule of Interest Rate Cap (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails" roleURI="http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails">
        <link:definition>2434417 - Disclosure - Fair Value of Financial Instruments - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.selectmedical.com/role/SegmentInformation">
        <link:definition>2135111 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.selectmedical.com/role/SegmentInformationTables">
        <link:definition>2336307 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSelectedFinancialDataDetails" roleURI="http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails">
        <link:definition>2437418 - Disclosure - Segment Information - Selected Financial Data (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails" roleURI="http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails">
        <link:definition>2438419 - Disclosure - Segment Information - Reconciliation of Adjusted EBITDA to Income Before Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromContractswithCustomers" roleURI="http://www.selectmedical.com/role/RevenuefromContractswithCustomers">
        <link:definition>2139112 - Disclosure - Revenue from Contracts with Customers</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromContractswithCustomersTables" roleURI="http://www.selectmedical.com/role/RevenuefromContractswithCustomersTables">
        <link:definition>2340308 - Disclosure - Revenue from Contracts with Customers (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuefromContractswithCustomersDetails" roleURI="http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails">
        <link:definition>2441420 - Disclosure - Revenue from Contracts with Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperShare" roleURI="http://www.selectmedical.com/role/EarningsperShare">
        <link:definition>2142113 - Disclosure - Earnings per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperShareTables" roleURI="http://www.selectmedical.com/role/EarningsperShareTables">
        <link:definition>2343309 - Disclosure - Earnings per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperShareNarrativeDetails" roleURI="http://www.selectmedical.com/role/EarningsperShareNarrativeDetails">
        <link:definition>2444421 - Disclosure - Earnings per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails" roleURI="http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails">
        <link:definition>2445422 - Disclosure - Earnings per Share - Net Income Attributable to the Company, Common Shares Outstanding, and Participating Securities Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperShareComputationofEPSUndertheTwoClassMethodDetails" roleURI="http://www.selectmedical.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails">
        <link:definition>2446423 - Disclosure - Earnings per Share - Computation of EPS Under the Two-Class Method (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.selectmedical.com/role/CommitmentsandContingencies">
        <link:definition>2147114 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesLitigationDetails" roleURI="http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails">
        <link:definition>2448424 - Disclosure - Commitments and Contingencies - Litigation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesMedicareDualEligibleLitigationDetails" roleURI="http://www.selectmedical.com/role/CommitmentsandContingenciesMedicareDualEligibleLitigationDetails">
        <link:definition>2449425 - Disclosure - Commitments and Contingencies - Medicare Dual-Eligible Litigation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CARESAct" roleURI="http://www.selectmedical.com/role/CARESAct">
        <link:definition>2150115 - Disclosure - CARES Act</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CARESActDetails" roleURI="http://www.selectmedical.com/role/CARESActDetails">
        <link:definition>2451426 - Disclosure - CARES Act (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvent" roleURI="http://www.selectmedical.com/role/SubsequentEvent">
        <link:definition>2152116 - Disclosure - Subsequent Event</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventDetails" roleURI="http://www.selectmedical.com/role/SubsequentEventDetails">
        <link:definition>2453427 - Disclosure - Subsequent Event (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct" abstract="false" name="ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_LongTermDebtGrossAndFinanceLeaseObligation" abstract="false" name="LongTermDebtGrossAndFinanceLeaseObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct" abstract="false" name="UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_OperatingLeaseLiabilityNoncurrentRelatedParties" abstract="false" name="OperatingLeaseLiabilityNoncurrentRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable" abstract="true" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sem_LeaseCostTotalAbstract" abstract="true" name="LeaseCostTotalAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sem_FinanceLeaseRightOfUseAssetAmortizationAbstract" abstract="true" name="FinanceLeaseRightOfUseAssetAmortizationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sem_SubleaseIncomeAbstract" abstract="true" name="SubleaseIncomeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree" abstract="false" name="LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_VariableLeaseCostRelatedParties" abstract="false" name="VariableLeaseCostRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract" abstract="true" name="WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sem_LongTermDebtAndFinanceLeaseObligation" abstract="false" name="LongTermDebtAndFinanceLeaseObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_OtherAccruedLiabilitiesCurrentMember" abstract="true" name="OtherAccruedLiabilitiesCurrentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sem_FinanceLeaseLiabilityCurrentRelatedParties" abstract="false" name="FinanceLeaseLiabilityCurrentRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_VariableLeaseCostUnrelatedParties" abstract="false" name="VariableLeaseCostUnrelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_UnearnedGovernmentAssistanceCARESAct" abstract="false" name="UnearnedGovernmentAssistanceCARESAct" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" abstract="false" name="LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_FinanceLeaseInterestExpenseUnrelatedParties" abstract="false" name="FinanceLeaseInterestExpenseUnrelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_GovernmentAssistanceRecognizedInEarningsCARESAct" abstract="false" name="GovernmentAssistanceRecognizedInEarningsCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_FinanceLeaseAssetsAndLiabilitiesAbstract" abstract="true" name="FinanceLeaseAssetsAndLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sem_WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract" abstract="true" name="WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sem_MedicareReceivableMember" abstract="true" name="MedicareReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties" abstract="false" name="FinanceLeaseLiabilityNoncurrentUnrelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_RehabilitationHospitalsMember" abstract="true" name="RehabilitationHospitalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" abstract="true" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sem_OperatingLeaseRightOfUseAssetAbstract" abstract="true" name="OperatingLeaseRightOfUseAssetAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties" abstract="false" name="FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties" abstract="false" name="FinanceLeaseRightOfUseAssetAmortizationRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_HealthCarePatientServiceNonMedicareMember" abstract="true" name="HealthCarePatientServiceNonMedicareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties" abstract="false" name="FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_LeaseCostRelatedParties" abstract="false" name="LeaseCostRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour" abstract="false" name="LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_AccreditationsMember" abstract="true" name="AccreditationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sem_OperatingLeaseCostUnrelatedParties" abstract="false" name="OperatingLeaseCostUnrelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_AssetsandLiabilitiesLesseeOperatingLeaseAbstract" abstract="true" name="AssetsandLiabilitiesLesseeOperatingLeaseAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sem_FinanceLeaseLiabilityUnrelatedParties" abstract="false" name="FinanceLeaseLiabilityUnrelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests" abstract="false" name="NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_OperatingLeaseLiabilityRelatedParties" abstract="false" name="OperatingLeaseLiabilityRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_FinanceLeaseInterestExpenseRelatedParties" abstract="false" name="FinanceLeaseInterestExpenseRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_ProceedsFromGovernmentAssistanceCARESAct" abstract="false" name="ProceedsFromGovernmentAssistanceCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear" abstract="false" name="LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_FirstLienCreditAgreementMember" abstract="true" name="FirstLienCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour" abstract="false" name="FinanceLeaseLiabilityPaymentsDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties" abstract="false" name="FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract" abstract="true" name="CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sem_SubleaseIncomeRelatedParties" abstract="false" name="SubleaseIncomeRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" abstract="false" name="ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" abstract="false" name="LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_OutpatientRehabilitationMember" abstract="true" name="OutpatientRehabilitationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sem_AdjustedEbitda" abstract="false" name="AdjustedEbitda" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent" abstract="false" name="AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_SubleaseIncomeUnrelatedParties" abstract="false" name="SubleaseIncomeUnrelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_LeaseCostUnrelatedParties" abstract="false" name="LeaseCostUnrelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_OperatingLeaseRightOfUseAssetUnrelatedParties" abstract="false" name="OperatingLeaseRightOfUseAssetUnrelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" abstract="true" name="RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sem_FinanceLeaseLiabilityNoncurrentRelatedParties" abstract="false" name="FinanceLeaseLiabilityNoncurrentRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_FinanceLeaseLiabilityNoncurrentAbstract" abstract="true" name="FinanceLeaseLiabilityNoncurrentAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sem_FinanceLeaseLiabilityCurrentAbstract" abstract="true" name="FinanceLeaseLiabilityCurrentAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour" abstract="false" name="LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_ConcentraMember" abstract="true" name="ConcentraMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sem_ProceedsFromLegalSettlementsAccruedInterest" abstract="false" name="ProceedsFromLegalSettlementsAccruedInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_HealthCarePatientServiceMedicareMember" abstract="true" name="HealthCarePatientServiceMedicareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo" abstract="false" name="LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension" abstract="false" name="IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sem_VariableLeaseCostAbstract" abstract="true" name="VariableLeaseCostAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sem_OperatingLeaseLiabilityCurrentUnrelatedParties" abstract="false" name="OperatingLeaseLiabilityCurrentUnrelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_CriticalIllnessRecoveryHospitalsMember" abstract="true" name="CriticalIllnessRecoveryHospitalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sem_OperatingLeaseLiabilityUnrelatedParties" abstract="false" name="OperatingLeaseLiabilityUnrelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_SelectMedicalCorporationMember" abstract="true" name="SelectMedicalCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sem_OperatingLeaseCostRelatedParties" abstract="false" name="OperatingLeaseCostRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_GovernmentAdvancesRecoupedCARESAct" abstract="false" name="GovernmentAdvancesRecoupedCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_OperatingLeaseLiabilityNoncurrentAbstract" abstract="true" name="OperatingLeaseLiabilityNoncurrentAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sem_FinanceLeaseInterestExpenseAbstract" abstract="true" name="FinanceLeaseInterestExpenseAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sem_FinanceLeaseLiabilityRelatedParties" abstract="false" name="FinanceLeaseLiabilityRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_CertificatesOfNeedMember" abstract="true" name="CertificatesOfNeedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sem_OperatingLeaseLiabilityCurrentRelatedParties" abstract="false" name="OperatingLeaseLiabilityCurrentRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties" abstract="false" name="OperatingLeaseLiabilityNoncurrentUnrelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_GovernmentAdvancesCARESAct" abstract="false" name="GovernmentAdvancesCARESAct" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_FinanceLeaseLiabilityCurrentUnrelatedParties" abstract="false" name="FinanceLeaseLiabilityCurrentUnrelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_DerivativeCostOfHedgeAnnualPremiumPercentage" abstract="false" name="DerivativeCostOfHedgeAnnualPremiumPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="sem_OperatingLeaseLiabilityCurrentAbstract" abstract="true" name="OperatingLeaseLiabilityCurrentAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sem_OperatingLeaseRightOfUseAssetRelatedParties" abstract="false" name="OperatingLeaseRightOfUseAssetRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct" abstract="false" name="IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>sem-20210630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:13e6905e-72a0-44f6-9164-f135c900c5bf,g:37e820a7-74f5-4c60-b984-336d3d990bf4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="simple" xlink:href="sem-20210630.xsd#CondensedConsolidatedBalanceSheetsunaudited"/>
  <link:calculationLink xlink:role="http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_21f4bbe6-f23a-44b9-b3d0-397c1a7f373f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_0be95e9f-536a-48a5-8585-e534f1a1ae4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_21f4bbe6-f23a-44b9-b3d0-397c1a7f373f" xlink:to="loc_us-gaap_CommonStockValue_0be95e9f-536a-48a5-8585-e534f1a1ae4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_7dfb267c-ed77-4699-91dd-992b39d839e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_21f4bbe6-f23a-44b9-b3d0-397c1a7f373f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_7dfb267c-ed77-4699-91dd-992b39d839e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_82db67ef-0d5e-4de5-be5d-dc8a28a19141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_21f4bbe6-f23a-44b9-b3d0-397c1a7f373f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_82db67ef-0d5e-4de5-be5d-dc8a28a19141" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4a78dc25-5059-4275-b844-f00a1d80eb48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_21f4bbe6-f23a-44b9-b3d0-397c1a7f373f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4a78dc25-5059-4275-b844-f00a1d80eb48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_80e0c661-341f-45d1-a9d0-28cae1e2799d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_70c05aae-eeb7-4ea9-b6a5-a5e7eda88ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_80e0c661-341f-45d1-a9d0-28cae1e2799d" xlink:to="loc_us-gaap_Liabilities_70c05aae-eeb7-4ea9-b6a5-a5e7eda88ab1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_5217df0f-a045-4bf1-8f05-6cae1aa9928c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_80e0c661-341f-45d1-a9d0-28cae1e2799d" xlink:to="loc_us-gaap_CommitmentsAndContingencies_5217df0f-a045-4bf1-8f05-6cae1aa9928c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_3f124eed-5e32-4bed-96a8-f1df231c232e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_80e0c661-341f-45d1-a9d0-28cae1e2799d" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_3f124eed-5e32-4bed-96a8-f1df231c232e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9be4bdf2-0230-44bd-beea-7762e0e8eade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_80e0c661-341f-45d1-a9d0-28cae1e2799d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9be4bdf2-0230-44bd-beea-7762e0e8eade" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0ff88db9-16bd-4a55-866f-3bdb7c6af203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d616039b-eca9-467a-8031-3339104ef6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0ff88db9-16bd-4a55-866f-3bdb7c6af203" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d616039b-eca9-467a-8031-3339104ef6c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_8e32ea9d-fbee-4aa6-a148-ae5dfb105fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0ff88db9-16bd-4a55-866f-3bdb7c6af203" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_8e32ea9d-fbee-4aa6-a148-ae5dfb105fb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_d1707dde-c0f4-42fd-be57-562b15d1a0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0ff88db9-16bd-4a55-866f-3bdb7c6af203" xlink:to="loc_us-gaap_PrepaidTaxes_d1707dde-c0f4-42fd-be57-562b15d1a0d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_24f261b3-d0e5-42c1-8df3-87552b44755f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0ff88db9-16bd-4a55-866f-3bdb7c6af203" xlink:to="loc_us-gaap_OtherAssetsCurrent_24f261b3-d0e5-42c1-8df3-87552b44755f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_79e814fe-a83a-420e-821c-61ea94186bca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e3623f50-0e52-4e43-b85f-87baec659dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_79e814fe-a83a-420e-821c-61ea94186bca" xlink:to="loc_us-gaap_AssetsCurrent_e3623f50-0e52-4e43-b85f-87baec659dc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_22aea822-65b4-4d87-b8f5-88b87f798a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_79e814fe-a83a-420e-821c-61ea94186bca" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_22aea822-65b4-4d87-b8f5-88b87f798a8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_393ae3e9-8e69-4154-8038-46b219b60193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_79e814fe-a83a-420e-821c-61ea94186bca" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_393ae3e9-8e69-4154-8038-46b219b60193" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c9c00cd0-3cdb-4aea-a2bb-427fa55f8621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_79e814fe-a83a-420e-821c-61ea94186bca" xlink:to="loc_us-gaap_Goodwill_c9c00cd0-3cdb-4aea-a2bb-427fa55f8621" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_eaebf625-7464-480c-8e49-32d402214a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_79e814fe-a83a-420e-821c-61ea94186bca" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_eaebf625-7464-480c-8e49-32d402214a9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c9be6771-9dd0-4686-9d8f-a3c8d9282f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_79e814fe-a83a-420e-821c-61ea94186bca" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c9be6771-9dd0-4686-9d8f-a3c8d9282f7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5840b685-72e2-47ad-8d39-c653b48371aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d6334246-5557-4420-9797-1d3ed49df57d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5840b685-72e2-47ad-8d39-c653b48371aa" xlink:to="loc_us-gaap_LiabilitiesCurrent_d6334246-5557-4420-9797-1d3ed49df57d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4dee2c80-c4f9-4b7c-8862-50a1ab986d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5840b685-72e2-47ad-8d39-c653b48371aa" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4dee2c80-c4f9-4b7c-8862-50a1ab986d20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_5601c10c-0d5a-4546-bb3b-62146e9c680a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5840b685-72e2-47ad-8d39-c653b48371aa" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_5601c10c-0d5a-4546-bb3b-62146e9c680a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_82b0dd3e-ee63-4c25-995e-91f3688c83f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5840b685-72e2-47ad-8d39-c653b48371aa" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_82b0dd3e-ee63-4c25-995e-91f3688c83f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_4e147a10-c438-4838-bff1-71da633b2d05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5840b685-72e2-47ad-8d39-c653b48371aa" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_4e147a10-c438-4838-bff1-71da633b2d05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e396d942-6738-46b3-9f86-576d63a1cf63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_b1a05c45-421c-4f49-8317-17f41109e6d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e396d942-6738-46b3-9f86-576d63a1cf63" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_b1a05c45-421c-4f49-8317-17f41109e6d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_6e976995-12b5-4997-b96a-48769e6a9f72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e396d942-6738-46b3-9f86-576d63a1cf63" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_6e976995-12b5-4997-b96a-48769e6a9f72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_3fca68c3-75eb-47be-bf72-8e939e8ed76a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e396d942-6738-46b3-9f86-576d63a1cf63" xlink:to="loc_us-gaap_AccountsPayableCurrent_3fca68c3-75eb-47be-bf72-8e939e8ed76a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent_fcf6cff6-288a-43b7-a1c3-a438947bb56c" xlink:href="sem-20210630.xsd#sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e396d942-6738-46b3-9f86-576d63a1cf63" xlink:to="loc_sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent_fcf6cff6-288a-43b7-a1c3-a438947bb56c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedVacationCurrent_76bd7a29-eda2-4994-a366-f4ec482f0eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedVacationCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e396d942-6738-46b3-9f86-576d63a1cf63" xlink:to="loc_us-gaap_AccruedVacationCurrent_76bd7a29-eda2-4994-a366-f4ec482f0eb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_a8ab3eb3-a341-4e6c-867a-79327b28a81d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e396d942-6738-46b3-9f86-576d63a1cf63" xlink:to="loc_us-gaap_InterestPayableCurrent_a8ab3eb3-a341-4e6c-867a-79327b28a81d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_84378da1-e6e8-4596-9cdb-c5682b54ef3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e396d942-6738-46b3-9f86-576d63a1cf63" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_84378da1-e6e8-4596-9cdb-c5682b54ef3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_GovernmentAdvancesCARESAct_d866d401-fde3-417a-933e-e64736227aef" xlink:href="sem-20210630.xsd#sem_GovernmentAdvancesCARESAct"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e396d942-6738-46b3-9f86-576d63a1cf63" xlink:to="loc_sem_GovernmentAdvancesCARESAct_d866d401-fde3-417a-933e-e64736227aef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_UnearnedGovernmentAssistanceCARESAct_4b18d20f-4466-4d20-8ca8-e9b63aa91bc3" xlink:href="sem-20210630.xsd#sem_UnearnedGovernmentAssistanceCARESAct"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e396d942-6738-46b3-9f86-576d63a1cf63" xlink:to="loc_sem_UnearnedGovernmentAssistanceCARESAct_4b18d20f-4466-4d20-8ca8-e9b63aa91bc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_91ae2352-268c-468b-ba31-b9bec8257886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e396d942-6738-46b3-9f86-576d63a1cf63" xlink:to="loc_us-gaap_TaxesPayableCurrent_91ae2352-268c-468b-ba31-b9bec8257886" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6afc5594-c244-49c8-ace0-f6bcbd8e18a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_901fc5a1-c0df-49b7-989f-8795976d0c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6afc5594-c244-49c8-ace0-f6bcbd8e18a6" xlink:to="loc_us-gaap_StockholdersEquity_901fc5a1-c0df-49b7-989f-8795976d0c0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_e051f493-8223-437f-85d3-44fe637d9401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6afc5594-c244-49c8-ace0-f6bcbd8e18a6" xlink:to="loc_us-gaap_MinorityInterest_e051f493-8223-437f-85d3-44fe637d9401" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited" xlink:type="simple" xlink:href="sem-20210630.xsd#CondensedConsolidatedStatementsofOperationsunaudited"/>
  <link:calculationLink xlink:role="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_847d01da-1c76-4f84-942f-38427dd05133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8902f25e-66a4-49eb-947e-d71fe5eaf86f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_847d01da-1c76-4f84-942f-38427dd05133" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8902f25e-66a4-49eb-947e-d71fe5eaf86f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_5ddb80e9-9997-474b-b50e-2f68ef16a952" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_847d01da-1c76-4f84-942f-38427dd05133" xlink:to="loc_us-gaap_CostsAndExpenses_5ddb80e9-9997-474b-b50e-2f68ef16a952" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_668f6896-f028-4d4b-ad01-f3b71c14b23c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_847d01da-1c76-4f84-942f-38427dd05133" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_668f6896-f028-4d4b-ad01-f3b71c14b23c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_6e18130e-636c-49f3-8c33-b0dd84150f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_52d767f0-85ac-4632-91fd-eef806a9ce0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6e18130e-636c-49f3-8c33-b0dd84150f6c" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_52d767f0-85ac-4632-91fd-eef806a9ce0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_e7e06463-bc9a-4856-b1bb-58c002a1c6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6e18130e-636c-49f3-8c33-b0dd84150f6c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_e7e06463-bc9a-4856-b1bb-58c002a1c6ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_77db36bb-0678-43f1-ba15-0098dfc0f160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6e18130e-636c-49f3-8c33-b0dd84150f6c" xlink:to="loc_us-gaap_DepreciationAndAmortization_77db36bb-0678-43f1-ba15-0098dfc0f160" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_89078cba-e5d0-43f3-b996-aa743af350a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_01d43c1f-2f66-4aa2-9733-86ab0eaf1ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_89078cba-e5d0-43f3-b996-aa743af350a6" xlink:to="loc_us-gaap_OperatingIncomeLoss_01d43c1f-2f66-4aa2-9733-86ab0eaf1ca1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_6b42eab7-6a42-46c0-b618-b5125b612df6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_89078cba-e5d0-43f3-b996-aa743af350a6" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_6b42eab7-6a42-46c0-b618-b5125b612df6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_b4836106-2a62-43fb-a389-eb429f69fe49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_89078cba-e5d0-43f3-b996-aa743af350a6" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_b4836106-2a62-43fb-a389-eb429f69fe49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementInterest_bdd8f7c4-6e4c-43ab-a8fd-3d2c3bf75471" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementInterest"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_89078cba-e5d0-43f3-b996-aa743af350a6" xlink:to="loc_us-gaap_LitigationSettlementInterest_bdd8f7c4-6e4c-43ab-a8fd-3d2c3bf75471" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_595665c3-49f4-43f3-8274-d443bbf20328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_89078cba-e5d0-43f3-b996-aa743af350a6" xlink:to="loc_us-gaap_InterestExpense_595665c3-49f4-43f3-8274-d443bbf20328" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b4ee4de8-c8d8-4e75-9b3b-5c0ce76d4009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ad77af0f-c4dc-4e61-87d3-12c373426e79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_b4ee4de8-c8d8-4e75-9b3b-5c0ce76d4009" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ad77af0f-c4dc-4e61-87d3-12c373426e79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8645ddb8-f372-4d97-9b02-95c1fe2c7fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_b4ee4de8-c8d8-4e75-9b3b-5c0ce76d4009" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8645ddb8-f372-4d97-9b02-95c1fe2c7fa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_685457de-6a74-4fe2-b4ac-335dd2c4c3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_64f7970d-cee3-44a7-9737-591909349b09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_685457de-6a74-4fe2-b4ac-335dd2c4c3ff" xlink:to="loc_us-gaap_ProfitLoss_64f7970d-cee3-44a7-9737-591909349b09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2a99b372-539d-4beb-b86b-9723ac0ebd5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_685457de-6a74-4fe2-b4ac-335dd2c4c3ff" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2a99b372-539d-4beb-b86b-9723ac0ebd5f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited" xlink:type="simple" xlink:href="sem-20210630.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"/>
  <link:calculationLink xlink:role="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e7d4798a-024b-44fc-96f7-fdd6a1a90e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3abf5e5b-e373-4b3a-bdbf-602ad469a46e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_e7d4798a-024b-44fc-96f7-fdd6a1a90e2b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3abf5e5b-e373-4b3a-bdbf-602ad469a46e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_30e05fdd-470b-4a26-9857-8242b418a9ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_e7d4798a-024b-44fc-96f7-fdd6a1a90e2b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_30e05fdd-470b-4a26-9857-8242b418a9ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_72a5f07d-034f-4d74-9446-c2aedfb17333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_757186fa-e8b3-4eab-8859-a0205591c627" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_72a5f07d-034f-4d74-9446-c2aedfb17333" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_757186fa-e8b3-4eab-8859-a0205591c627" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7f56bda7-04b6-452f-8cf5-7459fddb10cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_72a5f07d-034f-4d74-9446-c2aedfb17333" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7f56bda7-04b6-452f-8cf5-7459fddb10cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a329e775-c8fb-4eab-a2d6-c6a39a3f6b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_98cc0546-2d20-4c20-a6eb-7251629ec2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a329e775-c8fb-4eab-a2d6-c6a39a3f6b4e" xlink:to="loc_us-gaap_ProfitLoss_98cc0546-2d20-4c20-a6eb-7251629ec2a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_02406837-96a2-4cf0-815b-304b46ad94d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a329e775-c8fb-4eab-a2d6-c6a39a3f6b4e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_02406837-96a2-4cf0-815b-304b46ad94d1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="simple" xlink:href="sem-20210630.xsd#CondensedConsolidatedStatementsofCashFlowsunaudited"/>
  <link:calculationLink xlink:role="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd423e3d-c508-4a99-992d-2ec2fbba0f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_91c8745e-ff2c-41b2-873e-8cb9166d24f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd423e3d-c508-4a99-992d-2ec2fbba0f7b" xlink:to="loc_us-gaap_ProfitLoss_91c8745e-ff2c-41b2-873e-8cb9166d24f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_4a16812f-2ba8-4fff-8817-bc5bbc2ade71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd423e3d-c508-4a99-992d-2ec2fbba0f7b" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_4a16812f-2ba8-4fff-8817-bc5bbc2ade71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_1b473894-50da-4055-adc5-cb6c2f4d4d62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd423e3d-c508-4a99-992d-2ec2fbba0f7b" xlink:to="loc_us-gaap_DepreciationAndAmortization_1b473894-50da-4055-adc5-cb6c2f4d4d62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_7599e17b-53f7-49e3-a320-059c3314b4a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd423e3d-c508-4a99-992d-2ec2fbba0f7b" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_7599e17b-53f7-49e3-a320-059c3314b4a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0d6573d0-a4d9-4b20-a0a7-d1a919465490" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd423e3d-c508-4a99-992d-2ec2fbba0f7b" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0d6573d0-a4d9-4b20-a0a7-d1a919465490" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_1a49da8c-166d-465b-a2f7-baaf67e3d440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd423e3d-c508-4a99-992d-2ec2fbba0f7b" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_1a49da8c-166d-465b-a2f7-baaf67e3d440" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9feb72db-c6b3-4ce9-bef7-1268e45daa73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd423e3d-c508-4a99-992d-2ec2fbba0f7b" xlink:to="loc_us-gaap_ShareBasedCompensation_9feb72db-c6b3-4ce9-bef7-1268e45daa73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_757cee86-069c-4c10-b5bd-3bf24192d77c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd423e3d-c508-4a99-992d-2ec2fbba0f7b" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_757cee86-069c-4c10-b5bd-3bf24192d77c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_956d389d-8c06-4e5b-99fd-a447480145f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd423e3d-c508-4a99-992d-2ec2fbba0f7b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_956d389d-8c06-4e5b-99fd-a447480145f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_93214599-0032-4938-8a64-cdc353c1a971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd423e3d-c508-4a99-992d-2ec2fbba0f7b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_93214599-0032-4938-8a64-cdc353c1a971" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_30b38583-dc1a-4ad8-b7d6-d0c9d870b06c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd423e3d-c508-4a99-992d-2ec2fbba0f7b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_30b38583-dc1a-4ad8-b7d6-d0c9d870b06c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_5c8b7f9c-87db-497e-9cd1-b1823a31da46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd423e3d-c508-4a99-992d-2ec2fbba0f7b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_5c8b7f9c-87db-497e-9cd1-b1823a31da46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_45b77f81-f824-479e-b20a-d642cb22b40c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd423e3d-c508-4a99-992d-2ec2fbba0f7b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_45b77f81-f824-479e-b20a-d642cb22b40c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_0584a999-37ed-42d0-814d-15701f28ef11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd423e3d-c508-4a99-992d-2ec2fbba0f7b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_0584a999-37ed-42d0-814d-15701f28ef11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct_e0c3d879-8cde-4b06-940c-bc27cedf977d" xlink:href="sem-20210630.xsd#sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd423e3d-c508-4a99-992d-2ec2fbba0f7b" xlink:to="loc_sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct_e0c3d879-8cde-4b06-940c-bc27cedf977d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct_d3f2c6a0-7363-462b-9a62-afbc99650895" xlink:href="sem-20210630.xsd#sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd423e3d-c508-4a99-992d-2ec2fbba0f7b" xlink:to="loc_sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct_d3f2c6a0-7363-462b-9a62-afbc99650895" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxes_90e1c570-75b4-4c14-8718-588eb482e54a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxes"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dd423e3d-c508-4a99-992d-2ec2fbba0f7b" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxes_90e1c570-75b4-4c14-8718-588eb482e54a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_175603d6-d21a-40eb-892e-5ec8aa42c22c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_0423c278-5efc-4c4d-8ca5-2065e989d330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_175603d6-d21a-40eb-892e-5ec8aa42c22c" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_0423c278-5efc-4c4d-8ca5-2065e989d330" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_95a4a766-0a58-48c0-bb0c-e40ef9b4ce08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_175603d6-d21a-40eb-892e-5ec8aa42c22c" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_95a4a766-0a58-48c0-bb0c-e40ef9b4ce08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_5fd31386-534f-40ad-9c79-ed4531b2322d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_175603d6-d21a-40eb-892e-5ec8aa42c22c" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_5fd31386-534f-40ad-9c79-ed4531b2322d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherDebt_7bf035fe-cb17-40e0-b9f7-7ad67e77bec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromOtherDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_175603d6-d21a-40eb-892e-5ec8aa42c22c" xlink:to="loc_us-gaap_ProceedsFromOtherDebt_7bf035fe-cb17-40e0-b9f7-7ad67e77bec9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_4c21972d-c36b-4772-bb5c-18047481399a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_175603d6-d21a-40eb-892e-5ec8aa42c22c" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_4c21972d-c36b-4772-bb5c-18047481399a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_dc1d703d-e51f-45d7-b487-f28096614e72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_175603d6-d21a-40eb-892e-5ec8aa42c22c" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_dc1d703d-e51f-45d7-b487-f28096614e72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfEquity_62443f48-fd5d-4d60-a25d-e3fab48f6e08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfEquity"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_175603d6-d21a-40eb-892e-5ec8aa42c22c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfEquity_62443f48-fd5d-4d60-a25d-e3fab48f6e08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_51378043-d5ab-42f9-86df-16c79ac2bc46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_175603d6-d21a-40eb-892e-5ec8aa42c22c" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_51378043-d5ab-42f9-86df-16c79ac2bc46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_e5a46624-b562-4e38-9963-224e326233d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_175603d6-d21a-40eb-892e-5ec8aa42c22c" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_e5a46624-b562-4e38-9963-224e326233d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_8b43b85d-7024-4d56-b483-9e02a7174259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_175603d6-d21a-40eb-892e-5ec8aa42c22c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_8b43b85d-7024-4d56-b483-9e02a7174259" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8df157e7-92c6-48df-99ec-21bd7ff361d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3985bc91-55b7-40a6-9add-41fddbd5aa6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8df157e7-92c6-48df-99ec-21bd7ff361d6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3985bc91-55b7-40a6-9add-41fddbd5aa6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7db612a2-2b4c-4c91-9188-e7781e1a1d82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8df157e7-92c6-48df-99ec-21bd7ff361d6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7db612a2-2b4c-4c91-9188-e7781e1a1d82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ef7bb93a-0293-4d56-a829-dc807211fe45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8df157e7-92c6-48df-99ec-21bd7ff361d6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ef7bb93a-0293-4d56-a829-dc807211fe45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_adc6002d-c7c0-4410-84c9-ab82ba97b4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_849bfa4f-2c52-4983-ac72-1b5451e17673" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_adc6002d-c7c0-4410-84c9-ab82ba97b4ad" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_849bfa4f-2c52-4983-ac72-1b5451e17673" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_15e11ac2-a1ff-4f53-8bbe-0af5e75d1e17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_adc6002d-c7c0-4410-84c9-ab82ba97b4ad" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_15e11ac2-a1ff-4f53-8bbe-0af5e75d1e17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_2821c962-89df-4c9f-8325-8d5e5245f9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_adc6002d-c7c0-4410-84c9-ab82ba97b4ad" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_2821c962-89df-4c9f-8325-8d5e5245f9a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_328cea89-83a3-47f1-91d1-fce1203d03aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_adc6002d-c7c0-4410-84c9-ab82ba97b4ad" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_328cea89-83a3-47f1-91d1-fce1203d03aa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#LeasesScheduleofLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_b35b11f3-b3ef-4661-949e-59eac3e2819f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseInterestExpenseUnrelatedParties_b182d2d4-62b3-4f64-99aa-f6f90bd59522" xlink:href="sem-20210630.xsd#sem_FinanceLeaseInterestExpenseUnrelatedParties"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense_b35b11f3-b3ef-4661-949e-59eac3e2819f" xlink:to="loc_sem_FinanceLeaseInterestExpenseUnrelatedParties_b182d2d4-62b3-4f64-99aa-f6f90bd59522" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseInterestExpenseRelatedParties_9384ab00-d8b3-42f6-b945-52a3844456de" xlink:href="sem-20210630.xsd#sem_FinanceLeaseInterestExpenseRelatedParties"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense_b35b11f3-b3ef-4661-949e-59eac3e2819f" xlink:to="loc_sem_FinanceLeaseInterestExpenseRelatedParties_9384ab00-d8b3-42f6-b945-52a3844456de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_b2ce3061-aecb-4310-b739-363886452f85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_SubleaseIncomeRelatedParties_5d844642-bfa1-417b-a67f-76651f629e41" xlink:href="sem-20210630.xsd#sem_SubleaseIncomeRelatedParties"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SubleaseIncome_b2ce3061-aecb-4310-b739-363886452f85" xlink:to="loc_sem_SubleaseIncomeRelatedParties_5d844642-bfa1-417b-a67f-76651f629e41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_SubleaseIncomeUnrelatedParties_12dde79a-fb34-47b8-9e1a-b3b9dfa25c4e" xlink:href="sem-20210630.xsd#sem_SubleaseIncomeUnrelatedParties"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SubleaseIncome_b2ce3061-aecb-4310-b739-363886452f85" xlink:to="loc_sem_SubleaseIncomeUnrelatedParties_12dde79a-fb34-47b8-9e1a-b3b9dfa25c4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_19c16675-160b-4450-911d-8dac2a1f99a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties_001cbf5d-df5f-4952-9fe7-8eafe38ff487" xlink:href="sem-20210630.xsd#sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_19c16675-160b-4450-911d-8dac2a1f99a5" xlink:to="loc_sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties_001cbf5d-df5f-4952-9fe7-8eafe38ff487" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties_d533e53d-9cdd-4050-a2de-174185f6dd2d" xlink:href="sem-20210630.xsd#sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_19c16675-160b-4450-911d-8dac2a1f99a5" xlink:to="loc_sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties_d533e53d-9cdd-4050-a2de-174185f6dd2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LeaseCostUnrelatedParties_373de58d-bb58-4060-944f-d4521ea3689d" xlink:href="sem-20210630.xsd#sem_LeaseCostUnrelatedParties"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseCostUnrelatedParties_d8c2da93-09a1-468b-bd30-75901ec47d8f" xlink:href="sem-20210630.xsd#sem_OperatingLeaseCostUnrelatedParties"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_LeaseCostUnrelatedParties_373de58d-bb58-4060-944f-d4521ea3689d" xlink:to="loc_sem_OperatingLeaseCostUnrelatedParties_d8c2da93-09a1-468b-bd30-75901ec47d8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties_117ec4a4-a656-44ec-96ce-206724f5b54f" xlink:href="sem-20210630.xsd#sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_LeaseCostUnrelatedParties_373de58d-bb58-4060-944f-d4521ea3689d" xlink:to="loc_sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties_117ec4a4-a656-44ec-96ce-206724f5b54f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseInterestExpenseUnrelatedParties_671142db-8a6a-4eb9-82f8-e452418ddf08" xlink:href="sem-20210630.xsd#sem_FinanceLeaseInterestExpenseUnrelatedParties"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_LeaseCostUnrelatedParties_373de58d-bb58-4060-944f-d4521ea3689d" xlink:to="loc_sem_FinanceLeaseInterestExpenseUnrelatedParties_671142db-8a6a-4eb9-82f8-e452418ddf08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_VariableLeaseCostUnrelatedParties_381ce9dd-ddb1-4d93-a43d-237887a0aad1" xlink:href="sem-20210630.xsd#sem_VariableLeaseCostUnrelatedParties"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_LeaseCostUnrelatedParties_373de58d-bb58-4060-944f-d4521ea3689d" xlink:to="loc_sem_VariableLeaseCostUnrelatedParties_381ce9dd-ddb1-4d93-a43d-237887a0aad1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_SubleaseIncomeUnrelatedParties_d87bb13c-65f1-487c-b356-7daf50228dbc" xlink:href="sem-20210630.xsd#sem_SubleaseIncomeUnrelatedParties"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_LeaseCostUnrelatedParties_373de58d-bb58-4060-944f-d4521ea3689d" xlink:to="loc_sem_SubleaseIncomeUnrelatedParties_d87bb13c-65f1-487c-b356-7daf50228dbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_dab4ab7a-06f9-4b86-988a-421c05b0dc96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseCostRelatedParties_d9375f2e-cca6-4766-a507-46acf73535cd" xlink:href="sem-20210630.xsd#sem_OperatingLeaseCostRelatedParties"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseCost_dab4ab7a-06f9-4b86-988a-421c05b0dc96" xlink:to="loc_sem_OperatingLeaseCostRelatedParties_d9375f2e-cca6-4766-a507-46acf73535cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseCostUnrelatedParties_8d7dff39-ba37-45a6-9639-d88920d79d32" xlink:href="sem-20210630.xsd#sem_OperatingLeaseCostUnrelatedParties"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseCost_dab4ab7a-06f9-4b86-988a-421c05b0dc96" xlink:to="loc_sem_OperatingLeaseCostUnrelatedParties_8d7dff39-ba37-45a6-9639-d88920d79d32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LeaseCostRelatedParties_ea3a02e1-796f-4c13-b6de-e1452986c984" xlink:href="sem-20210630.xsd#sem_LeaseCostRelatedParties"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseCostRelatedParties_27912a4e-bf44-46a9-b2ac-d87a8e2c2e52" xlink:href="sem-20210630.xsd#sem_OperatingLeaseCostRelatedParties"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_LeaseCostRelatedParties_ea3a02e1-796f-4c13-b6de-e1452986c984" xlink:to="loc_sem_OperatingLeaseCostRelatedParties_27912a4e-bf44-46a9-b2ac-d87a8e2c2e52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties_f24567f9-1288-4f8f-be20-ea01ed72573f" xlink:href="sem-20210630.xsd#sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_LeaseCostRelatedParties_ea3a02e1-796f-4c13-b6de-e1452986c984" xlink:to="loc_sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties_f24567f9-1288-4f8f-be20-ea01ed72573f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseInterestExpenseRelatedParties_348b1c35-dbf4-478a-9bfe-001816b58bf7" xlink:href="sem-20210630.xsd#sem_FinanceLeaseInterestExpenseRelatedParties"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_LeaseCostRelatedParties_ea3a02e1-796f-4c13-b6de-e1452986c984" xlink:to="loc_sem_FinanceLeaseInterestExpenseRelatedParties_348b1c35-dbf4-478a-9bfe-001816b58bf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_VariableLeaseCostRelatedParties_bf3522a9-fe18-4438-ab2d-3f30b909cbf6" xlink:href="sem-20210630.xsd#sem_VariableLeaseCostRelatedParties"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_LeaseCostRelatedParties_ea3a02e1-796f-4c13-b6de-e1452986c984" xlink:to="loc_sem_VariableLeaseCostRelatedParties_bf3522a9-fe18-4438-ab2d-3f30b909cbf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_SubleaseIncomeRelatedParties_45b1e5c8-daad-45ca-b6da-f8d4f83935cf" xlink:href="sem-20210630.xsd#sem_SubleaseIncomeRelatedParties"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_LeaseCostRelatedParties_ea3a02e1-796f-4c13-b6de-e1452986c984" xlink:to="loc_sem_SubleaseIncomeRelatedParties_45b1e5c8-daad-45ca-b6da-f8d4f83935cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_f4f2e078-1388-4201-b272-dadc6303fe8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_e8083247-a6e4-4525-9be4-5c0e5f6617cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_f4f2e078-1388-4201-b272-dadc6303fe8e" xlink:to="loc_us-gaap_OperatingLeaseCost_e8083247-a6e4-4525-9be4-5c0e5f6617cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_21395d35-a39d-45db-8912-7865954ff96f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_f4f2e078-1388-4201-b272-dadc6303fe8e" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_21395d35-a39d-45db-8912-7865954ff96f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_0130fa3f-2298-410f-90f4-9dfd1e4dc20f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_f4f2e078-1388-4201-b272-dadc6303fe8e" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_0130fa3f-2298-410f-90f4-9dfd1e4dc20f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_3af806fc-9969-4536-961d-88288a35598f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_f4f2e078-1388-4201-b272-dadc6303fe8e" xlink:to="loc_us-gaap_VariableLeaseCost_3af806fc-9969-4536-961d-88288a35598f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_47f07e6b-1ed2-457d-9c57-d8cbcf04130a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_f4f2e078-1388-4201-b272-dadc6303fe8e" xlink:to="loc_us-gaap_SubleaseIncome_47f07e6b-1ed2-457d-9c57-d8cbcf04130a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_83bd1847-1cd4-4fc2-b017-4257be142bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_VariableLeaseCostRelatedParties_c0b962b3-c6c2-4715-b4ee-273d6deff42c" xlink:href="sem-20210630.xsd#sem_VariableLeaseCostRelatedParties"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_VariableLeaseCost_83bd1847-1cd4-4fc2-b017-4257be142bfd" xlink:to="loc_sem_VariableLeaseCostRelatedParties_c0b962b3-c6c2-4715-b4ee-273d6deff42c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_VariableLeaseCostUnrelatedParties_81ab2a11-c14a-474a-a7a7-7e7fa6781d60" xlink:href="sem-20210630.xsd#sem_VariableLeaseCostUnrelatedParties"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_VariableLeaseCost_83bd1847-1cd4-4fc2-b017-4257be142bfd" xlink:to="loc_sem_VariableLeaseCostUnrelatedParties_81ab2a11-c14a-474a-a7a7-7e7fa6781d60" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4893e701-477d-4210-9759-da22b3825184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties_40fcd9a3-4510-4c67-833d-7e435f010955" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4893e701-477d-4210-9759-da22b3825184" xlink:to="loc_sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties_40fcd9a3-4510-4c67-833d-7e435f010955" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityNoncurrentRelatedParties_dabce520-6eb1-4239-aa99-878c28d8f9ac" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityNoncurrentRelatedParties"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4893e701-477d-4210-9759-da22b3825184" xlink:to="loc_sem_OperatingLeaseLiabilityNoncurrentRelatedParties_dabce520-6eb1-4239-aa99-878c28d8f9ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_0b590f62-e38d-4737-b92c-03e3ef0181b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityCurrentUnrelatedParties_b8e7abfd-7a5e-447d-97a6-eba30b688e62" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityCurrentUnrelatedParties"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_0b590f62-e38d-4737-b92c-03e3ef0181b7" xlink:to="loc_sem_OperatingLeaseLiabilityCurrentUnrelatedParties_b8e7abfd-7a5e-447d-97a6-eba30b688e62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityCurrentRelatedParties_e97248e3-55c3-47b9-85e5-7ea8877aae6a" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityCurrentRelatedParties"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_0b590f62-e38d-4737-b92c-03e3ef0181b7" xlink:to="loc_sem_OperatingLeaseLiabilityCurrentRelatedParties_e97248e3-55c3-47b9-85e5-7ea8877aae6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityRelatedParties_1656a892-8dce-4609-97e3-e3a09c963885" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityRelatedParties"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityNoncurrentRelatedParties_1ed741c9-8935-4662-b65b-05266b172af8" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityNoncurrentRelatedParties"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_OperatingLeaseLiabilityRelatedParties_1656a892-8dce-4609-97e3-e3a09c963885" xlink:to="loc_sem_OperatingLeaseLiabilityNoncurrentRelatedParties_1ed741c9-8935-4662-b65b-05266b172af8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityCurrentRelatedParties_87277736-f5c9-4d76-83fe-86fd61cfeb2a" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityCurrentRelatedParties"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_OperatingLeaseLiabilityRelatedParties_1656a892-8dce-4609-97e3-e3a09c963885" xlink:to="loc_sem_OperatingLeaseLiabilityCurrentRelatedParties_87277736-f5c9-4d76-83fe-86fd61cfeb2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_af17bed2-8cf6-4917-acf7-c04d63dd8267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityRelatedParties_f8b0bdce-f2aa-4538-98b1-6af263335722" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityRelatedParties"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_af17bed2-8cf6-4917-acf7-c04d63dd8267" xlink:to="loc_sem_OperatingLeaseLiabilityRelatedParties_f8b0bdce-f2aa-4538-98b1-6af263335722" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityUnrelatedParties_feb5f2d8-524f-45d2-ba0a-886eebfa8aeb" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityUnrelatedParties"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_af17bed2-8cf6-4917-acf7-c04d63dd8267" xlink:to="loc_sem_OperatingLeaseLiabilityUnrelatedParties_feb5f2d8-524f-45d2-ba0a-886eebfa8aeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_f5f64f16-94eb-4d1f-bed7-fc98b083dd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_c1ee6aef-8204-4db8-a80e-5c91c0f245bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_f5f64f16-94eb-4d1f-bed7-fc98b083dd7e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_c1ee6aef-8204-4db8-a80e-5c91c0f245bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ff2024a8-f7f4-458a-831c-b963d7b836c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_f5f64f16-94eb-4d1f-bed7-fc98b083dd7e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ff2024a8-f7f4-458a-831c-b963d7b836c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityUnrelatedParties_bf0687e5-b318-4792-b13a-57b38ce555b3" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityUnrelatedParties"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityCurrentUnrelatedParties_b0ed1771-e944-4ad6-ae33-936ff804fa3d" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityCurrentUnrelatedParties"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_OperatingLeaseLiabilityUnrelatedParties_bf0687e5-b318-4792-b13a-57b38ce555b3" xlink:to="loc_sem_OperatingLeaseLiabilityCurrentUnrelatedParties_b0ed1771-e944-4ad6-ae33-936ff804fa3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties_ac423822-e842-4253-9624-2bcfcfd49fbe" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_OperatingLeaseLiabilityUnrelatedParties_bf0687e5-b318-4792-b13a-57b38ce555b3" xlink:to="loc_sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties_ac423822-e842-4253-9624-2bcfcfd49fbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_58b62210-6a4a-4ade-bc06-5f42c90e56b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties_debdac77-4951-49ce-90bf-0c3ff9efea9e" xlink:href="sem-20210630.xsd#sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset_58b62210-6a4a-4ade-bc06-5f42c90e56b7" xlink:to="loc_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties_debdac77-4951-49ce-90bf-0c3ff9efea9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties_c5a13238-3484-4bd8-913a-3750f1a32b3b" xlink:href="sem-20210630.xsd#sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset_58b62210-6a4a-4ade-bc06-5f42c90e56b7" xlink:to="loc_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties_c5a13238-3484-4bd8-913a-3750f1a32b3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_05ccb98a-5e95-4aee-85ac-acbd0baa7fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityCurrentRelatedParties_9863ecbc-79af-4586-9c57-9b3c0df430fc" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityCurrentRelatedParties"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent_05ccb98a-5e95-4aee-85ac-acbd0baa7fd1" xlink:to="loc_sem_FinanceLeaseLiabilityCurrentRelatedParties_9863ecbc-79af-4586-9c57-9b3c0df430fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityCurrentUnrelatedParties_eadd4429-979f-46b8-b315-7196e47ae065" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityCurrentUnrelatedParties"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent_05ccb98a-5e95-4aee-85ac-acbd0baa7fd1" xlink:to="loc_sem_FinanceLeaseLiabilityCurrentUnrelatedParties_eadd4429-979f-46b8-b315-7196e47ae065" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_0bcbcfe0-d613-4c17-8673-d8a59d87ea71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties_74ee3e31-9902-4691-9a9c-53f45e3fcac6" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_0bcbcfe0-d613-4c17-8673-d8a59d87ea71" xlink:to="loc_sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties_74ee3e31-9902-4691-9a9c-53f45e3fcac6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityNoncurrentRelatedParties_b2ce47fe-e8c8-482f-905f-c587441c6cae" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityNoncurrentRelatedParties"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_0bcbcfe0-d613-4c17-8673-d8a59d87ea71" xlink:to="loc_sem_FinanceLeaseLiabilityNoncurrentRelatedParties_b2ce47fe-e8c8-482f-905f-c587441c6cae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2cc3c839-1e64-4ca7-b13f-fdb21373a100" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseRightOfUseAssetUnrelatedParties_2b11f88f-f7c9-4a76-af2c-55bc9eb78366" xlink:href="sem-20210630.xsd#sem_OperatingLeaseRightOfUseAssetUnrelatedParties"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_2cc3c839-1e64-4ca7-b13f-fdb21373a100" xlink:to="loc_sem_OperatingLeaseRightOfUseAssetUnrelatedParties_2b11f88f-f7c9-4a76-af2c-55bc9eb78366" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseRightOfUseAssetRelatedParties_f75e8e48-19f0-4ae3-85bc-049ab9d45bb7" xlink:href="sem-20210630.xsd#sem_OperatingLeaseRightOfUseAssetRelatedParties"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_2cc3c839-1e64-4ca7-b13f-fdb21373a100" xlink:to="loc_sem_OperatingLeaseRightOfUseAssetRelatedParties_f75e8e48-19f0-4ae3-85bc-049ab9d45bb7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails_1" xlink:type="simple" xlink:href="sem-20210630.xsd#LeasesSupplementalBalanceSheetInformationDetails_1"/>
  <link:calculationLink xlink:role="http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b0243dda-b616-4f39-b3cf-e0dbe8dc5402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_edd02a8c-b22c-41e2-a522-738cd7e44381" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_b0243dda-b616-4f39-b3cf-e0dbe8dc5402" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_edd02a8c-b22c-41e2-a522-738cd7e44381" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fb3941d3-0314-4953-af4a-ed421958a214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_b0243dda-b616-4f39-b3cf-e0dbe8dc5402" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fb3941d3-0314-4953-af4a-ed421958a214" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_f2ccd02f-82b2-461b-938c-24d490fd682e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityUnrelatedParties_7c2322df-fe7c-4994-87ca-18eae177f4b2" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityUnrelatedParties"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_f2ccd02f-82b2-461b-938c-24d490fd682e" xlink:to="loc_sem_FinanceLeaseLiabilityUnrelatedParties_7c2322df-fe7c-4994-87ca-18eae177f4b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityRelatedParties_d17d1dd8-5788-4636-974e-6477539f8c24" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityRelatedParties"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_f2ccd02f-82b2-461b-938c-24d490fd682e" xlink:to="loc_sem_FinanceLeaseLiabilityRelatedParties_d17d1dd8-5788-4636-974e-6477539f8c24" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fec39c35-8a50-4cba-ad8d-f19519f3ce81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_316e9815-070c-4280-9ba9-7fff67989998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fec39c35-8a50-4cba-ad8d-f19519f3ce81" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_316e9815-070c-4280-9ba9-7fff67989998" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_05f7890b-c80c-474d-84ec-4c370fa2a8be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fec39c35-8a50-4cba-ad8d-f19519f3ce81" xlink:to="loc_us-gaap_OperatingLeaseLiability_05f7890b-c80c-474d-84ec-4c370fa2a8be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_58f05367-bed7-4257-9165-46731dcb7b61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_2a30c97d-4a46-4d8d-91fb-717795134281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_58f05367-bed7-4257-9165-46731dcb7b61" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_2a30c97d-4a46-4d8d-91fb-717795134281" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_e1c014ce-5a2d-4623-a3f3-2082dfc9a0db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_58f05367-bed7-4257-9165-46731dcb7b61" xlink:to="loc_us-gaap_FinanceLeaseLiability_e1c014ce-5a2d-4623-a3f3-2082dfc9a0db" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="sem-20210630.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_81e09622-09b7-4d72-97b1-d34b2b4d4d33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_56a65cee-d499-4846-b18b-d21ca9f3d55e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_81e09622-09b7-4d72-97b1-d34b2b4d4d33" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_56a65cee-d499-4846-b18b-d21ca9f3d55e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_286bc990-55a9-43eb-8730-f3fc8c5c07ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_81e09622-09b7-4d72-97b1-d34b2b4d4d33" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_286bc990-55a9-43eb-8730-f3fc8c5c07ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9de28bb1-dc22-49ea-a126-b25e6b8bfa27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_81e09622-09b7-4d72-97b1-d34b2b4d4d33" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9de28bb1-dc22-49ea-a126-b25e6b8bfa27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_dafcf02b-6d3d-4287-84af-305268ff85fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_81e09622-09b7-4d72-97b1-d34b2b4d4d33" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_dafcf02b-6d3d-4287-84af-305268ff85fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b82063f8-ac0a-44c5-a652-845babe101ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_81e09622-09b7-4d72-97b1-d34b2b4d4d33" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b82063f8-ac0a-44c5-a652-845babe101ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_2afcf982-df5c-4c3f-b033-c6e1f07ebf9b" xlink:href="sem-20210630.xsd#sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_81e09622-09b7-4d72-97b1-d34b2b4d4d33" xlink:to="loc_sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_2afcf982-df5c-4c3f-b033-c6e1f07ebf9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5d6e2244-22c8-4981-bd9a-e99fa527ab97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_6cc46155-5f54-4a01-aa75-fa5c2970d175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5d6e2244-22c8-4981-bd9a-e99fa527ab97" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_6cc46155-5f54-4a01-aa75-fa5c2970d175" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_fb91f415-0d96-4f77-9907-67b3fad7b367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5d6e2244-22c8-4981-bd9a-e99fa527ab97" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_fb91f415-0d96-4f77-9907-67b3fad7b367" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_265d4bd3-4bd9-4350-8e4c-764ed0cbbc89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5d6e2244-22c8-4981-bd9a-e99fa527ab97" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_265d4bd3-4bd9-4350-8e4c-764ed0cbbc89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_58cea54b-7577-4b64-806c-44b46722a67f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5d6e2244-22c8-4981-bd9a-e99fa527ab97" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_58cea54b-7577-4b64-806c-44b46722a67f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_a965ec36-56af-40a6-918b-f263aa2a5fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5d6e2244-22c8-4981-bd9a-e99fa527ab97" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_a965ec36-56af-40a6-918b-f263aa2a5fcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour_2b0b53d6-ec10-4237-9beb-0e469f3125ae" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5d6e2244-22c8-4981-bd9a-e99fa527ab97" xlink:to="loc_sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour_2b0b53d6-ec10-4237-9beb-0e469f3125ae" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6009ec62-3027-4e52-a063-44583da2f7df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d4dae3c1-8ac7-4e37-97b3-b3a5b6343215" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6009ec62-3027-4e52-a063-44583da2f7df" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d4dae3c1-8ac7-4e37-97b3-b3a5b6343215" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bc0ce207-bf4c-4597-b2c7-de011d167d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6009ec62-3027-4e52-a063-44583da2f7df" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bc0ce207-bf4c-4597-b2c7-de011d167d6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3a81b8f0-e710-4296-88c3-9538eeb07ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_796aa21f-92c6-43cf-ade4-926a28e3dee0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3a81b8f0-e710-4296-88c3-9538eeb07ebb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_796aa21f-92c6-43cf-ade4-926a28e3dee0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2cc39aa8-bfa9-40aa-b771-7a9c6d3c8d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_3a81b8f0-e710-4296-88c3-9538eeb07ebb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2cc39aa8-bfa9-40aa-b771-7a9c6d3c8d5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ad5fd27c-6cb2-405d-ac1d-035587a41ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ad3e6e24-c426-43bc-9704-5e7e7af4e05d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ad5fd27c-6cb2-405d-ac1d-035587a41ef3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ad3e6e24-c426-43bc-9704-5e7e7af4e05d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_00bd507d-f484-4db1-8156-0a546f1c5ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ad5fd27c-6cb2-405d-ac1d-035587a41ef3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_00bd507d-f484-4db1-8156-0a546f1c5ab7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails"/>
  <link:calculationLink xlink:role="http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligation_099bca2c-ea1c-4764-b20f-551f122dd751" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtGrossAndFinanceLeaseObligation_8600202d-b010-4fc7-8067-3a3e656dce77" xlink:href="sem-20210630.xsd#sem_LongTermDebtGrossAndFinanceLeaseObligation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_LongTermDebtAndFinanceLeaseObligation_099bca2c-ea1c-4764-b20f-551f122dd751" xlink:to="loc_sem_LongTermDebtGrossAndFinanceLeaseObligation_8600202d-b010-4fc7-8067-3a3e656dce77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_30ad13c9-f5f9-4476-9e4d-13116b13754d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_LongTermDebtAndFinanceLeaseObligation_099bca2c-ea1c-4764-b20f-551f122dd751" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_30ad13c9-f5f9-4476-9e4d-13116b13754d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_d27c5da5-90b4-427a-b25f-96632b453333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_LongTermDebtAndFinanceLeaseObligation_099bca2c-ea1c-4764-b20f-551f122dd751" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_d27c5da5-90b4-427a-b25f-96632b453333" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_2cb8a4ce-63d8-4a83-ba4a-6ae01272dedb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_0a57d2d3-c2b9-4903-949c-9b8be2174351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_2cb8a4ce-63d8-4a83-ba4a-6ae01272dedb" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_0a57d2d3-c2b9-4903-949c-9b8be2174351" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_2394dc2c-9ea3-4c4d-8980-ab12f66323fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_2cb8a4ce-63d8-4a83-ba4a-6ae01272dedb" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_2394dc2c-9ea3-4c4d-8980-ab12f66323fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_2c53d5d1-6bc0-41c7-b13a-258196091844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_2cb8a4ce-63d8-4a83-ba4a-6ae01272dedb" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_2c53d5d1-6bc0-41c7-b13a-258196091844" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtGrossAndFinanceLeaseObligation_3ad3d5d8-6fff-41f9-9365-c31097183a63" xlink:href="sem-20210630.xsd#sem_LongTermDebtGrossAndFinanceLeaseObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear_ebc5dbc4-1e35-4ca9-9624-4734b14b4e6a" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_LongTermDebtGrossAndFinanceLeaseObligation_3ad3d5d8-6fff-41f9-9365-c31097183a63" xlink:to="loc_sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear_ebc5dbc4-1e35-4ca9-9624-4734b14b4e6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_9c7f916b-9a26-4b2a-8171-0f2fab1c737e" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_LongTermDebtGrossAndFinanceLeaseObligation_3ad3d5d8-6fff-41f9-9365-c31097183a63" xlink:to="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_9c7f916b-9a26-4b2a-8171-0f2fab1c737e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo_c19f0b43-b777-4d75-b42a-205fd2e6bacd" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_LongTermDebtGrossAndFinanceLeaseObligation_3ad3d5d8-6fff-41f9-9365-c31097183a63" xlink:to="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo_c19f0b43-b777-4d75-b42a-205fd2e6bacd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree_b1b41c14-21fe-4347-9ffe-c5d050906d0c" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_LongTermDebtGrossAndFinanceLeaseObligation_3ad3d5d8-6fff-41f9-9365-c31097183a63" xlink:to="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree_b1b41c14-21fe-4347-9ffe-c5d050906d0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour_b3852d2e-ea82-4d85-ad19-358d855c4936" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_LongTermDebtGrossAndFinanceLeaseObligation_3ad3d5d8-6fff-41f9-9365-c31097183a63" xlink:to="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour_b3852d2e-ea82-4d85-ad19-358d855c4936" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour_f4c2ae9e-0181-41f9-9f5e-1d0eaa220d9d" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sem_LongTermDebtGrossAndFinanceLeaseObligation_3ad3d5d8-6fff-41f9-9365-c31097183a63" xlink:to="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour_f4c2ae9e-0181-41f9-9f5e-1d0eaa220d9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_718f5266-439e-40b8-95e2-b27f22ad24f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_c457ddd1-8425-416c-9509-21f7e7ac22bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_718f5266-439e-40b8-95e2-b27f22ad24f3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_c457ddd1-8425-416c-9509-21f7e7ac22bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e330c531-4672-4f1f-adaf-7d1df5fd2273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_718f5266-439e-40b8-95e2-b27f22ad24f3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e330c531-4672-4f1f-adaf-7d1df5fd2273" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_a9e10dd7-8584-4cfe-adc7-67079bcf6c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_718f5266-439e-40b8-95e2-b27f22ad24f3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_a9e10dd7-8584-4cfe-adc7-67079bcf6c8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_085fde21-a5f8-4e7f-8384-cc3fe276eb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_718f5266-439e-40b8-95e2-b27f22ad24f3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_085fde21-a5f8-4e7f-8384-cc3fe276eb4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0c699681-b752-4399-bd72-30725968393a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_718f5266-439e-40b8-95e2-b27f22ad24f3" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0c699681-b752-4399-bd72-30725968393a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour_7d93a6db-861e-4793-bfee-269caa20fbdd" xlink:href="sem-20210630.xsd#sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_718f5266-439e-40b8-95e2-b27f22ad24f3" xlink:to="loc_sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour_7d93a6db-861e-4793-bfee-269caa20fbdd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_664b66a6-33c0-435f-9c7c-aab7406447d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_AdjustedEbitda_3644dff7-492f-4bb9-bfca-bcb2430ad170" xlink:href="sem-20210630.xsd#sem_AdjustedEbitda"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_664b66a6-33c0-435f-9c7c-aab7406447d0" xlink:to="loc_sem_AdjustedEbitda_3644dff7-492f-4bb9-bfca-bcb2430ad170" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_8952f62e-7e4e-462b-992a-87c9ed3ee302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_664b66a6-33c0-435f-9c7c-aab7406447d0" xlink:to="loc_us-gaap_DepreciationAndAmortization_8952f62e-7e4e-462b-992a-87c9ed3ee302" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_60b8f3b5-8352-47e4-a61f-b07dcffbd8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_664b66a6-33c0-435f-9c7c-aab7406447d0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_60b8f3b5-8352-47e4-a61f-b07dcffbd8ae" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails"/>
  <link:calculationLink xlink:role="http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_c012b7be-d10a-4fa7-8ba7-7f605a6af637" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_b6928d77-e72a-4a5d-8d1c-b7014c06cd1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_c012b7be-d10a-4fa7-8ba7-7f605a6af637" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_b6928d77-e72a-4a5d-8d1c-b7014c06cd1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7a10f83a-44fa-4df0-91da-e6726114c9bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_c012b7be-d10a-4fa7-8ba7-7f605a6af637" xlink:to="loc_us-gaap_NetIncomeLoss_7a10f83a-44fa-4df0-91da-e6726114c9bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a04c5126-3d36-4ef7-bb85-851c927f992d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ee2c7750-85d6-49cd-ac11-269e93cc475a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a04c5126-3d36-4ef7-bb85-851c927f992d" xlink:to="loc_us-gaap_NetIncomeLoss_ee2c7750-85d6-49cd-ac11-269e93cc475a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_a15e1a48-67a1-414f-9790-565484480cca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a04c5126-3d36-4ef7-bb85-851c927f992d" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_a15e1a48-67a1-414f-9790-565484480cca" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>sem-20210630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:13e6905e-72a0-44f6-9164-f135c900c5bf,g:37e820a7-74f5-4c60-b984-336d3d990bf4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited" xlink:type="simple" xlink:href="sem-20210630.xsd#CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"/>
  <link:definitionLink xlink:role="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited" xlink:type="extended" id="i3e7f4e12cbda4ac087b88c055cdf1d97_CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fa2d9af7-d13e-4b6e-8bed-4d9d0a6b7e45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fa2d9af7-d13e-4b6e-8bed-4d9d0a6b7e45" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ef3b3f92-569f-4354-a2eb-b853cf5fe2fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_CommonStockSharesIssued_ef3b3f92-569f-4354-a2eb-b853cf5fe2fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b7b2324d-f295-4b27-b5e5-c1887d78a992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b7b2324d-f295-4b27-b5e5-c1887d78a992" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1b4e805a-5389-42f4-aa9f-c85dfa18d397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_NetIncomeLoss_1b4e805a-5389-42f4-aa9f-c85dfa18d397" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_d01602e5-f048-49ee-b680-e4cb2dcae597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_d01602e5-f048-49ee-b680-e4cb2dcae597" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_154b051a-a60a-4a77-8e9e-6199e0d0750b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_DividendsCommonStock_154b051a-a60a-4a77-8e9e-6199e0d0750b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_397e861a-cef2-42f6-a9c2-2254723597eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_397e861a-cef2-42f6-a9c2-2254723597eb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_ff7cfecd-0047-40aa-96b7-2c36670d3d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_ff7cfecd-0047-40aa-96b7-2c36670d3d4a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_48cec959-297c-4f5e-8559-793037afea82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_48cec959-297c-4f5e-8559-793037afea82" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_d2c6b8af-2477-4d81-a076-109683c8b3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_d2c6b8af-2477-4d81-a076-109683c8b3e1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7d68188b-3823-4690-a234-6ea13825c71b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7d68188b-3823-4690-a234-6ea13825c71b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_92257ee7-41fd-466f-ba17-8c1725cc0ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_92257ee7-41fd-466f-ba17-8c1725cc0ff1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_80551abc-404b-4eeb-842d-3952a8fe7f32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_80551abc-404b-4eeb-842d-3952a8fe7f32" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_593aa5b2-9c47-4d60-b4fa-999ee86e659f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_593aa5b2-9c47-4d60-b4fa-999ee86e659f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_dfee1e78-7962-4d5a-b099-1dd852775b33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_dfee1e78-7962-4d5a-b099-1dd852775b33" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_c318aa40-e2a1-4e61-90aa-4d4ebe15ed53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_c318aa40-e2a1-4e61-90aa-4d4ebe15ed53" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_e2b6317e-3aae-43c9-8fcd-8ce988c29b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_e2b6317e-3aae-43c9-8fcd-8ce988c29b0d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_907d361d-2411-4fc1-b2cf-7d26ede57053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_907d361d-2411-4fc1-b2cf-7d26ede57053" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_12a95cdb-8453-40cc-b1f3-93fb37b08cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_StockholdersEquityOther_12a95cdb-8453-40cc-b1f3-93fb37b08cbd" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_33bffc8c-943b-4400-8d8a-f29bc23e3c40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c4f5485b-3ac0-4411-b7a8-85d46d4de2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_36662bf4-2579-4b9b-92d1-a3d9b44113fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_fa2d9af7-d13e-4b6e-8bed-4d9d0a6b7e45" xlink:to="loc_us-gaap_StatementTable_36662bf4-2579-4b9b-92d1-a3d9b44113fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f5a78ad8-f907-4b26-99c2-f25d35dd820e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_36662bf4-2579-4b9b-92d1-a3d9b44113fc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f5a78ad8-f907-4b26-99c2-f25d35dd820e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f5a78ad8-f907-4b26-99c2-f25d35dd820e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f5a78ad8-f907-4b26-99c2-f25d35dd820e" xlink:to="loc_us-gaap_EquityComponentDomain_f5a78ad8-f907-4b26-99c2-f25d35dd820e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_129ee559-fe80-4cd5-9e36-7d69bfac2b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f5a78ad8-f907-4b26-99c2-f25d35dd820e" xlink:to="loc_us-gaap_EquityComponentDomain_129ee559-fe80-4cd5-9e36-7d69bfac2b6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_eff63ae7-b3f9-41b4-b2d4-aa9c74850c10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_129ee559-fe80-4cd5-9e36-7d69bfac2b6e" xlink:to="loc_us-gaap_ParentMember_eff63ae7-b3f9-41b4-b2d4-aa9c74850c10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_292355fe-4567-4d59-974a-244d68209ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_eff63ae7-b3f9-41b4-b2d4-aa9c74850c10" xlink:to="loc_us-gaap_CommonStockMember_292355fe-4567-4d59-974a-244d68209ad0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_50f8660d-ee6d-4f57-a9c0-22e0c7cfa221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_eff63ae7-b3f9-41b4-b2d4-aa9c74850c10" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_50f8660d-ee6d-4f57-a9c0-22e0c7cfa221" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_29cad1dd-1622-47f2-9f2e-a3a7fb46dd89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_eff63ae7-b3f9-41b4-b2d4-aa9c74850c10" xlink:to="loc_us-gaap_RetainedEarningsMember_29cad1dd-1622-47f2-9f2e-a3a7fb46dd89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f101d60f-ccce-44ce-867b-4f065b592fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_eff63ae7-b3f9-41b4-b2d4-aa9c74850c10" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f101d60f-ccce-44ce-867b-4f065b592fcd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_4cac37ff-7d95-4963-8341-2edbf3509248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_129ee559-fe80-4cd5-9e36-7d69bfac2b6e" xlink:to="loc_us-gaap_NoncontrollingInterestMember_4cac37ff-7d95-4963-8341-2edbf3509248" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CreditRiskConcentrationsDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#CreditRiskConcentrationsDetails"/>
  <link:definitionLink xlink:role="http://www.selectmedical.com/role/CreditRiskConcentrationsDetails" xlink:type="extended" id="ibf556c0e8d9948ce818d76b9b4db88bd_CreditRiskConcentrationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_29d1cd63-0419-4d91-9508-54cca1961991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_14955247-cdf0-4131-ab23-f64961eb3448" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_29d1cd63-0419-4d91-9508-54cca1961991" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_14955247-cdf0-4131-ab23-f64961eb3448" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_c8904fcb-042e-4550-b8fd-6f628f80711f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_29d1cd63-0419-4d91-9508-54cca1961991" xlink:to="loc_us-gaap_ConcentrationRiskTable_c8904fcb-042e-4550-b8fd-6f628f80711f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_22e5fe23-3952-4e8a-82ab-77a8804669ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_c8904fcb-042e-4550-b8fd-6f628f80711f" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_22e5fe23-3952-4e8a-82ab-77a8804669ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_22e5fe23-3952-4e8a-82ab-77a8804669ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_22e5fe23-3952-4e8a-82ab-77a8804669ed" xlink:to="loc_us-gaap_ReceivableTypeDomain_22e5fe23-3952-4e8a-82ab-77a8804669ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_bf59bedd-90d0-4a3a-b379-fbba5278cac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_22e5fe23-3952-4e8a-82ab-77a8804669ed" xlink:to="loc_us-gaap_ReceivableTypeDomain_bf59bedd-90d0-4a3a-b379-fbba5278cac7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_MedicareReceivableMember_b420d0da-651a-47b2-895e-18e4246fbe8c" xlink:href="sem-20210630.xsd#sem_MedicareReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_bf59bedd-90d0-4a3a-b379-fbba5278cac7" xlink:to="loc_sem_MedicareReceivableMember_b420d0da-651a-47b2-895e-18e4246fbe8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_c1386db0-c666-41ad-92bf-cd0346acbeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_c8904fcb-042e-4550-b8fd-6f628f80711f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_c1386db0-c666-41ad-92bf-cd0346acbeb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c1386db0-c666-41ad-92bf-cd0346acbeb7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_c1386db0-c666-41ad-92bf-cd0346acbeb7" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c1386db0-c666-41ad-92bf-cd0346acbeb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_a063f369-b11a-4f13-ad69-a74da27d748b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_c1386db0-c666-41ad-92bf-cd0346acbeb7" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_a063f369-b11a-4f13-ad69-a74da27d748b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_df184d14-cc1b-4420-9a9a-d43a5d3bf6ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_a063f369-b11a-4f13-ad69-a74da27d748b" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_df184d14-cc1b-4420-9a9a-d43a5d3bf6ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_38cd7389-5116-4d15-83ae-b6fee7cc0bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_c8904fcb-042e-4550-b8fd-6f628f80711f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_38cd7389-5116-4d15-83ae-b6fee7cc0bc5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_38cd7389-5116-4d15-83ae-b6fee7cc0bc5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_38cd7389-5116-4d15-83ae-b6fee7cc0bc5" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_38cd7389-5116-4d15-83ae-b6fee7cc0bc5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b7bfc0b1-942b-4ea3-8aa1-2cb57ba99eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_38cd7389-5116-4d15-83ae-b6fee7cc0bc5" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b7bfc0b1-942b-4ea3-8aa1-2cb57ba99eb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_f60c04f6-48e2-464b-857f-55f0e2006bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b7bfc0b1-942b-4ea3-8aa1-2cb57ba99eb9" xlink:to="loc_us-gaap_AccountsReceivableMember_f60c04f6-48e2-464b-857f-55f0e2006bb6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/VariableInterestEntitiesDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#VariableInterestEntitiesDetails"/>
  <link:definitionLink xlink:role="http://www.selectmedical.com/role/VariableInterestEntitiesDetails" xlink:type="extended" id="i5ce9a72ba4e749dfb4ef599f53c5dc32_VariableInterestEntitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_f4a5407f-8f4e-4413-a6a6-415f467bf5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_06514dff-9e5b-4eb0-a277-e4af7fa5a371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_f4a5407f-8f4e-4413-a6a6-415f467bf5b2" xlink:to="loc_us-gaap_Assets_06514dff-9e5b-4eb0-a277-e4af7fa5a371" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_251ae5cc-8dd7-4bc6-b727-549552b9c19e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_f4a5407f-8f4e-4413-a6a6-415f467bf5b2" xlink:to="loc_us-gaap_Liabilities_251ae5cc-8dd7-4bc6-b727-549552b9c19e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_5ad23a92-f855-4c4b-a095-31f2fc4d7181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_f4a5407f-8f4e-4413-a6a6-415f467bf5b2" xlink:to="loc_us-gaap_DueToAffiliateCurrent_5ad23a92-f855-4c4b-a095-31f2fc4d7181" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9dadf2ca-1c33-4525-a2a8-8085010bd010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_f4a5407f-8f4e-4413-a6a6-415f467bf5b2" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9dadf2ca-1c33-4525-a2a8-8085010bd010" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_e8e16c6f-c025-4dd5-8cd4-429fd5b18e57" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9dadf2ca-1c33-4525-a2a8-8085010bd010" xlink:to="loc_srt_ConsolidatedEntitiesAxis_e8e16c6f-c025-4dd5-8cd4-429fd5b18e57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_e8e16c6f-c025-4dd5-8cd4-429fd5b18e57_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_e8e16c6f-c025-4dd5-8cd4-429fd5b18e57" xlink:to="loc_srt_ConsolidatedEntitiesDomain_e8e16c6f-c025-4dd5-8cd4-429fd5b18e57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_a5bdd982-e936-4e7e-9de2-663e4b281f0b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_e8e16c6f-c025-4dd5-8cd4-429fd5b18e57" xlink:to="loc_srt_ConsolidatedEntitiesDomain_a5bdd982-e936-4e7e-9de2-663e4b281f0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_b5b0f95d-997b-4a82-9bc0-74da0dcf33b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_a5bdd982-e936-4e7e-9de2-663e4b281f0b" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_b5b0f95d-997b-4a82-9bc0-74da0dcf33b3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#IntangibleAssetsCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountofGoodwillDetails" xlink:type="extended" id="ie478582e60824c7282efb6238e0535c7_IntangibleAssetsCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_6b5b789b-1f33-4a97-a134-f3d85342d243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_0023e7c5-bf51-4a42-90c5-2ac1e98b0f85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_6b5b789b-1f33-4a97-a134-f3d85342d243" xlink:to="loc_us-gaap_GoodwillRollForward_0023e7c5-bf51-4a42-90c5-2ac1e98b0f85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cb935dae-3f86-4044-a5cd-43d389c0f3c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_0023e7c5-bf51-4a42-90c5-2ac1e98b0f85" xlink:to="loc_us-gaap_Goodwill_cb935dae-3f86-4044-a5cd-43d389c0f3c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_b932a2a5-4b9e-4fa9-acad-355cfae124a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_0023e7c5-bf51-4a42-90c5-2ac1e98b0f85" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_b932a2a5-4b9e-4fa9-acad-355cfae124a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_28985889-ee8d-463a-a7df-6155eb6bc974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_2941ac4e-9ffd-4de4-bdd9-cf2f6e20b6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_6b5b789b-1f33-4a97-a134-f3d85342d243" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_2941ac4e-9ffd-4de4-bdd9-cf2f6e20b6bd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c3c32041-5cf2-49b9-930a-551da840d5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2941ac4e-9ffd-4de4-bdd9-cf2f6e20b6bd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c3c32041-5cf2-49b9-930a-551da840d5ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c3c32041-5cf2-49b9-930a-551da840d5ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c3c32041-5cf2-49b9-930a-551da840d5ff" xlink:to="loc_us-gaap_SegmentDomain_c3c32041-5cf2-49b9-930a-551da840d5ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_33d496b1-f6ee-4c3e-97d4-706b5d4f3daf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c3c32041-5cf2-49b9-930a-551da840d5ff" xlink:to="loc_us-gaap_SegmentDomain_33d496b1-f6ee-4c3e-97d4-706b5d4f3daf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_CriticalIllnessRecoveryHospitalsMember_a3bf1f0e-a2c5-40b6-b10b-117085a199c2" xlink:href="sem-20210630.xsd#sem_CriticalIllnessRecoveryHospitalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_33d496b1-f6ee-4c3e-97d4-706b5d4f3daf" xlink:to="loc_sem_CriticalIllnessRecoveryHospitalsMember_a3bf1f0e-a2c5-40b6-b10b-117085a199c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_RehabilitationHospitalsMember_aa429a87-1989-4917-b452-73b8adee770f" xlink:href="sem-20210630.xsd#sem_RehabilitationHospitalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_33d496b1-f6ee-4c3e-97d4-706b5d4f3daf" xlink:to="loc_sem_RehabilitationHospitalsMember_aa429a87-1989-4917-b452-73b8adee770f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OutpatientRehabilitationMember_1f544eb0-7586-4422-861a-81987de76a4c" xlink:href="sem-20210630.xsd#sem_OutpatientRehabilitationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_33d496b1-f6ee-4c3e-97d4-706b5d4f3daf" xlink:to="loc_sem_OutpatientRehabilitationMember_1f544eb0-7586-4422-861a-81987de76a4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ConcentraMember_91b6960b-1a2f-45f6-b062-fce4ff5d199c" xlink:href="sem-20210630.xsd#sem_ConcentraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_33d496b1-f6ee-4c3e-97d4-706b5d4f3daf" xlink:to="loc_sem_ConcentraMember_91b6960b-1a2f-45f6-b062-fce4ff5d199c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails" xlink:type="extended" id="i73716b7675c6480285096feb5a3e98c5_IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_9234e85d-9c17-4ec0-80a4-6f1e869d5b17" xlink:href="sem-20210630.xsd#sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d72248dd-2faa-42b0-8aad-93812b59bbf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_9234e85d-9c17-4ec0-80a4-6f1e869d5b17" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d72248dd-2faa-42b0-8aad-93812b59bbf6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_77f146f7-acc0-4013-9ea4-56a45c1343b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_9234e85d-9c17-4ec0-80a4-6f1e869d5b17" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_77f146f7-acc0-4013-9ea4-56a45c1343b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a5160cc9-f517-4f31-99b8-7cece5f38e72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_9234e85d-9c17-4ec0-80a4-6f1e869d5b17" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a5160cc9-f517-4f31-99b8-7cece5f38e72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_412e41ab-a80d-4117-82e9-3f318675d6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_9234e85d-9c17-4ec0-80a4-6f1e869d5b17" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_412e41ab-a80d-4117-82e9-3f318675d6e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d2b0cabe-2b51-4bc7-8348-56af0f16966e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_9234e85d-9c17-4ec0-80a4-6f1e869d5b17" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d2b0cabe-2b51-4bc7-8348-56af0f16966e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_11705eec-a29b-4ff9-bc60-75097620325a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_9234e85d-9c17-4ec0-80a4-6f1e869d5b17" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_11705eec-a29b-4ff9-bc60-75097620325a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_ae02fc5c-c5aa-4eec-b1e8-a5235cc9d758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_9234e85d-9c17-4ec0-80a4-6f1e869d5b17" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_ae02fc5c-c5aa-4eec-b1e8-a5235cc9d758" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension_378eec7a-2156-4b1e-a92b-b4d89c78edb4" xlink:href="sem-20210630.xsd#sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_ae02fc5c-c5aa-4eec-b1e8-a5235cc9d758" xlink:to="loc_sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension_378eec7a-2156-4b1e-a92b-b4d89c78edb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3e8587a2-7464-4c67-92ff-6dec12719fed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_ae02fc5c-c5aa-4eec-b1e8-a5235cc9d758" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3e8587a2-7464-4c67-92ff-6dec12719fed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable_51fd2238-ffed-4ebb-8518-a710d58699d4" xlink:href="sem-20210630.xsd#sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_9234e85d-9c17-4ec0-80a4-6f1e869d5b17" xlink:to="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable_51fd2238-ffed-4ebb-8518-a710d58699d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f1454b24-79f9-44b7-8dac-e0d17ed50f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable_51fd2238-ffed-4ebb-8518-a710d58699d4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f1454b24-79f9-44b7-8dac-e0d17ed50f02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f1454b24-79f9-44b7-8dac-e0d17ed50f02_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f1454b24-79f9-44b7-8dac-e0d17ed50f02" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f1454b24-79f9-44b7-8dac-e0d17ed50f02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_efe50bbc-2dbf-4e0d-9ddc-8dfbb12407b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f1454b24-79f9-44b7-8dac-e0d17ed50f02" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_efe50bbc-2dbf-4e0d-9ddc-8dfbb12407b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_625cf060-0326-4214-9630-4ead9f40c616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_efe50bbc-2dbf-4e0d-9ddc-8dfbb12407b9" xlink:to="loc_us-gaap_TrademarksMember_625cf060-0326-4214-9630-4ead9f40c616" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_CertificatesOfNeedMember_847b146d-7da9-4489-9911-f349e22cce74" xlink:href="sem-20210630.xsd#sem_CertificatesOfNeedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_efe50bbc-2dbf-4e0d-9ddc-8dfbb12407b9" xlink:to="loc_sem_CertificatesOfNeedMember_847b146d-7da9-4489-9911-f349e22cce74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_AccreditationsMember_6e2722ca-e473-4aaf-bdfc-d08fec092c18" xlink:href="sem-20210630.xsd#sem_AccreditationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_efe50bbc-2dbf-4e0d-9ddc-8dfbb12407b9" xlink:to="loc_sem_AccreditationsMember_6e2722ca-e473-4aaf-bdfc-d08fec092c18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c48af90a-3bf4-4f3b-b341-4dcd07ad8d36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable_51fd2238-ffed-4ebb-8518-a710d58699d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c48af90a-3bf4-4f3b-b341-4dcd07ad8d36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c48af90a-3bf4-4f3b-b341-4dcd07ad8d36_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c48af90a-3bf4-4f3b-b341-4dcd07ad8d36" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c48af90a-3bf4-4f3b-b341-4dcd07ad8d36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_864b8a5f-6d57-4748-b918-2206b2a70a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c48af90a-3bf4-4f3b-b341-4dcd07ad8d36" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_864b8a5f-6d57-4748-b918-2206b2a70a1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_7b44a8ff-bae8-4cf4-a212-f2bb34e0a6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_864b8a5f-6d57-4748-b918-2206b2a70a1a" xlink:to="loc_us-gaap_TrademarksMember_7b44a8ff-bae8-4cf4-a212-f2bb34e0a6cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_0d60ceb9-8687-4e6f-8237-5d8dd559429a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_864b8a5f-6d57-4748-b918-2206b2a70a1a" xlink:to="loc_us-gaap_CustomerRelationshipsMember_0d60ceb9-8687-4e6f-8237-5d8dd559429a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_103d28de-2679-4e78-a14f-b8e608576bce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_864b8a5f-6d57-4748-b918-2206b2a70a1a" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_103d28de-2679-4e78-a14f-b8e608576bce" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails"/>
  <link:definitionLink xlink:role="http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails" xlink:type="extended" id="i448393f2d729454183bee86d4acfd72b_LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_cdcdee51-6dc4-484b-a592-e10ca1c3a972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_88605860-015f-404a-a755-f1fcd85bed35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cdcdee51-6dc4-484b-a592-e10ca1c3a972" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_88605860-015f-404a-a755-f1fcd85bed35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e26e3f95-2a51-4f21-8c70-b7d7a51f0fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cdcdee51-6dc4-484b-a592-e10ca1c3a972" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e26e3f95-2a51-4f21-8c70-b7d7a51f0fcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtGrossAndFinanceLeaseObligation_5034def7-f28f-4710-95a1-1486329bccdc" xlink:href="sem-20210630.xsd#sem_LongTermDebtGrossAndFinanceLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cdcdee51-6dc4-484b-a592-e10ca1c3a972" xlink:to="loc_sem_LongTermDebtGrossAndFinanceLeaseObligation_5034def7-f28f-4710-95a1-1486329bccdc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_1ee74f67-9e82-4d42-abed-595a11744936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cdcdee51-6dc4-484b-a592-e10ca1c3a972" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_1ee74f67-9e82-4d42-abed-595a11744936" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_9042fcd9-86ba-44ed-9f08-d11eea941982" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cdcdee51-6dc4-484b-a592-e10ca1c3a972" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_9042fcd9-86ba-44ed-9f08-d11eea941982" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6c80e17e-c365-40c3-bd82-03644e8a8524" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cdcdee51-6dc4-484b-a592-e10ca1c3a972" xlink:to="loc_us-gaap_LongTermDebt_6c80e17e-c365-40c3-bd82-03644e8a8524" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligation_15ef9fe1-2395-4e46-a0e6-3f00cd61f3b5" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cdcdee51-6dc4-484b-a592-e10ca1c3a972" xlink:to="loc_sem_LongTermDebtAndFinanceLeaseObligation_15ef9fe1-2395-4e46-a0e6-3f00cd61f3b5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_85f9f2de-20ed-4615-bc29-c1eee1a6114a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cdcdee51-6dc4-484b-a592-e10ca1c3a972" xlink:to="loc_us-gaap_DebtInstrumentFairValue_85f9f2de-20ed-4615-bc29-c1eee1a6114a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_39827e01-ba3e-4565-80e3-6a3afa3a15d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cdcdee51-6dc4-484b-a592-e10ca1c3a972" xlink:to="loc_us-gaap_DebtInstrumentTable_39827e01-ba3e-4565-80e3-6a3afa3a15d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_4aadfb18-e36c-421e-b9cc-3ca4d1ec2b36" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_39827e01-ba3e-4565-80e3-6a3afa3a15d4" xlink:to="loc_dei_LegalEntityAxis_4aadfb18-e36c-421e-b9cc-3ca4d1ec2b36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4aadfb18-e36c-421e-b9cc-3ca4d1ec2b36_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_4aadfb18-e36c-421e-b9cc-3ca4d1ec2b36" xlink:to="loc_dei_EntityDomain_4aadfb18-e36c-421e-b9cc-3ca4d1ec2b36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8b8ae086-da1b-4140-a170-0c633ab6e798" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_4aadfb18-e36c-421e-b9cc-3ca4d1ec2b36" xlink:to="loc_dei_EntityDomain_8b8ae086-da1b-4140-a170-0c633ab6e798" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_SelectMedicalCorporationMember_6ac2087e-32b6-4dce-9eaf-554fc4d51a95" xlink:href="sem-20210630.xsd#sem_SelectMedicalCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8b8ae086-da1b-4140-a170-0c633ab6e798" xlink:to="loc_sem_SelectMedicalCorporationMember_6ac2087e-32b6-4dce-9eaf-554fc4d51a95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1b757fb2-5271-46fe-9634-2ae4b0727f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_39827e01-ba3e-4565-80e3-6a3afa3a15d4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1b757fb2-5271-46fe-9634-2ae4b0727f81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1b757fb2-5271-46fe-9634-2ae4b0727f81_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1b757fb2-5271-46fe-9634-2ae4b0727f81" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1b757fb2-5271-46fe-9634-2ae4b0727f81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2b583c64-411c-4d5e-bc49-435da8641b91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1b757fb2-5271-46fe-9634-2ae4b0727f81" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2b583c64-411c-4d5e-bc49-435da8641b91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_66b47d55-999a-4119-8417-140362164a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2b583c64-411c-4d5e-bc49-435da8641b91" xlink:to="loc_us-gaap_SeniorNotesMember_66b47d55-999a-4119-8417-140362164a7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_efdf378c-520a-4965-b946-e810d8ab5c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2b583c64-411c-4d5e-bc49-435da8641b91" xlink:to="loc_us-gaap_SecuredDebtMember_efdf378c-520a-4965-b946-e810d8ab5c12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_b9aeb539-b3ab-47c4-8935-b9f8df34e79c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2b583c64-411c-4d5e-bc49-435da8641b91" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_b9aeb539-b3ab-47c4-8935-b9f8df34e79c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" xlink:type="extended" id="ia62b6d8dd6cb47bcb1bbdb02e3b98546_LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6be7342b-d16e-4d2e-a85c-b5379d87990c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6be7342b-d16e-4d2e-a85c-b5379d87990c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0ce6c0c5-674d-49ec-b7b1-c018f5bd280f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0ce6c0c5-674d-49ec-b7b1-c018f5bd280f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear_0aae13fa-d30c-45ec-933c-ed106c81b11c" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear_0aae13fa-d30c-45ec-933c-ed106c81b11c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2005752b-1f8b-497c-94e6-22b6b9dadeed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2005752b-1f8b-497c-94e6-22b6b9dadeed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e0450cee-6a41-4c27-8c1b-71150bfa6a43" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e0450cee-6a41-4c27-8c1b-71150bfa6a43" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_8633dfa9-8e9e-4f84-8c0f-cd2015ca6a22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_8633dfa9-8e9e-4f84-8c0f-cd2015ca6a22" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo_3e31bf9e-048e-453f-8efe-9d2520a082dc" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo_3e31bf9e-048e-453f-8efe-9d2520a082dc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_548e16cc-03b5-46d7-8340-0a09e8f9dc19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_548e16cc-03b5-46d7-8340-0a09e8f9dc19" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree_4ac68856-0ed0-4c26-910a-65ad8d72d7cf" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree_4ac68856-0ed0-4c26-910a-65ad8d72d7cf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_2a23e688-c526-4980-ba6f-28cb273d255e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_2a23e688-c526-4980-ba6f-28cb273d255e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour_08eaae3a-3afd-49a3-8ec0-7e872cb97235" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour_08eaae3a-3afd-49a3-8ec0-7e872cb97235" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour_d19a4667-d8e2-4750-8d67-a5275b6c1553" xlink:href="sem-20210630.xsd#sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour_d19a4667-d8e2-4750-8d67-a5275b6c1553" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour_42c2d17b-00e7-4269-bee0-30537039b325" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour_42c2d17b-00e7-4269-bee0-30537039b325" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_8430ce26-35bf-4b0f-a736-717523f7bde0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_8430ce26-35bf-4b0f-a736-717523f7bde0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtGrossAndFinanceLeaseObligation_c106d43c-53a3-411b-8b41-9a0acb6ea89e" xlink:href="sem-20210630.xsd#sem_LongTermDebtGrossAndFinanceLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_sem_LongTermDebtGrossAndFinanceLeaseObligation_c106d43c-53a3-411b-8b41-9a0acb6ea89e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_eaf5ed2d-40e0-4096-88b2-c1a555a3da1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_us-gaap_DebtInstrumentTable_eaf5ed2d-40e0-4096-88b2-c1a555a3da1c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_fc0907c1-59a3-4f0a-9e20-8033efee7bad" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eaf5ed2d-40e0-4096-88b2-c1a555a3da1c" xlink:to="loc_dei_LegalEntityAxis_fc0907c1-59a3-4f0a-9e20-8033efee7bad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fc0907c1-59a3-4f0a-9e20-8033efee7bad_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_fc0907c1-59a3-4f0a-9e20-8033efee7bad" xlink:to="loc_dei_EntityDomain_fc0907c1-59a3-4f0a-9e20-8033efee7bad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0e0cca66-eeb6-43b0-9e89-441b87d7006a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_fc0907c1-59a3-4f0a-9e20-8033efee7bad" xlink:to="loc_dei_EntityDomain_0e0cca66-eeb6-43b0-9e89-441b87d7006a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_SelectMedicalCorporationMember_68c3bb2f-f8eb-4ec0-92ab-8244691ea6f7" xlink:href="sem-20210630.xsd#sem_SelectMedicalCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_0e0cca66-eeb6-43b0-9e89-441b87d7006a" xlink:to="loc_sem_SelectMedicalCorporationMember_68c3bb2f-f8eb-4ec0-92ab-8244691ea6f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d547ff34-1d4e-45ed-a27d-8572475c05ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_eaf5ed2d-40e0-4096-88b2-c1a555a3da1c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d547ff34-1d4e-45ed-a27d-8572475c05ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d547ff34-1d4e-45ed-a27d-8572475c05ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d547ff34-1d4e-45ed-a27d-8572475c05ba" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d547ff34-1d4e-45ed-a27d-8572475c05ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a851b04a-7c42-4cc2-b8b4-1ffab885b31d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d547ff34-1d4e-45ed-a27d-8572475c05ba" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a851b04a-7c42-4cc2-b8b4-1ffab885b31d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_bd23a39a-cd88-46f9-83e0-66a29c74f22d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a851b04a-7c42-4cc2-b8b4-1ffab885b31d" xlink:to="loc_us-gaap_SeniorNotesMember_bd23a39a-cd88-46f9-83e0-66a29c74f22d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_d97590a8-6c8b-4e29-8653-773979c0e5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a851b04a-7c42-4cc2-b8b4-1ffab885b31d" xlink:to="loc_us-gaap_SecuredDebtMember_d97590a8-6c8b-4e29-8653-773979c0e5a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_805907e6-5621-4f46-9b61-eea2b0b20526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a851b04a-7c42-4cc2-b8b4-1ffab885b31d" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_805907e6-5621-4f46-9b61-eea2b0b20526" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#LongTermDebtandNotesPayableNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails" xlink:type="extended" id="i34b3b873105f4a81a6f399e43cfd1d81_LongTermDebtandNotesPayableNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_da003f3b-0b45-4bf1-a8cc-8209f458d5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_160c2b78-0663-48a3-b358-1a1cc9859805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_da003f3b-0b45-4bf1-a8cc-8209f458d5ab" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_160c2b78-0663-48a3-b358-1a1cc9859805" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_9fec0b65-644d-45fd-b90c-b1b4d25402a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_da003f3b-0b45-4bf1-a8cc-8209f458d5ab" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_9fec0b65-644d-45fd-b90c-b1b4d25402a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_3150b931-56ec-4a62-abed-b8ea9ebb3bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_da003f3b-0b45-4bf1-a8cc-8209f458d5ab" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_3150b931-56ec-4a62-abed-b8ea9ebb3bdb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9acd3ed6-f222-47e0-98d7-50e15c5d7e45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3150b931-56ec-4a62-abed-b8ea9ebb3bdb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9acd3ed6-f222-47e0-98d7-50e15c5d7e45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9acd3ed6-f222-47e0-98d7-50e15c5d7e45_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9acd3ed6-f222-47e0-98d7-50e15c5d7e45" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9acd3ed6-f222-47e0-98d7-50e15c5d7e45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_da906e4a-d683-4aca-9fa9-89a8f7fb2d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9acd3ed6-f222-47e0-98d7-50e15c5d7e45" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_da906e4a-d683-4aca-9fa9-89a8f7fb2d3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_4705e738-ce0c-423b-ba9e-838407aaa9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_da906e4a-d683-4aca-9fa9-89a8f7fb2d3f" xlink:to="loc_us-gaap_LineOfCreditMember_4705e738-ce0c-423b-ba9e-838407aaa9cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_15ad02d5-0be0-40df-9449-240a8f0ef248" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3150b931-56ec-4a62-abed-b8ea9ebb3bdb" xlink:to="loc_dei_LegalEntityAxis_15ad02d5-0be0-40df-9449-240a8f0ef248" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_15ad02d5-0be0-40df-9449-240a8f0ef248_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_15ad02d5-0be0-40df-9449-240a8f0ef248" xlink:to="loc_dei_EntityDomain_15ad02d5-0be0-40df-9449-240a8f0ef248_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_65d9e506-fff3-4ddb-bb4f-7760f347502a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_15ad02d5-0be0-40df-9449-240a8f0ef248" xlink:to="loc_dei_EntityDomain_65d9e506-fff3-4ddb-bb4f-7760f347502a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_SelectMedicalCorporationMember_43c5fce3-eeae-421f-84c6-c0b3ca5eabf8" xlink:href="sem-20210630.xsd#sem_SelectMedicalCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_65d9e506-fff3-4ddb-bb4f-7760f347502a" xlink:to="loc_sem_SelectMedicalCorporationMember_43c5fce3-eeae-421f-84c6-c0b3ca5eabf8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ConcentraMember_98fa0d12-4739-4338-b706-cf6e3115f1a4" xlink:href="sem-20210630.xsd#sem_ConcentraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_65d9e506-fff3-4ddb-bb4f-7760f347502a" xlink:to="loc_sem_ConcentraMember_98fa0d12-4739-4338-b706-cf6e3115f1a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2f922cc0-c92e-4f5c-b1ed-7f3307606742" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3150b931-56ec-4a62-abed-b8ea9ebb3bdb" xlink:to="loc_us-gaap_CreditFacilityAxis_2f922cc0-c92e-4f5c-b1ed-7f3307606742" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2f922cc0-c92e-4f5c-b1ed-7f3307606742_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_2f922cc0-c92e-4f5c-b1ed-7f3307606742" xlink:to="loc_us-gaap_CreditFacilityDomain_2f922cc0-c92e-4f5c-b1ed-7f3307606742_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2aea434b-5eeb-47a4-9bc3-9ea997f11e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_2f922cc0-c92e-4f5c-b1ed-7f3307606742" xlink:to="loc_us-gaap_CreditFacilityDomain_2aea434b-5eeb-47a4-9bc3-9ea997f11e0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c545fb3f-6b96-4d3f-b520-ac4b18242980" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2aea434b-5eeb-47a4-9bc3-9ea997f11e0d" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c545fb3f-6b96-4d3f-b520-ac4b18242980" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_7a5333c2-518f-454d-8212-0e8500de9a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2aea434b-5eeb-47a4-9bc3-9ea997f11e0d" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_7a5333c2-518f-454d-8212-0e8500de9a2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9b8f1a39-655b-49b9-968b-e4c2aa780a28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3150b931-56ec-4a62-abed-b8ea9ebb3bdb" xlink:to="loc_us-gaap_DebtInstrumentAxis_9b8f1a39-655b-49b9-968b-e4c2aa780a28" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9b8f1a39-655b-49b9-968b-e4c2aa780a28_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9b8f1a39-655b-49b9-968b-e4c2aa780a28" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9b8f1a39-655b-49b9-968b-e4c2aa780a28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9b1c5a3a-9be5-41a8-8606-1b19e5eaa11a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9b8f1a39-655b-49b9-968b-e4c2aa780a28" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9b1c5a3a-9be5-41a8-8606-1b19e5eaa11a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FirstLienCreditAgreementMember_14a71695-969d-4cf6-96f9-18651cb6e61a" xlink:href="sem-20210630.xsd#sem_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9b1c5a3a-9be5-41a8-8606-1b19e5eaa11a" xlink:to="loc_sem_FirstLienCreditAgreementMember_14a71695-969d-4cf6-96f9-18651cb6e61a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/InterestRateCapNarrativeDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#InterestRateCapNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.selectmedical.com/role/InterestRateCapNarrativeDetails" xlink:type="extended" id="ie76104e7e84f4dfd822c5600595961ba_InterestRateCapNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5bb8e388-71c0-4367-9a3c-67e9f1e2ef02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCapInterestRate_934d8f58-4898-4eb9-9add-2c6601afe7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeCapInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5bb8e388-71c0-4367-9a3c-67e9f1e2ef02" xlink:to="loc_us-gaap_DerivativeCapInterestRate_934d8f58-4898-4eb9-9add-2c6601afe7ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_0dd3bf3f-f5eb-444e-b1a8-e3f5173f3cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5bb8e388-71c0-4367-9a3c-67e9f1e2ef02" xlink:to="loc_us-gaap_DerivativeNotionalAmount_0dd3bf3f-f5eb-444e-b1a8-e3f5173f3cd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_DerivativeCostOfHedgeAnnualPremiumPercentage_666f7160-ba7a-45c1-905b-6adaabe05089" xlink:href="sem-20210630.xsd#sem_DerivativeCostOfHedgeAnnualPremiumPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5bb8e388-71c0-4367-9a3c-67e9f1e2ef02" xlink:to="loc_sem_DerivativeCostOfHedgeAnnualPremiumPercentage_666f7160-ba7a-45c1-905b-6adaabe05089" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_722e41ff-6257-4fd1-a0d0-a54c30b2726b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5bb8e388-71c0-4367-9a3c-67e9f1e2ef02" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_722e41ff-6257-4fd1-a0d0-a54c30b2726b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_832aad8b-66d0-4150-a837-a9bb694c94b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_5bb8e388-71c0-4367-9a3c-67e9f1e2ef02" xlink:to="loc_us-gaap_DerivativeTable_832aad8b-66d0-4150-a837-a9bb694c94b9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8406fa26-29bd-4b8a-9622-6f7e089d736d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_832aad8b-66d0-4150-a837-a9bb694c94b9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8406fa26-29bd-4b8a-9622-6f7e089d736d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8406fa26-29bd-4b8a-9622-6f7e089d736d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8406fa26-29bd-4b8a-9622-6f7e089d736d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8406fa26-29bd-4b8a-9622-6f7e089d736d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4c248762-0bbc-4618-bd21-8106fb0ce53f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8406fa26-29bd-4b8a-9622-6f7e089d736d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4c248762-0bbc-4618-bd21-8106fb0ce53f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_4b64edb1-f04c-49ff-a390-f7672a969d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4c248762-0bbc-4618-bd21-8106fb0ce53f" xlink:to="loc_us-gaap_InterestRateCapMember_4b64edb1-f04c-49ff-a390-f7672a969d3a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.selectmedical.com/role/InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" id="ifcb3b9712990407da14d13097379588e_InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d725b98b-0b12-4aee-8fb2-f14571a1df08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_524d2a15-9ec7-4249-b724-64459463ba5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d725b98b-0b12-4aee-8fb2-f14571a1df08" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_524d2a15-9ec7-4249-b724-64459463ba5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_163ad517-e6e1-4860-843c-4000e76b8f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_524d2a15-9ec7-4249-b724-64459463ba5e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_163ad517-e6e1-4860-843c-4000e76b8f64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_d197a86d-83a8-404a-981b-64893df77a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_524d2a15-9ec7-4249-b724-64459463ba5e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_d197a86d-83a8-404a-981b-64893df77a04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_0128fc19-590c-4d92-b3c5-f4ca1550e2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_524d2a15-9ec7-4249-b724-64459463ba5e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_0128fc19-590c-4d92-b3c5-f4ca1550e2ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b328fb31-8b22-4e62-a280-5fbb86b69a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_524d2a15-9ec7-4249-b724-64459463ba5e" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b328fb31-8b22-4e62-a280-5fbb86b69a4f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9a7283e0-d0a5-461e-89b5-891a89da960d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edbebe3d-192f-408e-95f9-dfebc6ae00ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d725b98b-0b12-4aee-8fb2-f14571a1df08" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edbebe3d-192f-408e-95f9-dfebc6ae00ec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a0d635cd-2a30-48d2-87d9-7c6fcee58d76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edbebe3d-192f-408e-95f9-dfebc6ae00ec" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a0d635cd-2a30-48d2-87d9-7c6fcee58d76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a0d635cd-2a30-48d2-87d9-7c6fcee58d76_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a0d635cd-2a30-48d2-87d9-7c6fcee58d76" xlink:to="loc_us-gaap_EquityComponentDomain_a0d635cd-2a30-48d2-87d9-7c6fcee58d76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d90cdf41-dfa1-4683-83fa-23ce2c917411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a0d635cd-2a30-48d2-87d9-7c6fcee58d76" xlink:to="loc_us-gaap_EquityComponentDomain_d90cdf41-dfa1-4683-83fa-23ce2c917411" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_29fface4-9118-40d9-91a3-3f9222b96c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d90cdf41-dfa1-4683-83fa-23ce2c917411" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_29fface4-9118-40d9-91a3-3f9222b96c45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_29812a3c-6d88-4d8b-8942-cafb4bf62373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edbebe3d-192f-408e-95f9-dfebc6ae00ec" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_29812a3c-6d88-4d8b-8942-cafb4bf62373" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_29812a3c-6d88-4d8b-8942-cafb4bf62373_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_29812a3c-6d88-4d8b-8942-cafb4bf62373" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_29812a3c-6d88-4d8b-8942-cafb4bf62373_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6825d909-d157-4748-89f5-0fd6c8ec790d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_29812a3c-6d88-4d8b-8942-cafb4bf62373" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6825d909-d157-4748-89f5-0fd6c8ec790d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_849f47de-db40-415d-a638-2a89b83f0d60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6825d909-d157-4748-89f5-0fd6c8ec790d" xlink:to="loc_us-gaap_InterestRateCapMember_849f47de-db40-415d-a638-2a89b83f0d60" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails"/>
  <link:definitionLink xlink:role="http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails" xlink:type="extended" id="i732353adca3a42e985c5058c1cff1044_FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b7589f1-dc8e-4081-88f4-683437ba57ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_aa113939-689a-4368-a0af-74875d1daebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b7589f1-dc8e-4081-88f4-683437ba57ba" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_aa113939-689a-4368-a0af-74875d1daebe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_36a64ae2-b69a-4a2b-9621-53954abbe9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b7589f1-dc8e-4081-88f4-683437ba57ba" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_36a64ae2-b69a-4a2b-9621-53954abbe9ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_c2d925de-b791-43ad-ac84-a8b06c2a05d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b7589f1-dc8e-4081-88f4-683437ba57ba" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_c2d925de-b791-43ad-ac84-a8b06c2a05d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a938c44f-eac2-409e-8380-c170e2f36173" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b7589f1-dc8e-4081-88f4-683437ba57ba" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a938c44f-eac2-409e-8380-c170e2f36173" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c26d6187-f13d-478f-aa6b-72ea7282efde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a938c44f-eac2-409e-8380-c170e2f36173" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c26d6187-f13d-478f-aa6b-72ea7282efde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c26d6187-f13d-478f-aa6b-72ea7282efde_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c26d6187-f13d-478f-aa6b-72ea7282efde" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c26d6187-f13d-478f-aa6b-72ea7282efde_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cf398411-349e-4858-bbf6-ce683d2ff704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c26d6187-f13d-478f-aa6b-72ea7282efde" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cf398411-349e-4858-bbf6-ce683d2ff704" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_953e0c98-20e5-4198-98b6-10f2e2e0fc55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cf398411-349e-4858-bbf6-ce683d2ff704" xlink:to="loc_us-gaap_InterestRateCapMember_953e0c98-20e5-4198-98b6-10f2e2e0fc55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7a0effe3-b856-4542-9b8a-6733d93b52b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a938c44f-eac2-409e-8380-c170e2f36173" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7a0effe3-b856-4542-9b8a-6733d93b52b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7a0effe3-b856-4542-9b8a-6733d93b52b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7a0effe3-b856-4542-9b8a-6733d93b52b2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7a0effe3-b856-4542-9b8a-6733d93b52b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_16330540-52b8-4141-b1b1-2dc7987fa468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7a0effe3-b856-4542-9b8a-6733d93b52b2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_16330540-52b8-4141-b1b1-2dc7987fa468" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_deb23c92-9b48-418e-ab57-375ca0783626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_16330540-52b8-4141-b1b1-2dc7987fa468" xlink:to="loc_us-gaap_OtherAssetsMember_deb23c92-9b48-418e-ab57-375ca0783626" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OtherAccruedLiabilitiesCurrentMember_5f975180-fbeb-49f4-8882-158056afbc07" xlink:href="sem-20210630.xsd#sem_OtherAccruedLiabilitiesCurrentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_16330540-52b8-4141-b1b1-2dc7987fa468" xlink:to="loc_sem_OtherAccruedLiabilitiesCurrentMember_5f975180-fbeb-49f4-8882-158056afbc07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_80f0d8f4-a782-441a-bb19-a80acc47072a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_16330540-52b8-4141-b1b1-2dc7987fa468" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_80f0d8f4-a782-441a-bb19-a80acc47072a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_15623943-947d-4855-a879-109805b57895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a938c44f-eac2-409e-8380-c170e2f36173" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_15623943-947d-4855-a879-109805b57895" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_15623943-947d-4855-a879-109805b57895_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_15623943-947d-4855-a879-109805b57895" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_15623943-947d-4855-a879-109805b57895_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8a271ca4-3693-4d0b-86f7-7c09f241f6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_15623943-947d-4855-a879-109805b57895" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8a271ca4-3693-4d0b-86f7-7c09f241f6cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ce789831-2229-42d7-ae8b-cc2938bac0e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8a271ca4-3693-4d0b-86f7-7c09f241f6cc" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ce789831-2229-42d7-ae8b-cc2938bac0e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a6f68a0a-1468-4d70-a5d3-f982e7b42ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a938c44f-eac2-409e-8380-c170e2f36173" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a6f68a0a-1468-4d70-a5d3-f982e7b42ef8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_a6f68a0a-1468-4d70-a5d3-f982e7b42ef8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a6f68a0a-1468-4d70-a5d3-f982e7b42ef8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_a6f68a0a-1468-4d70-a5d3-f982e7b42ef8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f2130517-b671-4a4d-9756-0438b690adb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a6f68a0a-1468-4d70-a5d3-f982e7b42ef8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f2130517-b671-4a4d-9756-0438b690adb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_779b9f2c-518a-4b28-8f11-907372153897" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f2130517-b671-4a4d-9756-0438b690adb1" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_779b9f2c-518a-4b28-8f11-907372153897" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails" xlink:type="extended" id="i647f78fcf4174f21a969206097272253_FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_aac3c930-2957-4c28-b98f-8cbe691a231e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a61bba30-c5fe-42c4-9150-aa4626252581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_aac3c930-2957-4c28-b98f-8cbe691a231e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a61bba30-c5fe-42c4-9150-aa4626252581" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ad26fcf3-a1f5-4086-b67e-ebb5cd578764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_aac3c930-2957-4c28-b98f-8cbe691a231e" xlink:to="loc_us-gaap_LongTermDebt_ad26fcf3-a1f5-4086-b67e-ebb5cd578764" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_2d6ea434-2a97-4529-a777-f866705465c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_aac3c930-2957-4c28-b98f-8cbe691a231e" xlink:to="loc_us-gaap_DebtInstrumentFairValue_2d6ea434-2a97-4529-a777-f866705465c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7bf7d6a0-6cfd-4bd5-a2ae-f0bb4e5c6995" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_aac3c930-2957-4c28-b98f-8cbe691a231e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7bf7d6a0-6cfd-4bd5-a2ae-f0bb4e5c6995" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3a77e280-e831-4dfa-862a-4827653d76f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7bf7d6a0-6cfd-4bd5-a2ae-f0bb4e5c6995" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3a77e280-e831-4dfa-862a-4827653d76f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3a77e280-e831-4dfa-862a-4827653d76f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3a77e280-e831-4dfa-862a-4827653d76f6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3a77e280-e831-4dfa-862a-4827653d76f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_094f6070-44a4-4887-afe0-819a0eab8ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3a77e280-e831-4dfa-862a-4827653d76f6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_094f6070-44a4-4887-afe0-819a0eab8ab2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_02fe43b8-ceb2-4a86-a2fb-92ca4d164bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_094f6070-44a4-4887-afe0-819a0eab8ab2" xlink:to="loc_us-gaap_SeniorNotesMember_02fe43b8-ceb2-4a86-a2fb-92ca4d164bbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_dfc450b3-a41f-4251-9dce-3dd7380fda35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_094f6070-44a4-4887-afe0-819a0eab8ab2" xlink:to="loc_us-gaap_SecuredDebtMember_dfc450b3-a41f-4251-9dce-3dd7380fda35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e2df10bb-caa9-4a55-9b27-c88b5f14c360" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7bf7d6a0-6cfd-4bd5-a2ae-f0bb4e5c6995" xlink:to="loc_dei_LegalEntityAxis_e2df10bb-caa9-4a55-9b27-c88b5f14c360" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e2df10bb-caa9-4a55-9b27-c88b5f14c360_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_e2df10bb-caa9-4a55-9b27-c88b5f14c360" xlink:to="loc_dei_EntityDomain_e2df10bb-caa9-4a55-9b27-c88b5f14c360_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_287f8ab5-35b8-4817-abad-6fd23d69d204" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_e2df10bb-caa9-4a55-9b27-c88b5f14c360" xlink:to="loc_dei_EntityDomain_287f8ab5-35b8-4817-abad-6fd23d69d204" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_SelectMedicalCorporationMember_d0d6ebf5-30b8-438a-9110-912793dedece" xlink:href="sem-20210630.xsd#sem_SelectMedicalCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_287f8ab5-35b8-4817-abad-6fd23d69d204" xlink:to="loc_sem_SelectMedicalCorporationMember_d0d6ebf5-30b8-438a-9110-912793dedece" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ef7c2f69-7498-4507-93c5-96af45cbe84c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7bf7d6a0-6cfd-4bd5-a2ae-f0bb4e5c6995" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ef7c2f69-7498-4507-93c5-96af45cbe84c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ef7c2f69-7498-4507-93c5-96af45cbe84c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ef7c2f69-7498-4507-93c5-96af45cbe84c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ef7c2f69-7498-4507-93c5-96af45cbe84c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e95bdab-724c-4acd-9d35-d28c1bc22fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ef7c2f69-7498-4507-93c5-96af45cbe84c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e95bdab-724c-4acd-9d35-d28c1bc22fd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a0ef54ae-5fe8-46a3-a0d6-a10fec0bdeb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e95bdab-724c-4acd-9d35-d28c1bc22fd2" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a0ef54ae-5fe8-46a3-a0d6-a10fec0bdeb2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#SegmentInformationSelectedFinancialDataDetails"/>
  <link:definitionLink xlink:role="http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails" xlink:type="extended" id="ib970179583c842039ca54c72d557b911_SegmentInformationSelectedFinancialDataDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6ae55570-d3f4-4be5-b3c0-17589e68cc25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d93f4c26-af85-4bea-ac35-1c9de8a3702c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ae55570-d3f4-4be5-b3c0-17589e68cc25" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d93f4c26-af85-4bea-ac35-1c9de8a3702c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_AdjustedEbitda_2c5c4b44-9b01-457d-8620-3c5aa12499d8" xlink:href="sem-20210630.xsd#sem_AdjustedEbitda"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ae55570-d3f4-4be5-b3c0-17589e68cc25" xlink:to="loc_sem_AdjustedEbitda_2c5c4b44-9b01-457d-8620-3c5aa12499d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5829306b-7c7a-4124-b21c-feeeb6b5f788" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ae55570-d3f4-4be5-b3c0-17589e68cc25" xlink:to="loc_us-gaap_Assets_5829306b-7c7a-4124-b21c-feeeb6b5f788" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_e1c042d7-74f0-4847-8047-6c774cf49052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ae55570-d3f4-4be5-b3c0-17589e68cc25" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_e1c042d7-74f0-4847-8047-6c774cf49052" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8569eae4-33d9-4767-8816-767121984eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ae55570-d3f4-4be5-b3c0-17589e68cc25" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8569eae4-33d9-4767-8816-767121984eb4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_9c5ec8c5-ef54-4979-bfe4-d765a8385505" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8569eae4-33d9-4767-8816-767121984eb4" xlink:to="loc_srt_ConsolidationItemsAxis_9c5ec8c5-ef54-4979-bfe4-d765a8385505" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9c5ec8c5-ef54-4979-bfe4-d765a8385505_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_9c5ec8c5-ef54-4979-bfe4-d765a8385505" xlink:to="loc_srt_ConsolidationItemsDomain_9c5ec8c5-ef54-4979-bfe4-d765a8385505_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b92510fe-c3e8-4e2c-8af0-3b2db327c4e7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_9c5ec8c5-ef54-4979-bfe4-d765a8385505" xlink:to="loc_srt_ConsolidationItemsDomain_b92510fe-c3e8-4e2c-8af0-3b2db327c4e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_bb496afa-e17b-4117-b6e6-2a1b5763913a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b92510fe-c3e8-4e2c-8af0-3b2db327c4e7" xlink:to="loc_us-gaap_OperatingSegmentsMember_bb496afa-e17b-4117-b6e6-2a1b5763913a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_4a5151ff-d5e9-4bcc-9190-99bcfd6f5d89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b92510fe-c3e8-4e2c-8af0-3b2db327c4e7" xlink:to="loc_us-gaap_CorporateNonSegmentMember_4a5151ff-d5e9-4bcc-9190-99bcfd6f5d89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3733885b-23fe-4a3b-9605-1c6433d0447a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8569eae4-33d9-4767-8816-767121984eb4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3733885b-23fe-4a3b-9605-1c6433d0447a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3733885b-23fe-4a3b-9605-1c6433d0447a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3733885b-23fe-4a3b-9605-1c6433d0447a" xlink:to="loc_us-gaap_SegmentDomain_3733885b-23fe-4a3b-9605-1c6433d0447a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f7fa8dde-50c1-4448-8d85-909eb7290a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3733885b-23fe-4a3b-9605-1c6433d0447a" xlink:to="loc_us-gaap_SegmentDomain_f7fa8dde-50c1-4448-8d85-909eb7290a68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_CriticalIllnessRecoveryHospitalsMember_b3c1bb46-4bbf-4eec-a250-6aeb6165e3c9" xlink:href="sem-20210630.xsd#sem_CriticalIllnessRecoveryHospitalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f7fa8dde-50c1-4448-8d85-909eb7290a68" xlink:to="loc_sem_CriticalIllnessRecoveryHospitalsMember_b3c1bb46-4bbf-4eec-a250-6aeb6165e3c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_RehabilitationHospitalsMember_49a4382f-04a0-48db-b859-281550531c3a" xlink:href="sem-20210630.xsd#sem_RehabilitationHospitalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f7fa8dde-50c1-4448-8d85-909eb7290a68" xlink:to="loc_sem_RehabilitationHospitalsMember_49a4382f-04a0-48db-b859-281550531c3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OutpatientRehabilitationMember_3147514c-2ea4-4007-9379-10202870f491" xlink:href="sem-20210630.xsd#sem_OutpatientRehabilitationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f7fa8dde-50c1-4448-8d85-909eb7290a68" xlink:to="loc_sem_OutpatientRehabilitationMember_3147514c-2ea4-4007-9379-10202870f491" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ConcentraMember_c0d6910f-0c0a-4a71-a81f-17c04cf23c85" xlink:href="sem-20210630.xsd#sem_ConcentraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f7fa8dde-50c1-4448-8d85-909eb7290a68" xlink:to="loc_sem_ConcentraMember_c0d6910f-0c0a-4a71-a81f-17c04cf23c85" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails" xlink:type="extended" id="ia574c014cb2f47f593a40b78189bb29b_SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_AdjustedEbitda_b4555bea-6377-4446-b179-c3a9c1a93280" xlink:href="sem-20210630.xsd#sem_AdjustedEbitda"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:to="loc_sem_AdjustedEbitda_b4555bea-6377-4446-b179-c3a9c1a93280" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_2ef8e648-df45-462e-8a55-848048143db1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:to="loc_us-gaap_DepreciationAndAmortization_2ef8e648-df45-462e-8a55-848048143db1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_74cfeb5a-ac80-4529-8e1d-a5f5416be1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_74cfeb5a-ac80-4529-8e1d-a5f5416be1b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ffe3fb34-8407-44da-8de8-80062e82374f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:to="loc_us-gaap_OperatingIncomeLoss_ffe3fb34-8407-44da-8de8-80062e82374f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_84af2cf6-95c7-46f5-9ebe-eb36ac37f1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_84af2cf6-95c7-46f5-9ebe-eb36ac37f1b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_f6a7a557-a7a1-41be-8879-059c19cfb49d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_f6a7a557-a7a1-41be-8879-059c19cfb49d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementInterest_a77816d5-3a6e-47b4-9a29-f463d7f8a8da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:to="loc_us-gaap_LitigationSettlementInterest_a77816d5-3a6e-47b4-9a29-f463d7f8a8da" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8bf748a1-0b7b-41f7-881b-9b97f55cdc83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:to="loc_us-gaap_InterestExpense_8bf748a1-0b7b-41f7-881b-9b97f55cdc83" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_60022bff-aa9a-4bc5-9b69-2e14c7dba1de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_60022bff-aa9a-4bc5-9b69-2e14c7dba1de" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3122ac47-07ee-4baa-9548-d99e95acb815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3122ac47-07ee-4baa-9548-d99e95acb815" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_ab9112ad-35d5-4f53-bc94-77a3ad3160bb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3122ac47-07ee-4baa-9548-d99e95acb815" xlink:to="loc_srt_ConsolidationItemsAxis_ab9112ad-35d5-4f53-bc94-77a3ad3160bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ab9112ad-35d5-4f53-bc94-77a3ad3160bb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_ab9112ad-35d5-4f53-bc94-77a3ad3160bb" xlink:to="loc_srt_ConsolidationItemsDomain_ab9112ad-35d5-4f53-bc94-77a3ad3160bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2c33207b-8f42-4bb3-9534-5b563cbe29a7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_ab9112ad-35d5-4f53-bc94-77a3ad3160bb" xlink:to="loc_srt_ConsolidationItemsDomain_2c33207b-8f42-4bb3-9534-5b563cbe29a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_434a623e-71e9-4616-b221-70486ff9518f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_2c33207b-8f42-4bb3-9534-5b563cbe29a7" xlink:to="loc_us-gaap_OperatingSegmentsMember_434a623e-71e9-4616-b221-70486ff9518f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_4e55220f-f98b-4563-8b03-dd7ea87bae13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_2c33207b-8f42-4bb3-9534-5b563cbe29a7" xlink:to="loc_us-gaap_CorporateNonSegmentMember_4e55220f-f98b-4563-8b03-dd7ea87bae13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bbe6fa92-3801-4fa4-a93f-302d6a5c9972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3122ac47-07ee-4baa-9548-d99e95acb815" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bbe6fa92-3801-4fa4-a93f-302d6a5c9972" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bbe6fa92-3801-4fa4-a93f-302d6a5c9972_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bbe6fa92-3801-4fa4-a93f-302d6a5c9972" xlink:to="loc_us-gaap_SegmentDomain_bbe6fa92-3801-4fa4-a93f-302d6a5c9972_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2af51e36-dbc3-4344-b11a-83e0c260c55b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bbe6fa92-3801-4fa4-a93f-302d6a5c9972" xlink:to="loc_us-gaap_SegmentDomain_2af51e36-dbc3-4344-b11a-83e0c260c55b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_CriticalIllnessRecoveryHospitalsMember_6f885682-c79e-42e8-bf8a-56a40f3883d2" xlink:href="sem-20210630.xsd#sem_CriticalIllnessRecoveryHospitalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2af51e36-dbc3-4344-b11a-83e0c260c55b" xlink:to="loc_sem_CriticalIllnessRecoveryHospitalsMember_6f885682-c79e-42e8-bf8a-56a40f3883d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_RehabilitationHospitalsMember_8c454264-5b28-4b2a-bc0d-25529222f188" xlink:href="sem-20210630.xsd#sem_RehabilitationHospitalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2af51e36-dbc3-4344-b11a-83e0c260c55b" xlink:to="loc_sem_RehabilitationHospitalsMember_8c454264-5b28-4b2a-bc0d-25529222f188" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OutpatientRehabilitationMember_f5a4d386-caa8-4b9b-8081-5a4c7e5eb7a6" xlink:href="sem-20210630.xsd#sem_OutpatientRehabilitationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2af51e36-dbc3-4344-b11a-83e0c260c55b" xlink:to="loc_sem_OutpatientRehabilitationMember_f5a4d386-caa8-4b9b-8081-5a4c7e5eb7a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ConcentraMember_04495132-12ab-4653-98ae-2a26fa5dd3e6" xlink:href="sem-20210630.xsd#sem_ConcentraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2af51e36-dbc3-4344-b11a-83e0c260c55b" xlink:to="loc_sem_ConcentraMember_04495132-12ab-4653-98ae-2a26fa5dd3e6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#RevenuefromContractswithCustomersDetails"/>
  <link:definitionLink xlink:role="http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails" xlink:type="extended" id="i7859795db6364283925ce7e7783bc4d1_RevenuefromContractswithCustomersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8d77dc25-d92e-4dd1-a29f-1d522ff175d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_21ca0a74-f9d0-486b-af59-70903c04f238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8d77dc25-d92e-4dd1-a29f-1d522ff175d4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_21ca0a74-f9d0-486b-af59-70903c04f238" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_203ef66e-939b-42b3-8d0f-91445398ff67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8d77dc25-d92e-4dd1-a29f-1d522ff175d4" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_203ef66e-939b-42b3-8d0f-91445398ff67" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f58252db-ef98-4f63-b569-697789d36dbb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_203ef66e-939b-42b3-8d0f-91445398ff67" xlink:to="loc_srt_ConsolidationItemsAxis_f58252db-ef98-4f63-b569-697789d36dbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f58252db-ef98-4f63-b569-697789d36dbb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_f58252db-ef98-4f63-b569-697789d36dbb" xlink:to="loc_srt_ConsolidationItemsDomain_f58252db-ef98-4f63-b569-697789d36dbb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_8d879aff-9227-4f93-b9d7-916639b00bc5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_f58252db-ef98-4f63-b569-697789d36dbb" xlink:to="loc_srt_ConsolidationItemsDomain_8d879aff-9227-4f93-b9d7-916639b00bc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_ccca7891-3e25-4cfb-abfa-27110e07d497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_8d879aff-9227-4f93-b9d7-916639b00bc5" xlink:to="loc_us-gaap_OperatingSegmentsMember_ccca7891-3e25-4cfb-abfa-27110e07d497" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_a8e3c7e7-37a3-4ad4-8329-256cb6fc1b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_8d879aff-9227-4f93-b9d7-916639b00bc5" xlink:to="loc_us-gaap_CorporateNonSegmentMember_a8e3c7e7-37a3-4ad4-8329-256cb6fc1b8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_642151cf-5de8-4974-b637-ee4a63ac772d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_203ef66e-939b-42b3-8d0f-91445398ff67" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_642151cf-5de8-4974-b637-ee4a63ac772d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_642151cf-5de8-4974-b637-ee4a63ac772d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_642151cf-5de8-4974-b637-ee4a63ac772d" xlink:to="loc_us-gaap_SegmentDomain_642151cf-5de8-4974-b637-ee4a63ac772d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_aca23a47-60b6-4a87-80b4-508acea77267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_642151cf-5de8-4974-b637-ee4a63ac772d" xlink:to="loc_us-gaap_SegmentDomain_aca23a47-60b6-4a87-80b4-508acea77267" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_CriticalIllnessRecoveryHospitalsMember_b284aacd-8072-4181-ac3d-8b539f30982b" xlink:href="sem-20210630.xsd#sem_CriticalIllnessRecoveryHospitalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_aca23a47-60b6-4a87-80b4-508acea77267" xlink:to="loc_sem_CriticalIllnessRecoveryHospitalsMember_b284aacd-8072-4181-ac3d-8b539f30982b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_RehabilitationHospitalsMember_f525fbb7-2c09-489f-8b6e-463528ef9dfb" xlink:href="sem-20210630.xsd#sem_RehabilitationHospitalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_aca23a47-60b6-4a87-80b4-508acea77267" xlink:to="loc_sem_RehabilitationHospitalsMember_f525fbb7-2c09-489f-8b6e-463528ef9dfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OutpatientRehabilitationMember_eb551482-fee8-4811-a89f-b1360deaf8a9" xlink:href="sem-20210630.xsd#sem_OutpatientRehabilitationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_aca23a47-60b6-4a87-80b4-508acea77267" xlink:to="loc_sem_OutpatientRehabilitationMember_eb551482-fee8-4811-a89f-b1360deaf8a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ConcentraMember_4118781d-bc42-4e25-a2a6-c3e2e01d5214" xlink:href="sem-20210630.xsd#sem_ConcentraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_aca23a47-60b6-4a87-80b4-508acea77267" xlink:to="loc_sem_ConcentraMember_4118781d-bc42-4e25-a2a6-c3e2e01d5214" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d51d825e-c3cc-498e-9a1b-2458c9bfcb84" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_203ef66e-939b-42b3-8d0f-91445398ff67" xlink:to="loc_srt_ProductOrServiceAxis_d51d825e-c3cc-498e-9a1b-2458c9bfcb84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d51d825e-c3cc-498e-9a1b-2458c9bfcb84_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d51d825e-c3cc-498e-9a1b-2458c9bfcb84" xlink:to="loc_srt_ProductsAndServicesDomain_d51d825e-c3cc-498e-9a1b-2458c9bfcb84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9aaee191-a819-4343-bb1f-69531b004205" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d51d825e-c3cc-498e-9a1b-2458c9bfcb84" xlink:to="loc_srt_ProductsAndServicesDomain_9aaee191-a819-4343-bb1f-69531b004205" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_ececa6b2-a0d2-4573-b8d7-5ce3b10eb417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9aaee191-a819-4343-bb1f-69531b004205" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_ececa6b2-a0d2-4573-b8d7-5ce3b10eb417" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_HealthCarePatientServiceMedicareMember_6dad881f-b00a-4c2f-9074-5316613fc6f1" xlink:href="sem-20210630.xsd#sem_HealthCarePatientServiceMedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_ececa6b2-a0d2-4573-b8d7-5ce3b10eb417" xlink:to="loc_sem_HealthCarePatientServiceMedicareMember_6dad881f-b00a-4c2f-9074-5316613fc6f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_HealthCarePatientServiceNonMedicareMember_6e42c415-1c0c-4915-b9d0-02b891beb42a" xlink:href="sem-20210630.xsd#sem_HealthCarePatientServiceNonMedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_ececa6b2-a0d2-4573-b8d7-5ce3b10eb417" xlink:to="loc_sem_HealthCarePatientServiceNonMedicareMember_6e42c415-1c0c-4915-b9d0-02b891beb42a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceOtherMember_67b16554-d727-4bd3-98ac-8b10b4dc7fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_9aaee191-a819-4343-bb1f-69531b004205" xlink:to="loc_us-gaap_ServiceOtherMember_67b16554-d727-4bd3-98ac-8b10b4dc7fcf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#CommitmentsandContingenciesLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails" xlink:type="extended" id="idc971859f2d4411aa210691722fbad46_CommitmentsandContingenciesLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_650ec1dc-9871-475c-9dbf-163994ed1158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeInsuranceAnnualCoverageLimit_4854032c-d6aa-4b8b-b228-11a30e911538" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MalpracticeInsuranceAnnualCoverageLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_650ec1dc-9871-475c-9dbf-163994ed1158" xlink:to="loc_us-gaap_MalpracticeInsuranceAnnualCoverageLimit_4854032c-d6aa-4b8b-b228-11a30e911538" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_8ea162d2-d561-47e1-b75b-c117bf4b40a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_650ec1dc-9871-475c-9dbf-163994ed1158" xlink:to="loc_us-gaap_LossContingenciesTable_8ea162d2-d561-47e1-b75b-c117bf4b40a8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_d014554e-83f2-4b80-b536-ba08284c690d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8ea162d2-d561-47e1-b75b-c117bf4b40a8" xlink:to="loc_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_d014554e-83f2-4b80-b536-ba08284c690d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeAndTierIdentifierDomain_d014554e-83f2-4b80-b536-ba08284c690d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeAndTierIdentifierDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_d014554e-83f2-4b80-b536-ba08284c690d" xlink:to="loc_us-gaap_TypeAndTierIdentifierDomain_d014554e-83f2-4b80-b536-ba08284c690d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeAndTierIdentifierDomain_7e9907b4-c9ee-4507-82b0-e738090031e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeAndTierIdentifierDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_d014554e-83f2-4b80-b536-ba08284c690d" xlink:to="loc_us-gaap_TypeAndTierIdentifierDomain_7e9907b4-c9ee-4507-82b0-e738090031e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalMalpracticeLiabilityMember_7e022da8-f7d1-4ae6-8f99-2a8251afac05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalMalpracticeLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeAndTierIdentifierDomain_7e9907b4-c9ee-4507-82b0-e738090031e3" xlink:to="loc_us-gaap_ProfessionalMalpracticeLiabilityMember_7e022da8-f7d1-4ae6-8f99-2a8251afac05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralLiabilityMember_ccc8aad1-a578-4a58-83b2-3fc35d7489f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeAndTierIdentifierDomain_7e9907b4-c9ee-4507-82b0-e738090031e3" xlink:to="loc_us-gaap_GeneralLiabilityMember_ccc8aad1-a578-4a58-83b2-3fc35d7489f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_95b518af-d135-49a2-8704-ae11cf889cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8ea162d2-d561-47e1-b75b-c117bf4b40a8" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_95b518af-d135-49a2-8704-ae11cf889cba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_95b518af-d135-49a2-8704-ae11cf889cba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_95b518af-d135-49a2-8704-ae11cf889cba" xlink:to="loc_us-gaap_RelatedPartyDomain_95b518af-d135-49a2-8704-ae11cf889cba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_a8993437-f87d-41ef-b72e-2fe7cd10d8e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_95b518af-d135-49a2-8704-ae11cf889cba" xlink:to="loc_us-gaap_RelatedPartyDomain_a8993437-f87d-41ef-b72e-2fe7cd10d8e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_52f08764-041d-4fa8-b5c6-f2c7aa0fc4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_a8993437-f87d-41ef-b72e-2fe7cd10d8e4" xlink:to="loc_us-gaap_CorporateJointVentureMember_52f08764-041d-4fa8-b5c6-f2c7aa0fc4d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_036b3faf-46b0-4899-b3c5-a16e2abf3ec1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8ea162d2-d561-47e1-b75b-c117bf4b40a8" xlink:to="loc_srt_RangeAxis_036b3faf-46b0-4899-b3c5-a16e2abf3ec1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_036b3faf-46b0-4899-b3c5-a16e2abf3ec1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_036b3faf-46b0-4899-b3c5-a16e2abf3ec1" xlink:to="loc_srt_RangeMember_036b3faf-46b0-4899-b3c5-a16e2abf3ec1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_96b7c0f1-79c3-4dd8-8759-258571ae6f2c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_036b3faf-46b0-4899-b3c5-a16e2abf3ec1" xlink:to="loc_srt_RangeMember_96b7c0f1-79c3-4dd8-8759-258571ae6f2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_88152088-2a37-4504-b357-031cd2c511c3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_96b7c0f1-79c3-4dd8-8759-258571ae6f2c" xlink:to="loc_srt_MinimumMember_88152088-2a37-4504-b357-031cd2c511c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4be2c036-bdc9-4341-a02f-38a4d25fa357" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_96b7c0f1-79c3-4dd8-8759-258571ae6f2c" xlink:to="loc_srt_MaximumMember_4be2c036-bdc9-4341-a02f-38a4d25fa357" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CommitmentsandContingenciesMedicareDualEligibleLitigationDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#CommitmentsandContingenciesMedicareDualEligibleLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.selectmedical.com/role/CommitmentsandContingenciesMedicareDualEligibleLitigationDetails" xlink:type="extended" id="ic8872d9b8265425aa1346a3a6f717cd1_CommitmentsandContingenciesMedicareDualEligibleLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems_89c7bcbe-1c64-4955-b333-edfafff00ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_23274d3b-2c46-456a-a02e-28220a7f7718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_89c7bcbe-1c64-4955-b333-edfafff00ef0" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_23274d3b-2c46-456a-a02e-28220a7f7718" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ProceedsFromLegalSettlementsAccruedInterest_c4fd8ceb-1b7b-4dd6-848a-02d000bc1f0f" xlink:href="sem-20210630.xsd#sem_ProceedsFromLegalSettlementsAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_89c7bcbe-1c64-4955-b333-edfafff00ef0" xlink:to="loc_sem_ProceedsFromLegalSettlementsAccruedInterest_c4fd8ceb-1b7b-4dd6-848a-02d000bc1f0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable_5c2fdd98-36da-46bc-ae7c-b6d11bfae373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GainContingenciesLineItems_89c7bcbe-1c64-4955-b333-edfafff00ef0" xlink:to="loc_us-gaap_GainContingenciesTable_5c2fdd98-36da-46bc-ae7c-b6d11bfae373" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_87b1bed1-05c2-4586-b17c-3b32e9ae62a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_GainContingenciesTable_5c2fdd98-36da-46bc-ae7c-b6d11bfae373" xlink:to="loc_us-gaap_LitigationStatusAxis_87b1bed1-05c2-4586-b17c-3b32e9ae62a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_87b1bed1-05c2-4586-b17c-3b32e9ae62a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_87b1bed1-05c2-4586-b17c-3b32e9ae62a5" xlink:to="loc_us-gaap_LitigationStatusDomain_87b1bed1-05c2-4586-b17c-3b32e9ae62a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_8a1a5f06-2ea7-48af-af45-839ff77efce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_87b1bed1-05c2-4586-b17c-3b32e9ae62a5" xlink:to="loc_us-gaap_LitigationStatusDomain_8a1a5f06-2ea7-48af-af45-839ff77efce7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_JudicialRulingMember_59a8db6c-3d42-4553-880e-20662da94791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_JudicialRulingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_8a1a5f06-2ea7-48af-af45-839ff77efce7" xlink:to="loc_us-gaap_JudicialRulingMember_59a8db6c-3d42-4553-880e-20662da94791" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#SubsequentEventDetails"/>
  <link:definitionLink xlink:role="http://www.selectmedical.com/role/SubsequentEventDetails" xlink:type="extended" id="i69245417d2234ef2a640750bd3b30b19_SubsequentEventDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_bdf07b3a-db70-4fca-a4ba-7d8fd4962a62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_d2d132b8-b164-4431-849a-603406ed30d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_bdf07b3a-db70-4fca-a4ba-7d8fd4962a62" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_d2d132b8-b164-4431-849a-603406ed30d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_137e4210-9cdc-48d4-8743-e204be496f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_bdf07b3a-db70-4fca-a4ba-7d8fd4962a62" xlink:to="loc_us-gaap_SubsequentEventTable_137e4210-9cdc-48d4-8743-e204be496f4c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2b68bc1a-d700-4092-944c-74bbff2ee991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_137e4210-9cdc-48d4-8743-e204be496f4c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2b68bc1a-d700-4092-944c-74bbff2ee991" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2b68bc1a-d700-4092-944c-74bbff2ee991_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2b68bc1a-d700-4092-944c-74bbff2ee991" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2b68bc1a-d700-4092-944c-74bbff2ee991_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a5f7f783-661c-4ad3-a2bc-15b488d0c062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2b68bc1a-d700-4092-944c-74bbff2ee991" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a5f7f783-661c-4ad3-a2bc-15b488d0c062" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6bb759d8-4492-4859-be86-69e9a4b8a210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a5f7f783-661c-4ad3-a2bc-15b488d0c062" xlink:to="loc_us-gaap_SubsequentEventMember_6bb759d8-4492-4859-be86-69e9a4b8a210" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>sem-20210630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:13e6905e-72a0-44f6-9164-f135c900c5bf,g:37e820a7-74f5-4c60-b984-336d3d990bf4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_0461ce22-4fcc-4321-a879-30883a3ab630_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FinanceLeaseInterestExpenseUnrelatedParties_20266464-0892-4443-a544-bae7d6cf71b2_terseLabel_en-US" xlink:label="lab_sem_FinanceLeaseInterestExpenseUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrelated Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseInterestExpenseUnrelatedParties_label_en-US" xlink:label="lab_sem_FinanceLeaseInterestExpenseUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense, Unrelated Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseInterestExpenseUnrelatedParties_documentation_en-US" xlink:label="lab_sem_FinanceLeaseInterestExpenseUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense, Unrelated Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseInterestExpenseUnrelatedParties" xlink:href="sem-20210630.xsd#sem_FinanceLeaseInterestExpenseUnrelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FinanceLeaseInterestExpenseUnrelatedParties" xlink:to="lab_sem_FinanceLeaseInterestExpenseUnrelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock_d6f85f8b-ee6c-4b72-881e-dd2842fe37fa_terseLabel_en-US" xlink:label="lab_sem_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental balance sheet information</link:label>
    <link:label id="lab_sem_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock_label_en-US" xlink:label="lab_sem_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Leases In Statement Of Financial Position [Table Text Block]</link:label>
    <link:label id="lab_sem_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock_documentation_en-US" xlink:label="lab_sem_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Leases In Statement Of Financial Position [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:href="sem-20210630.xsd#sem_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:to="lab_sem_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_029c1658-02c5-45ed-8b62-d54506ee1e57_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_91a98fe7-9bc9-4129-b512-707159288b05_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Select Medical Holdings Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_6b336c37-7ca6-4517-8a54-3419dfb2b716_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Select Medical Holdings Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_32c5ad32-8821-4517-96b3-3429f62e1f7d_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_2a262dfb-7d6f-49a8-ac61-a21ccdf87da8_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_d8a7dcf4-c52a-4bd8-90d8-b078a750e601_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_c2909250-e2a5-422e-9c80-f3f0628b70de_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedDistributed_889e5f55-bcbb-42b5-939a-42f7e5e175c4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedDistributed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared and contractual dividends paid, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedDistributed_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedDistributed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, Distributed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedDistributed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedDistributed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedDistributed" xlink:to="lab_us-gaap_EarningsPerShareDilutedDistributed" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_OperatingLeaseLiabilityNoncurrentRelatedParties_4c2967e3-2ad5-4eeb-adcc-2cbca75ac663_terseLabel_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityNoncurrentRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_sem_OperatingLeaseLiabilityNoncurrentRelatedParties_label_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityNoncurrentRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Related Parties</link:label>
    <link:label id="lab_sem_OperatingLeaseLiabilityNoncurrentRelatedParties_documentation_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityNoncurrentRelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityNoncurrentRelatedParties" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityNoncurrentRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_OperatingLeaseLiabilityNoncurrentRelatedParties" xlink:to="lab_sem_OperatingLeaseLiabilityNoncurrentRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_62857261-9e53-4e2e-8250-fa6f2b6381ab_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1b520bc2-e06a-42bf-8949-e187ba54df72_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_321744ad-7790-4583-9d95-e74ef0faf0a5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_bc90046c-f414-4444-bb1c-8cd30129f767_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_778fd2b0-be3c-4bd7-b2f0-f3372a8c287e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_2d8f0e75-c18a-42a6-932f-6dba0e8caf9e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of principal maturities of the Company's long-term debt and notes payable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_GovernmentAssistanceRecognizedInEarningsCARESAct_7b107a66-24d3-4787-a3ba-7b322fca3ae6_terseLabel_en-US" xlink:label="lab_sem_GovernmentAssistanceRecognizedInEarningsCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government assistance recognized in earnings, CARES Act</link:label>
    <link:label id="lab_sem_GovernmentAssistanceRecognizedInEarningsCARESAct_label_en-US" xlink:label="lab_sem_GovernmentAssistanceRecognizedInEarningsCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance Recognized In Earnings, CARES Act</link:label>
    <link:label id="lab_sem_GovernmentAssistanceRecognizedInEarningsCARESAct_documentation_en-US" xlink:label="lab_sem_GovernmentAssistanceRecognizedInEarningsCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance Recognized In Earnings, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_GovernmentAssistanceRecognizedInEarningsCARESAct" xlink:href="sem-20210630.xsd#sem_GovernmentAssistanceRecognizedInEarningsCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_GovernmentAssistanceRecognizedInEarningsCARESAct" xlink:to="lab_sem_GovernmentAssistanceRecognizedInEarningsCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_3fa4174d-2664-445e-805c-1f7a47b46e23_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour_0c29e7ff-d531-4aba-8e4c-1503ec9d030d_terseLabel_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour_label_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal After Year Four</link:label>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour_documentation_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour" xlink:to="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_OutpatientRehabilitationMember_69579ca4-7afd-4c9a-9a07-ee25e321e6ca_terseLabel_en-US" xlink:label="lab_sem_OutpatientRehabilitationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outpatient Rehabilitation</link:label>
    <link:label id="lab_sem_OutpatientRehabilitationMember_label_en-US" xlink:label="lab_sem_OutpatientRehabilitationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outpatient Rehabilitation [Member]</link:label>
    <link:label id="lab_sem_OutpatientRehabilitationMember_documentation_en-US" xlink:label="lab_sem_OutpatientRehabilitationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to outpatient rehabilitation, a reporting segment of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OutpatientRehabilitationMember" xlink:href="sem-20210630.xsd#sem_OutpatientRehabilitationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_OutpatientRehabilitationMember" xlink:to="lab_sem_OutpatientRehabilitationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_55befcc9-6e4d-4653-a58a-5942ad044ca7_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in excess of par</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_b188de6b-4cda-41f2-924f-e5249e2a3668_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4c55afc0-6150-4145-9eb1-8ceccf969410_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_ae8f8a18-f6b4-4017-9688-d30600e43b2e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_d31c2bcc-f087-4010-8e0b-d583f235e772_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_ff4d63df-c70d-4d41-a9cc-328b84f0d814_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of non-controlling interests</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:to="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1721b839-dd44-434b-b099-c9a9e6bdde55_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6f43cac7-eb2b-4336-8fc2-ebd984fd7302_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FinanceLeaseLiabilityNoncurrentAbstract_357d5a53-820f-40fe-9632-f69c31d0f50f_terseLabel_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of current portion</link:label>
    <link:label id="lab_sem_FinanceLeaseLiabilityNoncurrentAbstract_label_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Liability, Noncurrent [Abstract]</link:label>
    <link:label id="lab_sem_FinanceLeaseLiabilityNoncurrentAbstract_documentation_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityNoncurrentAbstract" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FinanceLeaseLiabilityNoncurrentAbstract" xlink:to="lab_sem_FinanceLeaseLiabilityNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4961a0e7-1e80-44ae-a1f8-32e40337b21c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeAndTierIdentifierDomain_36a52bfc-2cdf-4e57-9480-12c7f9ed4208_terseLabel_en-US" xlink:label="lab_us-gaap_TypeAndTierIdentifierDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type and Tier Identifier [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeAndTierIdentifierDomain_label_en-US" xlink:label="lab_us-gaap_TypeAndTierIdentifierDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type and Tier Identifier [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeAndTierIdentifierDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeAndTierIdentifierDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeAndTierIdentifierDomain" xlink:to="lab_us-gaap_TypeAndTierIdentifierDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_c1b27239-a08f-4c2b-adca-8305b3a36196_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_2b6ddf6e-e952-4f5a-a812-374685345dde_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditConcentrationRiskMember_82c21957-282f-4a5e-b8fd-275741497eed_terseLabel_en-US" xlink:label="lab_us-gaap_CreditConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CreditConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CreditConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditConcentrationRiskMember" xlink:to="lab_us-gaap_CreditConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_c34a6b80-869b-4be2-8ee9-7b38097b8352_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_186a6a1e-7cf1-49d4-87b1-b1ea2a9ccf30_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_63f7c6ed-f7ca-4f73-8618-3acc80dccd84_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_8b634680-44f3-4c3b-9474-6b6129bdef94_totalLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_fe361138-8355-4efc-bcaf-3058b66b3bdc_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_7303c301-ced2-4827-b977-d59eb910feed_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_SubleaseIncomeAbstract_57d3d619-8516-4a66-95b4-0bf13ec106da_terseLabel_en-US" xlink:label="lab_sem_SubleaseIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_sem_SubleaseIncomeAbstract_label_en-US" xlink:label="lab_sem_SubleaseIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income [Abstract]</link:label>
    <link:label id="lab_sem_SubleaseIncomeAbstract_documentation_en-US" xlink:label="lab_sem_SubleaseIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_SubleaseIncomeAbstract" xlink:href="sem-20210630.xsd#sem_SubleaseIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_SubleaseIncomeAbstract" xlink:to="lab_sem_SubleaseIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_04238f0a-0a98-4ce2-9c9a-90cd1353dc8c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_74005430-573b-4e1e-85fb-3d524b498a0d_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract_2722a9eb-b76f-4e5d-aa27-edf26d1ff1a9_terseLabel_en-US" xlink:label="lab_sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract_label_en-US" xlink:label="lab_sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Amounts Included in The Measurement Of Lease Liabilities [Abstract]</link:label>
    <link:label id="lab_sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract_documentation_en-US" xlink:label="lab_sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Amounts Included In The Measurement Of Lease Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract" xlink:href="sem-20210630.xsd#sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract" xlink:to="lab_sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_c551b62e-7a8a-4e32-9c05-9402d44768de_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost:</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Description [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:to="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_df960ae8-95b9-4f90-85c0-249db867ceeb_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_03de9392-182e-4ac3-acbd-c23ab04c9e37_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_CriticalIllnessRecoveryHospitalsMember_58b192d1-6b69-42b6-a36f-eb56c9762d56_terseLabel_en-US" xlink:label="lab_sem_CriticalIllnessRecoveryHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Critical Illness Recovery Hospital</link:label>
    <link:label id="lab_sem_CriticalIllnessRecoveryHospitalsMember_54c15462-b12c-491d-bce5-fc0ead9b85cd_verboseLabel_en-US" xlink:label="lab_sem_CriticalIllnessRecoveryHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Critical Illness Recovery Hospital</link:label>
    <link:label id="lab_sem_CriticalIllnessRecoveryHospitalsMember_label_en-US" xlink:label="lab_sem_CriticalIllnessRecoveryHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Critical Illness Recovery Hospitals [Member]</link:label>
    <link:label id="lab_sem_CriticalIllnessRecoveryHospitalsMember_documentation_en-US" xlink:label="lab_sem_CriticalIllnessRecoveryHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Critical Illness Recovery Hospitals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_CriticalIllnessRecoveryHospitalsMember" xlink:href="sem-20210630.xsd#sem_CriticalIllnessRecoveryHospitalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_CriticalIllnessRecoveryHospitalsMember" xlink:to="lab_sem_CriticalIllnessRecoveryHospitalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_f258ce85-9fa3-4c99-a9b1-751fac23ed51_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption value adjustment on non-controlling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_55231a70-b62e-4df4-90e3-bf04c16145d5_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption value adjustment on redeemable non-controlling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_label_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Change in Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:to="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_a025edc4-5534-4e86-b67c-41a1ea50d23c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_cc883f6d-cfeb-46e5-9551-46f19299d5cd_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_80281c23-0a15-4fd3-acf8-40062910c42e_terseLabel_en-US" xlink:label="lab_sem_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for lease liabilities:</link:label>
    <link:label id="lab_sem_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_label_en-US" xlink:label="lab_sem_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-Of-Use Assets Obtained In Exchange For Lease Liabilities [Abstract]</link:label>
    <link:label id="lab_sem_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_documentation_en-US" xlink:label="lab_sem_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-Of-Use Assets Obtained In Exchange For Lease Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" xlink:href="sem-20210630.xsd#sem_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" xlink:to="lab_sem_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_ff60f909-71c5-4496-a597-40461b223060_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_fd6a0ea5-eb2d-4f1f-b62c-98a57e16f96a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_8aa1eb27-a4df-477d-b911-dd3076f5febf_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of concentration risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_f36c85fe-77e1-4a9d-98b1-2a36de415167_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to and purchases of non-controlling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3a9a8af6-1fac-4587-8a9c-b70cc2c4913b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_c784367d-4ffd-4a97-b67d-107850c80f36_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_a5a5341d-54d1-4986-bb33-69ee9aa2bf0e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_41bf3429-096b-41a1-9d94-c514930ac058_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear_b901e9d6-6639-43c6-837d-7c87128d8e12_terseLabel_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt And Finance Lease Obligation, Repayments Of Principal, Remainder Of Fiscal Year</link:label>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear_documentation_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt And Finance Lease Obligation, Repayments Of Principal, Remainder Of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock_6f89b9de-a1dd-466b-b378-a0cee21fd009_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Items, or Both, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock" xlink:to="lab_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f79a4899-bf75-46ca-99ff-8434e6eded88_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfessionalMalpracticeLiabilityMember_77eb1251-e3b2-410c-a085-c6bc400ff6a2_terseLabel_en-US" xlink:label="lab_us-gaap_ProfessionalMalpracticeLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional liability claims</link:label>
    <link:label id="lab_us-gaap_ProfessionalMalpracticeLiabilityMember_label_en-US" xlink:label="lab_us-gaap_ProfessionalMalpracticeLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Malpractice Liability Insurance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalMalpracticeLiabilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalMalpracticeLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfessionalMalpracticeLiabilityMember" xlink:to="lab_us-gaap_ProfessionalMalpracticeLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a81d04e7-d658-4bef-9dd2-af02d42379fd_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_8841f654-cc07-49ad-a602-22269d9e9baf_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions from unconsolidated subsidiaries</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_2e962af9-8210-44fe-b08c-b0e041930422_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_6fae4599-ca84-4d28-84f9-5b81ceefb154_verboseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loans</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_25377b4b-f667-4b9a-96c4-c7c361cd3709_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_694b27ee-a5fb-4f69-a24e-9dd6383cfc5a_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour_fa7c5632-16c2-4cd8-8283-91eddd8d08d5_terseLabel_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Four</link:label>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour_documentation_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MalpracticeInsuranceAnnualCoverageLimit_0f549644-dc95-4060-9533-78b9e0ddd34b_terseLabel_en-US" xlink:label="lab_us-gaap_MalpracticeInsuranceAnnualCoverageLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total annual aggregate limit of insurance coverage</link:label>
    <link:label id="lab_us-gaap_MalpracticeInsuranceAnnualCoverageLimit_label_en-US" xlink:label="lab_us-gaap_MalpracticeInsuranceAnnualCoverageLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malpractice Insurance, Annual Coverage Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeInsuranceAnnualCoverageLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MalpracticeInsuranceAnnualCoverageLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MalpracticeInsuranceAnnualCoverageLimit" xlink:to="lab_us-gaap_MalpracticeInsuranceAnnualCoverageLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract_f12be9df-c646-406e-914e-18951c9e6ae3_terseLabel_en-US" xlink:label="lab_sem_WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate:</link:label>
    <link:label id="lab_sem_WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract_label_en-US" xlink:label="lab_sem_WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Discount Rate Operating And Finance Leases [Abstract]</link:label>
    <link:label id="lab_sem_WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract_documentation_en-US" xlink:label="lab_sem_WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Discount Rate Operating And Finance Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract" xlink:href="sem-20210630.xsd#sem_WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract" xlink:to="lab_sem_WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_670ec830-d8dc-4fed-9aec-9a764d996749_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ea8e6d03-e802-40d4-9098-6ffdbe8067b9_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5315ffb9-cfaf-47c9-b0c5-bdd5f902f58d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_7edbffdb-6be9-49fb-a56e-de5904ef634f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_ce54973c-1aff-4e94-a64e-e1dec3c3bfda_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows for finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_131e5a7e-50a1-45ae-aa64-fd97c1deacfa_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_HealthCarePatientServiceMedicareMember_35adb2e2-cf78-4e99-9a4f-48a8bd5d0fb4_terseLabel_en-US" xlink:label="lab_sem_HealthCarePatientServiceMedicareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_sem_HealthCarePatientServiceMedicareMember_label_en-US" xlink:label="lab_sem_HealthCarePatientServiceMedicareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service, Medicare [Member]</link:label>
    <link:label id="lab_sem_HealthCarePatientServiceMedicareMember_documentation_en-US" xlink:label="lab_sem_HealthCarePatientServiceMedicareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service, Medicare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_HealthCarePatientServiceMedicareMember" xlink:href="sem-20210630.xsd#sem_HealthCarePatientServiceMedicareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_HealthCarePatientServiceMedicareMember" xlink:to="lab_sem_HealthCarePatientServiceMedicareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_OtherAccruedLiabilitiesCurrentMember_7880f37e-e67c-4017-b302-c4a7f9ae586b_terseLabel_en-US" xlink:label="lab_sem_OtherAccruedLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued other</link:label>
    <link:label id="lab_sem_OtherAccruedLiabilitiesCurrentMember_label_en-US" xlink:label="lab_sem_OtherAccruedLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current [Member]</link:label>
    <link:label id="lab_sem_OtherAccruedLiabilitiesCurrentMember_documentation_en-US" xlink:label="lab_sem_OtherAccruedLiabilitiesCurrentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OtherAccruedLiabilitiesCurrentMember" xlink:href="sem-20210630.xsd#sem_OtherAccruedLiabilitiesCurrentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_OtherAccruedLiabilitiesCurrentMember" xlink:to="lab_sem_OtherAccruedLiabilitiesCurrentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_3461dc92-088f-4dbf-b55c-959d5add929a_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on sale or disposal of assets and businesses</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_9c8c49e2-59f3-4c40-9c8a-cfec229f12b3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_cd489b29-1fc0-438a-83fd-cb8eb7ae4c6b_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5900b1f9-64ac-4a09-bc4e-19b8c326cf56_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_af729448-668b-4b9a-9385-2077158e6c96_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_c046efa6-366c-49d8-84ee-452079a134cb_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of assets and businesses</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sales of Business, Affiliate and Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_e2c112d4-8962-4dd1-a688-b6c749749231_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contracts with Customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_d9fad0d9-b86b-4c01-b8b0-7ac60f220ef8_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligation_c8c4df7c-9664-4593-9d04-5c29ad5e1841_totalLabel_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligation_label_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt And Finance Lease Obligation</link:label>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligation_documentation_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt And Finance Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligation" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_LongTermDebtAndFinanceLeaseObligation" xlink:to="lab_sem_LongTermDebtAndFinanceLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_5d5f7e27-1a7f-475b-a2ed-33a6248be91c_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1c382df4-a13e-4054-b783-0075981dba23_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_VariableLeaseCostRelatedParties_72d383f0-0839-4927-9fa1-b8ab8d507f2c_terseLabel_en-US" xlink:label="lab_sem_VariableLeaseCostRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_sem_VariableLeaseCostRelatedParties_label_en-US" xlink:label="lab_sem_VariableLeaseCostRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost, Related Parties</link:label>
    <link:label id="lab_sem_VariableLeaseCostRelatedParties_documentation_en-US" xlink:label="lab_sem_VariableLeaseCostRelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_VariableLeaseCostRelatedParties" xlink:href="sem-20210630.xsd#sem_VariableLeaseCostRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_VariableLeaseCostRelatedParties" xlink:to="lab_sem_VariableLeaseCostRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_3b54bdd6-23c2-43bf-a2df-1fa0130b9f92_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of disaggregation of net operating revenues by operating segment</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingenciesLineItems_5832d8b4-d456-4d01-beae-58173932eefe_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_GainContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_GainContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingenciesLineItems" xlink:to="lab_us-gaap_GainContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_28d25d55-56be-4963-9972-5afae1d9f995_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted EPS</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_867ad896-a9a8-4563-9512-d904c943c9de_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo_bd693cbd-6800-4df6-9a1b-daf76604937c_terseLabel_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Two</link:label>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo_documentation_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_3f1f94b2-886c-4066-88eb-83b5b69c1dd3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows for operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_525a9d2f-a599-4f51-8640-5a91e0d66aa7_verboseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for expected credit losses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_93ae0f2d-499b-4ab6-a3c1-601b6b3c54d9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_adcab7cd-d1d8-476a-90d9-58df22cc953a_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_98ed0784-aac5-4849-9b1b-5e5c0c5631b2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_7834d365-857f-4ec6-9e6f-7a85c65906f6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt and notes payable</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_458201a1-cca6-4b09-8618-3abcfb0ef9df_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_b12b1adc-7657-4c90-b7c0-69c6959cd763_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_62ada085-c383-4036-99b6-65f7191303cd_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfEquity_8c333734-ed40-4d4e-8c46-b96580540b6b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfEquity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfEquity_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfEquity" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeCapInterestRate_bd31d264-877d-408b-b0ac-31414d70015d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeCapInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative cap interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DerivativeCapInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeCapInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Cap Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCapInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeCapInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeCapInterestRate" xlink:to="lab_us-gaap_DerivativeCapInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_5a87bb24-ce54-4d7a-a7d5-3adc463b66fe_terseLabel_en-US" xlink:label="lab_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]</link:label>
    <link:label id="lab_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]</link:label>
    <link:label id="lab_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_documentation_en-US" xlink:label="lab_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Finite Lived And Indefinite Lived Intangible Assets By Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="sem-20210630.xsd#sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_9f3d2988-a0e0-412a-a67c-6c86d17c2875_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_76fb6c6f-1e5e-4c26-b847-56d794ad4da0_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_JudicialRulingMember_c850b747-3938-4156-9264-4c4a41a73b3e_terseLabel_en-US" xlink:label="lab_us-gaap_JudicialRulingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judicial Ruling</link:label>
    <link:label id="lab_us-gaap_JudicialRulingMember_label_en-US" xlink:label="lab_us-gaap_JudicialRulingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judicial Ruling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_JudicialRulingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_JudicialRulingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_JudicialRulingMember" xlink:to="lab_us-gaap_JudicialRulingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_ConcentraMember_86f52ff1-e75b-4771-b536-1c7a69d81c3a_terseLabel_en-US" xlink:label="lab_sem_ConcentraMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentra</link:label>
    <link:label id="lab_sem_ConcentraMember_label_en-US" xlink:label="lab_sem_ConcentraMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentra [Member]</link:label>
    <link:label id="lab_sem_ConcentraMember_documentation_en-US" xlink:label="lab_sem_ConcentraMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to Concentra, a reporting segment of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ConcentraMember" xlink:href="sem-20210630.xsd#sem_ConcentraMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_ConcentraMember" xlink:to="lab_sem_ConcentraMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_c1271462-70df-4c88-96a6-db27b49553df_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_AdjustedEbitda_3db14f09-2d65-4a16-957a-cd74c847d655_terseLabel_en-US" xlink:label="lab_sem_AdjustedEbitda" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted EBITDA</link:label>
    <link:label id="lab_sem_AdjustedEbitda_label_en-US" xlink:label="lab_sem_AdjustedEbitda" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted EBITDA</link:label>
    <link:label id="lab_sem_AdjustedEbitda_documentation_en-US" xlink:label="lab_sem_AdjustedEbitda" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure of profit (loss) for reportable segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_AdjustedEbitda" xlink:href="sem-20210630.xsd#sem_AdjustedEbitda"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_AdjustedEbitda" xlink:to="lab_sem_AdjustedEbitda" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_b0921ecd-511d-4022-ac6d-62a6a6fd8490_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_78c809c0-e777-48aa-b571-7a6026546a7b_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Non-Controlling Interests</link:label>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_6558b7ff-5cef-4ca1-9f57-f3d09bed92c8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_164ce180-94e1-4aa3-928c-94e81ee2bc9e_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change, net of tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_7da41a58-ce8e-4e3d-9aab-b9719fe02df8_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-compete agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_779924e4-52ee-4975-b69f-ff05debbf8ed_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1005e3d5-470d-4956-bdca-4ce8879e7dd7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_3dacf9eb-c4b4-410c-b1bc-8cc8f862685f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_1df45289-4bf2-4f8f-94a6-56c0f63c7010_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_747ace7d-9b9b-4685-814a-a4db6e852dbd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_5c40d3bf-133e-4559-a655-fb3c09bfe722_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap contract, current portion</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromOtherDebt_4b81c939-c4f2-4f07-9fc5-693331857f69_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromOtherDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings of other debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromOtherDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromOtherDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Other Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromOtherDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromOtherDebt" xlink:to="lab_us-gaap_ProceedsFromOtherDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_275c0c5c-053e-4241-9a77-e7420fc986c9_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_77ef884d-0b6d-4185-a758-7ebef03fa1af_terseLabel_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit</link:label>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_label_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandbyLettersOfCreditMember" xlink:to="lab_us-gaap_StandbyLettersOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_2aa2abe2-690d-4fa4-97cb-6e1060c0f87f_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsAbstract_561f0150-93d8-4431-bf44-0ea2667d3ce8_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Allocation</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsAbstract_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsAbstract" xlink:to="lab_us-gaap_UndistributedEarningsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_ecf8b3b9-63f5-4029-8dd1-e264f4eb4d08_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralLiabilityMember_96e5f5da-6fcc-43f1-b8d3-2ba76c387779_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Liability</link:label>
    <link:label id="lab_us-gaap_GeneralLiabilityMember_label_en-US" xlink:label="lab_us-gaap_GeneralLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralLiabilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralLiabilityMember" xlink:to="lab_us-gaap_GeneralLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_4ebf8e5e-d36b-46f9-ab6d-009107d7c917_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_d3b18598-d759-4961-a1de-037e8b7ca24a_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_8fadc507-a96c-4899-8338-c67221643dc5_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive income attributable to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_5dff5c51-a423-4727-ad44-57d718cd76a5_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Issuance Costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_5749f99d-075a-4976-8b83-ae122e3a6d8c_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceOtherMember_fe59afde-254b-490e-a96b-8fb6c1bb18ec_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenue</link:label>
    <link:label id="lab_us-gaap_ServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceOtherMember" xlink:to="lab_us-gaap_ServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract_3ee03d7c-2b3c-447c-83ed-03119a0c9bf7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_b6309492-9121-4448-86cb-b330ecb233e7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_0247c050-e617-4f02-92cd-a21cbb2b2443_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on interest rate cap cash flow hedge</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_c22e8fdc-48ba-4c3e-a027-c22ad3de4a2a_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_fdb9191e-7cc3-400a-9fd3-68a695f7608c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_28afcff9-dd9c-4caa-96a7-20742788b4c3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_cc3fae84-6a8d-482d-a2ba-151fa670928f_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties_bba6efc4-bd79-4209-8807-f8e3bb34e845_terseLabel_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrelated Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties_label_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Unrelated Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties_documentation_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Unrelated Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties" xlink:to="lab_sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_8a82f7a7-c8ac-451f-ad40-38b6368dec83_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b4163abc-1c3c-4983-b790-e8448ec71a7a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combinations, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_ede513cb-071e-4d7e-bf4f-8e1ba569492b_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Notes Payable</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_b256fbb2-bb84-4874-9fa0-6ea75796cc54_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_cc6fc371-c353-4248-89f4-15343c007f9f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving facilities</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_2f723d92-5f71-4ad1-aaf3-218a5dacca2f_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_e6116a9d-1361-49c4-b26b-d46e1c4f5d11_terseLabel_en-US" xlink:label="lab_sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_label_en-US" xlink:label="lab_sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due After Year Four</link:label>
    <link:label id="lab_sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_documentation_en-US" xlink:label="lab_sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:href="sem-20210630.xsd#sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="lab_sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_e752c7cd-0530-4ce1-900e-7267d4bbc065_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid to common stockholders</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_bd505735-39a0-4920-b6a1-a64f160b86f8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_54f26070-98c4-4a67-9f1d-1d71c449cbb2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour_e0bfb4b8-b261-47e6-aadb-cde739148ea4_terseLabel_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour_label_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due After Year Four</link:label>
    <link:label id="lab_sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour_documentation_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="lab_sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FinanceLeaseLiabilityNoncurrentRelatedParties_81e3264f-2bdf-426b-b0f3-7fbf05b12d29_terseLabel_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityNoncurrentRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseLiabilityNoncurrentRelatedParties_label_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityNoncurrentRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Related Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseLiabilityNoncurrentRelatedParties_documentation_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityNoncurrentRelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityNoncurrentRelatedParties" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityNoncurrentRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FinanceLeaseLiabilityNoncurrentRelatedParties" xlink:to="lab_sem_FinanceLeaseLiabilityNoncurrentRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_a1014a65-73e9-4860-9f2e-4e830ac277dc_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_28be24f2-eb0e-444a-93f3-2d9550cd2df0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total discounted lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_0443857e-8c04-4d0a-9103-9f8751735356_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable non-controlling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_e2998d66-ed6e-4517-abef-2aa340bce55b_periodStartLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_4bcbcc79-dc6e-435e-be87-dd023f32b758_periodEndLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, ending</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_2f1b79ac-eb4f-47d9-984f-c520ce7afe52_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value, 700,000,000 shares authorized, 134,850,735 and 135,005,369 shares issued and outstanding at 2020 and 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_c764bf26-d03e-4649-8418-1029a3ea4083_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_074685f5-e927-413b-862d-c82a62580d67_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_b238d99b-f54d-440a-9cab-d17c11c14109_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of businesses</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_65839f33-1bcd-46ec-bf31-076480ff5966_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 14)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_2edc8484-4307-4b17-9ca4-50a68440f3e4_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_0cda60be-7616-4952-9ed0-44c68ffe7089_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FinanceLeaseLiabilityCurrentRelatedParties_6b9aa9bf-a472-46a5-8218-45c2debdc912_terseLabel_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityCurrentRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseLiabilityCurrentRelatedParties_label_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityCurrentRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Related Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseLiabilityCurrentRelatedParties_documentation_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityCurrentRelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityCurrentRelatedParties" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityCurrentRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FinanceLeaseLiabilityCurrentRelatedParties" xlink:to="lab_sem_FinanceLeaseLiabilityCurrentRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_b8874781-a220-4b01-9c77-75537429285a_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of redeemable non-controlling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cbba3ef0-23f4-417d-8f75-3e9151d1ba69_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_18fb4fc8-2da7-4476-997c-08739c7411fd_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividend declared (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_label_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Amount Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableAmountPerShare" xlink:to="lab_us-gaap_DividendsPayableAmountPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_21325529-3f61-43e4-b05c-5bc20764f94d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Rate Cap</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_7700b6f5-257f-4aab-85cc-685c64bc2c91_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent_eafba279-5f4b-40e2-b2f0-babc16810821_terseLabel_en-US" xlink:label="lab_sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll</link:label>
    <link:label id="lab_sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent_label_en-US" xlink:label="lab_sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Accrued Bonuses, And Accrued Payroll Taxes, Current</link:label>
    <link:label id="lab_sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent_documentation_en-US" xlink:label="lab_sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Accrued Bonuses, And Accrued Payroll Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent" xlink:href="sem-20210630.xsd#sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent" xlink:to="lab_sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_7f73ec5c-a5fd-4c02-a867-9308d5b1ffda_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 (remainder of year)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_VariableLeaseCostAbstract_0bf0a895-d637-49bb-92d9-936c304c698b_terseLabel_en-US" xlink:label="lab_sem_VariableLeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_sem_VariableLeaseCostAbstract_label_en-US" xlink:label="lab_sem_VariableLeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost [Abstract]</link:label>
    <link:label id="lab_sem_VariableLeaseCostAbstract_documentation_en-US" xlink:label="lab_sem_VariableLeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_VariableLeaseCostAbstract" xlink:href="sem-20210630.xsd#sem_VariableLeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_VariableLeaseCostAbstract" xlink:to="lab_sem_VariableLeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_aeceffd4-85ad-4328-aede-de48ec1f3ea3_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of non-controlling interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Subsidiary Equity Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FinanceLeaseInterestExpenseRelatedParties_0078a984-a056-4c2b-bb44-d22173187ddb_terseLabel_en-US" xlink:label="lab_sem_FinanceLeaseInterestExpenseRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseInterestExpenseRelatedParties_label_en-US" xlink:label="lab_sem_FinanceLeaseInterestExpenseRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense, Related Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseInterestExpenseRelatedParties_documentation_en-US" xlink:label="lab_sem_FinanceLeaseInterestExpenseRelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseInterestExpenseRelatedParties" xlink:href="sem-20210630.xsd#sem_FinanceLeaseInterestExpenseRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FinanceLeaseInterestExpenseRelatedParties" xlink:to="lab_sem_FinanceLeaseInterestExpenseRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_511eee24-5c22-48b6-b67a-0d2ab1a02372_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit (expense) on components of other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_6153824a-7808-4274-9874-e08fb736d5d1_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_8cb3af50-3d83-4251-a470-2c368e4dc806_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_a87093ba-5f17-4a3d-86d0-e8b73ae9cc67_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_be1d6c9f-52bb-451e-ba31-9b40057aed27_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on interest rate cap cash flow hedge</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_fbcbc394-7065-42f2-b08d-63a5221a98bb_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FinanceLeaseLiabilityUnrelatedParties_ea8cbc67-3523-4b25-bb05-811fc497bf82_terseLabel_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrelated Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseLiabilityUnrelatedParties_label_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Unrelated Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseLiabilityUnrelatedParties_documentation_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Unrelated Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityUnrelatedParties" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityUnrelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FinanceLeaseLiabilityUnrelatedParties" xlink:to="lab_sem_FinanceLeaseLiabilityUnrelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct_e9a85da3-7a81-49a1-a532-052e142f2b0d_terseLabel_en-US" xlink:label="lab_sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government advances</link:label>
    <link:label id="lab_sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct_label_en-US" xlink:label="lab_sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From (Repayments Of) Government Advances, CARES Act</link:label>
    <link:label id="lab_sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct_documentation_en-US" xlink:label="lab_sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From (Repayments Of) Government Advances, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct" xlink:href="sem-20210630.xsd#sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct" xlink:to="lab_sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_04b6ae8a-18ab-41df-99f0-0ac0ae5a5bae_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_c630a643-4a77-43fc-9e49-b725a2ba6173_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of membership interests of Concentra Group Holdings Parent</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_f6f930ca-c942-4ffe-85e2-4cb0e38b02e4_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient services revenue</link:label>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_label_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCarePatientServiceMember" xlink:to="lab_us-gaap_HealthCarePatientServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_e6982295-2883-4c2f-9a19-59c7c4c4bf39_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_48204207-1353-4571-9286-d01a97dff28a_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_f71fe702-aadc-4865-a9c0-f31fca1cb079_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividend declared (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4c632589-86be-4d93-84ba-3d156cecd64a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_41e78cc1-4f8e-43fa-8a90-8897997bba50_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_6cb6fa87-9347-4482-8941-eb2bc1bd91bb_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties_a47edc65-65b6-4538-94b6-94b6fe1cf04d_terseLabel_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrelated Parties</link:label>
    <link:label id="lab_sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties_label_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Unrelated Parties</link:label>
    <link:label id="lab_sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties_documentation_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Unrelated Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties" xlink:to="lab_sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedVacationCurrent_3a34354b-c96b-471d-ba77-037600938300_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedVacationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued vacation</link:label>
    <link:label id="lab_us-gaap_AccruedVacationCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedVacationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Vacation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedVacationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedVacationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedVacationCurrent" xlink:to="lab_us-gaap_AccruedVacationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_0214c31f-12a4-43bd-8c96-9e13a013c801_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_21371a31-11a7-4585-947e-c029242b2347_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_943b6ce0-9f63-4af8-b33a-a3c9a1e0760a_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other debt, including finance leases</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_2967150a-5649-45f9-9e06-b65364337851_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties_57d3fefd-ed30-411e-819a-edf59b95acd8_terseLabel_en-US" xlink:label="lab_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrelated Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties_label_en-US" xlink:label="lab_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, After Accumulated Amortization, Unrelated Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties_documentation_en-US" xlink:label="lab_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, After Accumulated Amortization, Unrelated Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties" xlink:href="sem-20210630.xsd#sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties" xlink:to="lab_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_339e03f5-ddb3-42d6-bef6-6d2fd633998c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_bd764673-82ab-46d2-87f7-9eae4d948242_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_bb249974-a57c-4cfe-b616-810cc6dc7079_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of membership interests of Concentra Group Holdings Parent</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_725e3e69-f5a0-402b-a111-65e3dc710cc5_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests_96284347-6234-4a16-bd6b-b92392d64640_negatedLabel_en-US" xlink:label="lab_sem_NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to and purchases of redeemable non-controlling interests</link:label>
    <link:label id="lab_sem_NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests_label_en-US" xlink:label="lab_sem_NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Distributions to Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_sem_NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests_documentation_en-US" xlink:label="lab_sem_NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Distributions to Redeemable Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests" xlink:href="sem-20210630.xsd#sem_NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests" xlink:to="lab_sem_NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_62f1604a-c9e0-4255-9c6a-a9c8bca58cf4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_0dcb571c-ae47-4a89-bc79-94364e6d745a_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_209ac0d3-2bfd-46ac-aafe-1d0e4a50e371_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FinanceLeaseLiabilityCurrentAbstract_63eb47d8-756b-4de2-968a-426037837c0d_terseLabel_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt and notes payable</link:label>
    <link:label id="lab_sem_FinanceLeaseLiabilityCurrentAbstract_label_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current [Abstract]</link:label>
    <link:label id="lab_sem_FinanceLeaseLiabilityCurrentAbstract_documentation_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityCurrentAbstract" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FinanceLeaseLiabilityCurrentAbstract" xlink:to="lab_sem_FinanceLeaseLiabilityCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_4118e951-4280-4935-9048-0feb7f747066_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_LeaseCostRelatedParties_b0c38b0c-23e7-4d78-a7b5-bf148f28d9e5_totalLabel_en-US" xlink:label="lab_sem_LeaseCostRelatedParties" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_sem_LeaseCostRelatedParties_label_en-US" xlink:label="lab_sem_LeaseCostRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost, Related Parties</link:label>
    <link:label id="lab_sem_LeaseCostRelatedParties_documentation_en-US" xlink:label="lab_sem_LeaseCostRelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LeaseCostRelatedParties" xlink:href="sem-20210630.xsd#sem_LeaseCostRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_LeaseCostRelatedParties" xlink:to="lab_sem_LeaseCostRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_3ebfc8ea-41c8-4835-b7ad-171db5cd4e7a_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in Excess of&#160;Par</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_c9a84c1c-db90-4d0c-b2f5-3be0bd5c3b47_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_f75ec7a2-bbb4-434a-819a-5503524bdf71_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Type and Tier Identifier [Axis]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Type and Tier Identifier [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis" xlink:to="lab_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_866e4175-6b83-4245-ab0f-00bc5aa93827_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_c96ea61f-3ae9-4244-81e9-b46818ae55e0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_ProceedsFromGovernmentAssistanceCARESAct_62888b7e-aa15-48bc-bdd2-cd813847dfba_terseLabel_en-US" xlink:label="lab_sem_ProceedsFromGovernmentAssistanceCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government assistance, provider relief payments received, CARES Act</link:label>
    <link:label id="lab_sem_ProceedsFromGovernmentAssistanceCARESAct_label_en-US" xlink:label="lab_sem_ProceedsFromGovernmentAssistanceCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Government Assistance, CARES Act</link:label>
    <link:label id="lab_sem_ProceedsFromGovernmentAssistanceCARESAct_documentation_en-US" xlink:label="lab_sem_ProceedsFromGovernmentAssistanceCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Government Assistance, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ProceedsFromGovernmentAssistanceCARESAct" xlink:href="sem-20210630.xsd#sem_ProceedsFromGovernmentAssistanceCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_ProceedsFromGovernmentAssistanceCARESAct" xlink:to="lab_sem_ProceedsFromGovernmentAssistanceCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_43b1c719-b6e5-43ac-9c39-b70955258931_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings on revolving facilities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_1db8af0b-7b3c-4028-a4a0-1e250ca51756_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_LeaseCostTotalAbstract_e0a92748-9e26-4846-9718-e6f515ad2edc_terseLabel_en-US" xlink:label="lab_sem_LeaseCostTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_sem_LeaseCostTotalAbstract_label_en-US" xlink:label="lab_sem_LeaseCostTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost, Total [Abstract]</link:label>
    <link:label id="lab_sem_LeaseCostTotalAbstract_documentation_en-US" xlink:label="lab_sem_LeaseCostTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost, Total</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LeaseCostTotalAbstract" xlink:href="sem-20210630.xsd#sem_LeaseCostTotalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_LeaseCostTotalAbstract" xlink:to="lab_sem_LeaseCostTotalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_2e84a6ed-5d5e-475f-8813-68aaf5bc4340_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_de0a55fe-21e3-4c12-b895-ca0e7ce2364e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditLossAbstract_6ee7db55-e1b8-4c42-aa33-dfb9fcceccd5_terseLabel_en-US" xlink:label="lab_us-gaap_CreditLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Loss [Abstract]</link:label>
    <link:label id="lab_us-gaap_CreditLossAbstract_label_en-US" xlink:label="lab_us-gaap_CreditLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditLossAbstract" xlink:to="lab_us-gaap_CreditLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_080b47ae-f6e1-4574-8291-88afad30dd08_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_bd38efc7-7344-48da-b8c1-124d3b47b1fa_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_3120497a-abe6-4d31-8945-6d14ec7b07ff_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_802d5d41-e4b7-4d78-8317-2e3b031c1fe6_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityOtherChanges_9ea582f4-179b-4726-8942-97099a345df7_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityOtherChanges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityOtherChanges_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityOtherChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Other Changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityOtherChanges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityOtherChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityOtherChanges" xlink:to="lab_us-gaap_TemporaryEquityOtherChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3f0bcaee-0638-4d99-b67d-49680eff1570_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_4762476c-e5b3-404a-a85c-e9aecdf17582_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_457517a9-b1c7-41e3-8adc-a30f90c7ab19_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_3c3479ba-1271-4da7-9951-5fdbc87dab6d_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_f5bcd2e3-3200-4a3d-8076-1df69e08960c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ab2bf54f-a9ec-457f-aea2-b5276108a66b_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ccc86313-3520-48f4-9234-45aec401a9a7_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FinanceLeaseLiabilityRelatedParties_bd36a4d0-a6cb-4faa-88a3-093942c6b245_terseLabel_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseLiabilityRelatedParties_label_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Related Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseLiabilityRelatedParties_documentation_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityRelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityRelatedParties" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FinanceLeaseLiabilityRelatedParties" xlink:to="lab_sem_FinanceLeaseLiabilityRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_SubleaseIncomeRelatedParties_bcb00529-f649-4bd8-a200-38447c24a38d_negatedLabel_en-US" xlink:label="lab_sem_SubleaseIncomeRelatedParties" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_sem_SubleaseIncomeRelatedParties_label_en-US" xlink:label="lab_sem_SubleaseIncomeRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income, Related Parties</link:label>
    <link:label id="lab_sem_SubleaseIncomeRelatedParties_documentation_en-US" xlink:label="lab_sem_SubleaseIncomeRelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_SubleaseIncomeRelatedParties" xlink:href="sem-20210630.xsd#sem_SubleaseIncomeRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_SubleaseIncomeRelatedParties" xlink:to="lab_sem_SubleaseIncomeRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_c4e10e8a-dc71-469e-b6a3-3d65e01ec775_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4c867678-c99b-41ad-9139-aba3ab3eb42f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_4acd16d2-8e82-4acc-984f-869fd63125ae_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties_86902903-05c8-4fea-88ce-25aa778dc9d3_terseLabel_en-US" xlink:label="lab_sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties_label_en-US" xlink:label="lab_sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Amortization, Related Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties_documentation_en-US" xlink:label="lab_sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Amortization, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties" xlink:href="sem-20210630.xsd#sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties" xlink:to="lab_sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_20c19f4a-efda-4e2a-93ef-124c60f5e860_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_193e472d-9c6c-484c-99f5-24742deeff13_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_441ff176-8d2f-4caf-af6a-de979ba9ec38_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of businesses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_9444bf83-575a-49cf-9f7c-65e54ce553fd_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of businesses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_add0408e-b515-4ce8-8673-a80b2f84241e_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Risk Concentrations</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_c1ebd092-4ec4-4a50-a6f2-e10fd500aaf9_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_ff2903b8-ae4a-4b22-a610-65a87c4fd5a6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_8594e93d-f64e-46a3-9254-24b81256626e_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsNoncurrent_6c998f9e-5b6d-4221-ab44-11071bcab358_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap contract, non-current portion</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsNoncurrent" xlink:to="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_0e8be0b8-4830-47cd-953d-50a3da2245f6_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted cash flows</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_401ec0dc-70ef-4bef-93d4-1a57992ad7db_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_a831db93-6d4a-4bde-8c6b-9183f713b14a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_a9dceb1f-59bb-4e41-9e02-906c9e67c207_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_ebd362c6-41d2-4de0-ac1c-d2fe0c6e0e1b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_8b56fe80-f19c-4670-9c85-f1a02213a8db_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_b3ff3d8a-2315-4a4a-b9fa-3859f5cd1d50_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtraordinaryAndUnusualItemsAbstract_label_en-US" xlink:label="lab_us-gaap_ExtraordinaryAndUnusualItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Items, or Both [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtraordinaryAndUnusualItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtraordinaryAndUnusualItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtraordinaryAndUnusualItemsAbstract" xlink:to="lab_us-gaap_ExtraordinaryAndUnusualItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_33c121ff-af02-456f-83b8-51106e3eb2ff_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_c5390a76-86ed-4327-b68d-a1a0af617668_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_b25c9a86-ddf1-4a59-81de-121ba2315bec_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_885141e2-5b56-4e25-bb03-e2a5529c4771_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_d73824d3-8f12-4fbb-83e0-5f346484bc51_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateJointVentureMember_5d0b7436-be1e-46e7-a3bc-24ce7bdab5df_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Operations</link:label>
    <link:label id="lab_us-gaap_CorporateJointVentureMember_label_en-US" xlink:label="lab_us-gaap_CorporateJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateJointVentureMember" xlink:to="lab_us-gaap_CorporateJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_4138e628-7b49-4508-b0e4-2ea07a1557bb_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FinanceLeaseRightOfUseAssetAmortizationAbstract_51e92fe1-d951-4e4b-af4e-e0c704563628_terseLabel_en-US" xlink:label="lab_sem_FinanceLeaseRightOfUseAssetAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_sem_FinanceLeaseRightOfUseAssetAmortizationAbstract_label_en-US" xlink:label="lab_sem_FinanceLeaseRightOfUseAssetAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization [Abstract]</link:label>
    <link:label id="lab_sem_FinanceLeaseRightOfUseAssetAmortizationAbstract_documentation_en-US" xlink:label="lab_sem_FinanceLeaseRightOfUseAssetAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseRightOfUseAssetAmortizationAbstract" xlink:href="sem-20210630.xsd#sem_FinanceLeaseRightOfUseAssetAmortizationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FinanceLeaseRightOfUseAssetAmortizationAbstract" xlink:to="lab_sem_FinanceLeaseRightOfUseAssetAmortizationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_f12f5a23-040e-4764-81c3-c6884a2ab10e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_4e98378e-fa13-4d7a-8fc9-69edfb168881_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2a9cf156-d686-4c52-9167-6b21cc33298e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets, carrying amount</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_VariableLeaseCostUnrelatedParties_f293992d-7986-489d-84b6-9acee3ffd060_terseLabel_en-US" xlink:label="lab_sem_VariableLeaseCostUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrelated Parties</link:label>
    <link:label id="lab_sem_VariableLeaseCostUnrelatedParties_label_en-US" xlink:label="lab_sem_VariableLeaseCostUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost, Unrelated Parties</link:label>
    <link:label id="lab_sem_VariableLeaseCostUnrelatedParties_documentation_en-US" xlink:label="lab_sem_VariableLeaseCostUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost, Unrelated Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_VariableLeaseCostUnrelatedParties" xlink:href="sem-20210630.xsd#sem_VariableLeaseCostUnrelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_VariableLeaseCostUnrelatedParties" xlink:to="lab_sem_VariableLeaseCostUnrelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_76a60554-e82a-45d1-af4a-66bbd5b7cf09_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_b3c01c86-a64e-4379-b3c1-cb7eff2e20fd_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2ca5811b-8f1b-4533-8712-c3bbbeef260f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_729a79f8-780b-4633-9795-90550fb7285f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c4b07990-b714-4c8f-9f9d-91151cc485da_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_43d5c55f-6e19-405d-b5d6-e92a9b3145cb_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f0d14871-0da0-47f6-9609-6c9754aaaa6d_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_5e8fe43d-967b-4803-a651-41358989a4b3_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_a33b2cae-61bf-4d49-a86a-18e67579e8ae_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_14cf1767-d5af-4d5e-8005-ff08bf44473f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e4a339a2-a5a4-4f71-a9a2-927208d951f0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_dab371fa-30fc-4b4f-a67d-b5c50e8d8d51_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_f3ab6e10-559b-467f-a516-0d7b20247ecb_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9b2e6029-d894-4f7c-8236-9346178bdfe8_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted cash flows</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_e3ca5bac-5a2c-46a6-8d04-140ca61f14b1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_bdf193b3-3752-4cfe-86a9-3eb1e2caebc4_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_4b58b625-a82a-4f91-ad10-0c09e0318cba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification adjustment for (gains) losses included in net income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_8d570553-b607-4fc4-8525-fd205ca440b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of selected financial data for the Company's reportable segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_aa30293d-6654-4701-92e5-d35d513d5576_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_56ad5562-bbb2-4e31-8791-35f50edcec49_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_9f0287bf-130d-40b4-86a0-69f65742e155_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_9ddf419c-cf96-4bc8-8650-1e54310eb7f3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_add4d943-2768-4a87-98f0-ae7e278129f9_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Distributed and undistributed income attributable to participating securities - Basic EPS</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_fda93f0c-2b32-4d10-b2e0-26ab729156f0_verboseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income allocated to participating securities</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings (Loss) Allocated to Participating Securities, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:to="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_MedicareReceivableMember_fe5ff339-661b-495a-947f-28b090850cf7_terseLabel_en-US" xlink:label="lab_sem_MedicareReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Receivable</link:label>
    <link:label id="lab_sem_MedicareReceivableMember_label_en-US" xlink:label="lab_sem_MedicareReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Receivable [Member]</link:label>
    <link:label id="lab_sem_MedicareReceivableMember_documentation_en-US" xlink:label="lab_sem_MedicareReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_MedicareReceivableMember" xlink:href="sem-20210630.xsd#sem_MedicareReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_MedicareReceivableMember" xlink:to="lab_sem_MedicareReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_ebd845d7-6d34-4080-aa83-e353016fb73a_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests acquired in business combination</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxes_bbe67039-5f22-4b7a-9cde-16e81a7fc116_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_7931d84f-0c0c-48c8-938c-43de0c54d3eb_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_ee8af7fe-2c3d-4873-88eb-4a0f9887bd21_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_99f9488f-05a3-49f7-914d-7ff4b7752a77_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_d9422f74-16e3-4cd6-85eb-374d69db00da_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree_2e8b89c9-95c2-4d4e-90d8-6fd981b2b4e8_terseLabel_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Three</link:label>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree_documentation_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_766949c4-3278-435a-a638-7bac53bea31f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_10e9e832-1468-4494-9d04-28d6b67a51cd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_52525b0e-fdc0-431d-bb97-bc52ac00350c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_bd532c86-3c68-4527-9dbe-adf4d140a7b4_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_e5f7483a-62bb-4f3d-9d69-1ebfd89ad48c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on other debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct_2fd72dc4-eb18-4b3a-bc40-45d6bbe84661_terseLabel_en-US" xlink:label="lab_sem_UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned government assistance, amount expected to be repaid, CARES Act</link:label>
    <link:label id="lab_sem_UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct_label_en-US" xlink:label="lab_sem_UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned Government Assistance, Amount Expected To Be Repaid, CARES Act</link:label>
    <link:label id="lab_sem_UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct_documentation_en-US" xlink:label="lab_sem_UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned Government Assistance, Amount Expected To Be Repaid, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct" xlink:href="sem-20210630.xsd#sem_UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct" xlink:to="lab_sem_UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_ab5b428b-5ddc-42a3-a414-cd93bb0eb5fd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_5873ff1e-e084-4b75-a81c-64b82a6f3527_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on interest rate cap cash flow hedge</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_582c4df9-a773-43fd-b3eb-957816ef8d74_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties_11d98f7c-cf8f-41ed-9bb9-9b7b8c2b5db3_terseLabel_en-US" xlink:label="lab_sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrelated Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties_label_en-US" xlink:label="lab_sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Amortization, Unrelated Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties_documentation_en-US" xlink:label="lab_sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Amortization, Unrelated Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties" xlink:href="sem-20210630.xsd#sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties" xlink:to="lab_sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_e62fdb3c-6c46-4b31-b72b-73245f57d2b7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeitures of unvested restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension_a9386e73-0ea2-4d57-9ad5-4a6de7e93f27_terseLabel_en-US" xlink:label="lab_sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average time until next renewal</link:label>
    <link:label id="lab_sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension_label_en-US" xlink:label="lab_sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Asset, Weighted Average Period before Next Renewal or Extension</link:label>
    <link:label id="lab_sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension_documentation_en-US" xlink:label="lab_sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Asset, Weighted Average Period before Next Renewal or Extension</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension" xlink:href="sem-20210630.xsd#sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension" xlink:to="lab_sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_bda12e25-2195-4aed-aed5-75499c9452fe_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total identifiable intangible assets, gross carrying amount</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_71110350-9065-45c0-8c7e-42ae7b5f2cc8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_8b2fe666-eafa-4351-ab53-f72fea9a0e0b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_LeaseCostUnrelatedParties_381e658e-85bd-4220-bebc-dd786f4adb83_totalLabel_en-US" xlink:label="lab_sem_LeaseCostUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrelated Parties</link:label>
    <link:label id="lab_sem_LeaseCostUnrelatedParties_label_en-US" xlink:label="lab_sem_LeaseCostUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost - Unrelated Parties</link:label>
    <link:label id="lab_sem_LeaseCostUnrelatedParties_documentation_en-US" xlink:label="lab_sem_LeaseCostUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost - Unrelated Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LeaseCostUnrelatedParties" xlink:href="sem-20210630.xsd#sem_LeaseCostUnrelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_LeaseCostUnrelatedParties" xlink:to="lab_sem_LeaseCostUnrelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_d6d8a3ff-3b3a-486a-a54e-7edb7606e9fb_terseLabel_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligations payable</link:label>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_label_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Affiliate, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToAffiliateCurrent" xlink:to="lab_us-gaap_DueToAffiliateCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_8b6634f1-b853-4e6c-808f-b81e4a993e14_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_44e44360-a1fe-4326-b97a-57c8e1597e83_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f20290bb-05ca-4245-a38d-79a58f52c7b2_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ac3e08da-a691-4a3a-810a-75ba0ed188e4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_33696310-c49a-4947-b9fb-eedb80effd5e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementInterest_1d8348c0-7f97-48bf-99c1-99dce177405a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementInterest_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementInterest" xlink:to="lab_us-gaap_LitigationSettlementInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_06f46044-883a-4572-8526-61e86c5c1793_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of carrying value and amortization of identifiable intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights_3f53e289-cc14-4fb1-89bc-154e70d6e5d1_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average participating securities outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Participating Nonvested Shares with Non-forfeitable Dividend Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityAbstract_233c7b4d-d0bb-45ed-85ff-0b4b0e7b3ddc_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_89119588-cc36-4a84-af70-f61a13b6ae0c_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_5eab96fc-caf6-4527-8a2c-890916d32c91_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_18d4521f-b56a-46db-bc98-714ab65a5828_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_OperatingLeaseLiabilityUnrelatedParties_317403d2-65b4-4668-8976-cf0b4866ac80_totalLabel_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrelated Parties</link:label>
    <link:label id="lab_sem_OperatingLeaseLiabilityUnrelatedParties_label_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Unrelated Parties</link:label>
    <link:label id="lab_sem_OperatingLeaseLiabilityUnrelatedParties_documentation_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Unrelated Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityUnrelatedParties" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityUnrelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_OperatingLeaseLiabilityUnrelatedParties" xlink:to="lab_sem_OperatingLeaseLiabilityUnrelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_0cb9abbf-7f32-4a85-a2df-09328a49b035_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_ca966b5f-46ca-47ea-b0ea-3bab9c9d33e6_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d011c992-1d01-4152-8780-546c45fc4b3b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of computation of basic and diluted earnings per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_UnearnedGovernmentAssistanceCARESAct_3420bbd2-7be0-4cc0-8729-aa4cb6239657_terseLabel_en-US" xlink:label="lab_sem_UnearnedGovernmentAssistanceCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned government assistance (Note 15)</link:label>
    <link:label id="lab_sem_UnearnedGovernmentAssistanceCARESAct_7ca25bc5-68a6-4a6c-8d89-d5a6a611f782_verboseLabel_en-US" xlink:label="lab_sem_UnearnedGovernmentAssistanceCARESAct" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned government assistance, CARES Act</link:label>
    <link:label id="lab_sem_UnearnedGovernmentAssistanceCARESAct_label_en-US" xlink:label="lab_sem_UnearnedGovernmentAssistanceCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned Government Assistance, CARES Act</link:label>
    <link:label id="lab_sem_UnearnedGovernmentAssistanceCARESAct_documentation_en-US" xlink:label="lab_sem_UnearnedGovernmentAssistanceCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned Government Assistance, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_UnearnedGovernmentAssistanceCARESAct" xlink:href="sem-20210630.xsd#sem_UnearnedGovernmentAssistanceCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_UnearnedGovernmentAssistanceCARESAct" xlink:to="lab_sem_UnearnedGovernmentAssistanceCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_8ab2827f-9d7c-410e-ad55-c47f5eaf612a_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_7c687727-1d82-49bb-9b82-7c9f838f7df9_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_393e193f-5fa8-4a1c-92dd-99eaca0be332_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_3525d566-f809-492c-93b1-883c4846cd94_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated pre-tax losses expected to be reclassified in the next twelve months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_fe8ee176-d559-4c23-a715-3496aeb60c28_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_d06e6bd9-a2cb-4007-a93c-63322e72b9c8_verboseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_e3fec689-a93f-4afc-b93d-a8c1aec28437_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FinanceLeaseLiabilityCurrentUnrelatedParties_b205f321-24ce-4540-a24e-897a84f964d8_terseLabel_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityCurrentUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrelated Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseLiabilityCurrentUnrelatedParties_label_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityCurrentUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Unrelated Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseLiabilityCurrentUnrelatedParties_documentation_en-US" xlink:label="lab_sem_FinanceLeaseLiabilityCurrentUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Unrelated Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityCurrentUnrelatedParties" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityCurrentUnrelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FinanceLeaseLiabilityCurrentUnrelatedParties" xlink:to="lab_sem_FinanceLeaseLiabilityCurrentUnrelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_8d38c646-7c6a-4d6a-b1b2-a536a5e3cf3a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_d8f2dc6f-163b-4c98-bf0f-aa71e968487a_terseLabel_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Next Twelve Months</link:label>
    <link:label id="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_documentation_en-US" xlink:label="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_1f392015-40a3-46de-b305-f8794c730999_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_31abb211-324d-46a0-9f62-e09264ebcf54_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributed and undistributed income attributable to common shares</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_ca90f384-082d-4caa-8327-4dabcf13f42d_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income allocated to common shares - diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_97be1c25-18d2-4ac4-92a9-79df888ed7b8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on term loans</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:to="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_57d1045f-f64d-4e0a-b482-1924512338d6_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributed and undistributed income attributable to common shares</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_d54cd077-5d58-413c-9622-1535bbf37c2f_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income allocated to common shares - basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_ce5d2bd1-d2d8-47f1-9fc3-d757e2e8cc42_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_41fb7c37-ea6b-43a5-9a76-53eb5f267210_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_GovernmentAdvancesRecoupedCARESAct_80628ece-7c8a-4a54-b505-7c72e007dfb0_verboseLabel_en-US" xlink:label="lab_sem_GovernmentAdvancesRecoupedCARESAct" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government advances recouped, CARES Act</link:label>
    <link:label id="lab_sem_GovernmentAdvancesRecoupedCARESAct_label_en-US" xlink:label="lab_sem_GovernmentAdvancesRecoupedCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Advances Recouped, CARES Act</link:label>
    <link:label id="lab_sem_GovernmentAdvancesRecoupedCARESAct_documentation_en-US" xlink:label="lab_sem_GovernmentAdvancesRecoupedCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Advances Recouped, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_GovernmentAdvancesRecoupedCARESAct" xlink:href="sem-20210630.xsd#sem_GovernmentAdvancesRecoupedCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_GovernmentAdvancesRecoupedCARESAct" xlink:to="lab_sem_GovernmentAdvancesRecoupedCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_fc640900-97d8-4d59-bf09-e293eae142de_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_0077613e-1ab2-47a8-9830-0805a6f6ec1d_negatedLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_d503f9d7-d6f9-401b-9a84-518a8fb74d54_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate of debt (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_4c58a536-7af5-4229-93a9-0fe8166e4a00_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8214e20a-770c-4e7a-a3d5-7840344cd50b_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net income attributable to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_8619a21c-3056-4f50-9d9a-6951edba5cab_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Non-Controlling Interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_8f8b9b54-0cbc-48d6-8e09-830280d78900_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_86f4ed02-38ef-46bb-a8e3-7f35fed9e3ad_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_ac060e68-556f-4cfb-aa43-572319805089_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_fae65be3-cb72-4519-8797-2b84b7bbcb4b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_ed8c70ac-6ba2-4b9a-a488-518e5f33529c_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4b079dd4-cdc3-494f-8198-37cecc21ec2a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_bee01ae6-1453-41db-98c1-2fda8e10d004_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_18872e62-54cb-42dc-90e7-0d4691d9e48d_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_0ab3ddb9-9a10-4d95-a641-17270e74f61e_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_25719b24-7286-4ec9-bdf3-81a61ff30121_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_c891a6df-8de2-47be-9838-de171947130e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic EPS</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7eb3d1b0-67a5-461b-a846-c843d1934ce1_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_745fbc0b-c94c-4ea9-adbd-a2b1bfe31b5a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_0b4b16ef-1595-45ef-a098-1d22956efe79_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_7085ff99-79bc-4736-a784-1991eff44774_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FinanceLeaseInterestExpenseAbstract_a5a4f5b7-d70f-4a0f-9cec-b13fbe5144e8_terseLabel_en-US" xlink:label="lab_sem_FinanceLeaseInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_sem_FinanceLeaseInterestExpenseAbstract_label_en-US" xlink:label="lab_sem_FinanceLeaseInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense [Abstract]</link:label>
    <link:label id="lab_sem_FinanceLeaseInterestExpenseAbstract_documentation_en-US" xlink:label="lab_sem_FinanceLeaseInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseInterestExpenseAbstract" xlink:href="sem-20210630.xsd#sem_FinanceLeaseInterestExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FinanceLeaseInterestExpenseAbstract" xlink:to="lab_sem_FinanceLeaseInterestExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_ae7d6f23-29b4-4c12-99d2-ea89a583c327_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on revolving facilities</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_74fa3f53-b759-4a2a-87ca-ecdfd6292f5d_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount, premium and issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_dd008a87-2eee-476b-b53f-e57ce1f65ae0_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to redeemable non-controlling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_ProceedsFromLegalSettlementsAccruedInterest_3b2fa604-562e-46ad-8621-ed222f5c860a_terseLabel_en-US" xlink:label="lab_sem_ProceedsFromLegalSettlementsAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_sem_ProceedsFromLegalSettlementsAccruedInterest_label_en-US" xlink:label="lab_sem_ProceedsFromLegalSettlementsAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Legal Settlements, Accrued Interest</link:label>
    <link:label id="lab_sem_ProceedsFromLegalSettlementsAccruedInterest_documentation_en-US" xlink:label="lab_sem_ProceedsFromLegalSettlementsAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Legal Settlements, Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ProceedsFromLegalSettlementsAccruedInterest" xlink:href="sem-20210630.xsd#sem_ProceedsFromLegalSettlementsAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_ProceedsFromLegalSettlementsAccruedInterest" xlink:to="lab_sem_ProceedsFromLegalSettlementsAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_5b9b32dd-ce1c-4231-9af7-6940cbe8a1ac_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_4a89ce47-5a29-4abe-914f-36e6ec187e1a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_9826a9d7-a8fc-48ad-bc5d-cfa4383f54cb_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_fef23d72-837c-40d4-99d9-01948fc5b351_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to and purchases of non-controlling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_86e4ebb4-f937-4bf4-993e-3a0452de84be_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to Select Medical Holdings Corporation</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_87c38ebc-60c5-47d8-898d-84d8dbfbad05_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_9de27bb5-303d-4574-b75a-f19bba11dca9_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total identifiable intangible assets, net carrying amount</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_SelectMedicalCorporationMember_e69e3288-b3b1-4c27-9c42-d8699182d894_terseLabel_en-US" xlink:label="lab_sem_SelectMedicalCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Select Medical Corporation</link:label>
    <link:label id="lab_sem_SelectMedicalCorporationMember_label_en-US" xlink:label="lab_sem_SelectMedicalCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Select Medical Corporation [Member]</link:label>
    <link:label id="lab_sem_SelectMedicalCorporationMember_documentation_en-US" xlink:label="lab_sem_SelectMedicalCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Select Medical Corporation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_SelectMedicalCorporationMember" xlink:href="sem-20210630.xsd#sem_SelectMedicalCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_SelectMedicalCorporationMember" xlink:to="lab_sem_SelectMedicalCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_OperatingLeaseRightOfUseAssetUnrelatedParties_ae950c40-7a21-4347-ad86-548b8ef1d95d_terseLabel_en-US" xlink:label="lab_sem_OperatingLeaseRightOfUseAssetUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrelated Parties</link:label>
    <link:label id="lab_sem_OperatingLeaseRightOfUseAssetUnrelatedParties_label_en-US" xlink:label="lab_sem_OperatingLeaseRightOfUseAssetUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Unrelated Parties</link:label>
    <link:label id="lab_sem_OperatingLeaseRightOfUseAssetUnrelatedParties_documentation_en-US" xlink:label="lab_sem_OperatingLeaseRightOfUseAssetUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Unrelated Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseRightOfUseAssetUnrelatedParties" xlink:href="sem-20210630.xsd#sem_OperatingLeaseRightOfUseAssetUnrelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_OperatingLeaseRightOfUseAssetUnrelatedParties" xlink:to="lab_sem_OperatingLeaseRightOfUseAssetUnrelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_dc7e2b6b-8448-476f-b7f0-635844b5c7f0_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties_40f21a13-1b6e-46f6-9e71-1878465931ae_terseLabel_en-US" xlink:label="lab_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties_label_en-US" xlink:label="lab_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, After Accumulated Amortization, Related Parties</link:label>
    <link:label id="lab_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties_documentation_en-US" xlink:label="lab_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, After Accumulated Amortization, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties" xlink:href="sem-20210630.xsd#sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties" xlink:to="lab_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_3a3916a7-2ab8-4730-9613-7affd4a8e279_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_a0b62792-bf43-4b1f-a7bf-1315986b516e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_d00c11e4-fdc9-43c7-93c7-1a59733d7332_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of unconsolidated subsidiaries</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_c4491f75-58f3-441e-b2db-346008d40b1e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of unconsolidated subsidiaries</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_21b80fba-16a0-4dce-900a-d91af6481dbd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap contract, non-current portion</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_GovernmentAdvancesCARESAct_8de6a7a9-22b0-4858-afad-aefe46722a5a_terseLabel_en-US" xlink:label="lab_sem_GovernmentAdvancesCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government advances (Note 15)</link:label>
    <link:label id="lab_sem_GovernmentAdvancesCARESAct_b7e93611-e38a-4e93-95d0-9d4a6f5c7d19_verboseLabel_en-US" xlink:label="lab_sem_GovernmentAdvancesCARESAct" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government advances, CARES Act</link:label>
    <link:label id="lab_sem_GovernmentAdvancesCARESAct_label_en-US" xlink:label="lab_sem_GovernmentAdvancesCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Advances, CARES Act</link:label>
    <link:label id="lab_sem_GovernmentAdvancesCARESAct_documentation_en-US" xlink:label="lab_sem_GovernmentAdvancesCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Advances, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_GovernmentAdvancesCARESAct" xlink:href="sem-20210630.xsd#sem_GovernmentAdvancesCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_GovernmentAdvancesCARESAct" xlink:to="lab_sem_GovernmentAdvancesCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_6c56acf1-f1a0-4194-a047-a089720a1f07_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeitures of unvested restricted stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_RehabilitationHospitalsMember_8473f3b6-80cb-4f44-88fc-8edc768b59ba_terseLabel_en-US" xlink:label="lab_sem_RehabilitationHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rehabilitation Hospital</link:label>
    <link:label id="lab_sem_RehabilitationHospitalsMember_label_en-US" xlink:label="lab_sem_RehabilitationHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rehabilitation Hospitals [Member]</link:label>
    <link:label id="lab_sem_RehabilitationHospitalsMember_documentation_en-US" xlink:label="lab_sem_RehabilitationHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rehabilitation Hospitals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_RehabilitationHospitalsMember" xlink:href="sem-20210630.xsd#sem_RehabilitationHospitalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_RehabilitationHospitalsMember" xlink:to="lab_sem_RehabilitationHospitalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_2615e6b5-3a3b-4731-b42c-02b17903965d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_e8672c85-b7cc-4c4d-9063-1cfda2ea2403_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_c5947951-d4ba-41d9-a77d-9a598e3ffbd9_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_e1229de1-6d61-4a91-b527-7f2fb25d8fc0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_5e723241-9ced-4b31-b2c4-4da2347635b6_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_e7f90cfa-1f67-4d3d-bb94-9f7cda908f2d_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_5a8afd54-5252-4922-addc-9c04d36244c0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared for common stockholders ($0.125 per share)</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_45538a4b-32a6-4c7a-b854-57d7a8ce5f14_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_b5b7c4d7-c7de-45f2-b91a-65db6d3293dc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_76221b50-164f-4bf3-9a60-d26c50144881_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating income</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_d427d187-5125-4320-9ad7-cd2597a92812_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_5e720e94-115d-41e8-89ef-f6c2759d15f0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_OperatingLeaseLiabilityCurrentUnrelatedParties_9eb1eb48-2741-4179-9775-d0cb630b542b_terseLabel_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityCurrentUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrelated Parties</link:label>
    <link:label id="lab_sem_OperatingLeaseLiabilityCurrentUnrelatedParties_label_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityCurrentUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Unrelated Parties</link:label>
    <link:label id="lab_sem_OperatingLeaseLiabilityCurrentUnrelatedParties_documentation_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityCurrentUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Unrelated Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityCurrentUnrelatedParties" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityCurrentUnrelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_OperatingLeaseLiabilityCurrentUnrelatedParties" xlink:to="lab_sem_OperatingLeaseLiabilityCurrentUnrelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_LongTermDebtGrossAndFinanceLeaseObligation_8bd56f65-c567-4bdb-b11b-c0583a1df21a_terseLabel_en-US" xlink:label="lab_sem_LongTermDebtGrossAndFinanceLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Outstanding</link:label>
    <link:label id="lab_sem_LongTermDebtGrossAndFinanceLeaseObligation_60e460ba-215a-4776-90f7-d1174d6e525c_totalLabel_en-US" xlink:label="lab_sem_LongTermDebtGrossAndFinanceLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_sem_LongTermDebtGrossAndFinanceLeaseObligation_label_en-US" xlink:label="lab_sem_LongTermDebtGrossAndFinanceLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross And Finance Lease Obligation</link:label>
    <link:label id="lab_sem_LongTermDebtGrossAndFinanceLeaseObligation_documentation_en-US" xlink:label="lab_sem_LongTermDebtGrossAndFinanceLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross And Finance Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtGrossAndFinanceLeaseObligation" xlink:href="sem-20210630.xsd#sem_LongTermDebtGrossAndFinanceLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_LongTermDebtGrossAndFinanceLeaseObligation" xlink:to="lab_sem_LongTermDebtGrossAndFinanceLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_1f095793-906e-40e4-899d-f460bc856e3a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_ee1ac130-8c10-40d4-98f0-adfd9097f5c9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_ed6bdb30-4eee-4792-8719-93b50d1d8d17_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_OperatingLeaseLiabilityCurrentAbstract_a0cd1cc6-5c97-4084-af07-a4723f823cfb_terseLabel_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_sem_OperatingLeaseLiabilityCurrentAbstract_label_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current [Abstract]</link:label>
    <link:label id="lab_sem_OperatingLeaseLiabilityCurrentAbstract_documentation_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityCurrentAbstract" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_OperatingLeaseLiabilityCurrentAbstract" xlink:to="lab_sem_OperatingLeaseLiabilityCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_de366a5f-7b98-44a2-95bb-43e0ae0c0d5c_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_OperatingLeaseCostUnrelatedParties_73462be8-3825-45d6-9e33-66dc2a1e1173_terseLabel_en-US" xlink:label="lab_sem_OperatingLeaseCostUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrelated Parties</link:label>
    <link:label id="lab_sem_OperatingLeaseCostUnrelatedParties_label_en-US" xlink:label="lab_sem_OperatingLeaseCostUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost, Unrelated Parties</link:label>
    <link:label id="lab_sem_OperatingLeaseCostUnrelatedParties_documentation_en-US" xlink:label="lab_sem_OperatingLeaseCostUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost, Unrelated Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseCostUnrelatedParties" xlink:href="sem-20210630.xsd#sem_OperatingLeaseCostUnrelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_OperatingLeaseCostUnrelatedParties" xlink:to="lab_sem_OperatingLeaseCostUnrelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_b06c4515-4d31-413d-bb29-04316fba0f2e_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_9cb30b2c-e847-4f05-800e-97b7d4573273_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_eeb464dd-30d6-48e1-8760-3b58f114ac28_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Distributed and undistributed income attributable to participating securities - Diluted EPS</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:to="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_d485c645-10cf-42fa-b953-71223a7c9cf1_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_b0680293-294f-4d03-9795-9b165b286a25_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Risk Concentrations</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_4d840eaf-7ffc-4c71-becb-027e5f0c8de2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_5669ac99-a598-42db-8aa7-88a98fca71d4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_OperatingLeaseRightOfUseAssetAbstract_d9c86340-8e03-4407-a610-7ddf6ef5cbad_terseLabel_en-US" xlink:label="lab_sem_OperatingLeaseRightOfUseAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_sem_OperatingLeaseRightOfUseAssetAbstract_label_en-US" xlink:label="lab_sem_OperatingLeaseRightOfUseAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset [Abstract]</link:label>
    <link:label id="lab_sem_OperatingLeaseRightOfUseAssetAbstract_documentation_en-US" xlink:label="lab_sem_OperatingLeaseRightOfUseAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseRightOfUseAssetAbstract" xlink:href="sem-20210630.xsd#sem_OperatingLeaseRightOfUseAssetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_OperatingLeaseRightOfUseAssetAbstract" xlink:to="lab_sem_OperatingLeaseRightOfUseAssetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_d81ae8bd-eb7e-4a34-8dbe-bf0fde111632_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Company's long-term debt and notes payable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_cf938e64-39c7-4c61-af2e-6d03b9c3510e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_68f72ec2-a3c5-4f21-865b-c62cda7ec703_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per common share (Note 13):</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_OperatingLeaseCostRelatedParties_1697f42f-28d6-4713-92a9-c853d44623ba_terseLabel_en-US" xlink:label="lab_sem_OperatingLeaseCostRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_sem_OperatingLeaseCostRelatedParties_label_en-US" xlink:label="lab_sem_OperatingLeaseCostRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost, Related Parties</link:label>
    <link:label id="lab_sem_OperatingLeaseCostRelatedParties_documentation_en-US" xlink:label="lab_sem_OperatingLeaseCostRelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseCostRelatedParties" xlink:href="sem-20210630.xsd#sem_OperatingLeaseCostRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_OperatingLeaseCostRelatedParties" xlink:to="lab_sem_OperatingLeaseCostRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_af7d520f-5b98-4cb8-af0e-fe98954d2102_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_49f0917b-f1f0-41cc-a7f1-ce5ca1391f57_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from AOCI</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_9a01bee8-eb53-4788-88db-19d7a2ad4bd1_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityAbstract_8dea02c5-b210-401f-bac1-7373c750a780_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_54effe9d-d51c-484c-b8c4-62d1438f029b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_CertificatesOfNeedMember_b85ebe6c-5f20-417f-8eb9-1bfff2e540f4_terseLabel_en-US" xlink:label="lab_sem_CertificatesOfNeedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of need</link:label>
    <link:label id="lab_sem_CertificatesOfNeedMember_label_en-US" xlink:label="lab_sem_CertificatesOfNeedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates Of Need [Member]</link:label>
    <link:label id="lab_sem_CertificatesOfNeedMember_documentation_en-US" xlink:label="lab_sem_CertificatesOfNeedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to certificates of need, a legal document of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_CertificatesOfNeedMember" xlink:href="sem-20210630.xsd#sem_CertificatesOfNeedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_CertificatesOfNeedMember" xlink:to="lab_sem_CertificatesOfNeedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FinanceLeaseAssetsAndLiabilitiesAbstract_16d52385-9670-4db4-b54d-3178c539dcb8_terseLabel_en-US" xlink:label="lab_sem_FinanceLeaseAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_sem_FinanceLeaseAssetsAndLiabilitiesAbstract_label_en-US" xlink:label="lab_sem_FinanceLeaseAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Assets And Liabilities [Abstract]</link:label>
    <link:label id="lab_sem_FinanceLeaseAssetsAndLiabilitiesAbstract_documentation_en-US" xlink:label="lab_sem_FinanceLeaseAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Assets And Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseAssetsAndLiabilitiesAbstract" xlink:href="sem-20210630.xsd#sem_FinanceLeaseAssetsAndLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FinanceLeaseAssetsAndLiabilitiesAbstract" xlink:to="lab_sem_FinanceLeaseAssetsAndLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_bdcbb97e-34b6-4ad5-ab40-b65cd81dbe47_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_653bcee0-b707-4058-bfc6-99b022a47b70_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_64dc07d5-8aea-4634-9169-b7bbe4368d93_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_48a2ad97-e1b0-4a35-921a-4690e45b7379_negatedLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_034d751f-c75c-4e19-addf-11be5c7db987_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_SubleaseIncomeUnrelatedParties_379828b6-d74b-49b8-810b-4cad4095267d_negatedLabel_en-US" xlink:label="lab_sem_SubleaseIncomeUnrelatedParties" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrelated Parties</link:label>
    <link:label id="lab_sem_SubleaseIncomeUnrelatedParties_label_en-US" xlink:label="lab_sem_SubleaseIncomeUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income, Unrelated Parties</link:label>
    <link:label id="lab_sem_SubleaseIncomeUnrelatedParties_documentation_en-US" xlink:label="lab_sem_SubleaseIncomeUnrelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income, Unrelated Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_SubleaseIncomeUnrelatedParties" xlink:href="sem-20210630.xsd#sem_SubleaseIncomeUnrelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_SubleaseIncomeUnrelatedParties" xlink:to="lab_sem_SubleaseIncomeUnrelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_567f62f8-1f3e-4a3f-a188-9f6826b7f581_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_2d81883b-a97c-4345-9682-4819daabf96b_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FirstLienCreditAgreementMember_7c6e2dd5-baee-4d38-8044-7d3f70257ef1_terseLabel_en-US" xlink:label="lab_sem_FirstLienCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentra-JPM First Lien Credit Agreement</link:label>
    <link:label id="lab_sem_FirstLienCreditAgreementMember_label_en-US" xlink:label="lab_sem_FirstLienCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement [Member]</link:label>
    <link:label id="lab_sem_FirstLienCreditAgreementMember_documentation_en-US" xlink:label="lab_sem_FirstLienCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FirstLienCreditAgreementMember" xlink:href="sem-20210630.xsd#sem_FirstLienCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FirstLienCreditAgreementMember" xlink:to="lab_sem_FirstLienCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_OperatingLeaseRightOfUseAssetRelatedParties_51449f38-5696-49da-876f-ade83aadb24b_terseLabel_en-US" xlink:label="lab_sem_OperatingLeaseRightOfUseAssetRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_sem_OperatingLeaseRightOfUseAssetRelatedParties_label_en-US" xlink:label="lab_sem_OperatingLeaseRightOfUseAssetRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Related Parties</link:label>
    <link:label id="lab_sem_OperatingLeaseRightOfUseAssetRelatedParties_documentation_en-US" xlink:label="lab_sem_OperatingLeaseRightOfUseAssetRelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseRightOfUseAssetRelatedParties" xlink:href="sem-20210630.xsd#sem_OperatingLeaseRightOfUseAssetRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_OperatingLeaseRightOfUseAssetRelatedParties" xlink:to="lab_sem_OperatingLeaseRightOfUseAssetRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_OperatingLeaseLiabilityRelatedParties_a7382850-7737-426e-ae12-b5689156c485_totalLabel_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityRelatedParties" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_sem_OperatingLeaseLiabilityRelatedParties_label_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Related Parties</link:label>
    <link:label id="lab_sem_OperatingLeaseLiabilityRelatedParties_documentation_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityRelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityRelatedParties" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_OperatingLeaseLiabilityRelatedParties" xlink:to="lab_sem_OperatingLeaseLiabilityRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cd2ed006-61cc-443e-b372-e9de57b84fb7_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bdd4ae1c-3510-4eb4-92d0-9b37d8a32df6_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_871ee31c-9425-4590-8f25-7512f5ec795b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_3e00f651-f304-44c1-a1d0-5e43284c5b43_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_072e24ea-924e-41a9-9664-816f14f90102_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_f010dc3e-a290-477d-a8ca-2036e7a38364_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_ab90b6df-5418-4f0b-b662-43c2c0704b9e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, gross carrying amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_da388736-de6f-4ea6-8639-8d230056de22_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_0b675c76-69a5-437b-858b-4ed817bf4caf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_87512373-942d-4d94-be90-93182cfe8cf8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized intangible assets:</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_82a1a325-aa76-4542-95df-94e4f4d4fa96_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_dd205d36-0a14-4694-95dd-6c4a7fe5aab7_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3152283d-1e3b-44eb-ac78-9b89d3cb1be2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3236388f-b988-4bfc-a40c-485fcd893d11_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e0ac3606-270d-4f3b-8eee-1fa3cfad5323_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_b0863f36-8a0c-4ae4-b5ed-c35eb11d7344_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_313a447d-d1b6-4b55-8d9b-c48d71d99bba_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_1adbbeba-e379-449f-8f6d-df5cf6a22d8a_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_9e5ae10e-37ab-4265-bbe1-cdc1b7905f35_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_fa6c7f52-5d51-485e-941c-6f0b3318f53c_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_HealthCarePatientServiceNonMedicareMember_cfb33d3b-8a20-42e9-a060-87c221223f99_terseLabel_en-US" xlink:label="lab_sem_HealthCarePatientServiceNonMedicareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Medicare</link:label>
    <link:label id="lab_sem_HealthCarePatientServiceNonMedicareMember_label_en-US" xlink:label="lab_sem_HealthCarePatientServiceNonMedicareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service, Non-Medicare [Member]</link:label>
    <link:label id="lab_sem_HealthCarePatientServiceNonMedicareMember_documentation_en-US" xlink:label="lab_sem_HealthCarePatientServiceNonMedicareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service, Non-Medicare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_HealthCarePatientServiceNonMedicareMember" xlink:href="sem-20210630.xsd#sem_HealthCarePatientServiceNonMedicareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_HealthCarePatientServiceNonMedicareMember" xlink:to="lab_sem_HealthCarePatientServiceNonMedicareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_6d1dfef0-f638-43f8-95de-bca6c5706087_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_AssetsandLiabilitiesLesseeOperatingLeaseAbstract_c273fe29-6fc2-4620-9c94-bdc523a086dd_terseLabel_en-US" xlink:label="lab_sem_AssetsandLiabilitiesLesseeOperatingLeaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_sem_AssetsandLiabilitiesLesseeOperatingLeaseAbstract_label_en-US" xlink:label="lab_sem_AssetsandLiabilitiesLesseeOperatingLeaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Lessee, Operating Lease [Abstract]</link:label>
    <link:label id="lab_sem_AssetsandLiabilitiesLesseeOperatingLeaseAbstract_documentation_en-US" xlink:label="lab_sem_AssetsandLiabilitiesLesseeOperatingLeaseAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Lessee, Operating Lease [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_AssetsandLiabilitiesLesseeOperatingLeaseAbstract" xlink:href="sem-20210630.xsd#sem_AssetsandLiabilitiesLesseeOperatingLeaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_AssetsandLiabilitiesLesseeOperatingLeaseAbstract" xlink:to="lab_sem_AssetsandLiabilitiesLesseeOperatingLeaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_aa43f3ab-b59d-495f-b164-cb91258e9ee3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_03223bf6-3e44-4764-a9e0-33f692fec7ac_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income and expense:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_6b65d62a-9b44-4db0-b246-35e5a232e274_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in businesses</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_2bc4261e-1019-44bf-9f55-f58305c68b0f_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cc0afd20-5fcc-40a2-bc92-92e206124582_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_a5c4743c-cb72-4583-84b7-df95ad629b03_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_4d37a887-7fb1-46f2-9e30-95b8ce6bab27_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reconciliation of Adjusted EBITDA to income before income taxes</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2e07bdc4-fdb0-4550-9884-225572af7c3e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of effects of business combinations:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_40ad153e-9dac-4808-9796-20be441c0677_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_82f6c655-36ff-4c99-ad18-3e3b567e2ded_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour_0ba08ba1-e1b3-480c-ac2a-0baa6dad752e_terseLabel_en-US" xlink:label="lab_sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour_label_en-US" xlink:label="lab_sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments Of Principal After Year Four</link:label>
    <link:label id="lab_sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour_documentation_en-US" xlink:label="lab_sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments Of Principal After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" xlink:href="sem-20210630.xsd#sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" xlink:to="lab_sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_e9dcde31-694a-4cc2-bbf7-87f65d1f5205_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicDistributed_0fdef98f-131b-4ef3-a6f2-ae0349019be7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicDistributed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared and contractual dividends paid, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicDistributed_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicDistributed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, Distributed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicDistributed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicDistributed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicDistributed" xlink:to="lab_us-gaap_EarningsPerShareBasicDistributed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1da12dc6-6b71-4d8b-850a-c43c3ecbcf6d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_c28c7138-a3e7-4b76-8efc-e5532b90fc24_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows for finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_114ee7e2-10f1-4fc1-8d00-153fb194534b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_8fb0d56d-415f-42fa-b825-d6bdbcf75e1f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_f6e458c0-aaa6-40dd-a5a2-6ab34fc80a89_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_e19ae096-0d91-4a43-bca8-e6c9b38af721_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_DerivativeCostOfHedgeAnnualPremiumPercentage_bbc6bb00-45e3-4e3b-b6e9-77554ee3c599_terseLabel_en-US" xlink:label="lab_sem_DerivativeCostOfHedgeAnnualPremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual premium (in percent)</link:label>
    <link:label id="lab_sem_DerivativeCostOfHedgeAnnualPremiumPercentage_label_en-US" xlink:label="lab_sem_DerivativeCostOfHedgeAnnualPremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Cost of Hedge, Annual Premium, Percentage</link:label>
    <link:label id="lab_sem_DerivativeCostOfHedgeAnnualPremiumPercentage_documentation_en-US" xlink:label="lab_sem_DerivativeCostOfHedgeAnnualPremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Cost of Hedge, Annual Premium, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_DerivativeCostOfHedgeAnnualPremiumPercentage" xlink:href="sem-20210630.xsd#sem_DerivativeCostOfHedgeAnnualPremiumPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_DerivativeCostOfHedgeAnnualPremiumPercentage" xlink:to="lab_sem_DerivativeCostOfHedgeAnnualPremiumPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_6a65fd9c-fa42-4b85-810d-e9335cfec18e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_AccreditationsMember_b7b3d544-565d-4902-81ec-1061be97d024_terseLabel_en-US" xlink:label="lab_sem_AccreditationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accreditations</link:label>
    <link:label id="lab_sem_AccreditationsMember_label_en-US" xlink:label="lab_sem_AccreditationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accreditations [Member]</link:label>
    <link:label id="lab_sem_AccreditationsMember_documentation_en-US" xlink:label="lab_sem_AccreditationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to accreditations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_AccreditationsMember" xlink:href="sem-20210630.xsd#sem_AccreditationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_AccreditationsMember" xlink:to="lab_sem_AccreditationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_ea39f9a5-88f1-4ead-b6c3-f54f7e937aeb_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 (remainder of year)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_bc05b181-f1af-447c-add6-321f05bd520a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_46e50c1b-a50d-4489-9976-f28fc653d10c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_02e2cf7f-8707-45b4-ab3c-c10c9068cc6f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_57e8abe6-e6f3-4b1f-aa58-6849d1e499cb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_207923d6-a34e-4cd5-a146-b6cb781752ae_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_168a1722-2f1b-435e-b669-8d61d4a9571a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_a887eba7-9db3-4d23-8093-a93e921860ae_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of services, exclusive of depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_593bbb0e-3eea-4ac4-8e7d-5f6a546596a4_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_0d5b2192-7403-4d7e-825f-7bf20186a607_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Premium (Discount)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_c31415a0-c5a2-43c1-b99d-8359649aa40a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract_19ae33fe-fff9-47ec-9c1e-ac6563a62308_terseLabel_en-US" xlink:label="lab_sem_WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years):</link:label>
    <link:label id="lab_sem_WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract_label_en-US" xlink:label="lab_sem_WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Lease Term Operating And Finance Leases [Abstract]</link:label>
    <link:label id="lab_sem_WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract_documentation_en-US" xlink:label="lab_sem_WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Lease Term Operating And Finance Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract" xlink:href="sem-20210630.xsd#sem_WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract" xlink:to="lab_sem_WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_83643b20-e9f9-45ea-9be5-4c31e3455c2d_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_2164232f-77f3-4865-872b-7fbbec235ca4_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_04a5808e-d2d4-480d-9493-b4301b620912_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, net carrying amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_a51cc93b-487f-4a1a-921e-9c75791a64b5_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_c0c8759d-57cd-48bc-b4f3-d8f60d828aca_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_fac8db34-7592-46fb-866f-b9234b5898bf_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Ending Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_0e2bd0c2-55a9-4d6c-b69e-152c8d521f90_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminated obligations</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_OperatingLeaseLiabilityNoncurrentAbstract_db905644-1205-4302-89d9-5fbbc49d9ad4_terseLabel_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current operating lease liabilities</link:label>
    <link:label id="lab_sem_OperatingLeaseLiabilityNoncurrentAbstract_label_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent [Abstract]</link:label>
    <link:label id="lab_sem_OperatingLeaseLiabilityNoncurrentAbstract_documentation_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityNoncurrentAbstract" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_OperatingLeaseLiabilityNoncurrentAbstract" xlink:to="lab_sem_OperatingLeaseLiabilityNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_be40ade2-bb93-4d8f-8b80-42a4dff038dd_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_OperatingLeaseLiabilityCurrentRelatedParties_d23ee699-0023-4161-b593-98c299419d93_terseLabel_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityCurrentRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_sem_OperatingLeaseLiabilityCurrentRelatedParties_label_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityCurrentRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Related Parties</link:label>
    <link:label id="lab_sem_OperatingLeaseLiabilityCurrentRelatedParties_documentation_en-US" xlink:label="lab_sem_OperatingLeaseLiabilityCurrentRelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityCurrentRelatedParties" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityCurrentRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_OperatingLeaseLiabilityCurrentRelatedParties" xlink:to="lab_sem_OperatingLeaseLiabilityCurrentRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_f7f5938c-8188-4eef-a85e-29c66d51dc43_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare bad debt reimbursement claim</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLegalSettlements" xlink:to="lab_us-gaap_ProceedsFromLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_b0f403a7-f6a4-4bea-a1bd-1bf3fe9ca584_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of carrying amount of goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_775a7028-bcae-4261-b541-e37a8c096dd8_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_470c1222-cc3b-4d4d-a2e1-6990c0bae2b7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_17194c16-0279-4b0e-9b23-87d16c7429df_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable_2ab7a5d1-c4ed-451f-bce0-c7b0d8a9a086_terseLabel_en-US" xlink:label="lab_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived And Indefinite Lived Intangible Assets By Major Class [Table]</link:label>
    <link:label id="lab_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable_label_en-US" xlink:label="lab_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived And Indefinite Lived Intangible Assets And Liabilities By Major Class [Table]</link:label>
    <link:label id="lab_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable_documentation_en-US" xlink:label="lab_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of finite-lived and indefinite-lived intangible assets and liabilities, excluding goodwill, in total and by major class.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable" xlink:href="sem-20210630.xsd#sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable" xlink:to="lab_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct_db115881-579e-4081-905d-2dbd14464065_terseLabel_en-US" xlink:label="lab_sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned government assistance</link:label>
    <link:label id="lab_sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct_label_en-US" xlink:label="lab_sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Unearned Government Assistance, CARES Act</link:label>
    <link:label id="lab_sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct_documentation_en-US" xlink:label="lab_sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Unearned Government Assistance, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct" xlink:href="sem-20210630.xsd#sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct" xlink:to="lab_sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingenciesTable_8d52a039-72f3-4792-b627-563ccace01b9_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_GainContingenciesTable_label_en-US" xlink:label="lab_us-gaap_GainContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingenciesTable" xlink:to="lab_us-gaap_GainContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_7be02fa1-cfdc-46e0-91ef-f3c726626507_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_ed2f4a01-d068-4402-8ef5-2c6b5e5696df_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>sem-20210630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:13e6905e-72a0-44f6-9164-f135c900c5bf,g:37e820a7-74f5-4c60-b984-336d3d990bf4-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.selectmedical.com/role/Cover" xlink:type="simple" xlink:href="sem-20210630.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_2ab10118-1cb9-46de-a4cc-5ca8b8aaf7dc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_DocumentType_2ab10118-1cb9-46de-a4cc-5ca8b8aaf7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_2bae4e4f-c755-4462-8a9b-58c05e64b113" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_DocumentQuarterlyReport_2bae4e4f-c755-4462-8a9b-58c05e64b113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_816d23bf-328e-4eb7-a388-963734cc181f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_DocumentPeriodEndDate_816d23bf-328e-4eb7-a388-963734cc181f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_259a01cb-0d75-473b-bf16-9edf9fc67270" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_DocumentTransitionReport_259a01cb-0d75-473b-bf16-9edf9fc67270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_7acfbef2-4c9a-4114-a069-ae370299d58e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_EntityFileNumber_7acfbef2-4c9a-4114-a069-ae370299d58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_39771f05-882f-47b6-9f65-146f6ae4681d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_EntityRegistrantName_39771f05-882f-47b6-9f65-146f6ae4681d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e0f02704-9285-47d4-b4d2-9291f02846db" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e0f02704-9285-47d4-b4d2-9291f02846db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_39069362-362b-4067-9815-e3b5fc06f3b9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_EntityTaxIdentificationNumber_39069362-362b-4067-9815-e3b5fc06f3b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_32e2ea70-ed72-4b51-add2-95bd80c10d40" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_EntityAddressAddressLine1_32e2ea70-ed72-4b51-add2-95bd80c10d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_7f51fceb-f91a-431b-bf5a-902e4286feda" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_EntityAddressAddressLine2_7f51fceb-f91a-431b-bf5a-902e4286feda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_75344856-758f-4672-8b30-75ddc72fac86" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_EntityAddressCityOrTown_75344856-758f-4672-8b30-75ddc72fac86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_c918c218-617f-4354-b337-d961648793f7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_EntityAddressStateOrProvince_c918c218-617f-4354-b337-d961648793f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_197ee4a3-dfb9-4baa-91d7-111856bece56" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_EntityAddressPostalZipCode_197ee4a3-dfb9-4baa-91d7-111856bece56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d5d14af1-25d3-450e-a3c9-2d105f631d5c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_CityAreaCode_d5d14af1-25d3-450e-a3c9-2d105f631d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_bfcbfaf1-1101-4077-885f-d75926a2dbbc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_LocalPhoneNumber_bfcbfaf1-1101-4077-885f-d75926a2dbbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8380cfc1-2cc5-4123-922b-adc13f73b778" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_Security12bTitle_8380cfc1-2cc5-4123-922b-adc13f73b778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_014ea624-6837-40c0-8dca-d6a789b97402" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_TradingSymbol_014ea624-6837-40c0-8dca-d6a789b97402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_936936c5-f92c-45ad-9ed9-caedae05b2d0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_SecurityExchangeName_936936c5-f92c-45ad-9ed9-caedae05b2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_dc45e92c-fe39-457e-9710-20a289363c6c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_EntityCurrentReportingStatus_dc45e92c-fe39-457e-9710-20a289363c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_7773f77a-bb25-4c36-a09b-cb2a08bc46cf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_EntityInteractiveDataCurrent_7773f77a-bb25-4c36-a09b-cb2a08bc46cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_f393e9c2-1278-4568-889a-eced78d8cbe2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_EntityFilerCategory_f393e9c2-1278-4568-889a-eced78d8cbe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_8bd10b3b-6e05-4b69-9edb-8668fca0ca3d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_EntitySmallBusiness_8bd10b3b-6e05-4b69-9edb-8668fca0ca3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_1047df7d-b200-4c54-9efd-f716ba7137be" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_EntityEmergingGrowthCompany_1047df7d-b200-4c54-9efd-f716ba7137be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_850e3ed3-6c81-458b-905c-b51fe405a6c7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_EntityShellCompany_850e3ed3-6c81-458b-905c-b51fe405a6c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_745202f0-0333-4e42-b09b-49a66da93677" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_745202f0-0333-4e42-b09b-49a66da93677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_5ce44e85-3f4b-4211-9e36-f33b290977a9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_CurrentFiscalYearEndDate_5ce44e85-3f4b-4211-9e36-f33b290977a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_79a42316-d25a-4c82-a340-6f94e0e53176" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_AmendmentFlag_79a42316-d25a-4c82-a340-6f94e0e53176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_b39ef3b0-5bd5-41b4-861a-d9476ac937dc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_DocumentFiscalYearFocus_b39ef3b0-5bd5-41b4-861a-d9476ac937dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_d7722f9c-6079-4fc5-b327-027160d11463" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_DocumentFiscalPeriodFocus_d7722f9c-6079-4fc5-b327-027160d11463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_07c4fc1f-3e37-4ce7-acdd-2e1e87f5aa25" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_33c6972d-7617-4cbb-a263-b4bcd4651329" xlink:to="loc_dei_EntityCentralIndexKey_07c4fc1f-3e37-4ce7-acdd-2e1e87f5aa25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="simple" xlink:href="sem-20210630.xsd#CondensedConsolidatedBalanceSheetsunaudited"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_1a2c272f-af3b-47d8-a24c-b4c711222678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_a58e7e3f-fbf3-45ca-a7d2-b771fcf713de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1a2c272f-af3b-47d8-a24c-b4c711222678" xlink:to="loc_us-gaap_AssetsAbstract_a58e7e3f-fbf3-45ca-a7d2-b771fcf713de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_c11ec21e-b29d-40cb-ad48-138cacbac05f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a58e7e3f-fbf3-45ca-a7d2-b771fcf713de" xlink:to="loc_us-gaap_AssetsCurrentAbstract_c11ec21e-b29d-40cb-ad48-138cacbac05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b05b0c47-db52-4ecf-bfa9-911d328b53b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c11ec21e-b29d-40cb-ad48-138cacbac05f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b05b0c47-db52-4ecf-bfa9-911d328b53b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f12e8ecd-3d83-40f6-82a2-6077697fce51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c11ec21e-b29d-40cb-ad48-138cacbac05f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f12e8ecd-3d83-40f6-82a2-6077697fce51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_395c0c1b-a4e3-45e1-8362-1599bc5098ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c11ec21e-b29d-40cb-ad48-138cacbac05f" xlink:to="loc_us-gaap_PrepaidTaxes_395c0c1b-a4e3-45e1-8362-1599bc5098ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_4a846554-ba63-456e-998f-49c7f58c35fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c11ec21e-b29d-40cb-ad48-138cacbac05f" xlink:to="loc_us-gaap_OtherAssetsCurrent_4a846554-ba63-456e-998f-49c7f58c35fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cc86fa0e-0f06-476b-8c72-aef5da5ce2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_c11ec21e-b29d-40cb-ad48-138cacbac05f" xlink:to="loc_us-gaap_AssetsCurrent_cc86fa0e-0f06-476b-8c72-aef5da5ce2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_77d7416e-0142-4927-8fa8-949b6dc74028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a58e7e3f-fbf3-45ca-a7d2-b771fcf713de" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_77d7416e-0142-4927-8fa8-949b6dc74028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_90bc1877-5d18-46d4-8176-69bc6158b8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a58e7e3f-fbf3-45ca-a7d2-b771fcf713de" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_90bc1877-5d18-46d4-8176-69bc6158b8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_335ab861-346a-47d8-8cbb-38980fcb48f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a58e7e3f-fbf3-45ca-a7d2-b771fcf713de" xlink:to="loc_us-gaap_Goodwill_335ab861-346a-47d8-8cbb-38980fcb48f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_956b59c1-c49e-490c-8792-781eeb99ad21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a58e7e3f-fbf3-45ca-a7d2-b771fcf713de" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_956b59c1-c49e-490c-8792-781eeb99ad21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5946efe6-e50e-4660-ae20-52c804795f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a58e7e3f-fbf3-45ca-a7d2-b771fcf713de" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5946efe6-e50e-4660-ae20-52c804795f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a5924fcc-8b5e-4c5e-ad0c-8e9c113c1e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a58e7e3f-fbf3-45ca-a7d2-b771fcf713de" xlink:to="loc_us-gaap_Assets_a5924fcc-8b5e-4c5e-ad0c-8e9c113c1e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_048b0c78-3879-4bed-9211-87f228ee21ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1a2c272f-af3b-47d8-a24c-b4c711222678" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_048b0c78-3879-4bed-9211-87f228ee21ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_4bb4480e-866e-4a51-9c99-26f3b5c4b40f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_048b0c78-3879-4bed-9211-87f228ee21ef" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_4bb4480e-866e-4a51-9c99-26f3b5c4b40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c32de7ba-6cdb-4cc0-a47f-baeac2f174b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4bb4480e-866e-4a51-9c99-26f3b5c4b40f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c32de7ba-6cdb-4cc0-a47f-baeac2f174b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_cc96cab7-1b18-4796-b6f8-180641bdee46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4bb4480e-866e-4a51-9c99-26f3b5c4b40f" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_cc96cab7-1b18-4796-b6f8-180641bdee46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_fe2eb931-8c59-4a05-907a-eea5f0982c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4bb4480e-866e-4a51-9c99-26f3b5c4b40f" xlink:to="loc_us-gaap_AccountsPayableCurrent_fe2eb931-8c59-4a05-907a-eea5f0982c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent_45360d55-df83-4a5e-8c80-d5e4fc76c028" xlink:href="sem-20210630.xsd#sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4bb4480e-866e-4a51-9c99-26f3b5c4b40f" xlink:to="loc_sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent_45360d55-df83-4a5e-8c80-d5e4fc76c028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedVacationCurrent_36bbec3b-dbcd-4310-ab16-d4f90a7731fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedVacationCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4bb4480e-866e-4a51-9c99-26f3b5c4b40f" xlink:to="loc_us-gaap_AccruedVacationCurrent_36bbec3b-dbcd-4310-ab16-d4f90a7731fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_7f829db9-5029-47f5-86c2-bdc19c6f0b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4bb4480e-866e-4a51-9c99-26f3b5c4b40f" xlink:to="loc_us-gaap_InterestPayableCurrent_7f829db9-5029-47f5-86c2-bdc19c6f0b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_1ea0c569-065a-4520-a11e-377b6fc70710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4bb4480e-866e-4a51-9c99-26f3b5c4b40f" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_1ea0c569-065a-4520-a11e-377b6fc70710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_GovernmentAdvancesCARESAct_36531f65-05e3-4bef-8eb7-37ade5826182" xlink:href="sem-20210630.xsd#sem_GovernmentAdvancesCARESAct"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4bb4480e-866e-4a51-9c99-26f3b5c4b40f" xlink:to="loc_sem_GovernmentAdvancesCARESAct_36531f65-05e3-4bef-8eb7-37ade5826182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_UnearnedGovernmentAssistanceCARESAct_ac18e5cf-471a-489f-becc-b423a91e5164" xlink:href="sem-20210630.xsd#sem_UnearnedGovernmentAssistanceCARESAct"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4bb4480e-866e-4a51-9c99-26f3b5c4b40f" xlink:to="loc_sem_UnearnedGovernmentAssistanceCARESAct_ac18e5cf-471a-489f-becc-b423a91e5164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_9e80d43d-c846-4387-8c57-f25981cc466d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4bb4480e-866e-4a51-9c99-26f3b5c4b40f" xlink:to="loc_us-gaap_TaxesPayableCurrent_9e80d43d-c846-4387-8c57-f25981cc466d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a2ea9b76-8117-48a2-8418-b8e129e9de3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_4bb4480e-866e-4a51-9c99-26f3b5c4b40f" xlink:to="loc_us-gaap_LiabilitiesCurrent_a2ea9b76-8117-48a2-8418-b8e129e9de3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4c6177a1-4c54-44e8-afb5-770764c838eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_048b0c78-3879-4bed-9211-87f228ee21ef" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4c6177a1-4c54-44e8-afb5-770764c838eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_9f50b195-aaf4-45d9-ba8d-6d10316b4fab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_048b0c78-3879-4bed-9211-87f228ee21ef" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_9f50b195-aaf4-45d9-ba8d-6d10316b4fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d9a13abb-392e-4958-84fb-caf5d990f9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_048b0c78-3879-4bed-9211-87f228ee21ef" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d9a13abb-392e-4958-84fb-caf5d990f9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_5508e11a-7e93-44fc-a48d-d26f60babe07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_048b0c78-3879-4bed-9211-87f228ee21ef" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_5508e11a-7e93-44fc-a48d-d26f60babe07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_059e0c97-0f4d-40f9-9be0-ad4444539a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_048b0c78-3879-4bed-9211-87f228ee21ef" xlink:to="loc_us-gaap_Liabilities_059e0c97-0f4d-40f9-9be0-ad4444539a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_0fec08e4-6c6b-4bcc-8fb2-2a270617ba00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_048b0c78-3879-4bed-9211-87f228ee21ef" xlink:to="loc_us-gaap_CommitmentsAndContingencies_0fec08e4-6c6b-4bcc-8fb2-2a270617ba00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_7ed5254f-2f1e-47b3-a704-3e0a5588ad38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_048b0c78-3879-4bed-9211-87f228ee21ef" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_7ed5254f-2f1e-47b3-a704-3e0a5588ad38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1f244ba7-209f-4a1a-8783-89e23f1df1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_048b0c78-3879-4bed-9211-87f228ee21ef" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1f244ba7-209f-4a1a-8783-89e23f1df1c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f0bcf2ac-47c0-476a-ad60-3ecdd219c09a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1f244ba7-209f-4a1a-8783-89e23f1df1c2" xlink:to="loc_us-gaap_CommonStockValue_f0bcf2ac-47c0-476a-ad60-3ecdd219c09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1c6d02e6-9df1-47fd-be61-c664f3cf2570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1f244ba7-209f-4a1a-8783-89e23f1df1c2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1c6d02e6-9df1-47fd-be61-c664f3cf2570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_14c566ca-a176-432f-b25d-df0988e2f601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1f244ba7-209f-4a1a-8783-89e23f1df1c2" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_14c566ca-a176-432f-b25d-df0988e2f601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_18c3be32-0eee-4d95-b854-587411666909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1f244ba7-209f-4a1a-8783-89e23f1df1c2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_18c3be32-0eee-4d95-b854-587411666909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f6a54d74-acf0-43b3-89b2-058e928bac3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1f244ba7-209f-4a1a-8783-89e23f1df1c2" xlink:to="loc_us-gaap_StockholdersEquity_f6a54d74-acf0-43b3-89b2-058e928bac3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_ace6c906-edab-4acc-8364-365c3598c8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1f244ba7-209f-4a1a-8783-89e23f1df1c2" xlink:to="loc_us-gaap_MinorityInterest_ace6c906-edab-4acc-8364-365c3598c8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2a0def91-d742-4e8b-b3f8-6489342c1287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1f244ba7-209f-4a1a-8783-89e23f1df1c2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2a0def91-d742-4e8b-b3f8-6489342c1287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_3f1b7073-2365-4377-98e2-8d336d7b8d03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_048b0c78-3879-4bed-9211-87f228ee21ef" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_3f1b7073-2365-4377-98e2-8d336d7b8d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical" xlink:type="simple" xlink:href="sem-20210630.xsd#CondensedConsolidatedBalanceSheetsunauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_9660298a-71f1-40da-83d0-be91c6dde0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4ece1b4a-b374-4e78-a47d-954c9de2ff89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9660298a-71f1-40da-83d0-be91c6dde0c8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4ece1b4a-b374-4e78-a47d-954c9de2ff89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_325870ef-7fbd-4de0-aea7-cdea63f876ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9660298a-71f1-40da-83d0-be91c6dde0c8" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_325870ef-7fbd-4de0-aea7-cdea63f876ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_36642929-bcca-4cc7-96b8-0c85c9557e75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9660298a-71f1-40da-83d0-be91c6dde0c8" xlink:to="loc_us-gaap_CommonStockSharesIssued_36642929-bcca-4cc7-96b8-0c85c9557e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_52a438f7-2baa-41f1-8cdf-ee7006549e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9660298a-71f1-40da-83d0-be91c6dde0c8" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_52a438f7-2baa-41f1-8cdf-ee7006549e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited" xlink:type="simple" xlink:href="sem-20210630.xsd#CondensedConsolidatedStatementsofOperationsunaudited"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_8e713ca9-8977-4795-9087-f6c3a002ee30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fd5a4dd7-56ec-4bf2-9dc0-00b5db983bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8e713ca9-8977-4795-9087-f6c3a002ee30" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fd5a4dd7-56ec-4bf2-9dc0-00b5db983bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_fdd79d93-1c90-4af2-a1f6-4316648dc3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8e713ca9-8977-4795-9087-f6c3a002ee30" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_fdd79d93-1c90-4af2-a1f6-4316648dc3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_88abf3b8-f90c-4fda-b7f4-7addb255f326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_fdd79d93-1c90-4af2-a1f6-4316648dc3c1" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_88abf3b8-f90c-4fda-b7f4-7addb255f326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_30db4a00-1836-4ffa-9903-ee130b7ef514" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_fdd79d93-1c90-4af2-a1f6-4316648dc3c1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_30db4a00-1836-4ffa-9903-ee130b7ef514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_1122c93c-59d3-49cf-981c-3aeeaf718938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_fdd79d93-1c90-4af2-a1f6-4316648dc3c1" xlink:to="loc_us-gaap_DepreciationAndAmortization_1122c93c-59d3-49cf-981c-3aeeaf718938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_234ff576-c575-445d-a019-1fb6b0632faa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_fdd79d93-1c90-4af2-a1f6-4316648dc3c1" xlink:to="loc_us-gaap_CostsAndExpenses_234ff576-c575-445d-a019-1fb6b0632faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_f3525121-b523-4475-ada1-8c8aca5847bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8e713ca9-8977-4795-9087-f6c3a002ee30" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_f3525121-b523-4475-ada1-8c8aca5847bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_725a1701-2b03-476e-b9e9-e9f3150f7435" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8e713ca9-8977-4795-9087-f6c3a002ee30" xlink:to="loc_us-gaap_OperatingIncomeLoss_725a1701-2b03-476e-b9e9-e9f3150f7435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_1d301698-a576-487e-ade4-438ab2a646e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8e713ca9-8977-4795-9087-f6c3a002ee30" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_1d301698-a576-487e-ade4-438ab2a646e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7699fd94-cdb3-4e5c-83a5-4cea7790a22e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_1d301698-a576-487e-ade4-438ab2a646e2" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7699fd94-cdb3-4e5c-83a5-4cea7790a22e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_6231491a-84e6-41f5-befd-2cf57a32b209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_1d301698-a576-487e-ade4-438ab2a646e2" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_6231491a-84e6-41f5-befd-2cf57a32b209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementInterest_9568db0d-c93a-4802-9e8c-2cfe932ebcbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_1d301698-a576-487e-ade4-438ab2a646e2" xlink:to="loc_us-gaap_LitigationSettlementInterest_9568db0d-c93a-4802-9e8c-2cfe932ebcbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_5a0385bd-35e7-4489-b295-0fc28dc937d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_1d301698-a576-487e-ade4-438ab2a646e2" xlink:to="loc_us-gaap_InterestExpense_5a0385bd-35e7-4489-b295-0fc28dc937d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c5cc206c-c00f-4f39-8512-306d8e2217d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8e713ca9-8977-4795-9087-f6c3a002ee30" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c5cc206c-c00f-4f39-8512-306d8e2217d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b2ad2729-21df-48d0-bb76-b1ab22989bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8e713ca9-8977-4795-9087-f6c3a002ee30" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b2ad2729-21df-48d0-bb76-b1ab22989bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_34addc2b-280d-4391-be6d-b95c4b97db9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8e713ca9-8977-4795-9087-f6c3a002ee30" xlink:to="loc_us-gaap_ProfitLoss_34addc2b-280d-4391-be6d-b95c4b97db9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6bc1f69f-bbb0-4873-a2b4-04a4385b8e14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8e713ca9-8977-4795-9087-f6c3a002ee30" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6bc1f69f-bbb0-4873-a2b4-04a4385b8e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ac0548de-3dad-4ca0-a2a4-39d1405282f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8e713ca9-8977-4795-9087-f6c3a002ee30" xlink:to="loc_us-gaap_NetIncomeLoss_ac0548de-3dad-4ca0-a2a4-39d1405282f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_369f8a9c-cfe6-4302-b090-f2ef3644d3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_8e713ca9-8977-4795-9087-f6c3a002ee30" xlink:to="loc_us-gaap_EarningsPerShareAbstract_369f8a9c-cfe6-4302-b090-f2ef3644d3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b13c57e3-d95f-49b9-bc0e-4804d9a5b889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_369f8a9c-cfe6-4302-b090-f2ef3644d3d4" xlink:to="loc_us-gaap_EarningsPerShareBasic_b13c57e3-d95f-49b9-bc0e-4804d9a5b889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0bfa1796-8b1b-4388-9da2-a1d2d49a250d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_369f8a9c-cfe6-4302-b090-f2ef3644d3d4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0bfa1796-8b1b-4388-9da2-a1d2d49a250d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited" xlink:type="simple" xlink:href="sem-20210630.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8ae38cec-bd1e-420a-b2c7-042b295ab69f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0a30fe67-e1b0-472d-ad9b-30689ae163ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8ae38cec-bd1e-420a-b2c7-042b295ab69f" xlink:to="loc_us-gaap_ProfitLoss_0a30fe67-e1b0-472d-ad9b-30689ae163ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_dec75690-96b0-4bbf-9ea8-4124bb16b178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8ae38cec-bd1e-420a-b2c7-042b295ab69f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_dec75690-96b0-4bbf-9ea8-4124bb16b178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_bf08ad59-dfab-44a2-85b5-a714d30a9635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_dec75690-96b0-4bbf-9ea8-4124bb16b178" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_bf08ad59-dfab-44a2-85b5-a714d30a9635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7b1743be-c0d8-425a-93f7-f64cc39ee8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_dec75690-96b0-4bbf-9ea8-4124bb16b178" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7b1743be-c0d8-425a-93f7-f64cc39ee8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_45b67f1d-128f-4981-a3ef-7e3501025228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_dec75690-96b0-4bbf-9ea8-4124bb16b178" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_45b67f1d-128f-4981-a3ef-7e3501025228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_60c1006a-fd5d-409c-b24d-fa1526dec971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8ae38cec-bd1e-420a-b2c7-042b295ab69f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_60c1006a-fd5d-409c-b24d-fa1526dec971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_af7d25fa-e0cc-4b99-9f55-b599c2d49d69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8ae38cec-bd1e-420a-b2c7-042b295ab69f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_af7d25fa-e0cc-4b99-9f55-b599c2d49d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_fbfd74d2-ce5e-4246-b560-c833729e5830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8ae38cec-bd1e-420a-b2c7-042b295ab69f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_fbfd74d2-ce5e-4246-b560-c833729e5830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical" xlink:type="simple" xlink:href="sem-20210630.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f781670f-e2b1-41bd-9712-8d3d05fdd17f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_135ece63-5ff8-4e2f-a7e8-2f2c5d0232c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f781670f-e2b1-41bd-9712-8d3d05fdd17f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_135ece63-5ff8-4e2f-a7e8-2f2c5d0232c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited" xlink:type="simple" xlink:href="sem-20210630.xsd#CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_5872f31f-e134-481e-8d71-a84a584f5430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_36662bf4-2579-4b9b-92d1-a3d9b44113fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_5872f31f-e134-481e-8d71-a84a584f5430" xlink:to="loc_us-gaap_StatementTable_36662bf4-2579-4b9b-92d1-a3d9b44113fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f5a78ad8-f907-4b26-99c2-f25d35dd820e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_36662bf4-2579-4b9b-92d1-a3d9b44113fc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f5a78ad8-f907-4b26-99c2-f25d35dd820e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_129ee559-fe80-4cd5-9e36-7d69bfac2b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f5a78ad8-f907-4b26-99c2-f25d35dd820e" xlink:to="loc_us-gaap_EquityComponentDomain_129ee559-fe80-4cd5-9e36-7d69bfac2b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_eff63ae7-b3f9-41b4-b2d4-aa9c74850c10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_129ee559-fe80-4cd5-9e36-7d69bfac2b6e" xlink:to="loc_us-gaap_ParentMember_eff63ae7-b3f9-41b4-b2d4-aa9c74850c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_292355fe-4567-4d59-974a-244d68209ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_eff63ae7-b3f9-41b4-b2d4-aa9c74850c10" xlink:to="loc_us-gaap_CommonStockMember_292355fe-4567-4d59-974a-244d68209ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_50f8660d-ee6d-4f57-a9c0-22e0c7cfa221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_eff63ae7-b3f9-41b4-b2d4-aa9c74850c10" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_50f8660d-ee6d-4f57-a9c0-22e0c7cfa221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_29cad1dd-1622-47f2-9f2e-a3a7fb46dd89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_eff63ae7-b3f9-41b4-b2d4-aa9c74850c10" xlink:to="loc_us-gaap_RetainedEarningsMember_29cad1dd-1622-47f2-9f2e-a3a7fb46dd89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f101d60f-ccce-44ce-867b-4f065b592fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_eff63ae7-b3f9-41b4-b2d4-aa9c74850c10" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f101d60f-ccce-44ce-867b-4f065b592fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_4cac37ff-7d95-4963-8341-2edbf3509248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_129ee559-fe80-4cd5-9e36-7d69bfac2b6e" xlink:to="loc_us-gaap_NoncontrollingInterestMember_4cac37ff-7d95-4963-8341-2edbf3509248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fa2d9af7-d13e-4b6e-8bed-4d9d0a6b7e45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_36662bf4-2579-4b9b-92d1-a3d9b44113fc" xlink:to="loc_us-gaap_StatementLineItems_fa2d9af7-d13e-4b6e-8bed-4d9d0a6b7e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fa2d9af7-d13e-4b6e-8bed-4d9d0a6b7e45" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ef3b3f92-569f-4354-a2eb-b853cf5fe2fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_CommonStockSharesIssued_ef3b3f92-569f-4354-a2eb-b853cf5fe2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b7b2324d-f295-4b27-b5e5-c1887d78a992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b7b2324d-f295-4b27-b5e5-c1887d78a992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1b4e805a-5389-42f4-aa9f-c85dfa18d397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_NetIncomeLoss_1b4e805a-5389-42f4-aa9f-c85dfa18d397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_d01602e5-f048-49ee-b680-e4cb2dcae597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest_d01602e5-f048-49ee-b680-e4cb2dcae597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_154b051a-a60a-4a77-8e9e-6199e0d0750b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_DividendsCommonStock_154b051a-a60a-4a77-8e9e-6199e0d0750b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_397e861a-cef2-42f6-a9c2-2254723597eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_397e861a-cef2-42f6-a9c2-2254723597eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_ff7cfecd-0047-40aa-96b7-2c36670d3d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_ff7cfecd-0047-40aa-96b7-2c36670d3d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_48cec959-297c-4f5e-8559-793037afea82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_48cec959-297c-4f5e-8559-793037afea82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_d2c6b8af-2477-4d81-a076-109683c8b3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_d2c6b8af-2477-4d81-a076-109683c8b3e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7d68188b-3823-4690-a234-6ea13825c71b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7d68188b-3823-4690-a234-6ea13825c71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_92257ee7-41fd-466f-ba17-8c1725cc0ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_92257ee7-41fd-466f-ba17-8c1725cc0ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_80551abc-404b-4eeb-842d-3952a8fe7f32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_80551abc-404b-4eeb-842d-3952a8fe7f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_593aa5b2-9c47-4d60-b4fa-999ee86e659f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_593aa5b2-9c47-4d60-b4fa-999ee86e659f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_dfee1e78-7962-4d5a-b099-1dd852775b33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_dfee1e78-7962-4d5a-b099-1dd852775b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_c318aa40-e2a1-4e61-90aa-4d4ebe15ed53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_c318aa40-e2a1-4e61-90aa-4d4ebe15ed53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_e2b6317e-3aae-43c9-8fcd-8ce988c29b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_e2b6317e-3aae-43c9-8fcd-8ce988c29b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_907d361d-2411-4fc1-b2cf-7d26ede57053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_907d361d-2411-4fc1-b2cf-7d26ede57053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_12a95cdb-8453-40cc-b1f3-93fb37b08cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_StockholdersEquityOther_12a95cdb-8453-40cc-b1f3-93fb37b08cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_33bffc8c-943b-4400-8d8a-f29bc23e3c40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_CommonStockSharesIssued_33bffc8c-943b-4400-8d8a-f29bc23e3c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c4f5485b-3ac0-4411-b7a8-85d46d4de2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a93e34d9-85b4-4674-94d8-416b83134867" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c4f5485b-3ac0-4411-b7a8-85d46d4de2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunauditedParenthetical" xlink:type="simple" xlink:href="sem-20210630.xsd#CondensedConsolidatedStatementsofChangesinEquityandIncomeunauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_49d4f24e-51d5-410e-8aef-e3b12b646063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_b47a8eec-6a6c-4b46-849b-de9ea105cc86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_49d4f24e-51d5-410e-8aef-e3b12b646063" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_b47a8eec-6a6c-4b46-849b-de9ea105cc86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="simple" xlink:href="sem-20210630.xsd#CondensedConsolidatedStatementsofCashFlowsunaudited"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_3928ecc4-b857-4a5b-a0ec-1f877933da0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3747129b-1034-471f-b628-92aaac86742d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3928ecc4-b857-4a5b-a0ec-1f877933da0b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3747129b-1034-471f-b628-92aaac86742d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_83d25a17-2837-40fb-ae27-e3bd261189f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3747129b-1034-471f-b628-92aaac86742d" xlink:to="loc_us-gaap_ProfitLoss_83d25a17-2837-40fb-ae27-e3bd261189f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_668e0c39-1e55-4683-b7e8-863d5b55c200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3747129b-1034-471f-b628-92aaac86742d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_668e0c39-1e55-4683-b7e8-863d5b55c200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_414d3751-f3b4-4504-b835-2a5c188c7dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_668e0c39-1e55-4683-b7e8-863d5b55c200" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_414d3751-f3b4-4504-b835-2a5c188c7dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_3d7f9d95-9d62-4336-aca2-7aa2876f1a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_668e0c39-1e55-4683-b7e8-863d5b55c200" xlink:to="loc_us-gaap_DepreciationAndAmortization_3d7f9d95-9d62-4336-aca2-7aa2876f1a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_7dd51373-f7d7-469a-9052-68bb1cce0f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_668e0c39-1e55-4683-b7e8-863d5b55c200" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_7dd51373-f7d7-469a-9052-68bb1cce0f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_d71255a8-5c6e-4a12-9066-8ea32eab1c20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_668e0c39-1e55-4683-b7e8-863d5b55c200" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_d71255a8-5c6e-4a12-9066-8ea32eab1c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_2d80e063-3f28-4489-9dac-b82030be1bef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_668e0c39-1e55-4683-b7e8-863d5b55c200" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_2d80e063-3f28-4489-9dac-b82030be1bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_1e15d856-119f-462e-bef7-f58f95716586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_668e0c39-1e55-4683-b7e8-863d5b55c200" xlink:to="loc_us-gaap_ShareBasedCompensation_1e15d856-119f-462e-bef7-f58f95716586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_59a6c40c-a654-424e-b388-8544234e657f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_668e0c39-1e55-4683-b7e8-863d5b55c200" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_59a6c40c-a654-424e-b388-8544234e657f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d947ce3b-cf75-4335-9c03-a2e56adcf444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_668e0c39-1e55-4683-b7e8-863d5b55c200" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d947ce3b-cf75-4335-9c03-a2e56adcf444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39898710-60ec-4638-9ad5-4116fdcdff13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_668e0c39-1e55-4683-b7e8-863d5b55c200" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39898710-60ec-4638-9ad5-4116fdcdff13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4f9c1623-c571-45b9-85ed-39a676f5fb6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39898710-60ec-4638-9ad5-4116fdcdff13" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4f9c1623-c571-45b9-85ed-39a676f5fb6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_63c141af-2093-4820-b929-a32e3855cb73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39898710-60ec-4638-9ad5-4116fdcdff13" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_63c141af-2093-4820-b929-a32e3855cb73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_0d77de56-640e-4280-a626-ffe82366ac61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39898710-60ec-4638-9ad5-4116fdcdff13" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_0d77de56-640e-4280-a626-ffe82366ac61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1be53c83-edd9-4b02-90fd-06da61c3b555" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39898710-60ec-4638-9ad5-4116fdcdff13" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1be53c83-edd9-4b02-90fd-06da61c3b555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_34106c84-5ca2-456c-8880-842db17fb56e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39898710-60ec-4638-9ad5-4116fdcdff13" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_34106c84-5ca2-456c-8880-842db17fb56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct_a44ec6bc-03d4-4bd2-b743-5b6087222eab" xlink:href="sem-20210630.xsd#sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39898710-60ec-4638-9ad5-4116fdcdff13" xlink:to="loc_sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct_a44ec6bc-03d4-4bd2-b743-5b6087222eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct_c3c2c958-13d8-4069-9941-86580907ac37" xlink:href="sem-20210630.xsd#sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39898710-60ec-4638-9ad5-4116fdcdff13" xlink:to="loc_sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct_c3c2c958-13d8-4069-9941-86580907ac37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxes_d39689f5-cd56-4a56-aa54-a7cf13f58870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39898710-60ec-4638-9ad5-4116fdcdff13" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxes_d39689f5-cd56-4a56-aa54-a7cf13f58870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_29357b66-a253-4a34-9c29-d65dc4df377e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3747129b-1034-471f-b628-92aaac86742d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_29357b66-a253-4a34-9c29-d65dc4df377e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7277f537-1daa-4745-8098-6c1bdd6c2f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3928ecc4-b857-4a5b-a0ec-1f877933da0b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7277f537-1daa-4745-8098-6c1bdd6c2f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_91791066-e415-48d3-936c-d239423ac27f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7277f537-1daa-4745-8098-6c1bdd6c2f7b" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_91791066-e415-48d3-936c-d239423ac27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_056bed22-9083-4ae1-8f59-159a2e22ad88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7277f537-1daa-4745-8098-6c1bdd6c2f7b" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_056bed22-9083-4ae1-8f59-159a2e22ad88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_41459be9-2620-4f26-b812-ddf9c24bc847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7277f537-1daa-4745-8098-6c1bdd6c2f7b" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_41459be9-2620-4f26-b812-ddf9c24bc847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_017ea58a-dc00-434e-af3d-098b748e1dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7277f537-1daa-4745-8098-6c1bdd6c2f7b" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_017ea58a-dc00-434e-af3d-098b748e1dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_200478db-7a80-4e20-bace-9e642a12a1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7277f537-1daa-4745-8098-6c1bdd6c2f7b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_200478db-7a80-4e20-bace-9e642a12a1ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1ea3e85a-2189-4c62-b957-1b216b62e099" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3928ecc4-b857-4a5b-a0ec-1f877933da0b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1ea3e85a-2189-4c62-b957-1b216b62e099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_5f1d9105-031c-455d-9161-777040931a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1ea3e85a-2189-4c62-b957-1b216b62e099" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_5f1d9105-031c-455d-9161-777040931a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_6616a2df-af42-441e-bb35-814ee1388285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1ea3e85a-2189-4c62-b957-1b216b62e099" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_6616a2df-af42-441e-bb35-814ee1388285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_e3f0885a-21cb-416e-9d87-182b8eccd80f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1ea3e85a-2189-4c62-b957-1b216b62e099" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_e3f0885a-21cb-416e-9d87-182b8eccd80f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherDebt_6c2e2f8a-0b15-462b-9c9e-adf62e49e2f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromOtherDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1ea3e85a-2189-4c62-b957-1b216b62e099" xlink:to="loc_us-gaap_ProceedsFromOtherDebt_6c2e2f8a-0b15-462b-9c9e-adf62e49e2f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_d6f704e6-41a7-43d8-9e05-fbf83a41edd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1ea3e85a-2189-4c62-b957-1b216b62e099" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_d6f704e6-41a7-43d8-9e05-fbf83a41edd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_d6551ac3-6d4b-4eaf-985b-e1f07248183a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1ea3e85a-2189-4c62-b957-1b216b62e099" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_d6551ac3-6d4b-4eaf-985b-e1f07248183a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfEquity_506954df-649f-406c-8212-bac5dd24733b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1ea3e85a-2189-4c62-b957-1b216b62e099" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfEquity_506954df-649f-406c-8212-bac5dd24733b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_b2d043f5-48d0-447b-a035-88dc1eaff799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1ea3e85a-2189-4c62-b957-1b216b62e099" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_b2d043f5-48d0-447b-a035-88dc1eaff799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_797238f2-b257-4406-a71e-583b14859de2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1ea3e85a-2189-4c62-b957-1b216b62e099" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_797238f2-b257-4406-a71e-583b14859de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_ce7f6a1d-2a98-4b80-8147-1430e2af3015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1ea3e85a-2189-4c62-b957-1b216b62e099" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_ce7f6a1d-2a98-4b80-8147-1430e2af3015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_278a3cd6-2781-4359-8769-6c2709ce7820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1ea3e85a-2189-4c62-b957-1b216b62e099" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_278a3cd6-2781-4359-8769-6c2709ce7820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c82b8095-752f-44d6-83bc-19cf0dabe846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3928ecc4-b857-4a5b-a0ec-1f877933da0b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c82b8095-752f-44d6-83bc-19cf0dabe846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0a0fd255-7ae1-47e0-80d5-c6b7ff60b8f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3928ecc4-b857-4a5b-a0ec-1f877933da0b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0a0fd255-7ae1-47e0-80d5-c6b7ff60b8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ba537e7-5260-4c3e-b5d8-5b4fb2a14dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3928ecc4-b857-4a5b-a0ec-1f877933da0b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ba537e7-5260-4c3e-b5d8-5b4fb2a14dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_646f03be-affc-460d-8132-0c562afa7309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3928ecc4-b857-4a5b-a0ec-1f877933da0b" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_646f03be-affc-460d-8132-0c562afa7309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_9eeef765-f177-4aa1-808d-eec38895cb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_646f03be-affc-460d-8132-0c562afa7309" xlink:to="loc_us-gaap_InterestPaidNet_9eeef765-f177-4aa1-808d-eec38895cb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_0476618e-c444-41e2-a50a-0f17689ae034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_646f03be-affc-460d-8132-0c562afa7309" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_0476618e-c444-41e2-a50a-0f17689ae034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/BasisofPresentation" xlink:type="simple" xlink:href="sem-20210630.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd6cd98b-ee93-4c34-8477-b911b08471da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_14f8d3b5-99b3-4c8a-a259-6150b6e40c83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd6cd98b-ee93-4c34-8477-b911b08471da" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_14f8d3b5-99b3-4c8a-a259-6150b6e40c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/AccountingPolicies" xlink:type="simple" xlink:href="sem-20210630.xsd#AccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/AccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_45b3ec65-bf4c-48c5-9028-7169d5ac632b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_972c4913-0155-4a00-92cc-cefb65353772" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_45b3ec65-bf4c-48c5-9028-7169d5ac632b" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_972c4913-0155-4a00-92cc-cefb65353772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/AccountingPoliciesPolicies" xlink:type="simple" xlink:href="sem-20210630.xsd#AccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/AccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6e0a77e3-7bcf-45c2-bdd9-bb28edd0c269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_5624756d-e8ef-4dde-a8ba-276831b57ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6e0a77e3-7bcf-45c2-bdd9-bb28edd0c269" xlink:to="loc_us-gaap_UseOfEstimates_5624756d-e8ef-4dde-a8ba-276831b57ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2e24be73-5c6d-4306-8544-8676e6291c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6e0a77e3-7bcf-45c2-bdd9-bb28edd0c269" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2e24be73-5c6d-4306-8544-8676e6291c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_81039ae3-9e48-40f3-ac68-efeb64eab9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6e0a77e3-7bcf-45c2-bdd9-bb28edd0c269" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_81039ae3-9e48-40f3-ac68-efeb64eab9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_f6def2c5-7272-45d4-bf4b-66f6fd843b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6e0a77e3-7bcf-45c2-bdd9-bb28edd0c269" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_f6def2c5-7272-45d4-bf4b-66f6fd843b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_bb9cbd55-f055-489f-87db-1664623f9d85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6e0a77e3-7bcf-45c2-bdd9-bb28edd0c269" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_bb9cbd55-f055-489f-87db-1664623f9d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CreditRiskConcentrations" xlink:type="simple" xlink:href="sem-20210630.xsd#CreditRiskConcentrations"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/CreditRiskConcentrations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossAbstract_ae937aee-bbdc-4867-a52c-1e575c3b9b14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditLossAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_a25b48fe-d9bf-4c9e-b877-a2fdf90f2670" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditLossAbstract_ae937aee-bbdc-4867-a52c-1e575c3b9b14" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_a25b48fe-d9bf-4c9e-b877-a2fdf90f2670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CreditRiskConcentrationsDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#CreditRiskConcentrationsDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/CreditRiskConcentrationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditLossAbstract_ea9c4068-961d-43cd-97cc-607085b7ee4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditLossAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_c8904fcb-042e-4550-b8fd-6f628f80711f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditLossAbstract_ea9c4068-961d-43cd-97cc-607085b7ee4e" xlink:to="loc_us-gaap_ConcentrationRiskTable_c8904fcb-042e-4550-b8fd-6f628f80711f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_22e5fe23-3952-4e8a-82ab-77a8804669ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_c8904fcb-042e-4550-b8fd-6f628f80711f" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_22e5fe23-3952-4e8a-82ab-77a8804669ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_bf59bedd-90d0-4a3a-b379-fbba5278cac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_22e5fe23-3952-4e8a-82ab-77a8804669ed" xlink:to="loc_us-gaap_ReceivableTypeDomain_bf59bedd-90d0-4a3a-b379-fbba5278cac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_MedicareReceivableMember_b420d0da-651a-47b2-895e-18e4246fbe8c" xlink:href="sem-20210630.xsd#sem_MedicareReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_bf59bedd-90d0-4a3a-b379-fbba5278cac7" xlink:to="loc_sem_MedicareReceivableMember_b420d0da-651a-47b2-895e-18e4246fbe8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_c1386db0-c666-41ad-92bf-cd0346acbeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_c8904fcb-042e-4550-b8fd-6f628f80711f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_c1386db0-c666-41ad-92bf-cd0346acbeb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_a063f369-b11a-4f13-ad69-a74da27d748b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_c1386db0-c666-41ad-92bf-cd0346acbeb7" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_a063f369-b11a-4f13-ad69-a74da27d748b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_df184d14-cc1b-4420-9a9a-d43a5d3bf6ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_a063f369-b11a-4f13-ad69-a74da27d748b" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_df184d14-cc1b-4420-9a9a-d43a5d3bf6ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_38cd7389-5116-4d15-83ae-b6fee7cc0bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_c8904fcb-042e-4550-b8fd-6f628f80711f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_38cd7389-5116-4d15-83ae-b6fee7cc0bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b7bfc0b1-942b-4ea3-8aa1-2cb57ba99eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_38cd7389-5116-4d15-83ae-b6fee7cc0bc5" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b7bfc0b1-942b-4ea3-8aa1-2cb57ba99eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_f60c04f6-48e2-464b-857f-55f0e2006bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b7bfc0b1-942b-4ea3-8aa1-2cb57ba99eb9" xlink:to="loc_us-gaap_AccountsReceivableMember_f60c04f6-48e2-464b-857f-55f0e2006bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_29d1cd63-0419-4d91-9508-54cca1961991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_c8904fcb-042e-4550-b8fd-6f628f80711f" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_29d1cd63-0419-4d91-9508-54cca1961991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_14955247-cdf0-4131-ab23-f64961eb3448" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_29d1cd63-0419-4d91-9508-54cca1961991" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_14955247-cdf0-4131-ab23-f64961eb3448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/RedeemableNonControllingInterests" xlink:type="simple" xlink:href="sem-20210630.xsd#RedeemableNonControllingInterests"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/RedeemableNonControllingInterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_0f0da597-0e7b-4d08-93a1-c22e1fab743c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock_78018a82-56b8-458b-bd0f-e7f40ad9af7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_0f0da597-0e7b-4d08-93a1-c22e1fab743c" xlink:to="loc_us-gaap_MinorityInterestDisclosureTextBlock_78018a82-56b8-458b-bd0f-e7f40ad9af7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/RedeemableNonControllingInterestsTables" xlink:type="simple" xlink:href="sem-20210630.xsd#RedeemableNonControllingInterestsTables"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/RedeemableNonControllingInterestsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_a6797c3d-599a-4516-84aa-b6fcead76827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_b1aada14-a22a-4840-a371-3bb9fc06431f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_a6797c3d-599a-4516-84aa-b6fcead76827" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestTableTextBlock_b1aada14-a22a-4840-a371-3bb9fc06431f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_0fbd5e59-16f1-4803-9ecd-26692d1d2698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1c03f680-05b1-4bad-90be-98338fc0cc37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_0fbd5e59-16f1-4803-9ecd-26692d1d2698" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1c03f680-05b1-4bad-90be-98338fc0cc37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_a51fd4fb-dae0-47c2-b737-29091ccd1619" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1c03f680-05b1-4bad-90be-98338fc0cc37" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_a51fd4fb-dae0-47c2-b737-29091ccd1619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_5a1f06ae-b119-4dd8-962f-a7b38e313a97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1c03f680-05b1-4bad-90be-98338fc0cc37" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_5a1f06ae-b119-4dd8-962f-a7b38e313a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests_2a951d31-5a6e-4696-85cd-2ec55a2a53b7" xlink:href="sem-20210630.xsd#sem_NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1c03f680-05b1-4bad-90be-98338fc0cc37" xlink:to="loc_sem_NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests_2a951d31-5a6e-4696-85cd-2ec55a2a53b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_f86612c8-80ec-444e-8fbd-de8e8b6fcf83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1c03f680-05b1-4bad-90be-98338fc0cc37" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_f86612c8-80ec-444e-8fbd-de8e8b6fcf83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_b0ef645d-ed99-4b3e-aa5c-dee9f6fddcf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1c03f680-05b1-4bad-90be-98338fc0cc37" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_b0ef645d-ed99-4b3e-aa5c-dee9f6fddcf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityOtherChanges_f4ac013f-4201-48fe-9c56-3165e57e782b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityOtherChanges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1c03f680-05b1-4bad-90be-98338fc0cc37" xlink:to="loc_us-gaap_TemporaryEquityOtherChanges_f4ac013f-4201-48fe-9c56-3165e57e782b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_3c3e4295-75bf-4238-946c-5a1d1f3042f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1c03f680-05b1-4bad-90be-98338fc0cc37" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_3c3e4295-75bf-4238-946c-5a1d1f3042f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/VariableInterestEntities" xlink:type="simple" xlink:href="sem-20210630.xsd#VariableInterestEntities"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/VariableInterestEntities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f010312e-3170-457f-840d-bdecb58981b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_3d4f6dcd-c3b4-4cbc-bb29-48d967779600" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f010312e-3170-457f-840d-bdecb58981b9" xlink:to="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_3d4f6dcd-c3b4-4cbc-bb29-48d967779600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/VariableInterestEntitiesDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#VariableInterestEntitiesDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/VariableInterestEntitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c10ac798-1984-4bae-8213-470922d6db6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9dadf2ca-1c33-4525-a2a8-8085010bd010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c10ac798-1984-4bae-8213-470922d6db6c" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9dadf2ca-1c33-4525-a2a8-8085010bd010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_e8e16c6f-c025-4dd5-8cd4-429fd5b18e57" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9dadf2ca-1c33-4525-a2a8-8085010bd010" xlink:to="loc_srt_ConsolidatedEntitiesAxis_e8e16c6f-c025-4dd5-8cd4-429fd5b18e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_a5bdd982-e936-4e7e-9de2-663e4b281f0b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_e8e16c6f-c025-4dd5-8cd4-429fd5b18e57" xlink:to="loc_srt_ConsolidatedEntitiesDomain_a5bdd982-e936-4e7e-9de2-663e4b281f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_b5b0f95d-997b-4a82-9bc0-74da0dcf33b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_a5bdd982-e936-4e7e-9de2-663e4b281f0b" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_b5b0f95d-997b-4a82-9bc0-74da0dcf33b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_f4a5407f-8f4e-4413-a6a6-415f467bf5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_9dadf2ca-1c33-4525-a2a8-8085010bd010" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_f4a5407f-8f4e-4413-a6a6-415f467bf5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_06514dff-9e5b-4eb0-a277-e4af7fa5a371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_f4a5407f-8f4e-4413-a6a6-415f467bf5b2" xlink:to="loc_us-gaap_Assets_06514dff-9e5b-4eb0-a277-e4af7fa5a371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_251ae5cc-8dd7-4bc6-b727-549552b9c19e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_f4a5407f-8f4e-4413-a6a6-415f467bf5b2" xlink:to="loc_us-gaap_Liabilities_251ae5cc-8dd7-4bc6-b727-549552b9c19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_5ad23a92-f855-4c4b-a095-31f2fc4d7181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_f4a5407f-8f4e-4413-a6a6-415f467bf5b2" xlink:to="loc_us-gaap_DueToAffiliateCurrent_5ad23a92-f855-4c4b-a095-31f2fc4d7181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/Leases" xlink:type="simple" xlink:href="sem-20210630.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5a343c95-61fd-44ce-871b-1e715d738bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_e8708ad7-8540-4aba-a04d-bb538c2f75b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a343c95-61fd-44ce-871b-1e715d738bb6" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_e8708ad7-8540-4aba-a04d-bb538c2f75b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_2a0a4c9f-e169-43c3-8b35-fad436341142" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a343c95-61fd-44ce-871b-1e715d738bb6" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_2a0a4c9f-e169-43c3-8b35-fad436341142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LeasesTables" xlink:type="simple" xlink:href="sem-20210630.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7d593560-df36-43aa-b839-49f4f1544c48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_78589ce6-8237-4cd8-93a6-a0a3fe8cb64b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7d593560-df36-43aa-b839-49f4f1544c48" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_78589ce6-8237-4cd8-93a6-a0a3fe8cb64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_02f3ecb4-d896-4062-aacb-7b50ceef64b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7d593560-df36-43aa-b839-49f4f1544c48" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_02f3ecb4-d896-4062-aacb-7b50ceef64b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock_302e910e-6a61-41cc-8ec2-41f6230ee895" xlink:href="sem-20210630.xsd#sem_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7d593560-df36-43aa-b839-49f4f1544c48" xlink:to="loc_sem_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock_302e910e-6a61-41cc-8ec2-41f6230ee895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_ee937aa4-a44e-4013-85cc-334fa87f5abc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7d593560-df36-43aa-b839-49f4f1544c48" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_ee937aa4-a44e-4013-85cc-334fa87f5abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ba24a4d1-c522-47c2-b5d8-b6bfb18d1b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7d593560-df36-43aa-b839-49f4f1544c48" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ba24a4d1-c522-47c2-b5d8-b6bfb18d1b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#LeasesScheduleofLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ada9cf0e-a2ed-4dce-b9e6-ab0f2b78eef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_972923c4-bd79-467e-a3b0-2e107a171acc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ada9cf0e-a2ed-4dce-b9e6-ab0f2b78eef2" xlink:to="loc_us-gaap_LeaseCostAbstract_972923c4-bd79-467e-a3b0-2e107a171acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseCostUnrelatedParties_5242d2f9-d211-4dd5-bade-16fa8c07ce5e" xlink:href="sem-20210630.xsd#sem_OperatingLeaseCostUnrelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_972923c4-bd79-467e-a3b0-2e107a171acc" xlink:to="loc_sem_OperatingLeaseCostUnrelatedParties_5242d2f9-d211-4dd5-bade-16fa8c07ce5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseCostRelatedParties_a40621fa-9c0f-4241-9b9e-0de568fcd9c9" xlink:href="sem-20210630.xsd#sem_OperatingLeaseCostRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_972923c4-bd79-467e-a3b0-2e107a171acc" xlink:to="loc_sem_OperatingLeaseCostRelatedParties_a40621fa-9c0f-4241-9b9e-0de568fcd9c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_8c95a312-a131-4227-955c-3a13faa44f73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_972923c4-bd79-467e-a3b0-2e107a171acc" xlink:to="loc_us-gaap_OperatingLeaseCost_8c95a312-a131-4227-955c-3a13faa44f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_1108952c-ff8a-4d75-a82b-57a9de1eff1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ada9cf0e-a2ed-4dce-b9e6-ab0f2b78eef2" xlink:to="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_1108952c-ff8a-4d75-a82b-57a9de1eff1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseRightOfUseAssetAmortizationAbstract_981f333a-0426-41c3-a048-cab83bff7ff9" xlink:href="sem-20210630.xsd#sem_FinanceLeaseRightOfUseAssetAmortizationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_1108952c-ff8a-4d75-a82b-57a9de1eff1a" xlink:to="loc_sem_FinanceLeaseRightOfUseAssetAmortizationAbstract_981f333a-0426-41c3-a048-cab83bff7ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties_cdf84998-c3f5-4d92-a8dc-4521d4d9c8e4" xlink:href="sem-20210630.xsd#sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FinanceLeaseRightOfUseAssetAmortizationAbstract_981f333a-0426-41c3-a048-cab83bff7ff9" xlink:to="loc_sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties_cdf84998-c3f5-4d92-a8dc-4521d4d9c8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties_20195f0e-5704-4b86-bf4a-3e086ceabe18" xlink:href="sem-20210630.xsd#sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FinanceLeaseRightOfUseAssetAmortizationAbstract_981f333a-0426-41c3-a048-cab83bff7ff9" xlink:to="loc_sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties_20195f0e-5704-4b86-bf4a-3e086ceabe18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6552e657-f84c-43a8-bbb9-6fa28ffca2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FinanceLeaseRightOfUseAssetAmortizationAbstract_981f333a-0426-41c3-a048-cab83bff7ff9" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6552e657-f84c-43a8-bbb9-6fa28ffca2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseInterestExpenseAbstract_8ee52966-b926-4c6e-a804-d46a7cdaeab7" xlink:href="sem-20210630.xsd#sem_FinanceLeaseInterestExpenseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_1108952c-ff8a-4d75-a82b-57a9de1eff1a" xlink:to="loc_sem_FinanceLeaseInterestExpenseAbstract_8ee52966-b926-4c6e-a804-d46a7cdaeab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseInterestExpenseUnrelatedParties_7b6ad99e-5d3b-4ba5-9ec1-db85c9d29050" xlink:href="sem-20210630.xsd#sem_FinanceLeaseInterestExpenseUnrelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FinanceLeaseInterestExpenseAbstract_8ee52966-b926-4c6e-a804-d46a7cdaeab7" xlink:to="loc_sem_FinanceLeaseInterestExpenseUnrelatedParties_7b6ad99e-5d3b-4ba5-9ec1-db85c9d29050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseInterestExpenseRelatedParties_bdddbc69-d720-4789-b30d-c9f923e07fcc" xlink:href="sem-20210630.xsd#sem_FinanceLeaseInterestExpenseRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FinanceLeaseInterestExpenseAbstract_8ee52966-b926-4c6e-a804-d46a7cdaeab7" xlink:to="loc_sem_FinanceLeaseInterestExpenseRelatedParties_bdddbc69-d720-4789-b30d-c9f923e07fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_c8468c83-b44a-4560-977c-43add8887465" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FinanceLeaseInterestExpenseAbstract_8ee52966-b926-4c6e-a804-d46a7cdaeab7" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_c8468c83-b44a-4560-977c-43add8887465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_VariableLeaseCostAbstract_b2bfdfbf-9c22-47b2-81b2-03d359bbff1e" xlink:href="sem-20210630.xsd#sem_VariableLeaseCostAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ada9cf0e-a2ed-4dce-b9e6-ab0f2b78eef2" xlink:to="loc_sem_VariableLeaseCostAbstract_b2bfdfbf-9c22-47b2-81b2-03d359bbff1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_VariableLeaseCostUnrelatedParties_6325e3aa-5d0a-47a8-bb21-ea0383bea1ee" xlink:href="sem-20210630.xsd#sem_VariableLeaseCostUnrelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_VariableLeaseCostAbstract_b2bfdfbf-9c22-47b2-81b2-03d359bbff1e" xlink:to="loc_sem_VariableLeaseCostUnrelatedParties_6325e3aa-5d0a-47a8-bb21-ea0383bea1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_VariableLeaseCostRelatedParties_a8c4fab3-cefc-4dee-b742-5eb21a786c18" xlink:href="sem-20210630.xsd#sem_VariableLeaseCostRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_VariableLeaseCostAbstract_b2bfdfbf-9c22-47b2-81b2-03d359bbff1e" xlink:to="loc_sem_VariableLeaseCostRelatedParties_a8c4fab3-cefc-4dee-b742-5eb21a786c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_a8ed2b75-9b1e-4cd2-aea0-7d572945afde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_VariableLeaseCostAbstract_b2bfdfbf-9c22-47b2-81b2-03d359bbff1e" xlink:to="loc_us-gaap_VariableLeaseCost_a8ed2b75-9b1e-4cd2-aea0-7d572945afde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_SubleaseIncomeAbstract_ca0e4bd2-59e6-4801-982b-ae09e0cb7097" xlink:href="sem-20210630.xsd#sem_SubleaseIncomeAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ada9cf0e-a2ed-4dce-b9e6-ab0f2b78eef2" xlink:to="loc_sem_SubleaseIncomeAbstract_ca0e4bd2-59e6-4801-982b-ae09e0cb7097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_SubleaseIncomeUnrelatedParties_23d2ec36-803a-400a-ae00-3554cb0fcceb" xlink:href="sem-20210630.xsd#sem_SubleaseIncomeUnrelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_SubleaseIncomeAbstract_ca0e4bd2-59e6-4801-982b-ae09e0cb7097" xlink:to="loc_sem_SubleaseIncomeUnrelatedParties_23d2ec36-803a-400a-ae00-3554cb0fcceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_SubleaseIncomeRelatedParties_0e4d3f2b-de4a-4794-89f0-6b6be7d2f2dd" xlink:href="sem-20210630.xsd#sem_SubleaseIncomeRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_SubleaseIncomeAbstract_ca0e4bd2-59e6-4801-982b-ae09e0cb7097" xlink:to="loc_sem_SubleaseIncomeRelatedParties_0e4d3f2b-de4a-4794-89f0-6b6be7d2f2dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_5f3f2ccc-1324-4b8d-ae2f-1ec142486535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_SubleaseIncomeAbstract_ca0e4bd2-59e6-4801-982b-ae09e0cb7097" xlink:to="loc_us-gaap_SubleaseIncome_5f3f2ccc-1324-4b8d-ae2f-1ec142486535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LeaseCostTotalAbstract_6ff4ca2d-2454-4c80-b23b-d5bf5dac1e3b" xlink:href="sem-20210630.xsd#sem_LeaseCostTotalAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ada9cf0e-a2ed-4dce-b9e6-ab0f2b78eef2" xlink:to="loc_sem_LeaseCostTotalAbstract_6ff4ca2d-2454-4c80-b23b-d5bf5dac1e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LeaseCostUnrelatedParties_3036c408-d340-4429-9ed1-bd29f4232a01" xlink:href="sem-20210630.xsd#sem_LeaseCostUnrelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_LeaseCostTotalAbstract_6ff4ca2d-2454-4c80-b23b-d5bf5dac1e3b" xlink:to="loc_sem_LeaseCostUnrelatedParties_3036c408-d340-4429-9ed1-bd29f4232a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LeaseCostRelatedParties_11eec0db-38ce-4bfa-a096-896ddfae12c1" xlink:href="sem-20210630.xsd#sem_LeaseCostRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_LeaseCostTotalAbstract_6ff4ca2d-2454-4c80-b23b-d5bf5dac1e3b" xlink:to="loc_sem_LeaseCostRelatedParties_11eec0db-38ce-4bfa-a096-896ddfae12c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_70c85e5e-3f72-495b-9575-eb613ca18f46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_LeaseCostTotalAbstract_6ff4ca2d-2454-4c80-b23b-d5bf5dac1e3b" xlink:to="loc_us-gaap_LeaseCost_70c85e5e-3f72-495b-9575-eb613ca18f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#LeasesSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_719bd606-3999-4e97-ac84-e801a81b2531" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract_f0091e80-b02c-489a-b427-15e90c8a2842" xlink:href="sem-20210630.xsd#sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_719bd606-3999-4e97-ac84-e801a81b2531" xlink:to="loc_sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract_f0091e80-b02c-489a-b427-15e90c8a2842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_ea537a38-6b34-4582-af59-937da4563e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract_f0091e80-b02c-489a-b427-15e90c8a2842" xlink:to="loc_us-gaap_OperatingLeasePayments_ea537a38-6b34-4582-af59-937da4563e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_62aefff1-d98e-4d66-8dbe-7e822b1e32cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract_f0091e80-b02c-489a-b427-15e90c8a2842" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_62aefff1-d98e-4d66-8dbe-7e822b1e32cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_d23823c5-4648-4f5c-b410-de0a1e1d0ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract_f0091e80-b02c-489a-b427-15e90c8a2842" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_d23823c5-4648-4f5c-b410-de0a1e1d0ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_adb88546-4dc6-4652-a265-9a506b301f94" xlink:href="sem-20210630.xsd#sem_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_719bd606-3999-4e97-ac84-e801a81b2531" xlink:to="loc_sem_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_adb88546-4dc6-4652-a265-9a506b301f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_d3b8e7db-55e1-4476-8593-d12bf208955e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_adb88546-4dc6-4652-a265-9a506b301f94" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_d3b8e7db-55e1-4476-8593-d12bf208955e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_c561494d-6088-473e-b96d-ecc4fb2b43c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract_adb88546-4dc6-4652-a265-9a506b301f94" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_c561494d-6088-473e-b96d-ecc4fb2b43c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_594e5b3d-6b33-4705-acb7-93b0588b69a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_AssetsandLiabilitiesLesseeOperatingLeaseAbstract_4c999903-c2a9-473a-9f04-d681b89e0451" xlink:href="sem-20210630.xsd#sem_AssetsandLiabilitiesLesseeOperatingLeaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_594e5b3d-6b33-4705-acb7-93b0588b69a0" xlink:to="loc_sem_AssetsandLiabilitiesLesseeOperatingLeaseAbstract_4c999903-c2a9-473a-9f04-d681b89e0451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseRightOfUseAssetAbstract_2cde86aa-f328-4b1c-a990-054266770b5d" xlink:href="sem-20210630.xsd#sem_OperatingLeaseRightOfUseAssetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_AssetsandLiabilitiesLesseeOperatingLeaseAbstract_4c999903-c2a9-473a-9f04-d681b89e0451" xlink:to="loc_sem_OperatingLeaseRightOfUseAssetAbstract_2cde86aa-f328-4b1c-a990-054266770b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseRightOfUseAssetUnrelatedParties_d81e78fe-47b2-4794-96c6-1e363c2180c7" xlink:href="sem-20210630.xsd#sem_OperatingLeaseRightOfUseAssetUnrelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_OperatingLeaseRightOfUseAssetAbstract_2cde86aa-f328-4b1c-a990-054266770b5d" xlink:to="loc_sem_OperatingLeaseRightOfUseAssetUnrelatedParties_d81e78fe-47b2-4794-96c6-1e363c2180c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseRightOfUseAssetRelatedParties_c68b923b-a691-4f39-a7b3-fdc7082ea892" xlink:href="sem-20210630.xsd#sem_OperatingLeaseRightOfUseAssetRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_OperatingLeaseRightOfUseAssetAbstract_2cde86aa-f328-4b1c-a990-054266770b5d" xlink:to="loc_sem_OperatingLeaseRightOfUseAssetRelatedParties_c68b923b-a691-4f39-a7b3-fdc7082ea892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1f886c08-8413-4147-a878-78c576cbfda3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_OperatingLeaseRightOfUseAssetAbstract_2cde86aa-f328-4b1c-a990-054266770b5d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1f886c08-8413-4147-a878-78c576cbfda3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityCurrentAbstract_5e1d19ea-8495-4762-a2f7-4df4910f87cf" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityCurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_AssetsandLiabilitiesLesseeOperatingLeaseAbstract_4c999903-c2a9-473a-9f04-d681b89e0451" xlink:to="loc_sem_OperatingLeaseLiabilityCurrentAbstract_5e1d19ea-8495-4762-a2f7-4df4910f87cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityCurrentUnrelatedParties_a5956739-5be6-49dd-ad6e-a14f79d81f5f" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityCurrentUnrelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_OperatingLeaseLiabilityCurrentAbstract_5e1d19ea-8495-4762-a2f7-4df4910f87cf" xlink:to="loc_sem_OperatingLeaseLiabilityCurrentUnrelatedParties_a5956739-5be6-49dd-ad6e-a14f79d81f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityCurrentRelatedParties_7ebcab9f-f998-4f23-849e-227132ef64af" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityCurrentRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_OperatingLeaseLiabilityCurrentAbstract_5e1d19ea-8495-4762-a2f7-4df4910f87cf" xlink:to="loc_sem_OperatingLeaseLiabilityCurrentRelatedParties_7ebcab9f-f998-4f23-849e-227132ef64af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_69e3e23b-2712-4181-91ee-55efa5011622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_OperatingLeaseLiabilityCurrentAbstract_5e1d19ea-8495-4762-a2f7-4df4910f87cf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_69e3e23b-2712-4181-91ee-55efa5011622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityNoncurrentAbstract_4cf7dab0-2f01-4a07-8c1c-cafe4baae700" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityNoncurrentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_AssetsandLiabilitiesLesseeOperatingLeaseAbstract_4c999903-c2a9-473a-9f04-d681b89e0451" xlink:to="loc_sem_OperatingLeaseLiabilityNoncurrentAbstract_4cf7dab0-2f01-4a07-8c1c-cafe4baae700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties_586bb236-b17a-4d77-920a-2809067145ee" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_OperatingLeaseLiabilityNoncurrentAbstract_4cf7dab0-2f01-4a07-8c1c-cafe4baae700" xlink:to="loc_sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties_586bb236-b17a-4d77-920a-2809067145ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityNoncurrentRelatedParties_0e910a08-b215-4db7-9b8d-e374804a12dc" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityNoncurrentRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_OperatingLeaseLiabilityNoncurrentAbstract_4cf7dab0-2f01-4a07-8c1c-cafe4baae700" xlink:to="loc_sem_OperatingLeaseLiabilityNoncurrentRelatedParties_0e910a08-b215-4db7-9b8d-e374804a12dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1cda4e43-0bc5-4482-baf2-8223f6900287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_OperatingLeaseLiabilityNoncurrentAbstract_4cf7dab0-2f01-4a07-8c1c-cafe4baae700" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1cda4e43-0bc5-4482-baf2-8223f6900287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityAbstract_29bc9bcc-64ad-4e22-aaa9-dc02aa74a861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_AssetsandLiabilitiesLesseeOperatingLeaseAbstract_4c999903-c2a9-473a-9f04-d681b89e0451" xlink:to="loc_us-gaap_OperatingLeaseLiabilityAbstract_29bc9bcc-64ad-4e22-aaa9-dc02aa74a861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityUnrelatedParties_9374c130-9c7e-4c2a-be06-eb6304d43412" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityUnrelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_29bc9bcc-64ad-4e22-aaa9-dc02aa74a861" xlink:to="loc_sem_OperatingLeaseLiabilityUnrelatedParties_9374c130-9c7e-4c2a-be06-eb6304d43412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OperatingLeaseLiabilityRelatedParties_a9ba6fb5-1f02-4c77-a439-4f08b236ea2c" xlink:href="sem-20210630.xsd#sem_OperatingLeaseLiabilityRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_29bc9bcc-64ad-4e22-aaa9-dc02aa74a861" xlink:to="loc_sem_OperatingLeaseLiabilityRelatedParties_a9ba6fb5-1f02-4c77-a439-4f08b236ea2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a0944467-dad7-4ddf-a8a9-c9007b7444f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_29bc9bcc-64ad-4e22-aaa9-dc02aa74a861" xlink:to="loc_us-gaap_OperatingLeaseLiability_a0944467-dad7-4ddf-a8a9-c9007b7444f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseAssetsAndLiabilitiesAbstract_d3178a8c-ba5e-4c68-9715-59b660c5a221" xlink:href="sem-20210630.xsd#sem_FinanceLeaseAssetsAndLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_594e5b3d-6b33-4705-acb7-93b0588b69a0" xlink:to="loc_sem_FinanceLeaseAssetsAndLiabilitiesAbstract_d3178a8c-ba5e-4c68-9715-59b660c5a221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract_2c44754a-6e18-47a2-9369-96639ec50bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FinanceLeaseAssetsAndLiabilitiesAbstract_d3178a8c-ba5e-4c68-9715-59b660c5a221" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract_2c44754a-6e18-47a2-9369-96639ec50bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties_63a3fb7c-6b87-40c1-bdc4-598e1bf173a5" xlink:href="sem-20210630.xsd#sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract_2c44754a-6e18-47a2-9369-96639ec50bcd" xlink:to="loc_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties_63a3fb7c-6b87-40c1-bdc4-598e1bf173a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties_af85da65-dc26-4277-bd3c-5e88eced717c" xlink:href="sem-20210630.xsd#sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract_2c44754a-6e18-47a2-9369-96639ec50bcd" xlink:to="loc_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties_af85da65-dc26-4277-bd3c-5e88eced717c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_f67a154c-e773-492f-8d1a-3b7f194a3fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract_2c44754a-6e18-47a2-9369-96639ec50bcd" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_f67a154c-e773-492f-8d1a-3b7f194a3fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityCurrentAbstract_67499f43-71ad-4a61-b645-c3a8978bfc69" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityCurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FinanceLeaseAssetsAndLiabilitiesAbstract_d3178a8c-ba5e-4c68-9715-59b660c5a221" xlink:to="loc_sem_FinanceLeaseLiabilityCurrentAbstract_67499f43-71ad-4a61-b645-c3a8978bfc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityCurrentUnrelatedParties_9c9ce999-cc7b-47fa-9fec-4311d469f12d" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityCurrentUnrelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FinanceLeaseLiabilityCurrentAbstract_67499f43-71ad-4a61-b645-c3a8978bfc69" xlink:to="loc_sem_FinanceLeaseLiabilityCurrentUnrelatedParties_9c9ce999-cc7b-47fa-9fec-4311d469f12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityCurrentRelatedParties_2eaa75f9-6580-42f2-b3fb-babd580d6f7e" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityCurrentRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FinanceLeaseLiabilityCurrentAbstract_67499f43-71ad-4a61-b645-c3a8978bfc69" xlink:to="loc_sem_FinanceLeaseLiabilityCurrentRelatedParties_2eaa75f9-6580-42f2-b3fb-babd580d6f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_a37d1a32-d37f-4ef6-a831-b46d2e1d8e58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FinanceLeaseLiabilityCurrentAbstract_67499f43-71ad-4a61-b645-c3a8978bfc69" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_a37d1a32-d37f-4ef6-a831-b46d2e1d8e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityNoncurrentAbstract_1bcbc815-9ef8-4c1c-8b93-679402b940cc" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityNoncurrentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FinanceLeaseAssetsAndLiabilitiesAbstract_d3178a8c-ba5e-4c68-9715-59b660c5a221" xlink:to="loc_sem_FinanceLeaseLiabilityNoncurrentAbstract_1bcbc815-9ef8-4c1c-8b93-679402b940cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties_63ee8435-7d92-4891-8e64-f6e245a50995" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FinanceLeaseLiabilityNoncurrentAbstract_1bcbc815-9ef8-4c1c-8b93-679402b940cc" xlink:to="loc_sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties_63ee8435-7d92-4891-8e64-f6e245a50995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityNoncurrentRelatedParties_ff9c2bdb-4834-43bc-8e5c-826d38415000" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityNoncurrentRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FinanceLeaseLiabilityNoncurrentAbstract_1bcbc815-9ef8-4c1c-8b93-679402b940cc" xlink:to="loc_sem_FinanceLeaseLiabilityNoncurrentRelatedParties_ff9c2bdb-4834-43bc-8e5c-826d38415000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_7f5d2bb2-ebc1-457f-99bf-e8df99386352" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FinanceLeaseLiabilityNoncurrentAbstract_1bcbc815-9ef8-4c1c-8b93-679402b940cc" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_7f5d2bb2-ebc1-457f-99bf-e8df99386352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract_5eb09b01-cdd2-4934-850b-78393378d456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FinanceLeaseAssetsAndLiabilitiesAbstract_d3178a8c-ba5e-4c68-9715-59b660c5a221" xlink:to="loc_us-gaap_FinanceLeaseLiabilityAbstract_5eb09b01-cdd2-4934-850b-78393378d456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityUnrelatedParties_414238ac-411c-404a-b591-e92010b92a6e" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityUnrelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_5eb09b01-cdd2-4934-850b-78393378d456" xlink:to="loc_sem_FinanceLeaseLiabilityUnrelatedParties_414238ac-411c-404a-b591-e92010b92a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityRelatedParties_e0a0f797-889e-4e87-8ff1-b8747b0c2280" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_5eb09b01-cdd2-4934-850b-78393378d456" xlink:to="loc_sem_FinanceLeaseLiabilityRelatedParties_e0a0f797-889e-4e87-8ff1-b8747b0c2280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_f1cf63d1-c3c4-4111-a963-cefd6e662efd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_5eb09b01-cdd2-4934-850b-78393378d456" xlink:to="loc_us-gaap_FinanceLeaseLiability_f1cf63d1-c3c4-4111-a963-cefd6e662efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails_1" xlink:type="simple" xlink:href="sem-20210630.xsd#LeasesSupplementalBalanceSheetInformationDetails_1"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LeasesWeightedAverageLeaseTermsandDiscountRatesDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#LeasesWeightedAverageLeaseTermsandDiscountRatesDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/LeasesWeightedAverageLeaseTermsandDiscountRatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a87587f8-824f-4fc2-bfec-7da478d35021" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract_088d144e-3133-4554-9167-e5f3bc2363ac" xlink:href="sem-20210630.xsd#sem_WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a87587f8-824f-4fc2-bfec-7da478d35021" xlink:to="loc_sem_WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract_088d144e-3133-4554-9167-e5f3bc2363ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_ad850562-6d5a-4c68-acb8-fc8aae619e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract_088d144e-3133-4554-9167-e5f3bc2363ac" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_ad850562-6d5a-4c68-acb8-fc8aae619e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_702becf9-4085-4c76-bd84-6f3edb0ed52a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract_088d144e-3133-4554-9167-e5f3bc2363ac" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_702becf9-4085-4c76-bd84-6f3edb0ed52a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract_e72b8a21-a1cc-4188-b04c-2bde5c05309f" xlink:href="sem-20210630.xsd#sem_WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a87587f8-824f-4fc2-bfec-7da478d35021" xlink:to="loc_sem_WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract_e72b8a21-a1cc-4188-b04c-2bde5c05309f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_05296de0-e27a-4cb8-bb2d-013cd35f3f34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract_e72b8a21-a1cc-4188-b04c-2bde5c05309f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_05296de0-e27a-4cb8-bb2d-013cd35f3f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_96367aea-39d2-4a1b-bd3e-484fa4ebd1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract_e72b8a21-a1cc-4188-b04c-2bde5c05309f" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_96367aea-39d2-4a1b-bd3e-484fa4ebd1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7ae9def4-acc6-430e-b5ae-0653993ed7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_06ecc6eb-543f-4a41-a9d0-d0e6c58ce6ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7ae9def4-acc6-430e-b5ae-0653993ed7e2" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_06ecc6eb-543f-4a41-a9d0-d0e6c58ce6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_1b62da43-5b33-4df0-991e-2625590b8ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_06ecc6eb-543f-4a41-a9d0-d0e6c58ce6ff" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_1b62da43-5b33-4df0-991e-2625590b8ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a469d227-682c-44e7-9c8c-82b1429d2192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_06ecc6eb-543f-4a41-a9d0-d0e6c58ce6ff" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a469d227-682c-44e7-9c8c-82b1429d2192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_adf5d479-9ef5-412b-934f-3c4a4c09af73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_06ecc6eb-543f-4a41-a9d0-d0e6c58ce6ff" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_adf5d479-9ef5-412b-934f-3c4a4c09af73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_93a540b2-ff7e-46fe-a294-ced27d3ba02e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_06ecc6eb-543f-4a41-a9d0-d0e6c58ce6ff" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_93a540b2-ff7e-46fe-a294-ced27d3ba02e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5f3189e0-c043-4824-bb8a-7d13206b27c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_06ecc6eb-543f-4a41-a9d0-d0e6c58ce6ff" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5f3189e0-c043-4824-bb8a-7d13206b27c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_30ad76eb-bb2c-4817-8d63-f4b77856c7a1" xlink:href="sem-20210630.xsd#sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_06ecc6eb-543f-4a41-a9d0-d0e6c58ce6ff" xlink:to="loc_sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_30ad76eb-bb2c-4817-8d63-f4b77856c7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_424647c9-5555-445d-a3e7-77fbf83fde4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_06ecc6eb-543f-4a41-a9d0-d0e6c58ce6ff" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_424647c9-5555-445d-a3e7-77fbf83fde4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1c9de23f-d659-4d4e-b858-2c587ada0792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_06ecc6eb-543f-4a41-a9d0-d0e6c58ce6ff" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1c9de23f-d659-4d4e-b858-2c587ada0792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_95c74f28-d0e1-4c81-a1b1-4ab02cd98eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_06ecc6eb-543f-4a41-a9d0-d0e6c58ce6ff" xlink:to="loc_us-gaap_OperatingLeaseLiability_95c74f28-d0e1-4c81-a1b1-4ab02cd98eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e573f0be-a3de-445d-b67c-169ce04088fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7ae9def4-acc6-430e-b5ae-0653993ed7e2" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e573f0be-a3de-445d-b67c-169ce04088fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_ddef7380-95c9-47cc-9364-a96c8f49d49c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e573f0be-a3de-445d-b67c-169ce04088fa" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_ddef7380-95c9-47cc-9364-a96c8f49d49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_fc2af33a-9f4f-4f9d-bb02-f81cb9b3f052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e573f0be-a3de-445d-b67c-169ce04088fa" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_fc2af33a-9f4f-4f9d-bb02-f81cb9b3f052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_3df1b71d-bacf-4455-a5b8-617463d9ff00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e573f0be-a3de-445d-b67c-169ce04088fa" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_3df1b71d-bacf-4455-a5b8-617463d9ff00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_fb92f4a4-9062-47ec-804f-64620184df06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e573f0be-a3de-445d-b67c-169ce04088fa" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_fb92f4a4-9062-47ec-804f-64620184df06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_15a8e021-e274-4a2a-a20e-0c1fdbe69d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e573f0be-a3de-445d-b67c-169ce04088fa" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_15a8e021-e274-4a2a-a20e-0c1fdbe69d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour_21e2aff2-bfbb-4eaa-b29a-1e394c81c707" xlink:href="sem-20210630.xsd#sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e573f0be-a3de-445d-b67c-169ce04088fa" xlink:to="loc_sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour_21e2aff2-bfbb-4eaa-b29a-1e394c81c707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5707bace-21e4-440c-b235-c6e16e1b33ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e573f0be-a3de-445d-b67c-169ce04088fa" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5707bace-21e4-440c-b235-c6e16e1b33ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_d0de9c0c-1f19-4f0a-aa26-61c470af5112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e573f0be-a3de-445d-b67c-169ce04088fa" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_d0de9c0c-1f19-4f0a-aa26-61c470af5112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_67d65085-cd78-434d-8e48-afa2e1e3c442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_e573f0be-a3de-445d-b67c-169ce04088fa" xlink:to="loc_us-gaap_FinanceLeaseLiability_67d65085-cd78-434d-8e48-afa2e1e3c442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="sem-20210630.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.selectmedical.com/role/IntangibleAssets" xlink:type="simple" xlink:href="sem-20210630.xsd#IntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/IntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_090f7e5e-7d00-42ea-af63-9afef15efb39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_f7776517-918f-495f-a0b4-052bead05900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_090f7e5e-7d00-42ea-af63-9afef15efb39" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_f7776517-918f-495f-a0b4-052bead05900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/IntangibleAssetsTables" xlink:type="simple" xlink:href="sem-20210630.xsd#IntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/IntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7b050989-dc41-4c5a-b0e5-b3af67a44490" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_9e451bbf-d168-4a9a-a46f-b17ab100a7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7b050989-dc41-4c5a-b0e5-b3af67a44490" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_9e451bbf-d168-4a9a-a46f-b17ab100a7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_b24bd56b-27c4-470b-90b6-3b1b9da75c76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7b050989-dc41-4c5a-b0e5-b3af67a44490" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_b24bd56b-27c4-470b-90b6-3b1b9da75c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#IntangibleAssetsCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2585fdda-79f5-4657-a062-706f7aa11829" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_2941ac4e-9ffd-4de4-bdd9-cf2f6e20b6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2585fdda-79f5-4657-a062-706f7aa11829" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_2941ac4e-9ffd-4de4-bdd9-cf2f6e20b6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c3c32041-5cf2-49b9-930a-551da840d5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2941ac4e-9ffd-4de4-bdd9-cf2f6e20b6bd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c3c32041-5cf2-49b9-930a-551da840d5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_33d496b1-f6ee-4c3e-97d4-706b5d4f3daf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c3c32041-5cf2-49b9-930a-551da840d5ff" xlink:to="loc_us-gaap_SegmentDomain_33d496b1-f6ee-4c3e-97d4-706b5d4f3daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_CriticalIllnessRecoveryHospitalsMember_a3bf1f0e-a2c5-40b6-b10b-117085a199c2" xlink:href="sem-20210630.xsd#sem_CriticalIllnessRecoveryHospitalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_33d496b1-f6ee-4c3e-97d4-706b5d4f3daf" xlink:to="loc_sem_CriticalIllnessRecoveryHospitalsMember_a3bf1f0e-a2c5-40b6-b10b-117085a199c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_RehabilitationHospitalsMember_aa429a87-1989-4917-b452-73b8adee770f" xlink:href="sem-20210630.xsd#sem_RehabilitationHospitalsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_33d496b1-f6ee-4c3e-97d4-706b5d4f3daf" xlink:to="loc_sem_RehabilitationHospitalsMember_aa429a87-1989-4917-b452-73b8adee770f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OutpatientRehabilitationMember_1f544eb0-7586-4422-861a-81987de76a4c" xlink:href="sem-20210630.xsd#sem_OutpatientRehabilitationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_33d496b1-f6ee-4c3e-97d4-706b5d4f3daf" xlink:to="loc_sem_OutpatientRehabilitationMember_1f544eb0-7586-4422-861a-81987de76a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ConcentraMember_91b6960b-1a2f-45f6-b062-fce4ff5d199c" xlink:href="sem-20210630.xsd#sem_ConcentraMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_33d496b1-f6ee-4c3e-97d4-706b5d4f3daf" xlink:to="loc_sem_ConcentraMember_91b6960b-1a2f-45f6-b062-fce4ff5d199c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_6b5b789b-1f33-4a97-a134-f3d85342d243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2941ac4e-9ffd-4de4-bdd9-cf2f6e20b6bd" xlink:to="loc_us-gaap_GoodwillLineItems_6b5b789b-1f33-4a97-a134-f3d85342d243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_0023e7c5-bf51-4a42-90c5-2ac1e98b0f85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_6b5b789b-1f33-4a97-a134-f3d85342d243" xlink:to="loc_us-gaap_GoodwillRollForward_0023e7c5-bf51-4a42-90c5-2ac1e98b0f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cb935dae-3f86-4044-a5cd-43d389c0f3c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0023e7c5-bf51-4a42-90c5-2ac1e98b0f85" xlink:to="loc_us-gaap_Goodwill_cb935dae-3f86-4044-a5cd-43d389c0f3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_b932a2a5-4b9e-4fa9-acad-355cfae124a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0023e7c5-bf51-4a42-90c5-2ac1e98b0f85" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_b932a2a5-4b9e-4fa9-acad-355cfae124a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_28985889-ee8d-463a-a7df-6155eb6bc974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_0023e7c5-bf51-4a42-90c5-2ac1e98b0f85" xlink:to="loc_us-gaap_Goodwill_28985889-ee8d-463a-a7df-6155eb6bc974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f1df851-ed1b-4867-a431-03fe32eb5356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable_51fd2238-ffed-4ebb-8518-a710d58699d4" xlink:href="sem-20210630.xsd#sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f1df851-ed1b-4867-a431-03fe32eb5356" xlink:to="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable_51fd2238-ffed-4ebb-8518-a710d58699d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f1454b24-79f9-44b7-8dac-e0d17ed50f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable_51fd2238-ffed-4ebb-8518-a710d58699d4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f1454b24-79f9-44b7-8dac-e0d17ed50f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_efe50bbc-2dbf-4e0d-9ddc-8dfbb12407b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f1454b24-79f9-44b7-8dac-e0d17ed50f02" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_efe50bbc-2dbf-4e0d-9ddc-8dfbb12407b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_625cf060-0326-4214-9630-4ead9f40c616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_efe50bbc-2dbf-4e0d-9ddc-8dfbb12407b9" xlink:to="loc_us-gaap_TrademarksMember_625cf060-0326-4214-9630-4ead9f40c616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_CertificatesOfNeedMember_847b146d-7da9-4489-9911-f349e22cce74" xlink:href="sem-20210630.xsd#sem_CertificatesOfNeedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_efe50bbc-2dbf-4e0d-9ddc-8dfbb12407b9" xlink:to="loc_sem_CertificatesOfNeedMember_847b146d-7da9-4489-9911-f349e22cce74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_AccreditationsMember_6e2722ca-e473-4aaf-bdfc-d08fec092c18" xlink:href="sem-20210630.xsd#sem_AccreditationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_efe50bbc-2dbf-4e0d-9ddc-8dfbb12407b9" xlink:to="loc_sem_AccreditationsMember_6e2722ca-e473-4aaf-bdfc-d08fec092c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c48af90a-3bf4-4f3b-b341-4dcd07ad8d36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable_51fd2238-ffed-4ebb-8518-a710d58699d4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c48af90a-3bf4-4f3b-b341-4dcd07ad8d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_864b8a5f-6d57-4748-b918-2206b2a70a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c48af90a-3bf4-4f3b-b341-4dcd07ad8d36" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_864b8a5f-6d57-4748-b918-2206b2a70a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_7b44a8ff-bae8-4cf4-a212-f2bb34e0a6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_864b8a5f-6d57-4748-b918-2206b2a70a1a" xlink:to="loc_us-gaap_TrademarksMember_7b44a8ff-bae8-4cf4-a212-f2bb34e0a6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_0d60ceb9-8687-4e6f-8237-5d8dd559429a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_864b8a5f-6d57-4748-b918-2206b2a70a1a" xlink:to="loc_us-gaap_CustomerRelationshipsMember_0d60ceb9-8687-4e6f-8237-5d8dd559429a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_103d28de-2679-4e78-a14f-b8e608576bce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_864b8a5f-6d57-4748-b918-2206b2a70a1a" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_103d28de-2679-4e78-a14f-b8e608576bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_9234e85d-9c17-4ec0-80a4-6f1e869d5b17" xlink:href="sem-20210630.xsd#sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable_51fd2238-ffed-4ebb-8518-a710d58699d4" xlink:to="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_9234e85d-9c17-4ec0-80a4-6f1e869d5b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d72248dd-2faa-42b0-8aad-93812b59bbf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_9234e85d-9c17-4ec0-80a4-6f1e869d5b17" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_d72248dd-2faa-42b0-8aad-93812b59bbf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_77f146f7-acc0-4013-9ea4-56a45c1343b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_9234e85d-9c17-4ec0-80a4-6f1e869d5b17" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_77f146f7-acc0-4013-9ea4-56a45c1343b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a5160cc9-f517-4f31-99b8-7cece5f38e72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_9234e85d-9c17-4ec0-80a4-6f1e869d5b17" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a5160cc9-f517-4f31-99b8-7cece5f38e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_412e41ab-a80d-4117-82e9-3f318675d6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_9234e85d-9c17-4ec0-80a4-6f1e869d5b17" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_412e41ab-a80d-4117-82e9-3f318675d6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d2b0cabe-2b51-4bc7-8348-56af0f16966e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_9234e85d-9c17-4ec0-80a4-6f1e869d5b17" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d2b0cabe-2b51-4bc7-8348-56af0f16966e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_11705eec-a29b-4ff9-bc60-75097620325a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_9234e85d-9c17-4ec0-80a4-6f1e869d5b17" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_11705eec-a29b-4ff9-bc60-75097620325a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_ae02fc5c-c5aa-4eec-b1e8-a5235cc9d758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_9234e85d-9c17-4ec0-80a4-6f1e869d5b17" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_ae02fc5c-c5aa-4eec-b1e8-a5235cc9d758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension_378eec7a-2156-4b1e-a92b-b4d89c78edb4" xlink:href="sem-20210630.xsd#sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_ae02fc5c-c5aa-4eec-b1e8-a5235cc9d758" xlink:to="loc_sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension_378eec7a-2156-4b1e-a92b-b4d89c78edb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3e8587a2-7464-4c67-92ff-6dec12719fed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_ae02fc5c-c5aa-4eec-b1e8-a5235cc9d758" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3e8587a2-7464-4c67-92ff-6dec12719fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LongTermDebtandNotesPayable" xlink:type="simple" xlink:href="sem-20210630.xsd#LongTermDebtandNotesPayable"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/LongTermDebtandNotesPayable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_54ed97f4-c4bb-4f4b-b492-38f0ddaa3bce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_7c188a90-f91a-4376-98bf-13c8a2548ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_54ed97f4-c4bb-4f4b-b492-38f0ddaa3bce" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_7c188a90-f91a-4376-98bf-13c8a2548ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LongTermDebtandNotesPayableTables" xlink:type="simple" xlink:href="sem-20210630.xsd#LongTermDebtandNotesPayableTables"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/LongTermDebtandNotesPayableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0c067e70-7798-4d83-a5e3-e3952fc776ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_6e4896e9-c59e-412a-a801-cee22ae22bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0c067e70-7798-4d83-a5e3-e3952fc776ac" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_6e4896e9-c59e-412a-a801-cee22ae22bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1ef3a5f7-1d7e-487f-bfc3-db8196b86dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0c067e70-7798-4d83-a5e3-e3952fc776ac" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1ef3a5f7-1d7e-487f-bfc3-db8196b86dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ea7f9aba-1e8f-4f44-827a-9eb0b0c177df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_39827e01-ba3e-4565-80e3-6a3afa3a15d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ea7f9aba-1e8f-4f44-827a-9eb0b0c177df" xlink:to="loc_us-gaap_DebtInstrumentTable_39827e01-ba3e-4565-80e3-6a3afa3a15d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_4aadfb18-e36c-421e-b9cc-3ca4d1ec2b36" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_39827e01-ba3e-4565-80e3-6a3afa3a15d4" xlink:to="loc_dei_LegalEntityAxis_4aadfb18-e36c-421e-b9cc-3ca4d1ec2b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8b8ae086-da1b-4140-a170-0c633ab6e798" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_4aadfb18-e36c-421e-b9cc-3ca4d1ec2b36" xlink:to="loc_dei_EntityDomain_8b8ae086-da1b-4140-a170-0c633ab6e798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_SelectMedicalCorporationMember_6ac2087e-32b6-4dce-9eaf-554fc4d51a95" xlink:href="sem-20210630.xsd#sem_SelectMedicalCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8b8ae086-da1b-4140-a170-0c633ab6e798" xlink:to="loc_sem_SelectMedicalCorporationMember_6ac2087e-32b6-4dce-9eaf-554fc4d51a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1b757fb2-5271-46fe-9634-2ae4b0727f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_39827e01-ba3e-4565-80e3-6a3afa3a15d4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1b757fb2-5271-46fe-9634-2ae4b0727f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2b583c64-411c-4d5e-bc49-435da8641b91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1b757fb2-5271-46fe-9634-2ae4b0727f81" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2b583c64-411c-4d5e-bc49-435da8641b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_66b47d55-999a-4119-8417-140362164a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2b583c64-411c-4d5e-bc49-435da8641b91" xlink:to="loc_us-gaap_SeniorNotesMember_66b47d55-999a-4119-8417-140362164a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_efdf378c-520a-4965-b946-e810d8ab5c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2b583c64-411c-4d5e-bc49-435da8641b91" xlink:to="loc_us-gaap_SecuredDebtMember_efdf378c-520a-4965-b946-e810d8ab5c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_b9aeb539-b3ab-47c4-8935-b9f8df34e79c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2b583c64-411c-4d5e-bc49-435da8641b91" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_b9aeb539-b3ab-47c4-8935-b9f8df34e79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_cdcdee51-6dc4-484b-a592-e10ca1c3a972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_39827e01-ba3e-4565-80e3-6a3afa3a15d4" xlink:to="loc_us-gaap_DebtInstrumentLineItems_cdcdee51-6dc4-484b-a592-e10ca1c3a972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_88605860-015f-404a-a755-f1fcd85bed35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cdcdee51-6dc4-484b-a592-e10ca1c3a972" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_88605860-015f-404a-a755-f1fcd85bed35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e26e3f95-2a51-4f21-8c70-b7d7a51f0fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cdcdee51-6dc4-484b-a592-e10ca1c3a972" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e26e3f95-2a51-4f21-8c70-b7d7a51f0fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtGrossAndFinanceLeaseObligation_5034def7-f28f-4710-95a1-1486329bccdc" xlink:href="sem-20210630.xsd#sem_LongTermDebtGrossAndFinanceLeaseObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cdcdee51-6dc4-484b-a592-e10ca1c3a972" xlink:to="loc_sem_LongTermDebtGrossAndFinanceLeaseObligation_5034def7-f28f-4710-95a1-1486329bccdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_1ee74f67-9e82-4d42-abed-595a11744936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cdcdee51-6dc4-484b-a592-e10ca1c3a972" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_1ee74f67-9e82-4d42-abed-595a11744936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_9042fcd9-86ba-44ed-9f08-d11eea941982" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cdcdee51-6dc4-484b-a592-e10ca1c3a972" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_9042fcd9-86ba-44ed-9f08-d11eea941982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6c80e17e-c365-40c3-bd82-03644e8a8524" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cdcdee51-6dc4-484b-a592-e10ca1c3a972" xlink:to="loc_us-gaap_LongTermDebt_6c80e17e-c365-40c3-bd82-03644e8a8524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligation_15ef9fe1-2395-4e46-a0e6-3f00cd61f3b5" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cdcdee51-6dc4-484b-a592-e10ca1c3a972" xlink:to="loc_sem_LongTermDebtAndFinanceLeaseObligation_15ef9fe1-2395-4e46-a0e6-3f00cd61f3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_85f9f2de-20ed-4615-bc29-c1eee1a6114a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cdcdee51-6dc4-484b-a592-e10ca1c3a972" xlink:to="loc_us-gaap_DebtInstrumentFairValue_85f9f2de-20ed-4615-bc29-c1eee1a6114a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6d52e186-f99f-4faa-a119-08fac27749d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_eaf5ed2d-40e0-4096-88b2-c1a555a3da1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6d52e186-f99f-4faa-a119-08fac27749d4" xlink:to="loc_us-gaap_DebtInstrumentTable_eaf5ed2d-40e0-4096-88b2-c1a555a3da1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_fc0907c1-59a3-4f0a-9e20-8033efee7bad" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eaf5ed2d-40e0-4096-88b2-c1a555a3da1c" xlink:to="loc_dei_LegalEntityAxis_fc0907c1-59a3-4f0a-9e20-8033efee7bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0e0cca66-eeb6-43b0-9e89-441b87d7006a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_fc0907c1-59a3-4f0a-9e20-8033efee7bad" xlink:to="loc_dei_EntityDomain_0e0cca66-eeb6-43b0-9e89-441b87d7006a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_SelectMedicalCorporationMember_68c3bb2f-f8eb-4ec0-92ab-8244691ea6f7" xlink:href="sem-20210630.xsd#sem_SelectMedicalCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_0e0cca66-eeb6-43b0-9e89-441b87d7006a" xlink:to="loc_sem_SelectMedicalCorporationMember_68c3bb2f-f8eb-4ec0-92ab-8244691ea6f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d547ff34-1d4e-45ed-a27d-8572475c05ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eaf5ed2d-40e0-4096-88b2-c1a555a3da1c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d547ff34-1d4e-45ed-a27d-8572475c05ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a851b04a-7c42-4cc2-b8b4-1ffab885b31d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d547ff34-1d4e-45ed-a27d-8572475c05ba" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a851b04a-7c42-4cc2-b8b4-1ffab885b31d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_bd23a39a-cd88-46f9-83e0-66a29c74f22d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a851b04a-7c42-4cc2-b8b4-1ffab885b31d" xlink:to="loc_us-gaap_SeniorNotesMember_bd23a39a-cd88-46f9-83e0-66a29c74f22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_d97590a8-6c8b-4e29-8653-773979c0e5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a851b04a-7c42-4cc2-b8b4-1ffab885b31d" xlink:to="loc_us-gaap_SecuredDebtMember_d97590a8-6c8b-4e29-8653-773979c0e5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_805907e6-5621-4f46-9b61-eea2b0b20526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a851b04a-7c42-4cc2-b8b4-1ffab885b31d" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_805907e6-5621-4f46-9b61-eea2b0b20526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_eaf5ed2d-40e0-4096-88b2-c1a555a3da1c" xlink:to="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6be7342b-d16e-4d2e-a85c-b5379d87990c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6be7342b-d16e-4d2e-a85c-b5379d87990c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0ce6c0c5-674d-49ec-b7b1-c018f5bd280f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0ce6c0c5-674d-49ec-b7b1-c018f5bd280f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear_0aae13fa-d30c-45ec-933c-ed106c81b11c" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear_0aae13fa-d30c-45ec-933c-ed106c81b11c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2005752b-1f8b-497c-94e6-22b6b9dadeed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2005752b-1f8b-497c-94e6-22b6b9dadeed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e0450cee-6a41-4c27-8c1b-71150bfa6a43" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_e0450cee-6a41-4c27-8c1b-71150bfa6a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_8633dfa9-8e9e-4f84-8c0f-cd2015ca6a22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_8633dfa9-8e9e-4f84-8c0f-cd2015ca6a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo_3e31bf9e-048e-453f-8efe-9d2520a082dc" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo_3e31bf9e-048e-453f-8efe-9d2520a082dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_548e16cc-03b5-46d7-8340-0a09e8f9dc19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_548e16cc-03b5-46d7-8340-0a09e8f9dc19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree_4ac68856-0ed0-4c26-910a-65ad8d72d7cf" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree_4ac68856-0ed0-4c26-910a-65ad8d72d7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_2a23e688-c526-4980-ba6f-28cb273d255e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_2a23e688-c526-4980-ba6f-28cb273d255e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour_08eaae3a-3afd-49a3-8ec0-7e872cb97235" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour_08eaae3a-3afd-49a3-8ec0-7e872cb97235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour_d19a4667-d8e2-4750-8d67-a5275b6c1553" xlink:href="sem-20210630.xsd#sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour_d19a4667-d8e2-4750-8d67-a5275b6c1553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour_42c2d17b-00e7-4269-bee0-30537039b325" xlink:href="sem-20210630.xsd#sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour_42c2d17b-00e7-4269-bee0-30537039b325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_8430ce26-35bf-4b0f-a736-717523f7bde0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_8430ce26-35bf-4b0f-a736-717523f7bde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_LongTermDebtGrossAndFinanceLeaseObligation_c106d43c-53a3-411b-8b41-9a0acb6ea89e" xlink:href="sem-20210630.xsd#sem_LongTermDebtGrossAndFinanceLeaseObligation"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9695d07e-e40a-4dd9-8193-81bbc76c553e" xlink:to="loc_sem_LongTermDebtGrossAndFinanceLeaseObligation_c106d43c-53a3-411b-8b41-9a0acb6ea89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#LongTermDebtandNotesPayableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bdc294ac-1bfb-4e3c-808f-36a6e3a64859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_3150b931-56ec-4a62-abed-b8ea9ebb3bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bdc294ac-1bfb-4e3c-808f-36a6e3a64859" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_3150b931-56ec-4a62-abed-b8ea9ebb3bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9acd3ed6-f222-47e0-98d7-50e15c5d7e45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3150b931-56ec-4a62-abed-b8ea9ebb3bdb" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9acd3ed6-f222-47e0-98d7-50e15c5d7e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_da906e4a-d683-4aca-9fa9-89a8f7fb2d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9acd3ed6-f222-47e0-98d7-50e15c5d7e45" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_da906e4a-d683-4aca-9fa9-89a8f7fb2d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_4705e738-ce0c-423b-ba9e-838407aaa9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_da906e4a-d683-4aca-9fa9-89a8f7fb2d3f" xlink:to="loc_us-gaap_LineOfCreditMember_4705e738-ce0c-423b-ba9e-838407aaa9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_15ad02d5-0be0-40df-9449-240a8f0ef248" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3150b931-56ec-4a62-abed-b8ea9ebb3bdb" xlink:to="loc_dei_LegalEntityAxis_15ad02d5-0be0-40df-9449-240a8f0ef248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_65d9e506-fff3-4ddb-bb4f-7760f347502a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_15ad02d5-0be0-40df-9449-240a8f0ef248" xlink:to="loc_dei_EntityDomain_65d9e506-fff3-4ddb-bb4f-7760f347502a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_SelectMedicalCorporationMember_43c5fce3-eeae-421f-84c6-c0b3ca5eabf8" xlink:href="sem-20210630.xsd#sem_SelectMedicalCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_65d9e506-fff3-4ddb-bb4f-7760f347502a" xlink:to="loc_sem_SelectMedicalCorporationMember_43c5fce3-eeae-421f-84c6-c0b3ca5eabf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ConcentraMember_98fa0d12-4739-4338-b706-cf6e3115f1a4" xlink:href="sem-20210630.xsd#sem_ConcentraMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_65d9e506-fff3-4ddb-bb4f-7760f347502a" xlink:to="loc_sem_ConcentraMember_98fa0d12-4739-4338-b706-cf6e3115f1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2f922cc0-c92e-4f5c-b1ed-7f3307606742" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3150b931-56ec-4a62-abed-b8ea9ebb3bdb" xlink:to="loc_us-gaap_CreditFacilityAxis_2f922cc0-c92e-4f5c-b1ed-7f3307606742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2aea434b-5eeb-47a4-9bc3-9ea997f11e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_2f922cc0-c92e-4f5c-b1ed-7f3307606742" xlink:to="loc_us-gaap_CreditFacilityDomain_2aea434b-5eeb-47a4-9bc3-9ea997f11e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c545fb3f-6b96-4d3f-b520-ac4b18242980" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2aea434b-5eeb-47a4-9bc3-9ea997f11e0d" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c545fb3f-6b96-4d3f-b520-ac4b18242980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_7a5333c2-518f-454d-8212-0e8500de9a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2aea434b-5eeb-47a4-9bc3-9ea997f11e0d" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_7a5333c2-518f-454d-8212-0e8500de9a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9b8f1a39-655b-49b9-968b-e4c2aa780a28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3150b931-56ec-4a62-abed-b8ea9ebb3bdb" xlink:to="loc_us-gaap_DebtInstrumentAxis_9b8f1a39-655b-49b9-968b-e4c2aa780a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9b1c5a3a-9be5-41a8-8606-1b19e5eaa11a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9b8f1a39-655b-49b9-968b-e4c2aa780a28" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9b1c5a3a-9be5-41a8-8606-1b19e5eaa11a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_FirstLienCreditAgreementMember_14a71695-969d-4cf6-96f9-18651cb6e61a" xlink:href="sem-20210630.xsd#sem_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9b1c5a3a-9be5-41a8-8606-1b19e5eaa11a" xlink:to="loc_sem_FirstLienCreditAgreementMember_14a71695-969d-4cf6-96f9-18651cb6e61a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_da003f3b-0b45-4bf1-a8cc-8209f458d5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3150b931-56ec-4a62-abed-b8ea9ebb3bdb" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_da003f3b-0b45-4bf1-a8cc-8209f458d5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_160c2b78-0663-48a3-b358-1a1cc9859805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_da003f3b-0b45-4bf1-a8cc-8209f458d5ab" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_160c2b78-0663-48a3-b358-1a1cc9859805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_9fec0b65-644d-45fd-b90c-b1b4d25402a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_da003f3b-0b45-4bf1-a8cc-8209f458d5ab" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_9fec0b65-644d-45fd-b90c-b1b4d25402a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/InterestRateCap" xlink:type="simple" xlink:href="sem-20210630.xsd#InterestRateCap"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/InterestRateCap" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_307df04c-8d66-4197-96fb-6571616c0eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_3fc12c88-2ae9-47ac-ae86-accd1d494473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_307df04c-8d66-4197-96fb-6571616c0eb4" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_3fc12c88-2ae9-47ac-ae86-accd1d494473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/InterestRateCapTables" xlink:type="simple" xlink:href="sem-20210630.xsd#InterestRateCapTables"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/InterestRateCapTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_07848437-c2b5-4d96-9e79-412668c35cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2e64657f-e5a5-4a23-b953-aabb051ccb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_07848437-c2b5-4d96-9e79-412668c35cd3" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2e64657f-e5a5-4a23-b953-aabb051ccb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/InterestRateCapNarrativeDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#InterestRateCapNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/InterestRateCapNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cba6da1e-386e-413c-935b-f076d968845b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_832aad8b-66d0-4150-a837-a9bb694c94b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cba6da1e-386e-413c-935b-f076d968845b" xlink:to="loc_us-gaap_DerivativeTable_832aad8b-66d0-4150-a837-a9bb694c94b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8406fa26-29bd-4b8a-9622-6f7e089d736d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_832aad8b-66d0-4150-a837-a9bb694c94b9" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8406fa26-29bd-4b8a-9622-6f7e089d736d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4c248762-0bbc-4618-bd21-8106fb0ce53f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8406fa26-29bd-4b8a-9622-6f7e089d736d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4c248762-0bbc-4618-bd21-8106fb0ce53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_4b64edb1-f04c-49ff-a390-f7672a969d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4c248762-0bbc-4618-bd21-8106fb0ce53f" xlink:to="loc_us-gaap_InterestRateCapMember_4b64edb1-f04c-49ff-a390-f7672a969d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5bb8e388-71c0-4367-9a3c-67e9f1e2ef02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_832aad8b-66d0-4150-a837-a9bb694c94b9" xlink:to="loc_us-gaap_DerivativeLineItems_5bb8e388-71c0-4367-9a3c-67e9f1e2ef02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCapInterestRate_934d8f58-4898-4eb9-9add-2c6601afe7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeCapInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5bb8e388-71c0-4367-9a3c-67e9f1e2ef02" xlink:to="loc_us-gaap_DerivativeCapInterestRate_934d8f58-4898-4eb9-9add-2c6601afe7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_0dd3bf3f-f5eb-444e-b1a8-e3f5173f3cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5bb8e388-71c0-4367-9a3c-67e9f1e2ef02" xlink:to="loc_us-gaap_DerivativeNotionalAmount_0dd3bf3f-f5eb-444e-b1a8-e3f5173f3cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_DerivativeCostOfHedgeAnnualPremiumPercentage_666f7160-ba7a-45c1-905b-6adaabe05089" xlink:href="sem-20210630.xsd#sem_DerivativeCostOfHedgeAnnualPremiumPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5bb8e388-71c0-4367-9a3c-67e9f1e2ef02" xlink:to="loc_sem_DerivativeCostOfHedgeAnnualPremiumPercentage_666f7160-ba7a-45c1-905b-6adaabe05089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_722e41ff-6257-4fd1-a0d0-a54c30b2726b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5bb8e388-71c0-4367-9a3c-67e9f1e2ef02" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_722e41ff-6257-4fd1-a0d0-a54c30b2726b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3e0326c5-1b8e-4f1d-842e-589a2b87a790" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edbebe3d-192f-408e-95f9-dfebc6ae00ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3e0326c5-1b8e-4f1d-842e-589a2b87a790" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edbebe3d-192f-408e-95f9-dfebc6ae00ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a0d635cd-2a30-48d2-87d9-7c6fcee58d76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edbebe3d-192f-408e-95f9-dfebc6ae00ec" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a0d635cd-2a30-48d2-87d9-7c6fcee58d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d90cdf41-dfa1-4683-83fa-23ce2c917411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a0d635cd-2a30-48d2-87d9-7c6fcee58d76" xlink:to="loc_us-gaap_EquityComponentDomain_d90cdf41-dfa1-4683-83fa-23ce2c917411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_29fface4-9118-40d9-91a3-3f9222b96c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d90cdf41-dfa1-4683-83fa-23ce2c917411" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_29fface4-9118-40d9-91a3-3f9222b96c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_29812a3c-6d88-4d8b-8942-cafb4bf62373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edbebe3d-192f-408e-95f9-dfebc6ae00ec" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_29812a3c-6d88-4d8b-8942-cafb4bf62373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6825d909-d157-4748-89f5-0fd6c8ec790d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_29812a3c-6d88-4d8b-8942-cafb4bf62373" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6825d909-d157-4748-89f5-0fd6c8ec790d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_849f47de-db40-415d-a638-2a89b83f0d60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6825d909-d157-4748-89f5-0fd6c8ec790d" xlink:to="loc_us-gaap_InterestRateCapMember_849f47de-db40-415d-a638-2a89b83f0d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d725b98b-0b12-4aee-8fb2-f14571a1df08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_edbebe3d-192f-408e-95f9-dfebc6ae00ec" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d725b98b-0b12-4aee-8fb2-f14571a1df08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_524d2a15-9ec7-4249-b724-64459463ba5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_d725b98b-0b12-4aee-8fb2-f14571a1df08" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_524d2a15-9ec7-4249-b724-64459463ba5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_163ad517-e6e1-4860-843c-4000e76b8f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_524d2a15-9ec7-4249-b724-64459463ba5e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_163ad517-e6e1-4860-843c-4000e76b8f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_d197a86d-83a8-404a-981b-64893df77a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_524d2a15-9ec7-4249-b724-64459463ba5e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_d197a86d-83a8-404a-981b-64893df77a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_0128fc19-590c-4d92-b3c5-f4ca1550e2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_524d2a15-9ec7-4249-b724-64459463ba5e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_0128fc19-590c-4d92-b3c5-f4ca1550e2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b328fb31-8b22-4e62-a280-5fbb86b69a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_524d2a15-9ec7-4249-b724-64459463ba5e" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b328fb31-8b22-4e62-a280-5fbb86b69a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9a7283e0-d0a5-461e-89b5-891a89da960d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_524d2a15-9ec7-4249-b724-64459463ba5e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9a7283e0-d0a5-461e-89b5-891a89da960d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/FairValueofFinancialInstruments" xlink:type="simple" xlink:href="sem-20210630.xsd#FairValueofFinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/FairValueofFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2aca9759-37d5-424d-9fb4-f4fd1384b52f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_1db79c23-b7bc-4500-8c10-b71c8b85da05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2aca9759-37d5-424d-9fb4-f4fd1384b52f" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_1db79c23-b7bc-4500-8c10-b71c8b85da05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/FairValueofFinancialInstrumentsTables" xlink:type="simple" xlink:href="sem-20210630.xsd#FairValueofFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/FairValueofFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_fc0c560d-53fd-41cd-84f7-8e18b6a90d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_ba186bad-c04c-456d-a499-0f3316861190" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_fc0c560d-53fd-41cd-84f7-8e18b6a90d9e" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_ba186bad-c04c-456d-a499-0f3316861190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_a397f542-edd3-4529-9b02-ec9471628186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_fc0c560d-53fd-41cd-84f7-8e18b6a90d9e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_a397f542-edd3-4529-9b02-ec9471628186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b237ade9-abf2-4a31-9f02-19a17a7546d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a938c44f-eac2-409e-8380-c170e2f36173" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b237ade9-abf2-4a31-9f02-19a17a7546d0" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a938c44f-eac2-409e-8380-c170e2f36173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c26d6187-f13d-478f-aa6b-72ea7282efde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a938c44f-eac2-409e-8380-c170e2f36173" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c26d6187-f13d-478f-aa6b-72ea7282efde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cf398411-349e-4858-bbf6-ce683d2ff704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c26d6187-f13d-478f-aa6b-72ea7282efde" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cf398411-349e-4858-bbf6-ce683d2ff704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_953e0c98-20e5-4198-98b6-10f2e2e0fc55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_cf398411-349e-4858-bbf6-ce683d2ff704" xlink:to="loc_us-gaap_InterestRateCapMember_953e0c98-20e5-4198-98b6-10f2e2e0fc55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7a0effe3-b856-4542-9b8a-6733d93b52b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a938c44f-eac2-409e-8380-c170e2f36173" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7a0effe3-b856-4542-9b8a-6733d93b52b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_16330540-52b8-4141-b1b1-2dc7987fa468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7a0effe3-b856-4542-9b8a-6733d93b52b2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_16330540-52b8-4141-b1b1-2dc7987fa468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_deb23c92-9b48-418e-ab57-375ca0783626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_16330540-52b8-4141-b1b1-2dc7987fa468" xlink:to="loc_us-gaap_OtherAssetsMember_deb23c92-9b48-418e-ab57-375ca0783626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OtherAccruedLiabilitiesCurrentMember_5f975180-fbeb-49f4-8882-158056afbc07" xlink:href="sem-20210630.xsd#sem_OtherAccruedLiabilitiesCurrentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_16330540-52b8-4141-b1b1-2dc7987fa468" xlink:to="loc_sem_OtherAccruedLiabilitiesCurrentMember_5f975180-fbeb-49f4-8882-158056afbc07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_80f0d8f4-a782-441a-bb19-a80acc47072a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_16330540-52b8-4141-b1b1-2dc7987fa468" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_80f0d8f4-a782-441a-bb19-a80acc47072a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_15623943-947d-4855-a879-109805b57895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a938c44f-eac2-409e-8380-c170e2f36173" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_15623943-947d-4855-a879-109805b57895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8a271ca4-3693-4d0b-86f7-7c09f241f6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_15623943-947d-4855-a879-109805b57895" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8a271ca4-3693-4d0b-86f7-7c09f241f6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_ce789831-2229-42d7-ae8b-cc2938bac0e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8a271ca4-3693-4d0b-86f7-7c09f241f6cc" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_ce789831-2229-42d7-ae8b-cc2938bac0e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a6f68a0a-1468-4d70-a5d3-f982e7b42ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a938c44f-eac2-409e-8380-c170e2f36173" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a6f68a0a-1468-4d70-a5d3-f982e7b42ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f2130517-b671-4a4d-9756-0438b690adb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a6f68a0a-1468-4d70-a5d3-f982e7b42ef8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f2130517-b671-4a4d-9756-0438b690adb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_779b9f2c-518a-4b28-8f11-907372153897" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f2130517-b671-4a4d-9756-0438b690adb1" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_779b9f2c-518a-4b28-8f11-907372153897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b7589f1-dc8e-4081-88f4-683437ba57ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_a938c44f-eac2-409e-8380-c170e2f36173" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b7589f1-dc8e-4081-88f4-683437ba57ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_aa113939-689a-4368-a0af-74875d1daebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b7589f1-dc8e-4081-88f4-683437ba57ba" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_aa113939-689a-4368-a0af-74875d1daebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_36a64ae2-b69a-4a2b-9621-53954abbe9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b7589f1-dc8e-4081-88f4-683437ba57ba" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_36a64ae2-b69a-4a2b-9621-53954abbe9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_c2d925de-b791-43ad-ac84-a8b06c2a05d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_7b7589f1-dc8e-4081-88f4-683437ba57ba" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_c2d925de-b791-43ad-ac84-a8b06c2a05d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_48c58682-8996-4206-a12a-260128f39fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7bf7d6a0-6cfd-4bd5-a2ae-f0bb4e5c6995" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_48c58682-8996-4206-a12a-260128f39fe0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7bf7d6a0-6cfd-4bd5-a2ae-f0bb4e5c6995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3a77e280-e831-4dfa-862a-4827653d76f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7bf7d6a0-6cfd-4bd5-a2ae-f0bb4e5c6995" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3a77e280-e831-4dfa-862a-4827653d76f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_094f6070-44a4-4887-afe0-819a0eab8ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3a77e280-e831-4dfa-862a-4827653d76f6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_094f6070-44a4-4887-afe0-819a0eab8ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_02fe43b8-ceb2-4a86-a2fb-92ca4d164bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_094f6070-44a4-4887-afe0-819a0eab8ab2" xlink:to="loc_us-gaap_SeniorNotesMember_02fe43b8-ceb2-4a86-a2fb-92ca4d164bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_dfc450b3-a41f-4251-9dce-3dd7380fda35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_094f6070-44a4-4887-afe0-819a0eab8ab2" xlink:to="loc_us-gaap_SecuredDebtMember_dfc450b3-a41f-4251-9dce-3dd7380fda35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e2df10bb-caa9-4a55-9b27-c88b5f14c360" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7bf7d6a0-6cfd-4bd5-a2ae-f0bb4e5c6995" xlink:to="loc_dei_LegalEntityAxis_e2df10bb-caa9-4a55-9b27-c88b5f14c360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_287f8ab5-35b8-4817-abad-6fd23d69d204" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_e2df10bb-caa9-4a55-9b27-c88b5f14c360" xlink:to="loc_dei_EntityDomain_287f8ab5-35b8-4817-abad-6fd23d69d204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_SelectMedicalCorporationMember_d0d6ebf5-30b8-438a-9110-912793dedece" xlink:href="sem-20210630.xsd#sem_SelectMedicalCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_287f8ab5-35b8-4817-abad-6fd23d69d204" xlink:to="loc_sem_SelectMedicalCorporationMember_d0d6ebf5-30b8-438a-9110-912793dedece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ef7c2f69-7498-4507-93c5-96af45cbe84c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7bf7d6a0-6cfd-4bd5-a2ae-f0bb4e5c6995" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ef7c2f69-7498-4507-93c5-96af45cbe84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e95bdab-724c-4acd-9d35-d28c1bc22fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ef7c2f69-7498-4507-93c5-96af45cbe84c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e95bdab-724c-4acd-9d35-d28c1bc22fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a0ef54ae-5fe8-46a3-a0d6-a10fec0bdeb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7e95bdab-724c-4acd-9d35-d28c1bc22fd2" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a0ef54ae-5fe8-46a3-a0d6-a10fec0bdeb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_aac3c930-2957-4c28-b98f-8cbe691a231e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7bf7d6a0-6cfd-4bd5-a2ae-f0bb4e5c6995" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_aac3c930-2957-4c28-b98f-8cbe691a231e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a61bba30-c5fe-42c4-9150-aa4626252581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_aac3c930-2957-4c28-b98f-8cbe691a231e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a61bba30-c5fe-42c4-9150-aa4626252581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ad26fcf3-a1f5-4086-b67e-ebb5cd578764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_aac3c930-2957-4c28-b98f-8cbe691a231e" xlink:to="loc_us-gaap_LongTermDebt_ad26fcf3-a1f5-4086-b67e-ebb5cd578764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_2d6ea434-2a97-4529-a777-f866705465c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_aac3c930-2957-4c28-b98f-8cbe691a231e" xlink:to="loc_us-gaap_DebtInstrumentFairValue_2d6ea434-2a97-4529-a777-f866705465c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/SegmentInformation" xlink:type="simple" xlink:href="sem-20210630.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_865ae7ad-5350-4ff6-b2e7-83dadbc754ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_0e10cfe5-5722-4b7c-a53b-2beccdfbe235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_865ae7ad-5350-4ff6-b2e7-83dadbc754ec" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_0e10cfe5-5722-4b7c-a53b-2beccdfbe235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="sem-20210630.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ebd41aad-62a7-4069-9c62-95c51724ae23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_34c480cc-fc91-4e95-ab24-0e0dbb777f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ebd41aad-62a7-4069-9c62-95c51724ae23" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_34c480cc-fc91-4e95-ab24-0e0dbb777f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_3e8f5a28-17ad-4454-b0db-03048c5f5f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ebd41aad-62a7-4069-9c62-95c51724ae23" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_3e8f5a28-17ad-4454-b0db-03048c5f5f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#SegmentInformationSelectedFinancialDataDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_24e34b60-cc0b-4fd5-bf0d-9886b8368391" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8569eae4-33d9-4767-8816-767121984eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_24e34b60-cc0b-4fd5-bf0d-9886b8368391" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8569eae4-33d9-4767-8816-767121984eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_9c5ec8c5-ef54-4979-bfe4-d765a8385505" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8569eae4-33d9-4767-8816-767121984eb4" xlink:to="loc_srt_ConsolidationItemsAxis_9c5ec8c5-ef54-4979-bfe4-d765a8385505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b92510fe-c3e8-4e2c-8af0-3b2db327c4e7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_9c5ec8c5-ef54-4979-bfe4-d765a8385505" xlink:to="loc_srt_ConsolidationItemsDomain_b92510fe-c3e8-4e2c-8af0-3b2db327c4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_bb496afa-e17b-4117-b6e6-2a1b5763913a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b92510fe-c3e8-4e2c-8af0-3b2db327c4e7" xlink:to="loc_us-gaap_OperatingSegmentsMember_bb496afa-e17b-4117-b6e6-2a1b5763913a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_4a5151ff-d5e9-4bcc-9190-99bcfd6f5d89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b92510fe-c3e8-4e2c-8af0-3b2db327c4e7" xlink:to="loc_us-gaap_CorporateNonSegmentMember_4a5151ff-d5e9-4bcc-9190-99bcfd6f5d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3733885b-23fe-4a3b-9605-1c6433d0447a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8569eae4-33d9-4767-8816-767121984eb4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3733885b-23fe-4a3b-9605-1c6433d0447a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f7fa8dde-50c1-4448-8d85-909eb7290a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3733885b-23fe-4a3b-9605-1c6433d0447a" xlink:to="loc_us-gaap_SegmentDomain_f7fa8dde-50c1-4448-8d85-909eb7290a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_CriticalIllnessRecoveryHospitalsMember_b3c1bb46-4bbf-4eec-a250-6aeb6165e3c9" xlink:href="sem-20210630.xsd#sem_CriticalIllnessRecoveryHospitalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f7fa8dde-50c1-4448-8d85-909eb7290a68" xlink:to="loc_sem_CriticalIllnessRecoveryHospitalsMember_b3c1bb46-4bbf-4eec-a250-6aeb6165e3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_RehabilitationHospitalsMember_49a4382f-04a0-48db-b859-281550531c3a" xlink:href="sem-20210630.xsd#sem_RehabilitationHospitalsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f7fa8dde-50c1-4448-8d85-909eb7290a68" xlink:to="loc_sem_RehabilitationHospitalsMember_49a4382f-04a0-48db-b859-281550531c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OutpatientRehabilitationMember_3147514c-2ea4-4007-9379-10202870f491" xlink:href="sem-20210630.xsd#sem_OutpatientRehabilitationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f7fa8dde-50c1-4448-8d85-909eb7290a68" xlink:to="loc_sem_OutpatientRehabilitationMember_3147514c-2ea4-4007-9379-10202870f491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ConcentraMember_c0d6910f-0c0a-4a71-a81f-17c04cf23c85" xlink:href="sem-20210630.xsd#sem_ConcentraMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f7fa8dde-50c1-4448-8d85-909eb7290a68" xlink:to="loc_sem_ConcentraMember_c0d6910f-0c0a-4a71-a81f-17c04cf23c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6ae55570-d3f4-4be5-b3c0-17589e68cc25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8569eae4-33d9-4767-8816-767121984eb4" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_6ae55570-d3f4-4be5-b3c0-17589e68cc25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d93f4c26-af85-4bea-ac35-1c9de8a3702c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ae55570-d3f4-4be5-b3c0-17589e68cc25" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d93f4c26-af85-4bea-ac35-1c9de8a3702c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_AdjustedEbitda_2c5c4b44-9b01-457d-8620-3c5aa12499d8" xlink:href="sem-20210630.xsd#sem_AdjustedEbitda"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ae55570-d3f4-4be5-b3c0-17589e68cc25" xlink:to="loc_sem_AdjustedEbitda_2c5c4b44-9b01-457d-8620-3c5aa12499d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5829306b-7c7a-4124-b21c-feeeb6b5f788" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ae55570-d3f4-4be5-b3c0-17589e68cc25" xlink:to="loc_us-gaap_Assets_5829306b-7c7a-4124-b21c-feeeb6b5f788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_e1c042d7-74f0-4847-8047-6c774cf49052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6ae55570-d3f4-4be5-b3c0-17589e68cc25" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_e1c042d7-74f0-4847-8047-6c774cf49052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0ec09050-6b49-4b80-b489-f67ffd3e92ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3122ac47-07ee-4baa-9548-d99e95acb815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0ec09050-6b49-4b80-b489-f67ffd3e92ec" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3122ac47-07ee-4baa-9548-d99e95acb815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_ab9112ad-35d5-4f53-bc94-77a3ad3160bb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3122ac47-07ee-4baa-9548-d99e95acb815" xlink:to="loc_srt_ConsolidationItemsAxis_ab9112ad-35d5-4f53-bc94-77a3ad3160bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2c33207b-8f42-4bb3-9534-5b563cbe29a7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_ab9112ad-35d5-4f53-bc94-77a3ad3160bb" xlink:to="loc_srt_ConsolidationItemsDomain_2c33207b-8f42-4bb3-9534-5b563cbe29a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_434a623e-71e9-4616-b221-70486ff9518f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_2c33207b-8f42-4bb3-9534-5b563cbe29a7" xlink:to="loc_us-gaap_OperatingSegmentsMember_434a623e-71e9-4616-b221-70486ff9518f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_4e55220f-f98b-4563-8b03-dd7ea87bae13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_2c33207b-8f42-4bb3-9534-5b563cbe29a7" xlink:to="loc_us-gaap_CorporateNonSegmentMember_4e55220f-f98b-4563-8b03-dd7ea87bae13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bbe6fa92-3801-4fa4-a93f-302d6a5c9972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3122ac47-07ee-4baa-9548-d99e95acb815" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bbe6fa92-3801-4fa4-a93f-302d6a5c9972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2af51e36-dbc3-4344-b11a-83e0c260c55b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bbe6fa92-3801-4fa4-a93f-302d6a5c9972" xlink:to="loc_us-gaap_SegmentDomain_2af51e36-dbc3-4344-b11a-83e0c260c55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_CriticalIllnessRecoveryHospitalsMember_6f885682-c79e-42e8-bf8a-56a40f3883d2" xlink:href="sem-20210630.xsd#sem_CriticalIllnessRecoveryHospitalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2af51e36-dbc3-4344-b11a-83e0c260c55b" xlink:to="loc_sem_CriticalIllnessRecoveryHospitalsMember_6f885682-c79e-42e8-bf8a-56a40f3883d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_RehabilitationHospitalsMember_8c454264-5b28-4b2a-bc0d-25529222f188" xlink:href="sem-20210630.xsd#sem_RehabilitationHospitalsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2af51e36-dbc3-4344-b11a-83e0c260c55b" xlink:to="loc_sem_RehabilitationHospitalsMember_8c454264-5b28-4b2a-bc0d-25529222f188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OutpatientRehabilitationMember_f5a4d386-caa8-4b9b-8081-5a4c7e5eb7a6" xlink:href="sem-20210630.xsd#sem_OutpatientRehabilitationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2af51e36-dbc3-4344-b11a-83e0c260c55b" xlink:to="loc_sem_OutpatientRehabilitationMember_f5a4d386-caa8-4b9b-8081-5a4c7e5eb7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ConcentraMember_04495132-12ab-4653-98ae-2a26fa5dd3e6" xlink:href="sem-20210630.xsd#sem_ConcentraMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2af51e36-dbc3-4344-b11a-83e0c260c55b" xlink:to="loc_sem_ConcentraMember_04495132-12ab-4653-98ae-2a26fa5dd3e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3122ac47-07ee-4baa-9548-d99e95acb815" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_AdjustedEbitda_b4555bea-6377-4446-b179-c3a9c1a93280" xlink:href="sem-20210630.xsd#sem_AdjustedEbitda"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:to="loc_sem_AdjustedEbitda_b4555bea-6377-4446-b179-c3a9c1a93280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_2ef8e648-df45-462e-8a55-848048143db1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:to="loc_us-gaap_DepreciationAndAmortization_2ef8e648-df45-462e-8a55-848048143db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_74cfeb5a-ac80-4529-8e1d-a5f5416be1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_74cfeb5a-ac80-4529-8e1d-a5f5416be1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ffe3fb34-8407-44da-8de8-80062e82374f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:to="loc_us-gaap_OperatingIncomeLoss_ffe3fb34-8407-44da-8de8-80062e82374f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_84af2cf6-95c7-46f5-9ebe-eb36ac37f1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_84af2cf6-95c7-46f5-9ebe-eb36ac37f1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_f6a7a557-a7a1-41be-8879-059c19cfb49d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_f6a7a557-a7a1-41be-8879-059c19cfb49d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementInterest_a77816d5-3a6e-47b4-9a29-f463d7f8a8da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:to="loc_us-gaap_LitigationSettlementInterest_a77816d5-3a6e-47b4-9a29-f463d7f8a8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8bf748a1-0b7b-41f7-881b-9b97f55cdc83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:to="loc_us-gaap_InterestExpense_8bf748a1-0b7b-41f7-881b-9b97f55cdc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_60022bff-aa9a-4bc5-9b69-2e14c7dba1de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_40bac846-78fd-4776-aed7-d133ec28ef38" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_60022bff-aa9a-4bc5-9b69-2e14c7dba1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/RevenuefromContractswithCustomers" xlink:type="simple" xlink:href="sem-20210630.xsd#RevenuefromContractswithCustomers"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/RevenuefromContractswithCustomers" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2f7a0998-e0a3-4353-a944-e5877070d58a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_932b50ad-fd57-4f6d-8916-d38c2f578c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2f7a0998-e0a3-4353-a944-e5877070d58a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_932b50ad-fd57-4f6d-8916-d38c2f578c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/RevenuefromContractswithCustomersTables" xlink:type="simple" xlink:href="sem-20210630.xsd#RevenuefromContractswithCustomersTables"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/RevenuefromContractswithCustomersTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2bd041b6-e19e-421e-91ab-7940ed8e86e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_8b65bf20-3110-4562-a780-0acb98611b27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2bd041b6-e19e-421e-91ab-7940ed8e86e2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_8b65bf20-3110-4562-a780-0acb98611b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#RevenuefromContractswithCustomersDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7fc83ad1-7c19-42f0-887e-e76e0d532da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_203ef66e-939b-42b3-8d0f-91445398ff67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7fc83ad1-7c19-42f0-887e-e76e0d532da2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_203ef66e-939b-42b3-8d0f-91445398ff67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_f58252db-ef98-4f63-b569-697789d36dbb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_203ef66e-939b-42b3-8d0f-91445398ff67" xlink:to="loc_srt_ConsolidationItemsAxis_f58252db-ef98-4f63-b569-697789d36dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_8d879aff-9227-4f93-b9d7-916639b00bc5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_f58252db-ef98-4f63-b569-697789d36dbb" xlink:to="loc_srt_ConsolidationItemsDomain_8d879aff-9227-4f93-b9d7-916639b00bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_ccca7891-3e25-4cfb-abfa-27110e07d497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_8d879aff-9227-4f93-b9d7-916639b00bc5" xlink:to="loc_us-gaap_OperatingSegmentsMember_ccca7891-3e25-4cfb-abfa-27110e07d497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_a8e3c7e7-37a3-4ad4-8329-256cb6fc1b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_8d879aff-9227-4f93-b9d7-916639b00bc5" xlink:to="loc_us-gaap_CorporateNonSegmentMember_a8e3c7e7-37a3-4ad4-8329-256cb6fc1b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_642151cf-5de8-4974-b637-ee4a63ac772d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_203ef66e-939b-42b3-8d0f-91445398ff67" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_642151cf-5de8-4974-b637-ee4a63ac772d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_aca23a47-60b6-4a87-80b4-508acea77267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_642151cf-5de8-4974-b637-ee4a63ac772d" xlink:to="loc_us-gaap_SegmentDomain_aca23a47-60b6-4a87-80b4-508acea77267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_CriticalIllnessRecoveryHospitalsMember_b284aacd-8072-4181-ac3d-8b539f30982b" xlink:href="sem-20210630.xsd#sem_CriticalIllnessRecoveryHospitalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_aca23a47-60b6-4a87-80b4-508acea77267" xlink:to="loc_sem_CriticalIllnessRecoveryHospitalsMember_b284aacd-8072-4181-ac3d-8b539f30982b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_RehabilitationHospitalsMember_f525fbb7-2c09-489f-8b6e-463528ef9dfb" xlink:href="sem-20210630.xsd#sem_RehabilitationHospitalsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_aca23a47-60b6-4a87-80b4-508acea77267" xlink:to="loc_sem_RehabilitationHospitalsMember_f525fbb7-2c09-489f-8b6e-463528ef9dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_OutpatientRehabilitationMember_eb551482-fee8-4811-a89f-b1360deaf8a9" xlink:href="sem-20210630.xsd#sem_OutpatientRehabilitationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_aca23a47-60b6-4a87-80b4-508acea77267" xlink:to="loc_sem_OutpatientRehabilitationMember_eb551482-fee8-4811-a89f-b1360deaf8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ConcentraMember_4118781d-bc42-4e25-a2a6-c3e2e01d5214" xlink:href="sem-20210630.xsd#sem_ConcentraMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_aca23a47-60b6-4a87-80b4-508acea77267" xlink:to="loc_sem_ConcentraMember_4118781d-bc42-4e25-a2a6-c3e2e01d5214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d51d825e-c3cc-498e-9a1b-2458c9bfcb84" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_203ef66e-939b-42b3-8d0f-91445398ff67" xlink:to="loc_srt_ProductOrServiceAxis_d51d825e-c3cc-498e-9a1b-2458c9bfcb84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9aaee191-a819-4343-bb1f-69531b004205" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d51d825e-c3cc-498e-9a1b-2458c9bfcb84" xlink:to="loc_srt_ProductsAndServicesDomain_9aaee191-a819-4343-bb1f-69531b004205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_ececa6b2-a0d2-4573-b8d7-5ce3b10eb417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9aaee191-a819-4343-bb1f-69531b004205" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_ececa6b2-a0d2-4573-b8d7-5ce3b10eb417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_HealthCarePatientServiceMedicareMember_6dad881f-b00a-4c2f-9074-5316613fc6f1" xlink:href="sem-20210630.xsd#sem_HealthCarePatientServiceMedicareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_ececa6b2-a0d2-4573-b8d7-5ce3b10eb417" xlink:to="loc_sem_HealthCarePatientServiceMedicareMember_6dad881f-b00a-4c2f-9074-5316613fc6f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_HealthCarePatientServiceNonMedicareMember_6e42c415-1c0c-4915-b9d0-02b891beb42a" xlink:href="sem-20210630.xsd#sem_HealthCarePatientServiceNonMedicareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCarePatientServiceMember_ececa6b2-a0d2-4573-b8d7-5ce3b10eb417" xlink:to="loc_sem_HealthCarePatientServiceNonMedicareMember_6e42c415-1c0c-4915-b9d0-02b891beb42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceOtherMember_67b16554-d727-4bd3-98ac-8b10b4dc7fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9aaee191-a819-4343-bb1f-69531b004205" xlink:to="loc_us-gaap_ServiceOtherMember_67b16554-d727-4bd3-98ac-8b10b4dc7fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8d77dc25-d92e-4dd1-a29f-1d522ff175d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_203ef66e-939b-42b3-8d0f-91445398ff67" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_8d77dc25-d92e-4dd1-a29f-1d522ff175d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_21ca0a74-f9d0-486b-af59-70903c04f238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8d77dc25-d92e-4dd1-a29f-1d522ff175d4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_21ca0a74-f9d0-486b-af59-70903c04f238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/EarningsperShare" xlink:type="simple" xlink:href="sem-20210630.xsd#EarningsperShare"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/EarningsperShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_74ede4e2-31d7-4ccc-84ac-57419adf58ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_8c12ddea-8849-4b09-ac79-575c3f53eb17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_74ede4e2-31d7-4ccc-84ac-57419adf58ba" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_8c12ddea-8849-4b09-ac79-575c3f53eb17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/EarningsperShareTables" xlink:type="simple" xlink:href="sem-20210630.xsd#EarningsperShareTables"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/EarningsperShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_396edf05-30bf-4f36-b306-e36956c3602b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b2133488-7dc5-407c-9369-cc9afd2b8f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_396edf05-30bf-4f36-b306-e36956c3602b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b2133488-7dc5-407c-9369-cc9afd2b8f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/EarningsperShareNarrativeDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#EarningsperShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/EarningsperShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4ff088ca-b9aa-4d48-a87f-8536446f01f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicDistributed_0ddf63bc-c559-40be-b751-575d1c4b6eec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicDistributed"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4ff088ca-b9aa-4d48-a87f-8536446f01f1" xlink:to="loc_us-gaap_EarningsPerShareBasicDistributed_0ddf63bc-c559-40be-b751-575d1c4b6eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedDistributed_1f484735-b7d9-4d1e-bc1d-4097372c124e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedDistributed"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4ff088ca-b9aa-4d48-a87f-8536446f01f1" xlink:to="loc_us-gaap_EarningsPerShareDilutedDistributed_1f484735-b7d9-4d1e-bc1d-4097372c124e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_714be1ff-e809-4d92-8ecb-dc93492910b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_994c025d-4b8c-47de-9c30-09c8eebce944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_714be1ff-e809-4d92-8ecb-dc93492910b7" xlink:to="loc_us-gaap_ProfitLoss_994c025d-4b8c-47de-9c30-09c8eebce944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7e62cacd-4c01-44c8-bc23-a0532cd4f04e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_714be1ff-e809-4d92-8ecb-dc93492910b7" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7e62cacd-4c01-44c8-bc23-a0532cd4f04e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2c88de00-1452-4547-add6-746234bd5cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_714be1ff-e809-4d92-8ecb-dc93492910b7" xlink:to="loc_us-gaap_NetIncomeLoss_2c88de00-1452-4547-add6-746234bd5cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_0b4fe1d7-4779-46e4-b2ae-6ab7de733844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_714be1ff-e809-4d92-8ecb-dc93492910b7" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_0b4fe1d7-4779-46e4-b2ae-6ab7de733844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_48aac9a0-4c24-4a8d-932f-47ef17ad6fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_0b4fe1d7-4779-46e4-b2ae-6ab7de733844" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_48aac9a0-4c24-4a8d-932f-47ef17ad6fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_5f1dcb12-5e13-42de-8873-fd13b2d83c07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_0b4fe1d7-4779-46e4-b2ae-6ab7de733844" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_5f1dcb12-5e13-42de-8873-fd13b2d83c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_c24841fc-b504-45d8-8204-10119257c294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_714be1ff-e809-4d92-8ecb-dc93492910b7" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_c24841fc-b504-45d8-8204-10119257c294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_701359a2-e51c-42c6-9d92-405cdf07c88b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_c24841fc-b504-45d8-8204-10119257c294" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_701359a2-e51c-42c6-9d92-405cdf07c88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_31867e98-cda3-4994-b1a7-d85d67893835" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_c24841fc-b504-45d8-8204-10119257c294" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_31867e98-cda3-4994-b1a7-d85d67893835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#EarningsperShareComputationofEPSUndertheTwoClassMethodDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c505accd-00f7-446e-9b2b-65a4293fe21a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsAbstract_a9560f43-4161-441c-bdbc-b757b5eaeca3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c505accd-00f7-446e-9b2b-65a4293fe21a" xlink:to="loc_us-gaap_UndistributedEarningsAbstract_a9560f43-4161-441c-bdbc-b757b5eaeca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_21352046-ec43-4f7b-af99-82fc509d803f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UndistributedEarningsAbstract_a9560f43-4161-441c-bdbc-b757b5eaeca3" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_21352046-ec43-4f7b-af99-82fc509d803f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_3ec8c228-2311-4460-99f3-ef4bcdb13342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UndistributedEarningsAbstract_a9560f43-4161-441c-bdbc-b757b5eaeca3" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_3ec8c228-2311-4460-99f3-ef4bcdb13342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_7e281ade-7a79-410c-9032-8209a23ce880" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UndistributedEarningsAbstract_a9560f43-4161-441c-bdbc-b757b5eaeca3" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_7e281ade-7a79-410c-9032-8209a23ce880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_30f56a0d-6893-4b68-9028-18792ae24a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c505accd-00f7-446e-9b2b-65a4293fe21a" xlink:to="loc_us-gaap_NetIncomeLoss_30f56a0d-6893-4b68-9028-18792ae24a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_318f1097-7770-478e-9c47-befcce887c14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c505accd-00f7-446e-9b2b-65a4293fe21a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_318f1097-7770-478e-9c47-befcce887c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f2aa0cb7-c885-48e8-859e-1c685623f8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c505accd-00f7-446e-9b2b-65a4293fe21a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f2aa0cb7-c885-48e8-859e-1c685623f8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights_d92ba813-74c0-4598-9ec8-6f10a1c5b221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c505accd-00f7-446e-9b2b-65a4293fe21a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights_d92ba813-74c0-4598-9ec8-6f10a1c5b221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_d7c28fbc-9920-47fb-9112-9d680909afde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c505accd-00f7-446e-9b2b-65a4293fe21a" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_d7c28fbc-9920-47fb-9112-9d680909afde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b28ed151-bc9c-40b4-b14b-8918b42ca17b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_d7c28fbc-9920-47fb-9112-9d680909afde" xlink:to="loc_us-gaap_EarningsPerShareBasic_b28ed151-bc9c-40b4-b14b-8918b42ca17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_74a03abf-3bf0-4f6a-847a-07b3b3fbf066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c505accd-00f7-446e-9b2b-65a4293fe21a" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_74a03abf-3bf0-4f6a-847a-07b3b3fbf066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f15a1745-b6b5-4e91-aa40-e81af6db4aae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_74a03abf-3bf0-4f6a-847a-07b3b3fbf066" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f15a1745-b6b5-4e91-aa40-e81af6db4aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="sem-20210630.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b4aff3ed-ae7f-44ad-859a-3c6379001157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ac60805f-18cd-4e34-8c44-0f288382aae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b4aff3ed-ae7f-44ad-859a-3c6379001157" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ac60805f-18cd-4e34-8c44-0f288382aae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#CommitmentsandContingenciesLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d887e17c-8026-4ee4-92d7-5d4e657c1d47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_8ea162d2-d561-47e1-b75b-c117bf4b40a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d887e17c-8026-4ee4-92d7-5d4e657c1d47" xlink:to="loc_us-gaap_LossContingenciesTable_8ea162d2-d561-47e1-b75b-c117bf4b40a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_d014554e-83f2-4b80-b536-ba08284c690d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8ea162d2-d561-47e1-b75b-c117bf4b40a8" xlink:to="loc_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_d014554e-83f2-4b80-b536-ba08284c690d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeAndTierIdentifierDomain_7e9907b4-c9ee-4507-82b0-e738090031e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeAndTierIdentifierDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis_d014554e-83f2-4b80-b536-ba08284c690d" xlink:to="loc_us-gaap_TypeAndTierIdentifierDomain_7e9907b4-c9ee-4507-82b0-e738090031e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalMalpracticeLiabilityMember_7e022da8-f7d1-4ae6-8f99-2a8251afac05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalMalpracticeLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeAndTierIdentifierDomain_7e9907b4-c9ee-4507-82b0-e738090031e3" xlink:to="loc_us-gaap_ProfessionalMalpracticeLiabilityMember_7e022da8-f7d1-4ae6-8f99-2a8251afac05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralLiabilityMember_ccc8aad1-a578-4a58-83b2-3fc35d7489f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralLiabilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeAndTierIdentifierDomain_7e9907b4-c9ee-4507-82b0-e738090031e3" xlink:to="loc_us-gaap_GeneralLiabilityMember_ccc8aad1-a578-4a58-83b2-3fc35d7489f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_95b518af-d135-49a2-8704-ae11cf889cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8ea162d2-d561-47e1-b75b-c117bf4b40a8" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_95b518af-d135-49a2-8704-ae11cf889cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_a8993437-f87d-41ef-b72e-2fe7cd10d8e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_95b518af-d135-49a2-8704-ae11cf889cba" xlink:to="loc_us-gaap_RelatedPartyDomain_a8993437-f87d-41ef-b72e-2fe7cd10d8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_52f08764-041d-4fa8-b5c6-f2c7aa0fc4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_a8993437-f87d-41ef-b72e-2fe7cd10d8e4" xlink:to="loc_us-gaap_CorporateJointVentureMember_52f08764-041d-4fa8-b5c6-f2c7aa0fc4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_036b3faf-46b0-4899-b3c5-a16e2abf3ec1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8ea162d2-d561-47e1-b75b-c117bf4b40a8" xlink:to="loc_srt_RangeAxis_036b3faf-46b0-4899-b3c5-a16e2abf3ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_96b7c0f1-79c3-4dd8-8759-258571ae6f2c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_036b3faf-46b0-4899-b3c5-a16e2abf3ec1" xlink:to="loc_srt_RangeMember_96b7c0f1-79c3-4dd8-8759-258571ae6f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_88152088-2a37-4504-b357-031cd2c511c3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_96b7c0f1-79c3-4dd8-8759-258571ae6f2c" xlink:to="loc_srt_MinimumMember_88152088-2a37-4504-b357-031cd2c511c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4be2c036-bdc9-4341-a02f-38a4d25fa357" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_96b7c0f1-79c3-4dd8-8759-258571ae6f2c" xlink:to="loc_srt_MaximumMember_4be2c036-bdc9-4341-a02f-38a4d25fa357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_650ec1dc-9871-475c-9dbf-163994ed1158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8ea162d2-d561-47e1-b75b-c117bf4b40a8" xlink:to="loc_us-gaap_LossContingenciesLineItems_650ec1dc-9871-475c-9dbf-163994ed1158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeInsuranceAnnualCoverageLimit_4854032c-d6aa-4b8b-b228-11a30e911538" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MalpracticeInsuranceAnnualCoverageLimit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_650ec1dc-9871-475c-9dbf-163994ed1158" xlink:to="loc_us-gaap_MalpracticeInsuranceAnnualCoverageLimit_4854032c-d6aa-4b8b-b228-11a30e911538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CommitmentsandContingenciesMedicareDualEligibleLitigationDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#CommitmentsandContingenciesMedicareDualEligibleLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/CommitmentsandContingenciesMedicareDualEligibleLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0100436e-e55c-488c-82c4-d0fee4379747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable_5c2fdd98-36da-46bc-ae7c-b6d11bfae373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0100436e-e55c-488c-82c4-d0fee4379747" xlink:to="loc_us-gaap_GainContingenciesTable_5c2fdd98-36da-46bc-ae7c-b6d11bfae373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_87b1bed1-05c2-4586-b17c-3b32e9ae62a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesTable_5c2fdd98-36da-46bc-ae7c-b6d11bfae373" xlink:to="loc_us-gaap_LitigationStatusAxis_87b1bed1-05c2-4586-b17c-3b32e9ae62a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_8a1a5f06-2ea7-48af-af45-839ff77efce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_87b1bed1-05c2-4586-b17c-3b32e9ae62a5" xlink:to="loc_us-gaap_LitigationStatusDomain_8a1a5f06-2ea7-48af-af45-839ff77efce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_JudicialRulingMember_59a8db6c-3d42-4553-880e-20662da94791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_JudicialRulingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_8a1a5f06-2ea7-48af-af45-839ff77efce7" xlink:to="loc_us-gaap_JudicialRulingMember_59a8db6c-3d42-4553-880e-20662da94791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems_89c7bcbe-1c64-4955-b333-edfafff00ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesTable_5c2fdd98-36da-46bc-ae7c-b6d11bfae373" xlink:to="loc_us-gaap_GainContingenciesLineItems_89c7bcbe-1c64-4955-b333-edfafff00ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_23274d3b-2c46-456a-a02e-28220a7f7718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_89c7bcbe-1c64-4955-b333-edfafff00ef0" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_23274d3b-2c46-456a-a02e-28220a7f7718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ProceedsFromLegalSettlementsAccruedInterest_c4fd8ceb-1b7b-4dd6-848a-02d000bc1f0f" xlink:href="sem-20210630.xsd#sem_ProceedsFromLegalSettlementsAccruedInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_89c7bcbe-1c64-4955-b333-edfafff00ef0" xlink:to="loc_sem_ProceedsFromLegalSettlementsAccruedInterest_c4fd8ceb-1b7b-4dd6-848a-02d000bc1f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CARESAct" xlink:type="simple" xlink:href="sem-20210630.xsd#CARESAct"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/CARESAct" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtraordinaryAndUnusualItemsAbstract_9c08f63f-ec1e-422a-a1b4-a4b1ce32a8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtraordinaryAndUnusualItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock_f665d13c-bb7b-48fe-a4c3-c6fcc49dea43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtraordinaryAndUnusualItemsAbstract_9c08f63f-ec1e-422a-a1b4-a4b1ce32a8c3" xlink:to="loc_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock_f665d13c-bb7b-48fe-a4c3-c6fcc49dea43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/CARESActDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#CARESActDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/CARESActDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtraordinaryAndUnusualItemsAbstract_8257dc16-8a17-4ca2-8793-e50e9e365181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtraordinaryAndUnusualItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_ProceedsFromGovernmentAssistanceCARESAct_2c934cdd-ccf1-4447-9834-b42016b543b5" xlink:href="sem-20210630.xsd#sem_ProceedsFromGovernmentAssistanceCARESAct"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtraordinaryAndUnusualItemsAbstract_8257dc16-8a17-4ca2-8793-e50e9e365181" xlink:to="loc_sem_ProceedsFromGovernmentAssistanceCARESAct_2c934cdd-ccf1-4447-9834-b42016b543b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_GovernmentAssistanceRecognizedInEarningsCARESAct_36a1dd5a-69d4-4074-a30e-a2e43cb96303" xlink:href="sem-20210630.xsd#sem_GovernmentAssistanceRecognizedInEarningsCARESAct"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtraordinaryAndUnusualItemsAbstract_8257dc16-8a17-4ca2-8793-e50e9e365181" xlink:to="loc_sem_GovernmentAssistanceRecognizedInEarningsCARESAct_36a1dd5a-69d4-4074-a30e-a2e43cb96303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_e3b4f189-d981-47b3-a02a-fdabdab3d618" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtraordinaryAndUnusualItemsAbstract_8257dc16-8a17-4ca2-8793-e50e9e365181" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_e3b4f189-d981-47b3-a02a-fdabdab3d618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_UnearnedGovernmentAssistanceCARESAct_839a904a-b117-4838-8e4e-4839aee3c162" xlink:href="sem-20210630.xsd#sem_UnearnedGovernmentAssistanceCARESAct"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtraordinaryAndUnusualItemsAbstract_8257dc16-8a17-4ca2-8793-e50e9e365181" xlink:to="loc_sem_UnearnedGovernmentAssistanceCARESAct_839a904a-b117-4838-8e4e-4839aee3c162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct_baed6c58-b007-40f2-802b-2427585f6c5b" xlink:href="sem-20210630.xsd#sem_UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtraordinaryAndUnusualItemsAbstract_8257dc16-8a17-4ca2-8793-e50e9e365181" xlink:to="loc_sem_UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct_baed6c58-b007-40f2-802b-2427585f6c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_GovernmentAdvancesCARESAct_58fd96bb-8665-4656-87a9-df15b39bf0f3" xlink:href="sem-20210630.xsd#sem_GovernmentAdvancesCARESAct"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtraordinaryAndUnusualItemsAbstract_8257dc16-8a17-4ca2-8793-e50e9e365181" xlink:to="loc_sem_GovernmentAdvancesCARESAct_58fd96bb-8665-4656-87a9-df15b39bf0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sem_GovernmentAdvancesRecoupedCARESAct_17231ee4-5fcf-4123-8cb1-ce32e914964a" xlink:href="sem-20210630.xsd#sem_GovernmentAdvancesRecoupedCARESAct"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtraordinaryAndUnusualItemsAbstract_8257dc16-8a17-4ca2-8793-e50e9e365181" xlink:to="loc_sem_GovernmentAdvancesRecoupedCARESAct_17231ee4-5fcf-4123-8cb1-ce32e914964a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/SubsequentEvent" xlink:type="simple" xlink:href="sem-20210630.xsd#SubsequentEvent"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/SubsequentEvent" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_0d0abc23-a647-40af-a529-2873f74e8c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_036ad661-1cea-4fc7-a06c-fab0ccfc6867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_0d0abc23-a647-40af-a529-2873f74e8c7e" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_036ad661-1cea-4fc7-a06c-fab0ccfc6867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.selectmedical.com/role/SubsequentEventDetails" xlink:type="simple" xlink:href="sem-20210630.xsd#SubsequentEventDetails"/>
  <link:presentationLink xlink:role="http://www.selectmedical.com/role/SubsequentEventDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_d98b5ec7-fb0b-4c4d-a2f0-05253a07cf6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_137e4210-9cdc-48d4-8743-e204be496f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_d98b5ec7-fb0b-4c4d-a2f0-05253a07cf6e" xlink:to="loc_us-gaap_SubsequentEventTable_137e4210-9cdc-48d4-8743-e204be496f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2b68bc1a-d700-4092-944c-74bbff2ee991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_137e4210-9cdc-48d4-8743-e204be496f4c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2b68bc1a-d700-4092-944c-74bbff2ee991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a5f7f783-661c-4ad3-a2bc-15b488d0c062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2b68bc1a-d700-4092-944c-74bbff2ee991" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a5f7f783-661c-4ad3-a2bc-15b488d0c062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6bb759d8-4492-4859-be86-69e9a4b8a210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a5f7f783-661c-4ad3-a2bc-15b488d0c062" xlink:to="loc_us-gaap_SubsequentEventMember_6bb759d8-4492-4859-be86-69e9a4b8a210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_bdf07b3a-db70-4fca-a4ba-7d8fd4962a62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_137e4210-9cdc-48d4-8743-e204be496f4c" xlink:to="loc_us-gaap_SubsequentEventLineItems_bdf07b3a-db70-4fca-a4ba-7d8fd4962a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_d2d132b8-b164-4431-849a-603406ed30d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_bdf07b3a-db70-4fca-a4ba-7d8fd4962a62" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_d2d132b8-b164-4431-849a-603406ed30d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>sem-20210630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:sem="http://www.selectmedical.com/20210630"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="sem-20210630.xsd" xlink:type="simple"/>
    <context id="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib7edbe299d2e4cef8af2828feb10a42e_I20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="ib27967ed4eaf45369238e20d447ab83e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i632267a60f314ae3bccec20a793b8465_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifdefa3d6cdb34858b7e182fc46afa080_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i45d9d93694034373837c3f573d2d7ecb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if5bfd431ead745a5a4f73a79e9a90180_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e6a554b8f8b45e8990535f027a788ff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if240d4208ad5471cb7b4b597c1a3ca8f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2806b7f400f4487e923e629b54913b07_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i99b36c5b771943a6b90df106ee6a8bdb_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iae8baa77c8704ff2859751da1e6a993f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i73ab481852c04d249b8c95efbb1484d3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3a7594d5c1e845f08d5c0cfb7e2dd9be_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8442ecf8486d42759fe367c2de8b4c85_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i91c3a6aa3d9d463fb2244dc55d06fda9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4eaf841b3bc54e8887fcaab6cc4ba423_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i73199de2eb734a1aa6d9d339b39814ea_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic13effada5f24e1dad9e29d7a8d0c5fb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic1a6dc4d8592426aab6aeb9d0584fc06_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if551e4794f2b45c9a16a1f7ed95b3aae_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibb9ee276a38c43b39dc4a7f012322150_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia25336bcc81845369b7acc4ef55a0c51_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i16c67f9004aa4dfc83ced10a10230d97_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i89986053f5394ec4bd4e69b2d52aa4e5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9fbafc1a282f4ad88e8b769cba297e21_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5cbdf661e9ee48f8a93652e5f73c501d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifbb0e9e9121e4076a912834a8c0a2178_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i878a9c337abc406cbfa8912be660cfd9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3d78995f73114fd9a07a5844ce1ebb86_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia507842de06c463cab8ad4f320a68bc7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i06ac0cf032dc44e1baa12c616a1ab18f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i29a8b026887f4d80b776c2643d660e67_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5c472725691f4294afa81232749b2c38_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i748a28affcd7487d875035c464368d05_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6c17c8cd7cac4115a14753f94ab8ab6c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i452ed919b2244df887431ff7b2c2d508_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0f1d1941a2d54dd682218923f73f78e5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3996149e08774457b7cf81521fc7a46f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6e001ee24b8d4e398bb154b6b74d75a6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i80fc7da8ac2f44c1a89ba81702a6efef_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3fcf10033def4edc8873b5e817d0b994_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i98dbdae0901944a8bb7a4850bf5db8e1_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic4d382e1e08d4eb1ba65b7ff2dc29af0_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ibc6557fef505437581efa07d7b365cb0_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0f9c8016c7f342c79de1144a230d1612_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i757df6705cb74d08b9e53d576ac2c1f7_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i07ef9561e63c46ecbfdf268105880ec9_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i5ab6f6ed4c5c40c785bf0ec5a56f7a7f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8979c36c27b948e7a75318aa470eb1c5_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4b4a592cf00044548cc38f91879e81fa_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7e12f979c9064796bbcd7735451cbf07_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i228ce0ec788848459a6778243cdfe2f9_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="idfaaf0f42d9042e7b77d153a10a8eeb5_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if41275a882144f35838503cdd9e3b9d8_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i072109b8da604643af13c0729800e1df_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie6fcb443a0464cef95544365b85db50b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i55f4763f21f4479ba3089c7486346215_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i150a45bd54dd4d4fa4ee7374f6bc72d3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8ca9e03469c34d19aa6464835674249e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia2386c06e6394e9192e485e15d848c39_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i966afdef72fe4d53ac2ff6217e8e9793_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id3c7dc108fdc4209adb112435c46e453_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic33ba2829aad4672a382563462592dcf_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i139e861ba4e7472982269ee17ca2c68b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i2126fcb95b794e1d9f9873202b50af46_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i54986ecc7fc44b8686d9e92cd152643d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">sem:MedicareReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6cd99a1029914dfba302e3c8d1747dc9_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">sem:MedicareReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i419b57ae7aed4416a0c64ed51064c3f9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i47ca05e15f9b40f489ce514ca61c046e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i700401d3c9d145e5a4af74e91aa63697_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i72f4a9b9828d4a3b943644bbd290287b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i94d49e31dfc5481b83733fba9533f7e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0fb9c18f057d4a6cac88d6653d9ec800_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ied45fa8b01774a98b132e46124b37c0a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia19667dc075545788618f5c66316f37a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i097daf64265140a892929bd7dac3e0fd_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1e821cac29074fc185f5771945e60d79_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2eb84cd5898941968056ee90d2e078ac_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5447d034988f4dba82554eb01fc5e2a2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5cee8f7161ea4a8a92cd3e773a1e4ece_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3cc51a7a4bbb48fd82bfef91f2d58ed8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2722863174014f129b2ae71613b5e3ef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie50961b97f5d4e09a5947761afae9b15_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6d92202a78304997b52107c3a7f606b2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">sem:CertificatesOfNeedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i50009e4e14044151932827ba2b1bbb8f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">sem:CertificatesOfNeedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ice892a1481a14854bded5d410c627ea7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">sem:AccreditationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i330f8d443bf84101a754a226814bfe6c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">sem:AccreditationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i602fead3b8954e80b8ecfba7f8e331a4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib04ddc4871e84537b195da0e20d46573_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i008b3ba5aedd4b238f380f5108ca88c2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if929eb1eca084fde8793ca88f272572d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i302b948d2285436d8d4925ae04d98b18_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i48c41d6695124d31993223ed4735ed45_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9f259df1c9c14a91877a5d8ddebfe895_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">sem:AccreditationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1c8e70e09d574bd5bf50455cec27484e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i230304098a504f6e8bb8d87b3c8ff168_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i25db1c92c0d94c90a36f23378754f459_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if091ae9541ec4cc8b5912d42e54eaf33_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i857a4ce6f52d4c159052310deeec6c7a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idac118b21fb34cc0987c43b0e5069eca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8a6556d47b534c46b69474e970b014e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie6837d0c7f474574b480bbb7ab422f4a_I20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-01</instant>
        </period>
    </context>
    <context id="i04dc07ecbc4842379f1b38ab30b5eba8_I20210602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-02</instant>
        </period>
    </context>
    <context id="i08f710aa7b9e476e9cfe1eb202bb9575_I20210602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-02</instant>
        </period>
    </context>
    <context id="i80ee1121b7294df28e95de1abb339e57_D20210602-20210602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">sem:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-02</startDate>
            <endDate>2021-06-02</endDate>
        </period>
    </context>
    <context id="if1a2d014fb1e4ad28dd4c378b19640ec_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6032142566484e849a1c5d74fc32c36c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id8bac61b83244def99333977ca6bc8dd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4c19072c8de04863a294aa039b4d4f1c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if569ced9cfba4b40a89af8439239b76d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id57e27efd97745c990ac963fa61e26b6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id110289f580b4bf99ef20d4061298d26_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7224211964a0414eb6d46f88101082e5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i318011501b1440e589143c06cf03d2a6_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i583e60e6ec66438ca44ad0bd1c978df3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if7536a90c020479993c3e239213bd5b9_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6547976a10ee43418548a025bba5b82a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i83e6ab5f1d91457a8c4e1283a5492962_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0b2a61478b0140669828a01db0126a67_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i394d4e4cc11347d6bbe4d04a5195d6fa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sem:OtherAccruedLiabilitiesCurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ide56b585b96145e2a275a4c246014f7a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sem:OtherAccruedLiabilitiesCurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6e07cda8fc2f4dfbb5b2dd986ade2878_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i17c6a45ecdbf4d0f95f5f9be53712a5c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i902a144fb9c24c4c9a915b36772f9aa3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i101b81566dfb4f6083f1433734385dd6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i81a4a93b5710486380910f66202cea4c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i698e8ca3bbf14329ad97debd8fc5d02d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sem:SelectMedicalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1e1d48a74eba45399c9304871d02e6ac_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4d9eaba867e94987bae380499ef0dea5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i83fa48e193ef409091a5469b91556348_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i842ce964455440c8bf019b096558985c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i153dba6636544126b8b590e3eceb746a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie40b7ae534f84659b72f603832026b2c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic7fe7ee2784746f5af6d2429cd8a2219_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8083b69f958c4c0f8dbe5292758beec8_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4101982ebb88440ab0a78e005d9ac883_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i51d714fd1694458d8c8a2740933d72d8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iae89f2bc1bb34c1c88b6b97eb1162a82_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie1f26863a74d46b3807377370b9f5c71_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaed2d25f9da44d15a8e75aa82e738f7c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8878162e48ac455b871924e5a7f16043_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iffb407c8a9fd406bbddf4aaba0a22fbf_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie1d773ec12ea468d884922f6a9c624ab_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i78b5037d6f24467bb284a7f3daadf67d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i593f37f6bebf4b5c8147fc667686329b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8a46c953c7a44137882933b2fccefa90_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9da22e6ac16b4906870e768509e1fb6f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3fe3df84cda8454c8ffd79d805543ebf_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i197ea75654664fa7a7dd48b4a0515835_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i699f8bdade4a44e29271a7ea09f9b932_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if588fc73933845bbb155e472e99ba08e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i232ac557a5c14113bafaf53b25c2801d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibfa155817d6141a5af84386d83aa6d7d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i71ae59b24b3143e89410ddfca8316817_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia4876618fa9e49bfae481558c3925540_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1c27e0254b2645b0bdf18d8599991191_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i98da6697f91448bfa929dfa3d12ec44d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia2445574d08d460aadb6cb824e13b57b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i17a8bda6aa364b458b46c6989204116a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i08f65e64fc704e26b6d0c36a9b3e98cc_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2ad499a02f004e11a55a3d20c113db01_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib6157d64fab14d1f866ca5d716c12912_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i51ff975211194a639c5584cea74d9cb5_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5664ca3bf1834ed1b346b6f980fe1645_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1932c1a031b842f497c5e4232f3f980c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia82ee7626c034379a7ef163f2061e2bf_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ieb2712f735bf4472b74c12c452e1727d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id9163058a56849f4b1b6ebd3958a1728_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i43209435be314fa6a83374c8722c58a5_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2eb9a05c181e4145a86c46192acc8653_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id5dc54ed53b94d6eabdf4d733168a430_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie5110b434e804f27b249daa0ac18bd3d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1301e820f4e544f99fea1fdaef7b153a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia49b80360ab44d889a87b1c6f86dba3d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic6e87f49cddf4c0993fcc9475663950b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6d3595ddefe5469b964256337e3fb034_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4a40e1e8ef2b4a6ca0e3d8215ef692c7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iae9d25c4a62e4670a396e7b6215efe42_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iddb712476dc64adeae838bf8e4757e71_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i32cc5b0f0da748fa964f8bee8c8e5eab_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i424eb507e0b64cc39d53cf96c199d2c3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia2f065968f664f51a97a9c4c8a8f6786_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iedc923ca54a245aa839e41b3bd36de0e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i97ccae97127f42ec84a3a9dd4735f5cd_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i091aa3c41eb94571a18e7d780ed4b261_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i77d3137a60484a139d63c1c58d70fceb_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i42b3c528abf945e9859cc7f7f223fceb_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibd3ac5b6dbc749ff8ee6bfd8cf0ca211_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iddc4d97079e3443eba00958c5b46559d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i76832d2c4ca64519914f4773ca5655bc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icbd9fe5a16a7443b8f6b7fb4c8339e17_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i18f495ab15c4472ea5245942bf95dbc0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic066865053b14c43b32c73b1cbc2a459_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibe618caa2cdd41b493cccea11ad44386_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icb0e1422e48941919179e0c5e60cc063_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i21b8f9d9710f4d46bba3b4cd219bcae3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i116e543b7d364332a96e426369913e91_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7ce5d7ae1f3b480f9d278936f6173744_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie4d10e3e03a54b60a9d607bc62d66b9d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9c16ab56e4cf48229de650aa8e6455b3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i473b076cbb2248cda45ee5fecdf6c6d9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i22bf8e5a71a74e0ab969fc88fc9d25f9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i31fd5c81c9e74201ae6e106c98ca01c6_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i02680b33aed34a55a6fe418edcde45ed_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8fcbd9d03f874759a798ba9dfa435489_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id6f011f7031b41769857679e22ff5b33_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i25ea57bf51c745e29ae8656720141e04_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4602a266daee48acb939fda3366b3e59_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i52fcf8fa0e7f407ca9b2a0421d3c01b8_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5b1c9f6d7cde4d229d84a29158db43c5_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifb336581b1ab46dabf7a10b846ee714d_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7cf7cf902b774976a354f108a49e122b_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i09e5085e732d4d6fb28c986bae301d35_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6c5c1a4ea8b1455f8ea9b309f782aed0_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iabcbf2354ad849b5a607f2c23acf92b6_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8f1e3f7f1bd3482cb8ed258cb9ada854_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i30d728f258204b97bb72e03b6261514d_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i059d076681264fbfb89b79347f63c29a_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8f1cf5853d5f4c45936b37bfbdffa0db_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i063dc8bb9c604cb991c0938ed63900c1_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7e73da1de31a46198a088e1a579b197e_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i013ac78a834a4a17a349b46fff225ede_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i241f967097904b2e90e2c1981d5bfb2f_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i606bd30a10194d7c92111ec05dd70ef2_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i14aff568d487484d955b6414e353d276_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9f5bf5cc569148f08c2f756e392e095a_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i513bb2ed05384cf0b367f1a1f2df60cd_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7ae7544550d341458079a0f82f73a2f8_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1343d1d64ee546f4b3bc8de894d6a417_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i446969a89bf54833b066ad6cadf438aa_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i35be1d23264d4ef8900b083084bae9b1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i228091dd94e94a2fb65278d548b96136_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i84a37576ff314681abd2c231a24ffea5_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibef36a70c20e4c0e98c28b191ddfb97b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4bd1eaf1ae624135ac4bc8d0d22d46d6_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceMedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic8c4a3d34c3f41908312ed9c79fa8fd3_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie29532d76e2d4dee8c6c7b7b1be770c1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i45fee6050b8a4216a0f668de2e12e95b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i982e0b3f126040f69ce41b2c2252c0bc_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1882e5c4817847d286a5e4ee18cd8c03_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i89fb0d7ade4b445bbe6adb3867b94148_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sem:HealthCarePatientServiceNonMedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i39ec355699c047d88cd0a6ed1979c79b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaee340f3a6b64cbdbe9dbc79ba2744d6_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3e316619ee3b482d9c7fae4209c447ad_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i27949e6e57514846a097e4475475890d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i101f8dba1cbb472ab5d1e292ca9ad014_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i67f288ba5c84408f889c40613f2a07b4_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1950866dbcfb4c3e96407bec7d05b210_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:CriticalIllnessRecoveryHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1e70dfbd95e342bd9f7d99e607af7d63_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:RehabilitationHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4760aa7fcf714911a502ad44e9ed68ac_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:OutpatientRehabilitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic39be75c367b45e1a92d762771bc3eec_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">sem:ConcentraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i71dc8bf60a54443290451e38ffa4cbb0_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icf91d28d1f7f4831a5c56411e190d606_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6bd31c72edeb45d9b4601581e31a0e89_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis">us-gaap:ProfessionalMalpracticeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia491adcb999943c481f80ad4aaeebcae_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if67ed923fb524d7e88c6828d4a0c423a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis">us-gaap:ProfessionalMalpracticeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ied10c49f8e374623bcde2e89b5b25289_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis">us-gaap:ProfessionalMalpracticeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i465d9175e18d4165b2f6834e5d9e0b7a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis">us-gaap:ProfessionalMalpracticeLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i760d525b19534ec8bf2275b1a4759394_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="i69380e325f114ea89df7916749073905_D20200327-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
        </entity>
        <period>
            <startDate>2020-03-27</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1e1fc4e7b10d4564ae73da8aaf8268ca_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="ib0cd8e5fc1d2451fa507e01087b5e757_I20210804">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001320414</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-04</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80L2ZyYWc6ZjdmNDg2YzQ2NDAzNDk3ZDkyMTljNmE4N2QzMWY1ZWEvdGFibGU6NWYwZGUyNmY0NjJkNDIyOTgzZWU2NWUwMDFhM2E4NzQvdGFibGVyYW5nZTo1ZjBkZTI2ZjQ2MmQ0MjI5ODNlZTY1ZTAwMWEzYTg3NF8yLTEtMS0xLTA_7e288311-ae8b-4fb0-99f2-12900725e184">0001320414</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80L2ZyYWc6ZjdmNDg2YzQ2NDAzNDk3ZDkyMTljNmE4N2QzMWY1ZWEvdGFibGU6NWYwZGUyNmY0NjJkNDIyOTgzZWU2NWUwMDFhM2E4NzQvdGFibGVyYW5nZTo1ZjBkZTI2ZjQ2MmQ0MjI5ODNlZTY1ZTAwMWEzYTg3NF8zLTEtMS0xLTA_fb422ddb-a7ed-4b3f-a6a5-692420c76ff3">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80L2ZyYWc6ZjdmNDg2YzQ2NDAzNDk3ZDkyMTljNmE4N2QzMWY1ZWEvdGFibGU6NWYwZGUyNmY0NjJkNDIyOTgzZWU2NWUwMDFhM2E4NzQvdGFibGVyYW5nZTo1ZjBkZTI2ZjQ2MmQ0MjI5ODNlZTY1ZTAwMWEzYTg3NF80LTEtMS0xLTA_5820f1be-fed9-415e-a832-8e0c7b350ec2">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80L2ZyYWc6ZjdmNDg2YzQ2NDAzNDk3ZDkyMTljNmE4N2QzMWY1ZWEvdGFibGU6NWYwZGUyNmY0NjJkNDIyOTgzZWU2NWUwMDFhM2E4NzQvdGFibGVyYW5nZTo1ZjBkZTI2ZjQ2MmQ0MjI5ODNlZTY1ZTAwMWEzYTg3NF81LTEtMS0xLTA_e2632f9e-91bb-435b-a595-080d44a1f28d">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80L2ZyYWc6ZjdmNDg2YzQ2NDAzNDk3ZDkyMTljNmE4N2QzMWY1ZWEvdGFibGU6NWYwZGUyNmY0NjJkNDIyOTgzZWU2NWUwMDFhM2E4NzQvdGFibGVyYW5nZTo1ZjBkZTI2ZjQ2MmQ0MjI5ODNlZTY1ZTAwMWEzYTg3NF82LTEtMS0xLTA_dd5a9197-d15f-41aa-a44c-d437ecd4ab37">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentType
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjI3_59fa01a8-66ce-40ae-ab49-f5547e2ea23d">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGFibGU6ZjhmNjQ0NWFkYzg3NDZmODg2OTUyZjlhNjMyMTk2NzQvdGFibGVyYW5nZTpmOGY2NDQ1YWRjODc0NmY4ODY5NTJmOWE2MzIxOTY3NF8wLTAtMS0xLTA_f34bf8a5-f145-464e-a79f-d89bd779b253">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8xMzg_1b023975-bce6-4e3f-8e78-8967077ed38a">2021-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGFibGU6ZjgyOTg1MTg3MmZjNDUyNzg4OWI0MzZlMzAyZmI4MjQvdGFibGVyYW5nZTpmODI5ODUxODcyZmM0NTI3ODg5YjQzNmUzMDJmYjgyNF8wLTAtMS0xLTA_9ec2549a-f3f2-4176-be08-e012240e0a6d">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjMy_706705ad-90de-4891-bcff-3696423f3e73">001-34465</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjMz_77c71a19-f83f-43aa-9d72-a2c1fe6d174e">SELECT MEDICAL HOLDINGS CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGFibGU6ZmY5MWM2MTAyMzY2NDdkOTgwMzU1ZGU1YWYwNjczNWMvdGFibGVyYW5nZTpmZjkxYzYxMDIzNjY0N2Q5ODAzNTVkZTVhZjA2NzM1Y18wLTAtMS0xLTA_4b056974-152a-414c-8eaa-db2dae08a226">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGFibGU6ZmY5MWM2MTAyMzY2NDdkOTgwMzU1ZGU1YWYwNjczNWMvdGFibGVyYW5nZTpmZjkxYzYxMDIzNjY0N2Q5ODAzNTVkZTVhZjA2NzM1Y18wLTItMS0xLTA_e311d890-8f2c-4d5f-9a56-77a8f57ca889">20-1764048</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjM0_7e893baa-a670-4f5b-b98e-f95ae96974d7">4714 Gettysburg Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjI4_0b2a6c29-dec3-471a-bb3e-1bf00943f5bc">P.O.&#160;Box&#160;2034</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjI5_5f1bbd55-112a-4ae5-afde-ed05b8c465c1">Mechanicsburg</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjM1_eb8bec23-3762-40a9-8c35-e10668b85e29">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjM2_b44881e5-3e4a-42d3-a43d-e8c593c3a95a">17055</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjMw_a2601d22-5e43-405d-937c-903c60ad2412">717</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjM3_44022ec6-a88f-463a-9fe0-6fe7bf37ea73">972-1100</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGFibGU6ZGNhMjExZTczN2Y4NDQwMWIzMjRjMDdiODNiNzM2ZDYvdGFibGVyYW5nZTpkY2EyMTFlNzM3Zjg0NDAxYjMyNGMwN2I4M2I3MzZkNl8xLTAtMS0xLTA_63349353-0bda-4d6d-b7f9-ad626f7bba69">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGFibGU6ZGNhMjExZTczN2Y4NDQwMWIzMjRjMDdiODNiNzM2ZDYvdGFibGVyYW5nZTpkY2EyMTFlNzM3Zjg0NDAxYjMyNGMwN2I4M2I3MzZkNl8xLTEtMS0xLTA_c60ee474-1b76-42d6-8cb5-a2dc6f65938b">SEM</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGFibGU6ZGNhMjExZTczN2Y4NDQwMWIzMjRjMDdiODNiNzM2ZDYvdGFibGVyYW5nZTpkY2EyMTFlNzM3Zjg0NDAxYjMyNGMwN2I4M2I3MzZkNl8xLTItMS0xLTA_f9fcf529-23f0-41ec-aa06-8a34cd47284f">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjM4_d027717c-49a9-49e3-89e3-419c852a27a5">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjMx_8a840003-a953-4d12-8ada-9699793e9c47">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGFibGU6MmMxNTA4ODg3YjBjNGY5Mzk1N2JlODg1NmU0MTc2M2QvdGFibGVyYW5nZToyYzE1MDg4ODdiMGM0ZjkzOTU3YmU4ODU2ZTQxNzYzZF8wLTAtMS0xLTA_e7cb627c-1a34-4e6d-a0c6-aa7587fd9da4">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGFibGU6MmMxNTA4ODg3YjBjNGY5Mzk1N2JlODg1NmU0MTc2M2QvdGFibGVyYW5nZToyYzE1MDg4ODdiMGM0ZjkzOTU3YmU4ODU2ZTQxNzYzZF8xLTMtMS0xLTA_cc8b9fe9-0690-42bd-b6b9-76b9109fea4d">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGFibGU6MmMxNTA4ODg3YjBjNGY5Mzk1N2JlODg1NmU0MTc2M2QvdGFibGVyYW5nZToyYzE1MDg4ODdiMGM0ZjkzOTU3YmU4ODU2ZTQxNzYzZF8yLTMtMS0xLTA_c4f8ad5c-0be3-46c7-97f1-a3de86a08b92">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yNjM5_bf215d61-9fd1-4eec-807a-320671803c4e">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ib7edbe299d2e4cef8af2828feb10a42e_I20210731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xL2ZyYWc6OThhYWQyNTkwYTZhNDg5ZTg1YWMyYTkzNzAzOWViMWYvdGV4dHJlZ2lvbjo5OGFhZDI1OTBhNmE0ODllODVhYzJhOTM3MDM5ZWIxZl8yMDU1_f2140d7d-2d50-40f1-8530-0ff4db465d74"
      unitRef="shares">134576139</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMy0xLTEtMS0w_e5eb0d23-1a5d-4c0c-b19e-77efd7e430c6"
      unitRef="usd">577061000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMy0zLTEtMS0w_8df53029-0272-4672-a8c8-debd6e16a755"
      unitRef="usd">803493000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNC0xLTEtMS0w_8aa31406-d4e1-4e28-a01c-ed6628a79b1a"
      unitRef="usd">896763000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNC0zLTEtMS0w_7a1164ea-bd9f-4ea5-9013-5f28cddc9aa6"
      unitRef="usd">931179000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidTaxes
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNS0xLTEtMS0w_16b85a4c-1476-45f1-b3ed-5ee71c418085"
      unitRef="usd">5686000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNS0zLTEtMS0w_6b8bc16d-fced-4c1d-a589-a60fca666e90"
      unitRef="usd">5417000</us-gaap:PrepaidTaxes>
    <us-gaap:OtherAssetsCurrent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNi0xLTEtMS0w_957d3e47-05d4-4530-b17f-0e18dac0dc93"
      unitRef="usd">114490000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNi0zLTEtMS0w_acff1a66-c861-4ff5-9ee7-28d3035bed66"
      unitRef="usd">128081000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNy0xLTEtMS0w_6de70e18-d3ac-4723-8186-4383e8027941"
      unitRef="usd">1594000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNy0zLTEtMS0w_bb6a201b-8123-4f17-bf25-90f72d2bb422"
      unitRef="usd">1868170000</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfOC0xLTEtMS0w_a5a6c0f2-1584-44b4-82f0-fb805af3d68a"
      unitRef="usd">1032217000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfOC0zLTEtMS0w_bc54db35-29cb-4fc0-8fa2-8ddc20c3843a"
      unitRef="usd">1053331000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfOS0xLTEtMS0w_3abddb5c-44a4-4edd-a49c-3b213db1979a"
      unitRef="usd">943420000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfOS0zLTEtMS0w_90d3bf3d-179f-4fa0-9acb-e033c4e8fd86"
      unitRef="usd">928226000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTAtMS0xLTEtMA_a7359be4-cd35-45f7-9930-471fe1987209"
      unitRef="usd">3379014000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTAtMy0xLTEtMA_3aa2dc5f-0e5a-4233-b7a6-c408c7d10c55"
      unitRef="usd">3391040000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTEtMS0xLTEtMA_b19a4009-d221-4663-92c0-ce0ecc3d237b"
      unitRef="usd">387541000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTEtMy0xLTEtMA_08993796-e16b-4c6b-a4ac-fdbf61f68711"
      unitRef="usd">380302000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTItMS0xLTEtMA_da54d785-c7ee-4cf8-82fe-6da383529d6f"
      unitRef="usd">319207000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTItMy0xLTEtMA_b8354370-86ca-473c-9325-ab18e636cc5b"
      unitRef="usd">335310000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTMtMS0xLTEtMA_a170ac76-c4e6-459e-b56e-ff0f5124eb77"
      unitRef="usd">7655399000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTMtMy0xLTEtMA_cd34b8db-7a80-4cc7-96f4-50e541d00624"
      unitRef="usd">7956379000</us-gaap:Assets>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTctMS0xLTEtMA_8a5559ed-b88a-48dc-8918-fecff7bb7dde"
      unitRef="usd">220413000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTctMy0xLTEtMA_b864be02-3fb6-41e5-b77c-c030f11ecb30"
      unitRef="usd">224868000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTgtMS0xLTEtMA_4ab9212a-2283-443c-b47e-46a960537881"
      unitRef="usd">12621000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTgtMy0xLTEtMA_370d4ee1-1dda-4623-a1ac-0d743cbad972"
      unitRef="usd">11608000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTktMS0xLTEtMA_bb050a24-f830-4480-b037-d3723d2b8d9f"
      unitRef="usd">177087000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMTktMy0xLTEtMA_efaab3d8-6872-4f10-8559-67fb8e3c0711"
      unitRef="usd">187736000</us-gaap:AccountsPayableCurrent>
    <sem:AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjAtMS0xLTEtMA_8101b440-f473-433c-bbfb-89ec08be20b9"
      unitRef="usd">224876000</sem:AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent>
    <sem:AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjAtMy0xLTEtMA_5c29fe0d-d42d-49ba-b995-8db7327abf19"
      unitRef="usd">246960000</sem:AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent>
    <us-gaap:AccruedVacationCurrent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjEtMS0xLTEtMA_94a602a9-b574-4e6e-af75-29b57f84dc0f"
      unitRef="usd">132811000</us-gaap:AccruedVacationCurrent>
    <us-gaap:AccruedVacationCurrent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjEtMy0xLTEtMA_9225aee2-65b7-4b37-9ed4-28aac43348ca"
      unitRef="usd">146790000</us-gaap:AccruedVacationCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjItMS0xLTEtMA_7fbe273d-ba58-442d-b95c-3dc658f8a634"
      unitRef="usd">29240000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjItMy0xLTEtMA_2fe306ef-3529-4378-97e5-40c2e00cded1"
      unitRef="usd">28938000</us-gaap:InterestPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjMtMS0xLTEtMA_b2b98773-565e-4536-91c3-2e4f393a02eb"
      unitRef="usd">228948000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjMtMy0xLTEtMA_96b4c8b7-a2b8-4b31-82c9-2f3b54b22287"
      unitRef="usd">256095000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <sem:GovernmentAdvancesCARESAct
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjQtMS0xLTEtMA_949a8fdb-5f2f-49e5-878c-94709f4d4325"
      unitRef="usd">321807000</sem:GovernmentAdvancesCARESAct>
    <sem:GovernmentAdvancesCARESAct
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjQtMy0xLTEtMA_d29dba24-2146-4542-9f33-8c6108532788"
      unitRef="usd">251272000</sem:GovernmentAdvancesCARESAct>
    <sem:UnearnedGovernmentAssistanceCARESAct
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjUtMS0xLTEtMA_14103402-dd23-4697-964e-758464f68725"
      unitRef="usd">82607000</sem:UnearnedGovernmentAssistanceCARESAct>
    <sem:UnearnedGovernmentAssistanceCARESAct
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjUtMy0xLTEtMA_66cda929-1bea-4b05-9db0-6f9a09d94e2a"
      unitRef="usd">4099000</sem:UnearnedGovernmentAssistanceCARESAct>
    <us-gaap:TaxesPayableCurrent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjctMS0xLTEtMA_84fd72a7-6156-445f-86aa-f7dbe3cff54b"
      unitRef="usd">7956000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjctMy0xLTEtMA_b9880ac9-4c4a-4b66-a40b-fc0cc3d490f5"
      unitRef="usd">50662000</us-gaap:TaxesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjgtMS0xLTEtMA_147575cf-2a36-4493-aaa3-a9d4a064796d"
      unitRef="usd">1438366000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjgtMy0xLTEtMA_fb9ce31f-ac8c-4ad1-a501-7f44ba954bf4"
      unitRef="usd">1409028000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjktMS0xLTEtMA_c6d2a619-ba04-4b31-b559-9ec8d5ff5c1c"
      unitRef="usd">875367000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMjktMy0xLTEtMA_f0d8f6bd-3c2f-4ffd-bd52-865429785da9"
      unitRef="usd">893478000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzAtMS0xLTEtMA_e721de50-5d51-4118-89ad-d00b09300af2"
      unitRef="usd">3389398000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzAtMy0xLTEtMA_a3cc097f-55ec-4605-b262-629f4dbaeaf7"
      unitRef="usd">3386214000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzEtMS0xLTEtMA_155352d7-8586-4443-8bdf-f1879c1dbc8b"
      unitRef="usd">132421000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzEtMy0xLTEtMA_09e11995-750c-43cf-8c2d-26d8cec60a9d"
      unitRef="usd">123559000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzItMS0xLTEtMA_ea4f6ef3-e8bb-4e5c-b2d1-1bb56fe35267"
      unitRef="usd">168703000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzItMy0xLTEtMA_fdfa59b0-62a6-407f-92b7-871c4be25c80"
      unitRef="usd">172656000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzMtMS0xLTEtMA_f6c8fcb0-29ec-4cde-aefc-bcee3d02a6ba"
      unitRef="usd">6004255000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzMtMy0xLTEtMA_dff11d37-086e-494c-9d74-cd8df141fe7e"
      unitRef="usd">5984935000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzQtMS0xLTEtMA_4bb85344-c7f3-4cfc-93da-9d40cef152e2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzQtMy0xLTEtMA_6f6eab80-21b9-403f-8609-92847f53b6e8"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzUtMS0xLTEtMA_21d59ba7-2c0a-434c-9046-8c2f2065b57f"
      unitRef="usd">398171000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzUtMy0xLTEtMA_3a0bd9ea-80da-4312-84b4-364c821d5f14"
      unitRef="usd">521552000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjkyOGU1ZTc0YWVmNDRkMzg5Njg4NTI1M2I3NjQ1N2VlXzE4_332b79e9-dbae-42d9-b95f-c49410ee6aaf"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjkyOGU1ZTc0YWVmNDRkMzg5Njg4NTI1M2I3NjQ1N2VlXzE4_861ba9cd-8d51-4f2e-b7ec-de2c6a9047f3"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjkyOGU1ZTc0YWVmNDRkMzg5Njg4NTI1M2I3NjQ1N2VlXzMy_22494d95-cfc3-43a3-b5eb-4d451f5085ef"
      unitRef="shares">700000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjkyOGU1ZTc0YWVmNDRkMzg5Njg4NTI1M2I3NjQ1N2VlXzMy_4dc7a78a-ef54-4d29-bd26-fdde39ead2cb"
      unitRef="shares">700000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjkyOGU1ZTc0YWVmNDRkMzg5Njg4NTI1M2I3NjQ1N2VlXzU0_8f303d2f-c6c6-4326-9563-5bf223a68d57"
      unitRef="shares">134850735</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjkyOGU1ZTc0YWVmNDRkMzg5Njg4NTI1M2I3NjQ1N2VlXzU0_e46e0d69-af0e-45fb-af35-03bf84e3e6fb"
      unitRef="shares">134850735</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjkyOGU1ZTc0YWVmNDRkMzg5Njg4NTI1M2I3NjQ1N2VlXzYx_205a0edd-a3b8-4cd1-a690-2f9ba0cdc178"
      unitRef="shares">135005369</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjkyOGU1ZTc0YWVmNDRkMzg5Njg4NTI1M2I3NjQ1N2VlXzYx_adea7643-1c10-4acf-9baf-a21c51c2638f"
      unitRef="shares">135005369</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzctMS0xLTEtMA_18fce4ac-d559-4aaf-9ef6-f1c4b3854ea0"
      unitRef="usd">135000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzctMy0xLTEtMA_c8e9d597-7e5b-4a69-9a8a-6126af05f81d"
      unitRef="usd">135000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzgtMS0xLTEtMA_c1ef6530-682b-44aa-90da-7994d8611eec"
      unitRef="usd">509128000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzgtMy0xLTEtMA_3ba45421-2c60-4083-8693-c78ba513b296"
      unitRef="usd">516172000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzktMS0xLTEtMA_5dbb9d8f-1090-48ec-9f02-b02fe96af42a"
      unitRef="usd">553244000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfMzktMy0xLTEtMA_ed8032d8-3552-465a-86d7-91d4ec2fdf66"
      unitRef="usd">713191000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNDAtMS0xLTEtMA_bcad5f55-ea2b-409f-9cfe-c0f5b93ef7d5"
      unitRef="usd">-2027000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNDAtMy0xLTEtMA_fa39c45d-ef64-4846-b976-4e44f0abd204"
      unitRef="usd">4727000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNDEtMS0xLTEtMA_fa600c6f-b18f-4e71-a28a-305d2ae1c8af"
      unitRef="usd">1060480000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNDEtMy0xLTEtMA_d947d38f-45ee-47f5-8dad-d003f7ef7cb3"
      unitRef="usd">1234225000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNDItMS0xLTEtMA_89c9b41e-2609-4387-b5b0-ffc134c0ae81"
      unitRef="usd">192493000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNDItMy0xLTEtMA_bebf7eff-a3a6-4924-981d-91d117bde9b2"
      unitRef="usd">215667000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNDMtMS0xLTEtMA_daa32da2-b5bd-4977-9601-39e799a7c34f"
      unitRef="usd">1252973000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNDMtMy0xLTEtMA_7786c03c-14a5-422f-bcd1-972e3738b6d2"
      unitRef="usd">1449892000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNDQtMS0xLTEtMA_40800c2d-9de2-4d0d-a0d4-0e38c2fd0e84"
      unitRef="usd">7655399000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xNi9mcmFnOjA1OWUwOWYyM2NjYzQzM2U5NGRhMDgwNDc3ZjI3NWFjL3RhYmxlOjgzMTkzMTg4YThlODQwNDZiYWViYmFiNTVkNzI4NmY5L3RhYmxlcmFuZ2U6ODMxOTMxODhhOGU4NDA0NmJhZWJiYWI1NWQ3Mjg2ZjlfNDQtMy0xLTEtMA_45837ca3-d064-4ffd-aa88-768d3bd1c1ac"
      unitRef="usd">7956379000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMi0xLTEtMS03OTA_ccbf0263-4768-4de3-b7e3-82e7610550c4"
      unitRef="usd">1232718000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMi0zLTEtMS03OTA_9ac2da6a-bc35-4393-8865-1ea99e30c097"
      unitRef="usd">1564020000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMi0xLTEtMS0w_e4fdd68a-896f-41b1-897a-a758986d6b6f"
      unitRef="usd">2647350000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMi0zLTEtMS0w_a9b74e5a-cbca-4eb1-89b1-66b7cec84cd6"
      unitRef="usd">3110483000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNC0xLTEtMS03OTA_7a51112c-5723-4bc9-8914-7382b4181c52"
      unitRef="usd">1082456000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNC0zLTEtMS03OTA_f0ed8b41-912f-4d9d-8a1a-5af9e5db7026"
      unitRef="usd">1291448000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNC0xLTEtMS0w_bd259109-6442-46f4-ab47-9d6db0c0428e"
      unitRef="usd">2282827000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNC0zLTEtMS0w_6826d89d-b760-42f1-95af-120b6256a8ea"
      unitRef="usd">2584897000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNS0xLTEtMS03OTA_8aa16b1e-9169-487b-949f-8c6431c42020"
      unitRef="usd">33461000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNS0zLTEtMS03OTA_a7d9f313-e658-4a74-9434-e776869aefd4"
      unitRef="usd">35737000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNS0xLTEtMS0w_524ba628-c173-4739-9289-146c60837534"
      unitRef="usd">67292000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNS0zLTEtMS0w_58785d20-0d6c-40f1-bd57-1910af8d9ca1"
      unitRef="usd">71140000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNi0xLTEtMS03OTA_2180dece-4c1c-4b50-a482-20bd8a364fe3"
      unitRef="usd">52271000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNi0zLTEtMS03OTA_2e6d270c-bd52-4d90-96ad-b5ce1bf67e5c"
      unitRef="usd">50954000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNi0xLTEtMS0w_ffa3d312-813a-4479-b37c-69812ea25fe5"
      unitRef="usd">104023000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNi0zLTEtMS0w_0da8753a-1904-4896-906a-d93acf05e623"
      unitRef="usd">100574000</us-gaap:DepreciationAndAmortization>
    <us-gaap:CostsAndExpenses
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNy0xLTEtMS03OTA_63171a17-44db-46b9-aaba-bb88d5c5caaa"
      unitRef="usd">1168188000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNy0zLTEtMS03OTA_f596f393-80cb-4c7d-8827-667272b38375"
      unitRef="usd">1378139000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNy0xLTEtMS0w_4f60336d-2f3a-4084-bb77-294895d56ad7"
      unitRef="usd">2454142000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfNy0zLTEtMS0w_151f4f24-0939-4881-bbe7-50f76b6a32e7"
      unitRef="usd">2756611000</us-gaap:CostsAndExpenses>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfOC0xLTEtMS03OTA_90fe16a4-238d-436b-8a16-b0a18d4a0eed"
      unitRef="usd">54988000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfOC0zLTEtMS03OTA_4e7d016c-98cb-4f21-8f7f-0748b54cd3a9"
      unitRef="usd">98087000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfOC0xLTEtMS0w_2afab8c0-143e-4c4d-bfa5-ee3a0d77871e"
      unitRef="usd">54988000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfOC0xLTEtMS0w_64d3bdf5-51fe-4937-b243-1e0cd4bf7964"
      unitRef="usd">54988000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfOC0zLTEtMS0w_f98ae8c8-23b7-4554-8008-5db63b8de0e0"
      unitRef="usd">132108000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfOS0xLTEtMS03OTA_2b6ab58b-d497-45c0-954a-f57cd6f696e3"
      unitRef="usd">119518000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfOS0zLTEtMS03OTA_0841b466-1243-4715-aeb9-7003790ef200"
      unitRef="usd">283968000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfOS0xLTEtMS0w_93273f01-8b37-40da-9e70-8c26bfb530e5"
      unitRef="usd">248196000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfOS0zLTEtMS0w_42e70b0e-f8b5-43bd-b7e5-e2fde33b5fe2"
      unitRef="usd">485980000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTItMS0xLTEtNzkw_be5e2bec-eb28-478e-8096-c3af6b578629"
      unitRef="usd">8324000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTItMy0xLTEtNzkw_a515021a-f923-4d40-a30a-8c257ca64970"
      unitRef="usd">11809000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTItMS0xLTEtMA_d6512f0e-9cc1-49e1-ac25-0af904c3d24b"
      unitRef="usd">10912000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTItMy0xLTEtMA_aff10776-bc34-4e81-a816-9dd878435476"
      unitRef="usd">21728000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTMtMS0xLTEtNzkw_a0547508-f3b4-4fce-b022-a6cde5aa53ae"
      unitRef="usd">346000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTMtMy0xLTEtNzkw_3d613e50-d8bf-4306-9457-b62ebab4ca9d"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTMtMS0xLTEtMA_30920f22-4616-48c6-a011-e5ab33004903"
      unitRef="usd">7547000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTMtMy0xLTEtMA_bc3154b8-c06c-4259-b51b-d45d761667dd"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:LitigationSettlementInterest
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTQtMS0xLTEtNzkw_203f6e03-ff1c-45ce-8af2-a9bbf66bb4a1"
      unitRef="usd">0</us-gaap:LitigationSettlementInterest>
    <us-gaap:LitigationSettlementInterest
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTQtMy0xLTEtNzkw_0138ddc7-6d30-488d-a8d8-272f502c7490"
      unitRef="usd">0</us-gaap:LitigationSettlementInterest>
    <us-gaap:LitigationSettlementInterest
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTQtMS0xLTEtMA_29d08a63-574d-463b-9906-a2430969e4d0"
      unitRef="usd">0</us-gaap:LitigationSettlementInterest>
    <us-gaap:LitigationSettlementInterest
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTQtMy0xLTEtMA_d7c30e00-71fd-4774-8ba5-7daf3138327d"
      unitRef="usd">-4749000</us-gaap:LitigationSettlementInterest>
    <us-gaap:InterestExpense
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTUtMS0xLTEtNzkw_84475845-6461-4b69-be3c-bb074edb0d07"
      unitRef="usd">37366000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTUtMy0xLTEtNzkw_b176745e-de66-491b-b7ff-328c0d7e120b"
      unitRef="usd">33888000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTUtMS0xLTEtMA_84170ae5-834f-4d5b-9887-c6df5adacf84"
      unitRef="usd">83473000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTUtMy0xLTEtMA_c18c29af-35dd-4e2a-8ff1-335bbe375785"
      unitRef="usd">68290000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTYtMS0xLTEtNzkw_f037e50f-e6ab-4aec-ba25-ab983dc8b61f"
      unitRef="usd">90822000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTYtMy0xLTEtNzkw_288edd8d-7299-40c1-876d-2a6db84e6097"
      unitRef="usd">261889000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTYtMS0xLTEtMA_cfdae4cf-9c57-4c43-813e-6286db0ac907"
      unitRef="usd">183182000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTYtMy0xLTEtMA_0811f256-11de-4127-81e7-45cf33f1db46"
      unitRef="usd">444167000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTctMS0xLTEtNzkw_8c58409e-c99b-48fa-9e9f-018bde2bf4f5"
      unitRef="usd">23336000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTctMy0xLTEtNzkw_f71451c9-9533-4c3b-94b7-913434cfc6f7"
      unitRef="usd">65681000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTctMS0xLTEtMA_f8d4249c-359c-47fe-aadf-7005ddcca824"
      unitRef="usd">45248000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTctMy0xLTEtMA_c7d392a5-0865-4135-8de6-d1b2640db3c1"
      unitRef="usd">110745000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTgtMS0xLTEtNzkw_91326bc0-55b2-4385-8d85-4ca4a2d896f9"
      unitRef="usd">67486000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTgtMy0xLTEtNzkw_ef3b8a02-cbe4-40bc-9daa-c790714059c8"
      unitRef="usd">196208000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTgtMS0xLTEtMA_e690abae-d247-415d-be1a-69a36ae81c13"
      unitRef="usd">137934000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTgtMy0xLTEtMA_6cd6400d-3615-4f2a-812f-530aee92fd40"
      unitRef="usd">333422000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTktMS0xLTEtNzkw_e3400c37-a4d9-4ed7-ae57-ace4c30cafa4"
      unitRef="usd">15836000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTktMy0xLTEtNzkw_9a059b87-e98f-4e91-8946-bdf65cc69757"
      unitRef="usd">31314000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTktMS0xLTEtMA_cf3c7816-51cc-4ea1-a28b-5fbc4bf3122a"
      unitRef="usd">33159000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMTktMy0xLTEtMA_948fd0a0-9352-4f9b-8b3a-b972491c8790"
      unitRef="usd">57982000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjAtMS0xLTEtNzkw_16557c47-757b-4df3-b97e-3d0f5c0711fa"
      unitRef="usd">51650000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjAtMy0xLTEtNzkw_25ee18a5-ee76-4bf3-ba6e-dc80d559e4a4"
      unitRef="usd">164894000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjAtMS0xLTEtMA_bf144b6c-8364-4c38-82a5-1c7e36c94444"
      unitRef="usd">104775000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjAtMy0xLTEtMA_2b9fe718-fe35-4778-8151-2f22db9fdac5"
      unitRef="usd">275440000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjItMS0xLTEtNzkw_791ff8e9-e4d1-434a-b3ea-9be3b10de37e"
      unitRef="usdPerShare">0.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjItMS0xLTEtNzkw_7c2caddf-8264-4743-8953-ad4dc1f9e6c3"
      unitRef="usdPerShare">0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjItMy0xLTEtNzkw_05bb455e-1dd4-4bc7-a629-f5ce1823ae1e"
      unitRef="usdPerShare">1.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjItMy0xLTEtNzkw_c15f3d1a-56f8-4f4d-818a-072a8a792f4d"
      unitRef="usdPerShare">1.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjItMS0xLTEtMA_544a41fe-0485-4f50-8182-7ca8ad4f5421"
      unitRef="usdPerShare">0.78</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjItMS0xLTEtMA_c29dd232-fa30-4471-b148-aa18ab911e06"
      unitRef="usdPerShare">0.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjItMy0xLTEtMA_754ca5a9-335e-41c4-977d-092385232238"
      unitRef="usdPerShare">2.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8xOS9mcmFnOjgwZjkyZjk4NmMyNzQ5NmNiOGM0ZmJjZjUzZjI5MTU0L3RhYmxlOjUwZjY0Y2QzN2I5NTRjZGU5MDExNDdiNWM2MWM0NmUyL3RhYmxlcmFuZ2U6NTBmNjRjZDM3Yjk1NGNkZTkwMTE0N2I1YzYxYzQ2ZTJfMjItMy0xLTEtMA_f3eed5d9-e397-4829-a6a1-754c100ae96d"
      unitRef="usdPerShare">2.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:ProfitLoss
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfMi0xLTEtMS04NTM_4fab6bd7-099e-44e7-86bd-50b067b74a4e"
      unitRef="usd">67486000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfMi0zLTEtMS04NTM_36b54f1b-bff0-4dc0-9264-f3246b6e678e"
      unitRef="usd">196208000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfMi0xLTEtMS0w_5ca0d6f5-3e6a-4087-b027-8a9aaad0b091"
      unitRef="usd">137934000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfMi0zLTEtMS0w_7725064e-45de-42a7-91fb-584354ab8933"
      unitRef="usd">333422000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNC0xLTEtMS00NDQ1_aa55fd51-8016-4452-8611-7c237db4b740"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNC0zLTEtMS00NDQ1_6504035c-77e4-448d-941d-78048e33425b"
      unitRef="usd">-1403000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNC01LTEtMS00NDQ1_1033adcb-ba4e-49cb-877a-8a9f63abe63b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNC03LTEtMS00NDQ1_38308db4-28ba-4030-8e39-08e6bda1fd0f"
      unitRef="usd">6748000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNC0xLTEtMS04NTg_ec9373d8-9807-4200-8b75-bf4f122878ef"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNC0zLTEtMS04NTg_491289b8-1bc0-4514-8d93-9e0b8ecbfabf"
      unitRef="usd">-6000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNC0xLTEtMS0w_73007707-13d3-4c10-ae91-951be509c15f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNC0zLTEtMS0w_6c6721cd-cf55-4298-b9e2-18b60af8b67d"
      unitRef="usd">-6000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi0wLTEtMS00NTA3L3RleHRyZWdpb246Mjk0MjkzNDI5YjczNDk0ODk5ODQwODUyNTVlMTZkZmNfMjc0ODc3OTA2OTUxOA_0e4ab380-2896-44f2-9899-8fa0c7b093f9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi0wLTEtMS00NTA3L3RleHRyZWdpb246Mjk0MjkzNDI5YjczNDk0ODk5ODQwODUyNTVlMTZkZmNfMjc0ODc3OTA2OTQ5Mw_02e4098e-1168-4e0d-a1ac-6c4606f72303"
      unitRef="usd">486000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi0wLTEtMS00NTA3L3RleHRyZWdpb246Mjk0MjkzNDI5YjczNDk0ODk5ODQwODUyNTVlMTZkZmNfMjc0ODc3OTA2OTQ5OA_c4a88c93-80c1-462d-a1eb-94f736e9aa72"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi0wLTEtMS00NTA3L3RleHRyZWdpb246Mjk0MjkzNDI5YjczNDk0ODk5ODQwODUyNTVlMTZkZmNfMjc0ODc3OTA2OTUwNw_169328da-fcbb-49a7-b137-b168d7c24114"
      unitRef="usd">-2348000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi0xLTEtMS00NTAx_c34d9351-aa97-4f25-96c4-082488932b44"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi0zLTEtMS01MTEw_68729bd2-55eb-438d-b0bd-b6c62f38af5b"
      unitRef="usd">-1397000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi01LTEtMS01MTEw_0ae48a1b-f90b-43cf-a9da-a282a1cfbce4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi03LTEtMS01MTEw_2f87b697-9f2e-4b5e-ab37-0d8394572a75"
      unitRef="usd">6754000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi0xLTEtMS04ODM_6a1068db-cf9e-43b4-9193-e64495c7a0b9"
      unitRef="usd">67486000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi0zLTEtMS04ODM_ac00428a-ab6d-4dce-a025-d71319fae5aa"
      unitRef="usd">194811000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi0xLTEtMS0w_2fc6389a-d1e7-4760-9cc3-3814e1d349c2"
      unitRef="usd">137934000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNi0zLTEtMS0w_cb3c652e-8e4a-4f57-9816-7c3b8ca706f9"
      unitRef="usd">340176000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNy0xLTEtMS04NjI_450949a8-a600-476b-a3e9-ccf480170310"
      unitRef="usd">15836000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNy0zLTEtMS04NjI_8931942c-eac9-4ae4-a5ea-67fa288080ed"
      unitRef="usd">31314000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNy0xLTEtMS0w_422e6e03-fe8e-4df8-92dc-d7b2d9b6709e"
      unitRef="usd">33159000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfNy0zLTEtMS0w_334f40d6-7e38-4f32-ba53-c970a564ff57"
      unitRef="usd">57982000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfOC0xLTEtMS04ODM_e84d6303-d96d-4d36-abeb-cfee59fe4dbe"
      unitRef="usd">51650000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfOC0zLTEtMS04ODM_2eff6375-1242-4cf3-bd95-1f54ef066f83"
      unitRef="usd">163497000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfOC0xLTEtMS0w_e93ef35c-00ea-4bab-b2c3-5a2490f5ce47"
      unitRef="usd">104775000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yNS9mcmFnOjNhNGE1MjZjNjJiYzQ4ODNhZjRlNWIxMDdjY2Q5ZWY4L3RhYmxlOjVjNjM1Y2FkOGQ4MjQ5OWM4OTI0MjE0ZmZjZGRlZTRhL3RhYmxlcmFuZ2U6NWM2MzVjYWQ4ZDgyNDk5Yzg5MjQyMTRmZmNkZGVlNGFfOC0zLTEtMS0w_8829c734-76a3-42b6-bebf-9bec2977369e"
      unitRef="usd">282194000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesIssued
      contextRef="ifdefa3d6cdb34858b7e182fc46afa080_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNC0xLTEtMS0w_1fc0f834-f557-40e9-a312-e3a2e1167636"
      unitRef="shares">134850000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifdefa3d6cdb34858b7e182fc46afa080_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNC0zLTEtMS0w_57917cd7-e535-4931-a1fe-6be123755fa0"
      unitRef="usd">135000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i45d9d93694034373837c3f573d2d7ecb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNC01LTEtMS0w_577820da-6327-44dd-abc6-ae74bbb03caa"
      unitRef="usd">509128000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if5bfd431ead745a5a4f73a79e9a90180_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNC03LTEtMS0w_7ab97d76-81c6-4558-a812-5df8aa74320d"
      unitRef="usd">553244000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5e6a554b8f8b45e8990535f027a788ff_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNC05LTEtMS0w_5c4b65cc-7378-4f2e-aff4-6b702e07ce33"
      unitRef="usd">-2027000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if240d4208ad5471cb7b4b597c1a3ca8f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNC0xMS0xLTEtMA_15295ecd-734e-4bca-a4fe-5a593759084b"
      unitRef="usd">1060480000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2806b7f400f4487e923e629b54913b07_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNC0xMy0xLTEtMA_78cbe167-3b34-4ac9-b5c5-b7cc20fc4a44"
      unitRef="usd">192493000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNC0xNS0xLTEtMA_6a8ab140-ebc0-4800-8e75-84891d30089e"
      unitRef="usd">1252973000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i99b36c5b771943a6b90df106ee6a8bdb_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNS03LTEtMS0w_63981dfa-316d-4d5b-bb5a-f80cf61536fd"
      unitRef="usd">110546000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iae8baa77c8704ff2859751da1e6a993f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNS0xMS0xLTEtMA_bf25313d-501c-4200-9482-86ed4bf07bd2"
      unitRef="usd">110546000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNS0xNS0xLTEtMA_9864f513-53aa-463f-89e9-f6fbbaabe90d"
      unitRef="usd">110546000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
      contextRef="i73ab481852c04d249b8c95efbb1484d3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNi0xMy0xLTEtMA_9f10b20b-0807-4be3-a57e-18545a3cb690"
      unitRef="usd">17042000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
      contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNi0xNS0xLTEtMA_7b4d7604-0b4d-4b0e-bfad-39e8a1aaa0cd"
      unitRef="usd">17042000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="i3a7594d5c1e845f08d5c0cfb7e2dd9be_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNy0xLTEtMS0w_36359f78-5d1b-4e2e-8c45-448fa48e2f7d"
      unitRef="shares">2000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i3a7594d5c1e845f08d5c0cfb7e2dd9be_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNy0zLTEtMS0w_e40b847c-0ae1-4148-841e-4f82ba3200b0"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i8442ecf8486d42759fe367c2de8b4c85_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNy01LTEtMS0w_4aca02d8-4392-4045-a56c-e3b0569d504d"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfNy0xNS0xLTEtNTE5Mg_c34f2152-b483-43ff-9266-0d3228950adf"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="i3a7594d5c1e845f08d5c0cfb7e2dd9be_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfOC0xLTEtMS0w_8513316b-e1ef-4090-9a49-b35b20b66b0b"
      unitRef="shares">14000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i3a7594d5c1e845f08d5c0cfb7e2dd9be_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfOC0zLTEtMS0w_fe253e61-e6bf-4fc1-a348-97e848b0fc86"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i8442ecf8486d42759fe367c2de8b4c85_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfOC01LTEtMS0w_2f6ce454-10e1-4467-8485-ed898a4fb251"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfOC0xNS0xLTEtNTE5Mg_77442032-0650-4eae-b966-514eb71b86ed"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8442ecf8486d42759fe367c2de8b4c85_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfOS01LTEtMS0w_01b43042-2c2a-44f6-a51c-aff4685df8fd"
      unitRef="usd">6173000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iae8baa77c8704ff2859751da1e6a993f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfOS0xMS0xLTEtMA_925e3ea7-9f5f-4948-a9eb-d96cb280c29f"
      unitRef="usd">6173000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfOS0xNS0xLTEtMA_c087e882-b233-490c-8f97-c35e6aa5f18a"
      unitRef="usd">6173000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i73ab481852c04d249b8c95efbb1484d3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTItMTMtMS0xLTA_61a2396f-fdca-4300-81b0-673e91014f70"
      unitRef="usd">8193000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTItMTUtMS0xLTA_7349425f-49c7-499d-aab5-eb7b89d24214"
      unitRef="usd">8193000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i8442ecf8486d42759fe367c2de8b4c85_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTMtNS0xLTEtMA_ab456684-1356-41ce-a13c-7e1ba0de4bf1"
      unitRef="usd">787000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="iae8baa77c8704ff2859751da1e6a993f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTMtMTEtMS0xLTA_ee5f5a32-a6c6-4512-8c53-234f3447e7cd"
      unitRef="usd">787000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i73ab481852c04d249b8c95efbb1484d3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTMtMTMtMS0xLTA_fe738154-5324-40eb-8fad-fdd46a7d62e0"
      unitRef="usd">13458000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTMtMTUtMS0xLTA_3682eb55-f700-42bb-a202-5770168e1e93"
      unitRef="usd">14245000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i99b36c5b771943a6b90df106ee6a8bdb_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTQtNy0xLTEtMA_f76b124b-4cf6-4b3d-9989-c86b1bb09bc5"
      unitRef="usd">-38405000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="iae8baa77c8704ff2859751da1e6a993f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTQtMTEtMS0xLTA_20789dc6-41a6-4a45-8d32-81c46af82177"
      unitRef="usd">-38405000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTQtMTUtMS0xLTA_21cf2633-82f6-4355-b7c4-911820e027b3"
      unitRef="usd">-38405000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i91c3a6aa3d9d463fb2244dc55d06fda9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTUtOS0xLTEtMA_ce796ab0-a21e-4bf3-b74d-91806f595168"
      unitRef="usd">8151000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iae8baa77c8704ff2859751da1e6a993f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTUtMTEtMS0xLTA_11f3278f-0cc1-4e9c-a9f0-761b6ccfd8d1"
      unitRef="usd">8151000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTUtMTUtMS0xLTA_73c0fa9f-af86-4abb-b02a-453213d86d58"
      unitRef="usd">8151000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityOther
      contextRef="i8442ecf8486d42759fe367c2de8b4c85_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTYtNS0xLTEtMA_545bb45e-0cac-4a38-9864-43de403a636a"
      unitRef="usd">178000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i99b36c5b771943a6b90df106ee6a8bdb_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTYtNy0xLTEtMA_adeaa735-74f8-44cb-af88-ddbff4f8fee4"
      unitRef="usd">4000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="iae8baa77c8704ff2859751da1e6a993f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTYtMTEtMS0xLTA_357223cb-72c8-4ab9-9efc-aaac73979fd1"
      unitRef="usd">182000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i73ab481852c04d249b8c95efbb1484d3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTYtMTMtMS0xLTA_b250aecd-2073-4d18-a859-929de074bba2"
      unitRef="usd">-371000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTYtMTUtMS0xLTA_8a9a6ebf-d16b-4075-91c0-7279f0afadad"
      unitRef="usd">-189000</us-gaap:StockholdersEquityOther>
    <us-gaap:CommonStockSharesIssued
      contextRef="i4eaf841b3bc54e8887fcaab6cc4ba423_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTctMS0xLTEtMA_dfe4e488-c402-4e71-8c12-1fc3b082d403"
      unitRef="shares">134838000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4eaf841b3bc54e8887fcaab6cc4ba423_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTctMy0xLTEtMA_d437dccd-6505-4020-82ab-9b12edf44ced"
      unitRef="usd">135000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73199de2eb734a1aa6d9d339b39814ea_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTctNS0xLTEtMA_83ab60cc-a317-4962-a073-ae20b4226cb0"
      unitRef="usd">514336000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic13effada5f24e1dad9e29d7a8d0c5fb_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTctNy0xLTEtMA_7610f863-7e97-4622-81a2-b7111e97fbd1"
      unitRef="usd">625381000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic1a6dc4d8592426aab6aeb9d0584fc06_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTctOS0xLTEtMA_eb187a99-86e4-4f75-a6a9-5e79ce0297dd"
      unitRef="usd">6124000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if551e4794f2b45c9a16a1f7ed95b3aae_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTctMTEtMS0xLTA_13f501e2-b750-4211-9c94-663242a66a0a"
      unitRef="usd">1145976000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibb9ee276a38c43b39dc4a7f012322150_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTctMTMtMS0xLTA_2737d14f-392c-4b40-b394-f333f406d235"
      unitRef="usd">204641000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia25336bcc81845369b7acc4ef55a0c51_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTctMTUtMS0xLTA_c4fa8e67-7887-46a6-9449-f893f29026b4"
      unitRef="usd">1350617000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i16c67f9004aa4dfc83ced10a10230d97_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTgtNy0xLTEtMA_d6f527a8-aece-48d7-93f7-e62487572908"
      unitRef="usd">164894000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i89986053f5394ec4bd4e69b2d52aa4e5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTgtMTEtMS0xLTA_3562516d-c57f-46f8-82db-d1beb3cb70d7"
      unitRef="usd">164894000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTgtMTUtMS0xLTA_6d6f3ba4-4ae4-4470-b60e-b9067893d3e1"
      unitRef="usd">164894000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
      contextRef="i9fbafc1a282f4ad88e8b769cba297e21_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTktMTMtMS0xLTA_9a03c61e-d971-42a8-914e-41855858566e"
      unitRef="usd">13241000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMTktMTUtMS0xLTA_07812cb4-adde-4223-95c2-6783db891a4a"
      unitRef="usd">13241000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjAtMC0xLTEtOTQ0L3RleHRyZWdpb246ZjUyNjZhYWZjNjE5NDQzN2IyN2MzNDI3NmU1YjZiNGZfMjc0ODc3OTA2OTQ4Nw_54cb17a6-2b67-49e5-83c3-f32b3f2b2659"
      unitRef="usdPerShare">0.125</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStock
      contextRef="i16c67f9004aa4dfc83ced10a10230d97_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjAtNy0xLTEtOTI5_195ffcf2-739d-4cd7-ad5c-3d077776de1c"
      unitRef="usd">16876000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i89986053f5394ec4bd4e69b2d52aa4e5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjAtMTEtMS0xLTc1NjQ_400fa24e-549e-41df-bb2f-84d66e8c749a"
      unitRef="usd">16876000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjAtMTUtMS0xLTUxMjY_ccd4d844-ca0b-4565-9580-bdd430e83efd"
      unitRef="usd">16876000</us-gaap:DividendsCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="i5cbdf661e9ee48f8a93652e5f73c501d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjAtMS0xLTEtMA_9b1286ed-a83e-4b87-a9f1-9045ff360aa5"
      unitRef="shares">211000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i5cbdf661e9ee48f8a93652e5f73c501d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjAtMy0xLTEtMA_19081fc4-6e4b-4581-82dc-6849d9e7a3ef"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="ifbb0e9e9121e4076a912834a8c0a2178_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjAtNS0xLTEtMA_ca9aad44-b9e4-4405-8ab5-168311e334b1"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjAtMTUtMS0xLTA_fb3efa73-8f1c-4208-9851-ba82b35462f8"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="i5cbdf661e9ee48f8a93652e5f73c501d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjEtMS0xLTEtMA_6c2ee68f-99cc-49ee-9110-abe7b7f387a2"
      unitRef="shares">2000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i5cbdf661e9ee48f8a93652e5f73c501d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjEtMy0xLTEtMA_9c17a40e-9b07-48b2-9b89-94100d435d4c"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ifbb0e9e9121e4076a912834a8c0a2178_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjEtNS0xLTEtMA_094acf88-010b-4075-8a65-32525d04dc36"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjEtMTUtMS0xLTA_e27f2b20-f7c0-47b1-a673-a81d2e60b64a"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifbb0e9e9121e4076a912834a8c0a2178_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjItNS0xLTEtMA_b68fb5c9-49c5-4ec1-b6b2-a91c55694f5f"
      unitRef="usd">6564000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i89986053f5394ec4bd4e69b2d52aa4e5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjItMTEtMS0xLTA_14eff136-0941-49ff-9c6a-be7efe5a1f5d"
      unitRef="usd">6564000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjItMTUtMS0xLTA_74260dae-5368-4b89-ad24-53accb575f7f"
      unitRef="usd">6564000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i5cbdf661e9ee48f8a93652e5f73c501d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjMtMS0xLTEtMA_123b4065-f56a-4dad-8d6b-ad1b73b335d0"
      unitRef="shares">42000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i5cbdf661e9ee48f8a93652e5f73c501d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjMtMy0xLTEtMA_fc27cdc7-8fdf-46dc-99f4-305892fd8a26"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ifbb0e9e9121e4076a912834a8c0a2178_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjMtNS0xLTEtMA_b6e1ea49-e236-40fc-bf6e-78ff7f444309"
      unitRef="usd">707000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i16c67f9004aa4dfc83ced10a10230d97_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjMtNy0xLTEtMA_0160d493-6896-4e6e-a238-1635d3d6513d"
      unitRef="usd">903000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i89986053f5394ec4bd4e69b2d52aa4e5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjMtMTEtMS0xLTA_b0eaf59f-1294-4292-8e30-cc79f1e2acb5"
      unitRef="usd">1610000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjMtMTUtMS0xLTA_74f86817-4c9d-42c8-b1d8-136857544653"
      unitRef="usd">1610000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="ifbb0e9e9121e4076a912834a8c0a2178_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjUtNS0xLTEtNTQ0OQ_a1f49c47-d0db-4af2-a4cb-8580c95e21cc"
      unitRef="usd">-1051000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="i89986053f5394ec4bd4e69b2d52aa4e5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjUtMTEtMS0xLTc1NjE_16d742f8-ccb7-4dc6-ad24-4d74f4b35278"
      unitRef="usd">-1051000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="i9fbafc1a282f4ad88e8b769cba297e21_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjQtMTMtMS0xLTA_9baed192-1c07-41ef-bc8e-4f4ce375ffe0"
      unitRef="usd">6739000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjQtMTUtMS0xLTA_0a2fdd8c-05e0-4db6-95fc-20fe597935d7"
      unitRef="usd">5688000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ifbb0e9e9121e4076a912834a8c0a2178_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjUtNS0xLTEtMA_00d2f68a-f3aa-4088-89ef-1eca92c7c17a"
      unitRef="usd">2970000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i89986053f5394ec4bd4e69b2d52aa4e5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjUtMTEtMS0xLTA_7b6dd211-0e6f-4e55-80fc-2a2e8de252ea"
      unitRef="usd">2970000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i9fbafc1a282f4ad88e8b769cba297e21_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjUtMTMtMS0xLTA_144df745-f67b-4956-8003-bc6798f15ba0"
      unitRef="usd">9324000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjUtMTUtMS0xLTA_743f8c60-4c2b-43eb-adb1-54924dc53c02"
      unitRef="usd">12294000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i16c67f9004aa4dfc83ced10a10230d97_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjYtNy0xLTEtMA_6bce18cf-7cce-40f8-b8a3-a2fe8556fc44"
      unitRef="usd">-59370000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i89986053f5394ec4bd4e69b2d52aa4e5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjYtMTEtMS0xLTA_b0277a2c-d012-40dc-ba0f-8a76ca9432fd"
      unitRef="usd">-59370000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjYtMTUtMS0xLTA_b8c4ab59-fc13-4cb7-abdf-7e3631e752e5"
      unitRef="usd">-59370000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i878a9c337abc406cbfa8912be660cfd9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjgtOS0xLTEtMTA2MQ_91fccdba-4d66-4269-a5b3-e96e1ed95995"
      unitRef="usd">-1397000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i89986053f5394ec4bd4e69b2d52aa4e5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjgtMTEtMS0xLTc1Njg_9de42a06-7e9c-44fc-8682-47d9b3ffb358"
      unitRef="usd">-1397000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjgtMTUtMS0xLTU0MDk_ec2de41e-7568-49a3-87e1-f25cf11245be"
      unitRef="usd">-1397000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityOther
      contextRef="ifbb0e9e9121e4076a912834a8c0a2178_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjctNS0xLTEtMA_202967fb-5ce3-4040-ab05-33b1886d66e7"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquityOther
      contextRef="i16c67f9004aa4dfc83ced10a10230d97_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjctNy0xLTEtMA_db5f5847-0608-4b03-ab12-dc5f50848f87"
      unitRef="usd">-65000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i89986053f5394ec4bd4e69b2d52aa4e5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjctMTEtMS0xLTA_d2e058f1-a5a6-44e7-afe2-68b50b93482f"
      unitRef="usd">-65000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i9fbafc1a282f4ad88e8b769cba297e21_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjctMTMtMS0xLTA_c0f61900-e972-4f41-b0a6-58f178324875"
      unitRef="usd">-370000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjctMTUtMS0xLTA_e0692a31-4675-4f34-8aed-58514ae03b2b"
      unitRef="usd">-435000</us-gaap:StockholdersEquityOther>
    <us-gaap:CommonStockSharesIssued
      contextRef="i3d78995f73114fd9a07a5844ce1ebb86_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjgtMS0xLTEtMA_7bbc0a63-1dd6-46df-8430-ab658d540274"
      unitRef="shares">135005000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3d78995f73114fd9a07a5844ce1ebb86_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjgtMy0xLTEtMA_43770855-d77f-43ca-9624-60b21836fecf"
      unitRef="usd">135000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia507842de06c463cab8ad4f320a68bc7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjgtNS0xLTEtMA_d63b6375-be2d-45cc-ab95-87758a1544b9"
      unitRef="usd">516172000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i06ac0cf032dc44e1baa12c616a1ab18f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjgtNy0xLTEtMA_12da5081-163b-40ad-ac41-4161c35fff1c"
      unitRef="usd">713191000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i29a8b026887f4d80b776c2643d660e67_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMzAtOS0xLTEtNTE2NQ_62de3439-8d62-4344-8f93-ccff4861ad7a"
      unitRef="usd">4727000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5c472725691f4294afa81232749b2c38_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjgtMTEtMS0xLTA_606f675e-79e9-4935-a3a1-44d837d8de8d"
      unitRef="usd">1234225000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i748a28affcd7487d875035c464368d05_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjgtMTMtMS0xLTA_10286cae-f8bb-43e5-8f63-9e7f89824421"
      unitRef="usd">215667000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOmIzMzcyMGQ4MDhjOTRlY2Y4NGEzOGY4MjA0NGU5ZDI5L3RhYmxlcmFuZ2U6YjMzNzIwZDgwOGM5NGVjZjg0YTM4ZjgyMDQ0ZTlkMjlfMjgtMTUtMS0xLTA_06415e33-b7c0-40b6-bf14-a8be8b12af95"
      unitRef="usd">1449892000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6c17c8cd7cac4115a14753f94ab8ab6c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNC0xLTEtMS0w_66d67462-0085-4499-8b81-52cd96919277"
      unitRef="shares">134328000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6c17c8cd7cac4115a14753f94ab8ab6c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNC0zLTEtMS0w_89e7dab7-3149-4316-9444-e497f6162886"
      unitRef="usd">134000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i452ed919b2244df887431ff7b2c2d508_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNC01LTEtMS0w_ce41be6f-cb05-493f-93ca-100c4405729c"
      unitRef="usd">491038000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0f1d1941a2d54dd682218923f73f78e5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNC03LTEtMS0w_34a234ac-e420-4831-b959-d24430c8cfa8"
      unitRef="usd">279800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3996149e08774457b7cf81521fc7a46f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNC05LTEtMS0w_702c5520-306f-4abc-a31f-03b216a54a70"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6e001ee24b8d4e398bb154b6b74d75a6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNC0xMS0xLTEtMA_35d6b1f5-954d-445e-9781-f0ab10464579"
      unitRef="usd">770972000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i80fc7da8ac2f44c1a89ba81702a6efef_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNC0xMy0xLTEtMA_c3a94acd-df1f-42f4-915e-d50d5aa53989"
      unitRef="usd">158063000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3fcf10033def4edc8873b5e817d0b994_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNC0xNS0xLTEtMA_0197b41b-157b-4950-879a-635d251d5114"
      unitRef="usd">929035000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i98dbdae0901944a8bb7a4850bf5db8e1_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNS03LTEtMS0w_69bfa152-80e8-4f8d-8abd-0c437b532922"
      unitRef="usd">53125000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic4d382e1e08d4eb1ba65b7ff2dc29af0_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNS0xMS0xLTEtMA_73f21d05-ae89-49ee-8e16-d90e0661f597"
      unitRef="usd">53125000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNS0xNS0xLTEtMA_48eb8921-a7a0-4bc4-ab8b-955f8cea0d45"
      unitRef="usd">53125000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
      contextRef="ibc6557fef505437581efa07d7b365cb0_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNi0xMy0xLTEtMA_b979f4f3-12c1-410f-9460-78f3d890fe0f"
      unitRef="usd">10067000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
      contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNi0xNS0xLTEtMA_9caa9470-88b5-4466-90a4-a649583b0a00"
      unitRef="usd">10067000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="i0f9c8016c7f342c79de1144a230d1612_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNy0xLTEtMS0w_fe621cbf-9ba0-4737-aca8-ad29b19a65c5"
      unitRef="shares">2000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i0f9c8016c7f342c79de1144a230d1612_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNy0zLTEtMS0w_e77ab3d4-db5b-4e54-ada1-2d264728beda"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i757df6705cb74d08b9e53d576ac2c1f7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNy01LTEtMS0w_ab87182e-f235-438d-92d7-a48dc20ecb38"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfNy0xNS0xLTEtMA_73022523-eed7-475d-990e-5a1ada07fa79"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="i0f9c8016c7f342c79de1144a230d1612_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfOC0xLTEtMS0w_d8d536a8-99bf-49a9-99e5-726c9f10a039"
      unitRef="shares">15000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i0f9c8016c7f342c79de1144a230d1612_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfOC0zLTEtMS0w_53375d6b-7aa9-4e63-b644-f9b0521c625d"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i757df6705cb74d08b9e53d576ac2c1f7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfOC01LTEtMS0w_86dba23b-ca92-4ee0-9d15-0bc82c678940"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfOC0xNS0xLTEtMA_ff46cc4a-5295-4c51-827b-1347b0813498"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i757df6705cb74d08b9e53d576ac2c1f7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfOS01LTEtMS0w_e9d198cc-8cf2-4209-bea4-98f86a75786c"
      unitRef="usd">6136000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic4d382e1e08d4eb1ba65b7ff2dc29af0_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfOS0xMS0xLTEtMA_fc53e458-fcb4-4f15-b881-03b5c82e288d"
      unitRef="usd">6136000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfOS0xNS0xLTEtMA_07ff4b49-4119-48fc-88db-4eb709a03075"
      unitRef="usd">6136000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i0f9c8016c7f342c79de1144a230d1612_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTAtMS0xLTEtMA_80360559-117b-4c87-b53c-be3e13e7024d"
      unitRef="shares">492000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i0f9c8016c7f342c79de1144a230d1612_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTAtMy0xLTEtMA_2efd8a4f-c082-4b30-a9e5-3153284429eb"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i757df6705cb74d08b9e53d576ac2c1f7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTAtNS0xLTEtMA_bef1f9a6-3c09-454c-847e-75d7aba94004"
      unitRef="usd">5350000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i98dbdae0901944a8bb7a4850bf5db8e1_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTAtNy0xLTEtMA_74704757-554b-4fcf-ac22-934c177b832e"
      unitRef="usd">3341000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ic4d382e1e08d4eb1ba65b7ff2dc29af0_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTAtMTEtMS0xLTA_e5ef7971-63d4-4c11-b563-933584fc4bbd"
      unitRef="usd">8691000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTAtMTUtMS0xLTA_1f6aeff7-a686-45f9-b5cb-d300b0ac1233"
      unitRef="usd">8691000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="ibc6557fef505437581efa07d7b365cb0_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTEtMTMtMS0xLTA_9dd0fb00-d685-4882-9840-6d6e7271509d"
      unitRef="usd">1679000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTEtMTUtMS0xLTA_19cc7e7f-b67a-4d97-965d-aa4677236f53"
      unitRef="usd">1679000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i98dbdae0901944a8bb7a4850bf5db8e1_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTItNy0xLTEtMA_08e4a2d3-8869-4c35-96ef-657c07693cc9"
      unitRef="usd">2726000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ic4d382e1e08d4eb1ba65b7ff2dc29af0_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTItMTEtMS0xLTA_d0342d53-f533-47bc-a0a8-700b905d927a"
      unitRef="usd">2726000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ibc6557fef505437581efa07d7b365cb0_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTItMTMtMS0xLTA_bfdaf31a-410a-4244-b4fc-a9d96ef57753"
      unitRef="usd">4048000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTItMTUtMS0xLTA_c4db6783-b7a1-41ee-9216-0b85a52b12c4"
      unitRef="usd">6774000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i98dbdae0901944a8bb7a4850bf5db8e1_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTMtNy0xLTEtMA_ae62e29f-1a2c-4876-9453-f77e5c4904a6"
      unitRef="usd">-10123000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="ic4d382e1e08d4eb1ba65b7ff2dc29af0_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTMtMTEtMS0xLTA_b0ab224d-d5c2-401f-8d38-b282079f81ae"
      unitRef="usd">-10123000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTMtMTUtMS0xLTA_c990771f-e83a-404b-9872-910a603e91b7"
      unitRef="usd">-10123000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:StockholdersEquityOther
      contextRef="i98dbdae0901944a8bb7a4850bf5db8e1_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTQtNy0xLTEtMA_af910dde-d4f7-42c0-b651-d5aecb1bea60"
      unitRef="usd">55000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ic4d382e1e08d4eb1ba65b7ff2dc29af0_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTQtMTEtMS0xLTA_bb7bac23-0816-4fb5-a152-06dd6ebfc4b7"
      unitRef="usd">55000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ibc6557fef505437581efa07d7b365cb0_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTQtMTMtMS0xLTA_3e066c7d-5eb5-42ea-b88f-048f315e72b3"
      unitRef="usd">-420000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTQtMTUtMS0xLTA_0268b5ea-737a-4347-8d40-b8419a1a3476"
      unitRef="usd">-365000</us-gaap:StockholdersEquityOther>
    <us-gaap:CommonStockSharesIssued
      contextRef="i07ef9561e63c46ecbfdf268105880ec9_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTUtMS0xLTEtMA_17d6806c-8dd5-4ad0-8fc5-48d903b2e9a2"
      unitRef="shares">133823000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i07ef9561e63c46ecbfdf268105880ec9_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTUtMy0xLTEtMA_fd3f7922-3f31-4db0-b969-b173876f01e7"
      unitRef="usd">134000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5ab6f6ed4c5c40c785bf0ec5a56f7a7f_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTUtNS0xLTEtMA_0fa07383-8312-4cd1-beec-10d3990e0a5d"
      unitRef="usd">491824000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8979c36c27b948e7a75318aa470eb1c5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTUtNy0xLTEtMA_b66279a2-7559-47e2-94f1-175c247e2cec"
      unitRef="usd">316680000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4b4a592cf00044548cc38f91879e81fa_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTUtOS0xLTEtMA_5a69696b-608d-4e09-a691-cd6e86839b3c"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7e12f979c9064796bbcd7735451cbf07_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTUtMTEtMS0xLTA_e1dc52ea-9a6b-4a82-a2ea-ebbf91ec60bb"
      unitRef="usd">808638000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i228ce0ec788848459a6778243cdfe2f9_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTUtMTMtMS0xLTA_2bdccd42-0558-4234-8254-2dc01f83558f"
      unitRef="usd">166181000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idfaaf0f42d9042e7b77d153a10a8eeb5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTUtMTUtMS0xLTA_cdf591dd-5f1a-42e5-a36e-967600199a45"
      unitRef="usd">974819000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="if41275a882144f35838503cdd9e3b9d8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTYtNy0xLTEtMA_48efd554-ea94-430b-86dc-2762408058ec"
      unitRef="usd">51650000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i072109b8da604643af13c0729800e1df_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTYtMTEtMS0xLTA_764a7ffa-b1b6-46bd-9f2c-18b5b095ad22"
      unitRef="usd">51650000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTYtMTUtMS0xLTA_72a16338-1707-47a2-ba71-5a64a2d74d54"
      unitRef="usd">51650000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
      contextRef="ie6fcb443a0464cef95544365b85db50b_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTctMTMtMS0xLTA_2c30f6c1-1a2e-4120-acd8-a92ffea3ec8f"
      unitRef="usd">12572000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTctMTUtMS0xLTA_2ffa6099-673b-4b18-976d-7eda442cc478"
      unitRef="usd">12572000</us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="i55f4763f21f4479ba3089c7486346215_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTgtMS0xLTEtMA_77914127-b6e1-43b0-ab1e-99f3e7a151d7"
      unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i55f4763f21f4479ba3089c7486346215_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTgtMy0xLTEtMA_3a5f502c-4689-4310-81be-b7b0395632ba"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i150a45bd54dd4d4fa4ee7374f6bc72d3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTgtNS0xLTEtMA_200cd2f0-ef8d-4737-9120-9edf48052d34"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTgtMTUtMS0xLTA_ae0cb0b5-d77a-405a-bb0e-819b7bb3e1f9"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="i55f4763f21f4479ba3089c7486346215_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTktMS0xLTEtMA_48e7812a-b18d-46af-ab89-ccb30d41c904"
      unitRef="shares">7000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i55f4763f21f4479ba3089c7486346215_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTktMy0xLTEtMA_b2d4129e-9e18-4c8e-b016-304d739c9c1b"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i150a45bd54dd4d4fa4ee7374f6bc72d3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTktNS0xLTEtMA_1a3b53cc-6705-4bfd-955f-e87929ce843e"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMTktMTUtMS0xLTA_1f2168f2-b0d1-4a58-9f5c-64042aaa939c"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i150a45bd54dd4d4fa4ee7374f6bc72d3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjAtNS0xLTEtMA_c2c6d202-1551-486f-9eef-e533c806e8b1"
      unitRef="usd">6262000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i072109b8da604643af13c0729800e1df_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjAtMTEtMS0xLTA_5d073b2e-6f78-4ec6-b146-b2248d6b17f4"
      unitRef="usd">6262000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjAtMTUtMS0xLTA_1fa04255-3c30-4fc1-b561-77f941e3f9e4"
      unitRef="usd">6262000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i55f4763f21f4479ba3089c7486346215_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjEtMS0xLTEtMA_f9bec19f-d33c-4b5e-a8fa-a9a8c720ab5b"
      unitRef="shares">46000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i55f4763f21f4479ba3089c7486346215_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjEtMy0xLTEtMA_c31c79ae-fb2d-430e-a5e7-cd66f4a4a6c5"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i150a45bd54dd4d4fa4ee7374f6bc72d3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjEtNS0xLTEtMA_0295ec95-15c1-422d-badc-32134eeb5171"
      unitRef="usd">441000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="if41275a882144f35838503cdd9e3b9d8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjEtNy0xLTEtMA_66d90ef0-067f-4fef-a280-5537fecbadc8"
      unitRef="usd">283000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i072109b8da604643af13c0729800e1df_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjEtMTEtMS0xLTA_5d3c4902-e6d3-400a-980f-5a7283454dff"
      unitRef="usd">724000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjEtMTUtMS0xLTA_f03ac2a6-e392-45dd-a210-1eb138a129c6"
      unitRef="usd">724000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="i150a45bd54dd4d4fa4ee7374f6bc72d3_D20200401-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjMtNS0xLTEtMA_1ad6c666-9d05-423a-af7e-9bbb1327bc89"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="i072109b8da604643af13c0729800e1df_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjMtMTEtMS0xLTA_0723d702-9576-46f7-9ec4-fae76dfe5993"
      unitRef="usd">0</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="ie6fcb443a0464cef95544365b85db50b_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjMtMTMtMS0xLTA_55960f22-bfb0-4aa4-bce5-fe9e22956583"
      unitRef="usd">7000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjMtMTUtMS0xLTA_0fa3935f-f0f5-4bc0-82ee-bf4f31ca5ec9"
      unitRef="usd">7000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i150a45bd54dd4d4fa4ee7374f6bc72d3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjQtNS0xLTEtMA_3549db3b-e537-4143-b4c3-036d9257e38b"
      unitRef="usd">65000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i072109b8da604643af13c0729800e1df_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjQtMTEtMS0xLTA_ac7fcf4a-f41e-4469-a68b-369596bad99e"
      unitRef="usd">65000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ie6fcb443a0464cef95544365b85db50b_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjQtMTMtMS0xLTA_bd09e230-a1d6-4c3a-9bb5-8516ee0ace00"
      unitRef="usd">418000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjQtMTUtMS0xLTA_21753c58-c684-40a8-89a3-8bda785d2cd7"
      unitRef="usd">483000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="if41275a882144f35838503cdd9e3b9d8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjUtNy0xLTEtMA_19a2de3c-e7b6-4730-8644-619ea8129e13"
      unitRef="usd">127916000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i072109b8da604643af13c0729800e1df_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjUtMTEtMS0xLTA_e9e4c0ac-2fb4-4469-8a46-3cae3b42b081"
      unitRef="usd">127916000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjUtMTUtMS0xLTA_b1b6e042-82b8-4d20-85f6-22c897ca3228"
      unitRef="usd">127916000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:StockholdersEquityOther
      contextRef="i150a45bd54dd4d4fa4ee7374f6bc72d3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjYtNS0xLTEtMA_3d76140d-f77b-4775-9aed-da81d3d1cc20"
      unitRef="usd">795000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="if41275a882144f35838503cdd9e3b9d8_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjYtNy0xLTEtMA_98da3d36-46e5-4e81-a92f-973496f4b211"
      unitRef="usd">-1000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i072109b8da604643af13c0729800e1df_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjYtMTEtMS0xLTA_ab5ffc7e-8b78-49b9-a35a-3c7b85c5ddb5"
      unitRef="usd">794000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ie6fcb443a0464cef95544365b85db50b_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjYtMTMtMS0xLTA_849919e3-76e4-429d-a05e-7eb15a024aad"
      unitRef="usd">-1205000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjYtMTUtMS0xLTA_557e10c3-986e-4d0c-80b5-efd49e67235c"
      unitRef="usd">-411000</us-gaap:StockholdersEquityOther>
    <us-gaap:CommonStockSharesIssued
      contextRef="i8ca9e03469c34d19aa6464835674249e_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjctMS0xLTEtMA_23eca9e8-770c-43e9-994e-210cbf548dbb"
      unitRef="shares">133970000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8ca9e03469c34d19aa6464835674249e_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjctMy0xLTEtMA_25edb57a-9070-409e-8db8-23afaf942ba5"
      unitRef="usd">134000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia2386c06e6394e9192e485e15d848c39_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjctNS0xLTEtMA_6e72349b-184c-48d4-8a05-eb0c19c4f026"
      unitRef="usd">496785000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i966afdef72fe4d53ac2ff6217e8e9793_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjctNy0xLTEtMA_42f78a9d-54aa-43cf-98bf-b441cd39918d"
      unitRef="usd">495964000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id3c7dc108fdc4209adb112435c46e453_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjctOS0xLTEtNTE5NA_6ffdb529-8ffb-4c99-b9ec-cf9bc7928253"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic33ba2829aad4672a382563462592dcf_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjctMTEtMS0xLTA_27c26280-b24d-457c-b84c-832d62d1b88f"
      unitRef="usd">992883000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i139e861ba4e7472982269ee17ca2c68b_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjctMTMtMS0xLTA_dcaca6a0-eaab-45a4-941a-9c7d58f9abbf"
      unitRef="usd">179547000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2126fcb95b794e1d9f9873202b50af46_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8yOC9mcmFnOmMwNGU3ODIwZGZjYTRkNGY4YTQ0YjNmZTM0ODlhODhhL3RhYmxlOjc5Yjg2YmU5NzhkYzRiZTk4MTg2ZWNiNWJlYjg4YWYyL3RhYmxlcmFuZ2U6NzliODZiZTk3OGRjNGJlOTgxODZlY2I1YmViODhhZjJfMjctMTUtMS0xLTA_00def69b-271d-457f-878a-3db7ebee6d30"
      unitRef="usd">1172430000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMy0xLTEtMS0w_5ca0d6f5-3e6a-4087-b027-8a9aaad0b091"
      unitRef="usd">137934000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMy0zLTEtMS0w_7725064e-45de-42a7-91fb-584354ab8933"
      unitRef="usd">333422000</us-gaap:ProfitLoss>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNS0xLTEtMS0w_9eeabab6-a522-4f58-80ee-9ab220a03129"
      unitRef="usd">11223000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNS0zLTEtMS0w_827fd25b-2a0c-4aaa-8eb6-f02dc5158bbb"
      unitRef="usd">19384000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:DepreciationAndAmortization
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNi0xLTEtMS0w_b3e9151e-51a3-4a8a-a5a4-dbf6f2a4e25d"
      unitRef="usd">104023000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNi0zLTEtMS0w_9cc4097f-1b45-4be9-908f-e2aa11aa2180"
      unitRef="usd">100574000</us-gaap:DepreciationAndAmortization>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNy0xLTEtMS0w_5f1c81be-0d13-4d78-9d0a-5523fd4e49db"
      unitRef="usd">253000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNy0zLTEtMS0w_8ca77750-5de5-4d97-a8eb-2b4f73252e1e"
      unitRef="usd">212000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfOC0xLTEtMS0w_88d4efcc-9bf2-47ef-9b80-3f369c1ac419"
      unitRef="usd">10912000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfOC0zLTEtMS0w_a4c8554f-70ef-4c6a-a280-dc05eb6b80f7"
      unitRef="usd">21728000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTAtMS0xLTEtMA_47fd2d54-f77e-4c63-aeeb-ee2eff319a0d"
      unitRef="usd">7881000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTAtMy0xLTEtMA_155a39db-de03-4f1d-bd1d-b7e4a37f4de3"
      unitRef="usd">-494000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:ShareBasedCompensation
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTEtMS0xLTEtMA_297ae879-a497-4973-9274-1e0a402133e3"
      unitRef="usd">13866000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTEtMy0xLTEtMA_4cf50f6c-8261-49cc-a13b-09a587b70fa8"
      unitRef="usd">13808000</us-gaap:ShareBasedCompensation>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTItMS0xLTEtMA_4e57b306-075b-4987-aa90-9ee90d61b76e"
      unitRef="usd">1093000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTItMy0xLTEtMA_0d3a872c-6aaf-4288-976e-8e8aca7e97ef"
      unitRef="usd">1095000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTMtMS0xLTEtMA_ee452e6d-ea6c-4c26-81dc-e0eedeaa21a7"
      unitRef="usd">-3416000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTMtMy0xLTEtMA_1aa17f9e-6ce2-455d-9e9f-c61e1ed83274"
      unitRef="usd">-8323000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTUtMS0xLTEtMA_c66153d4-f0a7-45d5-9a4b-52d22f835b5b"
      unitRef="usd">-13179000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTUtMy0xLTEtMA_7de9544b-f519-45b2-ab8f-23a5e247954d"
      unitRef="usd">31751000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTYtMS0xLTEtMA_87f995ce-afc5-4713-98f9-ba537c4d737d"
      unitRef="usd">-713000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTYtMy0xLTEtMA_30c9f474-ddd7-4373-bad6-887f8d97fc2e"
      unitRef="usd">12856000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTctMS0xLTEtMA_1e442230-60e7-4cb3-b898-4389d4b42035"
      unitRef="usd">-11504000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTctMy0xLTEtMA_7d9cc051-0334-4ff5-90a6-4be6f441d8e9"
      unitRef="usd">11984000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTgtMS0xLTEtMA_f35691c9-b0cc-4268-9b15-a5a74edd0974"
      unitRef="usd">4251000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTgtMy0xLTEtMA_7f501873-22fe-4819-b0c0-10b73160daeb"
      unitRef="usd">18881000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTktMS0xLTEtMA_f0688cb7-a1ed-4900-96fe-7361a1e6a5f0"
      unitRef="usd">4028000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMTktMy0xLTEtMA_72110424-129b-43bf-b763-35b217500e7c"
      unitRef="usd">71034000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <sem:ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjAtMS0xLTEtMA_df6d1391-0591-480c-83c5-1f3930161984"
      unitRef="usd">316992000</sem:ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct>
    <sem:ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjAtMy0xLTEtMA_d25f2d68-768c-4536-8785-cd0ae2b258f9"
      unitRef="usd">-73703000</sem:ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct>
    <sem:IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjEtMS0xLTEtMA_de73483e-b44e-4023-b3ed-eb55b3f64da4"
      unitRef="usd">45505000</sem:IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct>
    <sem:IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjEtMy0xLTEtMA_9dbcfed8-fba7-4498-828c-217c84af978b"
      unitRef="usd">-78509000</sem:IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct>
    <us-gaap:IncreaseDecreaseInIncomeTaxes
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjMtMS0xLTEtMA_1615c9e4-57ab-4bb2-b46e-b5b7bf645c2a"
      unitRef="usd">43743000</us-gaap:IncreaseDecreaseInIncomeTaxes>
    <us-gaap:IncreaseDecreaseInIncomeTaxes
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjMtMy0xLTEtMA_bd9a7116-16df-4ed9-8966-d05b746a6909"
      unitRef="usd">42976000</us-gaap:IncreaseDecreaseInIncomeTaxes>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjQtMS0xLTEtMA_4bea3c0a-ff8a-47dd-bae1-faec12e61ea2"
      unitRef="usd">686098000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjQtMy0xLTEtMA_26350be0-64e3-43b0-a2e4-1b871db08ffd"
      unitRef="usd">363026000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjYtMS0xLTEtMA_a613c4f8-6d8b-45f0-9f35-52e9c1562552"
      unitRef="usd">6961000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjYtMy0xLTEtMA_1436d724-7c7d-4dff-8032-f4c01f5c5508"
      unitRef="usd">10081000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjctMS0xLTEtMA_e45aec73-77c1-46a4-b653-d47cf282b492"
      unitRef="usd">71253000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjctMy0xLTEtMA_2e701706-4d83-480c-9965-b4161c86dfc7"
      unitRef="usd">76442000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjgtMS0xLTEtMA_a7255fa4-109c-4e75-b404-8f4e9d5298c8"
      unitRef="usd">14749000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjgtMy0xLTEtMA_26653562-d7f6-49f6-a044-82e67d8757e3"
      unitRef="usd">11185000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjktMS0xLTEtMA_bea19d7e-b1f0-4d30-b702-ab4a9c705140"
      unitRef="usd">12401000</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMjktMy0xLTEtMA_2ea8a3c1-a87c-49b1-8086-060187dbbb1a"
      unitRef="usd">9463000</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMzAtMS0xLTEtMA_fe6303b5-324f-44fb-803b-18cf4edb9cf6"
      unitRef="usd">-80562000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMzAtMy0xLTEtMA_a40ff8cd-e32d-453f-8e0e-2cc4f27b4553"
      unitRef="usd">-88245000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMzItMS0xLTEtMA_533a9912-aab6-44f3-88fb-1319ba578193"
      unitRef="usd">470000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMzItMy0xLTEtMA_801e72fd-9cd0-47dc-b8cc-a029462c5fa3"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMzMtMS0xLTEtMA_37f0acd9-1e77-4e7a-80a5-47a60d17cf8e"
      unitRef="usd">470000000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMzMtMy0xLTEtMA_509278e9-5b0d-4774-95ff-1d078d263c61"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMzUtMS0xLTEtMA_541c178c-4ab6-4eb4-888b-735313f094b9"
      unitRef="usd">39843000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMzUtMy0xLTEtMA_38b22bff-2413-4626-9d59-871486fd59ac"
      unitRef="usd">0</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:ProceedsFromOtherDebt
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMzktMS0xLTEtMA_2c6adbb4-abfb-4af5-bd5f-d68f7d55902c"
      unitRef="usd">31487000</us-gaap:ProceedsFromOtherDebt>
    <us-gaap:ProceedsFromOtherDebt
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfMzktMy0xLTEtMA_241c823f-e43d-4ba0-9b7c-72b00f9692ed"
      unitRef="usd">8915000</us-gaap:ProceedsFromOtherDebt>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDAtMS0xLTEtMA_1121305a-5819-4cc1-9d06-6ecbc4d027f2"
      unitRef="usd">35733000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDAtMy0xLTEtMA_655f4e53-7e27-4480-840e-a1d5500e95b8"
      unitRef="usd">15314000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDEtMS0xLTEtOTU0_6fc9ec72-5047-435e-a11b-c6ffa649b02a"
      unitRef="usd">0</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDEtMy0xLTEtOTU0_592fba68-3bdf-4db6-b751-8adbbefb53d8"
      unitRef="usd">16876000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsForRepurchaseOfEquity
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDEtMS0xLTEtMA_e93ed33c-2192-49b5-8ca0-667c4788a4e1"
      unitRef="usd">9415000</us-gaap:PaymentsForRepurchaseOfEquity>
    <us-gaap:PaymentsForRepurchaseOfEquity
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDEtMy0xLTEtMA_0a10ddf9-1108-4b91-bfcb-507f3c1169dc"
      unitRef="usd">1610000</us-gaap:PaymentsForRepurchaseOfEquity>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDQtMS0xLTEtMA_292f8240-6ae6-4e64-b817-4eff6887d12c"
      unitRef="usd">1686000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDQtMy0xLTEtMA_f42457d2-6a5c-4c4d-9e4f-079912825031"
      unitRef="usd">5688000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDUtMS0xLTEtMA_7ae698a8-a219-4d56-9231-29bc75f951d5"
      unitRef="usd">13660000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDUtMy0xLTEtMA_c972df5f-6a4a-41c3-97f4-5b17ad47254e"
      unitRef="usd">29152000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDYtMS0xLTEtMA_5c03a286-79fc-4b57-866f-7bf2aa19241f"
      unitRef="usd">366203000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDYtMy0xLTEtMA_fe21dc67-b324-494f-b46c-3eb7d8347a94"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDctMS0xLTEtMA_ca9c7e12-cc06-49f5-a6d7-2ce4fd7cdbf0"
      unitRef="usd">-431681000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDctMy0xLTEtMA_c3594d61-9b3e-40af-a045-f367bfa4347a"
      unitRef="usd">-48349000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDgtMS0xLTEtMA_84a1fa77-1e3d-415c-8536-a07334b60ff3"
      unitRef="usd">173855000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDgtMy0xLTEtMA_9a8e714c-d29a-49d6-aac5-23b757f5f34a"
      unitRef="usd">226432000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3fcf10033def4edc8873b5e817d0b994_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDktMS0xLTEtMA_e3306c2b-7b20-4409-a1ec-1e31ccb0a9c0"
      unitRef="usd">335882000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNDktMy0xLTEtMA_686ace5b-b9c5-4bd1-a833-aed50d8788d2"
      unitRef="usd">577061000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2126fcb95b794e1d9f9873202b50af46_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNTAtMS0xLTEtMA_400fe19b-72cb-42bb-bdbd-6edc32ac9840"
      unitRef="usd">509737000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNTAtMy0xLTEtMA_78c57c3f-e308-4604-910f-6e958b022027"
      unitRef="usd">803493000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNTItMS0xLTEtMA_af3c55f2-f103-4388-ad9a-0ca8c1ca09b0"
      unitRef="usd">86124000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNTItMy0xLTEtMA_c9d94ced-30ae-4ce6-bf66-1006219516b3"
      unitRef="usd">66955000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNTMtMS0xLTEtMA_bea3743a-c384-42e5-ba09-2271d82fdee7"
      unitRef="usd">4920000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zMS9mcmFnOmYyZmQ1ZjdmNmIzODQ3ZThhYjU3ZjIyZDk0NjE3OTU4L3RhYmxlOmQzMWI0ZDJiOTA4NTRmMmNhNWJlYWYzNmU2NzEwMjVlL3RhYmxlcmFuZ2U6ZDMxYjRkMmI5MDg1NGYyY2E1YmVhZjM2ZTY3MTAyNWVfNTMtMy0xLTEtMA_7028ec1c-7ec9-47f0-a1a4-8edb7887c171"
      unitRef="usd">76094000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl8zNy9mcmFnOmU5ZjIzNGY3ZTdmNjRjN2RiY2I4ZDAwMmNmZmM3MzA3L3RleHRyZWdpb246ZTlmMjM0ZjdlN2Y2NGM3ZGJjYjhkMDAyY2ZmYzczMDdfMTgxNA_9b32b194-1494-4ff3-88d2-344e164b7383">Basis of Presentation&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements of Select Medical Holdings Corporation (&#x201c;Holdings&#x201d;) include the accounts of its wholly owned subsidiary, Select Medical Corporation (&#x201c;Select&#x201d;). Holdings conducts substantially all of its business through Select and its subsidiaries. Holdings and Select and its subsidiaries are collectively referred to as the &#x201c;Company.&#x201d; The unaudited condensed consolidated financial statements of the Company as of June&#160;30, 2021, and for the three and six month periods ended June&#160;30, 2020 and 2021, have been prepared pursuant to the rules&#160;and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) for interim reporting and the accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;). Accordingly, certain information and disclosures required by GAAP, which are normally included in the notes to the consolidated financial statements, have been condensed or omitted pursuant to those rules&#160;and regulations, although the Company believes the disclosure is adequate to make the information presented not misleading. In the opinion of management, such information contains all adjustments, which are normal and recurring in nature, necessary for a fair statement of the financial position, results of operations and cash flow for such periods. All significant intercompany transactions and balances have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations for the three and six months ended June&#160;30, 2021, are not necessarily indicative of the results to be expected for the full fiscal year ending December&#160;31, 2021. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December&#160;31, 2020, contained in the Company&#x2019;s Annual Report on Form&#160;10-K filed with the SEC on February 25, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80MC9mcmFnOmU2YzFlYmE4MDAzZDQyZTNiNDY5ZmViYWJjMmVmYjI0L3RleHRyZWdpb246ZTZjMWViYTgwMDNkNDJlM2I0NjlmZWJhYmMyZWZiMjRfMjkz_aafc19af-54b0-47d8-8841-7c5c450797d0">Accounting Policies&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Instruments and Contracts on an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ASU simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#x2019;s own equity. As part of this update, convertible instruments are to be included in diluted earnings per share using the if-converted method, rather than the treasury stock method. Further, contracts which can be settled in cash or shares, excluding liability-classified share-based payment awards, are to be included in diluted earnings per share on an if-converted basis if the effect is dilutive, regardless of whether the entity or the counterparty can choose between cash and share settlement. The share-settlement presumption may not be rebutted based on past experience or a stated policy. This pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2021. The Company plans to adopt this pronouncement as of January 1, 2022. The use of either the modified retrospective or fully retrospective method of transition is permitted.&lt;/span&gt;&lt;/div&gt;Under the terms of the Amended and Restated Limited Liability Company Agreement of Concentra Group Holdings Parent, certain members of Concentra Group Holdings Parent have put rights that obligate the Company to purchase certain of such members&#x2019; equity interests in Concentra Group Holdings Parent when exercised. The Company can elect to pay the purchase price for those equity interests in cash or in shares of Holdings&#x2019; common stock. Under ASU 2020-06, the Company is no longer able to rebut the share-settlement presumption based on its past experience. Accordingly, if any of the put rights provided for under the Amended and Restated Limited Liability Company Agreement of Concentra Group Holdings Parent are outstanding upon adoption of ASU 2020-06, the shares which are potentially issuable will be included in diluted earnings per share, on an if-converted basis. At this time, the Company cannot reasonably estimate the impact that the adoption of ASU 2020-06 will have on its financial statements.</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80MC9mcmFnOmU2YzFlYmE4MDAzZDQyZTNiNDY5ZmViYWJjMmVmYjI0L3RleHRyZWdpb246ZTZjMWViYTgwMDNkNDJlM2I0NjlmZWJhYmMyZWZiMjRfMjk0_191e4c0a-c0ec-4ffa-b2a4-562a6fa53b40">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80MC9mcmFnOmU2YzFlYmE4MDAzZDQyZTNiNDY5ZmViYWJjMmVmYjI0L3RleHRyZWdpb246ZTZjMWViYTgwMDNkNDJlM2I0NjlmZWJhYmMyZWZiMjRfNjU5NzA2OTc2OTEwNA_aea74f1e-6c09-4182-874d-d6373188eb89">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Instruments and Contracts on an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ASU simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#x2019;s own equity. As part of this update, convertible instruments are to be included in diluted earnings per share using the if-converted method, rather than the treasury stock method. Further, contracts which can be settled in cash or shares, excluding liability-classified share-based payment awards, are to be included in diluted earnings per share on an if-converted basis if the effect is dilutive, regardless of whether the entity or the counterparty can choose between cash and share settlement. The share-settlement presumption may not be rebutted based on past experience or a stated policy. This pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2021. The Company plans to adopt this pronouncement as of January 1, 2022. The use of either the modified retrospective or fully retrospective method of transition is permitted.&lt;/span&gt;&lt;/div&gt;Under the terms of the Amended and Restated Limited Liability Company Agreement of Concentra Group Holdings Parent, certain members of Concentra Group Holdings Parent have put rights that obligate the Company to purchase certain of such members&#x2019; equity interests in Concentra Group Holdings Parent when exercised. The Company can elect to pay the purchase price for those equity interests in cash or in shares of Holdings&#x2019; common stock. Under ASU 2020-06, the Company is no longer able to rebut the share-settlement presumption based on its past experience. Accordingly, if any of the put rights provided for under the Amended and Restated Limited Liability Company Agreement of Concentra Group Holdings Parent are outstanding upon adoption of ASU 2020-06, the shares which are potentially issuable will be included in diluted earnings per share, on an if-converted basis. At this time, the Company cannot reasonably estimate the impact that the adoption of ASU 2020-06 will have on its financial statements.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80My9mcmFnOjBiNzg2ZTBlNjgzNjQ0M2I5NDFhOGI0MDVmMDhmMzQxL3RleHRyZWdpb246MGI3ODZlMGU2ODM2NDQzYjk0MWE4YjQwNWYwOGYzNDFfNzk2_a8166d89-6460-444d-8d77-355a3ae7b6dc">Credit Risk ConcentrationsFinancial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash balances and accounts receivable. The Company&#x2019;s excess cash is held with large financial institutions. The Company grants unsecured credit to its patients, most of whom reside in the service area of the Company&#x2019;s facilities and are insured under third-party payor agreements.Because of the diversity in the Company&#x2019;s non-governmental third-party payor base, as well as their geographic dispersion, accounts receivable due from the Medicare program represent the Company&#x2019;s only significant concentration of credit risk.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskDisclosureTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80My9mcmFnOjBiNzg2ZTBlNjgzNjQ0M2I5NDFhOGI0MDVmMDhmMzQxL3RleHRyZWdpb246MGI3ODZlMGU2ODM2NDQzYjk0MWE4YjQwNWYwOGYzNDFfNzk3_f3eb7a88-7cef-4b72-8d77-af3e6f206b82">Credit Risk Concentrations&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash balances and accounts receivable. The Company&#x2019;s excess cash is held with large financial institutions. The Company grants unsecured credit to its patients, most of whom reside in the service area of the Company&#x2019;s facilities and are insured under third-party payor agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because of the diversity in the Company&#x2019;s non-governmental third-party payor base, as well as their geographic dispersion, accounts receivable due from the Medicare program represent the Company&#x2019;s only significant concentration of credit risk. Approximately 18% and 15% of the Company&#x2019;s accounts receivable is due from Medicare at December&#160;31, 2020, and June&#160;30, 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i54986ecc7fc44b8686d9e92cd152643d_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80My9mcmFnOjBiNzg2ZTBlNjgzNjQ0M2I5NDFhOGI0MDVmMDhmMzQxL3RleHRyZWdpb246MGI3ODZlMGU2ODM2NDQzYjk0MWE4YjQwNWYwOGYzNDFfNjg4_96a9387f-5cdc-4dd0-9ad8-59de5b7b6d16"
      unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6cd99a1029914dfba302e3c8d1747dc9_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80My9mcmFnOjBiNzg2ZTBlNjgzNjQ0M2I5NDFhOGI0MDVmMDhmMzQxL3RleHRyZWdpb246MGI3ODZlMGU2ODM2NDQzYjk0MWE4YjQwNWYwOGYzNDFfNjk1_4ce48ccb-663f-42b9-902c-948c780700f9"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RleHRyZWdpb246YmUzYTdmZTlkNTVhNGExZWJmNThjZDMxMGIxMWMxZDRfOTky_78ca6e07-7149-49f0-b6ce-b2ee561c829d">Redeemable Non-Controlling Interests&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ownership interests held by outside parties in subsidiaries, which include limited liability companies and limited partnerships, controlled by the Company are classified as non-controlling interests. Some of the Company&#x2019;s non-controlling ownership interests consist of outside parties that have certain redemption rights that, if exercised, require the Company to purchase the parties&#x2019; ownership interests. These interests are classified and reported as redeemable non-controlling interests and have been adjusted to their approximate redemption values, after the attribution of net income or loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s redeemable non-controlling interests are comprised primarily of the voting membership interests owned by outside members of Concentra Group Holdings Parent, each of which have put rights with respect to their interests in Concentra Group Holdings Parent.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:MinorityInterestDisclosureTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RleHRyZWdpb246YmUzYTdmZTlkNTVhNGExZWJmNThjZDMxMGIxMWMxZDRfOTk1_85d093b8-67ce-472a-a9e3-2533ffaaccc7">Redeemable Non-Controlling Interests&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ownership interests held by outside parties in subsidiaries, which include limited liability companies and limited partnerships, controlled by the Company are classified as non-controlling interests. Some of the Company&#x2019;s non-controlling ownership interests consist of outside parties that have certain redemption rights that, if exercised, require the Company to purchase the parties&#x2019; ownership interests. These interests are classified and reported as redeemable non-controlling interests and have been adjusted to their approximate redemption values, after the attribution of net income or loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s redeemable non-controlling interests are comprised primarily of the voting membership interests owned by outside members of Concentra Group Holdings Parent, each of which have put rights with respect to their interests in Concentra Group Holdings Parent.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in redeemable non-controlling interests were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.735%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;974,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;398,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income attributable to redeemable non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Distributions to and purchases of redeemable non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,687)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(614)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchase of membership interests of Concentra Group Holdings Parent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(366,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Redemption value adjustment on redeemable non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of March 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;620,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;445,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income attributable to redeemable non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Distributions to and purchases of redeemable non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Redemption value adjustment on redeemable non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(127,916)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of June 30&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;495,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;521,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
    <us-gaap:RedeemableNoncontrollingInterestTableTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RleHRyZWdpb246YmUzYTdmZTlkNTVhNGExZWJmNThjZDMxMGIxMWMxZDRfOTk3_a93e8ace-41d7-469d-b9ee-789dad24aed7">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in redeemable non-controlling interests were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.735%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;974,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;398,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income attributable to redeemable non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Distributions to and purchases of redeemable non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,687)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(614)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchase of membership interests of Concentra Group Holdings Parent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(366,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Redemption value adjustment on redeemable non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of March 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;620,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;445,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income attributable to redeemable non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Distributions to and purchases of redeemable non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Redemption value adjustment on redeemable non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(127,916)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of June 30&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;495,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;521,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RedeemableNoncontrollingInterestTableTextBlock>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i3fcf10033def4edc8873b5e817d0b994_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMy0xLTEtMS0w_d19d6ed2-67d9-4814-a05f-b67bd675ca80"
      unitRef="usd">974541000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMy0zLTEtMS0w_dfcab369-7104-490f-a957-3a986ca9aeb0"
      unitRef="usd">398171000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfNC0xLTEtMS0w_e1acc91e-3cc2-4512-90f0-ffd0bafa7aff"
      unitRef="usd">7256000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfNC0zLTEtMS0w_129d40eb-656a-4a12-b32a-8f85eb2934d4"
      unitRef="usd">9626000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <sem:NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests
      contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfNi0xLTEtMS0w_dc4fafdd-1584-477b-b9aa-3d44f61dd24b"
      unitRef="usd">5687000</sem:NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests>
    <sem:NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests
      contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfNi0zLTEtMS0w_117755f2-eabc-422d-b9ef-7b0c1af2a0f9"
      unitRef="usd">614000</sem:NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfNy0xLTEtMS0w_68268e07-70a2-4299-8857-0d2639ba9f50"
      unitRef="usd">366203000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfNy0zLTEtMS0w_7951417f-594e-4e15-9b6c-79f81cad23dd"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfOC0xLTEtMS0w_9b8cd7bb-45c7-4b51-938a-a1574715d707"
      unitRef="usd">-10123000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfOC0zLTEtMS0w_15785f17-b9b2-486c-b1a0-b99e4018b8f6"
      unitRef="usd">-38405000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:TemporaryEquityOtherChanges
      contextRef="i4b899c314e504809b26712d7c02d8cfd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfOS0xLTEtMS0w_58ec3911-3c4d-4cef-9431-9a69b264a0cc"
      unitRef="usd">347000</us-gaap:TemporaryEquityOtherChanges>
    <us-gaap:TemporaryEquityOtherChanges
      contextRef="i590a7fa1d29b414fac45b6f6187b9201_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfOS0zLTEtMS0w_3b13cf56-296c-4509-adf3-c612fe1ff52b"
      unitRef="usd">343000</us-gaap:TemporaryEquityOtherChanges>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="idfaaf0f42d9042e7b77d153a10a8eeb5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTAtMS0xLTEtMA_fe860ae6-fb58-4f1e-b6ad-8033706a44bf"
      unitRef="usd">620377000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ia25336bcc81845369b7acc4ef55a0c51_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTAtMy0xLTEtMA_034a249f-7f73-4e3d-9a9a-707d97c4b275"
      unitRef="usd">445931000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTEtMS0xLTEtMA_d485e242-61a6-4354-99aa-a836623f50bc"
      unitRef="usd">3264000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTEtMy0xLTEtMA_57b621c9-97be-447f-8071-3aba67992c6c"
      unitRef="usd">18073000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <sem:NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTItMS0xLTEtMA_fe0e9eb3-f701-475c-b3f4-db8462e59a11"
      unitRef="usd">30000</sem:NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests>
    <sem:NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTItMy0xLTEtMA_b39fa787-5e89-4bb5-8f1b-43e9d54258bb"
      unitRef="usd">1987000</sem:NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTMtMS0xLTEtMA_9f85cb2b-917c-41bc-91f2-fbdd269e8c12"
      unitRef="usd">127916000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTMtMy0xLTEtMA_5f2467ed-744d-45b1-ba7a-366931818896"
      unitRef="usd">-59370000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:TemporaryEquityOtherChanges
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTQtMS0xLTEtMA_a8272457-fb35-42d0-a26b-fc42b50b770a"
      unitRef="usd">292000</us-gaap:TemporaryEquityOtherChanges>
    <us-gaap:TemporaryEquityOtherChanges
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTQtMy0xLTEtMA_ac4bb106-6a93-417c-ac87-1119d3b4603b"
      unitRef="usd">165000</us-gaap:TemporaryEquityOtherChanges>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i2126fcb95b794e1d9f9873202b50af46_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTUtMS0xLTEtMA_36345e6d-d8ee-4875-86d3-c95ede26724f"
      unitRef="usd">495987000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80Ni9mcmFnOmJlM2E3ZmU5ZDU1YTRhMWViZjU4Y2QzMTBiMTFjMWQ0L3RhYmxlOjE2ODc1OTdmMjZhOTQzOGY4MTI1NDVhYWMyNWM1MWY5L3RhYmxlcmFuZ2U6MTY4NzU5N2YyNmE5NDM4ZjgxMjU0NWFhYzI1YzUxZjlfMTUtMy0xLTEtMA_1aaccec2-3aa8-4084-a960-927bd80f8448"
      unitRef="usd">521552000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:VariableInterestEntityDisclosureTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80OS9mcmFnOjM1M2EzZjE2M2UzMDQ2YjJhYmVmMjY3ZTIwYjFlODY4L3RleHRyZWdpb246MzUzYTNmMTYzZTMwNDZiMmFiZWYyNjdlMjBiMWU4NjhfMTQwOA_73602305-9519-4fee-a712-16d959dd9d0c">Variable Interest Entities&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain states prohibit the &#x201c;corporate practice of medicine,&#x201d; which restricts the Company from owning medical practices which directly employ physicians and from exercising control over medical decisions by physicians. In these states, the Company enters into long-term management agreements with medical practices that are owned by licensed physicians, which, in turn, employ or contract with physicians who provide professional medical services. The management agreements provide for the Company to direct the transfer of ownership of the medical practices to new licensed physicians at any time. Based on the provisions of the management agreements, the medical practices are variable interest entities for which the Company is the primary beneficiary.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020 and June&#160;30, 2021, the total assets of the Company&#x2019;s variable interest entities were $208.4 million and $242.3 million, respectively, and are principally comprised of accounts receivable. As of December 31, 2020 and June&#160;30, 2021, the total liabilities of these variable interest entities were $55.1 million and $58.8 million, respectively, and are principally comprised of accounts payable and accrued expenses. The Company&#x2019;s variable interest entities have obligations payable for services received under the aforementioned management agreements of $151.8 million and $182.1 million as of December 31, 2020 and June&#160;30, 2021, respectively; these intercompany balances are eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <us-gaap:ConsolidationVariableInterestEntityPolicy
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80OS9mcmFnOjM1M2EzZjE2M2UzMDQ2YjJhYmVmMjY3ZTIwYjFlODY4L3RleHRyZWdpb246MzUzYTNmMTYzZTMwNDZiMmFiZWYyNjdlMjBiMWU4NjhfMTQwOQ_905aef61-8548-4c7f-9d8a-7d927f39fa5d">Variable Interest EntitiesCertain states prohibit the &#x201c;corporate practice of medicine,&#x201d; which restricts the Company from owning medical practices which directly employ physicians and from exercising control over medical decisions by physicians. In these states, the Company enters into long-term management agreements with medical practices that are owned by licensed physicians, which, in turn, employ or contract with physicians who provide professional medical services. The management agreements provide for the Company to direct the transfer of ownership of the medical practices to new licensed physicians at any time. Based on the provisions of the management agreements, the medical practices are variable interest entities for which the Company is the primary beneficiary.</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:Assets
      contextRef="i419b57ae7aed4416a0c64ed51064c3f9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80OS9mcmFnOjM1M2EzZjE2M2UzMDQ2YjJhYmVmMjY3ZTIwYjFlODY4L3RleHRyZWdpb246MzUzYTNmMTYzZTMwNDZiMmFiZWYyNjdlMjBiMWU4NjhfODg4_f5d520f1-111d-42e9-817c-94680ecc214d"
      unitRef="usd">208400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i47ca05e15f9b40f489ce514ca61c046e_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80OS9mcmFnOjM1M2EzZjE2M2UzMDQ2YjJhYmVmMjY3ZTIwYjFlODY4L3RleHRyZWdpb246MzUzYTNmMTYzZTMwNDZiMmFiZWYyNjdlMjBiMWU4NjhfODk1_170b5843-95c0-40b9-9142-1e022dd4bc76"
      unitRef="usd">242300000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="i419b57ae7aed4416a0c64ed51064c3f9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80OS9mcmFnOjM1M2EzZjE2M2UzMDQ2YjJhYmVmMjY3ZTIwYjFlODY4L3RleHRyZWdpb246MzUzYTNmMTYzZTMwNDZiMmFiZWYyNjdlMjBiMWU4NjhfMTA2MA_a89957cc-3704-4f06-bc6a-93e5611aac79"
      unitRef="usd">55100000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i47ca05e15f9b40f489ce514ca61c046e_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80OS9mcmFnOjM1M2EzZjE2M2UzMDQ2YjJhYmVmMjY3ZTIwYjFlODY4L3RleHRyZWdpb246MzUzYTNmMTYzZTMwNDZiMmFiZWYyNjdlMjBiMWU4NjhfMTA2Nw_e725950f-e376-438a-ae82-f2661a4601b1"
      unitRef="usd">58800000</us-gaap:Liabilities>
    <us-gaap:DueToAffiliateCurrent
      contextRef="i419b57ae7aed4416a0c64ed51064c3f9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80OS9mcmFnOjM1M2EzZjE2M2UzMDQ2YjJhYmVmMjY3ZTIwYjFlODY4L3RleHRyZWdpb246MzUzYTNmMTYzZTMwNDZiMmFiZWYyNjdlMjBiMWU4NjhfMTI5NQ_ebb2aae5-fe60-482b-88d8-a3f9dc251de0"
      unitRef="usd">151800000</us-gaap:DueToAffiliateCurrent>
    <us-gaap:DueToAffiliateCurrent
      contextRef="i47ca05e15f9b40f489ce514ca61c046e_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl80OS9mcmFnOjM1M2EzZjE2M2UzMDQ2YjJhYmVmMjY3ZTIwYjFlODY4L3RleHRyZWdpb246MzUzYTNmMTYzZTMwNDZiMmFiZWYyNjdlMjBiMWU4NjhfMTMwMg_0181eb96-668d-46d4-8433-59c186b94d6d"
      unitRef="usd">182100000</us-gaap:DueToAffiliateCurrent>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RleHRyZWdpb246YTM1NjBiOGFmMmU0NGY4ZmE3YjBlY2JjY2MyMjJiOTVfNTMy_dd924755-8c2c-443b-974a-0c6887286435">Leases&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating and finance leases for its facilities. The Company leases its corporate office space from related parties. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s total lease cost was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;78,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;80,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;81,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;83,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;142,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;140,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;144,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;158,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;163,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;166,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;140,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;132,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,002,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,032,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,026,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,053,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;214,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;220,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;218,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;224,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;848,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;875,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;869,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;893,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,062,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,095,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,088,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,118,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt and notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term debt, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average remaining lease terms and discount rates were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (in years):&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, maturities of lease liabilities were approximately as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021 (remainder of year)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;143,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;258,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;211,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;172,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;533,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total undiscounted cash flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,457,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;339,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total discounted lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,118,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RleHRyZWdpb246YTM1NjBiOGFmMmU0NGY4ZmE3YjBlY2JjY2MyMjJiOTVfNTMy_f28d70cc-b760-4b31-adaf-f8de94436033">Leases&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating and finance leases for its facilities. The Company leases its corporate office space from related parties. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s total lease cost was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;78,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;80,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;81,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;83,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;142,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;140,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;144,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;158,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;163,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;166,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;140,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;132,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,002,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,032,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,026,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,053,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;214,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;220,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;218,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;224,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;848,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;875,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;869,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;893,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,062,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,095,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,088,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,118,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt and notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term debt, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average remaining lease terms and discount rates were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (in years):&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, maturities of lease liabilities were approximately as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021 (remainder of year)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;143,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;258,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;211,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;172,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;533,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total undiscounted cash flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,457,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;339,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total discounted lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,118,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RleHRyZWdpb246YTM1NjBiOGFmMmU0NGY4ZmE3YjBlY2JjY2MyMjJiOTVfNTM5_37b1d5e3-da1e-451b-8722-53b5aafacc84">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s total lease cost was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,621)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;78,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;80,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;81,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;83,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;142,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;140,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;144,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,176)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;158,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;163,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;166,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average remaining lease terms and discount rates were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (in years):&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <sem:OperatingLeaseCostUnrelatedParties
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfMi0xLTEtMS03MTA_d34c5a0b-ca6b-4115-826b-ca8b96652301"
      unitRef="usd">69367000</sem:OperatingLeaseCostUnrelatedParties>
    <sem:OperatingLeaseCostRelatedParties
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfMi0zLTEtMS03MTA_80ac8eee-2ea8-4755-8abd-8d92917c808d"
      unitRef="usd">1787000</sem:OperatingLeaseCostRelatedParties>
    <us-gaap:OperatingLeaseCost
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfMi01LTEtMS03MTU_a49a500b-2802-4461-ad09-47ab86121d69"
      unitRef="usd">71154000</us-gaap:OperatingLeaseCost>
    <sem:OperatingLeaseCostUnrelatedParties
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfMi03LTEtMS03MTA_c4e67874-321f-4bf9-9feb-6e97375f46e2"
      unitRef="usd">70739000</sem:OperatingLeaseCostUnrelatedParties>
    <sem:OperatingLeaseCostRelatedParties
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfMi05LTEtMS03MTA_a172bc53-d1f3-4dd3-afef-c294ba1a36fa"
      unitRef="usd">1798000</sem:OperatingLeaseCostRelatedParties>
    <us-gaap:OperatingLeaseCost
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfMi0xMS0xLTEtNzE3_f6f6361c-4bb7-4da9-9621-8d2c7c20e460"
      unitRef="usd">72537000</us-gaap:OperatingLeaseCost>
    <sem:FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNC0xLTEtMS03MTA_5c20243c-41d3-4186-bfbe-8bf1da8b2860"
      unitRef="usd">69000</sem:FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties>
    <sem:FinanceLeaseRightOfUseAssetAmortizationRelatedParties
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNC0zLTEtMS03MTA_a5d2e8c4-2895-477a-8afa-f59652ae9f54"
      unitRef="usd">0</sem:FinanceLeaseRightOfUseAssetAmortizationRelatedParties>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNC01LTEtMS03MTU_d58df1fd-ca1b-4312-a3aa-0faad9751f23"
      unitRef="usd">69000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <sem:FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNC03LTEtMS03MTA_90b85a5f-85c1-4bd7-a327-8ae225b3cdbb"
      unitRef="usd">105000</sem:FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties>
    <sem:FinanceLeaseRightOfUseAssetAmortizationRelatedParties
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNC05LTEtMS03MTA_129d5b5e-81f0-476c-b971-a00255261578"
      unitRef="usd">0</sem:FinanceLeaseRightOfUseAssetAmortizationRelatedParties>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNC0xMS0xLTEtNzE3_c336e7ce-cf37-4f2a-8a38-5786531ad8dd"
      unitRef="usd">105000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <sem:FinanceLeaseInterestExpenseUnrelatedParties
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNS0xLTEtMS03MTA_929a7346-734d-47e5-a9ec-b418db02941c"
      unitRef="usd">231000</sem:FinanceLeaseInterestExpenseUnrelatedParties>
    <sem:FinanceLeaseInterestExpenseRelatedParties
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNS0zLTEtMS03MTA_4be44689-4ba1-4d26-a687-b23af1410406"
      unitRef="usd">0</sem:FinanceLeaseInterestExpenseRelatedParties>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNS01LTEtMS03MTU_9d282282-66f8-4799-b825-fcc9bb415cb4"
      unitRef="usd">231000</us-gaap:FinanceLeaseInterestExpense>
    <sem:FinanceLeaseInterestExpenseUnrelatedParties
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNS03LTEtMS03MTA_ced04936-6faf-4ea9-a688-848a960a98af"
      unitRef="usd">254000</sem:FinanceLeaseInterestExpenseUnrelatedParties>
    <sem:FinanceLeaseInterestExpenseRelatedParties
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNS05LTEtMS03MTA_71afc7a7-5557-410d-a15d-72e46b3ef737"
      unitRef="usd">0</sem:FinanceLeaseInterestExpenseRelatedParties>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNS0xMS0xLTEtNzE3_44f5c918-b42d-4444-8009-eb55726df4af"
      unitRef="usd">254000</us-gaap:FinanceLeaseInterestExpense>
    <sem:VariableLeaseCostUnrelatedParties
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNy0xLTEtMS03MTA_a9cc5eba-38f0-4aaf-8db1-5d619b698ffb"
      unitRef="usd">11780000</sem:VariableLeaseCostUnrelatedParties>
    <sem:VariableLeaseCostRelatedParties
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNy0zLTEtMS03MTA_efc426d9-18ab-445d-b9b4-c3ee4e0a8725"
      unitRef="usd">112000</sem:VariableLeaseCostRelatedParties>
    <us-gaap:VariableLeaseCost
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNy01LTEtMS03MTU_ab9a8e8f-77ac-4233-bbc9-2cb09dbdd1cd"
      unitRef="usd">11892000</us-gaap:VariableLeaseCost>
    <sem:VariableLeaseCostUnrelatedParties
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNy03LTEtMS03MTA_5b729ad7-6c5f-4b29-98e1-8627bd66d621"
      unitRef="usd">13086000</sem:VariableLeaseCostUnrelatedParties>
    <sem:VariableLeaseCostRelatedParties
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNy05LTEtMS03MTA_7567a3bc-6b84-4907-8253-b65907e14dfa"
      unitRef="usd">141000</sem:VariableLeaseCostRelatedParties>
    <us-gaap:VariableLeaseCost
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfNy0xMS0xLTEtNzE3_42b92bec-8072-44d5-b9aa-2e04e66a6b4f"
      unitRef="usd">13227000</us-gaap:VariableLeaseCost>
    <sem:SubleaseIncomeUnrelatedParties
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOC0xLTEtMS03MTA_b57c0001-f482-4373-b389-b7faa22e9cab"
      unitRef="usd">2621000</sem:SubleaseIncomeUnrelatedParties>
    <sem:SubleaseIncomeRelatedParties
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOC0zLTEtMS03MTA_a20ff5a2-1a60-4ab5-843d-6258eefa4112"
      unitRef="usd">0</sem:SubleaseIncomeRelatedParties>
    <us-gaap:SubleaseIncome
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOC01LTEtMS03MTU_f9bec3e8-749e-4532-959b-806c99ccd1d2"
      unitRef="usd">2621000</us-gaap:SubleaseIncome>
    <sem:SubleaseIncomeUnrelatedParties
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOC03LTEtMS03MTA_bca2f871-d8f6-4bde-9679-17f5ec3c6ef8"
      unitRef="usd">2229000</sem:SubleaseIncomeUnrelatedParties>
    <sem:SubleaseIncomeRelatedParties
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOC05LTEtMS03MTA_e0aa7949-828c-4c9f-8ef6-acc9f138566d"
      unitRef="usd">0</sem:SubleaseIncomeRelatedParties>
    <us-gaap:SubleaseIncome
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOC0xMS0xLTEtNzE3_c5275c33-1238-42f6-b3bc-7895b4944786"
      unitRef="usd">2229000</us-gaap:SubleaseIncome>
    <sem:LeaseCostUnrelatedParties
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOS0xLTEtMS03MTk_1df3c351-b606-40ba-ad17-75a36c3aea5d"
      unitRef="usd">78826000</sem:LeaseCostUnrelatedParties>
    <sem:LeaseCostRelatedParties
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOS0zLTEtMS03MTk_2e1e839a-ecb4-4aae-a007-becc3a72f967"
      unitRef="usd">1899000</sem:LeaseCostRelatedParties>
    <us-gaap:LeaseCost
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOS01LTEtMS03MTU_27cf4236-15c1-47ac-99ff-191f04b91701"
      unitRef="usd">80725000</us-gaap:LeaseCost>
    <sem:LeaseCostUnrelatedParties
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOS03LTEtMS03MTk_3c56dd78-ccf9-4abb-b445-4bffc5b4b3dc"
      unitRef="usd">81955000</sem:LeaseCostUnrelatedParties>
    <sem:LeaseCostRelatedParties
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOS05LTEtMS03MTk_cbde8809-818b-496d-95a6-6b29de43024b"
      unitRef="usd">1939000</sem:LeaseCostRelatedParties>
    <us-gaap:LeaseCost
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjJjMDJhNDJmYzQ3MTQyYTE4ODQ2ZTc5ZmI0ZmIxNDJiL3RhYmxlcmFuZ2U6MmMwMmE0MmZjNDcxNDJhMTg4NDZlNzlmYjRmYjE0MmJfOS0xMS0xLTEtNzE3_eae9d9e2-126a-4435-a0b2-815f0ba56062"
      unitRef="usd">83894000</us-gaap:LeaseCost>
    <sem:OperatingLeaseCostUnrelatedParties
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMy0xLTEtMS0w_5b67fe35-b55d-4867-ac97-102beec4426b"
      unitRef="usd">139159000</sem:OperatingLeaseCostUnrelatedParties>
    <sem:OperatingLeaseCostRelatedParties
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMy0zLTEtMS0w_b57025a4-5f0b-46be-950b-fd5397685b5c"
      unitRef="usd">3520000</sem:OperatingLeaseCostRelatedParties>
    <us-gaap:OperatingLeaseCost
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMy01LTEtMS0w_d3161de3-d112-4fbe-aeca-99b3a4c48f16"
      unitRef="usd">142679000</us-gaap:OperatingLeaseCost>
    <sem:OperatingLeaseCostUnrelatedParties
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMy03LTEtMS0w_5b2f658d-0e03-46e2-841b-31b16355c3b4"
      unitRef="usd">140853000</sem:OperatingLeaseCostUnrelatedParties>
    <sem:OperatingLeaseCostRelatedParties
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMy05LTEtMS0w_dd4604d7-0ac1-4c07-ba24-b98b450da34f"
      unitRef="usd">3597000</sem:OperatingLeaseCostRelatedParties>
    <us-gaap:OperatingLeaseCost
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMy0xMS0xLTEtMA_06a31924-6205-42c6-8243-1f57297e5712"
      unitRef="usd">144450000</us-gaap:OperatingLeaseCost>
    <sem:FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNS0xLTEtMS0w_541507a1-833d-4a19-873a-89d1ff3a09ad"
      unitRef="usd">131000</sem:FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties>
    <sem:FinanceLeaseRightOfUseAssetAmortizationRelatedParties
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNS0zLTEtMS0w_b92320d9-abe5-4a6d-8bf1-46a5c2388ae5"
      unitRef="usd">0</sem:FinanceLeaseRightOfUseAssetAmortizationRelatedParties>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNS01LTEtMS0w_89450b07-3066-4582-89d6-47cb4dfc6ca2"
      unitRef="usd">131000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <sem:FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNS03LTEtMS0w_30220f98-7e03-4dfc-8aab-6146edf25799"
      unitRef="usd">140000</sem:FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties>
    <sem:FinanceLeaseRightOfUseAssetAmortizationRelatedParties
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNS05LTEtMS0w_a4fa30b2-c186-4dfb-8b72-77e3892b65d1"
      unitRef="usd">0</sem:FinanceLeaseRightOfUseAssetAmortizationRelatedParties>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNS0xMS0xLTEtMA_a611c5eb-9933-4d51-b171-dc4aaf0b0ac5"
      unitRef="usd">140000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <sem:FinanceLeaseInterestExpenseUnrelatedParties
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNi0xLTEtMS0w_9e99b984-c7e9-459f-8c53-5f46ced0f4de"
      unitRef="usd">487000</sem:FinanceLeaseInterestExpenseUnrelatedParties>
    <sem:FinanceLeaseInterestExpenseRelatedParties
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNi0zLTEtMS0w_b7af220c-32ab-4af0-9be5-073a8ee24a36"
      unitRef="usd">0</sem:FinanceLeaseInterestExpenseRelatedParties>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNi01LTEtMS0w_df7759af-930e-4f41-afb7-7549976c5bcf"
      unitRef="usd">487000</us-gaap:FinanceLeaseInterestExpense>
    <sem:FinanceLeaseInterestExpenseUnrelatedParties
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNi03LTEtMS0w_1cfb404c-f095-48f2-a7a3-dc045354bf9a"
      unitRef="usd">505000</sem:FinanceLeaseInterestExpenseUnrelatedParties>
    <sem:FinanceLeaseInterestExpenseRelatedParties
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNi05LTEtMS0w_d2a602fa-b7a3-42e2-ac5e-5ccd7dccd4e7"
      unitRef="usd">0</sem:FinanceLeaseInterestExpenseRelatedParties>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfNi0xMS0xLTEtMA_06ee1424-3eac-4166-bd89-d04b45201fcc"
      unitRef="usd">505000</us-gaap:FinanceLeaseInterestExpense>
    <sem:VariableLeaseCostUnrelatedParties
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOC0xLTEtMS0w_2125e5f0-ba3b-4a8c-9743-fa6aeeeef080"
      unitRef="usd">24012000</sem:VariableLeaseCostUnrelatedParties>
    <sem:VariableLeaseCostRelatedParties
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOC0zLTEtMS0w_a2a18cf4-76c0-4132-8b2f-9d165d45d8b6"
      unitRef="usd">268000</sem:VariableLeaseCostRelatedParties>
    <us-gaap:VariableLeaseCost
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOC01LTEtMS0w_5c461e14-bbc5-462e-a1ee-fb0ad29887a8"
      unitRef="usd">24280000</us-gaap:VariableLeaseCost>
    <sem:VariableLeaseCostUnrelatedParties
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOC03LTEtMS0w_f1866691-224b-4a06-907c-ad904d8d9357"
      unitRef="usd">26095000</sem:VariableLeaseCostUnrelatedParties>
    <sem:VariableLeaseCostRelatedParties
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOC05LTEtMS0w_1770ad8f-84cf-41c9-96a9-aa49619f7b85"
      unitRef="usd">144000</sem:VariableLeaseCostRelatedParties>
    <us-gaap:VariableLeaseCost
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOC0xMS0xLTEtMA_124a688a-7c70-4feb-8703-5202a4cb1b84"
      unitRef="usd">26239000</us-gaap:VariableLeaseCost>
    <sem:SubleaseIncomeUnrelatedParties
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOS0xLTEtMS0w_c4caeffe-0e1b-4445-85f1-6304c6690d6e"
      unitRef="usd">5176000</sem:SubleaseIncomeUnrelatedParties>
    <sem:SubleaseIncomeRelatedParties
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOS0zLTEtMS0w_92f83d05-da73-469b-b734-021ad96b70df"
      unitRef="usd">0</sem:SubleaseIncomeRelatedParties>
    <us-gaap:SubleaseIncome
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOS01LTEtMS0w_119b5974-2549-47d7-a1e0-3a6d8ea806ed"
      unitRef="usd">5176000</us-gaap:SubleaseIncome>
    <sem:SubleaseIncomeUnrelatedParties
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOS03LTEtMS0w_80b6e376-611f-48b9-b059-0d5c3de835ab"
      unitRef="usd">4463000</sem:SubleaseIncomeUnrelatedParties>
    <sem:SubleaseIncomeRelatedParties
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOS05LTEtMS0w_f870efcc-0836-4338-9923-b1fa97f288fb"
      unitRef="usd">0</sem:SubleaseIncomeRelatedParties>
    <us-gaap:SubleaseIncome
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfOS0xMS0xLTEtMA_4e6b4823-557d-4a6d-a0ca-37a18ece692c"
      unitRef="usd">4463000</us-gaap:SubleaseIncome>
    <sem:LeaseCostUnrelatedParties
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMTAtMS0xLTEtMA_1e572497-8119-4d9b-864b-93ec1abfef97"
      unitRef="usd">158613000</sem:LeaseCostUnrelatedParties>
    <sem:LeaseCostRelatedParties
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMTAtMy0xLTEtMA_0760bc98-6d85-4c53-b799-5a8704bcb82a"
      unitRef="usd">3788000</sem:LeaseCostRelatedParties>
    <us-gaap:LeaseCost
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMTAtNS0xLTEtMA_f8adcd19-f7b0-4eb6-b119-bfebec7431b3"
      unitRef="usd">162401000</us-gaap:LeaseCost>
    <sem:LeaseCostUnrelatedParties
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMTAtNy0xLTEtMA_9188ae2f-2f8e-46ad-88db-83e93ef59b69"
      unitRef="usd">163130000</sem:LeaseCostUnrelatedParties>
    <sem:LeaseCostRelatedParties
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMTAtOS0xLTEtMA_8ec3311a-ee4a-4234-8111-470ef0d008ad"
      unitRef="usd">3741000</sem:LeaseCostRelatedParties>
    <us-gaap:LeaseCost
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjM1NjczMGEyMmRhMzQyNDU5MGNhOWNiOThjZGM3MmU2L3RhYmxlcmFuZ2U6MzU2NzMwYTIyZGEzNDI0NTkwY2E5Y2I5OGNkYzcyZTZfMTAtMTEtMS0xLTA_e88dc042-3fc4-4c4d-911e-aee2d5e8ff58"
      unitRef="usd">166871000</us-gaap:LeaseCost>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RleHRyZWdpb246YTM1NjBiOGFmMmU0NGY4ZmE3YjBlY2JjY2MyMjJiOTVfNTI2_f01893d3-1318-491f-80fa-eb21fa85041f">&lt;div style="margin-bottom:9pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;140,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;132,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOmU4NDQzMzM0NmFlNjQyZWRhMGVjNTE1ZjM2OGFiZjE1L3RhYmxlcmFuZ2U6ZTg0NDMzMzQ2YWU2NDJlZGEwZWM1MTVmMzY4YWJmMTVfNC0xLTEtMS0w_e8355191-916c-4a44-860c-b1a53484b406"
      unitRef="usd">140300000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOmU4NDQzMzM0NmFlNjQyZWRhMGVjNTE1ZjM2OGFiZjE1L3RhYmxlcmFuZ2U6ZTg0NDMzMzQ2YWU2NDJlZGEwZWM1MTVmMzY4YWJmMTVfNC0zLTEtMS0w_7c841671-d50f-49cd-a4a4-b66233bb3a52"
      unitRef="usd">145652000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOmU4NDQzMzM0NmFlNjQyZWRhMGVjNTE1ZjM2OGFiZjE1L3RhYmxlcmFuZ2U6ZTg0NDMzMzQ2YWU2NDJlZGEwZWM1MTVmMzY4YWJmMTVfNS0xLTEtMS0w_0db8fa69-0941-48dc-8c89-559277eb0161"
      unitRef="usd">487000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOmU4NDQzMzM0NmFlNjQyZWRhMGVjNTE1ZjM2OGFiZjE1L3RhYmxlcmFuZ2U6ZTg0NDMzMzQ2YWU2NDJlZGEwZWM1MTVmMzY4YWJmMTVfNS0zLTEtMS0w_490dace7-795f-4be4-bc95-a05208c3c1de"
      unitRef="usd">505000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOmU4NDQzMzM0NmFlNjQyZWRhMGVjNTE1ZjM2OGFiZjE1L3RhYmxlcmFuZ2U6ZTg0NDMzMzQ2YWU2NDJlZGEwZWM1MTVmMzY4YWJmMTVfNi0xLTEtMS0w_c2766077-329c-4a04-befc-5fbd41c16bcf"
      unitRef="usd">89000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOmU4NDQzMzM0NmFlNjQyZWRhMGVjNTE1ZjM2OGFiZjE1L3RhYmxlcmFuZ2U6ZTg0NDMzMzQ2YWU2NDJlZGEwZWM1MTVmMzY4YWJmMTVfNi0zLTEtMS0w_9ef2e678-0ac3-480a-8a3b-df6bdf58949d"
      unitRef="usd">145000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOmU4NDQzMzM0NmFlNjQyZWRhMGVjNTE1ZjM2OGFiZjE1L3RhYmxlcmFuZ2U6ZTg0NDMzMzQ2YWU2NDJlZGEwZWM1MTVmMzY4YWJmMTVfOC0xLTEtMS0w_c6b469bf-3c5f-4f37-873f-6f3cd979f4e6"
      unitRef="usd">132125000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOmU4NDQzMzM0NmFlNjQyZWRhMGVjNTE1ZjM2OGFiZjE1L3RhYmxlcmFuZ2U6ZTg0NDMzMzQ2YWU2NDJlZGEwZWM1MTVmMzY4YWJmMTVfOC0zLTEtMS0w_f8c7c589-869c-4d00-9aeb-1f4d9fbe1da0"
      unitRef="usd">138606000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOmU4NDQzMzM0NmFlNjQyZWRhMGVjNTE1ZjM2OGFiZjE1L3RhYmxlcmFuZ2U6ZTg0NDMzMzQ2YWU2NDJlZGEwZWM1MTVmMzY4YWJmMTVfOS0xLTEtMS0w_3c80f5af-3af1-47c4-ac71-9d60e77981de"
      unitRef="usd">989000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOmU4NDQzMzM0NmFlNjQyZWRhMGVjNTE1ZjM2OGFiZjE1L3RhYmxlcmFuZ2U6ZTg0NDMzMzQ2YWU2NDJlZGEwZWM1MTVmMzY4YWJmMTVfOS0zLTEtMS0w_e0f9318f-8abf-4d83-8f7e-27e6add1ca92"
      unitRef="usd">138000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <sem:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RleHRyZWdpb246YTM1NjBiOGFmMmU0NGY4ZmE3YjBlY2JjY2MyMjJiOTVfNTUy_04e8a8e8-27b2-40ed-8c23-3355efbe2999">&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,002,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,032,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,026,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,053,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;214,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;220,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;218,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;224,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;848,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;875,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;869,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;893,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,062,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,095,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,088,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,118,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrelated Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Related Parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt and notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term debt, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</sem:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock>
    <sem:OperatingLeaseRightOfUseAssetUnrelatedParties
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNC0xLTEtMS0w_61d23520-7e0b-4846-84d3-95c5c3f2deaf"
      unitRef="usd">1002151000</sem:OperatingLeaseRightOfUseAssetUnrelatedParties>
    <sem:OperatingLeaseRightOfUseAssetRelatedParties
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNC0zLTEtMS0w_d3b6cdce-cbaa-4442-b7cb-86763da4138d"
      unitRef="usd">30066000</sem:OperatingLeaseRightOfUseAssetRelatedParties>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNC01LTEtMS0w_196cf0dd-054c-4fa5-b11d-206797504dc7"
      unitRef="usd">1032217000</us-gaap:OperatingLeaseRightOfUseAsset>
    <sem:OperatingLeaseRightOfUseAssetUnrelatedParties
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNC03LTEtMS0w_7eb4b22f-7ac4-4e9b-8e92-05df4d73418d"
      unitRef="usd">1026058000</sem:OperatingLeaseRightOfUseAssetUnrelatedParties>
    <sem:OperatingLeaseRightOfUseAssetRelatedParties
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNC05LTEtMS0w_0af237a7-b35e-4106-a2a4-aa31cf48c1b9"
      unitRef="usd">27273000</sem:OperatingLeaseRightOfUseAssetRelatedParties>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNC0xMS0xLTEtMA_f0f7d816-bb56-4183-bf76-68d514fedc2a"
      unitRef="usd">1053331000</us-gaap:OperatingLeaseRightOfUseAsset>
    <sem:OperatingLeaseLiabilityCurrentUnrelatedParties
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNi0xLTEtMS0w_f5e529d7-f785-406d-ac1e-b1a3b9866e54"
      unitRef="usd">214377000</sem:OperatingLeaseLiabilityCurrentUnrelatedParties>
    <sem:OperatingLeaseLiabilityCurrentRelatedParties
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNi0zLTEtMS0w_e1715248-2b8f-48a3-bb2d-2fc7e118d9af"
      unitRef="usd">6036000</sem:OperatingLeaseLiabilityCurrentRelatedParties>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNi01LTEtMS0w_3e237f2f-0997-44f0-827b-7b12877b9a1c"
      unitRef="usd">220413000</us-gaap:OperatingLeaseLiabilityCurrent>
    <sem:OperatingLeaseLiabilityCurrentUnrelatedParties
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNi03LTEtMS0w_2dc52cbb-7f2d-4652-a0e0-1e96d9201daa"
      unitRef="usd">218723000</sem:OperatingLeaseLiabilityCurrentUnrelatedParties>
    <sem:OperatingLeaseLiabilityCurrentRelatedParties
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNi05LTEtMS0w_2101a581-9779-4ea3-b730-91c4f3e79fb7"
      unitRef="usd">6145000</sem:OperatingLeaseLiabilityCurrentRelatedParties>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNi0xMS0xLTEtMA_82dee6ea-7cd9-4ff4-82c8-2dd8d693c24f"
      unitRef="usd">224868000</us-gaap:OperatingLeaseLiabilityCurrent>
    <sem:OperatingLeaseLiabilityNoncurrentUnrelatedParties
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNy0xLTEtMS0w_894d5703-8539-4963-9180-7852e5663f47"
      unitRef="usd">848215000</sem:OperatingLeaseLiabilityNoncurrentUnrelatedParties>
    <sem:OperatingLeaseLiabilityNoncurrentRelatedParties
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNy0zLTEtMS0w_117a5d1b-89f4-47ae-8843-3946abd2b23e"
      unitRef="usd">27152000</sem:OperatingLeaseLiabilityNoncurrentRelatedParties>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNy01LTEtMS0w_c546f06c-a575-434a-8b30-358ea2d0e4c5"
      unitRef="usd">875367000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <sem:OperatingLeaseLiabilityNoncurrentUnrelatedParties
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNy03LTEtMS0w_4493a426-8470-494a-ae45-98f6a9fb9d68"
      unitRef="usd">869421000</sem:OperatingLeaseLiabilityNoncurrentUnrelatedParties>
    <sem:OperatingLeaseLiabilityNoncurrentRelatedParties
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNy05LTEtMS0w_0bad650a-f795-40b3-bd59-9abb72e46bf3"
      unitRef="usd">24057000</sem:OperatingLeaseLiabilityNoncurrentRelatedParties>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfNy0xMS0xLTEtMA_419c16d4-a151-4d61-8811-982aec83338f"
      unitRef="usd">893478000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <sem:OperatingLeaseLiabilityUnrelatedParties
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfOC0xLTEtMS0w_b663cf1d-f38f-46ee-acbe-450473f80ba0"
      unitRef="usd">1062592000</sem:OperatingLeaseLiabilityUnrelatedParties>
    <sem:OperatingLeaseLiabilityRelatedParties
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfOC0zLTEtMS0w_5d4bb6ee-27d6-4d73-a264-38b9fc468f27"
      unitRef="usd">33188000</sem:OperatingLeaseLiabilityRelatedParties>
    <us-gaap:OperatingLeaseLiability
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfOC01LTEtMS0w_7ec1c715-be35-482e-a8e6-18b28a6ef186"
      unitRef="usd">1095780000</us-gaap:OperatingLeaseLiability>
    <sem:OperatingLeaseLiabilityUnrelatedParties
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfOC03LTEtMS0w_5b83a2fe-6785-4428-b938-141cf0c9d8ab"
      unitRef="usd">1088144000</sem:OperatingLeaseLiabilityUnrelatedParties>
    <sem:OperatingLeaseLiabilityRelatedParties
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfOC05LTEtMS0w_8c5285b9-9435-4555-8096-5f00f16b70f6"
      unitRef="usd">30202000</sem:OperatingLeaseLiabilityRelatedParties>
    <us-gaap:OperatingLeaseLiability
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjhiMjQyYjkyOGQwNzQ4Zjc4YjcxZTVjZWU4ZjliZjc0L3RhYmxlcmFuZ2U6OGIyNDJiOTI4ZDA3NDhmNzhiNzFlNWNlZThmOWJmNzRfOC0xMS0xLTEtMA_03621a94-8e70-4e46-b8d1-f1fb2e1c73ab"
      unitRef="usd">1118346000</us-gaap:OperatingLeaseLiability>
    <sem:FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfNi0xLTEtMS0w_e8332188-c2f7-4788-a660-855da8d63181"
      unitRef="usd">5644000</sem:FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties>
    <sem:FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfNi0zLTEtMS0w_770ebb7d-39f1-4536-ba76-d16a323ffdd4"
      unitRef="usd">0</sem:FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfNi01LTEtMS0w_09c0d654-bb95-44d1-bb4f-eaf91138422b"
      unitRef="usd">5644000</us-gaap:FinanceLeaseRightOfUseAsset>
    <sem:FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfNi03LTEtMS0w_07e4f8a8-0b76-4816-8c70-e47c09e277ea"
      unitRef="usd">5711000</sem:FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties>
    <sem:FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfNi05LTEtMS0w_285fbded-5d60-4740-894b-415aafa036c2"
      unitRef="usd">0</sem:FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfNi0xMS0xLTEtMA_c13700e0-b907-4c3f-9628-4dad563bb080"
      unitRef="usd">5711000</us-gaap:FinanceLeaseRightOfUseAsset>
    <sem:FinanceLeaseLiabilityCurrentUnrelatedParties
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOC0xLTEtMS0w_1685f899-005f-4ac5-bd42-b78bb5354a00"
      unitRef="usd">663000</sem:FinanceLeaseLiabilityCurrentUnrelatedParties>
    <sem:FinanceLeaseLiabilityCurrentRelatedParties
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOC0zLTEtMS0w_45d1cba9-0b2e-4b71-bc15-dfd694b4b179"
      unitRef="usd">0</sem:FinanceLeaseLiabilityCurrentRelatedParties>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOC01LTEtMS0w_cf332086-56a4-47ac-97c4-ce580f1ba0b2"
      unitRef="usd">663000</us-gaap:FinanceLeaseLiabilityCurrent>
    <sem:FinanceLeaseLiabilityCurrentUnrelatedParties
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOC03LTEtMS0w_3a00a64b-dfee-49cd-b553-3996889f7378"
      unitRef="usd">638000</sem:FinanceLeaseLiabilityCurrentUnrelatedParties>
    <sem:FinanceLeaseLiabilityCurrentRelatedParties
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOC05LTEtMS0w_f98f86bd-b920-4694-af20-7a94c6148eaf"
      unitRef="usd">0</sem:FinanceLeaseLiabilityCurrentRelatedParties>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOC0xMS0xLTEtMA_8363d6d7-d589-4a5f-9061-652d172dedad"
      unitRef="usd">638000</us-gaap:FinanceLeaseLiabilityCurrent>
    <sem:FinanceLeaseLiabilityNoncurrentUnrelatedParties
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOS0xLTEtMS0w_a1c349b2-a286-4926-afda-4442ab9415ff"
      unitRef="usd">13491000</sem:FinanceLeaseLiabilityNoncurrentUnrelatedParties>
    <sem:FinanceLeaseLiabilityNoncurrentRelatedParties
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOS0zLTEtMS0w_070aa1c9-312f-4cac-9d68-aacbb6d1c1d3"
      unitRef="usd">0</sem:FinanceLeaseLiabilityNoncurrentRelatedParties>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOS01LTEtMS0w_cdb32974-47ba-4ba2-a9a8-d446e82a2829"
      unitRef="usd">13491000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <sem:FinanceLeaseLiabilityNoncurrentUnrelatedParties
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOS03LTEtMS0w_2bf696bc-b0a7-498a-96a2-3d580b12a10c"
      unitRef="usd">13509000</sem:FinanceLeaseLiabilityNoncurrentUnrelatedParties>
    <sem:FinanceLeaseLiabilityNoncurrentRelatedParties
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOS05LTEtMS0w_12b0e3ce-7f30-4888-b448-0199a57ed080"
      unitRef="usd">0</sem:FinanceLeaseLiabilityNoncurrentRelatedParties>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfOS0xMS0xLTEtMA_317cf9ee-5a5e-4a81-a5f2-376ff3ff8bcc"
      unitRef="usd">13509000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <sem:FinanceLeaseLiabilityUnrelatedParties
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfMTAtMS0xLTEtMA_d7d60167-3625-48d5-997a-5f19e49dba5b"
      unitRef="usd">14154000</sem:FinanceLeaseLiabilityUnrelatedParties>
    <sem:FinanceLeaseLiabilityRelatedParties
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfMTAtMy0xLTEtMA_2bd273cc-3c19-4b68-be1d-78e039c3853d"
      unitRef="usd">0</sem:FinanceLeaseLiabilityRelatedParties>
    <us-gaap:FinanceLeaseLiability
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfMTAtNS0xLTEtMA_5a5a920c-aa76-4142-a88b-df678fe44443"
      unitRef="usd">14154000</us-gaap:FinanceLeaseLiability>
    <sem:FinanceLeaseLiabilityUnrelatedParties
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfMTAtNy0xLTEtMA_697033e2-4128-489c-a0b6-eb7744aa54a7"
      unitRef="usd">14147000</sem:FinanceLeaseLiabilityUnrelatedParties>
    <sem:FinanceLeaseLiabilityRelatedParties
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfMTAtOS0xLTEtMA_5cf43e26-ed92-45b3-bcf7-95e369106837"
      unitRef="usd">0</sem:FinanceLeaseLiabilityRelatedParties>
    <us-gaap:FinanceLeaseLiability
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjUyNDg4MWMxMjEwZDQ5ZTliY2QyODAwYjVhMzVkZWQ4L3RhYmxlcmFuZ2U6NTI0ODgxYzEyMTBkNDllOWJjZDI4MDBiNWEzNWRlZDhfMTAtMTEtMS0xLTA_31de00de-c971-4717-baf8-be62aa6b7cf1"
      unitRef="usd">14147000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjRjNTUxYzcyNWUzZDQwYTU5MGIyMDQ1ZjQ3ZTdjMmJkL3RhYmxlcmFuZ2U6NGM1NTFjNzI1ZTNkNDBhNTkwYjIwNDVmNDdlN2MyYmRfMi0xLTEtMS0w_ad85779b-ac05-4e30-8d55-5d326cb735f4">P7Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjRjNTUxYzcyNWUzZDQwYTU5MGIyMDQ1ZjQ3ZTdjMmJkL3RhYmxlcmFuZ2U6NGM1NTFjNzI1ZTNkNDBhNTkwYjIwNDVmNDdlN2MyYmRfMi0zLTEtMS0w_2687eb8d-6e30-428e-a4f3-cf24c8aa7928">P7Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjRjNTUxYzcyNWUzZDQwYTU5MGIyMDQ1ZjQ3ZTdjMmJkL3RhYmxlcmFuZ2U6NGM1NTFjNzI1ZTNkNDBhNTkwYjIwNDVmNDdlN2MyYmRfMy0xLTEtMS0w_4848ac39-2b15-4364-af61-9f36774265d3">P31Y2M12D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjRjNTUxYzcyNWUzZDQwYTU5MGIyMDQ1ZjQ3ZTdjMmJkL3RhYmxlcmFuZ2U6NGM1NTFjNzI1ZTNkNDBhNTkwYjIwNDVmNDdlN2MyYmRfMy0zLTEtMS0w_13e37779-468a-4e69-995b-a09bc41832ff">P30Y7M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjRjNTUxYzcyNWUzZDQwYTU5MGIyMDQ1ZjQ3ZTdjMmJkL3RhYmxlcmFuZ2U6NGM1NTFjNzI1ZTNkNDBhNTkwYjIwNDVmNDdlN2MyYmRfNS0xLTEtMS0w_7be77971-d31c-4c8e-9925-1e91dfa0be79"
      unitRef="number">0.056</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjRjNTUxYzcyNWUzZDQwYTU5MGIyMDQ1ZjQ3ZTdjMmJkL3RhYmxlcmFuZ2U6NGM1NTFjNzI1ZTNkNDBhNTkwYjIwNDVmNDdlN2MyYmRfNS0zLTEtMS0w_5f66b426-06dd-4a6d-9144-ab3bf5e7cc1f"
      unitRef="number">0.055</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjRjNTUxYzcyNWUzZDQwYTU5MGIyMDQ1ZjQ3ZTdjMmJkL3RhYmxlcmFuZ2U6NGM1NTFjNzI1ZTNkNDBhNTkwYjIwNDVmNDdlN2MyYmRfNi0xLTEtMS0w_70f2342f-eae3-4ca7-a92d-dd42623c514c"
      unitRef="number">0.072</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjRjNTUxYzcyNWUzZDQwYTU5MGIyMDQ1ZjQ3ZTdjMmJkL3RhYmxlcmFuZ2U6NGM1NTFjNzI1ZTNkNDBhNTkwYjIwNDVmNDdlN2MyYmRfNi0zLTEtMS0w_317f30fa-98a4-490a-9b61-e86442e2624d"
      unitRef="number">0.072</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RleHRyZWdpb246YTM1NjBiOGFmMmU0NGY4ZmE3YjBlY2JjY2MyMjJiOTVfNTQ4_01eff225-dc28-4bd1-8ffa-45f700616e10">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, maturities of lease liabilities were approximately as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021 (remainder of year)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;143,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;258,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;211,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;172,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;533,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total undiscounted cash flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,457,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;339,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total discounted lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,118,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RleHRyZWdpb246YTM1NjBiOGFmMmU0NGY4ZmE3YjBlY2JjY2MyMjJiOTVfNTQ4_4cf1c011-692a-449c-be98-4322b5f337b3">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, maturities of lease liabilities were approximately as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021 (remainder of year)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;143,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;258,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;211,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;172,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;138,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;533,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total undiscounted cash flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,457,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;339,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total discounted lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,118,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfMi0xLTEtMS0w_dc78803d-b123-49f0-8406-a995464b83a2"
      unitRef="usd">143539000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfMi0zLTEtMS0w_ac6ab71e-088f-4600-b4fd-6b335e65b4d9"
      unitRef="usd">790000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfMy0xLTEtMS0w_225e5d7b-7655-41cd-a380-7e8dec2c414f"
      unitRef="usd">258011000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfMy0zLTEtMS0w_d7bf2377-d8ec-4ac8-b2bf-4108eaabd40e"
      unitRef="usd">1699000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfNC0xLTEtMS0w_9df71d00-ee21-4ee0-a30f-e781fa01350c"
      unitRef="usd">211514000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfNC0zLTEtMS0w_7ed88beb-29db-4e4b-b8c1-7200c377f979"
      unitRef="usd">1710000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfNS0xLTEtMS0w_6c3d5c81-0685-4c27-ad95-68f71f43ceb4"
      unitRef="usd">172183000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfNS0zLTEtMS0w_54abb1d1-9394-4966-b947-ea816a98cabb"
      unitRef="usd">1381000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfNi0xLTEtMS0w_4dabd00d-c001-4b58-b527-f0eccedb7574"
      unitRef="usd">138429000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfNi0zLTEtMS0w_8cbd1b95-38d4-4f72-93cb-0887098d4d95"
      unitRef="usd">1205000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <sem:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfNy0xLTEtMS0w_84c52fa7-9cca-4f42-a6b7-9cf7aa0933eb"
      unitRef="usd">533811000</sem:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour>
    <sem:FinanceLeaseLiabilityPaymentsDueAfterYearFour
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfNy0zLTEtMS0w_a45f9a7a-6698-44c8-84ec-8638d14de513"
      unitRef="usd">29019000</sem:FinanceLeaseLiabilityPaymentsDueAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfOC0xLTEtMS0w_065f89ee-41e8-42f0-8755-cd7b7e3c117e"
      unitRef="usd">1457487000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfOC0zLTEtMS0w_63b720c4-c6f6-4a4a-9066-fbab582f768b"
      unitRef="usd">35804000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfOS0xLTEtMS0w_57499aff-cfc5-4a3e-aa1d-327ddd3d2c4a"
      unitRef="usd">339141000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfOS0zLTEtMS0w_d564b462-a071-4507-a786-c63412b4b9f2"
      unitRef="usd">21657000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfMTAtMS0xLTEtMA_23cd47ed-26b7-4cad-adaa-81a841a5c6c5"
      unitRef="usd">1118346000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81Mi9mcmFnOmEzNTYwYjhhZjJlNDRmOGZhN2IwZWNiY2NjMjIyYjk1L3RhYmxlOjBjOTRmYWZiZjU3MTQ5ZGM4OGJmMWNjOGU0YjBlYzVjL3RhYmxlcmFuZ2U6MGM5NGZhZmJmNTcxNDlkYzg4YmYxY2M4ZTRiMGVjNWNfMTAtMy0xLTEtMA_5288dae6-50e0-455f-af19-75b36010f9ef"
      unitRef="usd">14147000</us-gaap:FinanceLeaseLiability>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RleHRyZWdpb246NWIxNTVkMWZiYTM5NGJjOGI4YWFmNDA2N2M1NjVkYTJfNzc2_d4fd591a-3dd6-4bc4-bdff-9d8b35b6f04c">Intangible Assets&lt;div style="margin-bottom:9pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows changes in the carrying amounts of goodwill by reporting unit for the six months ended June&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Critical Illness Recovery Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rehabilitation Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outpatient&lt;br/&gt;Rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,084,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;432,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;646,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,215,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,379,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquisition of businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,084,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;442,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;647,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,216,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,391,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:4pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Identifiable Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the gross carrying amounts, accumulated amortization, and net carrying amounts for the Company&#x2019;s identifiable intangible assets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;166,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;166,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;166,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;166,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Certificates of need&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accreditations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finite-lived intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;291,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(113,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;178,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(126,843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;171,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11,771)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13,365)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total identifiable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;517,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(130,117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;387,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;525,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(145,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;380,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:4pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s accreditations and trademarks have renewal terms and the costs to renew these intangible assets are expensed as incurred. At June&#160;30, 2021, the accreditations and trademarks have a weighted average time until next renewal of 1.5 years and 8.2 years, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s finite-lived intangible assets amortize over their estimated useful lives. Amortization expense was $6.9&#160;million and $7.3 million for the three months ended June&#160;30, 2020 and 2021, respectively. Amortization expense was $13.8 million and $14.4 million for the six months ended June&#160;30, 2020 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RleHRyZWdpb246NWIxNTVkMWZiYTM5NGJjOGI4YWFmNDA2N2M1NjVkYTJfNzcy_4b4c0460-1e5d-4ddd-af85-38fb13e73a57">&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows changes in the carrying amounts of goodwill by reporting unit for the six months ended June&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Critical Illness Recovery Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rehabilitation Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outpatient&lt;br/&gt;Rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,084,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;432,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;646,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,215,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,379,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquisition of businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,084,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;442,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;647,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,216,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,391,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i700401d3c9d145e5a4af74e91aa63697_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfMi0xLTEtMS0w_3a859e35-b0a9-4eae-ac50-e89dbe2e06e4"
      unitRef="usd">1084761000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i72f4a9b9828d4a3b943644bbd290287b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfMi0zLTEtMS0w_68c5e037-0b15-476a-8f96-9f9327988a19"
      unitRef="usd">432753000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i94d49e31dfc5481b83733fba9533f7e5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfMi01LTEtMS0w_cc45d983-226c-48d8-9ea7-37df4707eaf0"
      unitRef="usd">646433000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0fb9c18f057d4a6cac88d6653d9ec800_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfMi03LTEtMS0w_f8c4c61a-96e5-4bcd-bda9-f77f5627038d"
      unitRef="usd">1215067000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfMi05LTEtMS0w_6568f4c6-5a76-41bc-a7c0-c17cfd0c6497"
      unitRef="usd">3379014000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ied45fa8b01774a98b132e46124b37c0a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfMy0xLTEtMS0w_d34c6c77-08e2-45aa-a4c0-abec54f1447b"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia19667dc075545788618f5c66316f37a_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfMy0zLTEtMS0w_70dc60e3-575b-41f9-ae28-aba0cad231cc"
      unitRef="usd">9402000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i097daf64265140a892929bd7dac3e0fd_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfMy01LTEtMS0w_8207886c-2a7d-40f4-a506-ea461b424145"
      unitRef="usd">1436000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i1e821cac29074fc185f5771945e60d79_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfMy03LTEtMS0w_77078490-4251-4bf1-9669-53b44fc32f37"
      unitRef="usd">1188000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfMy05LTEtMS0w_15eeab14-6f7e-42a6-8542-3874427b337d"
      unitRef="usd">12026000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="i2eb84cd5898941968056ee90d2e078ac_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfNi0xLTEtMS0w_51f82e0d-f80e-4168-9d1f-58822e63f197"
      unitRef="usd">1084761000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5447d034988f4dba82554eb01fc5e2a2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfNi0zLTEtMS0w_230c3a9f-4642-4bd3-b856-afa0043eb271"
      unitRef="usd">442155000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5cee8f7161ea4a8a92cd3e773a1e4ece_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfNi01LTEtMS0w_81d4632d-a046-487e-a970-57cac1918b8b"
      unitRef="usd">647869000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3cc51a7a4bbb48fd82bfef91f2d58ed8_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfNi03LTEtMS0w_80170be5-a3dd-4024-816f-6a425c44c91e"
      unitRef="usd">1216255000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOjM1NTk0MWJlMDViYzQzNzlhNmNjY2I0ZDc2ZjYzYzk0L3RhYmxlcmFuZ2U6MzU1OTQxYmUwNWJjNDM3OWE2Y2NjYjRkNzZmNjNjOTRfNi05LTEtMS0w_106e691b-f2ba-4baa-81ba-a95b39cd7f92"
      unitRef="usd">3391040000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RleHRyZWdpb246NWIxNTVkMWZiYTM5NGJjOGI4YWFmNDA2N2M1NjVkYTJfNzg2_447a44fd-3905-4bee-b174-110bb4f4cb1c">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the gross carrying amounts, accumulated amortization, and net carrying amounts for the Company&#x2019;s identifiable intangible assets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;166,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;166,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;166,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;166,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Certificates of need&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accreditations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Finite-lived intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;291,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(113,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;178,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;298,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(126,843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;171,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(11,771)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13,365)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total identifiable intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;517,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(130,117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;387,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;525,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(145,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;380,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i2722863174014f129b2ae71613b5e3ef_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNC0yLTEtMS0w_06dc8d9e-b8e7-48ae-ba56-4446085927dc"
      unitRef="usd">166698000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i2722863174014f129b2ae71613b5e3ef_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNC02LTEtMS0w_188cdba3-18a1-44e1-a6a6-c8d116a4f05c"
      unitRef="usd">166698000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ie50961b97f5d4e09a5947761afae9b15_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNC04LTEtMS0w_008a22f1-1134-4721-899f-2ee6d07b98e0"
      unitRef="usd">166698000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ie50961b97f5d4e09a5947761afae9b15_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNC0xMi0xLTEtMA_43caac3b-6676-4de2-ac51-5ea90b24240a"
      unitRef="usd">166698000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i6d92202a78304997b52107c3a7f606b2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNS0yLTEtMS0w_18b86e30-bd4b-48b9-8cf9-c1617e95a125"
      unitRef="usd">18392000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i6d92202a78304997b52107c3a7f606b2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNS02LTEtMS0w_9ea2fa6a-a4cf-46a4-b700-9812ab8617d9"
      unitRef="usd">18392000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i50009e4e14044151932827ba2b1bbb8f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNS04LTEtMS0w_0782afe7-ca4a-4132-825d-83329490eb51"
      unitRef="usd">18413000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i50009e4e14044151932827ba2b1bbb8f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNS0xMi0xLTEtMA_a118ce4c-44e5-4280-8101-0cdc9b5bfe23"
      unitRef="usd">18413000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ice892a1481a14854bded5d410c627ea7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNi0yLTEtMS0w_6d485c1a-7fe0-4434-bf9c-0575b8a47488"
      unitRef="usd">1874000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ice892a1481a14854bded5d410c627ea7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNi02LTEtMS0w_3dec94d7-a1f1-4f82-b2ad-beadea9c676c"
      unitRef="usd">1874000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i330f8d443bf84101a754a226814bfe6c_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNi04LTEtMS0w_c651d174-ad99-43d7-aea1-3bb859bce420"
      unitRef="usd">1874000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i330f8d443bf84101a754a226814bfe6c_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfNi0xMi0xLTEtMA_47aca6ad-08b7-49ca-ac54-3f7817e8eb60"
      unitRef="usd">1874000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i602fead3b8954e80b8ecfba7f8e331a4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOC0yLTEtMS0w_f260dd93-9468-4c4e-8abd-2ee97aca23be"
      unitRef="usd">5000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i602fead3b8954e80b8ecfba7f8e331a4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOC00LTEtMS0w_4a894b8f-3272-4ed0-a40e-abe9c5b30fe5"
      unitRef="usd">5000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i602fead3b8954e80b8ecfba7f8e331a4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOC02LTEtMS0w_c86038fb-0e51-4322-866b-02b83080d095"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib04ddc4871e84537b195da0e20d46573_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOC04LTEtMS0w_26b6b779-7cf6-4bb3-8a5b-cef4cd4be400"
      unitRef="usd">5000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib04ddc4871e84537b195da0e20d46573_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOC0xMC0xLTEtMA_d835fc5e-c970-438e-9d0e-671bb6dd016e"
      unitRef="usd">5000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib04ddc4871e84537b195da0e20d46573_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOC0xMi0xLTEtMA_15651753-3e15-4ec7-bb3f-17b48ec87c57"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i008b3ba5aedd4b238f380f5108ca88c2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOS0yLTEtMS0w_ab12bbd2-acf7-4070-b91d-2a1d8a56b0cb"
      unitRef="usd">291923000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i008b3ba5aedd4b238f380f5108ca88c2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOS00LTEtMS0w_c6593f18-a9b3-4c0e-b7aa-65d958337cb3"
      unitRef="usd">113346000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i008b3ba5aedd4b238f380f5108ca88c2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOS02LTEtMS0w_7092c331-05a2-45cc-99ee-d79591ee3d65"
      unitRef="usd">178577000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if929eb1eca084fde8793ca88f272572d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOS04LTEtMS0w_45003ac9-7480-46dd-9b25-ef20f28669b2"
      unitRef="usd">298514000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if929eb1eca084fde8793ca88f272572d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOS0xMC0xLTEtMA_1cb7194f-25e9-45f8-b93c-16d57b5e087d"
      unitRef="usd">126843000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if929eb1eca084fde8793ca88f272572d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfOS0xMi0xLTEtMA_95614ba9-000d-4317-8605-348d226dfb6c"
      unitRef="usd">171671000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i302b948d2285436d8d4925ae04d98b18_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTAtMi0xLTEtMA_925faf7b-228d-4877-ab52-ab36fc788284"
      unitRef="usd">33771000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i302b948d2285436d8d4925ae04d98b18_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTAtNC0xLTEtMA_bfddbaf6-fdd8-4a78-b611-282b1b9e6067"
      unitRef="usd">11771000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i302b948d2285436d8d4925ae04d98b18_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTAtNi0xLTEtMA_474535a2-4fcc-40f7-9df2-f3ab5335d81c"
      unitRef="usd">22000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i48c41d6695124d31993223ed4735ed45_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTAtOC0xLTEtMA_e53a99f4-d281-41ea-a94a-c345174414d7"
      unitRef="usd">35011000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i48c41d6695124d31993223ed4735ed45_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTAtMTAtMS0xLTA_85343341-7249-4a39-be58-a1995901834c"
      unitRef="usd">13365000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i48c41d6695124d31993223ed4735ed45_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTAtMTItMS0xLTA_5c8efae7-26ad-4e2e-9f29-74e8749e406b"
      unitRef="usd">21646000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTEtMi0xLTEtMA_d09e7285-fd00-4ba7-8ecf-e2db1d412c52"
      unitRef="usd">517658000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTEtNC0xLTEtMA_a2374b91-1514-4690-af18-a6f872df19a6"
      unitRef="usd">130117000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTEtNi0xLTEtMA_9df716d3-494a-4fee-b63a-b1c6e49e2a32"
      unitRef="usd">387541000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTEtOC0xLTEtMA_49091265-e4a1-487d-9487-65792e27f60e"
      unitRef="usd">525510000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTEtMTAtMS0xLTA_e7717f87-b3af-4ec2-8b95-dfa89a10011e"
      unitRef="usd">145208000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RhYmxlOmQ1Y2EzOGI0YTVmZTRlOGQ5M2VlNmNjYzUwZTFhMGMzL3RhYmxlcmFuZ2U6ZDVjYTM4YjRhNWZlNGU4ZDkzZWU2Y2NjNTBlMWEwYzNfMTEtMTItMS0xLTA_d30554df-da90-4875-a9e3-fc52490e09c9"
      unitRef="usd">380302000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <sem:IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension
      contextRef="i9f259df1c9c14a91877a5d8ddebfe895_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RleHRyZWdpb246NWIxNTVkMWZiYTM5NGJjOGI4YWFmNDA2N2M1NjVkYTJfNTc1_e9beced6-af5c-4b41-ba61-2d138531588c">P1Y6M</sem:IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension>
    <sem:IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension
      contextRef="i1c8e70e09d574bd5bf50455cec27484e_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RleHRyZWdpb246NWIxNTVkMWZiYTM5NGJjOGI4YWFmNDA2N2M1NjVkYTJfNTgy_47a55ea2-8279-4992-8d58-b59126225e0c">P8Y2M12D</sem:IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RleHRyZWdpb246NWIxNTVkMWZiYTM5NGJjOGI4YWFmNDA2N2M1NjVkYTJfMTA5OTUxMTYyODYwNw_1dcd6b20-78af-4ce0-ac01-56de9d099031"
      unitRef="usd">6900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RleHRyZWdpb246NWIxNTVkMWZiYTM5NGJjOGI4YWFmNDA2N2M1NjVkYTJfMTA5OTUxMTYyODYxNg_f610a48b-94e1-4e8c-abbe-4557afb8f566"
      unitRef="usd">7300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RleHRyZWdpb246NWIxNTVkMWZiYTM5NGJjOGI4YWFmNDA2N2M1NjVkYTJfNzE0_c5dacefd-34b6-439f-bd9b-cde985b5abd8"
      unitRef="usd">13800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl81OC9mcmFnOjViMTU1ZDFmYmEzOTRiYzhiOGFhZjQwNjdjNTY1ZGEyL3RleHRyZWdpb246NWIxNTVkMWZiYTM5NGJjOGI4YWFmNDA2N2M1NjVkYTJfNzIx_b87a8fa6-a12c-48cb-8f01-ec7b70c7bd25"
      unitRef="usd">14400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RleHRyZWdpb246N2U1NDIyNDE4N2RkNGZkMTgyN2RkZThkZDgxYmY5MmFfMzA0_7df735f6-f6a9-49ee-9a9e-b119a1370e97">Long-Term Debt and Notes Payable&lt;div style="margin-bottom:15pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, the Company&#x2019;s long-term debt and notes payable were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unamortized Premium (Discount)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unamortized&lt;br/&gt;Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select 6.250% senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,225,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(15,463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,240,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,304,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select credit facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,103,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,064)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,087,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,077,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other debt, including finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,398,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(23,785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,397,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,451,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:7pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Principal maturities of the Company&#x2019;s long-term debt and notes payable were approximately as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.732%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select 6.250% senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,225,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,225,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select credit facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,087,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,103,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other debt, including finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;25,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,087,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,236,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,398,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:7pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the Company&#x2019;s long-term debt and notes payable were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unamortized Premium (Discount)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unamortized&lt;br/&gt;Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select 6.250% senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,225,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,241,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,316,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select credit facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,103,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,085,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,082,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other debt, including finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,403,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;25,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(26,404)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,402,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,473,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Select Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 2, 2021, Select entered into Amendment No. 5 to its senior secured credit agreement (the &#x201c;Select credit agreement&#x201d;) which, among other things, increased the aggregate commitments available under its revolving credit facility (the &#x201c;Select revolving facility&#x201d;) from $450.0 million to $650.0 million, including a $125.0 million sublimit for the issuance of standby letters of credit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentra-JPM Revolving Facility&lt;/span&gt;&lt;/div&gt;On June 2, 2021, Concentra Inc. terminated its obligations under its first lien credit agreement (the &#x201c;Concentra-JPM first lien credit agreement&#x201d;). The Concentra-JPM first lien credit agreement provided for commitments of $100.0&#160;million under a revolving credit facility (the &#x201c;Concentra-JPM revolving facility&#x201d;), which was set to mature on March 1, 2022.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RleHRyZWdpb246N2U1NDIyNDE4N2RkNGZkMTgyN2RkZThkZDgxYmY5MmFfMzA3_94a68c45-1572-429c-9213-a493e4b1911d">&lt;div style="margin-bottom:15pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, the Company&#x2019;s long-term debt and notes payable were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unamortized Premium (Discount)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unamortized&lt;br/&gt;Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select 6.250% senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,225,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(15,463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,240,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,304,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select credit facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,103,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,064)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,087,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,077,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other debt, including finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,398,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(23,785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,397,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,451,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:7pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the Company&#x2019;s long-term debt and notes payable were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unamortized Premium (Discount)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unamortized&lt;br/&gt;Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="30" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select 6.250% senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,225,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,241,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,316,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select credit facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,103,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,085,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,082,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other debt, including finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,403,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;25,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(26,404)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,402,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,473,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfMi0wLTEtMS0wL3RleHRyZWdpb246ODg3YjhkN2NhOGQyNDUwM2E2ODYwZDMyMGQ3ZDUxOGNfMTE_bd820632-c1a2-47c9-8199-6e79bfdd216a"
      unitRef="number">0.06250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfMi0xLTEtMS0w_aa50d8b7-f982-4bf4-862c-e08aabe32d64"
      unitRef="usd">1225000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfMi0zLTEtMS0w_f7e0da3a-76ac-4bd7-a530-9d091ef8c2d5"
      unitRef="usd">-30722000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfMi01LTEtMS0w_f7fd14ac-3f0a-4b56-ac4f-c9e31f890696"
      unitRef="usd">15463000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfMi03LTEtMS0w_e1f4c12d-05af-445e-b728-3344df46d672"
      unitRef="usd">1240259000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfMi0xMC0xLTEtMA_4647f3de-e925-441b-8f6c-085ace583320"
      unitRef="usd">1304625000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNS0xLTEtMS0w_ece8db95-c00b-4bb1-86eb-c1d347496950"
      unitRef="usd">2103437000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNS0zLTEtMS0w_d5927321-b7df-486e-9bc3-1e7877401574"
      unitRef="usd">7398000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNS01LTEtMS0w_5296af72-a92e-478c-b927-b7656830540c"
      unitRef="usd">8064000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNS03LTEtMS0w_20813784-9d25-4cd3-8d73-b468707ec1de"
      unitRef="usd">2087975000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNS0xMC0xLTEtMA_d2ebcf93-21b3-4bf6-9635-873928eaafa5"
      unitRef="usd">2077144000</us-gaap:DebtInstrumentFairValue>
    <sem:LongTermDebtGrossAndFinanceLeaseObligation
      contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNi0xLTEtMS0w_7e359313-1382-49b4-bd2c-7acaa7314fa1"
      unitRef="usd">69846000</sem:LongTermDebtGrossAndFinanceLeaseObligation>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNi0zLTEtMS0w_b02cd569-4a0f-4db7-b106-4f64ffc33449"
      unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNi01LTEtMS0w_8369a05e-7b6f-49ad-a5a1-fb8382f3d269"
      unitRef="usd">258000</us-gaap:DeferredFinanceCostsNet>
    <sem:LongTermDebtAndFinanceLeaseObligation
      contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNi03LTEtMS0w_66235e7f-76e5-45f4-89b9-d63ad2b65e74"
      unitRef="usd">69588000</sem:LongTermDebtAndFinanceLeaseObligation>
    <us-gaap:DebtInstrumentFairValue
      contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNi0xMC0xLTEtMA_11374a3e-bee7-49b9-8243-3a763727c751"
      unitRef="usd">69588000</us-gaap:DebtInstrumentFairValue>
    <sem:LongTermDebtGrossAndFinanceLeaseObligation
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNy0xLTEtMS0w_cc1d239f-7c55-4419-a07c-fe3dca32c871"
      unitRef="usd">3398283000</sem:LongTermDebtGrossAndFinanceLeaseObligation>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNy0zLTEtMS0w_4923642f-0a1c-4bbe-beb4-bf16d89d6984"
      unitRef="usd">-23324000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNy01LTEtMS0w_c4e5c24b-c916-48be-99cc-573dfdb1da4d"
      unitRef="usd">23785000</us-gaap:DeferredFinanceCostsNet>
    <sem:LongTermDebtAndFinanceLeaseObligation
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNy03LTEtMS0w_416b8f2f-a507-4c9a-958a-d9b8991ef618"
      unitRef="usd">3397822000</sem:LongTermDebtAndFinanceLeaseObligation>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjMwZDc3MTljMmE5MDRmOGM4ZGIyMTc0ZDQwYjQ0OWY2L3RhYmxlcmFuZ2U6MzBkNzcxOWMyYTkwNGY4YzhkYjIxNzRkNDBiNDQ5ZjZfNy0xMC0xLTEtMA_8dff42a8-67bd-4e12-b19d-ef0ecef58a75"
      unitRef="usd">3451357000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RleHRyZWdpb246N2U1NDIyNDE4N2RkNGZkMTgyN2RkZThkZDgxYmY5MmFfMzAy_5ad75260-d47a-4930-9e40-b37d967861e8">&lt;div style="margin-bottom:9pt;margin-top:7pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Principal maturities of the Company&#x2019;s long-term debt and notes payable were approximately as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.732%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select 6.250% senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,225,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,225,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select credit facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,087,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,103,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other debt, including finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;69,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;25,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,087,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,236,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,398,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfMi0wLTEtMS0wL3RleHRyZWdpb246OTg2NTA4ZmRjZGE2NGJjNTgyNjYyY2M1OTk3NTNjN2VfMTE_bd820632-c1a2-47c9-8199-6e79bfdd216a"
      unitRef="number">0.06250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfMi0xLTEtMS0w_26236ace-1f36-4550-98bb-0f98fa2dec1b"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfMi0zLTEtMS0w_a52ceb4c-2248-4b5b-9b48-8d092ab51039"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfMi01LTEtMS0w_3775cf67-7632-4ccc-a3cc-3acf6be86b46"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfMi03LTEtMS0w_04788564-47c9-45ed-8f9e-91ba8d92257d"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfMi05LTEtMS0w_208b0e9b-c1cc-4acd-b38b-a8edf34b998e"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <sem:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
      contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfMi0xMS0xLTEtMA_3eeb5826-4f62-4fae-8cbf-550cf0340927"
      unitRef="usd">1225000000</sem:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfMi0xMy0xLTEtMA_fdb268e0-7eab-481f-8fbc-cdb32225c671"
      unitRef="usd">1225000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNS0xLTEtMS0w_6a5d0f0c-5193-41ab-bbc7-cbf0ea1e9d73"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNS0zLTEtMS0w_395e0242-8228-49b3-a792-eb133b8c8f6f"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNS01LTEtMS0w_0668ba5a-a915-4a10-8c91-8c63d2d056f8"
      unitRef="usd">4757000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNS03LTEtMS0w_3f1c666d-91dc-4481-8872-a8bc6dd8d6de"
      unitRef="usd">11150000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNS05LTEtMS0w_9ec754bf-fc74-4304-b11b-f2f7efee3563"
      unitRef="usd">2087530000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <sem:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
      contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNS0xMS0xLTEtMA_cbf11cad-b657-484b-ae74-fb40da6a5a9b"
      unitRef="usd">0</sem:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i25db1c92c0d94c90a36f23378754f459_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNS0xMy0xLTEtMA_b4007e4a-7f38-4937-8ad9-de5de8927e5e"
      unitRef="usd">2103437000</us-gaap:DebtInstrumentCarryingAmount>
    <sem:LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNi0xLTEtMS0w_a9a31b53-64fa-421c-bcdc-b07a273596b6"
      unitRef="usd">9441000</sem:LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear>
    <sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNi0zLTEtMS0w_4437c923-a451-4e4d-9632-142e3f86cdaa"
      unitRef="usd">4035000</sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNi01LTEtMS0w_761bfd73-4158-450d-8a53-e2888a796946"
      unitRef="usd">20754000</sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo>
    <sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNi03LTEtMS0w_ce365975-f7bf-49b2-b437-59835d4e87dc"
      unitRef="usd">23717000</sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree>
    <sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNi05LTEtMS0w_513fd55f-8473-45d8-82cb-8903ff0f1428"
      unitRef="usd">334000</sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour>
    <sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour
      contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNi0xMS0xLTEtMA_5158f2a7-2875-4904-8d2e-a0f53e3fb821"
      unitRef="usd">11565000</sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour>
    <sem:LongTermDebtGrossAndFinanceLeaseObligation
      contextRef="if091ae9541ec4cc8b5912d42e54eaf33_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNi0xMy0xLTEtMA_c846e559-6cf0-4d35-8482-a6490fd6b4be"
      unitRef="usd">69846000</sem:LongTermDebtGrossAndFinanceLeaseObligation>
    <sem:LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNy0xLTEtMS0w_474b4467-20f2-4fa8-845f-b384cca6e17b"
      unitRef="usd">9441000</sem:LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear>
    <sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNy0zLTEtMS0w_47cf7460-5ea5-467a-a8c3-d98206d27e3f"
      unitRef="usd">4035000</sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNy01LTEtMS0w_c1100759-4dc2-4c04-98dd-e872d10ad762"
      unitRef="usd">25511000</sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo>
    <sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNy03LTEtMS0w_16e0cb71-b7de-4908-9cf8-7ac14688ef3d"
      unitRef="usd">34867000</sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree>
    <sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNy05LTEtMS0w_ba145458-7c95-47f7-a720-2aafd5a52a78"
      unitRef="usd">2087864000</sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour>
    <sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNy0xMS0xLTEtMA_febef1d0-463f-40d2-916d-d8369565c92e"
      unitRef="usd">1236565000</sem:LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour>
    <sem:LongTermDebtGrossAndFinanceLeaseObligation
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjcwMjAwOGJjZjZlZDRmMDJiY2UxNjhjMDNhYjljZTIxL3RhYmxlcmFuZ2U6NzAyMDA4YmNmNmVkNGYwMmJjZTE2OGMwM2FiOWNlMjFfNy0xMy0xLTEtMA_8e8dc77c-7121-42c4-a8ec-598a0ad8f85a"
      unitRef="usd">3398283000</sem:LongTermDebtGrossAndFinanceLeaseObligation>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i857a4ce6f52d4c159052310deeec6c7a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfMi0wLTEtMS0wL3RleHRyZWdpb246N2VkNjRkMDEwMGFjNDNjODlmMWFjZTZiMTQ2NWI0MDZfMTE_ba10e455-54f7-4574-8e87-c6a387d8baa6"
      unitRef="number">0.06250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i857a4ce6f52d4c159052310deeec6c7a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfMi0xLTEtMS0w_0eb492e8-1b20-4918-8ba1-a2eeec285932"
      unitRef="usd">1225000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i857a4ce6f52d4c159052310deeec6c7a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfMi0zLTEtMS0w_f8ede078-0023-4459-b347-3709164e773e"
      unitRef="usd">-33773000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i857a4ce6f52d4c159052310deeec6c7a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfMi01LTEtMS0w_b3b823c9-cbc2-4145-8a17-cdddbefc9a21"
      unitRef="usd">16953000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i857a4ce6f52d4c159052310deeec6c7a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfMi03LTEtMS0w_352550a7-ef58-4738-ab02-5ddec92ca544"
      unitRef="usd">1241820000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i857a4ce6f52d4c159052310deeec6c7a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfMi0xMC0xLTEtMA_90805979-7252-415f-a87c-4e19a6b3d8b5"
      unitRef="usd">1316875000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="idac118b21fb34cc0987c43b0e5069eca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNS0xLTEtMS0w_96511609-7131-4988-b5c6-96c59e65d51b"
      unitRef="usd">2103437000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="idac118b21fb34cc0987c43b0e5069eca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNS0zLTEtMS0w_869d037d-9438-4578-8455-eaae8dbcfb29"
      unitRef="usd">8393000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="idac118b21fb34cc0987c43b0e5069eca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNS01LTEtMS0w_dcfd66db-62df-444e-a2fa-1271026aff9d"
      unitRef="usd">9149000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="idac118b21fb34cc0987c43b0e5069eca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNS03LTEtMS0w_1b51b532-ad8b-4ed1-9008-479c5e183a79"
      unitRef="usd">2085895000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="idac118b21fb34cc0987c43b0e5069eca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNS0xMC0xLTEtMA_45594e84-87dd-46d3-813d-c22d78ebbcc5"
      unitRef="usd">2082403000</us-gaap:DebtInstrumentFairValue>
    <sem:LongTermDebtGrossAndFinanceLeaseObligation
      contextRef="i8a6556d47b534c46b69474e970b014e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNi0xLTEtMS0w_4cd44e03-60a6-4121-adba-1cafd13b93d5"
      unitRef="usd">74606000</sem:LongTermDebtGrossAndFinanceLeaseObligation>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i8a6556d47b534c46b69474e970b014e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNi0zLTEtMS0w_1f089388-f7f8-4d22-845b-14a5be85e727"
      unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i8a6556d47b534c46b69474e970b014e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNi01LTEtMS0w_f0ce44c6-9bbe-495f-a36d-4b1f322241b5"
      unitRef="usd">302000</us-gaap:DeferredFinanceCostsNet>
    <sem:LongTermDebtAndFinanceLeaseObligation
      contextRef="i8a6556d47b534c46b69474e970b014e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNi03LTEtMS0w_2f4a4f2e-af1d-4301-898d-4813b6ff23b2"
      unitRef="usd">74304000</sem:LongTermDebtAndFinanceLeaseObligation>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i8a6556d47b534c46b69474e970b014e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNi0xMC0xLTEtMA_3e5fa9be-bfbf-4af2-9ae7-2ce2d393efa3"
      unitRef="usd">74304000</us-gaap:DebtInstrumentFairValue>
    <sem:LongTermDebtGrossAndFinanceLeaseObligation
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNy0xLTEtMS0w_e8ad9fcb-89d6-4bfc-a516-387744a4ba3a"
      unitRef="usd">3403043000</sem:LongTermDebtGrossAndFinanceLeaseObligation>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNy0zLTEtMS0w_2a1b97e8-3a6d-45ff-b8b7-5a88e08f32ed"
      unitRef="usd">-25380000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNy01LTEtMS0w_26ceff6f-37c9-4d1f-88ce-fe648585a983"
      unitRef="usd">26404000</us-gaap:DeferredFinanceCostsNet>
    <sem:LongTermDebtAndFinanceLeaseObligation
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNy03LTEtMS0w_5776b5aa-e659-42d8-b12e-a159d604b5b5"
      unitRef="usd">3402019000</sem:LongTermDebtAndFinanceLeaseObligation>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib27967ed4eaf45369238e20d447ab83e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RhYmxlOjgzYmEyYjNlNWYxYjQzMjNiNTMwMzc5MTg0ODgwNDIxL3RhYmxlcmFuZ2U6ODNiYTJiM2U1ZjFiNDMyM2I1MzAzNzkxODQ4ODA0MjFfNy0xMC0xLTEtMA_f4493a4f-d71f-4c9c-82e3-329d25d68ff5"
      unitRef="usd">3473582000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ie6837d0c7f474574b480bbb7ab422f4a_I20210601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RleHRyZWdpb246N2U1NDIyNDE4N2RkNGZkMTgyN2RkZThkZDgxYmY5MmFfMjc0ODc3OTA3MTI3Nw_ad4e6969-ca9e-4d78-a6a1-d96eaeccd3b1"
      unitRef="usd">450000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i04dc07ecbc4842379f1b38ab30b5eba8_I20210602"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RleHRyZWdpb246N2U1NDIyNDE4N2RkNGZkMTgyN2RkZThkZDgxYmY5MmFfMjc0ODc3OTA3MTI5Ng_6fcc5752-a75a-4732-9d8c-af71c69315c8"
      unitRef="usd">650000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i08f710aa7b9e476e9cfe1eb202bb9575_I20210602"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RleHRyZWdpb246N2U1NDIyNDE4N2RkNGZkMTgyN2RkZThkZDgxYmY5MmFfMjc0ODc3OTA3MTMxNw_8a4664b5-5742-4502-bce6-1b0e8f5dc098"
      unitRef="usd">125000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i80ee1121b7294df28e95de1abb339e57_D20210602-20210602"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82NC9mcmFnOjdlNTQyMjQxODdkZDRmZDE4MjdkZGU4ZGQ4MWJmOTJhL3RleHRyZWdpb246N2U1NDIyNDE4N2RkNGZkMTgyN2RkZThkZDgxYmY5MmFfNjU5NzA2OTc3MTk5Mw_c7fcd4f2-b4ba-473e-8808-06aeadfe7cce"
      unitRef="usd">100000000.0</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RleHRyZWdpb246YjYxYmE0YWEyMmY3NGI3NDg4OTExMzhiZjM2NmQyYzZfMTg0Ng_6caf7967-5c6f-4eca-bd0f-c31ffa4d9ce1">Interest Rate Cap &lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to market risk exposure arising from changes in interest rates on the Select term loan, which bears interest at a variable interest rate. The Company&#x2019;s objective in using an interest rate derivative is to mitigate its exposure to increases in interest rates. The interest rate cap limits the Company&#x2019;s exposure to increases in the reference rate to 1.0% on $2.0&#160;billion of principal outstanding under the Select term loan. The interest rate cap became effective March 31, 2021 for the monthly periods from and including April 30, 2021 through September 30, 2024. The Company will pay a premium for the interest rate cap over the term of the agreement. The annual premium is equal to 0.0916% of the notional amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interest rate cap has been designated as a cash flow hedge and is highly effective at offsetting the changes in cash outflows when the reference rate exceeds 1.0%. Changes in the fair value of the interest rate cap, net of tax, are recognized in other comprehensive income and are reclassified out of accumulated other comprehensive income (&#x201c;AOCI&#x201d;) and into interest expense when the hedged interest obligations affect earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table outlines the changes in AOCI:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,027)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain on interest rate cap cash flow hedge&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of March 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss on interest rate cap cash flow hedge&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of June 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated pre-tax losses expected to be reclassified from AOCI into interest expense within the next twelve months are approximately $0.2&#160;million.  &lt;/span&gt;&lt;/div&gt;Refer to Note 10 &#x2013; Fair Value of Financial Instruments for information on the fair value of the Company&#x2019;s interest rate cap contract and its balance sheet classification.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeCapInterestRate
      contextRef="if1a2d014fb1e4ad28dd4c378b19640ec_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RleHRyZWdpb246YjYxYmE0YWEyMmY3NGI3NDg4OTExMzhiZjM2NmQyYzZfNDAw_80fc3589-d44b-4627-8650-07a4f218508f"
      unitRef="number">0.010</us-gaap:DerivativeCapInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="if1a2d014fb1e4ad28dd4c378b19640ec_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RleHRyZWdpb246YjYxYmE0YWEyMmY3NGI3NDg4OTExMzhiZjM2NmQyYzZfNDA2_8b552423-e914-4517-bb13-e9171a670355"
      unitRef="usd">2000000000.0</us-gaap:DerivativeNotionalAmount>
    <sem:DerivativeCostOfHedgeAnnualPremiumPercentage
      contextRef="i6032142566484e849a1c5d74fc32c36c_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RleHRyZWdpb246YjYxYmE0YWEyMmY3NGI3NDg4OTExMzhiZjM2NmQyYzZfNzI2_81f78dc7-9d90-41b6-9aef-606e1e450e23"
      unitRef="number">0.000916</sem:DerivativeCostOfHedgeAnnualPremiumPercentage>
    <us-gaap:DerivativeCapInterestRate
      contextRef="if1a2d014fb1e4ad28dd4c378b19640ec_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RleHRyZWdpb246YjYxYmE0YWEyMmY3NGI3NDg4OTExMzhiZjM2NmQyYzZfOTE1_ae2b5cf3-464b-4947-87ff-1144beec345b"
      unitRef="number">0.010</us-gaap:DerivativeCapInterestRate>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RleHRyZWdpb246YjYxYmE0YWEyMmY3NGI3NDg4OTExMzhiZjM2NmQyYzZfNjU5NzA2OTc3MTUyNw_64aacecf-5837-4013-aa59-35022a713297">&lt;div style="margin-top:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table outlines the changes in AOCI:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,027)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain on interest rate cap cash flow hedge&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of March 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Loss on interest rate cap cash flow hedge&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,403)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Balance as of June 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id8bac61b83244def99333977ca6bc8dd_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfMy0yLTEtMS0xMzM1_039828c1-16f0-4b6f-a6bf-c57e4d6488f3"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4c19072c8de04863a294aa039b4d4f1c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfMy00LTEtMS0xMzM1_4e744282-c034-4f29-8395-b9182362734f"
      unitRef="usd">-2027000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="if569ced9cfba4b40a89af8439239b76d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfNC0yLTEtMS0xMzM1_5fa8be7b-0267-4438-bad8-1e1408adbdcc"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="id57e27efd97745c990ac963fa61e26b6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfNC00LTEtMS0xMzM1_f537cdf3-cbfe-496c-b3f5-9403627c13bf"
      unitRef="usd">8151000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id110289f580b4bf99ef20d4061298d26_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfNi0yLTEtMS01MTM4_35820c85-d76f-4156-917b-ce8444f883b8"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7224211964a0414eb6d46f88101082e5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfNi00LTEtMS01MTM4_aded8e2d-7e5b-40a2-b184-a68f9b34e856"
      unitRef="usd">6124000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i318011501b1440e589143c06cf03d2a6_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfNy0yLTEtMS0xMzQw_264d4c84-aed3-4607-b466-7e09d68be791"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i583e60e6ec66438ca44ad0bd1c978df3_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfNy00LTEtMS0xMzQw_646819c0-5e13-40c7-82ce-58a4f72777eb"
      unitRef="usd">-1403000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i318011501b1440e589143c06cf03d2a6_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfOC0yLTEtMS0xMzQw_64ea67a2-9461-4b19-94a5-2d8c1b6cff7d"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i583e60e6ec66438ca44ad0bd1c978df3_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfOC00LTEtMS0xMzQw_bc579cf9-9330-4a1b-ba79-0aa48a729fd2"
      unitRef="usd">6000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if7536a90c020479993c3e239213bd5b9_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfOS0yLTEtMS01MTM4_9d152a36-2f97-416a-8617-f7b2206e23f3"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6547976a10ee43418548a025bba5b82a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RhYmxlOjhhZDYyNTMxMzJiYTQwZWQ4MDRhN2UyY2ZmOTY1MzQ1L3RhYmxlcmFuZ2U6OGFkNjI1MzEzMmJhNDBlZDgwNGE3ZTJjZmY5NjUzNDVfOS00LTEtMS01MTM4_7a5794cc-ef53-4aa3-8157-d7765cb0aee6"
      unitRef="usd">4727000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i6032142566484e849a1c5d74fc32c36c_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl82Ny9mcmFnOmI2MWJhNGFhMjJmNzRiNzQ4ODkxMTM4YmYzNjZkMmM2L3RleHRyZWdpb246YjYxYmE0YWEyMmY3NGI3NDg4OTExMzhiZjM2NmQyYzZfMTg0NA_4277cef6-47b3-44a1-bd40-45d7875537c2"
      unitRef="usd">-200000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RleHRyZWdpb246NDkyMWQ5YmEzOGNhNDY1ODllYjc5OTU4MTdhZWZiYTVfMTgyMQ_194c62ea-a1c8-4b53-85cc-f3797015f3a7">Fair Value of Financial Instruments&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments which are measured at fair value, or for which a fair value is disclosed, are classified in the fair value hierarchy, as outlined below, on the basis of the observability of the inputs used in the fair value measurement:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;Level 1 &#x2013; inputs are based upon quoted prices for identical instruments in active markets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;Level 2 &#x2013; inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant inputs are observable in the market or can be corroborated by observable market data. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;Level 3 &#x2013; inputs are generally unobservable and typically reflect management&#x2019;s estimates of assumptions that market participants would use in pricing the instrument.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s interest rate cap contract is recorded at its fair value on a recurring basis. The fair value of the interest rate cap contract is based upon a model-derived valuation using observable market inputs, such as interest rates and interest rate volatility, and the strike price. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate cap contract, non-current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate cap contract, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate cap contract, non-current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:4pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not measure its indebtedness at fair value in its condensed consolidated balance sheets. The fair value of the Select credit facilities is based on quoted market prices for this debt in the syndicated loan market. The fair value of the senior notes is based on quoted market prices. The carrying value of the Company&#x2019;s other debt, as disclosed in Note 8 &#x2013; Long-Term Debt and Notes Payable, approximates fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select 6.250% senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,241,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,316,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,240,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,304,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select credit facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,085,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,082,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,087,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,077,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The Company&#x2019;s other financial instruments, which primarily consist of cash and cash equivalents, accounts receivable, and accounts payable, approximate fair value because of the short-term maturities of these instruments.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RleHRyZWdpb246NDkyMWQ5YmEzOGNhNDY1ODllYjc5OTU4MTdhZWZiYTVfMTgyMg_f46a42c8-d573-43b7-ab7c-3b449526c611">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate cap contract, non-current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate cap contract, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest rate cap contract, non-current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="i83e6ab5f1d91457a8c4e1283a5492962_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOjY4ZDAwN2IwNzZlNjRhMzM4N2Q5MmMxZTdhMWRmNDgzL3RhYmxlcmFuZ2U6NjhkMDA3YjA3NmU2NGEzMzg3ZDkyYzFlN2ExZGY0ODNfMi02LTEtMS0w_161b7f2e-aeb0-437e-8aab-cdd97cc235c4"
      unitRef="usd">0</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="i0b2a61478b0140669828a01db0126a67_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOjY4ZDAwN2IwNzZlNjRhMzM4N2Q5MmMxZTdhMWRmNDgzL3RhYmxlcmFuZ2U6NjhkMDA3YjA3NmU2NGEzMzg3ZDkyYzFlN2ExZGY0ODNfMi04LTEtMS0w_8bff4056-0b06-4b92-863f-feae3651a129"
      unitRef="usd">8776000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i394d4e4cc11347d6bbe4d04a5195d6fa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOjY4ZDAwN2IwNzZlNjRhMzM4N2Q5MmMxZTdhMWRmNDgzL3RhYmxlcmFuZ2U6NjhkMDA3YjA3NmU2NGEzMzg3ZDkyYzFlN2ExZGY0ODNfNC02LTEtMS0w_d4c1636e-1ffa-4f78-823d-8541d95f84a4"
      unitRef="usd">1339000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="ide56b585b96145e2a275a4c246014f7a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOjY4ZDAwN2IwNzZlNjRhMzM4N2Q5MmMxZTdhMWRmNDgzL3RhYmxlcmFuZ2U6NjhkMDA3YjA3NmU2NGEzMzg3ZDkyYzFlN2ExZGY0ODNfNC04LTEtMS0w_717e245a-7f98-4c51-8d37-f57fe402339b"
      unitRef="usd">1948000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="i6e07cda8fc2f4dfbb5b2dd986ade2878_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOjY4ZDAwN2IwNzZlNjRhMzM4N2Q5MmMxZTdhMWRmNDgzL3RhYmxlcmFuZ2U6NjhkMDA3YjA3NmU2NGEzMzg3ZDkyYzFlN2ExZGY0ODNfNS02LTEtMS0w_ca2348c7-2298-4c23-8053-5b2f33b7c4d7"
      unitRef="usd">1392000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="i17c6a45ecdbf4d0f95f5f9be53712a5c_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOjY4ZDAwN2IwNzZlNjRhMzM4N2Q5MmMxZTdhMWRmNDgzL3RhYmxlcmFuZ2U6NjhkMDA3YjA3NmU2NGEzMzg3ZDkyYzFlN2ExZGY0ODNfNS04LTEtMS0w_88d9fe61-897e-405b-a3f3-efc4181a2ca1"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RleHRyZWdpb246NDkyMWQ5YmEzOGNhNDY1ODllYjc5OTU4MTdhZWZiYTVfMTgyMw_7b05ee43-5354-49ce-9e39-8c5f44c71211">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select 6.250% senior notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,241,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,316,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,240,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,304,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select credit facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Select term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,085,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,082,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,087,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,077,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i230304098a504f6e8bb8d87b3c8ff168_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOmFmMWM1MGUxMDYyMTQ3ODA5NjE4OGU3YWVjMDYyZDhkL3RhYmxlcmFuZ2U6YWYxYzUwZTEwNjIxNDc4MDk2MTg4ZTdhZWMwNjJkOGRfMy0wLTEtMS0wL3RleHRyZWdpb246YTA2ZmI4MzFkMDU0NDUyZGI3ZTdmNmMwZWVmMGNkMzBfMTE_bd820632-c1a2-47c9-8199-6e79bfdd216a"
      unitRef="number">0.06250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i902a144fb9c24c4c9a915b36772f9aa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOmFmMWM1MGUxMDYyMTQ3ODA5NjE4OGU3YWVjMDYyZDhkL3RhYmxlcmFuZ2U6YWYxYzUwZTEwNjIxNDc4MDk2MTg4ZTdhZWMwNjJkOGRfMy00LTEtMS0w_ac8a2c40-c395-4663-88a9-36288146b163"
      unitRef="usd">1241820000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i902a144fb9c24c4c9a915b36772f9aa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOmFmMWM1MGUxMDYyMTQ3ODA5NjE4OGU3YWVjMDYyZDhkL3RhYmxlcmFuZ2U6YWYxYzUwZTEwNjIxNDc4MDk2MTg4ZTdhZWMwNjJkOGRfMy02LTEtMS0w_4ce3ed79-88c9-4903-80ca-494b59ce8c23"
      unitRef="usd">1316875000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LongTermDebt
      contextRef="i101b81566dfb4f6083f1433734385dd6_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOmFmMWM1MGUxMDYyMTQ3ODA5NjE4OGU3YWVjMDYyZDhkL3RhYmxlcmFuZ2U6YWYxYzUwZTEwNjIxNDc4MDk2MTg4ZTdhZWMwNjJkOGRfMy04LTEtMS0w_d9e3c9d3-ad74-43ce-a77a-6963a445ced2"
      unitRef="usd">1240259000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i101b81566dfb4f6083f1433734385dd6_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOmFmMWM1MGUxMDYyMTQ3ODA5NjE4OGU3YWVjMDYyZDhkL3RhYmxlcmFuZ2U6YWYxYzUwZTEwNjIxNDc4MDk2MTg4ZTdhZWMwNjJkOGRfMy0xMC0xLTEtMA_6ade93f7-95d6-4dd8-99c0-fecc563034d2"
      unitRef="usd">1304625000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LongTermDebt
      contextRef="i81a4a93b5710486380910f66202cea4c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOmFmMWM1MGUxMDYyMTQ3ODA5NjE4OGU3YWVjMDYyZDhkL3RhYmxlcmFuZ2U6YWYxYzUwZTEwNjIxNDc4MDk2MTg4ZTdhZWMwNjJkOGRfNi00LTEtMS0w_b6e12765-4b6d-4874-a91c-d4f28826649a"
      unitRef="usd">2085895000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i81a4a93b5710486380910f66202cea4c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOmFmMWM1MGUxMDYyMTQ3ODA5NjE4OGU3YWVjMDYyZDhkL3RhYmxlcmFuZ2U6YWYxYzUwZTEwNjIxNDc4MDk2MTg4ZTdhZWMwNjJkOGRfNi02LTEtMS0w_518c8802-3246-4740-b377-83e7964dfaf1"
      unitRef="usd">2082403000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LongTermDebt
      contextRef="i698e8ca3bbf14329ad97debd8fc5d02d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOmFmMWM1MGUxMDYyMTQ3ODA5NjE4OGU3YWVjMDYyZDhkL3RhYmxlcmFuZ2U6YWYxYzUwZTEwNjIxNDc4MDk2MTg4ZTdhZWMwNjJkOGRfNi04LTEtMS0w_75c6ab37-7e85-490a-bf92-f87ead25e11d"
      unitRef="usd">2087975000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i698e8ca3bbf14329ad97debd8fc5d02d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83MC9mcmFnOjQ5MjFkOWJhMzhjYTQ2NTg5ZWI3OTk1ODE3YWVmYmE1L3RhYmxlOmFmMWM1MGUxMDYyMTQ3ODA5NjE4OGU3YWVjMDYyZDhkL3RhYmxlcmFuZ2U6YWYxYzUwZTEwNjIxNDc4MDk2MTg4ZTdhZWMwNjJkOGRfNi0xMC0xLTEtMA_967a66d0-86e7-406d-a8e5-b96592ef81d1"
      unitRef="usd">2077144000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RleHRyZWdpb246ZjBiZDlhMTQ3YWRiNGFjMTk3MmIwYzIxMGFiNmRlZGFfMTUwMA_0ee2acc5-4eca-421d-a0cf-57415d524bca">Segment Information&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reportable segments consist of the critical illness recovery hospital segment, rehabilitation hospital segment, outpatient rehabilitation segment, and Concentra segment. Other activities include the Company&#x2019;s corporate shared services, certain investments, and employee leasing services with non-consolidating subsidiaries. The Company&#x2019;s other activities also include other operating income related to the recognition of payments received under the Provider Relief Fund for health care related expenses and loss of revenue attributable to the coronavirus disease 2019 (&#x201c;COVID-19&#x201d;). Refer to Note 15 &#x2013; CARES Act for further information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates the performance of its segments based on Adjusted EBITDA. Adjusted EBITDA is defined as earnings excluding interest, income taxes, depreciation and amortization, gain (loss) on early retirement of debt, stock compensation expense, gain (loss) on sale of businesses, and equity in earnings (losses) of unconsolidated subsidiaries. The Company has provided additional information regarding its reportable segments, such as total assets, which contributes to the understanding of the Company and provides useful information to the users of the consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize selected financial data for the Company&#x2019;s reportable segments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Critical illness recovery hospital&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;519,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;544,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,020,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,138,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Rehabilitation hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;168,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;212,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;350,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;420,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outpatient rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;167,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;280,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;422,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;532,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;312,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;456,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;710,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;879,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;143,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,232,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,564,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,647,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,110,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Critical illness recovery hospital&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;89,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;178,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;186,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Rehabilitation hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;101,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outpatient rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;102,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;219,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;178,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;342,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;366,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;600,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Critical illness recovery hospital&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,115,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,187,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,115,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,187,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Rehabilitation hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,135,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,186,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,135,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,186,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outpatient rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,267,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,333,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,267,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,333,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,351,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,518,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,351,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,518,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;598,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;730,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;598,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;730,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,468,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,956,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,468,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,956,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchases of property and equipment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Critical illness recovery hospital&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Rehabilitation hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outpatient rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;76,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of Adjusted EBITDA to income before income taxes is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Critical Illness Recovery Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rehabilitation Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outpatient&lt;br/&gt;Rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;89,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13,892)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(21,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;119,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity in earnings of unconsolidated subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain on sale of businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(37,366)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;90,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Critical Illness Recovery Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rehabilitation Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outpatient&lt;br/&gt;Rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12,936)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(21,230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(535)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;43,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;115,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;283,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity in earnings of unconsolidated subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(33,888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;261,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Critical Illness Recovery Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rehabilitation Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outpatient&lt;br/&gt;Rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;178,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;102,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(26,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13,794)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(44,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,845)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12,398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19,448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;248,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity in earnings of unconsolidated subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain on sale of businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(83,473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;183,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Critical Illness Recovery Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rehabilitation Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outpatient&lt;br/&gt;Rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;186,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;101,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;219,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(25,986)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14,536)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(41,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,925)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12,737)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;160,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;87,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;57,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;176,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;485,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity in earnings of unconsolidated subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(68,290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;444,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RleHRyZWdpb246ZjBiZDlhMTQ3YWRiNGFjMTk3MmIwYzIxMGFiNmRlZGFfMTUwNw_a8ad3d19-6efe-4d43-8a27-a804816cad2e">&lt;div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize selected financial data for the Company&#x2019;s reportable segments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Critical illness recovery hospital&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;519,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;544,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,020,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,138,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Rehabilitation hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;168,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;212,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;350,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;420,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outpatient rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;167,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;280,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;422,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;532,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;312,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;456,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;710,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;879,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;143,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,232,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,564,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,647,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,110,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Critical illness recovery hospital&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;89,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;178,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;186,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Rehabilitation hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;101,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outpatient rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;102,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;219,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;178,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;342,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;366,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;600,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Critical illness recovery hospital&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,115,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,187,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,115,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,187,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Rehabilitation hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,135,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,186,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,135,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,186,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outpatient rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,267,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,333,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,267,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,333,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,351,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,518,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,351,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,518,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;598,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;730,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;598,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;730,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,468,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,956,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,468,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,956,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Purchases of property and equipment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Critical illness recovery hospital&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;16,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;23,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Rehabilitation hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Outpatient rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;14,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;76,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e1d48a74eba45399c9304871d02e6ac_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNC0xLTEtMS0w_f04512e0-ab50-4a36-810b-e2d0e8983c67"
      unitRef="usd">519626000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4d9eaba867e94987bae380499ef0dea5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNC0zLTEtMS0w_67f643b0-07a9-4aae-ac5b-4963f6799465"
      unitRef="usd">544059000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i83fa48e193ef409091a5469b91556348_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNC01LTEtMS0w_cda420a6-8cb1-41b9-841c-bece2f2e8ba6"
      unitRef="usd">1020147000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i842ce964455440c8bf019b096558985c_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNC03LTEtMS0w_b1c5f152-7675-4316-a495-2058e7dcc6b8"
      unitRef="usd">1138931000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i153dba6636544126b8b590e3eceb746a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNS0xLTEtMS0w_a6b2553a-4435-431d-bfad-39b0de5edfeb"
      unitRef="usd">168667000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie40b7ae534f84659b72f603832026b2c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNS0zLTEtMS0w_d42ffc98-b535-4302-a41c-119f9e8e4bbe"
      unitRef="usd">212666000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7fe7ee2784746f5af6d2429cd8a2219_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNS01LTEtMS0w_21056a7d-0fc7-43e7-a9a3-38142196fb49"
      unitRef="usd">350686000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8083b69f958c4c0f8dbe5292758beec8_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNS03LTEtMS0w_27a86827-da0b-4fe5-a700-80623c913133"
      unitRef="usd">420470000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4101982ebb88440ab0a78e005d9ac883_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNi0xLTEtMS0w_694d978f-0ea8-4107-851c-fc342a836d7b"
      unitRef="usd">167138000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i51d714fd1694458d8c8a2740933d72d8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNi0zLTEtMS0w_ba3504df-204f-47f2-a455-7142485e2d7e"
      unitRef="usd">280409000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae89f2bc1bb34c1c88b6b97eb1162a82_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNi01LTEtMS0w_b18b0d4d-b672-4535-a499-7b6018209b77"
      unitRef="usd">422387000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie1f26863a74d46b3807377370b9f5c71_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNi03LTEtMS0w_e0fb891f-4daf-487c-b6f3-56e107b79769"
      unitRef="usd">532370000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaed2d25f9da44d15a8e75aa82e738f7c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNy0xLTEtMS0w_a856743e-fad3-4f50-b65b-2b9fdcfd3b86"
      unitRef="usd">312338000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8878162e48ac455b871924e5a7f16043_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNy0zLTEtMS0w_467f0ee1-04c1-4336-b82f-87b7494a0277"
      unitRef="usd">456372000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iffb407c8a9fd406bbddf4aaba0a22fbf_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNy01LTEtMS0w_1b38acd1-f8b5-4af3-aa1c-529b03fbcf1e"
      unitRef="usd">710873000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie1d773ec12ea468d884922f6a9c624ab_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfNy03LTEtMS0w_d4776907-e311-4223-ae4b-f22636c8e9ca"
      unitRef="usd">879212000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78b5037d6f24467bb284a7f3daadf67d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfOC0xLTEtMS0w_d46947d9-e498-4834-9728-030d5f383288"
      unitRef="usd">64949000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i593f37f6bebf4b5c8147fc667686329b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfOC0zLTEtMS0w_87d963b1-9ec4-456b-bc30-e615cbaa2701"
      unitRef="usd">70514000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a46c953c7a44137882933b2fccefa90_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfOC01LTEtMS0w_cbd834f9-dfd8-451f-99b8-215886a3d650"
      unitRef="usd">143257000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9da22e6ac16b4906870e768509e1fb6f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfOC03LTEtMS0w_fa39a373-adea-4d4f-a8e9-c8f2f7f4feb5"
      unitRef="usd">139500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfOS0xLTEtMS0w_be091096-0a64-465f-8082-a14aca6051b7"
      unitRef="usd">1232718000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfOS0zLTEtMS0w_6aa2b8f4-4f6e-4105-a58c-60f87b1dc200"
      unitRef="usd">1564020000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfOS01LTEtMS0w_8be95aeb-d50f-4d34-bc1a-926e762f84d2"
      unitRef="usd">2647350000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfOS03LTEtMS0w_64a44998-4a14-4b6f-9b81-449dea8c6f65"
      unitRef="usd">3110483000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <sem:AdjustedEbitda
      contextRef="i1e1d48a74eba45399c9304871d02e6ac_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTEtMS0xLTEtMA_b7617adb-62ea-4e29-a6be-3e963d360056"
      unitRef="usd">89743000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i4d9eaba867e94987bae380499ef0dea5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTEtMy0xLTEtMA_5f5a07ce-adb8-447b-9f29-375ab9b60e8e"
      unitRef="usd">72904000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i83fa48e193ef409091a5469b91556348_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTEtNS0xLTEtMA_92be97f0-6a90-454e-9e8b-44f0e87c3f24"
      unitRef="usd">178313000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i842ce964455440c8bf019b096558985c_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTEtNy0xLTEtMA_bbc121c7-ae9e-4cd7-906b-71cae37ca3aa"
      unitRef="usd">186176000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i153dba6636544126b8b590e3eceb746a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTItMS0xLTEtMA_9eb87af0-7934-44ca-a6c0-74c7e1482951"
      unitRef="usd">27605000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="ie40b7ae534f84659b72f603832026b2c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTItMy0xLTEtMA_6b585eb3-f583-4230-bd97-64bd29c73c3f"
      unitRef="usd">50768000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="ic7fe7ee2784746f5af6d2429cd8a2219_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTItNS0xLTEtMA_083fe61e-c135-4cf3-99fa-bb054f80ad6e"
      unitRef="usd">66174000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i8083b69f958c4c0f8dbe5292758beec8_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTItNy0xLTEtMA_64e216c7-b58d-400e-b873-0d8100a9904c"
      unitRef="usd">101302000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i4101982ebb88440ab0a78e005d9ac883_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTMtMS0xLTEtMA_5c17c787-947c-4c42-b6ed-49fd95c674a9"
      unitRef="usd">-6282000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i51d714fd1694458d8c8a2740933d72d8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTMtMy0xLTEtMA_d0250b54-437e-42f6-84d9-32039362a1a9"
      unitRef="usd">45633000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="iae89f2bc1bb34c1c88b6b97eb1162a82_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTMtNS0xLTEtMA_2e4a84df-2ee9-498d-8a79-7b9d095bca55"
      unitRef="usd">20840000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="ie1f26863a74d46b3807377370b9f5c71_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTMtNy0xLTEtMA_dcc93ba9-8fd2-47a9-a06b-68092ad7a5ef"
      unitRef="usd">71962000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="iaed2d25f9da44d15a8e75aa82e738f7c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTQtMS0xLTEtMA_5124afaf-1886-4718-a720-607e1bd10d81"
      unitRef="usd">41497000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i8878162e48ac455b871924e5a7f16043_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTQtMy0xLTEtMA_4c42ebd2-73a9-475a-8259-8afb8bf441e2"
      unitRef="usd">137060000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="iffb407c8a9fd406bbddf4aaba0a22fbf_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTQtNS0xLTEtMA_cdf7a753-2929-411d-97d0-18039a1139f7"
      unitRef="usd">102963000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="ie1d773ec12ea468d884922f6a9c624ab_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTQtNy0xLTEtMA_5977fc70-4204-4e3b-981f-f33a8fb65d51"
      unitRef="usd">219075000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i78b5037d6f24467bb284a7f3daadf67d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTUtMS0xLTEtMA_fe9a6285-4531-4d61-a859-239a3390d241"
      unitRef="usd">26189000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i593f37f6bebf4b5c8147fc667686329b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTUtMy0xLTEtMA_cafa0a21-3ecb-4009-a2ed-31ffbcc79539"
      unitRef="usd">35656000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i8a46c953c7a44137882933b2fccefa90_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTUtNS0xLTEtMA_b80dd22f-08ad-41e7-a7c7-78e6023aa9e8"
      unitRef="usd">-2205000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i9da22e6ac16b4906870e768509e1fb6f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTUtNy0xLTEtMA_c12ecfef-3072-474c-bbe6-0c72d83d4e88"
      unitRef="usd">21847000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTYtMS0xLTEtMA_ce0cbd8c-360e-46f0-837e-fafb263e895f"
      unitRef="usd">178752000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTYtMy0xLTEtMA_bc4d7b3e-c960-43c0-9060-5b7cf64c418b"
      unitRef="usd">342021000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTYtNS0xLTEtMA_1810c9f6-2b18-4633-9b93-3beae85202c0"
      unitRef="usd">366085000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTYtNy0xLTEtMA_83149e5b-8f23-4231-8a41-5c44c8eeee60"
      unitRef="usd">600362000</sem:AdjustedEbitda>
    <us-gaap:Assets
      contextRef="i3fe3df84cda8454c8ffd79d805543ebf_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTgtMS0xLTEtMA_45967455-8eb6-496c-b10b-1166d5149480"
      unitRef="usd">2115294000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i197ea75654664fa7a7dd48b4a0515835_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTgtMy0xLTEtMA_49d61ce6-c50e-49e3-8710-73b4377028e6"
      unitRef="usd">2187181000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i3fe3df84cda8454c8ffd79d805543ebf_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTgtNS0xLTEtMA_70312b38-cc59-49db-a40a-36c593dae4e3"
      unitRef="usd">2115294000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i197ea75654664fa7a7dd48b4a0515835_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTgtNy0xLTEtMA_34588731-1c3b-4af3-924f-22e8c676ee80"
      unitRef="usd">2187181000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i699f8bdade4a44e29271a7ea09f9b932_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTktMS0xLTEtMA_b2516915-2ac9-4223-8196-5ebe2c0bbff4"
      unitRef="usd">1135206000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if588fc73933845bbb155e472e99ba08e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTktMy0xLTEtMA_fb426b77-3389-4ee1-9953-5ba4e649cd3f"
      unitRef="usd">1186886000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i699f8bdade4a44e29271a7ea09f9b932_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTktNS0xLTEtMA_78c8ffe2-fb00-40ab-a12c-9f94b64c6660"
      unitRef="usd">1135206000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if588fc73933845bbb155e472e99ba08e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMTktNy0xLTEtMA_ee4db283-17a1-41f7-81a1-b0b1fcaf66a7"
      unitRef="usd">1186886000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i232ac557a5c14113bafaf53b25c2801d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjAtMS0xLTEtMA_b990d5d5-8a2d-4532-82ef-1f606e3dfe9e"
      unitRef="usd">1267308000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ibfa155817d6141a5af84386d83aa6d7d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjAtMy0xLTEtMA_5d9f7c23-ca2d-474a-a217-c8059569dd4c"
      unitRef="usd">1333661000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i232ac557a5c14113bafaf53b25c2801d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjAtNS0xLTEtMA_42560918-da6c-4cee-895a-28fb8a4b1ca6"
      unitRef="usd">1267308000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ibfa155817d6141a5af84386d83aa6d7d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjAtNy0xLTEtMA_ed704b2b-ffb3-44dd-a43b-2b20adf6a725"
      unitRef="usd">1333661000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i71ae59b24b3143e89410ddfca8316817_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjEtMS0xLTEtMA_4502434f-9348-42ad-b9aa-33417a1a94d6"
      unitRef="usd">2351974000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia4876618fa9e49bfae481558c3925540_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjEtMy0xLTEtMA_16fb128a-90c3-4573-b12d-ca99f1c7f836"
      unitRef="usd">2518369000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i71ae59b24b3143e89410ddfca8316817_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjEtNS0xLTEtMA_78edd237-6de8-42fc-aa7d-c3a1b5a1f2bd"
      unitRef="usd">2351974000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia4876618fa9e49bfae481558c3925540_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjEtNy0xLTEtMA_00e05b61-3052-44f4-bade-aca2b7a26805"
      unitRef="usd">2518369000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1c27e0254b2645b0bdf18d8599991191_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjItMS0xLTEtMA_dce5227c-b2c6-4c18-b4cf-0e2a9a5ebac1"
      unitRef="usd">598676000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i98da6697f91448bfa929dfa3d12ec44d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjItMy0xLTEtMA_a52949aa-424e-42fc-b7e7-bcc809e7c8d9"
      unitRef="usd">730282000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1c27e0254b2645b0bdf18d8599991191_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjItNS0xLTEtMA_0d4ab62e-ac50-4a8a-bb09-fba519f8d0f7"
      unitRef="usd">598676000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i98da6697f91448bfa929dfa3d12ec44d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjItNy0xLTEtMA_249aa996-18fb-49a2-9786-8751eba44691"
      unitRef="usd">730282000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2126fcb95b794e1d9f9873202b50af46_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjMtMS0xLTEtMA_7ddd41ef-ed5c-43bf-8f31-bac3c7470f9a"
      unitRef="usd">7468458000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjMtMy0xLTEtMA_56e274ec-22c1-4cdb-8e07-7a988eee57c5"
      unitRef="usd">7956379000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2126fcb95b794e1d9f9873202b50af46_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjMtNS0xLTEtMA_fb94acbe-2195-496b-a346-f7ed199acce2"
      unitRef="usd">7468458000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjMtNy0xLTEtMA_466bf221-652a-4b6e-9622-b07ff9e55d0e"
      unitRef="usd">7956379000</us-gaap:Assets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i1e1d48a74eba45399c9304871d02e6ac_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjUtMS0xLTEtMA_a4a0f01c-42c3-4ccf-b241-b76f46dc10c7"
      unitRef="usd">14970000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i4d9eaba867e94987bae380499ef0dea5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjUtMy0xLTEtMA_253357c9-75f0-4c3c-adc0-34b9e4080b22"
      unitRef="usd">16499000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i83fa48e193ef409091a5469b91556348_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjUtNS0xLTEtMA_d592908e-3ce4-4288-b3b6-8995dac65ef4"
      unitRef="usd">23935000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i842ce964455440c8bf019b096558985c_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjUtNy0xLTEtMA_4f500071-211c-4966-84a9-46ad7141e765"
      unitRef="usd">30884000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i153dba6636544126b8b590e3eceb746a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjYtMS0xLTEtMA_ee2fd664-427c-4ff4-a1b6-78cb48d3923c"
      unitRef="usd">1923000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ie40b7ae534f84659b72f603832026b2c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjYtMy0xLTEtMA_9ea0b572-fb50-4c01-9f16-cb81015783b2"
      unitRef="usd">3257000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ic7fe7ee2784746f5af6d2429cd8a2219_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjYtNS0xLTEtMA_6cc8c7f2-4356-4421-b975-799a19c30c62"
      unitRef="usd">5248000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i8083b69f958c4c0f8dbe5292758beec8_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjYtNy0xLTEtMA_a7705a6c-a7fd-4abd-9d83-1acbda63b97a"
      unitRef="usd">3922000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i4101982ebb88440ab0a78e005d9ac883_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjctMS0xLTEtMA_772f2e4b-ba8e-4802-a293-a78ec083f76c"
      unitRef="usd">6593000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i51d714fd1694458d8c8a2740933d72d8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjctMy0xLTEtMA_c9af6224-59ba-4f6d-9c96-fd16732f9f7b"
      unitRef="usd">7448000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="iae89f2bc1bb34c1c88b6b97eb1162a82_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjctNS0xLTEtMA_a176696a-1b14-4655-947c-82ac77ae8ee2"
      unitRef="usd">14977000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ie1f26863a74d46b3807377370b9f5c71_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjctNy0xLTEtMA_5c2cdfec-a1ba-4081-af09-b264453b78a4"
      unitRef="usd">14783000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="iaed2d25f9da44d15a8e75aa82e738f7c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjgtMS0xLTEtMA_804acc2a-ca58-42da-a4d3-02cb8a7d479e"
      unitRef="usd">6820000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i8878162e48ac455b871924e5a7f16043_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjgtMy0xLTEtMA_8a8e3834-c438-4a7a-9deb-17e2c8b6f4ff"
      unitRef="usd">7591000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="iffb407c8a9fd406bbddf4aaba0a22fbf_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjgtNS0xLTEtMA_caf7c2ad-7ad6-4075-b84c-1f806d78acb2"
      unitRef="usd">22406000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ie1d773ec12ea468d884922f6a9c624ab_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjgtNy0xLTEtMA_d5e8176e-e5dd-41d6-aab4-d239a7489434"
      unitRef="usd">20271000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i78b5037d6f24467bb284a7f3daadf67d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjktMS0xLTEtMA_75ff3ad4-229a-496d-b2ba-53a46f50e0ab"
      unitRef="usd">1739000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i593f37f6bebf4b5c8147fc667686329b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjktMy0xLTEtMA_b7025177-8ca2-4572-95dd-4e1644b0a7b2"
      unitRef="usd">1928000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i8a46c953c7a44137882933b2fccefa90_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjktNS0xLTEtMA_e6ac2f50-255f-490c-a819-7a39203d909b"
      unitRef="usd">4687000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i9da22e6ac16b4906870e768509e1fb6f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMjktNy0xLTEtMA_eef50b73-37ee-41e1-9f84-6ba52cb951ce"
      unitRef="usd">6582000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMzAtMS0xLTEtMA_d6fab3fd-63cf-4c76-81a0-4cf79f7d2cf6"
      unitRef="usd">32045000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMzAtMy0xLTEtMA_fab7b41d-6986-4844-bbcb-d17ca69707e0"
      unitRef="usd">36723000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMzAtNS0xLTEtMA_0866ea91-c807-4ab8-bddc-adaac238b071"
      unitRef="usd">71253000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmI5YjQzMzQ1YzAwOTQyNjFiOTMwNmVkNzFjNDI1NDJlL3RhYmxlcmFuZ2U6YjliNDMzNDVjMDA5NDI2MWI5MzA2ZWQ3MWM0MjU0MmVfMzAtNy0xLTEtMA_5c0aa2a5-901b-40d2-b513-25a5033d1543"
      unitRef="usd">76442000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RleHRyZWdpb246ZjBiZDlhMTQ3YWRiNGFjMTk3MmIwYzIxMGFiNmRlZGFfMTQ5OA_1a3b0d8e-e3f0-4aa7-baeb-b62abc194682">&lt;div style="margin-bottom:12pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of Adjusted EBITDA to income before income taxes is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Critical Illness Recovery Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rehabilitation Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outpatient&lt;br/&gt;Rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;89,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;27,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,282)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;41,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13,892)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(21,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,262)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13,476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;119,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity in earnings of unconsolidated subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain on sale of businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(37,366)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;90,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Critical Illness Recovery Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rehabilitation Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outpatient&lt;br/&gt;Rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;72,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;50,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12,936)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(7,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(21,230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(535)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;43,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;115,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;283,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity in earnings of unconsolidated subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(33,888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;261,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Critical Illness Recovery Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rehabilitation Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outpatient&lt;br/&gt;Rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;178,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;102,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(26,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13,794)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(44,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,845)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12,398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;152,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19,448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;248,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity in earnings of unconsolidated subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain on sale of businesses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(83,473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;183,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Critical Illness Recovery Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rehabilitation Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outpatient&lt;br/&gt;Rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;186,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;101,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;219,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(25,986)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(13,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14,536)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(41,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,925)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Stock compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(12,737)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;160,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;87,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;57,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;176,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;485,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity in earnings of unconsolidated subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(68,290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;444,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <sem:AdjustedEbitda
      contextRef="i1e1d48a74eba45399c9304871d02e6ac_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfMy0xLTEtMS0xNTAx_34987edc-0615-4477-a479-9edda1942717"
      unitRef="usd">89743000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i153dba6636544126b8b590e3eceb746a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfMy0zLTEtMS0xNTAx_292534ea-da0f-47fd-bdfe-2eb253d6bb01"
      unitRef="usd">27605000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i4101982ebb88440ab0a78e005d9ac883_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfMy01LTEtMS0xNTAx_e4a23e6d-f789-40e4-8142-c49b2a4bf46f"
      unitRef="usd">-6282000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="iaed2d25f9da44d15a8e75aa82e738f7c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfMy03LTEtMS0xNTAx_9581a879-622e-46f4-9232-9d3be0d76a5a"
      unitRef="usd">41497000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i78b5037d6f24467bb284a7f3daadf67d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfMy05LTEtMS0xNTAx_3ee08f17-a1f6-4b45-b6c9-59faaef47cc4"
      unitRef="usd">26189000</sem:AdjustedEbitda>
    <us-gaap:DepreciationAndAmortization
      contextRef="i1e1d48a74eba45399c9304871d02e6ac_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNC0xLTEtMS0xNTAx_e6ab7679-a67f-46b5-b7f3-c1a8d2f25d1d"
      unitRef="usd">13892000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i153dba6636544126b8b590e3eceb746a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNC0zLTEtMS0xNTAx_14c1e970-2854-4137-be9f-1376d5d4f508"
      unitRef="usd">6907000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i4101982ebb88440ab0a78e005d9ac883_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNC01LTEtMS0xNTAx_0590548c-0b33-4fa2-af71-1cf7536315eb"
      unitRef="usd">7194000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iaed2d25f9da44d15a8e75aa82e738f7c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNC03LTEtMS0xNTAx_06592af6-81f2-4c1a-9676-911bc772d9fa"
      unitRef="usd">21857000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i78b5037d6f24467bb284a7f3daadf67d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNC05LTEtMS0xNTAx_5ef24939-9715-477c-973e-f9976e10d353"
      unitRef="usd">2421000</us-gaap:DepreciationAndAmortization>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1e1d48a74eba45399c9304871d02e6ac_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNS0xLTEtMS0xNTAx_768c5f74-64f1-48bd-a816-f941edac0ab6"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i153dba6636544126b8b590e3eceb746a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNS0zLTEtMS0xNTAx_ee14f21b-2a84-48e8-bdf3-4e28bd121809"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4101982ebb88440ab0a78e005d9ac883_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNS01LTEtMS0xNTAx_2d461683-ae5d-46f6-a22f-90e830f2f9f5"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iaed2d25f9da44d15a8e75aa82e738f7c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNS03LTEtMS0xNTAx_c1301970-db05-49a6-aa83-0bc829fa52d5"
      unitRef="usd">701000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i78b5037d6f24467bb284a7f3daadf67d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNS05LTEtMS0xNTAx_4f4dfa2e-c497-4b74-bd1b-8628aff4fc0c"
      unitRef="usd">6262000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1e1d48a74eba45399c9304871d02e6ac_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNi0xLTEtMS0xNTIy_c6a2a781-a344-4f71-9df4-2fed8322dabc"
      unitRef="usd">75851000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i153dba6636544126b8b590e3eceb746a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNi0zLTEtMS0xNTIy_2bcb7fd1-fd36-42ea-9596-7982e2b16f5e"
      unitRef="usd">20698000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4101982ebb88440ab0a78e005d9ac883_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNi01LTEtMS0xNTIy_f659d289-75f7-4d5d-9e0b-a267e0247d25"
      unitRef="usd">-13476000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iaed2d25f9da44d15a8e75aa82e738f7c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNi03LTEtMS0xNTIy_9307b4fb-9abe-4ef3-9137-0ee87dd9b4bc"
      unitRef="usd">18939000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i78b5037d6f24467bb284a7f3daadf67d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNi05LTEtMS0xNTIy_3897bd06-94df-467e-af99-ade2afe3531d"
      unitRef="usd">17506000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfNi0xMS0xLTEtMTUyMg_2bda2a43-9be4-4ef4-a0db-e9c31d093f15"
      unitRef="usd">119518000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfOC0xMS0xLTEtMTUwMQ_d7bdb352-f776-4126-94b7-6fd8a47b109c"
      unitRef="usd">8324000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfOS0xMS0xLTEtMTUwMQ_84833055-e873-4206-8c15-7fa07ade2cd8"
      unitRef="usd">346000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:InterestExpense
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfMTEtMTEtMS0xLTE1MDE_0e104543-922e-4a46-a3eb-8586c3e1f393"
      unitRef="usd">37366000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOmQwMjg0OWJjNDZiNjRmNzRiOWQ5NmU2NWQ5NDY1MzI1L3RhYmxlcmFuZ2U6ZDAyODQ5YmM0NmI2NGY3NGI5ZDk2ZTY1ZDk0NjUzMjVfMTItMTEtMS0xLTE1MjI_d02c9778-f9cd-49ec-a200-73aaa9c5e44a"
      unitRef="usd">90822000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <sem:AdjustedEbitda
      contextRef="i4d9eaba867e94987bae380499ef0dea5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfMy0xLTEtMS0xNTAx_15d8826a-c1f6-46a0-b6df-6118790d53f8"
      unitRef="usd">72904000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="ie40b7ae534f84659b72f603832026b2c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfMy0zLTEtMS0xNTAx_e10a48fb-830f-49f1-8e0b-6e6d342e5709"
      unitRef="usd">50768000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i51d714fd1694458d8c8a2740933d72d8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfMy01LTEtMS0xNTAx_d757e2de-e870-45ca-9df6-a94c3b16b086"
      unitRef="usd">45633000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i8878162e48ac455b871924e5a7f16043_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfMy03LTEtMS0xNTAx_9ad3f352-e488-4662-9c54-bb0f37c3278a"
      unitRef="usd">137060000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i593f37f6bebf4b5c8147fc667686329b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfMy05LTEtMS0xNTAx_3034ce89-5f2e-4ca4-b6f9-f5dc728695a7"
      unitRef="usd">35656000</sem:AdjustedEbitda>
    <us-gaap:DepreciationAndAmortization
      contextRef="i4d9eaba867e94987bae380499ef0dea5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNC0xLTEtMS0xNTAx_076b7bf5-be69-4ca0-956a-ae14b5e2fc46"
      unitRef="usd">12936000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie40b7ae534f84659b72f603832026b2c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNC0zLTEtMS0xNTAx_d0cebeaa-0312-4905-abbe-76ff415a40aa"
      unitRef="usd">6939000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i51d714fd1694458d8c8a2740933d72d8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNC01LTEtMS0xNTAx_0e483222-3245-4012-9a69-0fa5f615ba12"
      unitRef="usd">7345000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i8878162e48ac455b871924e5a7f16043_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNC03LTEtMS0xNTAx_814b62a8-ceb0-4b3c-9c58-595b80eaab14"
      unitRef="usd">21230000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i593f37f6bebf4b5c8147fc667686329b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNC05LTEtMS0xNTAx_b23271e9-9e6b-4209-8633-3532c34d3cde"
      unitRef="usd">2504000</us-gaap:DepreciationAndAmortization>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4d9eaba867e94987bae380499ef0dea5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNS0xLTEtMS0xNTAx_506e25be-5fd7-4a39-af87-2406b6bed5e9"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie40b7ae534f84659b72f603832026b2c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNS0zLTEtMS0xNTAx_d596876f-886b-4002-8a99-86fd04d23c58"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i51d714fd1694458d8c8a2740933d72d8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNS01LTEtMS0xNTAx_9351cb64-75b3-4fde-a6d3-059eadd9714b"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8878162e48ac455b871924e5a7f16043_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNS03LTEtMS0xNTAx_5c60aa81-0b3b-4a73-9ae0-2aa4df19ae70"
      unitRef="usd">535000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i593f37f6bebf4b5c8147fc667686329b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNS05LTEtMS0xNTAx_f1e4fa79-bf63-4045-bce2-0aea1da66e4d"
      unitRef="usd">6564000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4d9eaba867e94987bae380499ef0dea5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNi0xLTEtMS0xNTIw_bd65e164-0ba3-4b13-bc09-abeb0c6cbc00"
      unitRef="usd">59968000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie40b7ae534f84659b72f603832026b2c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNi0zLTEtMS0xNTIw_df631075-ced7-4c30-afb9-014bb01ad53a"
      unitRef="usd">43829000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i51d714fd1694458d8c8a2740933d72d8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNi01LTEtMS0xNTIw_835abdc7-dc4b-45f7-8543-bf6d1f2e323f"
      unitRef="usd">38288000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8878162e48ac455b871924e5a7f16043_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNi03LTEtMS0xNTIw_e7ad85c5-245c-455a-9146-90ee45305056"
      unitRef="usd">115295000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i593f37f6bebf4b5c8147fc667686329b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNi05LTEtMS0xNTIw_35eadc74-73b4-474c-aab8-c95dd51e6ed0"
      unitRef="usd">26588000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfNi0xMS0xLTEtMTUyMA_bd0fba15-a477-47dd-8707-50ebd586bb30"
      unitRef="usd">283968000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfOC0xMS0xLTEtMTUwMQ_ae9f0ee1-5ed8-4577-9605-cf97b9558ead"
      unitRef="usd">11809000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InterestExpense
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfMTEtMTEtMS0xLTE1MDE_8e0ab5f7-7d99-41d9-abcf-491bb36c636b"
      unitRef="usd">33888000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjFmYThmMGY4NTMzNDQ0YTVhOGYwMDcxOThjZjg1MmNlL3RhYmxlcmFuZ2U6MWZhOGYwZjg1MzM0NDRhNWE4ZjAwNzE5OGNmODUyY2VfMTItMTEtMS0xLTE1MjA_6fb22e9f-072f-4747-a7a2-7bd6d5efb918"
      unitRef="usd">261889000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <sem:AdjustedEbitda
      contextRef="i83fa48e193ef409091a5469b91556348_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfMy0xLTEtMS0w_4db94e08-7b2f-4cac-97c4-91d27390e1b6"
      unitRef="usd">178313000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="ic7fe7ee2784746f5af6d2429cd8a2219_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfMy0zLTEtMS0w_6568a889-ff06-46e7-9e79-179a52ad1643"
      unitRef="usd">66174000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="iae89f2bc1bb34c1c88b6b97eb1162a82_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfMy01LTEtMS0w_c8b71781-70c5-4f2f-a654-bd659d90b7e6"
      unitRef="usd">20840000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="iffb407c8a9fd406bbddf4aaba0a22fbf_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfMy03LTEtMS0w_3ace622e-2f7d-4ba5-ae1b-414272c37fbf"
      unitRef="usd">102963000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i8a46c953c7a44137882933b2fccefa90_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfMy05LTEtMS0w_06b786cb-6a74-466e-bac0-f373e2393355"
      unitRef="usd">-2205000</sem:AdjustedEbitda>
    <us-gaap:DepreciationAndAmortization
      contextRef="i83fa48e193ef409091a5469b91556348_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNC0xLTEtMS0w_9d6dae09-86fb-4351-ab34-70b43dae1158"
      unitRef="usd">26228000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic7fe7ee2784746f5af6d2429cd8a2219_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNC0zLTEtMS0w_cf119e67-4651-459e-89a2-0602ec4eb268"
      unitRef="usd">13794000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iae89f2bc1bb34c1c88b6b97eb1162a82_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNC01LTEtMS0w_c455a40d-e0d3-4f2c-b0e4-e65a97bd3588"
      unitRef="usd">14412000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iffb407c8a9fd406bbddf4aaba0a22fbf_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNC03LTEtMS0w_31cffee1-3f88-4fb7-889f-f592318962ca"
      unitRef="usd">44744000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i8a46c953c7a44137882933b2fccefa90_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNC05LTEtMS0w_5988d726-3e70-42f3-9a49-e8ba5c50d349"
      unitRef="usd">4845000</us-gaap:DepreciationAndAmortization>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i83fa48e193ef409091a5469b91556348_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNS0xLTEtMS0w_f940dc9d-7f4a-4cf4-b2f7-e97dffbc729d"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic7fe7ee2784746f5af6d2429cd8a2219_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNS0zLTEtMS0w_3ace75d1-7abf-4868-be5c-57cf3330cf45"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iae89f2bc1bb34c1c88b6b97eb1162a82_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNS01LTEtMS0w_ff6faaeb-2b8e-465e-bd86-fdb94aa1d7f5"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iffb407c8a9fd406bbddf4aaba0a22fbf_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNS03LTEtMS0w_4f3eee90-e420-4058-8192-6be054364ad9"
      unitRef="usd">1468000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8a46c953c7a44137882933b2fccefa90_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNS05LTEtMS0w_4e30e59c-2fbd-437d-8fed-96a0f7b5bf43"
      unitRef="usd">12398000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i83fa48e193ef409091a5469b91556348_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNi0xLTEtMS0w_89bb4e5a-9ba1-49fa-bb63-fe9f47baea56"
      unitRef="usd">152085000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic7fe7ee2784746f5af6d2429cd8a2219_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNi0zLTEtMS0w_da6e8cca-3011-42f7-a9a9-202dc679a13e"
      unitRef="usd">52380000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iae89f2bc1bb34c1c88b6b97eb1162a82_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNi01LTEtMS0w_1ce940a6-9fe7-4ebd-a607-80e8988e2c1b"
      unitRef="usd">6428000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iffb407c8a9fd406bbddf4aaba0a22fbf_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNi03LTEtMS0w_f8f0927f-3081-4a6e-a3ff-e03a870af1aa"
      unitRef="usd">56751000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8a46c953c7a44137882933b2fccefa90_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNi05LTEtMS0w_c29a56a0-fba2-4441-878f-35a46a38aa50"
      unitRef="usd">-19448000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfNi0xMS0xLTEtMA_c643da78-9781-4be4-a36c-60499ff48732"
      unitRef="usd">248196000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfOC0xMS0xLTEtMA_7ac5332a-cb6a-4d56-8198-2ea1b9e1e44a"
      unitRef="usd">10912000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfOS0xMS0xLTEtMA_44c1472b-fba3-42b4-bf18-383f132906a1"
      unitRef="usd">7547000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:InterestExpense
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfMTEtMTEtMS0xLTA_7ba3fd7f-207e-4d59-b742-19ba348dae83"
      unitRef="usd">83473000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjhkNTg0ZTdlYzNjNjQ2ODM4NjkwZDM0Y2QzODRlZDNjL3RhYmxlcmFuZ2U6OGQ1ODRlN2VjM2M2NDY4Mzg2OTBkMzRjZDM4NGVkM2NfMTItMTEtMS0xLTA_01a6f180-4646-400a-9e72-4ec87587c177"
      unitRef="usd">183182000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <sem:AdjustedEbitda
      contextRef="i842ce964455440c8bf019b096558985c_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfMy0xLTEtMS0w_cb3e40d7-298e-4538-a629-597b85a3da77"
      unitRef="usd">186176000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i8083b69f958c4c0f8dbe5292758beec8_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfMy0zLTEtMS0w_f5bf31a6-8bb9-4c92-8797-5b969977de25"
      unitRef="usd">101302000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="ie1f26863a74d46b3807377370b9f5c71_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfMy01LTEtMS0w_d232b91b-eaa1-43e6-a52a-a616f424a6ab"
      unitRef="usd">71962000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="ie1d773ec12ea468d884922f6a9c624ab_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfMy03LTEtMS0w_b5a3ae51-7287-491d-9b06-742fd64f1b48"
      unitRef="usd">219075000</sem:AdjustedEbitda>
    <sem:AdjustedEbitda
      contextRef="i9da22e6ac16b4906870e768509e1fb6f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfMy05LTEtMS0w_f162573a-0ada-402f-b31a-046457a1c1fb"
      unitRef="usd">21847000</sem:AdjustedEbitda>
    <us-gaap:DepreciationAndAmortization
      contextRef="i842ce964455440c8bf019b096558985c_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNC0xLTEtMS0w_7faf3798-b1d7-4b05-85d3-a4dc5945bb45"
      unitRef="usd">25986000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i8083b69f958c4c0f8dbe5292758beec8_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNC0zLTEtMS0w_d77b7ce7-1a36-411e-a609-44400c6a8266"
      unitRef="usd">13999000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie1f26863a74d46b3807377370b9f5c71_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNC01LTEtMS0w_3307bfc0-3ee8-4a09-9ebc-b880f2518eaa"
      unitRef="usd">14536000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie1d773ec12ea468d884922f6a9c624ab_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNC03LTEtMS0w_aa2a7536-14f2-4551-840a-cab4579cd3d0"
      unitRef="usd">41128000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i9da22e6ac16b4906870e768509e1fb6f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNC05LTEtMS0w_d4139b96-d4be-44c2-b9cc-3fc610562456"
      unitRef="usd">4925000</us-gaap:DepreciationAndAmortization>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i842ce964455440c8bf019b096558985c_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNS0xLTEtMS0w_9545e4dd-f6f3-40f8-a3e6-d2b9b522d30e"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8083b69f958c4c0f8dbe5292758beec8_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNS0zLTEtMS0w_4aa3bddb-4476-4958-a21b-1934e74b68ac"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie1f26863a74d46b3807377370b9f5c71_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNS01LTEtMS0w_ab7f85a5-0fcc-420b-b3c3-52d412ddcf7a"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie1d773ec12ea468d884922f6a9c624ab_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNS03LTEtMS0w_e994202b-56df-4651-817e-351bb0c425ac"
      unitRef="usd">1071000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9da22e6ac16b4906870e768509e1fb6f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNS05LTEtMS0w_dca2572e-3ef3-4941-9e6c-ae167c880b9a"
      unitRef="usd">12737000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i842ce964455440c8bf019b096558985c_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNi0xLTEtMS0w_64390600-c860-4c7d-adf8-cb1f73dcf2da"
      unitRef="usd">160190000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8083b69f958c4c0f8dbe5292758beec8_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNi0zLTEtMS0w_643eba1d-f9be-4fe2-9fcc-bff90329b4df"
      unitRef="usd">87303000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie1f26863a74d46b3807377370b9f5c71_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNi01LTEtMS0w_05485dfb-f913-4c2a-847a-be98caebf0d9"
      unitRef="usd">57426000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie1d773ec12ea468d884922f6a9c624ab_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNi03LTEtMS0w_edd3eeaf-d844-412c-834f-e13703cafca8"
      unitRef="usd">176876000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9da22e6ac16b4906870e768509e1fb6f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNi05LTEtMS0w_573dd910-27f7-4364-9475-fdc954489de6"
      unitRef="usd">4185000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfNi0xMS0xLTEtMA_90cf3adb-4f75-4857-86fc-7202fc5c5bc5"
      unitRef="usd">485980000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfOC0xMS0xLTEtMA_997fd60e-d37f-4a5b-ac39-b9a7d992f59f"
      unitRef="usd">21728000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:LitigationSettlementInterest
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfMTAtMTEtMS0xLTA_cf5fb8d5-7233-408d-8317-26cc5c924830"
      unitRef="usd">-4749000</us-gaap:LitigationSettlementInterest>
    <us-gaap:InterestExpense
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfMTEtMTEtMS0xLTA_e9bb841f-10e2-42ba-9546-6d2d93ab8edb"
      unitRef="usd">68290000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83My9mcmFnOmYwYmQ5YTE0N2FkYjRhYzE5NzJiMGMyMTBhYjZkZWRhL3RhYmxlOjkxZWE2MmFkNjVhYzRhOTY4YWViN2JhN2I4NjAxNWZlL3RhYmxlcmFuZ2U6OTFlYTYyYWQ2NWFjNGE5NjhhZWI3YmE3Yjg2MDE1ZmVfMTItMTEtMS0xLTA_e2248ec3-7a85-41a6-8832-04338bdc7f6d"
      unitRef="usd">444167000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RleHRyZWdpb246YWViZDE3ZWI2OGQ1NGY0NDg2MGI2NzU5NjNiMDZkOGFfMTQ4_1cc95d92-ae82-4d63-9c37-9884008af83f">Revenue from Contracts with Customers&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables disaggregate the Company&#x2019;s revenue for the three and six months ended June&#160;30, 2020 and 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Critical Illness Recovery Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rehabilitation Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outpatient&lt;br/&gt;Rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Patient service revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;215,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;307,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;301,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;87,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;135,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;309,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;833,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total patient services revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;516,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;155,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;309,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,140,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;92,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;519,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;168,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;167,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;312,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,232,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Critical Illness Recovery Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rehabilitation Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outpatient&lt;br/&gt;Rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Patient service revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;201,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;103,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;350,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;340,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;98,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;217,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;454,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,111,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total patient services revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;542,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;202,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;263,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;454,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,462,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;101,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;544,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;212,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;280,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;456,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,564,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Critical Illness Recovery Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rehabilitation Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outpatient&lt;br/&gt;Rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Patient service revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;457,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;680,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;557,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;169,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;331,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;704,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,762,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total patient services revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,014,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;331,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;392,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;705,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,443,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;143,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;203,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,020,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;350,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;422,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;710,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;143,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,647,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Critical Illness Recovery Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rehabilitation Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outpatient&lt;br/&gt;Rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Patient service revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;433,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;206,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;81,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;721,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;702,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;193,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;418,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;874,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,189,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total patient services revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,135,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;400,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;875,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,911,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;199,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,138,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;420,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;532,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;879,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,110,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RleHRyZWdpb246YWViZDE3ZWI2OGQ1NGY0NDg2MGI2NzU5NjNiMDZkOGFfMTU0_17b7f0ce-e5f9-4dec-ad74-50c70238a42e">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables disaggregate the Company&#x2019;s revenue for the three and six months ended June&#160;30, 2020 and 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Critical Illness Recovery Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rehabilitation Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outpatient&lt;br/&gt;Rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Patient service revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;215,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;71,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;307,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;301,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;87,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;135,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;309,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;833,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total patient services revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;516,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;155,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;309,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,140,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;92,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;519,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;168,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;167,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;312,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,232,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Critical Illness Recovery Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rehabilitation Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outpatient&lt;br/&gt;Rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Patient service revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;201,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;103,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;350,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;340,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;98,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;217,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;454,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,111,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total patient services revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;542,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;202,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;263,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;454,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,462,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;101,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;544,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;212,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;280,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;456,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;70,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,564,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Critical Illness Recovery Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rehabilitation Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outpatient&lt;br/&gt;Rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Patient service revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;457,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;60,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;680,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;557,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;169,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;331,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;704,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,762,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total patient services revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,014,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;331,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;392,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;705,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,443,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;29,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;143,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;203,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,020,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;350,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;422,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;710,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;143,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,647,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.531%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Critical Illness Recovery Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rehabilitation Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outpatient&lt;br/&gt;Rehabilitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Concentra&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Patient service revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;433,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;206,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;81,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;721,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Non-Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;702,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;193,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;418,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;874,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,189,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total patient services revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,135,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;400,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;875,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,911,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;199,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,138,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;420,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;532,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;879,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;139,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,110,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia2445574d08d460aadb6cb824e13b57b_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNC0xLTEtMS0xNTUy_5726d1c3-7c79-442a-b23b-126ece029156"
      unitRef="usd">215508000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i17a8bda6aa364b458b46c6989204116a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNC0zLTEtMS0xNTUy_cae7c3f5-115d-4a30-94db-dceb2ad94c05"
      unitRef="usd">71510000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08f65e64fc704e26b6d0c36a9b3e98cc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNC01LTEtMS0xNTUy_eccedc38-3f85-41e9-bc4c-3973e93dfa2f"
      unitRef="usd">20049000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ad499a02f004e11a55a3d20c113db01_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNC03LTEtMS0xNTUy_141884d3-9101-404d-b50c-64613d87a849"
      unitRef="usd">257000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib6157d64fab14d1f866ca5d716c12912_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNC05LTEtMS0xNTUy_696c57ef-b847-41db-82af-0608548b6c40"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i51ff975211194a639c5584cea74d9cb5_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNC0xMS0xLTEtMTU1OQ_e081314b-f524-424c-9cc0-9b1eb2c6059f"
      unitRef="usd">307324000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5664ca3bf1834ed1b346b6f980fe1645_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNS0xLTEtMS0xNTUy_e0bd33a4-dd72-4a32-bd78-d475ef102474"
      unitRef="usd">301065000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1932c1a031b842f497c5e4232f3f980c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNS0zLTEtMS0xNTUy_0c361177-b013-4df8-b9aa-b3c498901478"
      unitRef="usd">87697000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia82ee7626c034379a7ef163f2061e2bf_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNS01LTEtMS0xNTUy_a07e1088-0220-473d-b651-314246711d47"
      unitRef="usd">135103000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb2712f735bf4472b74c12c452e1727d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNS03LTEtMS0xNTUy_e81aa1cd-def3-4805-be7b-558297b83370"
      unitRef="usd">309467000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9163058a56849f4b1b6ebd3958a1728_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNS05LTEtMS0xNTUy_f2c4b27a-6825-48ef-b564-aa475554d808"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i43209435be314fa6a83374c8722c58a5_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNS0xMS0xLTEtMTU1OQ_8d811ce2-e112-4c75-b5c5-5a58a6ed6ba2"
      unitRef="usd">833332000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2eb9a05c181e4145a86c46192acc8653_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNi0xLTEtMS0xNTU5_f8339dda-0579-419f-b635-e211e3ddad80"
      unitRef="usd">516573000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id5dc54ed53b94d6eabdf4d733168a430_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNi0zLTEtMS0xNTU5_53b3efbe-df50-4d27-a0d1-69d7ffcbda84"
      unitRef="usd">159207000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie5110b434e804f27b249daa0ac18bd3d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNi01LTEtMS0xNTU5_0f035835-5c59-4143-9c39-2f0efbc06ce7"
      unitRef="usd">155152000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1301e820f4e544f99fea1fdaef7b153a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNi03LTEtMS0xNTU5_38bb232c-f29f-4482-88a8-42255e6a556f"
      unitRef="usd">309724000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia49b80360ab44d889a87b1c6f86dba3d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNi05LTEtMS0xNTU5_4a40bb93-5f12-4fee-bd24-6321152d1191"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic6e87f49cddf4c0993fcc9475663950b_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNi0xMS0xLTEtMTU1OQ_224d24eb-cb1e-442c-9e1a-6e46a60f67c7"
      unitRef="usd">1140656000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d3595ddefe5469b964256337e3fb034_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNy0xLTEtMS0xNTUy_0f67eb20-8949-47f3-9476-72d9c850da62"
      unitRef="usd">3053000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a40e1e8ef2b4a6ca0e3d8215ef692c7_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNy0zLTEtMS0xNTUy_c3e67732-88fe-45ff-8b57-eaf92560c477"
      unitRef="usd">9460000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae9d25c4a62e4670a396e7b6215efe42_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNy01LTEtMS0xNTUy_7592bec5-dc7d-4731-99af-d38ffd36d7db"
      unitRef="usd">11986000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iddb712476dc64adeae838bf8e4757e71_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNy03LTEtMS0xNTUy_cba56e5d-4536-418a-9a5a-b52fdcca742a"
      unitRef="usd">2614000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i32cc5b0f0da748fa964f8bee8c8e5eab_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNy05LTEtMS0xNTUy_032ed4c4-43e1-4de6-a8c5-8b3de2876255"
      unitRef="usd">64949000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i424eb507e0b64cc39d53cf96c199d2c3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfNy0xMS0xLTEtMTU1OQ_b6c002f6-af47-4453-9c4d-738096241e6c"
      unitRef="usd">92062000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e1d48a74eba45399c9304871d02e6ac_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfOC0xLTEtMS0xNTU5_213f3e9f-a8f9-4a51-bfbd-ca7d8d480eb4"
      unitRef="usd">519626000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i153dba6636544126b8b590e3eceb746a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfOC0zLTEtMS0xNTU5_98a5f6d9-7445-41d9-ac9c-272f99d793bc"
      unitRef="usd">168667000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4101982ebb88440ab0a78e005d9ac883_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfOC01LTEtMS0xNTU5_eda27160-5ac3-47c5-b447-5e70026b7edf"
      unitRef="usd">167138000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaed2d25f9da44d15a8e75aa82e738f7c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfOC03LTEtMS0xNTU5_7d09d9c6-ccef-4d5a-b9fe-7f21bd979934"
      unitRef="usd">312338000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78b5037d6f24467bb284a7f3daadf67d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfOC05LTEtMS0xNTU5_00e188be-6b63-469c-8d47-c7976a4828f5"
      unitRef="usd">64949000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOmU0ODQzZDAxYzc1NjQyZThhNTRmZjY2YzAwZGQzNTU5L3RhYmxlcmFuZ2U6ZTQ4NDNkMDFjNzU2NDJlOGE1NGZmNjZjMDBkZDM1NTlfOC0xMS0xLTEtMTU1OQ_36322c57-4ce4-4ec6-8484-f03cc22f7fdb"
      unitRef="usd">1232718000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia2f065968f664f51a97a9c4c8a8f6786_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNC0xLTEtMS0xNTUy_edecdf54-97b0-4216-a28d-f94b321992c4"
      unitRef="usd">201198000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iedc923ca54a245aa839e41b3bd36de0e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNC0zLTEtMS0xNTUy_e8838a3c-9460-4a15-89fd-d1d70865e48a"
      unitRef="usd">103865000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97ccae97127f42ec84a3a9dd4735f5cd_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNC01LTEtMS0xNTUy_98a126f5-4c46-492c-9127-2f2072bba4e2"
      unitRef="usd">45291000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i091aa3c41eb94571a18e7d780ed4b261_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNC03LTEtMS0xNTUy_1190882d-fe82-4789-a471-8aa462530c02"
      unitRef="usd">295000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77d3137a60484a139d63c1c58d70fceb_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNC05LTEtMS0xNTUy_553c5653-083f-479d-a0b9-5e56c72e075f"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42b3c528abf945e9859cc7f7f223fceb_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNC0xMS0xLTEtMTU2MQ_d6f51d70-04b7-4c40-90e7-a17f67d0fe2f"
      unitRef="usd">350649000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd3ac5b6dbc749ff8ee6bfd8cf0ca211_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNS0xLTEtMS0xNTUy_dc6de541-018c-46aa-86b8-f3b60e60069e"
      unitRef="usd">340929000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iddc4d97079e3443eba00958c5b46559d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNS0zLTEtMS0xNTUy_0360466a-5345-4d13-8401-373cb07d15bd"
      unitRef="usd">98443000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i76832d2c4ca64519914f4773ca5655bc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNS01LTEtMS0xNTUy_6b17122d-c8a4-4721-9787-baf8a422e3fe"
      unitRef="usd">217893000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icbd9fe5a16a7443b8f6b7fb4c8339e17_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNS03LTEtMS0xNTUy_1b9f2d9f-d1d2-41f3-80fa-0fe0cc247a37"
      unitRef="usd">454125000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18f495ab15c4472ea5245942bf95dbc0_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNS05LTEtMS0xNTUy_73fc8f3c-5eab-4de7-873f-6093ba245d86"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic066865053b14c43b32c73b1cbc2a459_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNS0xMS0xLTEtMTU2MQ_2f29f1cd-9036-4c29-b9b5-0ab64b22bf0a"
      unitRef="usd">1111390000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe618caa2cdd41b493cccea11ad44386_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNi0xLTEtMS0xNTYx_dfeb9c97-06fe-4739-987c-4a2593bded4e"
      unitRef="usd">542127000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb0e1422e48941919179e0c5e60cc063_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNi0zLTEtMS0xNTYx_6e3b1bb7-3c03-47b2-946c-057ccb879b3e"
      unitRef="usd">202308000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i21b8f9d9710f4d46bba3b4cd219bcae3_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNi01LTEtMS0xNTYx_70c17504-e802-48d4-818c-584f805e92f5"
      unitRef="usd">263184000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i116e543b7d364332a96e426369913e91_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNi03LTEtMS0xNTYx_b6d68334-e547-4b17-8dda-773463b2b3e7"
      unitRef="usd">454420000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ce5d7ae1f3b480f9d278936f6173744_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNi05LTEtMS0xNTYx_22b4fc78-38f4-4f33-a0e5-727c1e7345b5"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4d10e3e03a54b60a9d607bc62d66b9d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNi0xMS0xLTEtMTU2MQ_bebbfca2-6e81-4a25-9a10-b7d2404e6b4f"
      unitRef="usd">1462039000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c16ab56e4cf48229de650aa8e6455b3_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNy0xLTEtMS0xNTUy_3974955d-ec54-4e3f-a08b-0153e8ed19fd"
      unitRef="usd">1932000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i473b076cbb2248cda45ee5fecdf6c6d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNy0zLTEtMS0xNTUy_e58c613d-3db4-4ee5-89bd-11a7bedd1d4f"
      unitRef="usd">10358000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i22bf8e5a71a74e0ab969fc88fc9d25f9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNy01LTEtMS0xNTUy_c694e363-9e08-496a-bf04-7ec660c5a65e"
      unitRef="usd">17225000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i31fd5c81c9e74201ae6e106c98ca01c6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNy03LTEtMS0xNTUy_9fff1e0f-004c-43fa-a6be-fb961d99bc49"
      unitRef="usd">1952000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i02680b33aed34a55a6fe418edcde45ed_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNy05LTEtMS0xNTUy_3eff4132-245f-4a62-8239-8e58a9b0de0e"
      unitRef="usd">70514000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8fcbd9d03f874759a798ba9dfa435489_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfNy0xMS0xLTEtMTU2MQ_c116312b-aa74-4951-8e87-022dfa53391d"
      unitRef="usd">101981000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4d9eaba867e94987bae380499ef0dea5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfOC0xLTEtMS0xNTYx_53f38683-c992-49cd-8405-8dedbdf4a855"
      unitRef="usd">544059000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie40b7ae534f84659b72f603832026b2c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfOC0zLTEtMS0xNTYx_c4eae5a8-f669-4d7f-afa1-b0a5bb947d7c"
      unitRef="usd">212666000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i51d714fd1694458d8c8a2740933d72d8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfOC01LTEtMS0xNTYx_df65927d-1057-494b-87dc-4688fb10e8c1"
      unitRef="usd">280409000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8878162e48ac455b871924e5a7f16043_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfOC03LTEtMS0xNTYx_29fda258-2694-4aff-90d2-27b1d9d40cce"
      unitRef="usd">456372000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i593f37f6bebf4b5c8147fc667686329b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfOC05LTEtMS0xNTYx_f92194df-10c1-4a04-bea3-c2f253e8c790"
      unitRef="usd">70514000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjExZDMwMjYxYjVkNjRlNDZiYmQ3N2FmNjA4YWQ1OWYyL3RhYmxlcmFuZ2U6MTFkMzAyNjFiNWQ2NGU0NmJiZDc3YWY2MDhhZDU5ZjJfOC0xMS0xLTEtMTU2MQ_86cdba08-7f20-4587-8033-9d238f207312"
      unitRef="usd">1564020000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id6f011f7031b41769857679e22ff5b33_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNC0xLTEtMS0w_5b0139e7-c949-4a32-aeec-b0aa692488c8"
      unitRef="usd">457017000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i25ea57bf51c745e29ae8656720141e04_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNC0zLTEtMS0w_fe54914c-0481-483f-a973-4836997c3dd5"
      unitRef="usd">162262000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4602a266daee48acb939fda3366b3e59_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNC01LTEtMS0w_b1ffc60e-35d0-4d4a-a287-39ddb7a80f39"
      unitRef="usd">60881000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52fcf8fa0e7f407ca9b2a0421d3c01b8_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNC03LTEtMS0w_b77e31cc-3605-490d-ab31-c4eed03b9109"
      unitRef="usd">729000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b1c9f6d7cde4d229d84a29158db43c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNC05LTEtMS0w_de9b8610-f810-4d6c-8820-49321f995be7"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb336581b1ab46dabf7a10b846ee714d_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNC0xMS0xLTEtMA_9e67df56-046e-4557-9aef-176c8d5220b4"
      unitRef="usd">680889000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7cf7cf902b774976a354f108a49e122b_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNS0xLTEtMS0w_9e96c581-e247-431b-be41-07228cc26d9e"
      unitRef="usd">557012000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09e5085e732d4d6fb28c986bae301d35_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNS0zLTEtMS0w_005e6b87-54fd-4435-9ca3-1d2aebf0d87a"
      unitRef="usd">169133000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c5c1a4ea8b1455f8ea9b309f782aed0_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNS01LTEtMS0w_c399480c-b5c4-4fd0-9963-619a9ebefbf8"
      unitRef="usd">331993000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iabcbf2354ad849b5a607f2c23acf92b6_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNS03LTEtMS0w_7060ca97-094e-4953-b498-361de83895a0"
      unitRef="usd">704500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f1e3f7f1bd3482cb8ed258cb9ada854_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNS05LTEtMS0w_972e5923-fec3-4691-aee8-f2bc30f5b543"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i30d728f258204b97bb72e03b6261514d_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNS0xMS0xLTEtMA_10871f10-35ce-40ed-8bd5-1cae3a459c05"
      unitRef="usd">1762638000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i059d076681264fbfb89b79347f63c29a_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNi0xLTEtMS0w_bbbe7437-c3fb-4dfe-86ac-340ce14d82bd"
      unitRef="usd">1014029000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f1cf5853d5f4c45936b37bfbdffa0db_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNi0zLTEtMS0w_c09075ed-2831-4074-a634-a09cc2122247"
      unitRef="usd">331395000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i063dc8bb9c604cb991c0938ed63900c1_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNi01LTEtMS0w_71da70a6-2bd1-433d-be02-7e983e530e71"
      unitRef="usd">392874000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7e73da1de31a46198a088e1a579b197e_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNi03LTEtMS0w_006d0c52-c084-4986-bcc0-dd720e08172e"
      unitRef="usd">705229000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i013ac78a834a4a17a349b46fff225ede_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNi05LTEtMS0w_8d653c75-165f-43f4-a0fb-be0d05ec3390"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i241f967097904b2e90e2c1981d5bfb2f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNi0xMS0xLTEtMA_4e528dea-19be-4f9f-b5e0-0a904fa2178b"
      unitRef="usd">2443527000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i606bd30a10194d7c92111ec05dd70ef2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNy0xLTEtMS0w_dbc19cc7-d61e-483d-afa5-71a930ebe123"
      unitRef="usd">6118000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i14aff568d487484d955b6414e353d276_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNy0zLTEtMS0w_fa60521f-8d63-4b26-859f-05528de1ce62"
      unitRef="usd">19291000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f5bf5cc569148f08c2f756e392e095a_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNy01LTEtMS0w_2267b545-84e9-4a63-8ad7-e266ce36ec8e"
      unitRef="usd">29513000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i513bb2ed05384cf0b367f1a1f2df60cd_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNy03LTEtMS0w_9c03ba3c-01d7-4420-aaa5-a97253769594"
      unitRef="usd">5644000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ae7544550d341458079a0f82f73a2f8_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNy05LTEtMS0w_aca93d63-27da-431d-98d3-c3d30831a0d8"
      unitRef="usd">143257000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1343d1d64ee546f4b3bc8de894d6a417_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfNy0xMS0xLTEtMA_f8416c52-8d47-47ea-bbd7-69ff07f95be3"
      unitRef="usd">203823000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i83fa48e193ef409091a5469b91556348_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfOC0xLTEtMS0w_ed0c55ad-b4b7-47bc-ba5a-aa6d9efd28b8"
      unitRef="usd">1020147000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7fe7ee2784746f5af6d2429cd8a2219_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfOC0zLTEtMS0w_f6f7a25c-05f4-496b-b35f-553654b8bf35"
      unitRef="usd">350686000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae89f2bc1bb34c1c88b6b97eb1162a82_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfOC01LTEtMS0w_bd956b34-f5ec-4c24-8dd8-728ae8a7c2ea"
      unitRef="usd">422387000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iffb407c8a9fd406bbddf4aaba0a22fbf_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfOC03LTEtMS0w_f30e0cdb-826b-49ac-85be-5d6ad1a2026b"
      unitRef="usd">710873000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a46c953c7a44137882933b2fccefa90_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfOC05LTEtMS0w_70da29cd-b2dc-49e4-934e-c6ba7d4a48e7"
      unitRef="usd">143257000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjE1MzhmN2NhMGM4OTQ1YTY4NWVhYzU0NTAyYjU1MjRiL3RhYmxlcmFuZ2U6MTUzOGY3Y2EwYzg5NDVhNjg1ZWFjNTQ1MDJiNTUyNGJfOC0xMS0xLTEtMA_0b437221-5961-40ee-af77-d87a43478956"
      unitRef="usd">2647350000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i446969a89bf54833b066ad6cadf438aa_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNC0xLTEtMS0w_74474164-bd07-411f-8cdd-1288d3aa183b"
      unitRef="usd">433338000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i35be1d23264d4ef8900b083084bae9b1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNC0zLTEtMS0w_20728bbe-5251-469a-a392-de5661c7bc27"
      unitRef="usd">206240000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i228091dd94e94a2fb65278d548b96136_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNC01LTEtMS0w_4da4d391-48c5-4ca3-b3ea-a3d0717f9bc1"
      unitRef="usd">81582000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i84a37576ff314681abd2c231a24ffea5_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNC03LTEtMS0w_6f3b1090-4824-46d8-886c-5a56322f5c46"
      unitRef="usd">525000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibef36a70c20e4c0e98c28b191ddfb97b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNC05LTEtMS0w_438e91e9-c296-45f9-8b17-fd978454fccd"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4bd1eaf1ae624135ac4bc8d0d22d46d6_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNC0xMS0xLTEtMA_eec56441-cf0e-40d2-91c3-af43881c9f5a"
      unitRef="usd">721685000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8c4a3d34c3f41908312ed9c79fa8fd3_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNS0xLTEtMS0w_49f1901a-5239-4ea6-a748-235c361795d8"
      unitRef="usd">702081000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie29532d76e2d4dee8c6c7b7b1be770c1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNS0zLTEtMS0w_ad4c63b7-fc88-4e30-871b-c3087795149e"
      unitRef="usd">193785000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45fee6050b8a4216a0f668de2e12e95b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNS01LTEtMS0w_9ce5192d-931e-450b-982e-1c52436dd166"
      unitRef="usd">418712000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i982e0b3f126040f69ce41b2c2252c0bc_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNS03LTEtMS0w_a43553a0-9ca2-41d4-bf01-0fe0c07700df"
      unitRef="usd">874779000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1882e5c4817847d286a5e4ee18cd8c03_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNS05LTEtMS0w_472756dd-5437-40e0-8ee3-a64df44e8fa5"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i89fb0d7ade4b445bbe6adb3867b94148_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNS0xMS0xLTEtMA_760a80a3-57aa-4d0e-ad32-47266a8bccef"
      unitRef="usd">2189357000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i39ec355699c047d88cd0a6ed1979c79b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNi0xLTEtMS0w_25f7a1c4-cc08-465f-95ed-853d51322a96"
      unitRef="usd">1135419000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaee340f3a6b64cbdbe9dbc79ba2744d6_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNi0zLTEtMS0w_6c43f5ec-2fa8-486b-b986-6aea99fec7e5"
      unitRef="usd">400025000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e316619ee3b482d9c7fae4209c447ad_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNi01LTEtMS0w_007dc11d-5d97-45e8-a2ee-147f8f6c8c22"
      unitRef="usd">500294000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27949e6e57514846a097e4475475890d_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNi03LTEtMS0w_a0be5f93-4e44-4199-98cd-e1763e042e6a"
      unitRef="usd">875304000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i101f8dba1cbb472ab5d1e292ca9ad014_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNi05LTEtMS0w_e318737a-8e12-4593-a8a1-f0c30af0c47d"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67f288ba5c84408f889c40613f2a07b4_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNi0xMS0xLTEtMA_a7d8ae53-0eec-4a88-9003-a0addb53f42e"
      unitRef="usd">2911042000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1950866dbcfb4c3e96407bec7d05b210_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNy0xLTEtMS0w_b1ea1ed4-99db-4c07-a2e3-4292dd0014e7"
      unitRef="usd">3512000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e70dfbd95e342bd9f7d99e607af7d63_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNy0zLTEtMS0w_606419d6-d8e0-438a-9453-36913115d684"
      unitRef="usd">20445000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4760aa7fcf714911a502ad44e9ed68ac_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNy01LTEtMS0w_a9c97934-6c98-465c-8f6a-b63acbdea132"
      unitRef="usd">32076000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic39be75c367b45e1a92d762771bc3eec_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNy03LTEtMS0w_dad12120-6d10-45ee-bba3-f7d6fb1f03ab"
      unitRef="usd">3908000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i71dc8bf60a54443290451e38ffa4cbb0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNy05LTEtMS0w_7c66e09a-62c5-47f0-a9dc-6a2ee0400982"
      unitRef="usd">139500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf91d28d1f7f4831a5c56411e190d606_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfNy0xMS0xLTEtMA_4d5eeec4-72d3-4e9d-b6a3-39d5f90c7bda"
      unitRef="usd">199441000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i842ce964455440c8bf019b096558985c_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfOC0xLTEtMS0w_cc35e649-99b8-4777-bf56-ed184992c42b"
      unitRef="usd">1138931000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8083b69f958c4c0f8dbe5292758beec8_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfOC0zLTEtMS0w_d1a86286-e6b9-4437-b848-a0560f13ef5d"
      unitRef="usd">420470000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie1f26863a74d46b3807377370b9f5c71_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfOC01LTEtMS0w_0772660b-891a-413d-be0d-10c001d581ac"
      unitRef="usd">532370000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie1d773ec12ea468d884922f6a9c624ab_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfOC03LTEtMS0w_5ad07e98-4f2c-4a02-8310-ec2b23134353"
      unitRef="usd">879212000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9da22e6ac16b4906870e768509e1fb6f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfOC05LTEtMS0w_98dfa20b-7067-4e28-87c3-a03a99bdb813"
      unitRef="usd">139500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl83OS9mcmFnOmFlYmQxN2ViNjhkNTRmNDQ4NjBiNjc1OTYzYjA2ZDhhL3RhYmxlOjVmZWZhY2EyOGRjOTRhYTVhYjBjMTUzYTM5ODQ0MjE1L3RhYmxlcmFuZ2U6NWZlZmFjYTI4ZGM5NGFhNWFiMGMxNTNhMzk4NDQyMTVfOC0xMS0xLTEtMA_c1425991-e262-47c3-88be-f21892eb5833"
      unitRef="usd">3110483000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RleHRyZWdpb246NTgzYmNkMDUzZjE0NGEwNjkyMTNjM2VjZGM2ZjdhZGRfMTgwNQ_4986b233-4429-4198-a32c-e3f6186531c8">Earnings per Share&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s capital structure includes common stock and unvested restricted stock awards. To compute earnings per share (&#x201c;EPS&#x201d;), the Company applies the two-class method because the Company&#x2019;s unvested restricted stock awards are participating securities which are entitled to participate equally with the Company&#x2019;s common stock in undistributed earnings. Application of the Company&#x2019;s two-class method is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-20.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.82pt"&gt;Net income attributable to the Company is reduced by the amount of dividends declared and by the contractual amount of dividends that must be paid for the current period for each class of stock. There were no contractual dividends paid for the three and six months ended June&#160;30, 2020 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-20.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.05pt"&gt;The remaining undistributed net income of the Company is then equally allocated to its common stock and unvested restricted stock awards, as if all of the earnings for the period had been distributed. The total net income allocated to each security is determined by adding both distributed and undistributed net income for the period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-20.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.28pt"&gt;The net income allocated to each security is then divided by the weighted average number of outstanding shares for the period to determine the EPS for each security considered in the two-class method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the net income attributable to the Company, its common shares outstanding, and its participating securities outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basic and Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basic and Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;67,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;196,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;333,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: net income attributable to non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;57,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income attributable to the Company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;164,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;104,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;275,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: Distributed and undistributed income attributable to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Distributed and undistributed income attributable to common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;101,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;266,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the computation of EPS under the two-class method:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="36" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Income Allocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basic and Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Income Allocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basic and Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="36" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except for per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;129,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;164,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="36" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Income Allocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basic and Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Income Allocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basic and Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="36" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except for per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;101,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;129,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;266,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;104,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;275,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;_______________________________________________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Represents the weighted average share count outstanding during the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:EarningsPerShareDilutedDistributed
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RleHRyZWdpb246NTgzYmNkMDUzZjE0NGEwNjkyMTNjM2VjZGM2ZjdhZGRfNjUz_10dadca4-5ba9-42d3-b9e7-ce6306a21d4c"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDilutedDistributed>
    <us-gaap:EarningsPerShareDilutedDistributed
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RleHRyZWdpb246NTgzYmNkMDUzZjE0NGEwNjkyMTNjM2VjZGM2ZjdhZGRfNjUz_2139889d-5cf1-410c-92e9-0ebff3695f29"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDilutedDistributed>
    <us-gaap:EarningsPerShareBasicDistributed
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RleHRyZWdpb246NTgzYmNkMDUzZjE0NGEwNjkyMTNjM2VjZGM2ZjdhZGRfNjUz_39641ffc-80b0-47a2-9a0d-818445d81572"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasicDistributed>
    <us-gaap:EarningsPerShareDilutedDistributed
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RleHRyZWdpb246NTgzYmNkMDUzZjE0NGEwNjkyMTNjM2VjZGM2ZjdhZGRfNjUz_55202914-857e-4447-a4d0-b3cf7eec887e"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDilutedDistributed>
    <us-gaap:EarningsPerShareBasicDistributed
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RleHRyZWdpb246NTgzYmNkMDUzZjE0NGEwNjkyMTNjM2VjZGM2ZjdhZGRfNjUz_6e086e3c-c93e-45d8-963b-1a9f58bb8564"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasicDistributed>
    <us-gaap:EarningsPerShareBasicDistributed
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RleHRyZWdpb246NTgzYmNkMDUzZjE0NGEwNjkyMTNjM2VjZGM2ZjdhZGRfNjUz_84e5fcdc-3cfb-4905-bb92-d8af8c63b23b"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasicDistributed>
    <us-gaap:EarningsPerShareDilutedDistributed
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RleHRyZWdpb246NTgzYmNkMDUzZjE0NGEwNjkyMTNjM2VjZGM2ZjdhZGRfNjUz_8502984c-5c10-42e0-a085-5fcae9a39ca9"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDilutedDistributed>
    <us-gaap:EarningsPerShareBasicDistributed
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RleHRyZWdpb246NTgzYmNkMDUzZjE0NGEwNjkyMTNjM2VjZGM2ZjdhZGRfNjUz_af90e3a3-f22b-42d6-82e7-9df6289c9c12"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasicDistributed>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RleHRyZWdpb246NTgzYmNkMDUzZjE0NGEwNjkyMTNjM2VjZGM2ZjdhZGRfMTgxNA_bad45875-890b-40fd-bdce-f90f4e389ab3">&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the net income attributable to the Company, its common shares outstanding, and its participating securities outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basic and Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basic and Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;67,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;196,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;137,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;333,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: net income attributable to non-controlling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;57,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Net income attributable to the Company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;164,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;104,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;275,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less: Distributed and undistributed income attributable to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Distributed and undistributed income attributable to common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;101,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;266,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the computation of EPS under the two-class method:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="36" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Income Allocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basic and Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Income Allocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basic and Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="36" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except for per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;49,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;129,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;159,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;164,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="36" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Income Allocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basic and Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Income Allocation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Basic and Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="36" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except for per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;101,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;129,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;266,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;130,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Company&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;104,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;275,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;_______________________________________________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Represents the weighted average share count outstanding during the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNC0yLTEtMS0w_4fab6bd7-099e-44e7-86bd-50b067b74a4e"
      unitRef="usd">67486000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNC00LTEtMS0w_36b54f1b-bff0-4dc0-9264-f3246b6e678e"
      unitRef="usd">196208000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNC02LTEtMS0w_5ca0d6f5-3e6a-4087-b027-8a9aaad0b091"
      unitRef="usd">137934000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNC04LTEtMS0w_7725064e-45de-42a7-91fb-584354ab8933"
      unitRef="usd">333422000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNS0yLTEtMS0w_e3400c37-a4d9-4ed7-ae57-ace4c30cafa4"
      unitRef="usd">15836000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNS00LTEtMS0w_9a059b87-e98f-4e91-8946-bdf65cc69757"
      unitRef="usd">31314000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNS02LTEtMS0w_cf3c7816-51cc-4ea1-a28b-5fbc4bf3122a"
      unitRef="usd">33159000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNS04LTEtMS0w_948fd0a0-9352-4f9b-8b3a-b972491c8790"
      unitRef="usd">57982000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNi0yLTEtMS0w_bc31a35b-6e00-4dc8-9aed-5f8c3bae5f14"
      unitRef="usd">51650000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNi00LTEtMS0w_71d505cf-1b8b-4ac6-87d0-bb8303239e26"
      unitRef="usd">164894000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNi02LTEtMS0w_63e517e1-78b3-4b8f-9210-de4b9f271d0b"
      unitRef="usd">104775000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNi04LTEtMS0w_b55561fa-39ca-489d-b8ca-08d83f579630"
      unitRef="usd">275440000</us-gaap:NetIncomeLoss>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNy0yLTEtMS0w_3be30c60-7c56-4742-80dd-3b0edca4d396"
      unitRef="usd">1778000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNy0yLTEtMS0w_8e87a52d-9401-4cf6-961c-506264c6fa84"
      unitRef="usd">1778000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNy00LTEtMS0w_21422369-78ea-415f-b951-2867cdf05b7a"
      unitRef="usd">5560000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNy00LTEtMS0w_f2f63858-f5f9-4132-882e-d73b531abc30"
      unitRef="usd">5560000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNy02LTEtMS0w_7a93cd36-c644-4cca-8396-1d18a836a9b1"
      unitRef="usd">3596000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNy02LTEtMS0w_b2014949-83c7-45c8-83c9-3b6488a21445"
      unitRef="usd">3596000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNy04LTEtMS0w_3d112dac-8f9e-41a5-bcf9-6bb7e3425bcc"
      unitRef="usd">9250000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfNy04LTEtMS0w_4b30987e-552a-4f82-80f0-b40b422a9ff7"
      unitRef="usd">9250000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfOC0yLTEtMS0w_6dd0666f-ed01-47ba-a10e-cdb35875d584"
      unitRef="usd">49872000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfOC0yLTEtMS0w_fe9f17a9-3fc6-4fb7-9e07-e1fbdefadb1f"
      unitRef="usd">49872000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfOC00LTEtMS0w_08d5428c-6427-4bb6-80d1-9259ad039e5e"
      unitRef="usd">159334000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfOC00LTEtMS0w_cb133351-627c-4dab-ad1c-2999f5432449"
      unitRef="usd">159334000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfOC02LTEtMS0w_0c320909-7b3e-47d9-83b9-ad9d6d2118b6"
      unitRef="usd">101179000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfOC02LTEtMS0w_ba777ff9-a6e8-4b73-a00e-da18fb9babc7"
      unitRef="usd">101179000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfOC04LTEtMS0w_1396eab5-7852-4217-a1ea-54fd1906d3bd"
      unitRef="usd">266190000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOjMxMDZiNGZmOGIwOTQ0Yzc4ZGEzZGVmMzAzYzQ1NzBjL3RhYmxlcmFuZ2U6MzEwNmI0ZmY4YjA5NDRjNzhkYTNkZWYzMDNjNDU3MGNfOC04LTEtMS0w_d0ab700d-56fc-443e-a4a2-3a6faa36638d"
      unitRef="usd">266190000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC0yLTEtMS01NTY_2ae4a6d1-d5c3-4193-b7b1-ef5429fae7cb"
      unitRef="usd">49872000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC0yLTEtMS01NTY_475f76bb-e86d-497c-8689-20b66415d9cf"
      unitRef="usd">49872000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC00LTEtMS01NTY_7ed97e91-6861-491d-be3c-43341da6cf35"
      unitRef="shares">129319000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC00LTEtMS01NTY_cd6f1708-6a66-4e29-a423-745e6bf40baf"
      unitRef="shares">129319000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC02LTEtMS02MDQ_8b33aa84-ed6a-44ba-99cc-0804bd299fb0"
      unitRef="usdPerShare">0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC02LTEtMS02MDQ_a7465f37-6c0d-4084-ba2d-be20686b73fd"
      unitRef="usdPerShare">0.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC05LTEtMS01NTY_1c8fa848-c6b6-4805-83cb-7262e008a195"
      unitRef="usd">159334000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC05LTEtMS01NTY_3104abb1-84d5-4fac-bdb7-9ef7283cce8e"
      unitRef="usd">159334000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC0xMS0xLTEtNTU2_1e93e7f2-684c-483b-9108-5703c8b9ecfa"
      unitRef="shares">130396000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC0xMS0xLTEtNTU2_27bfe71e-2ea0-4e79-996f-a97107cdc6a6"
      unitRef="shares">130396000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC0xMy0xLTEtNjA2_08a6d9bb-53f4-45e6-9316-28b6dd32c255"
      unitRef="usdPerShare">1.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNC0xMy0xLTEtNjA2_5a107905-c886-44af-99c0-7a2d7959baba"
      unitRef="usdPerShare">1.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNS0yLTEtMS01NTY_3be30c60-7c56-4742-80dd-3b0edca4d396"
      unitRef="usd">1778000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNS0yLTEtMS01NTY_8e87a52d-9401-4cf6-961c-506264c6fa84"
      unitRef="usd">1778000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNS00LTEtMS01NTY_827609c3-78ef-49ff-b579-9b96c313213e"
      unitRef="shares">4610000</us-gaap:IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNS02LTEtMS02MDQ_4658f215-a732-415a-b382-0e09544ed0c1"
      unitRef="usdPerShare">0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNS02LTEtMS02MDQ_84ec6e78-8eae-4bc3-b808-9425573b80fa"
      unitRef="usdPerShare">0.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNS05LTEtMS01NTY_21422369-78ea-415f-b951-2867cdf05b7a"
      unitRef="usd">5560000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNS05LTEtMS01NTY_f2f63858-f5f9-4132-882e-d73b531abc30"
      unitRef="usd">5560000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNS0xMS0xLTEtNTU2_726ee58d-d5c0-4b41-ab28-eaa208fa8956"
      unitRef="shares">4550000</us-gaap:IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNS0xMy0xLTEtNjA2_87c4050b-de9b-48e6-8860-7f8e3165f0f3"
      unitRef="usdPerShare">1.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNS0xMy0xLTEtNjA2_fa00e817-7180-4e02-97ae-cb67d904e6bb"
      unitRef="usdPerShare">1.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLoss
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNi0yLTEtMS02MDg_9ce8f6e2-59f5-4e5f-962d-c22e9980b1e5"
      unitRef="usd">51650000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmU0YWVmMzMyZDA2ODQ5MjBiMGEzZjdjMzg1NTFhOTlhL3RhYmxlcmFuZ2U6ZTRhZWYzMzJkMDY4NDkyMGIwYTNmN2MzODU1MWE5OWFfNi05LTEtMS02MTA_da00df3b-fa00-4e37-8047-a293869c7603"
      unitRef="usd">164894000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC0yLTEtMS0w_32bc83e3-1cf4-4951-b067-a5f0a80850d9"
      unitRef="usd">101179000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC0yLTEtMS0w_527057f5-f791-43e1-8a39-3e92dfce1dfd"
      unitRef="usd">101179000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC00LTEtMS0w_4baed145-012e-4482-ac0f-a24f478d082e"
      unitRef="shares">129479000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC00LTEtMS0w_86d9ef53-a7c5-425f-a836-7a88ef8d8570"
      unitRef="shares">129479000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC02LTEtMS0w_161ae3f1-069e-4639-a6cb-7cd59908532d"
      unitRef="usdPerShare">0.78</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC02LTEtMS0w_ec5613aa-0648-49b0-b1de-4e41f1f20652"
      unitRef="usdPerShare">0.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC05LTEtMS0w_92d36281-bcb1-46a8-8102-836f362017ec"
      unitRef="usd">266190000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC05LTEtMS0w_c99f431e-5241-40d9-bdb9-d0edcaf0f28c"
      unitRef="usd">266190000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC0xMS0xLTEtMA_2cd27020-ec74-43c8-9cab-d119faffb677"
      unitRef="shares">130362000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC0xMS0xLTEtMA_90f1df1f-78ea-4e00-ad0f-de4be69d4e40"
      unitRef="shares">130362000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC0xMy0xLTEtMA_83f3bd06-4afb-4143-9949-2e1ae532069e"
      unitRef="usdPerShare">2.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNC0xMy0xLTEtMA_f623fa30-d899-4df6-b7ce-e2b1ac7fee6a"
      unitRef="usdPerShare">2.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNS0yLTEtMS0w_7a93cd36-c644-4cca-8396-1d18a836a9b1"
      unitRef="usd">3596000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNS0yLTEtMS0w_b2014949-83c7-45c8-83c9-3b6488a21445"
      unitRef="usd">3596000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNS00LTEtMS0w_49c1c006-1964-4893-ac97-dc7dc9ccce5c"
      unitRef="shares">4602000</us-gaap:IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNS02LTEtMS0w_01f0027c-5233-49ee-8591-90996a001730"
      unitRef="usdPerShare">0.78</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNS02LTEtMS0w_1d93acc2-621d-4f4a-b13a-e9b9a359c933"
      unitRef="usdPerShare">0.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNS05LTEtMS0w_3d112dac-8f9e-41a5-bcf9-6bb7e3425bcc"
      unitRef="usd">9250000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNS05LTEtMS0w_4b30987e-552a-4f82-80f0-b40b422a9ff7"
      unitRef="usd">9250000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNS0xMS0xLTEtMA_988e7e9a-8b40-4d58-8237-f21c88d52969"
      unitRef="shares">4530000</us-gaap:IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNS0xMy0xLTEtMA_08621c40-5deb-4490-9641-7bbc377d83c0"
      unitRef="usdPerShare">2.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNS0xMy0xLTEtMA_a73784da-65f3-4eb9-b27a-daee1c8cfb53"
      unitRef="usdPerShare">2.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLoss
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNi0yLTEtMS0w_59c26e44-3508-4636-aabf-04b3e39c039a"
      unitRef="usd">104775000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl84NS9mcmFnOjU4M2JjZDA1M2YxNDRhMDY5MjEzYzNlY2RjNmY3YWRkL3RhYmxlOmUzMTk2YWZiZDZlMjQ5YWZhMTAzMDRkZWFjOGNlZjQ3L3RhYmxlcmFuZ2U6ZTMxOTZhZmJkNmUyNDlhZmExMDMwNGRlYWM4Y2VmNDdfNi05LTEtMS0w_3c97207e-e4c1-4a02-91ee-34c4e9be90ee"
      unitRef="usd">275440000</us-gaap:NetIncomeLoss>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85MS9mcmFnOmM5YTZkZWNmNjZjYzRjMmY5MTlhMGVjMDg3NWMwYmE1L3RleHRyZWdpb246YzlhNmRlY2Y2NmNjNGMyZjkxOWEwZWMwODc1YzBiYTVfODYzOA_c5ae9fba-c954-40eb-adf4-5ee5411ff675">Commitments and Contingencies&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a party to various legal actions, proceedings, and claims (some of which are not insured), and regulatory and other governmental audits and investigations in the ordinary course of its business. The Company cannot predict the ultimate outcome of pending litigation, proceedings, and regulatory and other governmental audits and investigations. These matters could potentially subject the Company to sanctions, damages, recoupments, fines, and other penalties. The Department of Justice, Centers for Medicare &amp;amp; Medicaid Services (&#x201c;CMS&#x201d;), or other federal and state enforcement and regulatory agencies may conduct additional investigations related to the Company&#x2019;s businesses in the future that may, either individually or in the aggregate, have a material adverse effect on the Company&#x2019;s business, financial position, results of operations, and liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To address claims arising out of the Company&#x2019;s operations, the Company maintains professional malpractice liability insurance and general liability insurance coverages through a number of different programs that are dependent upon such factors as the state where the Company is operating and whether the operations are wholly owned or are operated through a joint venture.  For the Company&#x2019;s wholly owned operations, the Company currently maintains insurance coverages under a combination of policies with a total annual aggregate limit of up to $37.0 million for professional malpractice liability insurance and $40.0 million for general liability insurance. The Company&#x2019;s insurance for the professional liability coverage is written on a &#x201c;claims-made&#x201d; basis, and its commercial general liability coverage is maintained on an &#x201c;occurrence&#x201d; basis. These coverages apply after a self-insured retention limit is exceeded. For the Company&#x2019;s joint venture operations, the Company has designed a separate insurance program that responds to the risks of specific joint ventures. Most of the Company&#x2019;s joint ventures are insured under a master program with an annual aggregate limit of up to $80.0 million, subject to a sublimit aggregate ranging from $23.0 million to $33.0 million for most joint ventures. The policies are generally written on a &#x201c;claims-made&#x201d; basis. Each of these programs has either a deductible or self-insured retention limit. The Company reviews its insurance program annually and may make adjustments to the amount of insurance coverage and self-insured retentions in future years. The Company also maintains umbrella liability insurance covering claims which, due to their nature or amount, are not covered by or not fully covered by the Company&#x2019;s other insurance policies. These insurance policies also do not generally cover punitive damages and are subject to various deductibles and policy limits. Significant legal actions, as well as the cost and possible lack of available insurance, could subject the Company to substantial uninsured liabilities. In the Company&#x2019;s opinion, the outcome of these actions, individually or in the aggregate, will not have a material adverse effect on its financial position, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Healthcare providers are subject to lawsuits under the qui tam provisions of the federal False Claims Act. Qui tam lawsuits typically remain under seal (hence, usually unknown to the defendant) for some time while the government decides whether or not to intervene on behalf of a private qui tam plaintiff (known as a relator) and take the lead in the litigation. These lawsuits can involve significant monetary damages and penalties and award bounties to private plaintiffs who successfully bring the suits. The Company is and has been a defendant in these cases in the past, and may be named as a defendant in similar cases from time to time in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Therapy Subpoena.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In May 2017, the Company received a subpoena from the U.S. Attorney&#x2019;s Office for the District of New Jersey seeking various documents principally relating to the Company&#x2019;s contract therapy division, which contracted to furnish rehabilitation therapy services to residents of skilled nursing facilities (&#x201c;SNFs&#x201d;) and other providers. The Company operated its contract therapy division through a subsidiary until March 31, 2016, when the Company sold the stock of the subsidiary. The subpoena seeks documents that appear to be aimed at assessing whether therapy services were furnished and billed in compliance with Medicare SNF billing requirements, including whether therapy services were coded at inappropriate levels and whether excessive or unnecessary therapy was furnished to justify coding at higher paying levels. The U.S. Attorney&#x2019;s Office indicated that the subpoena was issued in connection with a qui tam lawsuit. The Company produced documents in response to the subpoena and fully cooperated with this investigation. In July 2021, the Company entered into a settlement agreement with the United States government, the plaintiff-relator who filed the qui tam lawsuit, and the purchaser of the Company&#x2019;s contract therapy division in March 2016. In satisfaction of its indemnity obligations under the purchase agreement signed in March 2016, the Company agreed to make payments related to the settlement that will not exceed the amount of a liability accrued, and a non-operating loss incurred, during the nine months ended September 30, 2020. Such payments, in the aggregate, are immaterial to the Company&#x2019;s financial statements. In the settlement agreement, the government and the plaintiff-relator released the Company from liability for all conduct alleged in the complaint, and the Company admitted no liability or wrongdoing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Oklahoma City Subpoena.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; On August 24, 2020, the Company and Select Specialty Hospital &#x2013; Oklahoma City, Inc. (&#x201c;SSH&#x2013;Oklahoma City&#x201d;) received Civil Investigative Demands from the U.S. Attorney&#x2019;s Office for the Western District of Oklahoma seeking responses to interrogatories and the production of various documents principally relating to the documentation, billing and reviews of medical services furnished to patients at SSH-Oklahoma City. The Company does not know whether the subpoena has been issued in connection with a qui tam lawsuit or in connection with possible civil, criminal or administrative proceedings by the government. The Company is producing documents in response to the subpoena and intends to fully cooperate with this investigation. At this time, the Company is unable to predict the timing and outcome of this matter. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New Jersey Litigation. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;   &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020, the United States District Court for the District of New Jersey unsealed a qui tam complaint in United States of America and State of New Jersey ex rel. Keith A. DiLello, Sr. v. Hackensack Meridian Health, Jersey Shore University Medical Center, Ocean Medical Center, Seaview Orthopaedics, Shrewsbury Surgery Center, Kessler Rehabilitation, Dr. Halambros Demetriades, Dr. Theodore Kutzan, Dr. Adam Myers, Dr. Hoan-Vu Nguyen, Dr. Frederick De Paola, ABC Corporations 1-10, and John/Jane Does 1-10, Case 3:20-cv-02949-FLW-ZNQ. The complaint was filed under seal in March 2020 and was unsealed after the United States and State of New Jersey declined to intervene in the case. In the complaint, the plaintiff-relator, an automobile accident victim and former patient of the defendant providers, alleges that they routinely billed both personal injury protection (&#x201c;PIP&#x201d;) carriers and CMS. He alleges that they violated federal and state law by billing CMS when other insurance is available and failing to return payment to CMS after payment was made by the PIP carriers. In March 2021, defendant Kessler Rehabilitation waived service of process of the complaint. The Company intends to vigorously defend this action, but at this time the Company is unable to predict the timing and outcome of this matter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Medicare Dual-Eligible Litigation&lt;/span&gt;&lt;/div&gt;The Company&#x2019;s critical illness recovery hospitals have pursued claims against CMS involving denied Medicare bad debt reimbursement for copayments and deductibles of dual-eligible Medicaid beneficiaries for cost reporting periods ending in 2005 through 2010. A U.S. District Court ruled in favor of the Company and ordered CMS to determine and pay the Medicare bad debt reimbursement plus interest and, in February 2021, the Company received reimbursement proceeds of $17.9 million plus accrued interest of $4.7 million. These amounts were recognized as other operating income and interest income, respectively, during the six months ended June&#160;30, 2021.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:MalpracticeInsuranceAnnualCoverageLimit
      contextRef="i6bd31c72edeb45d9b4601581e31a0e89_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85MS9mcmFnOmM5YTZkZWNmNjZjYzRjMmY5MTlhMGVjMDg3NWMwYmE1L3RleHRyZWdpb246YzlhNmRlY2Y2NmNjNGMyZjkxOWEwZWMwODc1YzBiYTVfMTQ2Ng_2821bb56-18be-4d05-97e9-16a9aa4907d6"
      unitRef="usd">37000000.0</us-gaap:MalpracticeInsuranceAnnualCoverageLimit>
    <us-gaap:MalpracticeInsuranceAnnualCoverageLimit
      contextRef="ia491adcb999943c481f80ad4aaeebcae_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85MS9mcmFnOmM5YTZkZWNmNjZjYzRjMmY5MTlhMGVjMDg3NWMwYmE1L3RleHRyZWdpb246YzlhNmRlY2Y2NmNjNGMyZjkxOWEwZWMwODc1YzBiYTVfMTUyMg_e124014f-ce8f-4175-94d9-cd1d9875a703"
      unitRef="usd">40000000.0</us-gaap:MalpracticeInsuranceAnnualCoverageLimit>
    <us-gaap:MalpracticeInsuranceAnnualCoverageLimit
      contextRef="if67ed923fb524d7e88c6828d4a0c423a_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85MS9mcmFnOmM5YTZkZWNmNjZjYzRjMmY5MTlhMGVjMDg3NWMwYmE1L3RleHRyZWdpb246YzlhNmRlY2Y2NmNjNGMyZjkxOWEwZWMwODc1YzBiYTVfMjA4Mg_c3aedb4c-744f-4386-af04-5f9a7c3758a6"
      unitRef="usd">80000000.0</us-gaap:MalpracticeInsuranceAnnualCoverageLimit>
    <us-gaap:MalpracticeInsuranceAnnualCoverageLimit
      contextRef="ied10c49f8e374623bcde2e89b5b25289_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85MS9mcmFnOmM5YTZkZWNmNjZjYzRjMmY5MTlhMGVjMDg3NWMwYmE1L3RleHRyZWdpb246YzlhNmRlY2Y2NmNjNGMyZjkxOWEwZWMwODc1YzBiYTVfMjEzMQ_1d685aa6-7b05-4c5c-b82b-be0ca614ce87"
      unitRef="usd">23000000.0</us-gaap:MalpracticeInsuranceAnnualCoverageLimit>
    <us-gaap:MalpracticeInsuranceAnnualCoverageLimit
      contextRef="i465d9175e18d4165b2f6834e5d9e0b7a_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85MS9mcmFnOmM5YTZkZWNmNjZjYzRjMmY5MTlhMGVjMDg3NWMwYmE1L3RleHRyZWdpb246YzlhNmRlY2Y2NmNjNGMyZjkxOWEwZWMwODc1YzBiYTVfMjEzNw_8f7ddccd-4aea-488c-8348-dbf1ada135fd"
      unitRef="usd">33000000.0</us-gaap:MalpracticeInsuranceAnnualCoverageLimit>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i760d525b19534ec8bf2275b1a4759394_D20210201-20210228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85MS9mcmFnOmM5YTZkZWNmNjZjYzRjMmY5MTlhMGVjMDg3NWMwYmE1L3RleHRyZWdpb246YzlhNmRlY2Y2NmNjNGMyZjkxOWEwZWMwODc1YzBiYTVfODI5Ng_6b6d5b5c-c4d0-4dab-9be6-9340679e60d4"
      unitRef="usd">17900000</us-gaap:ProceedsFromLegalSettlements>
    <sem:ProceedsFromLegalSettlementsAccruedInterest
      contextRef="i760d525b19534ec8bf2275b1a4759394_D20210201-20210228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85MS9mcmFnOmM5YTZkZWNmNjZjYzRjMmY5MTlhMGVjMDg3NWMwYmE1L3RleHRyZWdpb246YzlhNmRlY2Y2NmNjNGMyZjkxOWEwZWMwODc1YzBiYTVfODMyNA_bc0257c3-5ed2-4002-90ec-7b3e5da0f870"
      unitRef="usd">4700000</sem:ProceedsFromLegalSettlementsAccruedInterest>
    <us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfNDIxMA_a1226f85-daef-42fa-8b3d-33ea64a8a5e8">CARES Act&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Provider Relief Funds&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;) was enacted. Since the enactment of the CARES Act, the Company&#x2019;s consolidated subsidiaries have received approximately $208.4 million of payments from the Public Health and Social Services Emergency Fund, also referred to as the Provider Relief Fund. The Company is able to use payments received under the Provider Relief Fund for &#x201c;health care related expenses or lost revenues that are attributable to coronavirus.&#x201d; The Provider Relief Fund payments must first be applied against health care related expenses attributable to COVID-19. Provider Relief Fund payments not fully expended on healthcare related expenses attributable to COVID-19 are then applied to lost revenues. The provisions of the Provider Relief Fund payments permit a parent organization to allocate all or a portion of its general and targeted distributions among its subsidiaries which are eligible health care providers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since the CARES Act was enacted, the Department of Health and Human Services (&#x201c;HHS&#x201d;) has issued a series of post-payment notices of reporting requirements and other guidance which, in some instances, have significantly altered the terms and conditions surrounding the Provider Relief Fund payments. Additionally, certain provisions and reporting requirements associated with the Provider Relief Fund payments were signed into law as part of the Coronavirus Response and Relief Supplemental Appropriations Act of 2021 (&#x201c;CRRSA Act&#x201d;) on December 27, 2020. On June 11, 2021, HHS released an updated post-payment notice of reporting requirements and new and modified responses to its Frequently Asked Questions regarding the Provider Relief Fund payments. Among other things, HHS updated the period of time in which recipients must use the Provider Relief Fund payments. Under the revised guidance, the deadlines for utilizing the payments are based on the date in which the payments were received, rather than requiring all payments be used by June 30, 2021. The deadlines to use the Provider Relief Fund payments are now as follows: (i) payments received between April 10, 2020 and June 30, 2020 must have been used by June 30, 2021, (ii) payments received between July 1, 2020 and December 31, 2020 must be used by December 31, 2021, (iii)  payments received between January 1, 2021 and June 30, 2021 must be used by June 30, 2022, and (iv) payments received between July 1, 2021 and December 31, 2021 must be used by December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Company&#x2019;s accounting policy, payments are recognized as other operating income when it is probable that it has complied with the terms and conditions of the payments. The Company evaluated its eligibility to utilize certain Provider Relief Fund payments and whether those payments were used in accordance with the terms and conditions set forth within the CRRSA Act and by HHS as of June 30, 2021. The Company&#x2019;s assessment of uncertainties surrounding its ability to utilize certain of its Provider Relief Fund payments, including its ability to allocate general distributions among the Company&#x2019;s subsidiaries, was updated for additional information obtained during the period. Based on this updated assessment, the Company believes it is probable that it has complied with the terms and conditions associated with the Provider Relief Fund payments as of June 30, 2021. During the three and six months ended June&#160;30, 2021, the Company determined that it was eligible to recognize approximately $98.0 million and $114.1 million, respectively, of Provider Relief Fund payments as other operating income on the accompanying condensed consolidated statement of operations. The Company recognized $55.0 million of other operating income during both the three and six months ended June&#160;30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, $4.1 million of Provider Relief Fund payments have not yet been utilized by the Company in accordance with the regulations promulgated by HHS and the CRRSA Act and are reported as unearned government assistance on the accompanying condensed consolidated balance sheet. Of this amount, $1.7&#160;million will be repaid to the government because the payments could not be utilized by the deadlines specified by HHS. The remaining Provider Relief Fund payments may need to be repaid to the extent they cannot be utilized in accordance with the terms and conditions set forth within the CRRSA Act and by HHS. Further changes to the regulations surrounding the Provider Relief Fund payments or amended interpretations of existing guidance may change the Company&#x2019;s assessment of whether it is probable that is has complied with the terms of conditions of the Provider Relief Fund payments. These changes may result in the Company being unable to recognize additional Provider Relief Fund payments as other operating income or the reversal of amounts previously recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Medicare Accelerated and Advance Payments Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s consolidated subsidiaries received approximately $325.0 million of advance payments under CMS&#x2019;s Accelerated and Advance Payment Program, which was temporarily expanded by the CARES Act. Repayment of the advance payments begins one year from the issuance date of the payment. After that first year, the Medicare program automatically recoups 25.0% of the Medicare payments otherwise owed to the provider or supplier for eleven months. At the end of the eleven-month period, recoupment increases to 50.0% for another six months. Any amounts that remain unpaid after 29 months are subject to a 4.0% interest rate. &lt;/span&gt;&lt;/div&gt;The Company received the majority of its advance payments in April 2020. Accordingly, CMS began recouping a portion of the Medicare payments due to the Company beginning in April 2021. CMS recouped $73.7 million of Medicare payments during the three and six months ended June&#160;30, 2021. The remaining amounts owed to CMS under the Accelerated and Advance Payment Program are reflected as government advances on the accompanying condensed consolidated balance sheets</us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock>
    <sem:ProceedsFromGovernmentAssistanceCARESAct
      contextRef="i69380e325f114ea89df7916749073905_D20200327-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfMjQ5_408d4fb0-d748-465a-b97e-07ac2811fecd"
      unitRef="usd">208400000</sem:ProceedsFromGovernmentAssistanceCARESAct>
    <sem:GovernmentAssistanceRecognizedInEarningsCARESAct
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfMjc0ODc3OTA5MzAyNw_bf2661ed-4562-4164-972d-8646ee17962a"
      unitRef="usd">98000000.0</sem:GovernmentAssistanceRecognizedInEarningsCARESAct>
    <sem:GovernmentAssistanceRecognizedInEarningsCARESAct
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfMjc0ODc3OTA5MzAzNw_dc5b79af-1df9-43ee-ba07-3e2499e26e30"
      unitRef="usd">114100000</sem:GovernmentAssistanceRecognizedInEarningsCARESAct>
    <sem:GovernmentAssistanceRecognizedInEarningsCARESAct
      contextRef="i0aaa295e30874a5eb969c761f7c5086f_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfMjc0ODc3OTExNzgyMQ_7bb505b1-e95e-4223-bfd9-e5ec745b92ed"
      unitRef="usd">55000000.0</sem:GovernmentAssistanceRecognizedInEarningsCARESAct>
    <sem:GovernmentAssistanceRecognizedInEarningsCARESAct
      contextRef="ibde20a887a8b4f9bb3e1915d4c334574_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfMjc0ODc3OTExNzgyMQ_9b571b8f-a4e2-4696-b4d5-ac08a4ab957b"
      unitRef="usd">55000000.0</sem:GovernmentAssistanceRecognizedInEarningsCARESAct>
    <sem:UnearnedGovernmentAssistanceCARESAct
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfMjY0NA_87dd574d-f591-4df3-81cf-66411fcddddd"
      unitRef="usd">4100000</sem:UnearnedGovernmentAssistanceCARESAct>
    <sem:UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct
      contextRef="i632267a60f314ae3bccec20a793b8465_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfMzI5ODUzNDkzMTEwNQ_f10cbb29-b3b7-422c-8c46-828f69096ca1"
      unitRef="usd">1700000</sem:UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct>
    <sem:GovernmentAdvancesCARESAct
      contextRef="i1e1fc4e7b10d4564ae73da8aaf8268ca_I20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfMTA5OTUxMTY3MzU0MA_f9083a52-644e-4976-a0aa-6d8201dfb1aa"
      unitRef="usd">325000000.0</sem:GovernmentAdvancesCARESAct>
    <sem:GovernmentAdvancesRecoupedCARESAct
      contextRef="i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfMjc0ODc3OTA4ODI1Mw_002a8c21-3f06-426d-9c3e-b2a5dbb4f860"
      unitRef="usd">73700000</sem:GovernmentAdvancesRecoupedCARESAct>
    <sem:GovernmentAdvancesRecoupedCARESAct
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85NC9mcmFnOjI2YmZiNzk5MzYwYjQ4YjFiMjA2MDIyZGI3ZjkwNzI2L3RleHRyZWdpb246MjZiZmI3OTkzNjBiNDhiMWIyMDYwMjJkYjdmOTA3MjZfMjc0ODc3OTA4ODI1Mw_761bffd4-3fed-4c25-85c8-0d8d6221c238"
      unitRef="usd">73700000</sem:GovernmentAdvancesRecoupedCARESAct>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85Ny9mcmFnOjM1ZjY1Nzc0YmU0MzQ5ZGU5NmE5MWM3OTQyZjc0YjIxL3RleHRyZWdpb246MzVmNjU3NzRiZTQzNDlkZTk2YTkxYzc5NDJmNzRiMjFfMjQ0_5adc96d3-609d-4777-be0e-490360adfeec">Subsequent Event On August 4, 2021, the Company&#x2019;s board of directors declared a cash dividend of $0.125 per share. The dividend will be payable on or about August 30, 2021 to stockholders of record as of the close of business on August 18, 2021.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="ib0cd8e5fc1d2451fa507e01087b5e757_I20210804"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJjYTRhNjIwNzYxZjQwNDhhYmJlYjNiOGU2YjUxZDZmL3NlYzoyY2E0YTYyMDc2MWY0MDQ4YWJiZWIzYjhlNmI1MWQ2Zl85Ny9mcmFnOjM1ZjY1Nzc0YmU0MzQ5ZGU5NmE5MWM3OTQyZjc0YjIxL3RleHRyZWdpb246MzVmNjU3NzRiZTQzNDlkZTk2YTkxYzc5NDJmNzRiMjFfMTA1_e13560c0-4419-411b-b19c-529c2f10c19a"
      unitRef="usdPerShare">0.125</us-gaap:DividendsPayableAmountPerShare>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888051717608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SELECT MEDICAL HOLDINGS CORP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-1764048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4714 Gettysburg Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">P.O.&#160;Box&#160;2034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Mechanicsburg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">17055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">972-1100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SEM<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,576,139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001320414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888053261240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 803,493<span></span>
</td>
<td class="nump">$ 577,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">931,179<span></span>
</td>
<td class="nump">896,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">5,417<span></span>
</td>
<td class="nump">5,686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">128,081<span></span>
</td>
<td class="nump">114,490<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">1,868,170<span></span>
</td>
<td class="nump">1,594,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">1,053,331<span></span>
</td>
<td class="nump">1,032,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">928,226<span></span>
</td>
<td class="nump">943,420<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,391,040<span></span>
</td>
<td class="nump">3,379,014<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Identifiable intangible assets, net</a></td>
<td class="nump">380,302<span></span>
</td>
<td class="nump">387,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">335,310<span></span>
</td>
<td class="nump">319,207<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">7,956,379<span></span>
</td>
<td class="nump">7,655,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">224,868<span></span>
</td>
<td class="nump">220,413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt and notes payable</a></td>
<td class="nump">11,608<span></span>
</td>
<td class="nump">12,621<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">187,736<span></span>
</td>
<td class="nump">177,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent', window );">Accrued payroll</a></td>
<td class="nump">246,960<span></span>
</td>
<td class="nump">224,876<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedVacationCurrent', window );">Accrued vacation</a></td>
<td class="nump">146,790<span></span>
</td>
<td class="nump">132,811<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">28,938<span></span>
</td>
<td class="nump">29,240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued other</a></td>
<td class="nump">256,095<span></span>
</td>
<td class="nump">228,948<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_GovernmentAdvancesCARESAct', window );">Government advances (Note 15)</a></td>
<td class="nump">251,272<span></span>
</td>
<td class="nump">321,807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_UnearnedGovernmentAssistanceCARESAct', window );">Unearned government assistance (Note 15)</a></td>
<td class="nump">4,099<span></span>
</td>
<td class="nump">82,607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Income taxes payable</a></td>
<td class="nump">50,662<span></span>
</td>
<td class="nump">7,956<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">1,409,028<span></span>
</td>
<td class="nump">1,438,366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating lease liabilities</a></td>
<td class="nump">893,478<span></span>
</td>
<td class="nump">875,367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt, net of current portion</a></td>
<td class="nump">3,386,214<span></span>
</td>
<td class="nump">3,389,398<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Non-current deferred tax liability</a></td>
<td class="nump">123,559<span></span>
</td>
<td class="nump">132,421<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">172,656<span></span>
</td>
<td class="nump">168,703<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">5,984,935<span></span>
</td>
<td class="nump">6,004,255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 14)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable non-controlling interests</a></td>
<td class="nump">521,552<span></span>
</td>
<td class="nump">398,171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value, 700,000,000 shares authorized, 134,850,735 and 135,005,369 shares issued and outstanding at 2020 and 2021, respectively</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Capital in excess of par</a></td>
<td class="nump">516,172<span></span>
</td>
<td class="nump">509,128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">713,191<span></span>
</td>
<td class="nump">553,244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="nump">4,727<span></span>
</td>
<td class="num">(2,027)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders&#8217; Equity</a></td>
<td class="nump">1,234,225<span></span>
</td>
<td class="nump">1,060,480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interests</a></td>
<td class="nump">215,667<span></span>
</td>
<td class="nump">192,493<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total Equity</a></td>
<td class="nump">1,449,892<span></span>
</td>
<td class="nump">1,252,973<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Equity</a></td>
<td class="nump">$ 7,956,379<span></span>
</td>
<td class="nump">$ 7,655,399<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Salaries, Accrued Bonuses, And Accrued Payroll Taxes, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_GovernmentAdvancesCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Government Advances, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_GovernmentAdvancesCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_UnearnedGovernmentAssistanceCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unearned Government Assistance, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_UnearnedGovernmentAssistanceCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedVacationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6409733&amp;loc=d3e19396-108361<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedVacationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888051349272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">700,000,000<span></span>
</td>
<td class="nump">700,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">135,005,369<span></span>
</td>
<td class="nump">134,850,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">135,005,369<span></span>
</td>
<td class="nump">134,850,735<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888154527592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 1,564,020<span></span>
</td>
<td class="nump">$ 1,232,718<span></span>
</td>
<td class="nump">$ 3,110,483<span></span>
</td>
<td class="nump">$ 2,647,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services, exclusive of depreciation and amortization</a></td>
<td class="nump">1,291,448<span></span>
</td>
<td class="nump">1,082,456<span></span>
</td>
<td class="nump">2,584,897<span></span>
</td>
<td class="nump">2,282,827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">35,737<span></span>
</td>
<td class="nump">33,461<span></span>
</td>
<td class="nump">71,140<span></span>
</td>
<td class="nump">67,292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">50,954<span></span>
</td>
<td class="nump">52,271<span></span>
</td>
<td class="nump">100,574<span></span>
</td>
<td class="nump">104,023<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">1,378,139<span></span>
</td>
<td class="nump">1,168,188<span></span>
</td>
<td class="nump">2,756,611<span></span>
</td>
<td class="nump">2,454,142<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating income</a></td>
<td class="nump">98,087<span></span>
</td>
<td class="nump">54,988<span></span>
</td>
<td class="nump">132,108<span></span>
</td>
<td class="nump">54,988<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">283,968<span></span>
</td>
<td class="nump">119,518<span></span>
</td>
<td class="nump">485,980<span></span>
</td>
<td class="nump">248,196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income and expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of unconsolidated subsidiaries</a></td>
<td class="nump">11,809<span></span>
</td>
<td class="nump">8,324<span></span>
</td>
<td class="nump">21,728<span></span>
</td>
<td class="nump">10,912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Gain on sale of businesses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">346<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementInterest', window );">Interest income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,749<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(33,888)<span></span>
</td>
<td class="num">(37,366)<span></span>
</td>
<td class="num">(68,290)<span></span>
</td>
<td class="num">(83,473)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">261,889<span></span>
</td>
<td class="nump">90,822<span></span>
</td>
<td class="nump">444,167<span></span>
</td>
<td class="nump">183,182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">65,681<span></span>
</td>
<td class="nump">23,336<span></span>
</td>
<td class="nump">110,745<span></span>
</td>
<td class="nump">45,248<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">196,208<span></span>
</td>
<td class="nump">67,486<span></span>
</td>
<td class="nump">333,422<span></span>
</td>
<td class="nump">137,934<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to non-controlling interests</a></td>
<td class="nump">31,314<span></span>
</td>
<td class="nump">15,836<span></span>
</td>
<td class="nump">57,982<span></span>
</td>
<td class="nump">33,159<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Select Medical Holdings Corporation</a></td>
<td class="nump">$ 164,894<span></span>
</td>
<td class="nump">$ 51,650<span></span>
</td>
<td class="nump">$ 275,440<span></span>
</td>
<td class="nump">$ 104,775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per common share (Note 13):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 1.22<span></span>
</td>
<td class="nump">$ 0.39<span></span>
</td>
<td class="nump">$ 2.04<span></span>
</td>
<td class="nump">$ 0.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 1.22<span></span>
</td>
<td class="nump">$ 0.39<span></span>
</td>
<td class="nump">$ 2.04<span></span>
</td>
<td class="nump">$ 0.78<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest expense (income) directly attributable to an award in settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888051016728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 196,208<span></span>
</td>
<td class="nump">$ 67,486<span></span>
</td>
<td class="nump">$ 333,422<span></span>
</td>
<td class="nump">$ 137,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gain (loss) on interest rate cap cash flow hedge</a></td>
<td class="num">(1,403)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,748<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassification adjustment for (gains) losses included in net income</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net change, net of tax benefit (expense)</a></td>
<td class="num">(1,397)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,754<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">194,811<span></span>
</td>
<td class="nump">67,486<span></span>
</td>
<td class="nump">340,176<span></span>
</td>
<td class="nump">137,934<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive income attributable to non-controlling interests</a></td>
<td class="nump">31,314<span></span>
</td>
<td class="nump">15,836<span></span>
</td>
<td class="nump">57,982<span></span>
</td>
<td class="nump">33,159<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Select Medical Holdings Corporation</a></td>
<td class="nump">$ 163,497<span></span>
</td>
<td class="nump">$ 51,650<span></span>
</td>
<td class="nump">$ 282,194<span></span>
</td>
<td class="nump">$ 104,775<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888051973064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Tax benefit (expense) on components of other comprehensive income</a></td>
<td class="nump">$ 486<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (2,348)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888046388360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Equity and Income (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total Stockholders&#8217; Equity</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Capital in Excess of&#160;Par</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Non-controlling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,328,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 929,035<span></span>
</td>
<td class="nump">$ 770,972<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
<td class="nump">$ 491,038<span></span>
</td>
<td class="nump">$ 279,800<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 158,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Select Medical Holdings Corporation</a></td>
<td class="nump">53,125<span></span>
</td>
<td class="nump">53,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest', window );">Net income attributable to non-controlling interests</a></td>
<td class="nump">10,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Forfeitures of unvested restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Forfeitures of unvested restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Vesting of restricted stock</a></td>
<td class="nump">6,136<span></span>
</td>
<td class="nump">6,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of common shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(492,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of common shares</a></td>
<td class="num">(8,691)<span></span>
</td>
<td class="num">(8,691)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(5,350)<span></span>
</td>
<td class="num">(3,341)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Issuance of non-controlling interests</a></td>
<td class="nump">1,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,679<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to and purchases of non-controlling interests</a></td>
<td class="num">(6,774)<span></span>
</td>
<td class="num">(2,726)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,726)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,048)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Redemption value adjustment on non-controlling interests</a></td>
<td class="num">(10,123)<span></span>
</td>
<td class="num">(10,123)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,123)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">365<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">420<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,823,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2020</a></td>
<td class="nump">974,819<span></span>
</td>
<td class="nump">808,638<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
<td class="nump">491,824<span></span>
</td>
<td class="nump">316,680<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">166,181<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,328,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">929,035<span></span>
</td>
<td class="nump">770,972<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
<td class="nump">491,038<span></span>
</td>
<td class="nump">279,800<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">158,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Select Medical Holdings Corporation</a></td>
<td class="nump">104,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,970,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2020</a></td>
<td class="nump">1,172,430<span></span>
</td>
<td class="nump">992,883<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
<td class="nump">496,785<span></span>
</td>
<td class="nump">495,964<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">179,547<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,823,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2020</a></td>
<td class="nump">974,819<span></span>
</td>
<td class="nump">808,638<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
<td class="nump">491,824<span></span>
</td>
<td class="nump">316,680<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">166,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Select Medical Holdings Corporation</a></td>
<td class="nump">51,650<span></span>
</td>
<td class="nump">51,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest', window );">Net income attributable to non-controlling interests</a></td>
<td class="nump">12,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,572<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Forfeitures of unvested restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Forfeitures of unvested restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Vesting of restricted stock</a></td>
<td class="nump">6,262<span></span>
</td>
<td class="nump">6,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of common shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of common shares</a></td>
<td class="num">(724)<span></span>
</td>
<td class="num">(724)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(441)<span></span>
</td>
<td class="num">(283)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Issuance of non-controlling interests</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to and purchases of non-controlling interests</a></td>
<td class="num">(483)<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(418)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Redemption value adjustment on non-controlling interests</a></td>
<td class="nump">127,916<span></span>
</td>
<td class="nump">127,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">411<span></span>
</td>
<td class="num">(794)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(795)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,205<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,970,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2020</a></td>
<td class="nump">$ 1,172,430<span></span>
</td>
<td class="nump">992,883<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
<td class="nump">496,785<span></span>
</td>
<td class="nump">495,964<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">179,547<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">134,850,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 1,252,973<span></span>
</td>
<td class="nump">1,060,480<span></span>
</td>
<td class="nump">$ 135<span></span>
</td>
<td class="nump">509,128<span></span>
</td>
<td class="nump">553,244<span></span>
</td>
<td class="num">(2,027)<span></span>
</td>
<td class="nump">192,493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Select Medical Holdings Corporation</a></td>
<td class="nump">110,546<span></span>
</td>
<td class="nump">110,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest', window );">Net income attributable to non-controlling interests</a></td>
<td class="nump">17,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Forfeitures of unvested restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Forfeitures of unvested restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Vesting of restricted stock</a></td>
<td class="nump">6,173<span></span>
</td>
<td class="nump">6,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Non-controlling interests acquired in business combination</a></td>
<td class="nump">8,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to and purchases of non-controlling interests</a></td>
<td class="num">(14,245)<span></span>
</td>
<td class="num">(787)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(787)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,458)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Redemption value adjustment on non-controlling interests</a></td>
<td class="num">(38,405)<span></span>
</td>
<td class="num">(38,405)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38,405)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">8,151<span></span>
</td>
<td class="nump">8,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">189<span></span>
</td>
<td class="num">(182)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(178)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,838,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">$ 1,350,617<span></span>
</td>
<td class="nump">1,145,976<span></span>
</td>
<td class="nump">$ 135<span></span>
</td>
<td class="nump">514,336<span></span>
</td>
<td class="nump">625,381<span></span>
</td>
<td class="nump">6,124<span></span>
</td>
<td class="nump">204,641<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">134,850,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 1,252,973<span></span>
</td>
<td class="nump">1,060,480<span></span>
</td>
<td class="nump">$ 135<span></span>
</td>
<td class="nump">509,128<span></span>
</td>
<td class="nump">553,244<span></span>
</td>
<td class="num">(2,027)<span></span>
</td>
<td class="nump">192,493<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Select Medical Holdings Corporation</a></td>
<td class="nump">$ 275,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="nump">135,005,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,005,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="nump">$ 1,449,892<span></span>
</td>
<td class="nump">1,234,225<span></span>
</td>
<td class="nump">$ 135<span></span>
</td>
<td class="nump">516,172<span></span>
</td>
<td class="nump">713,191<span></span>
</td>
<td class="nump">4,727<span></span>
</td>
<td class="nump">215,667<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,838,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="nump">1,350,617<span></span>
</td>
<td class="nump">1,145,976<span></span>
</td>
<td class="nump">$ 135<span></span>
</td>
<td class="nump">514,336<span></span>
</td>
<td class="nump">625,381<span></span>
</td>
<td class="nump">6,124<span></span>
</td>
<td class="nump">204,641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Select Medical Holdings Corporation</a></td>
<td class="nump">164,894<span></span>
</td>
<td class="nump">164,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest', window );">Net income attributable to non-controlling interests</a></td>
<td class="nump">13,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared for common stockholders ($0.125 per share)</a></td>
<td class="num">(16,876)<span></span>
</td>
<td class="num">(16,876)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,876)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Issuance of restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Forfeitures of unvested restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Forfeitures of unvested restricted stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Vesting of restricted stock</a></td>
<td class="nump">6,564<span></span>
</td>
<td class="nump">6,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of common shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of common shares</a></td>
<td class="num">(1,610)<span></span>
</td>
<td class="num">(1,610)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(707)<span></span>
</td>
<td class="num">(903)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Issuance of non-controlling interests</a></td>
<td class="nump">5,688<span></span>
</td>
<td class="num">(1,051)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,051)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to and purchases of non-controlling interests</a></td>
<td class="num">(12,294)<span></span>
</td>
<td class="num">(2,970)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,970)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,324)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Redemption value adjustment on non-controlling interests</a></td>
<td class="num">(59,370)<span></span>
</td>
<td class="num">(59,370)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59,370)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(1,397)<span></span>
</td>
<td class="num">(1,397)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,397)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">$ 435<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="nump">135,005,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,005,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="nump">$ 1,449,892<span></span>
</td>
<td class="nump">$ 1,234,225<span></span>
</td>
<td class="nump">$ 135<span></span>
</td>
<td class="nump">$ 516,172<span></span>
</td>
<td class="nump">$ 713,191<span></span>
</td>
<td class="nump">$ 4,727<span></span>
</td>
<td class="nump">$ 215,667<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestChangeInRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 16(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestChangeInRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Portion of net income (loss) attributable to nonredeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares related to Restricted Stock Award forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888044442280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Equity and Income (unaudited) (Parenthetical)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividend declared (in dollars per share)</a></td>
<td class="nump">$ 0.125<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888150475496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 333,422<span></span>
</td>
<td class="nump">$ 137,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Distributions from unconsolidated subsidiaries</a></td>
<td class="nump">19,384<span></span>
</td>
<td class="nump">11,223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">100,574<span></span>
</td>
<td class="nump">104,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for expected credit losses</a></td>
<td class="nump">212<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of unconsolidated subsidiaries</a></td>
<td class="num">(21,728)<span></span>
</td>
<td class="num">(10,912)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Loss (gain) on sale or disposal of assets and businesses</a></td>
<td class="nump">494<span></span>
</td>
<td class="num">(7,881)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation expense</a></td>
<td class="nump">13,808<span></span>
</td>
<td class="nump">13,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount, premium and issuance costs</a></td>
<td class="nump">1,095<span></span>
</td>
<td class="nump">1,093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(8,323)<span></span>
</td>
<td class="num">(3,416)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of effects of business combinations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(31,751)<span></span>
</td>
<td class="nump">13,179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Other current assets</a></td>
<td class="num">(12,856)<span></span>
</td>
<td class="nump">713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="num">(11,984)<span></span>
</td>
<td class="nump">11,504<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">18,881<span></span>
</td>
<td class="nump">4,251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">71,034<span></span>
</td>
<td class="nump">4,028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct', window );">Government advances</a></td>
<td class="num">(73,703)<span></span>
</td>
<td class="nump">316,992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct', window );">Unearned government assistance</a></td>
<td class="num">(78,509)<span></span>
</td>
<td class="nump">45,505<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxes', window );">Income taxes</a></td>
<td class="nump">42,976<span></span>
</td>
<td class="nump">43,743<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">363,026<span></span>
</td>
<td class="nump">686,098<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business combinations, net of cash acquired</a></td>
<td class="num">(10,081)<span></span>
</td>
<td class="num">(6,961)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchases of property and equipment</a></td>
<td class="num">(76,442)<span></span>
</td>
<td class="num">(71,253)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment in businesses</a></td>
<td class="num">(11,185)<span></span>
</td>
<td class="num">(14,749)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets', window );">Proceeds from sale of assets and businesses</a></td>
<td class="nump">9,463<span></span>
</td>
<td class="nump">12,401<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(88,245)<span></span>
</td>
<td class="num">(80,562)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Borrowings on revolving facilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">470,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Payments on revolving facilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(470,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Payments on term loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(39,843)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherDebt', window );">Borrowings of other debt</a></td>
<td class="nump">8,915<span></span>
</td>
<td class="nump">31,487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations', window );">Principal payments on other debt</a></td>
<td class="num">(15,314)<span></span>
</td>
<td class="num">(35,733)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid to common stockholders</a></td>
<td class="num">(16,876)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfEquity', window );">Repurchase of common stock</a></td>
<td class="num">(1,610)<span></span>
</td>
<td class="num">(9,415)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMinorityShareholders', window );">Proceeds from issuance of non-controlling interests</a></td>
<td class="nump">5,688<span></span>
</td>
<td class="nump">1,686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to and purchases of non-controlling interests</a></td>
<td class="num">(29,152)<span></span>
</td>
<td class="num">(13,660)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Purchase of membership interests of Concentra Group Holdings Parent</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(366,203)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(48,349)<span></span>
</td>
<td class="num">(431,681)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">226,432<span></span>
</td>
<td class="nump">173,855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">577,061<span></span>
</td>
<td class="nump">335,882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">803,493<span></span>
</td>
<td class="nump">509,737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">66,955<span></span>
</td>
<td class="nump">86,124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for taxes</a></td>
<td class="nump">$ 76,094<span></span>
</td>
<td class="nump">$ 4,920<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Unearned Government Assistance, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From (Repayments Of) Government Advances, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes, and in deferred and other tax liabilities and assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123385561&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888044448824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements of Select Medical Holdings Corporation (&#8220;Holdings&#8221;) include the accounts of its wholly owned subsidiary, Select Medical Corporation (&#8220;Select&#8221;). Holdings conducts substantially all of its business through Select and its subsidiaries. Holdings and Select and its subsidiaries are collectively referred to as the &#8220;Company.&#8221; The unaudited condensed consolidated financial statements of the Company as of June&#160;30, 2021, and for the three and six month periods ended June&#160;30, 2020 and 2021, have been prepared pursuant to the rules&#160;and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;) for interim reporting and the accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). Accordingly, certain information and disclosures required by GAAP, which are normally included in the notes to the consolidated financial statements, have been condensed or omitted pursuant to those rules&#160;and regulations, although the Company believes the disclosure is adequate to make the information presented not misleading. In the opinion of management, such information contains all adjustments, which are normal and recurring in nature, necessary for a fair statement of the financial position, results of operations and cash flow for such periods. All significant intercompany transactions and balances have been eliminated.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three and six months ended June&#160;30, 2021, are not necessarily indicative of the results to be expected for the full fiscal year ending December&#160;31, 2021. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December&#160;31, 2020, contained in the Company&#8217;s Annual Report on Form&#160;10-K filed with the SEC on February 25, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888042841944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Accounting Policies</a></td>
<td class="text">Accounting Policies<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Actual results could differ from those estimates.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Instruments and Contracts on an Entity&#8217;s Own Equity</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ASU simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. As part of this update, convertible instruments are to be included in diluted earnings per share using the if-converted method, rather than the treasury stock method. Further, contracts which can be settled in cash or shares, excluding liability-classified share-based payment awards, are to be included in diluted earnings per share on an if-converted basis if the effect is dilutive, regardless of whether the entity or the counterparty can choose between cash and share settlement. The share-settlement presumption may not be rebutted based on past experience or a stated policy. This pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2021. The Company plans to adopt this pronouncement as of January 1, 2022. The use of either the modified retrospective or fully retrospective method of transition is permitted.</span></div>Under the terms of the Amended and Restated Limited Liability Company Agreement of Concentra Group Holdings Parent, certain members of Concentra Group Holdings Parent have put rights that obligate the Company to purchase certain of such members&#8217; equity interests in Concentra Group Holdings Parent when exercised. The Company can elect to pay the purchase price for those equity interests in cash or in shares of Holdings&#8217; common stock. Under ASU 2020-06, the Company is no longer able to rebut the share-settlement presumption based on its past experience. Accordingly, if any of the put rights provided for under the Amended and Restated Limited Liability Company Agreement of Concentra Group Holdings Parent are outstanding upon adoption of ASU 2020-06, the shares which are potentially issuable will be included in diluted earnings per share, on an if-converted basis. At this time, the Company cannot reasonably estimate the impact that the adoption of ASU 2020-06 will have on its financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888044475688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Credit Risk Concentrations<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditLossAbstract', window );"><strong>Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Credit Risk Concentrations</a></td>
<td class="text">Credit Risk Concentrations<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash balances and accounts receivable. The Company&#8217;s excess cash is held with large financial institutions. The Company grants unsecured credit to its patients, most of whom reside in the service area of the Company&#8217;s facilities and are insured under third-party payor agreements.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the diversity in the Company&#8217;s non-governmental third-party payor base, as well as their geographic dispersion, accounts receivable due from the Medicare program represent the Company&#8217;s only significant concentration of credit risk. Approximately 18% and 15% of the Company&#8217;s accounts receivable is due from Medicare at December&#160;31, 2020, and June&#160;30, 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888042807096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Non-Controlling Interests<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Redeemable Non-Controlling Interests</a></td>
<td class="text">Redeemable Non-Controlling Interests<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ownership interests held by outside parties in subsidiaries, which include limited liability companies and limited partnerships, controlled by the Company are classified as non-controlling interests. Some of the Company&#8217;s non-controlling ownership interests consist of outside parties that have certain redemption rights that, if exercised, require the Company to purchase the parties&#8217; ownership interests. These interests are classified and reported as redeemable non-controlling interests and have been adjusted to their approximate redemption values, after the attribution of net income or loss.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s redeemable non-controlling interests are comprised primarily of the voting membership interests owned by outside members of Concentra Group Holdings Parent, each of which have put rights with respect to their interests in Concentra Group Holdings Parent.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in redeemable non-controlling interests were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:66.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.735%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.737%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">974,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">398,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to and purchases of redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,687)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(614)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of membership interests of Concentra Group Holdings Parent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(366,203)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redemption value adjustment on redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">620,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">445,931&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to and purchases of redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,987)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redemption value adjustment on redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(127,916)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of June 30</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">495,987&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">521,552&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888044281304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">Variable Interest Entities</a></td>
<td class="text">Variable Interest Entities<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain states prohibit the &#8220;corporate practice of medicine,&#8221; which restricts the Company from owning medical practices which directly employ physicians and from exercising control over medical decisions by physicians. In these states, the Company enters into long-term management agreements with medical practices that are owned by licensed physicians, which, in turn, employ or contract with physicians who provide professional medical services. The management agreements provide for the Company to direct the transfer of ownership of the medical practices to new licensed physicians at any time. Based on the provisions of the management agreements, the medical practices are variable interest entities for which the Company is the primary beneficiary.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020 and June&#160;30, 2021, the total assets of the Company&#8217;s variable interest entities were $208.4 million and $242.3 million, respectively, and are principally comprised of accounts receivable. As of December 31, 2020 and June&#160;30, 2021, the total liabilities of these variable interest entities were $55.1 million and $58.8 million, respectively, and are principally comprised of accounts payable and accrued expenses. The Company&#8217;s variable interest entities have obligations payable for services received under the aforementioned management agreements of $151.8 million and $182.1 million as of December 31, 2020 and June&#160;30, 2021, respectively; these intercompany balances are eliminated in consolidation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888042961800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating and finance leases for its facilities. The Company leases its corporate office space from related parties. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s total lease cost was as follows:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease cost</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease cost:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,621)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,621)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78,826&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,899&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80,725&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81,955&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,939&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83,894&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease cost</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">142,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease cost:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,463)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,463)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158,613&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,788&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,401&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163,130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,741&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166,871&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,002,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,032,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,026,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,053,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">214,377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">220,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">218,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">224,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-current operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">848,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">875,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">869,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">893,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,062,592&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,188&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,095,780&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,088,144&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,202&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,118,346&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of long-term debt and notes payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,154&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,154&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,147&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,147&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease terms and discount rates were as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years):</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30.6</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, maturities of lease liabilities were approximately as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021 (remainder of year)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">258,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">211,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">172,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">533,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total undiscounted cash flows</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,457,487&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">339,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total discounted lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,118,346&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,147&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating and finance leases for its facilities. The Company leases its corporate office space from related parties. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s total lease cost was as follows:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease cost</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease cost:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,621)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,621)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78,826&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,899&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80,725&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81,955&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,939&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83,894&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease cost</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">142,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease cost:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,463)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,463)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158,613&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,788&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,401&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163,130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,741&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166,871&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,002,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,032,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,026,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,053,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">214,377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">220,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">218,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">224,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-current operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">848,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">875,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">869,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">893,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,062,592&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,188&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,095,780&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,088,144&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,202&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,118,346&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of long-term debt and notes payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,154&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,154&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,147&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,147&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease terms and discount rates were as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years):</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30.6</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, maturities of lease liabilities were approximately as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021 (remainder of year)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">258,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">211,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">172,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">533,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total undiscounted cash flows</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,457,487&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">339,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total discounted lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,118,346&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,147&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888041752248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text">Intangible Assets<div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows changes in the carrying amounts of goodwill by reporting unit for the six months ended June&#160;30, 2021:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:26.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.433%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,084,761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">432,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">646,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,215,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,379,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition of businesses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,084,761&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">442,155&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">647,869&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,216,255&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,391,040&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Identifiable Intangible Assets</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the gross carrying amounts, accumulated amortization, and net carrying amounts for the Company&#8217;s identifiable intangible assets:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:23.053%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certificates of need</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accreditations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finite-lived intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">291,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(113,346)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(126,843)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">171,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,771)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,365)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total identifiable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">517,658&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(130,117)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">387,541&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">525,510&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(145,208)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">380,302&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:4pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accreditations and trademarks have renewal terms and the costs to renew these intangible assets are expensed as incurred. At June&#160;30, 2021, the accreditations and trademarks have a weighted average time until next renewal of 1.5 years and 8.2 years, respectively.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s finite-lived intangible assets amortize over their estimated useful lives. Amortization expense was $6.9&#160;million and $7.3 million for the three months ended June&#160;30, 2020 and 2021, respectively. Amortization expense was $13.8 million and $14.4 million for the six months ended June&#160;30, 2020 and 2021, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888042745272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt and Notes Payable<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Debt and Notes Payable</a></td>
<td class="text">Long-Term Debt and Notes Payable<div style="margin-bottom:15pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company&#8217;s long-term debt and notes payable were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:25.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized Premium (Discount)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized<br/>Issuance Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select 6.250% senior notes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,225,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15,463)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,240,259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,304,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select credit facilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,103,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,398)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,064)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,087,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,077,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other debt, including finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(258)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,398,283&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,324&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23,785)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,397,822&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,451,357&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:7pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal maturities of the Company&#8217;s long-term debt and notes payable were approximately as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:25.732%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.726%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select 6.250% senior notes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,225,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,225,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select credit facilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,087,530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,103,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other debt, including finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,717&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,441&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,035&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,511&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,867&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,087,864&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,236,565&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,398,283&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:7pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company&#8217;s long-term debt and notes payable were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:25.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized Premium (Discount)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized<br/>Issuance Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select 6.250% senior notes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,225,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16,953)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,241,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,316,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select credit facilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,103,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,393)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,085,895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,082,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other debt, including finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,403,043&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,380&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(26,404)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,402,019&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,473,582&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:1pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Select Credit Facilities</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 2, 2021, Select entered into Amendment No. 5 to its senior secured credit agreement (the &#8220;Select credit agreement&#8221;) which, among other things, increased the aggregate commitments available under its revolving credit facility (the &#8220;Select revolving facility&#8221;) from $450.0 million to $650.0 million, including a $125.0 million sublimit for the issuance of standby letters of credit.</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentra-JPM Revolving Facility</span></div>On June 2, 2021, Concentra Inc. terminated its obligations under its first lien credit agreement (the &#8220;Concentra-JPM first lien credit agreement&#8221;). The Concentra-JPM first lien credit agreement provided for commitments of $100.0&#160;million under a revolving credit facility (the &#8220;Concentra-JPM revolving facility&#8221;), which was set to mature on March 1, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888044958632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest Rate Cap<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Interest Rate Cap</a></td>
<td class="text">Interest Rate Cap <div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to market risk exposure arising from changes in interest rates on the Select term loan, which bears interest at a variable interest rate. The Company&#8217;s objective in using an interest rate derivative is to mitigate its exposure to increases in interest rates. The interest rate cap limits the Company&#8217;s exposure to increases in the reference rate to 1.0% on $2.0&#160;billion of principal outstanding under the Select term loan. The interest rate cap became effective March 31, 2021 for the monthly periods from and including April 30, 2021 through September 30, 2024. The Company will pay a premium for the interest rate cap over the term of the agreement. The annual premium is equal to 0.0916% of the notional amount.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate cap has been designated as a cash flow hedge and is highly effective at offsetting the changes in cash outflows when the reference rate exceeds 1.0%. Changes in the fair value of the interest rate cap, net of tax, are recognized in other comprehensive income and are reclassified out of accumulated other comprehensive income (&#8220;AOCI&#8221;) and into interest expense when the hedged interest obligations affect earnings.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table outlines the changes in AOCI:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.668%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,027)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on interest rate cap cash flow hedge</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on interest rate cap cash flow hedge</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,403)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of June 30</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,727&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated pre-tax losses expected to be reclassified from AOCI into interest expense within the next twelve months are approximately $0.2&#160;million.  </span></div>Refer to Note 10 &#8211; Fair Value of Financial Instruments for information on the fair value of the Company&#8217;s interest rate cap contract and its balance sheet classification.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888052360552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text">Fair Value of Financial Instruments<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which are measured at fair value, or for which a fair value is disclosed, are classified in the fair value hierarchy, as outlined below, on the basis of the observability of the inputs used in the fair value measurement:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Level 1 &#8211; inputs are based upon quoted prices for identical instruments in active markets. </span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Level 2 &#8211; inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant inputs are observable in the market or can be corroborated by observable market data. </span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Level 3 &#8211; inputs are generally unobservable and typically reflect management&#8217;s estimates of assumptions that market participants would use in pricing the instrument.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s interest rate cap contract is recorded at its fair value on a recurring basis. The fair value of the interest rate cap contract is based upon a model-derived valuation using observable market inputs, such as interest rates and interest rate volatility, and the strike price. </span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap contract, non-current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap contract, current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap contract, non-current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:4pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not measure its indebtedness at fair value in its condensed consolidated balance sheets. The fair value of the Select credit facilities is based on quoted market prices for this debt in the syndicated loan market. The fair value of the senior notes is based on quoted market prices. The carrying value of the Company&#8217;s other debt, as disclosed in Note 8 &#8211; Long-Term Debt and Notes Payable, approximates fair value. </span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.379%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select 6.250% senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,241,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,316,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,240,259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,304,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select credit facilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select term loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,085,895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,082,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,087,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,077,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>The Company&#8217;s other financial instruments, which primarily consist of cash and cash equivalents, accounts receivable, and accounts payable, approximate fair value because of the short-term maturities of these instruments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888042829288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reportable segments consist of the critical illness recovery hospital segment, rehabilitation hospital segment, outpatient rehabilitation segment, and Concentra segment. Other activities include the Company&#8217;s corporate shared services, certain investments, and employee leasing services with non-consolidating subsidiaries. The Company&#8217;s other activities also include other operating income related to the recognition of payments received under the Provider Relief Fund for health care related expenses and loss of revenue attributable to the coronavirus disease 2019 (&#8220;COVID-19&#8221;). Refer to Note 15 &#8211; CARES Act for further information. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the performance of its segments based on Adjusted EBITDA. Adjusted EBITDA is defined as earnings excluding interest, income taxes, depreciation and amortization, gain (loss) on early retirement of debt, stock compensation expense, gain (loss) on sale of businesses, and equity in earnings (losses) of unconsolidated subsidiaries. The Company has provided additional information regarding its reportable segments, such as total assets, which contributes to the understanding of the Company and provides useful information to the users of the consolidated financial statements. </span></div><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize selected financial data for the Company&#8217;s reportable segments. </span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.694%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Critical illness recovery hospital</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">519,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">544,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,020,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,138,931&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rehabilitation hospital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">350,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">420,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outpatient rehabilitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">167,138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">422,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">532,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Concentra</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">456,372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">710,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">879,212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,232,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,564,020&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,647,350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,110,483&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Critical illness recovery hospital</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">186,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rehabilitation hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,768&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outpatient rehabilitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,282)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Concentra</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">219,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,752&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">342,021&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">366,085&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">600,362&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Critical illness recovery hospital</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,115,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,187,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,115,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,187,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rehabilitation hospital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,135,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,186,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,135,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,186,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outpatient rehabilitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,267,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,333,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,267,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,333,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Concentra</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,351,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,518,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,351,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,518,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">598,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">730,282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">598,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">730,282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,468,458&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,956,379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,468,458&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,956,379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Critical illness recovery hospital</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rehabilitation hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outpatient rehabilitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Concentra</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,045&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,723&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,253&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76,442&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of Adjusted EBITDA to income before income taxes is as follows:</span></div><div style="margin-bottom:12pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.704%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,282)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,892)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,907)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21,857)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(701)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,851&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,698&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,476)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,939&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,506&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">119,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on sale of businesses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(37,366)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90,822&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.704%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12,936)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,939)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,345)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21,230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,504)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(535)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,564)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,968&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43,829&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,288&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">115,295&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,588&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">283,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33,888)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">261,889&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.704%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(26,228)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,794)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14,412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(44,744)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,845)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12,398)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,085&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,380&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,428&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,751&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19,448)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">248,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on sale of businesses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(83,473)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">183,182&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.704%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">186,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">219,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25,986)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,999)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14,536)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41,128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,925)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,071)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12,737)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">160,190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87,303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57,426&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">176,876&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,185&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">485,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(68,290)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">444,167&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888044382744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contracts with Customers<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contracts with Customers</a></td>
<td class="text">Revenue from Contracts with Customers<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate the Company&#8217;s revenue for the three and six months ended June&#160;30, 2020 and 2021: </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:23.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.854%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patient service revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">215,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">307,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-Medicare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">301,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">309,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">833,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total patient services revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">516,573&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159,207&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155,152&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">309,724&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,140,656&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">92,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">519,626&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168,667&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">167,138&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312,338&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,949&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,232,718&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:23.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.854%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patient service revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">201,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">350,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-Medicare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">340,929&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98,443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">217,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">454,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,111,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total patient services revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">542,127&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">202,308&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">263,184&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">454,420&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,462,039&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101,981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">544,059&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212,666&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280,409&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">456,372&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,514&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,564,020&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:23.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.854%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patient service revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">457,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60,881&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">680,889&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-Medicare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">557,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">331,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">704,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,762,638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total patient services revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,014,029&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">331,395&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">392,874&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">705,229&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,443,527&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,513&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203,823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,020,147&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">350,686&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">422,387&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">710,873&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,257&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,647,350&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:23.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.854%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patient service revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">433,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">206,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">721,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-Medicare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">702,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">418,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">874,779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,189,357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total patient services revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,135,419&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">400,025&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500,294&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">875,304&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,911,042&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,445&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">199,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,138,931&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">420,470&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">532,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">879,212&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139,500&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,110,483&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888042894072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings per Share</a></td>
<td class="text">Earnings per Share<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s capital structure includes common stock and unvested restricted stock awards. To compute earnings per share (&#8220;EPS&#8221;), the Company applies the two-class method because the Company&#8217;s unvested restricted stock awards are participating securities which are entitled to participate equally with the Company&#8217;s common stock in undistributed earnings. Application of the Company&#8217;s two-class method is as follows:</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.82pt">Net income attributable to the Company is reduced by the amount of dividends declared and by the contractual amount of dividends that must be paid for the current period for each class of stock. There were no contractual dividends paid for the three and six months ended June&#160;30, 2020 and 2021.</span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.05pt">The remaining undistributed net income of the Company is then equally allocated to its common stock and unvested restricted stock awards, as if all of the earnings for the period had been distributed. The total net income allocated to each security is determined by adding both distributed and undistributed net income for the period. </span></div><div style="margin-bottom:9pt;margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.28pt">The net income allocated to each security is then divided by the weighted average number of outstanding shares for the period to determine the EPS for each security considered in the two-class method.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the net income attributable to the Company, its common shares outstanding, and its participating securities outstanding. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.800%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">196,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,934&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to the Company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">164,894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104,775&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">275,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Distributed and undistributed income attributable to participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributed and undistributed income attributable to common shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159,334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101,179&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">266,190&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the computation of EPS under the two-class method:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:31.300%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="36" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Allocation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Allocation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="36" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except for per share amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51,650&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">164,894&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:31.300%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="36" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Allocation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Allocation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="36" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except for per share amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">266,190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,362&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104,775&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">275,440&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Represents the weighted average share count outstanding during the period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888044514680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various legal actions, proceedings, and claims (some of which are not insured), and regulatory and other governmental audits and investigations in the ordinary course of its business. The Company cannot predict the ultimate outcome of pending litigation, proceedings, and regulatory and other governmental audits and investigations. These matters could potentially subject the Company to sanctions, damages, recoupments, fines, and other penalties. The Department of Justice, Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;), or other federal and state enforcement and regulatory agencies may conduct additional investigations related to the Company&#8217;s businesses in the future that may, either individually or in the aggregate, have a material adverse effect on the Company&#8217;s business, financial position, results of operations, and liquidity.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To address claims arising out of the Company&#8217;s operations, the Company maintains professional malpractice liability insurance and general liability insurance coverages through a number of different programs that are dependent upon such factors as the state where the Company is operating and whether the operations are wholly owned or are operated through a joint venture.  For the Company&#8217;s wholly owned operations, the Company currently maintains insurance coverages under a combination of policies with a total annual aggregate limit of up to $37.0 million for professional malpractice liability insurance and $40.0 million for general liability insurance. The Company&#8217;s insurance for the professional liability coverage is written on a &#8220;claims-made&#8221; basis, and its commercial general liability coverage is maintained on an &#8220;occurrence&#8221; basis. These coverages apply after a self-insured retention limit is exceeded. For the Company&#8217;s joint venture operations, the Company has designed a separate insurance program that responds to the risks of specific joint ventures. Most of the Company&#8217;s joint ventures are insured under a master program with an annual aggregate limit of up to $80.0 million, subject to a sublimit aggregate ranging from $23.0 million to $33.0 million for most joint ventures. The policies are generally written on a &#8220;claims-made&#8221; basis. Each of these programs has either a deductible or self-insured retention limit. The Company reviews its insurance program annually and may make adjustments to the amount of insurance coverage and self-insured retentions in future years. The Company also maintains umbrella liability insurance covering claims which, due to their nature or amount, are not covered by or not fully covered by the Company&#8217;s other insurance policies. These insurance policies also do not generally cover punitive damages and are subject to various deductibles and policy limits. Significant legal actions, as well as the cost and possible lack of available insurance, could subject the Company to substantial uninsured liabilities. In the Company&#8217;s opinion, the outcome of these actions, individually or in the aggregate, will not have a material adverse effect on its financial position, results of operations, or cash flows.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare providers are subject to lawsuits under the qui tam provisions of the federal False Claims Act. Qui tam lawsuits typically remain under seal (hence, usually unknown to the defendant) for some time while the government decides whether or not to intervene on behalf of a private qui tam plaintiff (known as a relator) and take the lead in the litigation. These lawsuits can involve significant monetary damages and penalties and award bounties to private plaintiffs who successfully bring the suits. The Company is and has been a defendant in these cases in the past, and may be named as a defendant in similar cases from time to time in the future.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Therapy Subpoena.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In May 2017, the Company received a subpoena from the U.S. Attorney&#8217;s Office for the District of New Jersey seeking various documents principally relating to the Company&#8217;s contract therapy division, which contracted to furnish rehabilitation therapy services to residents of skilled nursing facilities (&#8220;SNFs&#8221;) and other providers. The Company operated its contract therapy division through a subsidiary until March 31, 2016, when the Company sold the stock of the subsidiary. The subpoena seeks documents that appear to be aimed at assessing whether therapy services were furnished and billed in compliance with Medicare SNF billing requirements, including whether therapy services were coded at inappropriate levels and whether excessive or unnecessary therapy was furnished to justify coding at higher paying levels. The U.S. Attorney&#8217;s Office indicated that the subpoena was issued in connection with a qui tam lawsuit. The Company produced documents in response to the subpoena and fully cooperated with this investigation. In July 2021, the Company entered into a settlement agreement with the United States government, the plaintiff-relator who filed the qui tam lawsuit, and the purchaser of the Company&#8217;s contract therapy division in March 2016. In satisfaction of its indemnity obligations under the purchase agreement signed in March 2016, the Company agreed to make payments related to the settlement that will not exceed the amount of a liability accrued, and a non-operating loss incurred, during the nine months ended September 30, 2020. Such payments, in the aggregate, are immaterial to the Company&#8217;s financial statements. In the settlement agreement, the government and the plaintiff-relator released the Company from liability for all conduct alleged in the complaint, and the Company admitted no liability or wrongdoing.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oklahoma City Subpoena.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On August 24, 2020, the Company and Select Specialty Hospital &#8211; Oklahoma City, Inc. (&#8220;SSH&#8211;Oklahoma City&#8221;) received Civil Investigative Demands from the U.S. Attorney&#8217;s Office for the Western District of Oklahoma seeking responses to interrogatories and the production of various documents principally relating to the documentation, billing and reviews of medical services furnished to patients at SSH-Oklahoma City. The Company does not know whether the subpoena has been issued in connection with a qui tam lawsuit or in connection with possible civil, criminal or administrative proceedings by the government. The Company is producing documents in response to the subpoena and intends to fully cooperate with this investigation. At this time, the Company is unable to predict the timing and outcome of this matter. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Jersey Litigation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the United States District Court for the District of New Jersey unsealed a qui tam complaint in United States of America and State of New Jersey ex rel. Keith A. DiLello, Sr. v. Hackensack Meridian Health, Jersey Shore University Medical Center, Ocean Medical Center, Seaview Orthopaedics, Shrewsbury Surgery Center, Kessler Rehabilitation, Dr. Halambros Demetriades, Dr. Theodore Kutzan, Dr. Adam Myers, Dr. Hoan-Vu Nguyen, Dr. Frederick De Paola, ABC Corporations 1-10, and John/Jane Does 1-10, Case 3:20-cv-02949-FLW-ZNQ. The complaint was filed under seal in March 2020 and was unsealed after the United States and State of New Jersey declined to intervene in the case. In the complaint, the plaintiff-relator, an automobile accident victim and former patient of the defendant providers, alleges that they routinely billed both personal injury protection (&#8220;PIP&#8221;) carriers and CMS. He alleges that they violated federal and state law by billing CMS when other insurance is available and failing to return payment to CMS after payment was made by the PIP carriers. In March 2021, defendant Kessler Rehabilitation waived service of process of the complaint. The Company intends to vigorously defend this action, but at this time the Company is unable to predict the timing and outcome of this matter.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare Dual-Eligible Litigation</span></div>The Company&#8217;s critical illness recovery hospitals have pursued claims against CMS involving denied Medicare bad debt reimbursement for copayments and deductibles of dual-eligible Medicaid beneficiaries for cost reporting periods ending in 2005 through 2010. A U.S. District Court ruled in favor of the Company and ordered CMS to determine and pay the Medicare bad debt reimbursement plus interest and, in February 2021, the Company received reimbursement proceeds of $17.9 million plus accrued interest of $4.7 million. These amounts were recognized as other operating income and interest income, respectively, during the six months ended June&#160;30, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888042905896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CARES Act<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtraordinaryAndUnusualItemsAbstract', window );"><strong>Unusual or Infrequent Items, or Both [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock', window );">CARES Act</a></td>
<td class="text">CARES Act<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provider Relief Funds</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) was enacted. Since the enactment of the CARES Act, the Company&#8217;s consolidated subsidiaries have received approximately $208.4 million of payments from the Public Health and Social Services Emergency Fund, also referred to as the Provider Relief Fund. The Company is able to use payments received under the Provider Relief Fund for &#8220;health care related expenses or lost revenues that are attributable to coronavirus.&#8221; The Provider Relief Fund payments must first be applied against health care related expenses attributable to COVID-19. Provider Relief Fund payments not fully expended on healthcare related expenses attributable to COVID-19 are then applied to lost revenues. The provisions of the Provider Relief Fund payments permit a parent organization to allocate all or a portion of its general and targeted distributions among its subsidiaries which are eligible health care providers. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the CARES Act was enacted, the Department of Health and Human Services (&#8220;HHS&#8221;) has issued a series of post-payment notices of reporting requirements and other guidance which, in some instances, have significantly altered the terms and conditions surrounding the Provider Relief Fund payments. Additionally, certain provisions and reporting requirements associated with the Provider Relief Fund payments were signed into law as part of the Coronavirus Response and Relief Supplemental Appropriations Act of 2021 (&#8220;CRRSA Act&#8221;) on December 27, 2020. On June 11, 2021, HHS released an updated post-payment notice of reporting requirements and new and modified responses to its Frequently Asked Questions regarding the Provider Relief Fund payments. Among other things, HHS updated the period of time in which recipients must use the Provider Relief Fund payments. Under the revised guidance, the deadlines for utilizing the payments are based on the date in which the payments were received, rather than requiring all payments be used by June 30, 2021. The deadlines to use the Provider Relief Fund payments are now as follows: (i) payments received between April 10, 2020 and June 30, 2020 must have been used by June 30, 2021, (ii) payments received between July 1, 2020 and December 31, 2020 must be used by December 31, 2021, (iii)  payments received between January 1, 2021 and June 30, 2021 must be used by June 30, 2022, and (iv) payments received between July 1, 2021 and December 31, 2021 must be used by December 31, 2022.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Company&#8217;s accounting policy, payments are recognized as other operating income when it is probable that it has complied with the terms and conditions of the payments. The Company evaluated its eligibility to utilize certain Provider Relief Fund payments and whether those payments were used in accordance with the terms and conditions set forth within the CRRSA Act and by HHS as of June 30, 2021. The Company&#8217;s assessment of uncertainties surrounding its ability to utilize certain of its Provider Relief Fund payments, including its ability to allocate general distributions among the Company&#8217;s subsidiaries, was updated for additional information obtained during the period. Based on this updated assessment, the Company believes it is probable that it has complied with the terms and conditions associated with the Provider Relief Fund payments as of June 30, 2021. During the three and six months ended June&#160;30, 2021, the Company determined that it was eligible to recognize approximately $98.0 million and $114.1 million, respectively, of Provider Relief Fund payments as other operating income on the accompanying condensed consolidated statement of operations. The Company recognized $55.0 million of other operating income during both the three and six months ended June&#160;30, 2020. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, $4.1 million of Provider Relief Fund payments have not yet been utilized by the Company in accordance with the regulations promulgated by HHS and the CRRSA Act and are reported as unearned government assistance on the accompanying condensed consolidated balance sheet. Of this amount, $1.7&#160;million will be repaid to the government because the payments could not be utilized by the deadlines specified by HHS. The remaining Provider Relief Fund payments may need to be repaid to the extent they cannot be utilized in accordance with the terms and conditions set forth within the CRRSA Act and by HHS. Further changes to the regulations surrounding the Provider Relief Fund payments or amended interpretations of existing guidance may change the Company&#8217;s assessment of whether it is probable that is has complied with the terms of conditions of the Provider Relief Fund payments. These changes may result in the Company being unable to recognize additional Provider Relief Fund payments as other operating income or the reversal of amounts previously recognized.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare Accelerated and Advance Payments Program</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s consolidated subsidiaries received approximately $325.0 million of advance payments under CMS&#8217;s Accelerated and Advance Payment Program, which was temporarily expanded by the CARES Act. Repayment of the advance payments begins one year from the issuance date of the payment. After that first year, the Medicare program automatically recoups 25.0% of the Medicare payments otherwise owed to the provider or supplier for eleven months. At the end of the eleven-month period, recoupment increases to 50.0% for another six months. Any amounts that remain unpaid after 29 months are subject to a 4.0% interest rate. </span></div>The Company received the majority of its advance payments in April 2020. Accordingly, CMS began recouping a portion of the Medicare payments due to the Company beginning in April 2021. CMS recouped $73.7 million of Medicare payments during the three and six months ended June&#160;30, 2021. The remaining amounts owed to CMS under the Accelerated and Advance Payment Program are reflected as government advances on the accompanying condensed consolidated balance sheets<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtraordinaryAndUnusualItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtraordinaryAndUnusualItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an event or transaction that is unusual in nature or infrequent in occurrence, or both.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=114868817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888042809848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Event<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Event</a></td>
<td class="text">Subsequent Event On August 4, 2021, the Company&#8217;s board of directors declared a cash dividend of $0.125 per share. The dividend will be payable on or about August 30, 2021 to stockholders of record as of the close of business on August 18, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888137233640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Actual results could differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Instruments and Contracts on an Entity&#8217;s Own Equity</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ASU simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. As part of this update, convertible instruments are to be included in diluted earnings per share using the if-converted method, rather than the treasury stock method. Further, contracts which can be settled in cash or shares, excluding liability-classified share-based payment awards, are to be included in diluted earnings per share on an if-converted basis if the effect is dilutive, regardless of whether the entity or the counterparty can choose between cash and share settlement. The share-settlement presumption may not be rebutted based on past experience or a stated policy. This pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2021. The Company plans to adopt this pronouncement as of January 1, 2022. The use of either the modified retrospective or fully retrospective method of transition is permitted.</span></div>Under the terms of the Amended and Restated Limited Liability Company Agreement of Concentra Group Holdings Parent, certain members of Concentra Group Holdings Parent have put rights that obligate the Company to purchase certain of such members&#8217; equity interests in Concentra Group Holdings Parent when exercised. The Company can elect to pay the purchase price for those equity interests in cash or in shares of Holdings&#8217; common stock. Under ASU 2020-06, the Company is no longer able to rebut the share-settlement presumption based on its past experience. Accordingly, if any of the put rights provided for under the Amended and Restated Limited Liability Company Agreement of Concentra Group Holdings Parent are outstanding upon adoption of ASU 2020-06, the shares which are potentially issuable will be included in diluted earnings per share, on an if-converted basis. At this time, the Company cannot reasonably estimate the impact that the adoption of ASU 2020-06 will have on its financial statements.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Credit Risk Concentrations</a></td>
<td class="text">Credit Risk ConcentrationsFinancial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash balances and accounts receivable. The Company&#8217;s excess cash is held with large financial institutions. The Company grants unsecured credit to its patients, most of whom reside in the service area of the Company&#8217;s facilities and are insured under third-party payor agreements.Because of the diversity in the Company&#8217;s non-governmental third-party payor base, as well as their geographic dispersion, accounts receivable due from the Medicare program represent the Company&#8217;s only significant concentration of credit risk.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Redeemable Non-Controlling Interests</a></td>
<td class="text">Redeemable Non-Controlling Interests<div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ownership interests held by outside parties in subsidiaries, which include limited liability companies and limited partnerships, controlled by the Company are classified as non-controlling interests. Some of the Company&#8217;s non-controlling ownership interests consist of outside parties that have certain redemption rights that, if exercised, require the Company to purchase the parties&#8217; ownership interests. These interests are classified and reported as redeemable non-controlling interests and have been adjusted to their approximate redemption values, after the attribution of net income or loss.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s redeemable non-controlling interests are comprised primarily of the voting membership interests owned by outside members of Concentra Group Holdings Parent, each of which have put rights with respect to their interests in Concentra Group Holdings Parent.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entities</a></td>
<td class="text">Variable Interest EntitiesCertain states prohibit the &#8220;corporate practice of medicine,&#8221; which restricts the Company from owning medical practices which directly employ physicians and from exercising control over medical decisions by physicians. In these states, the Company enters into long-term management agreements with medical practices that are owned by licensed physicians, which, in turn, employ or contract with physicians who provide professional medical services. The management agreements provide for the Company to direct the transfer of ownership of the medical practices to new licensed physicians at any time. Based on the provisions of the management agreements, the medical practices are variable interest entities for which the Company is the primary beneficiary.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759068-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888047089016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Non-Controlling Interests (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock', window );">Schedule of redeemable non-controlling interests</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in redeemable non-controlling interests were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:66.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.735%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.737%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">974,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">398,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to and purchases of redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,687)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(614)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of membership interests of Concentra Group Holdings Parent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(366,203)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redemption value adjustment on redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">620,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">445,931&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to and purchases of redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,987)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Redemption value adjustment on redeemable non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(127,916)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of June 30</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">495,987&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">521,552&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888051637896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of lease cost</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s total lease cost was as follows:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease cost</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease cost:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,621)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,621)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78,826&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,899&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80,725&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81,955&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,939&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83,894&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease cost</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">142,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance lease cost:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,463)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,463)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158,613&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,788&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,401&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163,130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,741&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166,871&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease terms and discount rates were as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years):</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30.6</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average discount rate:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental cash flow information</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating cash flows for operating leases</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145,652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating cash flows for finance leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financing cash flows for finance leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock', window );">Supplemental balance sheet information</a></td>
<td class="text"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,002,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,032,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,026,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,053,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">214,377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">220,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">218,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">224,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-current operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">848,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">875,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">869,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">893,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,062,592&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,188&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,095,780&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,088,144&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,202&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,118,346&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrelated Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Related Parties</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of long-term debt and notes payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,154&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,154&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,147&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,147&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Maturities of finance lease liabilities</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, maturities of lease liabilities were approximately as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021 (remainder of year)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">258,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">211,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">172,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">533,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total undiscounted cash flows</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,457,487&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">339,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total discounted lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,118,346&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,147&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of operating lease liabilities</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, maturities of lease liabilities were approximately as follows:</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021 (remainder of year)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">790&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">258,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">211,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">172,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">533,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total undiscounted cash flows</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,457,487&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">339,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total discounted lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,118,346&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,147&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Leases In Statement Of Financial Position [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888042983944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of carrying amount of goodwill</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows changes in the carrying amounts of goodwill by reporting unit for the six months ended June&#160;30, 2021:</span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:26.988%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.433%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,084,761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">432,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">646,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,215,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,379,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition of businesses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,084,761&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">442,155&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">647,869&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,216,255&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,391,040&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of carrying value and amortization of identifiable intangible assets</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the gross carrying amounts, accumulated amortization, and net carrying amounts for the Company&#8217;s identifiable intangible assets:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:23.053%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certificates of need</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accreditations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Finite-lived intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">291,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(113,346)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">298,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(126,843)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">171,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,771)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,365)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total identifiable intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">517,658&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(130,117)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">387,541&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">525,510&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(145,208)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">380,302&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888042891288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt and Notes Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Company's long-term debt and notes payable</a></td>
<td class="text"><div style="margin-bottom:15pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company&#8217;s long-term debt and notes payable were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:25.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized Premium (Discount)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized<br/>Issuance Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select 6.250% senior notes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,225,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(15,463)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,240,259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,304,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select credit facilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,103,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,398)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,064)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,087,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,077,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other debt, including finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(258)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,398,283&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,324&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23,785)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,397,822&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,451,357&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:7pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company&#8217;s long-term debt and notes payable were as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:25.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized Premium (Discount)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized<br/>Issuance Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="30" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select 6.250% senior notes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,225,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16,953)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,241,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,316,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select credit facilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,103,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,393)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,085,895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,082,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other debt, including finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,403,043&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,380&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(26,404)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,402,019&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,473,582&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of principal maturities of the Company's long-term debt and notes payable</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:7pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal maturities of the Company&#8217;s long-term debt and notes payable were approximately as follows:</span></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:25.732%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.726%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select 6.250% senior notes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,225,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,225,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select credit facilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,087,530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,103,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other debt, including finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,717&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69,846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,441&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,035&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25,511&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34,867&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,087,864&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,236,565&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,398,283&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888052203608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest Rate Cap (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of accumulated other comprehensive income</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table outlines the changes in AOCI:</span></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.668%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,027)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on interest rate cap cash flow hedge</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on interest rate cap cash flow hedge</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,403)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of June 30</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,727&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888136529608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of Interest Rate Cap</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.683%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap contract, non-current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap contract, current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest rate cap contract, non-current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Long-Term Debt</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.379%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Instrument</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select 6.250% senior notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,241,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,316,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,240,259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,304,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select credit facilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Select term loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,085,895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,082,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,087,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,077,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888044378696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of selected financial data for the Company's reportable segments</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize selected financial data for the Company&#8217;s reportable segments. </span></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.694%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Critical illness recovery hospital</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">519,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">544,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,020,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,138,931&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rehabilitation hospital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">350,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">420,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outpatient rehabilitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">167,138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">422,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">532,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Concentra</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">456,372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">710,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">879,212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,232,718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,564,020&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,647,350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,110,483&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Critical illness recovery hospital</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">186,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rehabilitation hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,768&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outpatient rehabilitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,282)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Concentra</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">219,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,752&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">342,021&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">366,085&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">600,362&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Critical illness recovery hospital</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,115,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,187,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,115,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,187,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rehabilitation hospital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,135,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,186,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,135,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,186,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outpatient rehabilitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,267,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,333,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,267,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,333,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Concentra</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,351,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,518,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,351,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,518,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">598,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">730,282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">598,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">730,282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,468,458&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,956,379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,468,458&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,956,379&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Critical illness recovery hospital</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rehabilitation hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Outpatient rehabilitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Concentra</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,045&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,723&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,253&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76,442&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Schedule of reconciliation of Adjusted EBITDA to income before income taxes</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of Adjusted EBITDA to income before income taxes is as follows:</span></div><div style="margin-bottom:12pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.704%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,282)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,892)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,907)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21,857)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(701)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,262)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75,851&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,698&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,476)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,939&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,506&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">119,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on sale of businesses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(37,366)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90,822&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.704%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12,936)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,939)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,345)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21,230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,504)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(535)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,564)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,968&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43,829&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,288&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">115,295&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,588&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">283,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33,888)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">261,889&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.704%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">102,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(26,228)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,794)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14,412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(44,744)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,845)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12,398)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152,085&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,380&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,428&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,751&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19,448)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">248,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on sale of businesses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(83,473)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">183,182&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.704%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">186,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">219,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25,986)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(13,999)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14,536)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41,128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,925)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,071)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(12,737)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">160,190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87,303&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57,426&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">176,876&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,185&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">485,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity in earnings of unconsolidated subsidiaries</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21,728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(68,290)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">444,167&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888047058120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contracts with Customers (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of disaggregation of net operating revenues by operating segment</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate the Company&#8217;s revenue for the three and six months ended June&#160;30, 2020 and 2021: </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:23.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.854%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patient service revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">215,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">307,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-Medicare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">301,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">135,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">309,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">833,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total patient services revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">516,573&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159,207&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">155,152&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">309,724&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,140,656&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,949&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">92,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">519,626&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168,667&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">167,138&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312,338&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,949&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,232,718&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:23.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.854%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patient service revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">201,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">350,649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-Medicare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">340,929&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">98,443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">217,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">454,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,111,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total patient services revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">542,127&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">202,308&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">263,184&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">454,420&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,462,039&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101,981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">544,059&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">212,666&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280,409&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">456,372&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70,514&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,564,020&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:23.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.854%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patient service revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">457,017&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60,881&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">680,889&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-Medicare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">557,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">331,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">704,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,762,638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total patient services revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,014,029&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">331,395&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">392,874&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">705,229&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,443,527&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,513&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,257&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203,823&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,020,147&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">350,686&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">422,387&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">710,873&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143,257&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,647,350&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:23.531%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.854%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Critical Illness Recovery Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rehabilitation Hospital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outpatient<br/>Rehabilitation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Concentra</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Patient service revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">433,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">206,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">721,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-Medicare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">702,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">193,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">418,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">874,779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,189,357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total patient services revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,135,419&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">400,025&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500,294&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">875,304&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,911,042&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,445&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">199,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,138,931&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">420,470&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">532,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">879,212&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">139,500&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,110,483&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888044220808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of computation of basic and diluted earnings per share</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the net income attributable to the Company, its common shares outstanding, and its participating securities outstanding. </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.800%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">196,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">137,934&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: net income attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to the Company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">164,894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104,775&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">275,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less: Distributed and undistributed income attributable to participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributed and undistributed income attributable to common shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159,334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101,179&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">266,190&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the computation of EPS under the two-class method:</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:31.300%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="36" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Allocation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Allocation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="36" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except for per share amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51,650&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">164,894&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:31.300%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.362%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="36" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Allocation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income Allocation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Basic and Diluted EPS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="36" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except for per share amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">266,190&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130,362&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Company</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104,775&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">275,440&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________________________________________________________</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Represents the weighted average share count outstanding during the period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888051091336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Credit Risk Concentrations (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=sem_MedicareReceivableMember', window );">Medicare Receivable | Credit Concentration Risk | Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of concentration risk</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=sem_MedicareReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=sem_MedicareReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888052021272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Non-Controlling Interests - Schedule of Redeemable Non-Controlling Interests (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Balance, beginning</a></td>
<td class="nump">$ 445,931<span></span>
</td>
<td class="nump">$ 398,171<span></span>
</td>
<td class="nump">$ 620,377<span></span>
</td>
<td class="nump">$ 974,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to redeemable non-controlling interests</a></td>
<td class="nump">18,073<span></span>
</td>
<td class="nump">9,626<span></span>
</td>
<td class="nump">3,264<span></span>
</td>
<td class="nump">7,256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests', window );">Distributions to and purchases of redeemable non-controlling interests</a></td>
<td class="num">(1,987)<span></span>
</td>
<td class="num">(614)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="num">(5,687)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of membership interests of Concentra Group Holdings Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(366,203)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Redemption value adjustment on redeemable non-controlling interests</a></td>
<td class="nump">59,370<span></span>
</td>
<td class="nump">38,405<span></span>
</td>
<td class="num">(127,916)<span></span>
</td>
<td class="nump">10,123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityOtherChanges', window );">Other</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">343<span></span>
</td>
<td class="nump">292<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Balance, ending</a></td>
<td class="nump">$ 521,552<span></span>
</td>
<td class="nump">$ 445,931<span></span>
</td>
<td class="nump">$ 495,987<span></span>
</td>
<td class="nump">$ 620,377<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Distributions to Redeemable Noncontrolling Interests</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestChangeInRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 16(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestChangeInRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityOtherChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in temporary equity from changes classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityOtherChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888053254296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Variable Interest Entities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">$ 7,956,379<span></span>
</td>
<td class="nump">$ 7,655,399<span></span>
</td>
<td class="nump">$ 7,468,458<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="nump">5,984,935<span></span>
</td>
<td class="nump">6,004,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">242,300<span></span>
</td>
<td class="nump">208,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="nump">58,800<span></span>
</td>
<td class="nump">55,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Obligations payable</a></td>
<td class="nump">$ 182,100<span></span>
</td>
<td class="nump">$ 151,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToAffiliateCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToAffiliateCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888052940680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Lease Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Operating lease cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_OperatingLeaseCostUnrelatedParties', window );">Unrelated Parties</a></td>
<td class="nump">$ 70,739<span></span>
</td>
<td class="nump">$ 69,367<span></span>
</td>
<td class="nump">$ 140,853<span></span>
</td>
<td class="nump">$ 139,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_OperatingLeaseCostRelatedParties', window );">Related Parties</a></td>
<td class="nump">1,798<span></span>
</td>
<td class="nump">1,787<span></span>
</td>
<td class="nump">3,597<span></span>
</td>
<td class="nump">3,520<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Total</a></td>
<td class="nump">72,537<span></span>
</td>
<td class="nump">71,154<span></span>
</td>
<td class="nump">144,450<span></span>
</td>
<td class="nump">142,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FinanceLeaseRightOfUseAssetAmortizationAbstract', window );"><strong>Amortization of right-of-use assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties', window );">Unrelated Parties</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties', window );">Related Parties</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Total</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FinanceLeaseInterestExpenseAbstract', window );"><strong>Interest on lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FinanceLeaseInterestExpenseUnrelatedParties', window );">Unrelated Parties</a></td>
<td class="nump">254<span></span>
</td>
<td class="nump">231<span></span>
</td>
<td class="nump">505<span></span>
</td>
<td class="nump">487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FinanceLeaseInterestExpenseRelatedParties', window );">Related Parties</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Total</a></td>
<td class="nump">254<span></span>
</td>
<td class="nump">231<span></span>
</td>
<td class="nump">505<span></span>
</td>
<td class="nump">487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_VariableLeaseCostAbstract', window );"><strong>Variable lease cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_VariableLeaseCostUnrelatedParties', window );">Unrelated Parties</a></td>
<td class="nump">13,086<span></span>
</td>
<td class="nump">11,780<span></span>
</td>
<td class="nump">26,095<span></span>
</td>
<td class="nump">24,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_VariableLeaseCostRelatedParties', window );">Related Parties</a></td>
<td class="nump">141<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="nump">268<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Total</a></td>
<td class="nump">13,227<span></span>
</td>
<td class="nump">11,892<span></span>
</td>
<td class="nump">26,239<span></span>
</td>
<td class="nump">24,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_SubleaseIncomeAbstract', window );"><strong>Sublease income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_SubleaseIncomeUnrelatedParties', window );">Unrelated Parties</a></td>
<td class="num">(2,229)<span></span>
</td>
<td class="num">(2,621)<span></span>
</td>
<td class="num">(4,463)<span></span>
</td>
<td class="num">(5,176)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_SubleaseIncomeRelatedParties', window );">Related Parties</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Total</a></td>
<td class="num">(2,229)<span></span>
</td>
<td class="num">(2,621)<span></span>
</td>
<td class="num">(4,463)<span></span>
</td>
<td class="num">(5,176)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LeaseCostTotalAbstract', window );"><strong>Total lease cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LeaseCostUnrelatedParties', window );">Unrelated Parties</a></td>
<td class="nump">81,955<span></span>
</td>
<td class="nump">78,826<span></span>
</td>
<td class="nump">163,130<span></span>
</td>
<td class="nump">158,613<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LeaseCostRelatedParties', window );">Related Parties</a></td>
<td class="nump">1,939<span></span>
</td>
<td class="nump">1,899<span></span>
</td>
<td class="nump">3,741<span></span>
</td>
<td class="nump">3,788<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total</a></td>
<td class="nump">$ 83,894<span></span>
</td>
<td class="nump">$ 80,725<span></span>
</td>
<td class="nump">$ 166,871<span></span>
</td>
<td class="nump">$ 162,401<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_FinanceLeaseInterestExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Interest Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_FinanceLeaseInterestExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_FinanceLeaseInterestExpenseRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Interest Expense, Related Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_FinanceLeaseInterestExpenseRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_FinanceLeaseInterestExpenseUnrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Interest Expense, Unrelated Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_FinanceLeaseInterestExpenseUnrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_FinanceLeaseRightOfUseAssetAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Right-of-Use Asset, Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_FinanceLeaseRightOfUseAssetAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Right-Of-Use Asset, Amortization, Related Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Right-Of-Use Asset, Amortization, Unrelated Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_LeaseCostRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Cost, Related Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_LeaseCostRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_LeaseCostTotalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Cost, Total</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_LeaseCostTotalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_LeaseCostUnrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Cost - Unrelated Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_LeaseCostUnrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_OperatingLeaseCostRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Cost, Related Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_OperatingLeaseCostRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_OperatingLeaseCostUnrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Cost, Unrelated Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_OperatingLeaseCostUnrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_SubleaseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sublease Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_SubleaseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_SubleaseIncomeRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sublease Income, Related Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_SubleaseIncomeRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_SubleaseIncomeUnrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sublease Income, Unrelated Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_SubleaseIncomeUnrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_VariableLeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable Lease, Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_VariableLeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_VariableLeaseCostRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable Lease, Cost, Related Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_VariableLeaseCostRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_VariableLeaseCostUnrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable Lease, Cost, Unrelated Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_VariableLeaseCostUnrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888051849736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows for operating leases</a></td>
<td class="nump">$ 145,652<span></span>
</td>
<td class="nump">$ 140,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows for finance leases</a></td>
<td class="nump">505<span></span>
</td>
<td class="nump">487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows for finance leases</a></td>
<td class="nump">145<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract', window );"><strong>Right-of-use assets obtained in exchange for lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="nump">138,606<span></span>
</td>
<td class="nump">132,125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Finance leases</a></td>
<td class="nump">$ 138<span></span>
</td>
<td class="nump">$ 989<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Paid For Amounts Included In The Measurement Of Lease Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right-Of-Use Assets Obtained In Exchange For Lease Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888046902136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_OperatingLeaseRightOfUseAssetAbstract', window );"><strong>Operating lease right-of-use assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_OperatingLeaseRightOfUseAssetUnrelatedParties', window );">Unrelated Parties</a></td>
<td class="nump">$ 1,026,058<span></span>
</td>
<td class="nump">$ 1,002,151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_OperatingLeaseRightOfUseAssetRelatedParties', window );">Related Parties</a></td>
<td class="nump">27,273<span></span>
</td>
<td class="nump">30,066<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Total</a></td>
<td class="nump">1,053,331<span></span>
</td>
<td class="nump">1,032,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_OperatingLeaseLiabilityCurrentAbstract', window );"><strong>Current operating lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_OperatingLeaseLiabilityCurrentUnrelatedParties', window );">Unrelated Parties</a></td>
<td class="nump">218,723<span></span>
</td>
<td class="nump">214,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_OperatingLeaseLiabilityCurrentRelatedParties', window );">Related Parties</a></td>
<td class="nump">6,145<span></span>
</td>
<td class="nump">6,036<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Total</a></td>
<td class="nump">224,868<span></span>
</td>
<td class="nump">220,413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_OperatingLeaseLiabilityNoncurrentAbstract', window );"><strong>Non-current operating lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties', window );">Unrelated Parties</a></td>
<td class="nump">869,421<span></span>
</td>
<td class="nump">848,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_OperatingLeaseLiabilityNoncurrentRelatedParties', window );">Related Parties</a></td>
<td class="nump">24,057<span></span>
</td>
<td class="nump">27,152<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Total</a></td>
<td class="nump">893,478<span></span>
</td>
<td class="nump">875,367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityAbstract', window );"><strong>Total operating lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_OperatingLeaseLiabilityUnrelatedParties', window );">Unrelated Parties</a></td>
<td class="nump">1,088,144<span></span>
</td>
<td class="nump">1,062,592<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_OperatingLeaseLiabilityRelatedParties', window );">Related Parties</a></td>
<td class="nump">30,202<span></span>
</td>
<td class="nump">33,188<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">1,118,346<span></span>
</td>
<td class="nump">1,095,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract', window );"><strong>Property and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties', window );">Unrelated Parties</a></td>
<td class="nump">5,711<span></span>
</td>
<td class="nump">5,644<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties', window );">Related Parties</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Total</a></td>
<td class="nump">5,711<span></span>
</td>
<td class="nump">5,644<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FinanceLeaseLiabilityCurrentAbstract', window );"><strong>Current portion of long-term debt and notes payable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FinanceLeaseLiabilityCurrentUnrelatedParties', window );">Unrelated Parties</a></td>
<td class="nump">638<span></span>
</td>
<td class="nump">663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FinanceLeaseLiabilityCurrentRelatedParties', window );">Related Parties</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Total</a></td>
<td class="nump">638<span></span>
</td>
<td class="nump">663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FinanceLeaseLiabilityNoncurrentAbstract', window );"><strong>Long-term debt, net of current portion</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties', window );">Unrelated Parties</a></td>
<td class="nump">13,509<span></span>
</td>
<td class="nump">13,491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FinanceLeaseLiabilityNoncurrentRelatedParties', window );">Related Parties</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Total</a></td>
<td class="nump">13,509<span></span>
</td>
<td class="nump">13,491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityAbstract', window );"><strong>Total finance lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FinanceLeaseLiabilityUnrelatedParties', window );">Unrelated Parties</a></td>
<td class="nump">14,147<span></span>
</td>
<td class="nump">14,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FinanceLeaseLiabilityRelatedParties', window );">Related Parties</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total</a></td>
<td class="nump">$ 14,147<span></span>
</td>
<td class="nump">$ 14,154<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_FinanceLeaseLiabilityCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_FinanceLeaseLiabilityCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_FinanceLeaseLiabilityCurrentRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, Current, Related Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_FinanceLeaseLiabilityCurrentRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_FinanceLeaseLiabilityCurrentUnrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, Current, Unrelated Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_FinanceLeaseLiabilityCurrentUnrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_FinanceLeaseLiabilityNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_FinanceLeaseLiabilityNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_FinanceLeaseLiabilityNoncurrentRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, Noncurrent, Related Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_FinanceLeaseLiabilityNoncurrentRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, Noncurrent, Unrelated Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_FinanceLeaseLiabilityRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, Related Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_FinanceLeaseLiabilityRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_FinanceLeaseLiabilityUnrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, Unrelated Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_FinanceLeaseLiabilityUnrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Right-Of-Use Asset, After Accumulated Amortization, Related Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Right-Of-Use Asset, After Accumulated Amortization, Unrelated Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_OperatingLeaseLiabilityCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_OperatingLeaseLiabilityCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_OperatingLeaseLiabilityCurrentRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Liability, Current, Related Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_OperatingLeaseLiabilityCurrentRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_OperatingLeaseLiabilityCurrentUnrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Liability, Current, Unrelated Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_OperatingLeaseLiabilityCurrentUnrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_OperatingLeaseLiabilityNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_OperatingLeaseLiabilityNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_OperatingLeaseLiabilityNoncurrentRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Liability, Noncurrent, Related Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_OperatingLeaseLiabilityNoncurrentRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Liability, Noncurrent, Unrelated Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_OperatingLeaseLiabilityRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Liability, Related Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_OperatingLeaseLiabilityRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_OperatingLeaseLiabilityUnrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Liability, Unrelated Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_OperatingLeaseLiabilityUnrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_OperatingLeaseRightOfUseAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_OperatingLeaseRightOfUseAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_OperatingLeaseRightOfUseAssetRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-Of-Use Asset, Related Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_OperatingLeaseRightOfUseAssetRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_OperatingLeaseRightOfUseAssetUnrelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-Of-Use Asset, Unrelated Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_OperatingLeaseRightOfUseAssetUnrelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888042642504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Weighted Average Lease Terms and Discount Rates (Details)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract', window );"><strong>Weighted average remaining lease term (in years):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases</a></td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases</a></td>
<td class="text">30 years 7 months 6 days<span></span>
</td>
<td class="text">31 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract', window );"><strong>Weighted average discount rate:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="nump">5.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases</a></td>
<td class="nump">7.20%<span></span>
</td>
<td class="nump">7.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Discount Rate Operating And Finance Leases [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Lease Term Operating And Finance Leases [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888047214648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Operating and Finance Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2021 (remainder of year)</a></td>
<td class="nump">$ 143,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">258,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">211,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">172,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">138,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">533,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted cash flows</a></td>
<td class="nump">1,457,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="nump">339,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total discounted lease liabilities</a></td>
<td class="nump">1,118,346<span></span>
</td>
<td class="nump">$ 1,095,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2021 (remainder of year)</a></td>
<td class="nump">790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">1,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">1,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">1,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">1,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">29,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total undiscounted cash flows</a></td>
<td class="nump">35,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="nump">21,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">$ 14,147<span></span>
</td>
<td class="nump">$ 14,154<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, Payments, Due After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, Payments, Due After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888046809912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Carrying Amount of Goodwill (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">$ 3,379,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisition of businesses</a></td>
<td class="nump">12,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">3,391,040<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=sem_CriticalIllnessRecoveryHospitalsMember', window );">Critical Illness Recovery Hospital</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">1,084,761<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisition of businesses</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">1,084,761<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=sem_RehabilitationHospitalsMember', window );">Rehabilitation Hospital</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">432,753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisition of businesses</a></td>
<td class="nump">9,402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">442,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=sem_OutpatientRehabilitationMember', window );">Outpatient Rehabilitation</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">646,433<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisition of businesses</a></td>
<td class="nump">1,436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">647,869<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=sem_ConcentraMember', window );">Concentra</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">1,215,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisition of businesses</a></td>
<td class="nump">1,188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">$ 1,216,255<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sem_CriticalIllnessRecoveryHospitalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sem_CriticalIllnessRecoveryHospitalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sem_RehabilitationHospitalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sem_RehabilitationHospitalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sem_OutpatientRehabilitationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sem_OutpatientRehabilitationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sem_ConcentraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sem_ConcentraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888046621608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Carrying Value and Amortization of Identifiable Intangible Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Total identifiable intangible assets, gross carrying amount</a></td>
<td class="nump">$ 525,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 525,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 517,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(145,208)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(145,208)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(130,117)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total identifiable intangible assets, net carrying amount</a></td>
<td class="nump">380,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">380,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">387,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Amortized intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">7,300<span></span>
</td>
<td class="nump">$ 6,900<span></span>
</td>
<td class="nump">14,400<span></span>
</td>
<td class="nump">$ 13,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross carrying amount</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net carrying amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross carrying amount</a></td>
<td class="nump">298,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">291,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(126,843)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(126,843)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(113,346)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net carrying amount</a></td>
<td class="nump">171,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178,577<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross carrying amount</a></td>
<td class="nump">35,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(13,365)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,365)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,771)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net carrying amount</a></td>
<td class="nump">21,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets, carrying amount</a></td>
<td class="nump">166,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 166,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166,698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Amortized intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension', window );">Weighted average time until next renewal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=sem_CertificatesOfNeedMember', window );">Certificates of need</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets, carrying amount</a></td>
<td class="nump">18,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,392<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=sem_AccreditationsMember', window );">Accreditations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets, carrying amount</a></td>
<td class="nump">$ 1,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Amortized intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension', window );">Weighted average time until next renewal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Finite Lived And Indefinite Lived Intangible Assets By Major Class [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indefinite-lived Intangible Asset, Weighted Average Period before Next Renewal or Extension</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=sem_CertificatesOfNeedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=sem_CertificatesOfNeedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=sem_AccreditationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=sem_AccreditationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888045333960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt and Notes Payable - Components of Long-Term Debt And Notes Payable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LongTermDebtGrossAndFinanceLeaseObligation', window );">Principal Outstanding</a></td>
<td class="nump">$ 3,398,283<span></span>
</td>
<td class="nump">$ 3,403,043<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Unamortized Premium (Discount)</a></td>
<td class="nump">23,324<span></span>
</td>
<td class="nump">25,380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Unamortized Issuance Costs</a></td>
<td class="num">(23,785)<span></span>
</td>
<td class="num">(26,404)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LongTermDebtAndFinanceLeaseObligation', window );">Carrying Value</a></td>
<td class="nump">3,397,822<span></span>
</td>
<td class="nump">3,402,019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair Value</a></td>
<td class="nump">3,451,357<span></span>
</td>
<td class="nump">3,473,582<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Other debt, including finance leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LongTermDebtGrossAndFinanceLeaseObligation', window );">Principal Outstanding</a></td>
<td class="nump">69,846<span></span>
</td>
<td class="nump">74,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Unamortized Premium (Discount)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Unamortized Issuance Costs</a></td>
<td class="num">(258)<span></span>
</td>
<td class="num">(302)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LongTermDebtAndFinanceLeaseObligation', window );">Carrying Value</a></td>
<td class="nump">69,588<span></span>
</td>
<td class="nump">74,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair Value</a></td>
<td class="nump">$ 69,588<span></span>
</td>
<td class="nump">$ 74,304<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=sem_SelectMedicalCorporationMember', window );">Select Medical Corporation | Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt (as a percent)</a></td>
<td class="nump">6.25%<span></span>
</td>
<td class="nump">6.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal Outstanding</a></td>
<td class="nump">$ 1,225,000<span></span>
</td>
<td class="nump">$ 1,225,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Unamortized Premium (Discount)</a></td>
<td class="nump">30,722<span></span>
</td>
<td class="nump">33,773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Unamortized Issuance Costs</a></td>
<td class="num">(15,463)<span></span>
</td>
<td class="num">(16,953)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">1,240,259<span></span>
</td>
<td class="nump">1,241,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair Value</a></td>
<td class="nump">1,304,625<span></span>
</td>
<td class="nump">1,316,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=sem_SelectMedicalCorporationMember', window );">Select Medical Corporation | Term loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal Outstanding</a></td>
<td class="nump">2,103,437<span></span>
</td>
<td class="nump">2,103,437<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Unamortized Premium (Discount)</a></td>
<td class="num">(7,398)<span></span>
</td>
<td class="num">(8,393)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Unamortized Issuance Costs</a></td>
<td class="num">(8,064)<span></span>
</td>
<td class="num">(9,149)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">2,087,975<span></span>
</td>
<td class="nump">2,085,895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair Value</a></td>
<td class="nump">$ 2,077,144<span></span>
</td>
<td class="nump">$ 2,082,403<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_LongTermDebtAndFinanceLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt And Finance Lease Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_LongTermDebtAndFinanceLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_LongTermDebtGrossAndFinanceLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Gross And Finance Lease Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_LongTermDebtGrossAndFinanceLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=sem_SelectMedicalCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=sem_SelectMedicalCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888052375560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt and Notes Payable - Principal Maturities Of Long-Term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2021</a></td>
<td class="nump">$ 9,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">4,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">25,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">34,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">2,087,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour', window );">Thereafter</a></td>
<td class="nump">1,236,565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LongTermDebtGrossAndFinanceLeaseObligation', window );">Total</a></td>
<td class="nump">3,398,283<span></span>
</td>
<td class="nump">$ 3,403,043<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Other debt, including finance leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2021</a></td>
<td class="nump">9,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">4,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">20,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">23,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour', window );">Thereafter</a></td>
<td class="nump">11,565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LongTermDebtGrossAndFinanceLeaseObligation', window );">Total</a></td>
<td class="nump">$ 69,846<span></span>
</td>
<td class="nump">$ 74,606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=sem_SelectMedicalCorporationMember', window );">Select Medical Corporation | Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt (as a percent)</a></td>
<td class="nump">6.25%<span></span>
</td>
<td class="nump">6.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2021</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour', window );">Thereafter</a></td>
<td class="nump">1,225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">1,225,000<span></span>
</td>
<td class="nump">$ 1,225,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=sem_SelectMedicalCorporationMember', window );">Select Medical Corporation | Term loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">4,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">11,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">2,087,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">$ 2,103,437<span></span>
</td>
<td class="nump">$ 2,103,437<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Next Twelve Months</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt And Finance Lease Obligation, Repayments Of Principal, Remainder Of Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_LongTermDebtGrossAndFinanceLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Gross And Finance Lease Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_LongTermDebtGrossAndFinanceLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Maturities, Repayments Of Principal After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=sem_SelectMedicalCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=sem_SelectMedicalCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888164587384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt and Notes Payable - Narrative (Details) - Revolving facilities - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 02, 2021</div></th>
<th class="th"><div>Jun. 01, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Select Medical Corporation | Revolving facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 650.0<span></span>
</td>
<td class="nump">$ 450.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Select Medical Corporation | Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">125.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Concentra | Concentra-JPM First Lien Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Terminated obligations</a></td>
<td class="nump">$ 100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=sem_SelectMedicalCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=sem_SelectMedicalCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=sem_ConcentraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=sem_ConcentraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=sem_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=sem_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888050980168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest Rate Cap - Narrative (Details) - Interest Rate Cap<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeCapInterestRate', window );">Derivative cap interest rate (as a percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 2,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_DerivativeCostOfHedgeAnnualPremiumPercentage', window );">Annual premium (in percent)</a></td>
<td class="nump">0.000916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Estimated pre-tax losses expected to be reclassified in the next twelve months</a></td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_DerivativeCostOfHedgeAnnualPremiumPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative, Cost of Hedge, Annual Premium, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_DerivativeCostOfHedgeAnnualPremiumPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCapInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cap rate on an interest rate derivative such as an interest rate cap or collar. If market rates exceed the cap rate, a payment or receipt is triggered on the contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCapInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888046996600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest Rate Cap - Schedule of Accumulated Other Comprehensive Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 1,350,617<span></span>
</td>
<td class="nump">$ 1,252,973<span></span>
</td>
<td class="nump">$ 974,819<span></span>
</td>
<td class="nump">$ 929,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">1,449,892<span></span>
</td>
<td class="nump">1,350,617<span></span>
</td>
<td class="nump">1,172,430<span></span>
</td>
<td class="nump">974,819<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent | Interest Rate Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">6,124<span></span>
</td>
<td class="num">(2,027)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Gain on interest rate cap cash flow hedge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Loss on interest rate cap cash flow hedge</a></td>
<td class="num">(1,403)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from AOCI</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 4,727<span></span>
</td>
<td class="nump">$ 6,124<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888140578136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments - Schedule of Interest Rate Cap (Details) - Interest Rate Cap - Fair Value, Inputs, Level 2 - Fair Value, Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Interest rate cap contract, non-current portion</a></td>
<td class="nump">$ 8,776<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Accrued other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Interest rate cap contract, current portion</a></td>
<td class="nump">1,948<span></span>
</td>
<td class="nump">1,339<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Interest rate cap contract, non-current portion</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,392<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=sem_OtherAccruedLiabilitiesCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=sem_OtherAccruedLiabilitiesCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888052938712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments - Schedule of Long-Term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair Value</a></td>
<td class="nump">$ 3,451,357<span></span>
</td>
<td class="nump">$ 3,473,582<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Select Medical Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate of debt (as a percent)</a></td>
<td class="nump">6.25%<span></span>
</td>
<td class="nump">6.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">$ 1,240,259<span></span>
</td>
<td class="nump">$ 1,241,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair Value</a></td>
<td class="nump">1,304,625<span></span>
</td>
<td class="nump">1,316,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Select Medical Corporation | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">1,240,259<span></span>
</td>
<td class="nump">1,241,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair Value</a></td>
<td class="nump">1,304,625<span></span>
</td>
<td class="nump">1,316,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Term loans | Select Medical Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">2,087,975<span></span>
</td>
<td class="nump">2,085,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair Value</a></td>
<td class="nump">2,077,144<span></span>
</td>
<td class="nump">2,082,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Term loans | Select Medical Corporation | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying Value</a></td>
<td class="nump">2,087,975<span></span>
</td>
<td class="nump">2,085,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair Value</a></td>
<td class="nump">$ 2,077,144<span></span>
</td>
<td class="nump">$ 2,082,403<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=sem_SelectMedicalCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=sem_SelectMedicalCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888135649560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Selected Financial Data (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 1,564,020<span></span>
</td>
<td class="nump">$ 1,232,718<span></span>
</td>
<td class="nump">$ 3,110,483<span></span>
</td>
<td class="nump">$ 2,647,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_AdjustedEbitda', window );">Adjusted EBITDA</a></td>
<td class="nump">342,021<span></span>
</td>
<td class="nump">178,752<span></span>
</td>
<td class="nump">600,362<span></span>
</td>
<td class="nump">366,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">7,956,379<span></span>
</td>
<td class="nump">7,468,458<span></span>
</td>
<td class="nump">7,956,379<span></span>
</td>
<td class="nump">7,468,458<span></span>
</td>
<td class="nump">$ 7,655,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchases of property and equipment</a></td>
<td class="nump">36,723<span></span>
</td>
<td class="nump">32,045<span></span>
</td>
<td class="nump">76,442<span></span>
</td>
<td class="nump">71,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Critical Illness Recovery Hospital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">544,059<span></span>
</td>
<td class="nump">519,626<span></span>
</td>
<td class="nump">1,138,931<span></span>
</td>
<td class="nump">1,020,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_AdjustedEbitda', window );">Adjusted EBITDA</a></td>
<td class="nump">72,904<span></span>
</td>
<td class="nump">89,743<span></span>
</td>
<td class="nump">186,176<span></span>
</td>
<td class="nump">178,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,187,181<span></span>
</td>
<td class="nump">2,115,294<span></span>
</td>
<td class="nump">2,187,181<span></span>
</td>
<td class="nump">2,115,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchases of property and equipment</a></td>
<td class="nump">16,499<span></span>
</td>
<td class="nump">14,970<span></span>
</td>
<td class="nump">30,884<span></span>
</td>
<td class="nump">23,935<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Rehabilitation Hospital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">212,666<span></span>
</td>
<td class="nump">168,667<span></span>
</td>
<td class="nump">420,470<span></span>
</td>
<td class="nump">350,686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_AdjustedEbitda', window );">Adjusted EBITDA</a></td>
<td class="nump">50,768<span></span>
</td>
<td class="nump">27,605<span></span>
</td>
<td class="nump">101,302<span></span>
</td>
<td class="nump">66,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,186,886<span></span>
</td>
<td class="nump">1,135,206<span></span>
</td>
<td class="nump">1,186,886<span></span>
</td>
<td class="nump">1,135,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchases of property and equipment</a></td>
<td class="nump">3,257<span></span>
</td>
<td class="nump">1,923<span></span>
</td>
<td class="nump">3,922<span></span>
</td>
<td class="nump">5,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Outpatient Rehabilitation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">280,409<span></span>
</td>
<td class="nump">167,138<span></span>
</td>
<td class="nump">532,370<span></span>
</td>
<td class="nump">422,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_AdjustedEbitda', window );">Adjusted EBITDA</a></td>
<td class="nump">45,633<span></span>
</td>
<td class="num">(6,282)<span></span>
</td>
<td class="nump">71,962<span></span>
</td>
<td class="nump">20,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,333,661<span></span>
</td>
<td class="nump">1,267,308<span></span>
</td>
<td class="nump">1,333,661<span></span>
</td>
<td class="nump">1,267,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchases of property and equipment</a></td>
<td class="nump">7,448<span></span>
</td>
<td class="nump">6,593<span></span>
</td>
<td class="nump">14,783<span></span>
</td>
<td class="nump">14,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Concentra</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">456,372<span></span>
</td>
<td class="nump">312,338<span></span>
</td>
<td class="nump">879,212<span></span>
</td>
<td class="nump">710,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_AdjustedEbitda', window );">Adjusted EBITDA</a></td>
<td class="nump">137,060<span></span>
</td>
<td class="nump">41,497<span></span>
</td>
<td class="nump">219,075<span></span>
</td>
<td class="nump">102,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,518,369<span></span>
</td>
<td class="nump">2,351,974<span></span>
</td>
<td class="nump">2,518,369<span></span>
</td>
<td class="nump">2,351,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchases of property and equipment</a></td>
<td class="nump">7,591<span></span>
</td>
<td class="nump">6,820<span></span>
</td>
<td class="nump">20,271<span></span>
</td>
<td class="nump">22,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">70,514<span></span>
</td>
<td class="nump">64,949<span></span>
</td>
<td class="nump">139,500<span></span>
</td>
<td class="nump">143,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_AdjustedEbitda', window );">Adjusted EBITDA</a></td>
<td class="nump">35,656<span></span>
</td>
<td class="nump">26,189<span></span>
</td>
<td class="nump">21,847<span></span>
</td>
<td class="num">(2,205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">730,282<span></span>
</td>
<td class="nump">598,676<span></span>
</td>
<td class="nump">730,282<span></span>
</td>
<td class="nump">598,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchases of property and equipment</a></td>
<td class="nump">$ 1,928<span></span>
</td>
<td class="nump">$ 1,739<span></span>
</td>
<td class="nump">$ 6,582<span></span>
</td>
<td class="nump">$ 4,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_AdjustedEbitda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Measure of profit (loss) for reportable segments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_AdjustedEbitda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123385561&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sem_CriticalIllnessRecoveryHospitalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sem_CriticalIllnessRecoveryHospitalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sem_RehabilitationHospitalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sem_RehabilitationHospitalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sem_OutpatientRehabilitationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sem_OutpatientRehabilitationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sem_ConcentraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sem_ConcentraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888140931672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Reconciliation of Adjusted EBITDA to Income Before Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_AdjustedEbitda', window );">Adjusted EBITDA</a></td>
<td class="nump">$ 342,021<span></span>
</td>
<td class="nump">$ 178,752<span></span>
</td>
<td class="nump">$ 600,362<span></span>
</td>
<td class="nump">$ 366,085<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(50,954)<span></span>
</td>
<td class="num">(52,271)<span></span>
</td>
<td class="num">(100,574)<span></span>
</td>
<td class="num">(104,023)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">283,968<span></span>
</td>
<td class="nump">119,518<span></span>
</td>
<td class="nump">485,980<span></span>
</td>
<td class="nump">248,196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of unconsolidated subsidiaries</a></td>
<td class="nump">11,809<span></span>
</td>
<td class="nump">8,324<span></span>
</td>
<td class="nump">21,728<span></span>
</td>
<td class="nump">10,912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Gain on sale of businesses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">346<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementInterest', window );">Interest income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,749<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(33,888)<span></span>
</td>
<td class="num">(37,366)<span></span>
</td>
<td class="num">(68,290)<span></span>
</td>
<td class="num">(83,473)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">261,889<span></span>
</td>
<td class="nump">90,822<span></span>
</td>
<td class="nump">444,167<span></span>
</td>
<td class="nump">183,182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Critical Illness Recovery Hospital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_AdjustedEbitda', window );">Adjusted EBITDA</a></td>
<td class="nump">72,904<span></span>
</td>
<td class="nump">89,743<span></span>
</td>
<td class="nump">186,176<span></span>
</td>
<td class="nump">178,313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(12,936)<span></span>
</td>
<td class="num">(13,892)<span></span>
</td>
<td class="num">(25,986)<span></span>
</td>
<td class="num">(26,228)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">59,968<span></span>
</td>
<td class="nump">75,851<span></span>
</td>
<td class="nump">160,190<span></span>
</td>
<td class="nump">152,085<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Rehabilitation Hospital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_AdjustedEbitda', window );">Adjusted EBITDA</a></td>
<td class="nump">50,768<span></span>
</td>
<td class="nump">27,605<span></span>
</td>
<td class="nump">101,302<span></span>
</td>
<td class="nump">66,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(6,939)<span></span>
</td>
<td class="num">(6,907)<span></span>
</td>
<td class="num">(13,999)<span></span>
</td>
<td class="num">(13,794)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">43,829<span></span>
</td>
<td class="nump">20,698<span></span>
</td>
<td class="nump">87,303<span></span>
</td>
<td class="nump">52,380<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Outpatient Rehabilitation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_AdjustedEbitda', window );">Adjusted EBITDA</a></td>
<td class="nump">45,633<span></span>
</td>
<td class="num">(6,282)<span></span>
</td>
<td class="nump">71,962<span></span>
</td>
<td class="nump">20,840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(7,345)<span></span>
</td>
<td class="num">(7,194)<span></span>
</td>
<td class="num">(14,536)<span></span>
</td>
<td class="num">(14,412)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">38,288<span></span>
</td>
<td class="num">(13,476)<span></span>
</td>
<td class="nump">57,426<span></span>
</td>
<td class="nump">6,428<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Concentra</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_AdjustedEbitda', window );">Adjusted EBITDA</a></td>
<td class="nump">137,060<span></span>
</td>
<td class="nump">41,497<span></span>
</td>
<td class="nump">219,075<span></span>
</td>
<td class="nump">102,963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(21,230)<span></span>
</td>
<td class="num">(21,857)<span></span>
</td>
<td class="num">(41,128)<span></span>
</td>
<td class="num">(44,744)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="num">(535)<span></span>
</td>
<td class="num">(701)<span></span>
</td>
<td class="num">(1,071)<span></span>
</td>
<td class="num">(1,468)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">115,295<span></span>
</td>
<td class="nump">18,939<span></span>
</td>
<td class="nump">176,876<span></span>
</td>
<td class="nump">56,751<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_AdjustedEbitda', window );">Adjusted EBITDA</a></td>
<td class="nump">35,656<span></span>
</td>
<td class="nump">26,189<span></span>
</td>
<td class="nump">21,847<span></span>
</td>
<td class="num">(2,205)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(2,504)<span></span>
</td>
<td class="num">(2,421)<span></span>
</td>
<td class="num">(4,925)<span></span>
</td>
<td class="num">(4,845)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock compensation expense</a></td>
<td class="num">(6,564)<span></span>
</td>
<td class="num">(6,262)<span></span>
</td>
<td class="num">(12,737)<span></span>
</td>
<td class="num">(12,398)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">$ 26,588<span></span>
</td>
<td class="nump">$ 17,506<span></span>
</td>
<td class="nump">$ 4,185<span></span>
</td>
<td class="num">$ (19,448)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_AdjustedEbitda">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Measure of profit (loss) for reportable segments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_AdjustedEbitda</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest expense (income) directly attributable to an award in settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sem_CriticalIllnessRecoveryHospitalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sem_CriticalIllnessRecoveryHospitalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sem_RehabilitationHospitalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sem_RehabilitationHospitalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sem_OutpatientRehabilitationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sem_OutpatientRehabilitationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sem_ConcentraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sem_ConcentraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888048232776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contracts with Customers (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,564,020<span></span>
</td>
<td class="nump">$ 1,232,718<span></span>
</td>
<td class="nump">$ 3,110,483<span></span>
</td>
<td class="nump">$ 2,647,350<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember', window );">Patient services revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,462,039<span></span>
</td>
<td class="nump">1,140,656<span></span>
</td>
<td class="nump">2,911,042<span></span>
</td>
<td class="nump">2,443,527<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sem_HealthCarePatientServiceMedicareMember', window );">Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">350,649<span></span>
</td>
<td class="nump">307,324<span></span>
</td>
<td class="nump">721,685<span></span>
</td>
<td class="nump">680,889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=sem_HealthCarePatientServiceNonMedicareMember', window );">Non-Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,111,390<span></span>
</td>
<td class="nump">833,332<span></span>
</td>
<td class="nump">2,189,357<span></span>
</td>
<td class="nump">1,762,638<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceOtherMember', window );">Other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">101,981<span></span>
</td>
<td class="nump">92,062<span></span>
</td>
<td class="nump">199,441<span></span>
</td>
<td class="nump">203,823<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Critical Illness Recovery Hospital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">544,059<span></span>
</td>
<td class="nump">519,626<span></span>
</td>
<td class="nump">1,138,931<span></span>
</td>
<td class="nump">1,020,147<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Critical Illness Recovery Hospital | Patient services revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">542,127<span></span>
</td>
<td class="nump">516,573<span></span>
</td>
<td class="nump">1,135,419<span></span>
</td>
<td class="nump">1,014,029<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Critical Illness Recovery Hospital | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">201,198<span></span>
</td>
<td class="nump">215,508<span></span>
</td>
<td class="nump">433,338<span></span>
</td>
<td class="nump">457,017<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Critical Illness Recovery Hospital | Non-Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">340,929<span></span>
</td>
<td class="nump">301,065<span></span>
</td>
<td class="nump">702,081<span></span>
</td>
<td class="nump">557,012<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Critical Illness Recovery Hospital | Other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,932<span></span>
</td>
<td class="nump">3,053<span></span>
</td>
<td class="nump">3,512<span></span>
</td>
<td class="nump">6,118<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Rehabilitation Hospital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">212,666<span></span>
</td>
<td class="nump">168,667<span></span>
</td>
<td class="nump">420,470<span></span>
</td>
<td class="nump">350,686<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Rehabilitation Hospital | Patient services revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">202,308<span></span>
</td>
<td class="nump">159,207<span></span>
</td>
<td class="nump">400,025<span></span>
</td>
<td class="nump">331,395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Rehabilitation Hospital | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">103,865<span></span>
</td>
<td class="nump">71,510<span></span>
</td>
<td class="nump">206,240<span></span>
</td>
<td class="nump">162,262<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Rehabilitation Hospital | Non-Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">98,443<span></span>
</td>
<td class="nump">87,697<span></span>
</td>
<td class="nump">193,785<span></span>
</td>
<td class="nump">169,133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Rehabilitation Hospital | Other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">10,358<span></span>
</td>
<td class="nump">9,460<span></span>
</td>
<td class="nump">20,445<span></span>
</td>
<td class="nump">19,291<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Outpatient Rehabilitation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">280,409<span></span>
</td>
<td class="nump">167,138<span></span>
</td>
<td class="nump">532,370<span></span>
</td>
<td class="nump">422,387<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Outpatient Rehabilitation | Patient services revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">263,184<span></span>
</td>
<td class="nump">155,152<span></span>
</td>
<td class="nump">500,294<span></span>
</td>
<td class="nump">392,874<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Outpatient Rehabilitation | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">45,291<span></span>
</td>
<td class="nump">20,049<span></span>
</td>
<td class="nump">81,582<span></span>
</td>
<td class="nump">60,881<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Outpatient Rehabilitation | Non-Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">217,893<span></span>
</td>
<td class="nump">135,103<span></span>
</td>
<td class="nump">418,712<span></span>
</td>
<td class="nump">331,993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Outpatient Rehabilitation | Other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">17,225<span></span>
</td>
<td class="nump">11,986<span></span>
</td>
<td class="nump">32,076<span></span>
</td>
<td class="nump">29,513<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Concentra</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">456,372<span></span>
</td>
<td class="nump">312,338<span></span>
</td>
<td class="nump">879,212<span></span>
</td>
<td class="nump">710,873<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Concentra | Patient services revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">454,420<span></span>
</td>
<td class="nump">309,724<span></span>
</td>
<td class="nump">875,304<span></span>
</td>
<td class="nump">705,229<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Concentra | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">295<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="nump">525<span></span>
</td>
<td class="nump">729<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Concentra | Non-Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">454,125<span></span>
</td>
<td class="nump">309,467<span></span>
</td>
<td class="nump">874,779<span></span>
</td>
<td class="nump">704,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Concentra | Other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,952<span></span>
</td>
<td class="nump">2,614<span></span>
</td>
<td class="nump">3,908<span></span>
</td>
<td class="nump">5,644<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">70,514<span></span>
</td>
<td class="nump">64,949<span></span>
</td>
<td class="nump">139,500<span></span>
</td>
<td class="nump">143,257<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Other | Patient services revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Other | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Other | Non-Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Other | Other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 70,514<span></span>
</td>
<td class="nump">$ 64,949<span></span>
</td>
<td class="nump">$ 139,500<span></span>
</td>
<td class="nump">$ 143,257<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sem_HealthCarePatientServiceMedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sem_HealthCarePatientServiceMedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sem_HealthCarePatientServiceNonMedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sem_HealthCarePatientServiceNonMedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sem_CriticalIllnessRecoveryHospitalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sem_CriticalIllnessRecoveryHospitalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sem_RehabilitationHospitalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sem_RehabilitationHospitalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sem_OutpatientRehabilitationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sem_OutpatientRehabilitationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=sem_ConcentraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=sem_ConcentraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888051325352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share - Narrative (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicDistributed', window );">Dividends declared and contractual dividends paid, basic (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedDistributed', window );">Dividends declared and contractual dividends paid, diluted (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicDistributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividends declared in the period and the contractual amount of dividends (or interest on participating income bonds) that must be paid per security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicDistributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedDistributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividends declared in the period and the contractual amount of dividends (or interest on participating income bonds) that must be paid per security, taking into account all dilutive potential common shares outstanding during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedDistributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888050359224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share - Net Income Attributable to the Company, Common Shares Outstanding, and Participating Securities Outstanding (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 196,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 333,422<span></span>
</td>
<td class="nump">$ 137,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to non-controlling interests</a></td>
<td class="nump">31,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,982<span></span>
</td>
<td class="nump">33,159<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Select Medical Holdings Corporation</a></td>
<td class="nump">164,894<span></span>
</td>
<td class="nump">$ 110,546<span></span>
</td>
<td class="nump">51,650<span></span>
</td>
<td class="nump">$ 53,125<span></span>
</td>
<td class="nump">275,440<span></span>
</td>
<td class="nump">104,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic EPS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Less: Distributed and undistributed income attributable to participating securities - Basic EPS</a></td>
<td class="nump">5,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,250<span></span>
</td>
<td class="nump">3,596<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Distributed and undistributed income attributable to common shares</a></td>
<td class="nump">159,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">266,190<span></span>
</td>
<td class="nump">101,179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted EPS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted', window );">Less: Distributed and undistributed income attributable to participating securities - Diluted EPS</a></td>
<td class="nump">5,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,250<span></span>
</td>
<td class="nump">3,596<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Distributed and undistributed income attributable to common shares</a></td>
<td class="nump">$ 159,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 266,190<span></span>
</td>
<td class="nump">$ 101,179<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2793-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2740-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2793-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888053292024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share - Computation of EPS Under the Two-Class Method (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsAbstract', window );"><strong>Net Income Allocation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income allocated to common shares - basic</a></td>
<td class="nump">$ 159,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 266,190<span></span>
</td>
<td class="nump">$ 101,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income allocated to common shares - diluted</a></td>
<td class="nump">159,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">266,190<span></span>
</td>
<td class="nump">101,179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Net income allocated to participating securities</a></td>
<td class="nump">5,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,250<span></span>
</td>
<td class="nump">3,596<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Select Medical Holdings Corporation</a></td>
<td class="nump">$ 164,894<span></span>
</td>
<td class="nump">$ 110,546<span></span>
</td>
<td class="nump">$ 51,650<span></span>
</td>
<td class="nump">$ 53,125<span></span>
</td>
<td class="nump">$ 275,440<span></span>
</td>
<td class="nump">$ 104,775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding, basic (in shares)</a></td>
<td class="nump">130,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,362<span></span>
</td>
<td class="nump">129,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding, diluted (in shares)</a></td>
<td class="nump">130,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,362<span></span>
</td>
<td class="nump">129,479<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights', window );">Weighted average participating securities outstanding (in shares)</a></td>
<td class="nump">4,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,530<span></span>
</td>
<td class="nump">4,602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic EPS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share (in dollars per share)</a></td>
<td class="nump">$ 1.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.04<span></span>
</td>
<td class="nump">$ 0.78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted EPS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share (in dollars per share)</a></td>
<td class="nump">$ 1.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.04<span></span>
</td>
<td class="nump">$ 0.78<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents nonvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents (whether paid or unpaid). Basic and dilutive earnings per share are generally disclosed for such shares using the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 68B<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5498026-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2793-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888050706968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Litigation (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis=us-gaap_ProfessionalMalpracticeLiabilityMember', window );">Professional liability claims</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MalpracticeInsuranceAnnualCoverageLimit', window );">Total annual aggregate limit of insurance coverage</a></td>
<td class="nump">$ 37.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis=us-gaap_ProfessionalMalpracticeLiabilityMember', window );">Professional liability claims | Joint Venture Operations</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MalpracticeInsuranceAnnualCoverageLimit', window );">Total annual aggregate limit of insurance coverage</a></td>
<td class="nump">80.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis=us-gaap_ProfessionalMalpracticeLiabilityMember', window );">Professional liability claims | Joint Venture Operations | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MalpracticeInsuranceAnnualCoverageLimit', window );">Total annual aggregate limit of insurance coverage</a></td>
<td class="nump">23.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis=us-gaap_ProfessionalMalpracticeLiabilityMember', window );">Professional liability claims | Joint Venture Operations | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MalpracticeInsuranceAnnualCoverageLimit', window );">Total annual aggregate limit of insurance coverage</a></td>
<td class="nump">33.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis=us-gaap_GeneralLiabilityMember', window );">General Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and Contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MalpracticeInsuranceAnnualCoverageLimit', window );">Total annual aggregate limit of insurance coverage</a></td>
<td class="nump">$ 40.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MalpracticeInsuranceAnnualCoverageLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual coverage limit provided by the insurance arrangement for malpractice claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MalpracticeInsuranceAnnualCoverageLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis=us-gaap_ProfessionalMalpracticeLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis=us-gaap_ProfessionalMalpracticeLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis=us-gaap_GeneralLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis=us-gaap_GeneralLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888042885144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Medicare Dual-Eligible Litigation (Details) - Judicial Ruling<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Feb. 28, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesLineItems', window );"><strong>Gain Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLegalSettlements', window );">Medicare bad debt reimbursement claim</a></td>
<td class="nump">$ 17.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_ProceedsFromLegalSettlementsAccruedInterest', window );">Accrued interest</a></td>
<td class="nump">$ 4.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_ProceedsFromLegalSettlementsAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Legal Settlements, Accrued Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_ProceedsFromLegalSettlementsAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for the settlement of litigation during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_JudicialRulingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_JudicialRulingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888050653640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CARES Act (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">15 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtraordinaryAndUnusualItemsAbstract', window );"><strong>Unusual or Infrequent Items, or Both [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_ProceedsFromGovernmentAssistanceCARESAct', window );">Government assistance, provider relief payments received, CARES Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 208,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_GovernmentAssistanceRecognizedInEarningsCARESAct', window );">Government assistance recognized in earnings, CARES Act</a></td>
<td class="nump">$ 98,000<span></span>
</td>
<td class="nump">$ 55,000<span></span>
</td>
<td class="nump">$ 114,100<span></span>
</td>
<td class="nump">$ 55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating income</a></td>
<td class="nump">98,087<span></span>
</td>
<td class="nump">$ 54,988<span></span>
</td>
<td class="nump">132,108<span></span>
</td>
<td class="nump">$ 54,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_UnearnedGovernmentAssistanceCARESAct', window );">Unearned government assistance, CARES Act</a></td>
<td class="nump">4,099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,099<span></span>
</td>
<td class="nump">$ 82,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct', window );">Unearned government assistance, amount expected to be repaid, CARES Act</a></td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_GovernmentAdvancesCARESAct', window );">Government advances, CARES Act</a></td>
<td class="nump">251,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 251,272<span></span>
</td>
<td class="nump">$ 321,807<span></span>
</td>
<td class="nump">$ 325,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_sem_GovernmentAdvancesRecoupedCARESAct', window );">Government advances recouped, CARES Act</a></td>
<td class="nump">$ 73,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_GovernmentAdvancesCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Government Advances, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_GovernmentAdvancesCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_GovernmentAdvancesRecoupedCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Government Advances Recouped, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_GovernmentAdvancesRecoupedCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_GovernmentAssistanceRecognizedInEarningsCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Government Assistance Recognized In Earnings, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_GovernmentAssistanceRecognizedInEarningsCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_ProceedsFromGovernmentAssistanceCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Government Assistance, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_ProceedsFromGovernmentAssistanceCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unearned Government Assistance, Amount Expected To Be Repaid, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sem_UnearnedGovernmentAssistanceCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unearned Government Assistance, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sem_UnearnedGovernmentAssistanceCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sem_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtraordinaryAndUnusualItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtraordinaryAndUnusualItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139888042873976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Event (Details)<br></strong></div></th>
<th class="th">
<div>Aug. 04, 2021 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Cash dividend declared (in dollars per share)</a></td>
<td class="nump">$ 0.125<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>73
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M1-%>[GB2<MD X/NM@-7<WS0!AE\GKOX%4$L#!!0    ( )6$!5-6D18\#@0
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MX#-.&MG,V>:@164'R4IH'$MVF^/3!-(XX'TFA-X?C$#WV,5_ 5!+ P04
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M-,K%+QQZWS2!LG7>U#V8%-12=RM_[>MP LBF9P!9#\BB[BY05/F9>U[DUAS
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MCL5-9M80/VO^_-FRWZK=! N-:$ ,\:9=E$1!Z@K;F4#$3Z O]5FT/[^;(S-
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M:L+Y=,KC>3<Y,5>WPMC 2!WE7>@#QR\^MA)CAF>B4X0QQO'(-,/!&-\ L1>
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M"0H1M;^?>--&O=T:#_6.PQK/)=M@@/W2X*X.DQ!@?(#7_P%02P,$%     @
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MNGU1ONT?4COQ_CE*F5ISBIS %:D&)WGJ]1UAG!C9NF?54AIZI+EA1:]B5%:
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MGS6]$='R!EJOC/'#@!V,K\[M/U!+ P04    " "5A 53O20$L=<&  #_(
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M6I, SVQ8C?W6G5>/XOLH/J=;&!N5#]G=[H*O'\"EH@"XA*>)_/3JO>MB$_H
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MW(!HP")3P;1>.QY6J[9!%6H.BZV6V1H[:ZFT=0QM(RSJU%[,B">HN[QREU?
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M%7!_K?%B]A_^@/%?AXN_ 5!+ P04    " "5A 53>.G.G]X$  !,"P  &0
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M.&UO2$_'VWLF<H-/OB/%!4R3T='! !_$>'=K7[RIXWUI9CQN7_&QQ'67;3B
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M(0'<7VOT7)P00?<]=ODW4$L#!!0    ( )6$!5/>GEEEX@@  +T8   9
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M%(2#^*S!G$?WX-)717*/UX"Z7_3%MT/'X)5Q -B2$0T,64?.0E"\)&>+!(U
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MQ';#3!7E J6(P!X$JY([W]$Q ;Y(5? LT:*T>(_G&HAHF)CK"Z0('!32^+)
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;+59VVX;.1+]%4+K760
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MD9'C3@O#DI\V--Z!US=$;F_X#8;'<OD34$L#!!0    ( )6$!5-3\O1GP@@
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MQDSOK<K:KC@T><9#2(85E7%N-T'^.2/946RT*DQ%0VYFU4\F3+=U:+Y;Z>1
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M7 UHV/"F^MV@7%'CH5R[%F8+V.?.O]=@DB6O;]2LU/;H=.H %*>F\PW VP#
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M8YP!2_NM/V&9U2)Z30D:@8D5U&9.8V48HQ(:=%19TX2V>:$3!8*@J?"J6SN
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MF8[_>?1PY 7FO!WX@%SG#N!#&) C*P],Q]\5'@_C73^PC;<3V'B8L<;#)'4
M(/"X$/!*S&6;"@MZG^*QXF!6MRKN*##7KX,(CW/"<<*A].XP2K@6_3"GXYP>
M34);%!$2F#%LJC]'J"SHU;'LH+VC')K7P(11CZ%^3Y5!(<,$^BV.7"QZ\@".
M.$YQ]/^]./K.96;[<3 >)O[Q=H8?#T/Z>#N*'\*1IMZ9#D?>^PY'.I4>=#R>
M((;92KP:1\SR#D=6VA?@R.#CTD?XN#@ZQX30F/#21RALQH==7"G$*)JH7-2>
MO0)&<(X%.@>4]#"(F;.K!F%F%IX=P(Y"XN&S=><D.'ETG;0*]6VZ-&O@S$W9
M=C=+P^YP+W?>74<]'.\N]7[.ZML<SBK" J3LC<5<5W<79=U+6ZW3Y=2T:MMJ
ME9;+D,U#'0_@_T55M=N7*&"XK3S[/U!+ P04    " "5A 53[8'P="\%   5
M#0  &0   'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6S55]MN&S<0_15"-8H$
M8"/>+XYM('9;) 72&+;;/A1]6$F4M,AJJ2Y7OOQ]#ZE+I#BQV[?T1>(..8?#
M.6=FN2=WL?N8YB'TY'[1M.ET,._[Y?%PF,;SL*C2J[@,+6:FL5M4/1Z[V3 M
MNU!-BM.B&0K&S'!1U>W@[*38+KNSD[CJF[H-EQU)J\6BZA[.0Q/O3@=\L#5<
MU;-YGPW#LY-E-0O7H?]M>=GA:;A#F=2+T*8ZMJ0+T]/!&WY\KO+ZLN#W.MRE
MO3'))QG%^#$_O)N<#E@.*#1AW&>$"G^WX2(T309"&']O, >[+;/C_GB+_G,Y
M.\XRJE*XB,T?]:2?GP[<@$S"M%HU_56\>QLVY]$9;QR;5'[)W7JM50,R7J4^
M+C;.B&!1M^O_ZGZ3AST'Q[[B(#8.HL2]WJA$^6/55V<G7;PC75X-M#PH1RW>
M"*YN,RG7?8?9&G[]V56X#>TJD&D7%^0BMGV'/"4$T<_)1=D^=(F\N*E&34@O
M3X8]]LR>P_$&_WR-+[Z";\A[@,X3^:F=A,FA_Q"Q[@(6VX#/Q9. OZS:5T0R
M2@03_ D\N4N +'CROR3@\/SDSS>C5.Q_/;&AVFVHRH;J*QM>HZXFJR:0."63
M.E6S61=F59$H+"WJ$!77P=#.H/H27"*CASUK"C.41?\E,I[<.A?X<5I6XW Z
M0 6GT-V&P=G-'(>/#:HS8_>%Z/W  NFQXB(NEE7[\/UW3G#[.FTC@V=7YOMY
M%P*IV@E)]3U9K#D/F7,"QL*6,5:69.J.R4UQV9?'9TLONKJOQU5#WC5-&U(B
M5V$<;T/W0-[&M*Q[S%R%>36J&XQ+ G?V#ZM^"1.RE#D=ATPK^8! .W(3\X(7
M=8N8XRHAGO227&X6YYS4X[ ]WC%Y'R8(H0ODB BNJ68.(\NIYBR;&&7*YX&V
M^"W9$:\QDLQ2*13Y-;8_[" DXY0939REQEO"I::<29@]5<;NO)V45$JQ"71Y
M&%GZI G-#=56$JX]%0QX&GA:%#R+O;=XG'+%J-%FDX M=9(R+4G>FQ'.J7>&
M"&JX(D91CU-Y@6BW86R=CK"MIT88C+AQU!A;1I9RF5,CN4#P>;1!P2054E#+
MW7.,\V^.<1#&?3X,>*(.U!T1I:GP/$]Z?4BY1I)QX$/*D7DOD$M'E9*0D*7.
M2X HRH7>IP@,2,^>)UT)>-J<+BHA1F$DY4X51(6:^82H#/B3_C/2P3.DQ1F5
MVA%$(Q %;)"-91"UPE26 G],NU+02]$Z*#8F"T X1A7S)2N&2BMR;:QA,NT:
M$LAU?(V.\/\I<Z4M97RM:D&%R8<RC#J72;?"'Y!N7)[YC'1=$)!EXU$5*'")
ME()URQ0:R#Y'%CL85,MSK*-O\)Q+7[ DE"=1G<XJ8$*/L&\Q1=89U5#((>\&
M"@/AOHA7>' DB89>03C6Y_8ELL2%?$0\SQRBA=BMQEVF7@GHS]G2#)$"M*&C
M'=)1[B,*#5 _P_TW5_"JM%Y72M]0H7*/=Q"RRR+0XK#@K>!(AC[DWJ(N&:3"
MO:06DXH[M#Z!GJ^HM?L\<>>1(?LON,\O"L4]40RO&P0!#8%&!4R-'J#V,#VZ
M"%/B4:/7B  D*@7A(#YK8//H'ESZHDCN\1I0CXL^[^W0,7AA'  V9T0#0Y:1
MLQ 4S\G9(D$C4!I6.DF^=%D:[EU5<;6:E0MY(N.X:OOUK75GW=WYWZRONI^6
MKS\8WE?=K&X3:<(4KNR5U0/2K2_AZX<^+LO%=Q1[W./*<([OEM#E!9B?QMAO
M'_(&NR^ALW\ 4$L#!!0    ( )6$!5,(M7^?$P0  .(*   9    >&PO=V]R
M:W-H965T<R]S:&5E=#,U+GAM;-56VV[C-A#]E8&0AP3@6G?9"AP#N6S1770+
M(T[;AZ(H:(FVB)5(EZ36V;_OD+0591&[Q:(O]8/-R\R9F<,SR<SW4GW6#6,&
MGKM6Z)N@,69W'8:Z:EA']43NF,";C50=-;A5VU#O%*.U<^K:,(FB(NPH%\%B
M[LZ6:C&7O6FY8$L%NN\ZJK[>L5;N;X(X.!X\\FUC[$&XF._HEJV8^66W5+@+
M!Y2:=TQH+@4HMKD);N/KN\S:.X-?.=OKT1IL)6LI/]O-A_HFB&Q"K&65L0@4
M?[ZP>]:V%@C3^.N &0PAK>-X?43_P=6.M:RI9O>R_8W7IKD)9@'4;$/[UCS*
M_8_L4$]N\2K9:O<->V];9 %4O3:R.SAC!AT7_I<^'W@8.<RB$P[)P2%Q>?M
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M4B!" ^#]GG-U&F@'W;?'XG]02P,$%     @ E80%4W1JI)*U @  3@@  !D
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M25>KC_SP-QT*BDV^G-?2_J+#,#?P4-Y)Q9LA6#MH6-L?R;>A$4<!$"T$X"$
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MD7\@HF]<D12PYKAG)@12AO >+ 773<\>)Q#)^"97MK&]:RPL&RNJ_]TX0$$
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M?J5U07$9+Q.YJC[!H1X;CD"V5UH4M=AD4#!^_"9?ZXEH"6#D$:!:@$X5X%J
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M^Q]W60/-G[ZO/,L;/,@;)P.P8QUE7F]B['.TU,']U.DG 3Z9/=BR!P^PQ\>
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MY]2D.^#3<[5VU0;9HM*+F256GVJY9+E'%P)X?VXM[8Q0H/F!C'\#4$L#!!0
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M!F9_)81^F-C[J_Y?&?\!4$L#!!0    ( )6$!5/\[JJ]I@,  " /   9
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M4,VDZT08D-F-OW(WA$,S3@=D[))N?9[U[_N?J5,,.0L0H2O8"$IJ]^QW@J"
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MFZ?\FS=EMJJ?2M]D99DMZY<+$\U-7@'LY[=95CZ^J0;8_M;B^']02P,$%
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M1:#]PJ9KGS/Z)6?7-!CP7[OR%6+X>T0Q)<!X;LYOCB$Z?Z[W] _W?I0,ME]
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MI$Z)98!ZOF%,'F[*"IJO*]/_ %!+ P04    " "5A 53$NX@*^8"  "W"@
M&0   'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6R]5EUOVC 4_2M6U(=6VIHO
M2F@%2(7NJQH::M?NV2278-6QF>U *^W'[SH)"5TADRK!"XD=WW/./3>YW/Y:
MJB>] ##D.>-"#YR%,<LKU]7Q C*JS^42!#Z92Y51@TN5NGJI@"9%4,;=P/.Z
M;D:9<(;]8F^JAGV9&\X$3!71>991]3("+M<#QW<V&W<L71B[X0[[2YK"/9B'
MY53ARJU1$I:!T$P*HF ^<*[]JY$?V8#BQ".#M=ZZ)S:5F91/=O$M&3B>500<
M8F,A*%Y6, ;.+1+J^%V!.C6G#=R^WZ!_+I+'9&94PUCR7RPQBX'3<T@"<YIS
M<R?77Z%*Z,+BQ9+KXI>LR[/=R"%QKHW,JF!4D#%17NES9<160.#O"0BJ@*#0
M71(5*F^HH<.^DFNB[&E$LS=%JD4TBF/"5N7>*'S*,,X,QS++F$&;C294)&0L
MA6$B!1$ST.0C^<X,2VEAX.D-&,JX/B,GA DR89SCMNZ[!G58-#>N.$<E9["'
MLTLFR++0Y)-(('D=[Z+^.HE@D\0H: 6\S<4Y";T/)/ "_^'^AIR>G+7 AK4W
M80';V0,[57(.VKY_E!/.Z(QQ9EY(S"G+= M^I\;O%/CA>[QOP;^H\2]:]?^4
M!H53(7)[25,%6$G 3)"5R#D64>>*BAA(+%>@\"/<5<N2HUMPV&]\-0RCOKO:
MH:M;Z^J^WU?RA]Q*)@QY1%]R!>3'$J69MV_:*^JHIHX.8GFOQN\=P?*2XV++
M\IZWV_++6M?E02S'1Q,F6)9G+>;X7M-LO(/8[V^U,_\(!:A(MBL0A+LKX >-
MM.!@-:#/_ZM!T]3\\# U:-J:WSE&#3IO:A#NJT'3$?WVEO@%!!)R_%NK[&]+
MN.EG?O<PEC9MRX^.86GTII=W_FTL[M8LD8%*BXE)(VPN3#E6U+OU5'9=SB+-
M\7*DFU"5HC#"88ZAWGF$M5'EE%0NC%P6D\E,&IQSBML%3I:@[ %\/I?2;!:6
MH)Y5AW\!4$L#!!0    ( )6$!5-Z5^XI7P(  ",%   9    >&PO=V]R:W-H
M965T<R]S:&5E=#8P+GAM;'U4WT_;,!#^5ZR(!Y!&TX1V,)1&HBUL3%1"(+:'
M:0].<DTL_*.S+Y3]]SL[;=8QVI?$9]]]WW?G.V=K8Y]= X#L54GM)E&#N+J,
M8U<VH+@;F!5H.ED:JSB2:>O8K2SP*@0I&:?#X<=8<:&C/ M[]S;/3(M2:+BW
MS+5*<?M["M*L)U$2;3<>1-V@WXCS;,5K> 1\6MU;LN(>I1(*M!-&,PO+2725
M7$['WC\X?!.P=CMKYC,IC'GVQFTUB89>$$@HT2-P^KW #*3T0"3CUP8SZBE]
MX.YZBWX3<J=<"NY@9N1W46$SB2XB5L&2MQ(?S/H+;/() DLC7?BR]<9W&+&R
M=6C4)I@4**&[/W_=U&$G($WV!*2;@#3H[HB"RCE'GF?6K)GUWH3F%R'5$$WB
MA/:7\HB63@7%83XS2@FD*J-C7%=L9C0*78,N!3AVRA90B9);8/.6R]-K*6I1
M2&!W D7-0UV/YX!<2'="WE];\A9<LH>6B&IVQ(1F"R$E.;HL1A+L:>-R(V[:
MB4OWB$O8@N0TCEWK"JI_XV-*M,\VW68[30\"WD Q8.G%!Y8.T^3I<<Z.CTX.
MP)[U13P+L&=[8#]3\[^IW(\[\F&W",K]/, PZAE&@6&TAZ&_AH)7U'0%TD (
M5;36@;\[5DHNU'L%[F"38<#U$_J2)^>#3UG\\HZ:<:]F?%#-55G:%BJZ7 0+
M#M\C'O]//!J<O^&-=QI7@:W#>#I6FE9CU\/];O\"7'6-_]>]>SX6W-9".R9A
M2:'#P3D)L-U(=@::51B#PB -55@V](J!]0YTOC0&MX8GZ-_%_ ]02P,$%
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M3 'D^QVEXGV@#-3WMMG_4$L#!!0    ( )6$!5/3_!^9\0$  "H$   9
M>&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;(V476O;,!2&_XH0N^A@1([CM*,X
MAB;=6&&#T+#M8NQ"L4]B47VXDAQW_WY'LF,\6$-O+!WIO(_?(Q\Y[XQ]<C6
M)R]*:K>BM??-+6.NK$%Q-S,-:-PY&*NXQ] >F6LL\"J*E&1IDEPSQ86F11[7
MMK;(3>NET+"UQ+5*<?MG#=)T*SJGYX5'<:Q]6&!%WO C[,!_;[86(S92*J%
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M)@,  '(2   -    >&PO<W1Y;&5S+GAM;-U8;6_:,!#^*Y$[3:TT-4!&2E9
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MMZAW^YUZE^GSD,NUYVN-S_].JJ?SO?GZ^,ORZ^3LO5QP3K<5Y?DO4$L#!!0
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MKP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ E80%4YE<G",0!@
MG"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    " "5A 53+"J@<6$%   :%@  &               @($-"   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ E80%4T"G+?IX!P
M8AX  !@              ("!I T  'AL+W=O<FMS:&5E=',O<VAE970R+GAM
M;%!+ 0(4 Q0    ( )6$!5.T++8ND@(  .@&   8              " @5(5
M  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " "5A 53W4+R
MK#$&  "I&   &               @($:&   >&PO=V]R:W-H965T<R]S:&5E
M=#0N>&UL4$L! A0#%     @ E80%4U:1%CP.!   ?PT  !@
M ("!@1X  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( )6$
M!5.AWQ&NFP(  /@&   8              " @<4B  !X;"]W;W)K<VAE971S
M+W-H965T-BYX;6Q02P$"% ,4    " "5A 53?;1S7HP,  #04   &
M        @(&6)0  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%
M  @ E80%4X6T],!' @  M00  !@              ("!6#(  'AL+W=O<FMS
M:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( )6$!5/=]T@$6@@  "<B   8
M              " @=4T  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"
M% ,4    " "5A 53]G.NP/H$   A#   &0              @(%E/0  >&PO
M=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( )6$!5.V"5C;!04
M (T+   9              " @99"  !X;"]W;W)K<VAE971S+W-H965T,3$N
M>&UL4$L! A0#%     @ E80%4^L%CEU6 P  C <  !D              ("!
MTD<  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " "5A 53
MMK5RN7($  !S"P  &0              @(%?2P  >&PO=V]R:W-H965T<R]S
M:&5E=#$S+GAM;%!+ 0(4 Q0    ( )6$!5,F>'.G- 0  ($*   9
M      " @0A0  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%
M  @ E80%4[TD!+'7!@  _R   !D              ("!<U0  'AL+W=O<FMS
M:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " "5A 53>K,FL@ %  #U"P
M&0              @(&!6P  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+
M 0(4 Q0    ( )6$!5/3J1',Z 0  $8,   9              " @;A@  !X
M;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ E80%4WCISI_>
M!   3 L  !D              ("!UV4  'AL+W=O<FMS:&5E=',O<VAE970Q
M."YX;6Q02P$"% ,4    " "5A 53,P5N%C\%  ";#0  &0
M@('L:@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( )6$
M!5/>GEEEX@@  +T8   9              " @6)P  !X;"]W;W)K<VAE971S
M+W-H965T,C N>&UL4$L! A0#%     @ E80%4S)2\:(*!0  #@T  !D
M         ("!>WD  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
M    " "5A 53W]_ZXHP%  #3#P  &0              @(&\?@  >&PO=V]R
M:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( )6$!5.3N;O!<@T  !TD
M   9              " @7^$  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL
M4$L! A0#%     @ E80%4R?O=P=4"0  EAH  !D              ("!*)(
M 'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " "5A 53-Y:)
MHF("   X!0  &0              @(&SFP  >&PO=V]R:W-H965T<R]S:&5E
M=#(U+GAM;%!+ 0(4 Q0    ( )6$!5-3\O1GP@@  #$7   9
M  " @4R>  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @
ME80%4V$/_D54 P  Z0<  !D              ("!1:<  'AL+W=O<FMS:&5E
M=',O<VAE970R-RYX;6Q02P$"% ,4    " "5A 53#?C(H=(&   G%@  &0
M            @('0J@  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4
M Q0    ( )6$!5-4(NN[;@0  %P*   9              " @=FQ  !X;"]W
M;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ E80%4]CYF69'!
M7PL  !D              ("!?K8  'AL+W=O<FMS:&5E=',O<VAE970S,"YX
M;6Q02P$"% ,4    " "5A 53_C 1=^0"   B!@  &0              @('\
MN@  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( )6$!5,4
M--/=0@,  -8'   9              " @1>^  !X;"]W;W)K<VAE971S+W-H
M965T,S(N>&UL4$L! A0#%     @ E80%4U(_>3@Z!P  N10  !D
M     ("!D,$  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )6$!5-T:J22M0(  $X(   9              "
M@579  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ E80%
M4Q>%9J'W!   I!<  !D              ("!0=P  'AL+W=O<FMS:&5E=',O
M<VAE970S.2YX;6Q02P$"% ,4    " "5A 53M@+M%_<"  """   &0
M        @(%OX0  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0
M   ( )6$!5-&=6D<J@0  (<5   9              " @9WD  !X;"]W;W)K
M<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ E80%4X'E75QL @  D@<
M !D              ("!?ND  'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q0
M2P$"% ,4    " "5A 53TI\>%7X#   8#0  &0              @($A[
M>&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( )6$!5,UYO2Z
M@P,  % .   9              " @=;O  !X;"]W;W)K<VAE971S+W-H965T
M-#0N>&UL4$L! A0#%     @ E80%4V;##'.5!0  AQT  !D
M ("!D/,  'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " "5
MA 532,S? \8$  !6%   &0              @(%<^0  >&PO=V]R:W-H965T
M<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( )6$!5/ZQ\E8>@0   <4   9
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M970U,2YX;6Q02P$"% ,4    " "5A 53_.ZJO:8#   @#P  &0
M    @('^#P$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    (
M )6$!5,EO5#;O 8  '<A   9              " @=L3 0!X;"]W;W)K<VAE
M971S+W-H965T-3,N>&UL4$L! A0#%     @ E80%4YJ(,AMF!P  #"4  !D
M             ("!SAH! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"
M% ,4    " "5A 53#AG(]/,(  "K.@  &0              @(%K(@$ >&PO
M=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( )6$!5,_$S34C0(
M -0'   9              " @94K 0!X;"]W;W)K<VAE971S+W-H965T-38N
M>&UL4$L! A0#%     @ E80%4Q8VV><O!   J0\  !D              ("!
M62X! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " "5A 53
M@ZR,&&P$  !I$0  &0              @(&_,@$ >&PO=V]R:W-H965T<R]S
M:&5E=#4X+GAM;%!+ 0(4 Q0    ( )6$!5,2[B KY@(  +<*   9
M      " @6(W 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%
M  @ E80%4WI7[BE? @  (P4  !D              ("!?SH! 'AL+W=O<FMS
M:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    " "5A 53?NX\=+T#  ###0
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M+G)E;'-02P$"% ,4    " "5A 53)"#<AP$%   5*0  #P
M@ %K1P$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ E80%4W=+<84& @
M\20  !H              ( !F4P! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ E80%4_\GIW7C 0  ;"0  !,              ( !
MUTX! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     $8 1@ A$P  ZU !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>268</ContextCount>
  <ElementCount>381</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>49</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Operations (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Changes in Equity and Income (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Equity and Income (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Condensed Consolidated Statements of Changes in Equity and Income (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Equity and Income (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1008009 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/AccountingPolicies</Role>
      <ShortName>Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2104103 - Disclosure - Credit Risk Concentrations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/CreditRiskConcentrations</Role>
      <ShortName>Credit Risk Concentrations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2106104 - Disclosure - Redeemable Non-Controlling Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/RedeemableNonControllingInterests</Role>
      <ShortName>Redeemable Non-Controlling Interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2109105 - Disclosure - Variable Interest Entities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/VariableInterestEntities</Role>
      <ShortName>Variable Interest Entities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2111106 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2118107 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2122108 - Disclosure - Long-Term Debt and Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.selectmedical.com/role/LongTermDebtandNotesPayable</Role>
      <ShortName>Long-Term Debt and Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2127109 - Disclosure - Interest Rate Cap</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/InterestRateCap</Role>
      <ShortName>Interest Rate Cap</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2131110 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/FairValueofFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2135111 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2139112 - Disclosure - Revenue from Contracts with Customers</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/RevenuefromContractswithCustomers</Role>
      <ShortName>Revenue from Contracts with Customers</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2142113 - Disclosure - Earnings per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/EarningsperShare</Role>
      <ShortName>Earnings per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2147114 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2150115 - Disclosure - CARES Act</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/CARESAct</Role>
      <ShortName>CARES Act</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2152116 - Disclosure - Subsequent Event</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/SubsequentEvent</Role>
      <ShortName>Subsequent Event</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/AccountingPoliciesPolicies</Role>
      <ShortName>Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.selectmedical.com/role/AccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2307301 - Disclosure - Redeemable Non-Controlling Interests (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/RedeemableNonControllingInterestsTables</Role>
      <ShortName>Redeemable Non-Controlling Interests (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.selectmedical.com/role/RedeemableNonControllingInterests</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2312302 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.selectmedical.com/role/Leases</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2319303 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.selectmedical.com/role/IntangibleAssets</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2323304 - Disclosure - Long-Term Debt and Notes Payable (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.selectmedical.com/role/LongTermDebtandNotesPayableTables</Role>
      <ShortName>Long-Term Debt and Notes Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.selectmedical.com/role/LongTermDebtandNotesPayable</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2328305 - Disclosure - Interest Rate Cap (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/InterestRateCapTables</Role>
      <ShortName>Interest Rate Cap (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.selectmedical.com/role/InterestRateCap</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2332306 - Disclosure - Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/FairValueofFinancialInstrumentsTables</Role>
      <ShortName>Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.selectmedical.com/role/FairValueofFinancialInstruments</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2336307 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.selectmedical.com/role/SegmentInformation</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2340308 - Disclosure - Revenue from Contracts with Customers (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/RevenuefromContractswithCustomersTables</Role>
      <ShortName>Revenue from Contracts with Customers (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.selectmedical.com/role/RevenuefromContractswithCustomers</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2343309 - Disclosure - Earnings per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/EarningsperShareTables</Role>
      <ShortName>Earnings per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.selectmedical.com/role/EarningsperShare</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - Credit Risk Concentrations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/CreditRiskConcentrationsDetails</Role>
      <ShortName>Credit Risk Concentrations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.selectmedical.com/role/CreditRiskConcentrations</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2408402 - Disclosure - Redeemable Non-Controlling Interests - Schedule of Redeemable Non-Controlling Interests (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails</Role>
      <ShortName>Redeemable Non-Controlling Interests - Schedule of Redeemable Non-Controlling Interests (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2410403 - Disclosure - Variable Interest Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/VariableInterestEntitiesDetails</Role>
      <ShortName>Variable Interest Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.selectmedical.com/role/VariableInterestEntities</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2413404 - Disclosure - Leases - Schedule of Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails</Role>
      <ShortName>Leases - Schedule of Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2414405 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/LeasesSupplementalCashFlowInformationDetails</Role>
      <ShortName>Leases - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2415406 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2416407 - Disclosure - Leases - Weighted Average Lease Terms and Discount Rates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/LeasesWeightedAverageLeaseTermsandDiscountRatesDetails</Role>
      <ShortName>Leases - Weighted Average Lease Terms and Discount Rates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2417408 - Disclosure - Leases - Maturities of Operating and Finance Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Operating and Finance Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2420409 - Disclosure - Intangible Assets - Carrying Amount of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountofGoodwillDetails</Role>
      <ShortName>Intangible Assets - Carrying Amount of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2421410 - Disclosure - Intangible Assets - Carrying Value and Amortization of Identifiable Intangible Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails</Role>
      <ShortName>Intangible Assets - Carrying Value and Amortization of Identifiable Intangible Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2424411 - Disclosure - Long-Term Debt and Notes Payable - Components of Long-Term Debt And Notes Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails</Role>
      <ShortName>Long-Term Debt and Notes Payable - Components of Long-Term Debt And Notes Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2425412 - Disclosure - Long-Term Debt and Notes Payable - Principal Maturities Of Long-Term Debt (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails</Role>
      <ShortName>Long-Term Debt and Notes Payable - Principal Maturities Of Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2426413 - Disclosure - Long-Term Debt and Notes Payable - Narrative (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails</Role>
      <ShortName>Long-Term Debt and Notes Payable - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2429414 - Disclosure - Interest Rate Cap - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/InterestRateCapNarrativeDetails</Role>
      <ShortName>Interest Rate Cap - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2430415 - Disclosure - Interest Rate Cap - Schedule of Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Interest Rate Cap - Schedule of Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2433416 - Disclosure - Fair Value of Financial Instruments - Schedule of Interest Rate Cap (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails</Role>
      <ShortName>Fair Value of Financial Instruments - Schedule of Interest Rate Cap (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2434417 - Disclosure - Fair Value of Financial Instruments - Schedule of Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails</Role>
      <ShortName>Fair Value of Financial Instruments - Schedule of Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2437418 - Disclosure - Segment Information - Selected Financial Data (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails</Role>
      <ShortName>Segment Information - Selected Financial Data (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2438419 - Disclosure - Segment Information - Reconciliation of Adjusted EBITDA to Income Before Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails</Role>
      <ShortName>Segment Information - Reconciliation of Adjusted EBITDA to Income Before Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2441420 - Disclosure - Revenue from Contracts with Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails</Role>
      <ShortName>Revenue from Contracts with Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.selectmedical.com/role/RevenuefromContractswithCustomersTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2444421 - Disclosure - Earnings per Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/EarningsperShareNarrativeDetails</Role>
      <ShortName>Earnings per Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2445422 - Disclosure - Earnings per Share - Net Income Attributable to the Company, Common Shares Outstanding, and Participating Securities Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails</Role>
      <ShortName>Earnings per Share - Net Income Attributable to the Company, Common Shares Outstanding, and Participating Securities Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2446423 - Disclosure - Earnings per Share - Computation of EPS Under the Two-Class Method (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails</Role>
      <ShortName>Earnings per Share - Computation of EPS Under the Two-Class Method (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2448424 - Disclosure - Commitments and Contingencies - Litigation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails</Role>
      <ShortName>Commitments and Contingencies - Litigation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2449425 - Disclosure - Commitments and Contingencies - Medicare Dual-Eligible Litigation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/CommitmentsandContingenciesMedicareDualEligibleLitigationDetails</Role>
      <ShortName>Commitments and Contingencies - Medicare Dual-Eligible Litigation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2451426 - Disclosure - CARES Act (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/CARESActDetails</Role>
      <ShortName>CARES Act (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.selectmedical.com/role/CARESAct</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="sem-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2453427 - Disclosure - Subsequent Event (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.selectmedical.com/role/SubsequentEventDetails</Role>
      <ShortName>Subsequent Event (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.selectmedical.com/role/SubsequentEvent</ParentRole>
      <Position>62</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="sem-20210630.htm">sem-20210630.htm</File>
    <File>sem-20210630.xsd</File>
    <File>sem-20210630_cal.xml</File>
    <File>sem-20210630_def.xml</File>
    <File>sem-20210630_lab.xml</File>
    <File>sem-20210630_pre.xml</File>
    <File>sem-630202110qxex311.htm</File>
    <File>sem-630202110qxex312.htm</File>
    <File>sem-630202110qxex321.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>78
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "sem-20210630.htm": {
   "axisCustom": 0,
   "axisStandard": 23,
   "contextCount": 268,
   "dts": {
    "calculationLink": {
     "local": [
      "sem-20210630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "sem-20210630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "sem-20210630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sem-20210630_lab.xml"
     ],
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-doc-2021-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sem-20210630_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-ref-2021-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "sem-20210630.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-parts-codification-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd"
     ]
    }
   },
   "elementCount": 506,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 5
   },
   "keyCustom": 54,
   "keyStandard": 327,
   "memberCustom": 12,
   "memberStandard": 35,
   "nsprefix": "sem",
   "nsuri": "http://www.selectmedical.com/20210630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.selectmedical.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation",
     "role": "http://www.selectmedical.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - Accounting Policies",
     "role": "http://www.selectmedical.com/role/AccountingPolicies",
     "shortName": "Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ConcentrationRiskCreditRisk",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104103 - Disclosure - Credit Risk Concentrations",
     "role": "http://www.selectmedical.com/role/CreditRiskConcentrations",
     "shortName": "Credit Risk Concentrations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ConcentrationRiskCreditRisk",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106104 - Disclosure - Redeemable Non-Controlling Interests",
     "role": "http://www.selectmedical.com/role/RedeemableNonControllingInterests",
     "shortName": "Redeemable Non-Controlling Interests",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109105 - Disclosure - Variable Interest Entities",
     "role": "http://www.selectmedical.com/role/VariableInterestEntities",
     "shortName": "Variable Interest Entities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111106 - Disclosure - Leases",
     "role": "http://www.selectmedical.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118107 - Disclosure - Intangible Assets",
     "role": "http://www.selectmedical.com/role/IntangibleAssets",
     "shortName": "Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122108 - Disclosure - Long-Term Debt and Notes Payable",
     "role": "http://www.selectmedical.com/role/LongTermDebtandNotesPayable",
     "shortName": "Long-Term Debt and Notes Payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127109 - Disclosure - Interest Rate Cap",
     "role": "http://www.selectmedical.com/role/InterestRateCap",
     "shortName": "Interest Rate Cap",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131110 - Disclosure - Fair Value of Financial Instruments",
     "role": "http://www.selectmedical.com/role/FairValueofFinancialInstruments",
     "shortName": "Fair Value of Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i632267a60f314ae3bccec20a793b8465_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets (unaudited)",
     "role": "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited",
     "shortName": "Condensed Consolidated Balance Sheets (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i632267a60f314ae3bccec20a793b8465_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135111 - Disclosure - Segment Information",
     "role": "http://www.selectmedical.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139112 - Disclosure - Revenue from Contracts with Customers",
     "role": "http://www.selectmedical.com/role/RevenuefromContractswithCustomers",
     "shortName": "Revenue from Contracts with Customers",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2142113 - Disclosure - Earnings per Share",
     "role": "http://www.selectmedical.com/role/EarningsperShare",
     "shortName": "Earnings per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147114 - Disclosure - Commitments and Contingencies",
     "role": "http://www.selectmedical.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150115 - Disclosure - CARES Act",
     "role": "http://www.selectmedical.com/role/CARESAct",
     "shortName": "CARES Act",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152116 - Disclosure - Subsequent Event",
     "role": "http://www.selectmedical.com/role/SubsequentEvent",
     "shortName": "Subsequent Event",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - Accounting Policies (Policies)",
     "role": "http://www.selectmedical.com/role/AccountingPoliciesPolicies",
     "shortName": "Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307301 - Disclosure - Redeemable Non-Controlling Interests (Tables)",
     "role": "http://www.selectmedical.com/role/RedeemableNonControllingInterestsTables",
     "shortName": "Redeemable Non-Controlling Interests (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312302 - Disclosure - Leases (Tables)",
     "role": "http://www.selectmedical.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319303 - Disclosure - Intangible Assets (Tables)",
     "role": "http://www.selectmedical.com/role/IntangibleAssetsTables",
     "shortName": "Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i632267a60f314ae3bccec20a793b8465_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)",
     "role": "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i632267a60f314ae3bccec20a793b8465_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2323304 - Disclosure - Long-Term Debt and Notes Payable (Tables)",
     "role": "http://www.selectmedical.com/role/LongTermDebtandNotesPayableTables",
     "shortName": "Long-Term Debt and Notes Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328305 - Disclosure - Interest Rate Cap (Tables)",
     "role": "http://www.selectmedical.com/role/InterestRateCapTables",
     "shortName": "Interest Rate Cap (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2332306 - Disclosure - Fair Value of Financial Instruments (Tables)",
     "role": "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsTables",
     "shortName": "Fair Value of Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336307 - Disclosure - Segment Information (Tables)",
     "role": "http://www.selectmedical.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2340308 - Disclosure - Revenue from Contracts with Customers (Tables)",
     "role": "http://www.selectmedical.com/role/RevenuefromContractswithCustomersTables",
     "shortName": "Revenue from Contracts with Customers (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2343309 - Disclosure - Earnings per Share (Tables)",
     "role": "http://www.selectmedical.com/role/EarningsperShareTables",
     "shortName": "Earnings per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i6cd99a1029914dfba302e3c8d1747dc9_D20210101-20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - Credit Risk Concentrations (Details)",
     "role": "http://www.selectmedical.com/role/CreditRiskConcentrationsDetails",
     "shortName": "Credit Risk Concentrations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i6cd99a1029914dfba302e3c8d1747dc9_D20210101-20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "ia25336bcc81845369b7acc4ef55a0c51_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408402 - Disclosure - Redeemable Non-Controlling Interests - Schedule of Redeemable Non-Controlling Interests (Details)",
     "role": "http://www.selectmedical.com/role/RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails",
     "shortName": "Redeemable Non-Controlling Interests - Schedule of Redeemable Non-Controlling Interests (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RedeemableNoncontrollingInterestTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i3fcf10033def4edc8873b5e817d0b994_I20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i632267a60f314ae3bccec20a793b8465_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410403 - Disclosure - Variable Interest Entities (Details)",
     "role": "http://www.selectmedical.com/role/VariableInterestEntitiesDetails",
     "shortName": "Variable Interest Entities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i47ca05e15f9b40f489ce514ca61c046e_I20210630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "sem:OperatingLeaseCostUnrelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413404 - Disclosure - Leases - Schedule of Lease Cost (Details)",
     "role": "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails",
     "shortName": "Leases - Schedule of Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "sem:OperatingLeaseCostUnrelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations (unaudited)",
     "role": "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
     "shortName": "Condensed Consolidated Statements of Operations (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414405 - Disclosure - Leases - Supplemental Cash Flow Information (Details)",
     "role": "http://www.selectmedical.com/role/LeasesSupplementalCashFlowInformationDetails",
     "shortName": "Leases - Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sem:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i632267a60f314ae3bccec20a793b8465_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "sem:OperatingLeaseRightOfUseAssetUnrelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415406 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)",
     "role": "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sem:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i632267a60f314ae3bccec20a793b8465_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "sem:OperatingLeaseRightOfUseAssetUnrelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i632267a60f314ae3bccec20a793b8465_I20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416407 - Disclosure - Leases - Weighted Average Lease Terms and Discount Rates (Details)",
     "role": "http://www.selectmedical.com/role/LeasesWeightedAverageLeaseTermsandDiscountRatesDetails",
     "shortName": "Leases - Weighted Average Lease Terms and Discount Rates (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i632267a60f314ae3bccec20a793b8465_I20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i632267a60f314ae3bccec20a793b8465_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417408 - Disclosure - Leases - Maturities of Operating and Finance Lease Liabilities (Details)",
     "role": "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturities of Operating and Finance Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i632267a60f314ae3bccec20a793b8465_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "ib27967ed4eaf45369238e20d447ab83e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420409 - Disclosure - Intangible Assets - Carrying Amount of Goodwill (Details)",
     "role": "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountofGoodwillDetails",
     "shortName": "Intangible Assets - Carrying Amount of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i632267a60f314ae3bccec20a793b8465_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421410 - Disclosure - Intangible Assets - Carrying Value and Amortization of Identifiable Intangible Assets and Liabilities (Details)",
     "role": "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails",
     "shortName": "Intangible Assets - Carrying Value and Amortization of Identifiable Intangible Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "ib27967ed4eaf45369238e20d447ab83e_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i632267a60f314ae3bccec20a793b8465_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "sem:LongTermDebtGrossAndFinanceLeaseObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424411 - Disclosure - Long-Term Debt and Notes Payable - Components of Long-Term Debt And Notes Payable (Details)",
     "role": "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails",
     "shortName": "Long-Term Debt and Notes Payable - Components of Long-Term Debt And Notes Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i632267a60f314ae3bccec20a793b8465_I20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i632267a60f314ae3bccec20a793b8465_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "sem:LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425412 - Disclosure - Long-Term Debt and Notes Payable - Principal Maturities Of Long-Term Debt (Details)",
     "role": "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails",
     "shortName": "Long-Term Debt and Notes Payable - Principal Maturities Of Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i632267a60f314ae3bccec20a793b8465_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "sem:LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i04dc07ecbc4842379f1b38ab30b5eba8_I20210602",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426413 - Disclosure - Long-Term Debt and Notes Payable - Narrative (Details)",
     "role": "http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails",
     "shortName": "Long-Term Debt and Notes Payable - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i04dc07ecbc4842379f1b38ab30b5eba8_I20210602",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "if1a2d014fb1e4ad28dd4c378b19640ec_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeCapInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429414 - Disclosure - Interest Rate Cap - Narrative (Details)",
     "role": "http://www.selectmedical.com/role/InterestRateCapNarrativeDetails",
     "shortName": "Interest Rate Cap - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "if1a2d014fb1e4ad28dd4c378b19640ec_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeCapInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited)",
     "role": "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "ia25336bcc81845369b7acc4ef55a0c51_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430415 - Disclosure - Interest Rate Cap - Schedule of Accumulated Other Comprehensive Income (Details)",
     "role": "http://www.selectmedical.com/role/InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "Interest Rate Cap - Schedule of Accumulated Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i4c19072c8de04863a294aa039b4d4f1c_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i0b2a61478b0140669828a01db0126a67_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433416 - Disclosure - Fair Value of Financial Instruments - Schedule of Interest Rate Cap (Details)",
     "role": "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails",
     "shortName": "Fair Value of Financial Instruments - Schedule of Interest Rate Cap (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i0b2a61478b0140669828a01db0126a67_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i632267a60f314ae3bccec20a793b8465_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434417 - Disclosure - Fair Value of Financial Instruments - Schedule of Long-Term Debt (Details)",
     "role": "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails",
     "shortName": "Fair Value of Financial Instruments - Schedule of Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i101b81566dfb4f6083f1433734385dd6_I20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437418 - Disclosure - Segment Information - Selected Financial Data (Details)",
     "role": "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails",
     "shortName": "Segment Information - Selected Financial Data (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i4d9eaba867e94987bae380499ef0dea5_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireProductiveAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "sem:AdjustedEbitda",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438419 - Disclosure - Segment Information - Reconciliation of Adjusted EBITDA to Income Before Taxes (Details)",
     "role": "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails",
     "shortName": "Segment Information - Reconciliation of Adjusted EBITDA to Income Before Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i4d9eaba867e94987bae380499ef0dea5_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441420 - Disclosure - Revenue from Contracts with Customers (Details)",
     "role": "http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails",
     "shortName": "Revenue from Contracts with Customers (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "ie4d10e3e03a54b60a9d607bc62d66b9d_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareDilutedDistributed",
       "us-gaap:EarningsPerShareDilutedDistributed",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareBasicDistributed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444421 - Disclosure - Earnings per Share - Narrative (Details)",
     "role": "http://www.selectmedical.com/role/EarningsperShareNarrativeDetails",
     "shortName": "Earnings per Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareDilutedDistributed",
       "us-gaap:EarningsPerShareDilutedDistributed",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareBasicDistributed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445422 - Disclosure - Earnings per Share - Net Income Attributable to the Company, Common Shares Outstanding, and Participating Securities Outstanding (Details)",
     "role": "http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails",
     "shortName": "Earnings per Share - Net Income Attributable to the Company, Common Shares Outstanding, and Participating Securities Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446423 - Disclosure - Earnings per Share - Computation of EPS Under the Two-Class Method (Details)",
     "role": "http://www.selectmedical.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails",
     "shortName": "Earnings per Share - Computation of EPS Under the Two-Class Method (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i6bd31c72edeb45d9b4601581e31a0e89_D20210101-20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MalpracticeInsuranceAnnualCoverageLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448424 - Disclosure - Commitments and Contingencies - Litigation (Details)",
     "role": "http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails",
     "shortName": "Commitments and Contingencies - Litigation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i6bd31c72edeb45d9b4601581e31a0e89_D20210101-20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MalpracticeInsuranceAnnualCoverageLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical)",
     "role": "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i760d525b19534ec8bf2275b1a4759394_D20210201-20210228",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromLegalSettlements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449425 - Disclosure - Commitments and Contingencies - Medicare Dual-Eligible Litigation (Details)",
     "role": "http://www.selectmedical.com/role/CommitmentsandContingenciesMedicareDualEligibleLitigationDetails",
     "shortName": "Commitments and Contingencies - Medicare Dual-Eligible Litigation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i760d525b19534ec8bf2275b1a4759394_D20210201-20210228",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromLegalSettlements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i69380e325f114ea89df7916749073905_D20200327-20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "sem:ProceedsFromGovernmentAssistanceCARESAct",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451426 - Disclosure - CARES Act (Details)",
     "role": "http://www.selectmedical.com/role/CARESActDetails",
     "shortName": "CARES Act (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i69380e325f114ea89df7916749073905_D20200327-20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "sem:ProceedsFromGovernmentAssistanceCARESAct",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "ib0cd8e5fc1d2451fa507e01087b5e757_I20210804",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsPayableAmountPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453427 - Disclosure - Subsequent Event (Details)",
     "role": "http://www.selectmedical.com/role/SubsequentEventDetails",
     "shortName": "Subsequent Event (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "ib0cd8e5fc1d2451fa507e01087b5e757_I20210804",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsPayableAmountPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i6c17c8cd7cac4115a14753f94ab8ab6c_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Changes in Equity and Income (unaudited)",
     "role": "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited",
     "shortName": "Condensed Consolidated Statements of Changes in Equity and Income (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "ic4d382e1e08d4eb1ba65b7ff2dc29af0_D20200101-20200331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Condensed Consolidated Statements of Changes in Equity and Income (unaudited) (Parenthetical)",
     "role": "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunauditedParenthetical",
     "shortName": "Condensed Consolidated Statements of Changes in Equity and Income (unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i5c948dfc396147988ec58d9768ce83d9_D20210401-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1008009 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited)",
     "role": "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sem-20210630.htm",
      "contextRef": "i9541d12686d64ce9bb5f1608ea160247_D20210101-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentDividendsOrDistributions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 49,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.selectmedical.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "sem_AccreditationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to accreditations.",
        "label": "Accreditations [Member]",
        "terseLabel": "Accreditations"
       }
      }
     },
     "localname": "AccreditationsMember",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sem_AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Salaries, Accrued Bonuses, And Accrued Payroll Taxes, Current",
        "label": "Accrued Salaries, Accrued Bonuses, And Accrued Payroll Taxes, Current",
        "terseLabel": "Accrued payroll"
       }
      }
     },
     "localname": "AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_AdjustedEbitda": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measure of profit (loss) for reportable segments",
        "label": "Adjusted EBITDA",
        "terseLabel": "Adjusted EBITDA"
       }
      }
     },
     "localname": "AdjustedEbitda",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails",
      "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_AssetsandLiabilitiesLesseeOperatingLeaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets and Liabilities, Lessee, Operating Lease [Abstract]",
        "label": "Assets and Liabilities, Lessee, Operating Lease [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "AssetsandLiabilitiesLesseeOperatingLeaseAbstract",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sem_CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Paid For Amounts Included In The Measurement Of Lease Liabilities [Abstract]",
        "label": "Cash Paid For Amounts Included in The Measurement Of Lease Liabilities [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashPaidForAmountsIncludedinTheMeasurementOfLeaseLiabilitiesAbstract",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sem_CertificatesOfNeedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to certificates of need, a legal document of the entity.",
        "label": "Certificates Of Need [Member]",
        "terseLabel": "Certificates of need"
       }
      }
     },
     "localname": "CertificatesOfNeedMember",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sem_ConcentraMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to Concentra, a reporting segment of the entity.",
        "label": "Concentra [Member]",
        "terseLabel": "Concentra"
       }
      }
     },
     "localname": "ConcentraMember",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountofGoodwillDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails",
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails",
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails",
      "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sem_CriticalIllnessRecoveryHospitalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Critical Illness Recovery Hospitals [Member]",
        "label": "Critical Illness Recovery Hospitals [Member]",
        "terseLabel": "Critical Illness Recovery Hospital",
        "verboseLabel": "Critical Illness Recovery Hospital"
       }
      }
     },
     "localname": "CriticalIllnessRecoveryHospitalsMember",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountofGoodwillDetails",
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails",
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails",
      "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sem_DerivativeCostOfHedgeAnnualPremiumPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Cost of Hedge, Annual Premium, Percentage",
        "label": "Derivative, Cost of Hedge, Annual Premium, Percentage",
        "terseLabel": "Annual premium (in percent)"
       }
      }
     },
     "localname": "DerivativeCostOfHedgeAnnualPremiumPercentage",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/InterestRateCapNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "sem_FinanceLeaseAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Assets And Liabilities [Abstract]",
        "label": "Finance Lease Assets And Liabilities [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseAssetsAndLiabilitiesAbstract",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sem_FinanceLeaseInterestExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Interest Expense",
        "label": "Finance Lease, Interest Expense [Abstract]",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpenseAbstract",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sem_FinanceLeaseInterestExpenseRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails": {
       "order": 3.0,
       "parentTag": "sem_LeaseCostRelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Interest Expense, Related Parties",
        "label": "Finance Lease, Interest Expense, Related Parties",
        "terseLabel": "Related Parties"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpenseRelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_FinanceLeaseInterestExpenseUnrelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails": {
       "order": 3.0,
       "parentTag": "sem_LeaseCostUnrelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Interest Expense, Unrelated Parties",
        "label": "Finance Lease, Interest Expense, Unrelated Parties",
        "terseLabel": "Unrelated Parties"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpenseUnrelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_FinanceLeaseLiabilityCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Liability, Current",
        "label": "Finance Lease, Liability, Current [Abstract]",
        "terseLabel": "Current portion of long-term debt and notes payable"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentAbstract",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sem_FinanceLeaseLiabilityCurrentRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Liability, Current, Related Parties",
        "label": "Finance Lease, Liability, Current, Related Parties",
        "terseLabel": "Related Parties"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentRelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_FinanceLeaseLiabilityCurrentUnrelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Liability, Current, Unrelated Parties",
        "label": "Finance Lease, Liability, Current, Unrelated Parties",
        "terseLabel": "Unrelated Parties"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentUnrelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_FinanceLeaseLiabilityNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Liability, Noncurrent",
        "label": "Finance Lease Liability, Noncurrent [Abstract]",
        "terseLabel": "Long-term debt, net of current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrentAbstract",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sem_FinanceLeaseLiabilityNoncurrentRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Liability, Noncurrent, Related Parties",
        "label": "Finance Lease, Liability, Noncurrent, Related Parties",
        "terseLabel": "Related Parties"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrentRelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_FinanceLeaseLiabilityNoncurrentUnrelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Liability, Noncurrent, Unrelated Parties",
        "label": "Finance Lease, Liability, Noncurrent, Unrelated Parties",
        "terseLabel": "Unrelated Parties"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrentUnrelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_FinanceLeaseLiabilityPaymentsDueAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Liability, Payments, Due After Year Four",
        "label": "Finance Lease, Liability, Payments, Due After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFour",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_FinanceLeaseLiabilityRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Liability, Related Parties",
        "label": "Finance Lease, Liability, Related Parties",
        "terseLabel": "Related Parties"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityRelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_FinanceLeaseLiabilityUnrelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Liability, Unrelated Parties",
        "label": "Finance Lease, Liability, Unrelated Parties",
        "terseLabel": "Unrelated Parties"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUnrelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Right-Of-Use Asset, After Accumulated Amortization, Related Parties",
        "label": "Finance Lease, Right-Of-Use Asset, After Accumulated Amortization, Related Parties",
        "terseLabel": "Related Parties"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationRelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Right-Of-Use Asset, After Accumulated Amortization, Unrelated Parties",
        "label": "Finance Lease, Right-Of-Use Asset, After Accumulated Amortization, Unrelated Parties",
        "terseLabel": "Unrelated Parties"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationUnrelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_FinanceLeaseRightOfUseAssetAmortizationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Right-of-Use Asset, Amortization",
        "label": "Finance Lease, Right-of-Use Asset, Amortization [Abstract]",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortizationAbstract",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sem_FinanceLeaseRightOfUseAssetAmortizationRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "sem_LeaseCostRelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Right-Of-Use Asset, Amortization, Related Parties",
        "label": "Finance Lease, Right-Of-Use Asset, Amortization, Related Parties",
        "terseLabel": "Related Parties"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortizationRelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "sem_LeaseCostUnrelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Right-Of-Use Asset, Amortization, Unrelated Parties",
        "label": "Finance Lease, Right-Of-Use Asset, Amortization, Unrelated Parties",
        "terseLabel": "Unrelated Parties"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortizationUnrelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of finite-lived and indefinite-lived intangible assets and liabilities, excluding goodwill, in total and by major class.",
        "label": "Finite Lived And Indefinite Lived Intangible Assets And Liabilities By Major Class [Table]",
        "terseLabel": "Finite Lived And Indefinite Lived Intangible Assets By Major Class [Table]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAndLiabilitiesByMajorClassTable",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sem_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Finite Lived And Indefinite Lived Intangible Assets By Major Class [Table]",
        "label": "Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]",
        "terseLabel": "Finite Lived And Indefinite Lived Intangible Assets By Major Class [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sem_FirstLienCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Lien Credit Agreement",
        "label": "First Lien Credit Agreement [Member]",
        "terseLabel": "Concentra-JPM First Lien Credit Agreement"
       }
      }
     },
     "localname": "FirstLienCreditAgreementMember",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sem_GovernmentAdvancesCARESAct": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Advances, CARES Act",
        "label": "Government Advances, CARES Act",
        "terseLabel": "Government advances (Note 15)",
        "verboseLabel": "Government advances, CARES Act"
       }
      }
     },
     "localname": "GovernmentAdvancesCARESAct",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/CARESActDetails",
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_GovernmentAdvancesRecoupedCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Advances Recouped, CARES Act",
        "label": "Government Advances Recouped, CARES Act",
        "verboseLabel": "Government advances recouped, CARES Act"
       }
      }
     },
     "localname": "GovernmentAdvancesRecoupedCARESAct",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/CARESActDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_GovernmentAssistanceRecognizedInEarningsCARESAct": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Assistance Recognized In Earnings, CARES Act",
        "label": "Government Assistance Recognized In Earnings, CARES Act",
        "terseLabel": "Government assistance recognized in earnings, CARES Act"
       }
      }
     },
     "localname": "GovernmentAssistanceRecognizedInEarningsCARESAct",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/CARESActDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_HealthCarePatientServiceMedicareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care, Patient Service, Medicare [Member]",
        "label": "Health Care, Patient Service, Medicare [Member]",
        "terseLabel": "Medicare"
       }
      }
     },
     "localname": "HealthCarePatientServiceMedicareMember",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sem_HealthCarePatientServiceNonMedicareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care, Patient Service, Non-Medicare [Member]",
        "label": "Health Care, Patient Service, Non-Medicare [Member]",
        "terseLabel": "Non-Medicare"
       }
      }
     },
     "localname": "HealthCarePatientServiceNonMedicareMember",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sem_IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Unearned Government Assistance, CARES Act",
        "label": "Increase (Decrease) in Unearned Government Assistance, CARES Act",
        "terseLabel": "Unearned government assistance"
       }
      }
     },
     "localname": "IncreaseDecreaseInUnearnedGovernmentAssistanceCARESAct",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indefinite-lived Intangible Asset, Weighted Average Period before Next Renewal or Extension",
        "label": "Indefinite-lived Intangible Asset, Weighted Average Period before Next Renewal or Extension",
        "terseLabel": "Weighted average time until next renewal"
       }
      }
     },
     "localname": "IndefinitelivedIntangibleAssetWeightedAveragePeriodbeforeNextRenewalorExtension",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sem_LeaseCostRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Cost, Related Parties",
        "label": "Lease, Cost, Related Parties",
        "totalLabel": "Related Parties"
       }
      }
     },
     "localname": "LeaseCostRelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_LeaseCostTotalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Cost, Total",
        "label": "Lease, Cost, Total [Abstract]",
        "terseLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCostTotalAbstract",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sem_LeaseCostUnrelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Cost - Unrelated Parties",
        "label": "Lease, Cost - Unrelated Parties",
        "totalLabel": "Unrelated Parties"
       }
      }
     },
     "localname": "LeaseCostUnrelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, Payments, Due After Year Four",
        "label": "Lessee, Operating Lease, Liability, Payments, Due After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_LongTermDebtAndFinanceLeaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt And Finance Lease Obligation",
        "label": "Long-Term Debt And Finance Lease Obligation",
        "totalLabel": "Carrying Value"
       }
      }
     },
     "localname": "LongTermDebtAndFinanceLeaseObligation",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": {
       "order": 6.0,
       "parentTag": "sem_LongTermDebtGrossAndFinanceLeaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal After Year Four",
        "label": "Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFour",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "sem_LongTermDebtGrossAndFinanceLeaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Next Twelve Months",
        "label": "Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Next Twelve Months",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": {
       "order": 5.0,
       "parentTag": "sem_LongTermDebtGrossAndFinanceLeaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Four",
        "label": "Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": {
       "order": 4.0,
       "parentTag": "sem_LongTermDebtGrossAndFinanceLeaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Three",
        "label": "Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": {
       "order": 3.0,
       "parentTag": "sem_LongTermDebtGrossAndFinanceLeaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Two",
        "label": "Long-Term Debt And Finance Lease Obligation, Maturities, Repayments Of Principal In Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "sem_LongTermDebtGrossAndFinanceLeaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt And Finance Lease Obligation, Repayments Of Principal, Remainder Of Fiscal Year",
        "label": "Long-Term Debt And Finance Lease Obligation, Repayments Of Principal, Remainder Of Fiscal Year",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_LongTermDebtGrossAndFinanceLeaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails": {
       "order": 1.0,
       "parentTag": "sem_LongTermDebtAndFinanceLeaseObligation",
       "weight": 1.0
      },
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt, Gross And Finance Lease Obligation",
        "label": "Long-Term Debt, Gross And Finance Lease Obligation",
        "terseLabel": "Principal Outstanding",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LongTermDebtGrossAndFinanceLeaseObligation",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Debt, Maturities, Repayments Of Principal After Year Four",
        "label": "Long-term Debt, Maturities, Repayments Of Principal After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_MedicareReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Receivable [Member]",
        "label": "Medicare Receivable [Member]",
        "terseLabel": "Medicare Receivable"
       }
      }
     },
     "localname": "MedicareReceivableMember",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/CreditRiskConcentrationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sem_NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Distributions to Redeemable Noncontrolling Interests",
        "label": "Noncontrolling Interest, Distributions to Redeemable Noncontrolling Interests",
        "negatedLabel": "Distributions to and purchases of redeemable non-controlling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_OperatingLeaseCostRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "sem_LeaseCostRelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Cost, Related Parties",
        "label": "Operating Lease, Cost, Related Parties",
        "terseLabel": "Related Parties"
       }
      }
     },
     "localname": "OperatingLeaseCostRelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_OperatingLeaseCostUnrelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Cost, Unrelated Parties",
        "label": "Operating Lease, Cost, Unrelated Parties",
        "terseLabel": "Unrelated Parties"
       }
      }
     },
     "localname": "OperatingLeaseCostUnrelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_OperatingLeaseLiabilityCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Liability, Current",
        "label": "Operating Lease, Liability, Current [Abstract]",
        "terseLabel": "Current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentAbstract",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sem_OperatingLeaseLiabilityCurrentRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "sem_OperatingLeaseLiabilityRelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Liability, Current, Related Parties",
        "label": "Operating Lease, Liability, Current, Related Parties",
        "terseLabel": "Related Parties"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentRelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_OperatingLeaseLiabilityCurrentUnrelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "sem_OperatingLeaseLiabilityUnrelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Liability, Current, Unrelated Parties",
        "label": "Operating Lease, Liability, Current, Unrelated Parties",
        "terseLabel": "Unrelated Parties"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentUnrelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_OperatingLeaseLiabilityNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Liability, Noncurrent",
        "label": "Operating Lease, Liability, Noncurrent [Abstract]",
        "terseLabel": "Non-current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentAbstract",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sem_OperatingLeaseLiabilityNoncurrentRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiabilityNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Liability, Noncurrent, Related Parties",
        "label": "Operating Lease, Liability, Noncurrent, Related Parties",
        "terseLabel": "Related Parties"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentRelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_OperatingLeaseLiabilityNoncurrentUnrelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "sem_OperatingLeaseLiabilityUnrelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Liability, Noncurrent, Unrelated Parties",
        "label": "Operating Lease, Liability, Noncurrent, Unrelated Parties",
        "terseLabel": "Unrelated Parties"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentUnrelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_OperatingLeaseLiabilityRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Liability, Related Parties",
        "label": "Operating Lease, Liability, Related Parties",
        "totalLabel": "Related Parties"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityRelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_OperatingLeaseLiabilityUnrelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Liability, Unrelated Parties",
        "label": "Operating Lease, Liability, Unrelated Parties",
        "totalLabel": "Unrelated Parties"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityUnrelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_OperatingLeaseRightOfUseAssetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right-of-Use Asset",
        "label": "Operating Lease, Right-of-Use Asset [Abstract]",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAbstract",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sem_OperatingLeaseRightOfUseAssetRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right-Of-Use Asset, Related Parties",
        "label": "Operating Lease, Right-Of-Use Asset, Related Parties",
        "terseLabel": "Related Parties"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetRelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_OperatingLeaseRightOfUseAssetUnrelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right-Of-Use Asset, Unrelated Parties",
        "label": "Operating Lease, Right-Of-Use Asset, Unrelated Parties",
        "terseLabel": "Unrelated Parties"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetUnrelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_OtherAccruedLiabilitiesCurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Accrued Liabilities, Current",
        "label": "Other Accrued Liabilities, Current [Member]",
        "terseLabel": "Accrued other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrentMember",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sem_OutpatientRehabilitationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to outpatient rehabilitation, a reporting segment of the entity.",
        "label": "Outpatient Rehabilitation [Member]",
        "terseLabel": "Outpatient Rehabilitation"
       }
      }
     },
     "localname": "OutpatientRehabilitationMember",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountofGoodwillDetails",
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails",
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails",
      "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sem_ProceedsFromGovernmentAssistanceCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Government Assistance, CARES Act",
        "label": "Proceeds from Government Assistance, CARES Act",
        "terseLabel": "Government assistance, provider relief payments received, CARES Act"
       }
      }
     },
     "localname": "ProceedsFromGovernmentAssistanceCARESAct",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/CARESActDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_ProceedsFromLegalSettlementsAccruedInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Legal Settlements, Accrued Interest",
        "label": "Proceeds From Legal Settlements, Accrued Interest",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "ProceedsFromLegalSettlementsAccruedInterest",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesMedicareDualEligibleLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From (Repayments Of) Government Advances, CARES Act",
        "label": "Proceeds From (Repayments Of) Government Advances, CARES Act",
        "terseLabel": "Government advances"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfGovernmentAdvancesCARESAct",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_RehabilitationHospitalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rehabilitation Hospitals [Member]",
        "label": "Rehabilitation Hospitals [Member]",
        "terseLabel": "Rehabilitation Hospital"
       }
      }
     },
     "localname": "RehabilitationHospitalsMember",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountofGoodwillDetails",
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails",
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails",
      "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sem_RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-Of-Use Assets Obtained In Exchange For Lease Liabilities [Abstract]",
        "label": "Right-Of-Use Assets Obtained In Exchange For Lease Liabilities [Abstract]",
        "terseLabel": "Right-of-use assets obtained in exchange for lease liabilities:"
       }
      }
     },
     "localname": "RightOfUseAssetsObtainedInExchangeForLeaseLiabilitiesAbstract",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sem_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Leases In Statement Of Financial Position [Table Text Block]",
        "label": "Schedule Of Leases In Statement Of Financial Position [Table Text Block]",
        "terseLabel": "Supplemental balance sheet information"
       }
      }
     },
     "localname": "ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sem_SelectMedicalCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Select Medical Corporation [Member]",
        "label": "Select Medical Corporation [Member]",
        "terseLabel": "Select Medical Corporation"
       }
      }
     },
     "localname": "SelectMedicalCorporationMember",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sem_SubleaseIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sublease Income",
        "label": "Sublease Income [Abstract]",
        "terseLabel": "Sublease income"
       }
      }
     },
     "localname": "SubleaseIncomeAbstract",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sem_SubleaseIncomeRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails": {
       "order": 5.0,
       "parentTag": "sem_LeaseCostRelatedParties",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sublease Income, Related Parties",
        "label": "Sublease Income, Related Parties",
        "negatedLabel": "Related Parties"
       }
      }
     },
     "localname": "SubleaseIncomeRelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_SubleaseIncomeUnrelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails": {
       "order": 5.0,
       "parentTag": "sem_LeaseCostUnrelatedParties",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sublease Income, Unrelated Parties",
        "label": "Sublease Income, Unrelated Parties",
        "negatedLabel": "Unrelated Parties"
       }
      }
     },
     "localname": "SubleaseIncomeUnrelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unearned Government Assistance, Amount Expected To Be Repaid, CARES Act",
        "label": "Unearned Government Assistance, Amount Expected To Be Repaid, CARES Act",
        "terseLabel": "Unearned government assistance, amount expected to be repaid, CARES Act"
       }
      }
     },
     "localname": "UnearnedGovernmentAssistanceAmountExpectedToBeRepaidCARESAct",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/CARESActDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_UnearnedGovernmentAssistanceCARESAct": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unearned Government Assistance, CARES Act",
        "label": "Unearned Government Assistance, CARES Act",
        "terseLabel": "Unearned government assistance (Note 15)",
        "verboseLabel": "Unearned government assistance, CARES Act"
       }
      }
     },
     "localname": "UnearnedGovernmentAssistanceCARESAct",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/CARESActDetails",
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_VariableLeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Lease, Cost",
        "label": "Variable Lease, Cost [Abstract]",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCostAbstract",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sem_VariableLeaseCostRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails": {
       "order": 4.0,
       "parentTag": "sem_LeaseCostRelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Lease, Cost, Related Parties",
        "label": "Variable Lease, Cost, Related Parties",
        "terseLabel": "Related Parties"
       }
      }
     },
     "localname": "VariableLeaseCostRelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_VariableLeaseCostUnrelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails": {
       "order": 4.0,
       "parentTag": "sem_LeaseCostUnrelatedParties",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Lease, Cost, Unrelated Parties",
        "label": "Variable Lease, Cost, Unrelated Parties",
        "terseLabel": "Unrelated Parties"
       }
      }
     },
     "localname": "VariableLeaseCostUnrelatedParties",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sem_WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Discount Rate Operating And Finance Leases [Abstract]",
        "label": "Weighted Average Discount Rate Operating And Finance Leases [Abstract]",
        "terseLabel": "Weighted average discount rate:"
       }
      }
     },
     "localname": "WeightedAverageDiscountRateOperatingAndFinanceLeasesAbstract",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesWeightedAverageLeaseTermsandDiscountRatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sem_WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Lease Term Operating And Finance Leases [Abstract]",
        "label": "Weighted Average Lease Term Operating And Finance Leases [Abstract]",
        "terseLabel": "Weighted average remaining lease term (in years):"
       }
      }
     },
     "localname": "WeightedAverageLeaseTermOperatingAndFinanceLeasesAbstract",
     "nsuri": "http://www.selectmedical.com/20210630",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesWeightedAverageLeaseTermsandDiscountRatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r109",
      "r249",
      "r254",
      "r262",
      "r380",
      "r381",
      "r391",
      "r392",
      "r481",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r109",
      "r249",
      "r254",
      "r262",
      "r380",
      "r381",
      "r391",
      "r392",
      "r481",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r109",
      "r166",
      "r179",
      "r180",
      "r181",
      "r182",
      "r184",
      "r186",
      "r190",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r256",
      "r257",
      "r259",
      "r261",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails",
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails",
      "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r109",
      "r166",
      "r179",
      "r180",
      "r181",
      "r182",
      "r184",
      "r186",
      "r190",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r256",
      "r257",
      "r259",
      "r261",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails",
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails",
      "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r267",
      "r304",
      "r342",
      "r343",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r554",
      "r556",
      "r570",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r267",
      "r304",
      "r342",
      "r343",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r554",
      "r556",
      "r570",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r193",
      "r321",
      "r323",
      "r498",
      "r553",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r193",
      "r321",
      "r323",
      "r498",
      "r553",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r267",
      "r304",
      "r332",
      "r342",
      "r343",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r554",
      "r556",
      "r570",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r267",
      "r304",
      "r332",
      "r342",
      "r343",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r554",
      "r556",
      "r570",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]",
        "terseLabel": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CreditRiskConcentrationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r31",
      "r484"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CreditRiskConcentrationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r6",
      "r22",
      "r198",
      "r199"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedVacationCurrent": {
     "auth_ref": [
      "r11",
      "r35",
      "r331"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Vacation, Current",
        "terseLabel": "Accrued vacation"
       }
      }
     },
     "localname": "AccruedVacationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r53",
      "r61",
      "r62",
      "r63",
      "r64",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r25",
      "r50",
      "r52",
      "r53",
      "r538",
      "r561",
      "r562"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r61",
      "r62",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r49",
      "r53",
      "r61",
      "r62",
      "r63",
      "r111",
      "r112",
      "r113",
      "r388",
      "r557",
      "r558",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Capital in excess of par"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r111",
      "r112",
      "r113",
      "r347",
      "r348",
      "r349",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Capital in Excess of\u00a0Par"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r344",
      "r345",
      "r352",
      "r353"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Vesting of restricted stock"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r345",
      "r346",
      "r351"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "negatedLabel": "Stock compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r96",
      "r287",
      "r296",
      "r297",
      "r456"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount, premium and issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r96",
      "r213",
      "r220"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r105",
      "r174",
      "r181",
      "r188",
      "r202",
      "r249",
      "r250",
      "r251",
      "r253",
      "r254",
      "r255",
      "r256",
      "r258",
      "r260",
      "r262",
      "r263",
      "r380",
      "r391",
      "r443",
      "r482",
      "r484",
      "r515",
      "r536"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total Assets",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails",
      "http://www.selectmedical.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r8",
      "r10",
      "r45",
      "r105",
      "r202",
      "r249",
      "r250",
      "r251",
      "r253",
      "r254",
      "r255",
      "r256",
      "r258",
      "r260",
      "r262",
      "r263",
      "r380",
      "r391",
      "r443",
      "r482",
      "r484"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r410",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r5",
      "r29",
      "r98"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r91",
      "r98",
      "r101"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r91",
      "r444"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r422"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months",
        "negatedTerseLabel": "Estimated pre-tax losses expected to be reclassified in the next twelve months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/InterestRateCapNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r40",
      "r234",
      "r520",
      "r543"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 14)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r231",
      "r232",
      "r233",
      "r242",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Cash dividend declared (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r111",
      "r112",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical",
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r21",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r21",
      "r484"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $0.001 par value, 700,000,000 shares authorized, 134,850,735 and 135,005,369 shares issued and outstanding at 2020 and 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r57",
      "r59",
      "r60",
      "r74",
      "r527",
      "r549"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to Select Medical Holdings Corporation"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r57",
      "r59",
      "r73",
      "r376",
      "r377",
      "r402",
      "r526",
      "r548"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Comprehensive income attributable to non-controlling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r57",
      "r59",
      "r72",
      "r375",
      "r402",
      "r525",
      "r547"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r155",
      "r156",
      "r196",
      "r440",
      "r441",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CreditRiskConcentrationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r155",
      "r156",
      "r196",
      "r440",
      "r441",
      "r563",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CreditRiskConcentrationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r155",
      "r156",
      "r196",
      "r440",
      "r441",
      "r563",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CreditRiskConcentrationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r151",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Credit Risk Concentrations"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/AccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "Concentration Risk Disclosure [Text Block]",
        "terseLabel": "Credit Risk Concentrations"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CreditRiskConcentrations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CreditRiskConcentrationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r155",
      "r156",
      "r196",
      "r440",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Percentage of concentration risk"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CreditRiskConcentrationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r157",
      "r440",
      "r442",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CreditRiskConcentrationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r155",
      "r156",
      "r196",
      "r440",
      "r441",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CreditRiskConcentrationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "terseLabel": "Redeemable Non-Controlling Interests"
       }
      }
     },
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/AccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "auth_ref": [
      "r390",
      "r394",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/AccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporation owned and operated by a small group of ventures to accomplish a mutually beneficial venture or project.",
        "label": "Corporate Joint Venture [Member]",
        "terseLabel": "Joint Venture Operations"
       }
      }
     },
     "localname": "CorporateJointVentureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r182",
      "r184",
      "r190",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails",
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails",
      "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r68",
      "r69"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.",
        "label": "Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization",
        "terseLabel": "Cost of services, exclusive of depreciation and amortization"
       }
      }
     },
     "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Costs and expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditConcentrationRiskMember": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified receivable or amount at risk from a counterparty under a contractual arrangement is to a specified benchmark, such as total receivables, net revenues, pretax results. Risk is the materially adverse effects of loss attributable to (a) the failure to collect a significant receivable from a major customer or group of homogeneous accounts, or (b) a failure by a counterparty to perform under terms of a contractual arrangement.",
        "label": "Credit Concentration Risk [Member]",
        "terseLabel": "Credit Concentration Risk"
       }
      }
     },
     "localname": "CreditConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CreditRiskConcentrationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Loss [Abstract]",
        "terseLabel": "Credit Loss [Abstract]"
       }
      }
     },
     "localname": "CreditLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r103",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r281",
      "r288",
      "r289",
      "r291",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Long-Term Debt and Notes Payable"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r17",
      "r18",
      "r19",
      "r104",
      "r109",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r271",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r294",
      "r295",
      "r296",
      "r297",
      "r458",
      "r516",
      "r517",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r19",
      "r292",
      "r517",
      "r535"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Principal Outstanding",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r279",
      "r294",
      "r295",
      "r437"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r37",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate of debt (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r38",
      "r104",
      "r109",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r271",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r294",
      "r295",
      "r296",
      "r297",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r38",
      "r104",
      "r109",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r271",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r290",
      "r294",
      "r295",
      "r296",
      "r297",
      "r306",
      "r307",
      "r308",
      "r309",
      "r454",
      "r455",
      "r458",
      "r459",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r277",
      "r454",
      "r455",
      "r456",
      "r457",
      "r459"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "negatedLabel": "Unamortized Premium (Discount)"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r30",
      "r277",
      "r456"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedLabel": "Unamortized Issuance Costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r96",
      "r106",
      "r357",
      "r361",
      "r362",
      "r363"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r354",
      "r355"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Non-current deferred tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r96",
      "r225"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "negatedLabel": "Depreciation and amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsNoncurrent": {
     "auth_ref": [
      "r46"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset, Noncurrent",
        "terseLabel": "Interest rate cap contract, non-current portion"
       }
      }
     },
     "localname": "DerivativeAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeCapInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cap rate on an interest rate derivative such as an interest rate cap or collar. If market rates exceed the cap rate, a payment or receipt is triggered on the contract.",
        "label": "Derivative, Cap Interest Rate",
        "terseLabel": "Derivative cap interest rate (as a percent)"
       }
      }
     },
     "localname": "DerivativeCapInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/InterestRateCapNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails",
      "http://www.selectmedical.com/role/InterestRateCapNarrativeDetails",
      "http://www.selectmedical.com/role/InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r47",
      "r411",
      "r412",
      "r415",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails",
      "http://www.selectmedical.com/role/InterestRateCapNarrativeDetails",
      "http://www.selectmedical.com/role/InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r423",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Interest Rate Cap"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/InterestRateCap"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeLiabilitiesCurrent": {
     "auth_ref": [
      "r46"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Current",
        "terseLabel": "Interest rate cap contract, current portion"
       }
      }
     },
     "localname": "DerivativeLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "auth_ref": [
      "r46"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Noncurrent",
        "terseLabel": "Interest rate cap contract, non-current portion"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/InterestRateCapNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r405",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/InterestRateCapNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r404",
      "r406",
      "r407",
      "r408",
      "r409",
      "r414",
      "r415",
      "r418",
      "r419",
      "r421",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/InterestRateCapNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r321",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of disaggregation of net operating revenues by operating segment"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r96",
      "r224",
      "r227"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "terseLabel": "Gain on sale of businesses",
        "verboseLabel": "Gain on sale of businesses"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r310",
      "r532"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "negatedTerseLabel": "Dividends declared for common stockholders ($0.125 per share)"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableAmountPerShare": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.",
        "label": "Dividends Payable, Amount Per Share",
        "terseLabel": "Cash dividend declared (in dollars per share)"
       }
      }
     },
     "localname": "DividendsPayableAmountPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DueToAffiliateCurrent": {
     "auth_ref": [
      "r16",
      "r108",
      "r479",
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to Affiliate, Current",
        "terseLabel": "Obligations payable"
       }
      }
     },
     "localname": "DueToAffiliateCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings per common share (Note 13):"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r75",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r124",
      "r127",
      "r136",
      "r140",
      "r141",
      "r145",
      "r146",
      "r425",
      "r426",
      "r528",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Basic earnings per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.selectmedical.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic EPS"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails",
      "http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicDistributed": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividends declared in the period and the contractual amount of dividends (or interest on participating income bonds) that must be paid per security.",
        "label": "Earnings Per Share, Basic, Distributed",
        "terseLabel": "Dividends declared and contractual dividends paid, basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasicDistributed",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/EarningsperShareNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r75",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r127",
      "r136",
      "r140",
      "r141",
      "r145",
      "r146",
      "r425",
      "r426",
      "r528",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Diluted earnings per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.selectmedical.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted EPS"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails",
      "http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDilutedDistributed": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividends declared in the period and the contractual amount of dividends (or interest on participating income bonds) that must be paid per security, taking into account all dilutive potential common shares outstanding during the period.",
        "label": "Earnings Per Share, Diluted, Distributed",
        "terseLabel": "Dividends declared and contractual dividends paid, diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDilutedDistributed",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/EarningsperShareNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r142",
      "r143",
      "r144",
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/EarningsperShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r61",
      "r62",
      "r63",
      "r111",
      "r112",
      "r113",
      "r115",
      "r121",
      "r123",
      "r148",
      "r203",
      "r305",
      "r310",
      "r347",
      "r348",
      "r349",
      "r358",
      "r359",
      "r424",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r451",
      "r557",
      "r558",
      "r559",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited",
      "http://www.selectmedical.com/role/InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "auth_ref": [
      "r67",
      "r90",
      "r96",
      "r544"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "terseLabel": "Distributions from unconsolidated subsidiaries"
       }
      }
     },
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Terminated obligations"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExtraordinaryAndUnusualItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unusual or Infrequent Items, or Both [Abstract]"
       }
      }
     },
     "localname": "ExtraordinaryAndUnusualItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r428",
      "r429",
      "r430",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r428",
      "r429",
      "r430",
      "r434",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "terseLabel": "Schedule of Long-Term Debt"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r428",
      "r438",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r428",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of Interest Rate Cap"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r279",
      "r294",
      "r295",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r341",
      "r429",
      "r488",
      "r489",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails",
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r428",
      "r429",
      "r431",
      "r432",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r279",
      "r294",
      "r295",
      "r333",
      "r334",
      "r339",
      "r341",
      "r429",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails",
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r279",
      "r294",
      "r295",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r341",
      "r488",
      "r489",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails",
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r433",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r462",
      "r466",
      "r476"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r464",
      "r470"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows for finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r461",
      "r475"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Total finance lease liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails",
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease Liability [Abstract]",
        "terseLabel": "Total finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r461"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Maturities of finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r461"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r475"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total undiscounted cash flows"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r475"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r475"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r475"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r475"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r475"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2021 (remainder of year)"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r475"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: Imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r463",
      "r470"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows for finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r460"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization [Abstract]",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r462",
      "r466",
      "r476"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r473",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesWeightedAverageLeaseTermsandDiscountRatesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r472",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesWeightedAverageLeaseTermsandDiscountRatesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r219"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Finite-lived intangible assets, accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r214",
      "r216",
      "r219",
      "r222",
      "r499",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r219",
      "r500"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Finite-lived intangible assets, gross carrying amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r214",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r219",
      "r499"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Finite-lived intangible assets, net carrying amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net [Abstract]",
        "terseLabel": "Amortized intangible assets:"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Gain Contingencies [Line Items]",
        "terseLabel": "Gain Contingencies [Line Items]"
       }
      }
     },
     "localname": "GainContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesMedicareDualEligibleLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainContingenciesTable": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sets forth the existing conditions, situations, or sets of circumstances involving uncertainties as of the balance sheet date (or before issuance of the financial statements) that might result in a gain, typically reflecting care to avoid misleading implications as to the likelihood of realization, and previously disclosed contingent gains that were recognized as income in the period.",
        "label": "Gain Contingencies [Table]",
        "terseLabel": "Gain Contingencies [Table]"
       }
      }
     },
     "localname": "GainContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesMedicareDualEligibleLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r96",
      "r389"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedLabel": "Loss (gain) on sale or disposal of assets and businesses"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of business insurance which provides insurance coverage for a wide variety of liability exposures including, but not limited to, contractual liability, product liability and personal injury liability.",
        "label": "General Liability [Member]",
        "terseLabel": "General Liability"
       }
      }
     },
     "localname": "GeneralLiabilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r207",
      "r208",
      "r484",
      "r514"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, Ending Balance",
        "periodStartLabel": "Goodwill, Beginning Balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r209"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "verboseLabel": "Acquisition of businesses"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Carrying amount of goodwill"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HealthCarePatientServiceMember": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service provided to patient for maintenance, diagnosis and treatment of physical and mental health. Excludes service to resident in health care facility.",
        "label": "Health Care, Patient Service [Member]",
        "terseLabel": "Patient services revenue"
       }
      }
     },
     "localname": "HealthCarePatientServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r66",
      "r174",
      "r180",
      "r184",
      "r187",
      "r190",
      "r513",
      "r522",
      "r530",
      "r551"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before income taxes",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r67",
      "r96",
      "r171",
      "r201",
      "r521",
      "r544"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Equity in earnings of unconsolidated subsidiaries",
        "verboseLabel": "Equity in earnings of unconsolidated subsidiaries"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r107",
      "r122",
      "r123",
      "r172",
      "r356",
      "r360",
      "r364",
      "r552"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r99"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxes": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes, and in deferred and other tax liabilities and assets.",
        "label": "Increase (Decrease) in Income Taxes",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of effects of business combinations:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current assets classified as other.",
        "label": "Increase (Decrease) in Other Current Assets",
        "negatedLabel": "Other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents nonvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents (whether paid or unpaid). Basic and dilutive earnings per share are generally disclosed for such shares using the two-class method.",
        "label": "Incremental Common Shares Attributable to Participating Nonvested Shares with Non-forfeitable Dividend Rights",
        "terseLabel": "Weighted average participating securities outstanding (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r215",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r221"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived intangible assets, carrying amount"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r215",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Total identifiable intangible assets, gross carrying amount"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r212",
      "r217"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Identifiable intangible assets, net",
        "totalLabel": "Total identifiable intangible assets, net carrying amount"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r65",
      "r168",
      "r453",
      "r456",
      "r529"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r88",
      "r93",
      "r99"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r35"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "Interest Rate Cap"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails",
      "http://www.selectmedical.com/role/InterestRateCapNarrativeDetails",
      "http://www.selectmedical.com/role/InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_JudicialRulingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation outcome that occurs as a result of judicial intervention, supervision, or approval.",
        "label": "Judicial Ruling [Member]",
        "terseLabel": "Judicial Ruling"
       }
      }
     },
     "localname": "JudicialRulingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesMedicareDualEligibleLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r474",
      "r476"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of lease cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeaseDescriptionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Finance Lease, Description [Abstract]",
        "terseLabel": "Finance lease cost:"
       }
      }
     },
     "localname": "LesseeFinanceLeaseDescriptionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Maturities of operating lease liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r475"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total undiscounted cash flows"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r475"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r475"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r475"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r475"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r475"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2021 (remainder of year)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r475"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: Imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r34",
      "r105",
      "r182",
      "r202",
      "r249",
      "r250",
      "r251",
      "r254",
      "r255",
      "r256",
      "r258",
      "r260",
      "r262",
      "r263",
      "r381",
      "r391",
      "r392",
      "r443",
      "r482",
      "r483"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.selectmedical.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r28",
      "r105",
      "r202",
      "r443",
      "r484",
      "r519",
      "r541"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r36",
      "r105",
      "r202",
      "r249",
      "r250",
      "r251",
      "r254",
      "r255",
      "r256",
      "r258",
      "r260",
      "r262",
      "r263",
      "r381",
      "r391",
      "r392",
      "r443",
      "r482",
      "r483",
      "r484"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r32"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r32",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Revolving facilities"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationSettlementInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest expense (income) directly attributable to an award in settlement of litigation.",
        "label": "Litigation Settlement Interest",
        "negatedTerseLabel": "Interest income"
       }
      }
     },
     "localname": "LitigationSettlementInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesMedicareDualEligibleLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesMedicareDualEligibleLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r19",
      "r278",
      "r293",
      "r294",
      "r295",
      "r517",
      "r537"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Carrying Value",
        "totalLabel": "Carrying Value"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term debt, net of current portion"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "terseLabel": "Current portion of long-term debt and notes payable"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r109",
      "r247",
      "r283"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r109",
      "r247",
      "r283"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r109",
      "r247",
      "r283"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r109",
      "r247",
      "r283"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r38",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r244",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MalpracticeInsuranceAnnualCoverageLimit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual coverage limit provided by the insurance arrangement for malpractice claims.",
        "label": "Malpractice Insurance, Annual Coverage Limit",
        "terseLabel": "Total annual aggregate limit of insurance coverage"
       }
      }
     },
     "localname": "MalpracticeInsuranceAnnualCoverageLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r43",
      "r105",
      "r202",
      "r249",
      "r254",
      "r255",
      "r256",
      "r262",
      "r263",
      "r443",
      "r518",
      "r540"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestChangeInRedemptionValue": {
     "auth_ref": [
      "r301",
      "r302",
      "r303",
      "r311"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.",
        "label": "Noncontrolling Interest, Change in Redemption Value",
        "negatedLabel": "Redemption value adjustment on redeemable non-controlling interests",
        "terseLabel": "Redemption value adjustment on non-controlling interests"
       }
      }
     },
     "localname": "MinorityInterestChangeInRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited",
      "http://www.selectmedical.com/role/RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r310"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions to and purchases of non-controlling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r310",
      "r378",
      "r379"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedTerseLabel": "Purchase of membership interests of Concentra Group Holdings Parent"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest Disclosure [Text Block]",
        "terseLabel": "Redeemable Non-Controlling Interests"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/RedeemableNonControllingInterests"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r91",
      "r94",
      "r97"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r3",
      "r55",
      "r58",
      "r63",
      "r70",
      "r97",
      "r105",
      "r114",
      "r116",
      "r117",
      "r118",
      "r119",
      "r122",
      "r123",
      "r133",
      "r174",
      "r180",
      "r184",
      "r187",
      "r190",
      "r202",
      "r249",
      "r250",
      "r251",
      "r254",
      "r255",
      "r256",
      "r258",
      "r260",
      "r262",
      "r263",
      "r426",
      "r443",
      "r523",
      "r545"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income attributable to Select Medical Holdings Corporation",
        "totalLabel": "Net income attributable to Select Medical Holdings Corporation"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited",
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.selectmedical.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails",
      "http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r55",
      "r58",
      "r63",
      "r122",
      "r123",
      "r384",
      "r401"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Net income attributable to non-controlling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r78"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of net income (loss) attributable to nonredeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net income attributable to non-controlling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r78"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "terseLabel": "Net income attributable to redeemable non-controlling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r119",
      "r124",
      "r125",
      "r135",
      "r141",
      "r174",
      "r180",
      "r184",
      "r187",
      "r190"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Distributed and undistributed income attributable to common shares",
        "verboseLabel": "Net income allocated to common shares - basic"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails",
      "http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r126",
      "r128",
      "r129",
      "r130",
      "r131",
      "r135",
      "r141"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "terseLabel": "Net income allocated to common shares - diluted",
        "totalLabel": "Distributed and undistributed income attributable to common shares"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails",
      "http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/AccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-compete agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]",
        "terseLabel": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": {
     "auth_ref": [
      "r311",
      "r365",
      "r386"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from a business combination.",
        "label": "Noncontrolling Interest, Increase from Business Combination",
        "terseLabel": "Non-controlling interests acquired in business combination"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": {
     "auth_ref": [
      "r311",
      "r378",
      "r386"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance",
        "terseLabel": "Issuance of non-controlling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r111",
      "r112",
      "r113",
      "r310",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income and expense:"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Other debt, including finance leases"
       }
      }
     },
     "localname": "NotesPayableOtherPayablesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r174",
      "r180",
      "r184",
      "r187",
      "r190"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r467",
      "r476"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r461"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total discounted lease liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails",
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability [Abstract]",
        "terseLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r461"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r461"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Non-current operating lease liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r465",
      "r470"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows for operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r460"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.selectmedical.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r473",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesWeightedAverageLeaseTermsandDiscountRatesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r472",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesWeightedAverageLeaseTermsandDiscountRatesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r182",
      "r184",
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails",
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails",
      "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r4",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r13",
      "r35"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Accrued other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r44",
      "r484"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r410",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r53",
      "r61",
      "r62",
      "r445",
      "r447",
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Gain on interest rate cap cash flow hedge"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r53",
      "r61",
      "r62",
      "r64",
      "r445",
      "r447",
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Loss on interest rate cap cash flow hedge"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r48",
      "r50"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "totalLabel": "Net change, net of tax benefit (expense)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Tax benefit (expense) on components of other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r48",
      "r50"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Gain (loss) on interest rate cap cash flow hedge"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r50",
      "r54"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Reclassification adjustment for (gains) losses included in net income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r56",
      "r59",
      "r61",
      "r62",
      "r64",
      "r71",
      "r305",
      "r445",
      "r450",
      "r451",
      "r524",
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofInterestRateCapDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "terseLabel": "Other operating income"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CARESActDetails",
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfEquity": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common and preferred stock.",
        "label": "Payments for Repurchase of Equity",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests.",
        "label": "Payments for Repurchase of Redeemable Noncontrolling Interest",
        "negatedLabel": "Purchase of membership interests of Concentra Group Holdings Parent"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedTerseLabel": "Dividends paid to common stockholders"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedLabel": "Distributions to and purchases of non-controlling interests"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Business combinations, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedTerseLabel": "Investment in businesses"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r83",
      "r369",
      "r370",
      "r371"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "negatedLabel": "Purchases of property and equipment",
        "verboseLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
      "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r7",
      "r9",
      "r205",
      "r206"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLegalSettlements": {
     "auth_ref": [
      "r92"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for the settlement of litigation during the current period.",
        "label": "Proceeds from Legal Settlements",
        "terseLabel": "Medicare bad debt reimbursement claim"
       }
      }
     },
     "localname": "ProceedsFromLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesMedicareDualEligibleLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r84",
      "r104"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Borrowings on revolving facilities"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMinorityShareholders": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.",
        "label": "Proceeds from Noncontrolling Interests",
        "terseLabel": "Proceeds from issuance of non-controlling interests"
       }
      }
     },
     "localname": "ProceedsFromMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromOtherDebt": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from debt classified as other.",
        "label": "Proceeds from Other Debt",
        "terseLabel": "Borrowings of other debt"
       }
      }
     },
     "localname": "ProceedsFromOtherDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Proceeds from Sales of Business, Affiliate and Productive Assets",
        "terseLabel": "Proceeds from sale of assets and businesses"
       }
      }
     },
     "localname": "ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfessionalMalpracticeLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business insurance coverage for professionals, such as doctors, lawyers, insurance agents, accountants, real estate agents, veterinarians, and others. This liability coverage insures losses for claims arising from mistakes and errors or omissions in the course of professional activities.",
        "label": "Professional Malpractice Liability Insurance [Member]",
        "terseLabel": "Professional liability claims"
       }
      }
     },
     "localname": "ProfessionalMalpracticeLiabilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r3",
      "r55",
      "r58",
      "r63",
      "r89",
      "r105",
      "r114",
      "r122",
      "r123",
      "r174",
      "r180",
      "r184",
      "r187",
      "r190",
      "r202",
      "r249",
      "r250",
      "r251",
      "r254",
      "r255",
      "r256",
      "r258",
      "r260",
      "r262",
      "r263",
      "r375",
      "r383",
      "r385",
      "r401",
      "r402",
      "r426",
      "r443",
      "r530"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited",
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeunaudited",
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r14",
      "r15",
      "r226",
      "r484",
      "r531",
      "r542"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r76",
      "r204"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "verboseLabel": "Provision for expected credit losses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
        "label": "Receivable [Domain]",
        "terseLabel": "Receivable [Domain]"
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CreditRiskConcentrationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r53",
      "r61",
      "r62",
      "r64",
      "r445",
      "r449",
      "r451"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Amounts reclassified from AOCI"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r180",
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of Adjusted EBITDA to income before income taxes"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r302"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "periodEndLabel": "Balance, ending",
        "periodStartLabel": "Balance, beginning",
        "terseLabel": "Redeemable non-controlling interests"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.selectmedical.com/role/RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.",
        "label": "Redeemable Noncontrolling Interest [Table Text Block]",
        "terseLabel": "Schedule of redeemable non-controlling interests"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/RedeemableNonControllingInterestsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r340",
      "r478",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r340",
      "r478",
      "r480",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for short-term and long-term debt and lease obligation.",
        "label": "Repayments of Debt and Lease Obligation",
        "negatedTerseLabel": "Principal payments on other debt"
       }
      }
     },
     "localname": "RepaymentsOfDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Repayments of Long-term Lines of Credit",
        "negatedLabel": "Payments on revolving facilities"
       }
      }
     },
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSecuredDebt": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.",
        "label": "Repayments of Secured Debt",
        "negatedTerseLabel": "Payments on term loans"
       }
      }
     },
     "localname": "RepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r24",
      "r310",
      "r350",
      "r484",
      "r539",
      "r560",
      "r562"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r111",
      "r112",
      "r113",
      "r115",
      "r121",
      "r123",
      "r203",
      "r347",
      "r348",
      "r349",
      "r358",
      "r359",
      "r424",
      "r557",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r165",
      "r166",
      "r179",
      "r185",
      "r186",
      "r193",
      "r194",
      "r196",
      "r320",
      "r321",
      "r498"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue",
        "verboseLabel": "Total revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofOperationsunaudited",
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails",
      "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r322",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contracts with Customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomers"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r471",
      "r476"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r471",
      "r476"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r53",
      "r450",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of accumulated other comprehensive income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/InterestRateCapTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental cash flow information"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r38",
      "r109",
      "r294",
      "r296",
      "r306",
      "r307",
      "r308",
      "r309",
      "r454",
      "r455",
      "r459",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Company's long-term debt and notes payable"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of computation of basic and diluted earnings per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/EarningsperShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r210",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r210",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of carrying amount of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of carrying value and amortization of identifiable intangible assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis": {
     "auth_ref": [
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of insurance coverage or layer of insurance that covers malpractice claims.",
        "label": "Insurance Type and Tier Identifier [Axis]",
        "terseLabel": "Insurance Type and Tier Identifier [Axis]"
       }
      }
     },
     "localname": "ScheduleOfMalpracticeInsuranceTypeAndTierIdentifierAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of principal maturities of the Company's long-term debt and notes payable"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r174",
      "r177",
      "r183",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails",
      "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r174",
      "r177",
      "r183",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of selected financial data for the Company's reportable segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r380",
      "r381",
      "r391",
      "r392",
      "r393",
      "r395",
      "r397",
      "r398",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "verboseLabel": "Term loans"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r162",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r179",
      "r180",
      "r181",
      "r182",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r196",
      "r229",
      "r230",
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountofGoodwillDetails",
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails",
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails",
      "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r174",
      "r178",
      "r184",
      "r188",
      "r189",
      "r190",
      "r191",
      "r193",
      "r195",
      "r196",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails",
      "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/FairValueofFinancialInstrumentsScheduleofLongTermDebtDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableComponentsofLongTermDebtAndNotesPayableDetails",
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayablePrincipalMaturitiesOfLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceOtherMember": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, financial service, and other financial service, classified as other.",
        "label": "Service, Other [Member]",
        "terseLabel": "Other revenue"
       }
      }
     },
     "localname": "ServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r102",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/AccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StandbyLettersOfCreditMember": {
     "auth_ref": [
      "r243",
      "r246",
      "r372",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.",
        "label": "Standby Letters of Credit [Member]",
        "terseLabel": "Standby Letters of Credit"
       }
      }
     },
     "localname": "StandbyLettersOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LongTermDebtandNotesPayableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r162",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r179",
      "r180",
      "r181",
      "r182",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r196",
      "r210",
      "r228",
      "r229",
      "r230",
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingAmountofGoodwillDetails",
      "http://www.selectmedical.com/role/RevenuefromContractswithCustomersDetails",
      "http://www.selectmedical.com/role/SegmentInformationReconciliationofAdjustedEBITDAtoIncomeBeforeTaxesDetails",
      "http://www.selectmedical.com/role/SegmentInformationSelectedFinancialDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r41",
      "r61",
      "r62",
      "r63",
      "r111",
      "r112",
      "r113",
      "r115",
      "r121",
      "r123",
      "r148",
      "r203",
      "r305",
      "r310",
      "r347",
      "r348",
      "r349",
      "r358",
      "r359",
      "r424",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r451",
      "r557",
      "r558",
      "r559",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited",
      "http://www.selectmedical.com/role/InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r111",
      "r112",
      "r113",
      "r148",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited": {
     "auth_ref": [
      "r20",
      "r21",
      "r305",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares related to Restricted Stock Award forfeited during the period.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Forfeited",
        "negatedTerseLabel": "Forfeitures of unvested restricted stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r305",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "terseLabel": "Issuance of restricted stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures": {
     "auth_ref": [
      "r20",
      "r21",
      "r305",
      "r310"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards forfeited during the period.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Forfeitures",
        "negatedTerseLabel": "Forfeitures of unvested restricted stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "auth_ref": [
      "r20",
      "r21",
      "r305",
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross",
        "terseLabel": "Issuance of restricted stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r20",
      "r21",
      "r305",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedTerseLabel": "Repurchase of common shares (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r20",
      "r21",
      "r305",
      "r310"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedTerseLabel": "Repurchase of common shares"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r21",
      "r26",
      "r27",
      "r105",
      "r200",
      "r202",
      "r443",
      "r484"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r62",
      "r105",
      "r111",
      "r112",
      "r113",
      "r115",
      "r121",
      "r202",
      "r203",
      "r310",
      "r347",
      "r348",
      "r349",
      "r358",
      "r359",
      "r373",
      "r374",
      "r400",
      "r424",
      "r443",
      "r445",
      "r446",
      "r451",
      "r558",
      "r559",
      "r578"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total Equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited",
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited",
      "http://www.selectmedical.com/role/InterestRateCapScheduleofAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders\u2019 Equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofChangesinEquityandIncomeunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r469",
      "r476"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedTotalLabel": "Total"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r452",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r452",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r452",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r452",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/SubsequentEventDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r485",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/SubsequentEvent"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CondensedConsolidatedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityOtherChanges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in temporary equity from changes classified as other.",
        "label": "Temporary Equity, Other Changes",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "TemporaryEquityOtherChanges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/RedeemableNonControllingInterestsScheduleofRedeemableNonControllingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/IntangibleAssetsCarryingValueandAmortizationofIdentifiableIntangibleAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeAndTierIdentifierDomain": {
     "auth_ref": [
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the type of insurance coverage or layer of insurance that covers malpractice claims.",
        "label": "Type and Tier Identifier [Domain]",
        "terseLabel": "Type and Tier Identifier [Domain]"
       }
      }
     },
     "localname": "TypeAndTierIdentifierDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CommitmentsandContingenciesLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UndistributedEarningsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Undistributed Earnings, Basic [Abstract]",
        "terseLabel": "Net Income Allocation"
       }
      }
     },
     "localname": "UndistributedEarningsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": {
     "auth_ref": [
      "r134",
      "r137",
      "r138"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic",
        "terseLabel": "Less: Distributed and undistributed income attributable to participating securities - Basic EPS",
        "verboseLabel": "Net income allocated to participating securities"
       }
      }
     },
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails",
      "http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted": {
     "auth_ref": [
      "r132",
      "r134",
      "r137",
      "r138"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted",
        "terseLabel": "Less: Distributed and undistributed income attributable to participating securities - Diluted EPS"
       }
      }
     },
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/EarningsperShareNetIncomeAttributabletotheCompanyCommonSharesOutstandingandParticipatingSecuritiesOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Items, or Both, Disclosure [Text Block]",
        "terseLabel": "CARES Act"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/CARESAct"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r149",
      "r150",
      "r152",
      "r153",
      "r158",
      "r159",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/AccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.",
        "label": "Variable Interest Entity Disclosure [Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/VariableInterestEntities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r380",
      "r381",
      "r391",
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r468",
      "r476"
     ],
     "calculation": {
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r126",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average common shares outstanding, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r124",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "verboseLabel": "Weighted average common shares outstanding, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.selectmedical.com/role/EarningsperShareComputationofEPSUndertheTwoClassMethodDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2740-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "65",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2793-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "66",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2814-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "68B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5498026-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123408193&loc=d3e12803-110250"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "16(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19396-108361"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116873149&loc=d3e923-111674"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569655-111683"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4616395-111683"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2AA",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759068-111685"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL7498348-110258"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=66023616&loc=SL35737432-115832"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r572": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r573": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r574": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r575": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r576": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r577": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/subtopic&trid=114868817"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>79
<FILENAME>0001628280-21-015891-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-21-015891-xbrl.zip
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M!X'+;H(;HW266EU$*A,*KG.%$R(446"P$Z)PGNN5EV_9%]"^N.UI]2 !*M(
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M[P8JL]\FFFA&B?4F.D5RZ8U+E =\TQI"@,:T?*C.*FTZ>RQ!I> %8IB1##D
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MA$GOG?2&N:<Y7["<K)EBJ2B:->=EHA&=)ZF="0(H,]Q)89E5)5A>^J=KNTZ
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MJ"*B#+M25/R9YTX3R0NBT<.V*>_1Y7V,23CG'7&,)9]*X!U5_)FK.Q31^X%
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MNIR=RE+W8JD_)ET,BI1P) Q"8!Q0FB(UB!&4R(8%2V^+XF)HUI959GZ-4?S
M'D9%\4.@^,K7D-(':Y@!ZJ(%=$1 =CX(R&0L,<%@9'9K&]MD=@'DQ>4MUD"'
M;:43+3M=WSN)K6&IE:Y"&\O?O1D5K=>MXQDX\[H^&::@F%4@J<CQ&8H$6EH+
M2047N4])H#L766Y0=%93*ROC^%3<SA&W$R)>1FMBO0'T6'P=*<$B<9 \*7TU
MT9"4(Q9!VE*N85JER0[#N+G.+?+,LR1/9NM0L<K4M CMKKI_/!LSO;N>2U%"
M"9^ 65X\"L/!6IM_F("62,S3&;:V:1NY;G,YK_/XC6E%,\=<R^:"?A'J7A7T
M,X/^RAU)SOC(:0+KM0>T@8(5A()*B,Z:'$0D'(&>F#9A\ZK]:EZOEAG[2(3.
M7Q?7/K']=YTNC._GL;Q^D?=G@V$G?5X.CO=Z7?!3J-/GAZHA5X-4W6M[TWLR
MWC7%,"\#LY(:<);@N$S.%=$A$[T.(B7AJ=_:UDID)Z=6I:POCI<GA5YQ?'\<
M3W@N).@D70#N2W592@%<$ RT%,B,TB)8DW%L>!O5&AZ>N<6K:%(RY;=KDN?M
M5C<.BQ*ZORZ.7LM2FBY\7AEJ&H;Z<DT[+"I&0Q0$1! 4D%(-VM@ @1!'#"?$
M)K:US=M<FS8W]5S-^L*Y,:+G%<[3POG*X;#<>V)4 B&B!Y1$@&.2@62EF-W9
M3-5J#&?99A0;!.<'R(8TT.683&^$F&+^+93RC\O<QN=:_K$\=^/9^8R,RW(.
M[*>)/.Y>K)'0=,1T34*,"L$%"PJTT&7C!CEH%Q(DJI7Q-#BOW5A"#&MKE35&
M\0*\C(KB.:/XRKT@)E):U$>5(-F]X#Z!]BP DT'G>93$FK+]RGA;B)G+8)N=
MSVA:9<CHS'JK.^%??*>9;PUZ%JP(,DE!-;-Z/R:ZIB@6+289$X>HG0.,PN=
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M$]MN?7/%#<J$#^:WV.[LI4^LP]&B&SPY&Q[U^IF20UU_2UE_NY\/&<L\%8P
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MLR)1??$4L['@;4.W3!+\^Q+'9UVLPV*;/3WIAIHQGY'WK[>)()J0TLG6A,@
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M7K]XLJV#;-)C:S>__VC0>IXM1FC]YZP;6YRT[U#HN>ZC\[KSZ0YC,^L2FDC
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MW"L5+)4*OERC BGR['+A0:F(F0IT )-C.%":H([9!##AMK9I.[_I!A'\HW)
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M9QYX!-^GD^B]:I^X%X?[Z<!^JL9K*N/UQW!_XGAK5$9:1\"RTJ[()9YM%^9
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MRJB]0F,KEU0N643;]04F92J7S(5++E(M?WS:??_FT/N 02."M\0!"BG "$W
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M$H(#PTX^(4!HB@SCGBCE-*-Q:YNU&2>;*=1-N<>S!Y?'](T4<'E /:!V 0/
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MT F!UIX8$5%1EP,=:,F8MKD2NTIC39'8AY'8N04&4ZF= #E5+!_#85PAX$)
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MQXB,=91BBQFA!C04TJ;TWFGHFJ>@%-%^ DI?1/LA17M.^S55*5#A$+6Y9!J
M-](1)#UA&KP@0KNJ9)II,]TDV\.*6/]:\))X!J2_4\7?M&POM.QI3EOU_7Q
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ME%3/F0D.S&I%/9+6)L2IULB (",=M?561:-BJJ5:-$BJGY'!8S>F.!C$,#L
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M<E:<P3H;YD*FK>SL.*Y-L@E-[@I7GD:@* $8CJW6)#"DVN8SROD7QX-O,)E
M!2:7O6C],A[DZ]H+7:M-KJ BY\8 =QIUZ[94QM#^Y/' G.+7Z9!-!_4;\EV@
M6WG*0GT9<C9;RL[JLB,M^R6#0'OYSM;#?:ZCKO(6=FJ;7ZPY('Q0W02$+'.\
M8WA:-SN$8!*^G,3)@,3)M+4F%K1J5<5!GJUO5;?]23^3/!='7RK+^S0-3MV4
M>D1R=RK;X*2?\T\KJ_B$H0)__599+"L+H!N/)@W/5OP>C H ;N:>@TZL:H1G
MLW7%E6'$*NJ6GP!].EO<>',GZ^YFFV>6A 5CYG#N$)IZ4J8.H"P1E?TO]^W\
M3^;)!JNHKIDAL47$@A5TYC(XZ]I)B='0/QO5R_M\$R?N*MNK[(.U(9+6-QG7
MZE#LS&;CM!_J%3.(HT%_>#;I6>[8N%NYVQ8_KA=N)5;9QMZI[0+56JF=(C=0
M\JNMDNNW95]M&[F=K>/R[VXDN=OO<HA:C20PTC-WW\YI;7O.JRXGE:@6[V^=
MTT[][P079DMGYW@09_Z8&\K!S=UPDWIRM_A-[5XY&X]:53SM1$/L.YC#RI&U
ML(IA_4X+(,T>! ^HG#R3!TZ ?8+I"[7LX-*;&@)X YO!USCP'1#W\P*40:9V
M..=& $3D=LT:<P;K-$[L^Y6R><73IU@,;VLXSDU?]-'G9OO^Z6F_5P/^BU8]
M@7E?G1&MQ>$ $>KU6]U^[QBNJN(*H6T59E67_1#E9HB6?><74.V"9Q7P.C]M
MLGH6)NIL4IVAZOAXMM@><'U5NU!_/,K!!-4V-C[+VTS&M(D%X])@3<9Z[I0\
MZ^>XRSH2(=/>:N"^=+K=V^]M[6LW-QBZ";J. #G.3Q<LH;ROY$V]WX.G?IO9
M)&I* %=5-A%;3]\UO:J;6LG,9/:NB:Z^!)J7/FF5$.P%=#:K",'FK(1@;V((
M]N:Y,=F+ZR-+']8&.L/X/(EO.L._7PUBZ(SRNZ<V=TX#-3_]W#GX?DP_'/W<
M/?AT_/W@TQ]XG^Z)@]U?3@Y_W8-[_'FZOWMRNO_]CZ\7S9W[O^ZQP]T/W7UH
MR^'N/CW8_0.>\S?>_^LU?Y_;^]?[+X>_OO\.]TH'W_^F'ZTF4@9MD.0RITOF
M >F@%&)"6&:C<C+XBP9.JQ20/&]RFBINM-:64HJ=-L%8Y:BZ9.!\Y!EM7 SN
M4TPM^YARP4BK-5(^)L2=HO746OA")HJET_3BU,(W%N:#2.H#Y]HYQI7!WGO!
MA1>.7IS:6GA:>=1;Y^;A"C_MTG[;&QNS.=ZPJP?@9D$[/WLY99RA40@""ET@
MU@;I.&AW3 GG.(4!^^5*VU?%^A:9Z7#L/DU=9 OJCS\WPWD3\_7\#_+\YZ"D
MSC 3?:"55:A5OB#K';-8MLH=-XW]'40?.Y_S=GA.V9D9Q^+7'+15WP$H[4GL
M3D**NC"O\8(9KS,:5XTZKS<=@\8/3QKWACD ,$=@U>V%OM2:QZA31PV>]H>C
MVNC3SZ&D0U LIK%/,*.?LWX%S-M>B+*=-359OV@CS$0?&E4]<:J9= 8!U18C
MT-^RX6:J>%S-EA_*Y<LK;M>H57[SJOTY>CLQ ]5!IY4IO5)QKYP.@!ETW(>+
M>I,T?9>'/VN@[6QV^A)S!&EE,.X,6L>Q#VOF#-2U'-IZ5EOLVU>MV588QZF'
M-TX"U+-^-\@WJ,*1ZUC7*QO8[V4A6X@%/2=9%P3KBO71VCF#!WVMU#>XT[5G
MT'OC;):X< P]0XF,WJOD.7<Z;[TF&L!8(JCD+%Q((W$Q13Z]<?_]/0[R!Z!W
MD-FA<T2?VQ;\Z9A_--(:IE5"P@>/> @8&1LT$B9$X3*Y(G)KF^A+9\;_3X4C
MR\VK],$82S UAO"0G&681N9U((HKV$5N2"]0YO66\_HW^0A,E6OO'9*2I9S!
MVB"#J4<&/E4:@\Z3#,SKY9Q"_^>Z'>0JA,G.B2G(S  &=NKKPG;SDKDJ"AJ
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MD?-D8W!2T=Y\R=6%]AZ#]D[.:0\S,!1T1#)*AB PG\Q&;9#$TFOIP%+)5]8
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M358$+C2B&'7-N:_^-=O4A25I^_YQ=G3<KZO+DB4&UBR<92%L2JB(SFINI89
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MO8\R1IQ46AW3FO!6)JN5@_/*$PE*79SA,ZFWSL3>JN3>#<,KV7+F[V,=K.+
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M>AYLI#D03ZA0P@MP05O+TSK&*ICT)P4YSL,A\R8R%NNM;F9B4]8;C8(KCW#
M+&E)@2(%Q")&+!&,<\<L9&;";<598:;"3(69BO6V,%[B$XW)@\#@)<(F'_=S
M^8"TH8"L5A8X]H;ETOO)>M--JKQ?6*FPTM.R4K'>:O-PGR4P;[SY@85A1"?Z
M$11S!-0)I"@P1"*75,O 92[A30#:B9L:Q$<+Z 0R?]AQMJ-(,R*1[[L'YL!-
M-^%^=74@LM9ZCN4>Y1Y-O4=C,A948](5WNSWT]A/3;7/]V.K(F#4C^@X<889
M#L/1\!;2>.F]T&KP7T^,KS%G5PK.ESR>S?AU&-[D>9B>J>(KFD,/ZOPU'>D'
MPK$T!"G&/ )#-%*2&:2T)S$R@[7)K819Z698$#Q'(Z([XKIX6N9!]52<7%-&
ML=?(V)!L&R,\4C82!,)P1YE2)O#:BJL79"\SLF==$'?$<4'N_9 [B2HK#1Q;
M+!'#0B#@BN:M./TDG04?G7"&EOUXN5%;@T^Q:-2/C.!)])5A2G'4"LDJ^IHP
MBY0Q%@D"(OA(N=2ZBKX6!!<$/[PQ4=&H'P'5D]BE@6A8KF[BB!(9U39IU)(B
M*0-3FEK!/2D:=4'VG??FHE$OUL,U%>DS@A"7C!^D-<L[<NYT07+;0 ?&Q*1M
M&\>;MB,W)LK7'%?]QWPV- R/6@FAHYA>KVMLM]>=.2-\?R?]L^VRU@0G_=FD
MO/OG,!P,E[6_Z2/15G?*,:^#UE8K0$X&C8#G_HB.,\0C"!<\CN##RAJHN5.E
M2F_$94;M?<R("U@NIL,\2)YRQDL3*<4.,6HL@J1Q()W=\E@RHT*@8)@HG4X+
MFN=RQE_ ;D'K_= Z=:PK2LFUB4@S'!!$(,A$FYOA@=92.&Y=+/ON<B-U80[X
MHBW7BMJ)TYVX: &#0Q%KCD!%BHPT+)GX&#CC8*,V*VL<S]T"HZ!VF5%;M.4G
M0O+4(2%JTFQ%@VS&+]"0D.QX0-PY+WWZ X(LVG)!\UR.]J(MS^>EFCE&$P(!
M"H@%XQ 0(9#U2B./P0*GF$3GFK;SWN)</ZO&GP8;;H9W^>3S_.1C'X1X JK]
M9@;=JO?$%6482U#W:0J#G<U)J7E1QT:T^78J7)*T01YXQ,@:EIVLRB$M@:65
M)4Q(_T2L\,H:A38FM$%AWI*>T3@DWP#78N/- ]9)1,100Y2+@*1P..F,C")E
M:43:$\$]<*^L2& 5JB"U(+6&LG>7@%R@>S_H3L(CW($@R>!#UCJ.0-" # D!
M18N-IUHI:52USU+5I'2J@M[&>6>*QOP42)Z$3")10@B=)HA"UIBQ0!I+AXS7
M&+SRFG&9-^$VUG4U#B](7DHD%XUY06"=1$6(E&E_51$I<#%IS$XC+8Q&QH 6
M1$=I597"7%>CU8+4I41JT9@?S3,U%2(A%(Q0RB#I9#)W8[!(2<P03]-DP%EB
M%50[+:VMPWQ#CR"<%0AK$ #_ROVCLX>\>^#Z^^%!/O)G&X_]5\,,]JQ#G$W(
MQVH^BKX_#P]-5_IQX$RBAH!P($G?!^!(I0T$I7D"EPP![$586>-M(L4E$OIW
MR:AH*(*;=9I@%KM%^9\'N1-WN:91,8\Y\D;F>N[:(BL9H*3D)6-=6(E]+"E1
MSQ3 3=N"SRR 62@7\-X/O!.'.2':<BT!40X:@?0R.\PQ8D;X9+HI+((OV^XR
MH_:Q?.5%<:X3P1-'N<)6!"8%$H1$!,IJ9#'7"'ONF ^*<6-7UJ -XG(SE8+@
MIB*X60<+BN)<'W(G7O.H) [1.805$P@84TAKRI ET6@9J5+1%L7YF0*X:5MP
M49QK\5=-^<TA" LJX95SZ4=5; UV!C%IB HN"$U=HS;>FM+*JV?+5<F;G6&^
MU3\RO1O2RV][:]L?^#! HU=XQ=)[^W[&3NMLY.,/'/4/7V6I#/N]KC^_N/S]
MDFJ43Z.)O&$.D*R.E72C6AHN;;TYF@Z#!BXI:(D4(1J!UQ8I 19I%APQ-H:H
MY<H:X:HM2%UM*>O#4,/;QQ4R+63:=#(M9NU\5'HR.70K!;9.*R2\X@AR73@K
MM4;<)(L7K+.*FMQ)4ZJZCE 4(BU$6HCTZ<-R)2'OH?39F6BB41GO?%)"H[08
M0; "V:R3)AW4!B>!$<N2)BIH&W!=C38*@18"+03ZM!'28M;71J837523W$Z,
M1D2C"KG#F$=*^63;LY L^\BU%;G?B6!MPNHZ$EC(M)!I(=.&D&DQZ^>BTLV)
M7JJ"8XP0@T( @X RR+Y2@B"'L;''6.5FK,FLAZ*5%B(M1/K\B;28]7-[14?)
M/HE"W_P(2?%T&"ABT0$"!QYI0@(R(5#/@XJ1JZR*BK:2R\.@5=;!'T?YN.9Y
M_YO1JW6.]Q-(W-FB'_^UAE5^(>/%[09_W N;\:T9[K[O]7__=7QXV O[X>#(
M]-:[0]?K#X\'8;B5Q[B5'OUGK^]^/<\%W@O_^^5DY[L_M!3$]E9>Z'^FL;S?
M3XL9=SYLP\[^.[:]]V=OFZ;QTXV3C;U/:<%_BYVMC_1'Q$1IYADBC"@$FD2D
M<$P;OJ4D&L4QD+C2"HD##I. CP;'8;8WT[X9_.P>G*TVG2AO_)MJ>=&K3UM.
MMV^B=)77W\")X-O(EX[.6DZ61<NEM=**:;&TN@<CGLQ\/+;+6T?]46;)L/7;
M#%OI_['?2Y\=OIIM]#0EFLLOGMZR0L4YAD=(3&_;,X?#\.KLA]=G)2*[!]68
MJR^]GA5USL6Y@,+J@:/+KW]W_=%NWF)6\6B;&6<!C9\\OKQ:7;K +*-K@JUR
MHJ^]C%?)M==NNBT1JU3+!]WVYFM,P2(&R_#UEZ=O>TNFU:T9D?K21Z]0ZES(
M98*?1GN15Q]6[O[3VDB?VAVVWB4\^]:GXX/08K@]LVO-*YPI-?RZO>NF0][-
M$UN.NEQ[L/L^;WMWD8UIX\)]ED>>I-85IQ>QXO:[WO?"TTCH7]V#UM%N_SC=
MP@__?1]9U5Y[^-K.CF25GF>8/GESQZPYM@Y-FNRD"[3,?A+ T3#79.@=9YZK
MQ!E:^TDE2(IDUB!:_7BY"^0%[6 A96B>\AZE*^BEA;-Y& 9)=3SX.5$HA]4:
MZI]?&"F25R^-N<]%/%_/SU5ON"R^F\=,R3A?@943Y[_F)-/3DOC!][]"9_WS
MZ<;I!N[LO^]U]CXGV_?+[L:';WN=K7=D9V^#)MNWN[/WCEQTY.QL_<2=]?3-
MT\]T^_M7VEG_U-OY\"X]:X-L;'W;WSC=SF/>W\BV\70I[WRB,ME"!&DB' (#
M@)3 #EEB. ,%%K"HVC6WD[6P?*>V"B,M)2,]IC>Y,%(=C#0IP"*= B)RQWB.
M(P+M/#*)EY 5@C)F+3.<9D;B;<'G[B[0O/-H+T)=C*/V4#<JBZ44Y6.VLAWS
MUN;!?\8&WDEAL/LPV'3Q-^RMBD9HA#40!,H[I)S2B'--I0P6$T%JZ6I;ZL<V
M%K2/TE&O@'9>T$[4#M#8&Q<DDIHGM<.&I'$XS9'!G&+EF",^U-):K]E%8Y^[
MRC&"R2)5CF=;PZ,I*L=_!]TT0X>F5VREAY!6=[K,+)5"8"D1HSI[;W BK1 =
MXM%Z((X(Z^+*FIJ[T'7S'#<%JH^A:!2HS@G5J;JR(=(@I$+8.):, FR0RMT3
M?1361ZXT:%^Y-1J$U<:X-!H5/?V2?T;]B(Z'H66&PW T;/7MD4D?K&*GX1^W
M:PY^ADKM*%'3A^FD(YK65RR>BXN@2;R]>5T8M(0;ECG<\)@!T(I]-N/787B3
MJ6=S3#P?#]Z-:>=]?S ;DBC.@8=LWC,-CYVPN1)\1,QEYT!D$BG)(A*1.:^E
MCA!RE)31-J%-VL!+E+305C.BI(6V'HVV3J=*\KJT RF-E,CN 8\QTB981")X
M'6T@WN!,6ZHM\.6"^,_>[GB>.N3[JQV5)<"R8!?E71AJVC=2^.E!_#0=*&5.
MX<A-4JM,S >O'2#C)$':"QRDU*J*N>CY_9<E4-I8'-?NORPX?B0<3_2,@*-F
M)#?,-<E& J\84E$&1&40:>T29S2M](P&X?@.!WFK7XY&9@=_K,TZ[A9SRK=J
M3W%^PK=:G\./!W\=F:/J',9F',<W3>^__6$WB_"%'_/]>O(#0U!&!966FZ4(
M</!(.<H08YR'I.52K?6(=+H'Q\&_R>9*E%Q&XXVG-@ WQ/*D(T3'P%FK,:<W
M'0M^-H=^K>E5FN1P-X2CA1W\O?[EKX+-TIPA9FR5<E'[L5R]2M7=3N4^_1'B
M,E:\JBA[-F-]3G)=U%CYHYQX)_QY'GE?#R[LVS!H,=)NW?$@]](*X^RX?ZOV
M$]A+=^;_O,1G:UR8KA0 J$^X7XIH%R7:JJM2'1PWK]B>G>1J17R-*W.YI%PC
M](N,[\P!<V_O2[>_/[S"RD-3 9_@)2?)6_^Y.?3VH'VA?+29'WWL'->GSTIL
M#2XGL,[C@5^RC)^KWG!9@FV62BUD\!!,!,Z$IDP%BCV -%:Q\.-C-OH)9>1!
M5<IG$W@N!.*6M W$;G=C[W/^W<GFAS2NT\^PL^=@>\_]L[/U;6_G^]?T]UXW
M_0Y?#+=M?OAXTEG/@8R/L+/^AJ5WVN^<[G8[I^][G>^=WL[6[O[F]T_I=U]F
M:[8(XBGC%",9L$6@0" %GB'-'7<L4I]F=V6-M#&F;<+KJKW;H.!Y8:?"3C6S
MTU+V57@T;IJD GAFA?,N(&>-00! D94N-Y^5@GD#A*G<50&WL9@[X[ 04R&F
MYTY,5U>1ND!.A8[N1T?DG(Z(%BYB[Q'FX!!$PW/S08\H%E)+CL$[6:E*C+8I
M6<*"+(61EI*1!*-42"-P9 1,8#:]K*/82,ULL@=XQ4@/;S=5#+D%LA.;E+H+
M%BRE$4F36Z@$G?2DH&DB*Q_!2P8D*TN)G:AH8]ZD[,G"3H6=FLE.Q9";AYOX
MI(B=B91)(Y%E/"!(LX4,-8",8<1%4(Y8O;)&99M*5HBI$--+)Z9BR"W"Y[TQ
MU4<>1^D5$<A:+A(A*89LE ()Y3F!&+RCIE*6.&LSUB2O]SC$>/:LL\4[8IRZ
MZV'=X1Y320D76NC5<OLRQ.8/L8SR$4;Y E(+WAX/!E5_H LI!E,%KTIJP8M0
MK1XU>'=^9G>\_HI+:AX]:[JB:.2!4^TEBE)Q!%AX9!P)N1\,LUH)$3@DLX]
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M]PR/4U\<2P]/OF)L$M3QT?5?N=0MN6Y6(?@V6J%Y3(3,BF/ZS]WSBL^'YF=
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MDT#I9?IH\ED6AG^*H$:QM^;@^(VM-T=3'.^E%Y@(B9B@/&EJGB.MI4$\$AU
M>VMX[FH*;<+K*J#U]"U-'RD[I-!IH=-F!Y6*O3L?CYZ<\RBUGDKF'&*.: 16
M)(LW$(^D"IAIQQ1GONY$N4*DA4@+D38KJ%<X])X<VIGHHMQPHREVR.1ZTD"
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M.]_0!:FFY(;;9CP)\6F")7^:7M6 RU1VVWIP(;?J;3%2F6"XM"IZ$=T_$BP
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M0J5 D5N28R0#,O 32:$,C50EB7/E)2KJ@CPY&*. :@'5MPBJ#ZH6_?RH6HP
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M-4X:]&-K\UNSW=C_>'=?XJU=VMQ:YSN'7_=W/GV@31A+,QO7]K=A'AID<^N
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M!<*<80&02?&ZQ//4!'76WKTBR;.0Y//8[03;VRM6OA>3Y(F5CR2L#=,:)95
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MGU7R6KO4_'S1%FLR?ZF(=F< MPB]?S]D6F=5+^8U0\E_M^TJ>,16;O(_[-'
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M*F&5U![.=65E$CRGI=S>@\PL5@^RR12WIKC'L %(5@ .H^U5'5UM?XIZU&M
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MST9>*<FKS%B9L3)CCP#>NPH"S'<*ZON?^CF?TN]LR8JNW/2$<[VW'U)T)9+
MM54\.LL%,\8;AKE6)& :I?65DP1C/G22X"?%LX\._H_=SF$.^LFC^];J[[T?
M]&"F8O?#V&^7.W/!OV'+GLY/K/OC?"JC6/?/8GO_RWGC_ O9/E\_V=SZ<M;<
M_]C:W&J<- __.6B>?]QO;GPFS8T_VM=BW??;K>9&X[RYD>/AUP5<!V/]+!KG
MZW3GVQ?6^-; C?V_<>/PG]P5_/0B4R5A+@B-&%DG,.*62:0)=BC2@*,VFGFI
M5M8$,75)Y1SU/)Q1G8D"5TL)5SR8:)W54D7#C5;.1J8Q-R8F'*(5(Y\NO^33
M+7 UKW!U?@%7,H>@,8<15M8 7-F(K!<.<2-9DLH8+@7 %>=U_/22=@6N"ER]
M3%8^2Y;K2 R+B6.##;&"2^,,$4(RKD?LBA1VM1!P12;MX(/E%%O@5-X1Q(DS
M2'/BD8L^TD2C=E;FJG>PJ'7"50&L EB+ 5B<^F@DYP*.6NRU2Y@8AXT4 G0&
MX6^,F2N -:^ Q2:5@H@7B0B*E%0"<48DLMP(6$6AHPK>RYR!1^J$Z;IA9(X
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M48NR:JYLS8QD/FI@(?"L;%32.JQEU6V7&]Z8J#'12C"1]N6EMMD$"AF"CDZ
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M2#C:O\S:VX>'@UC;'3W;QR']AB-*#RXLTUI5P+LI G]VR;VIN2&I S&=DV6
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MPH7<,+QP#)_[E)7B-N3(F2)R#+# UU.(+#C'L]3"46T>):"K5=/#ZXKAZ_?
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M4I87VB$PL%(P;YUE 7/Y!RE)Y:+(I;!=YQO(UQ?D,22?2:,P: N=!Y=-L#E
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M##Q/#(,2+ )1XBIXP0LE6;FHHW.-CQH?73,?!1%]-LG6*H2I]@AP@-(+[5(
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MU%)@25R"!A4-,48'HIS2@O.L@M1/GH)ZU?.CGA\]"'[D4Q;:531PFF2@R9H
M-@)#A2KC,/AK:D_]V*([XU+KJ@<I3+(L61*XU42J; F M"(YVLI()7,(\;;'
M%O6<JN=47]F+[B-++C.7-)=,*!<D=DRDD?,(DKBW\QX6N^K6#J04E):2D9!I
M(A) 2BP+@CB,CQ@6;%;NR=.*LZ$V]TFUNJ5,A0<2M=R=3LAYD<O5[K_WMJ[!
M!+#PHI!!9,DL=O3E*=I0V>Q,CJ+G4@^(2[WJQ/JDS0!.YHCBPA*9G":NDH9P
MH8+0K+(*^S97E ^IZ>>J/%X"3]PJP6.E$Z@=,243=*A\Y9E/5=5.A^\)_*$0
M^#HZYJ(,6G@PDX(Q0.""$E,Q3P(6JP)Y,VD3SDT2P^KF2DA/X/>6P,%>3DE3
M1;UQDC/M:-;:Q,032'*KKNL1Z0G\;@F<=0:K),4LC\0*G'L( ";6\$184%P*
M'2/3^LE3R<RP8C<.*/4$?F\)'(%.O<B,:RJ!N $O)/,\<*YXH#[T!/Z@"'P=
MG7%2*"4<)38X3B2+DO@,4*0YT4!!.Z,Q/WEJ*CD$>=X3^*,E<&: PE60AF$O
MZ,B-=BK)E)@)T01Z71N\CVG<&6UW8AH5KQ3(:**DJ+"]"&CG*0GBM(Q9RF2R
M4[<6T^AI^][2MK'9TUBYF*274GF?M(M>&%UY*UDS4*,7W@^%P+M1@$I39Z@3
M1%7.$1EI(BX*$.05U]H9C\WXL(,0,W8H[M5LM-NL7F)\B]_S0$ ]1.EPLX9Q
MWA8QSK\H-K#9S^D+6\8]9,8F; J@OFIK P6EQ8"N0IU.D=D*HP>]V^$A,;91
M)W# 5:X<"Y*$0 V16F5B58K$*!$5$YP[JW%2$!-J*-F-[9+K$M(=)VOTS.%J
M(Q>2D#0+I[V6P4>?;/3(%1ROI.QS'QX8<U@''720HDQ;X-D!<S XV\8:3;1+
MSMJ<0I7 K '\&=);2RKM6<-C8@TB":8UL\ AO#0<4PVR2Y)3&Z0$.ZEG#0^*
M-:S#%916,3 6B8JV(E(E0QQ/B3!999-U,('S)T\5L 9N;SP)OF<-CY U\,I*
MFW12E6+22.VHK1(P!07_,Y;VK.%AL89.H(/ZI+(51 (X"1@-EEBP%TEBE1:)
M2IZTPT"'&@K:LX:>-9P1(J$LF^C!+O5>5MQY%5GBE@=G7:1,]B&2A\(5UB$2
M4 1-)2I'3&(<% ;@#\XX1C(-@CKX*:M;+_OHN<)CX@JZRMP8[U0P4E*3C0$C
M@FHF,G>T\M?E"KW"<,<^R$YPQ571N*0$H0EG.SICB*44. 0%A/9*9% :,+AB
M&1N" O%0V,-WT"NRM&IM@RM]W<5Y"HW% 3(Z^I"]#")9+8%CI5!%JCRPJIYU
M/2#6==P)GWB6'$M1$FNC)S+0"MT@8/J MAHC!5T51WB)H>IS-A\S>:>*QHP#
MBI.0'/[-5;0V:5HY^$WW954/B[P[ 1"J);-1DV@2)=@.DU@):HK0E@G&5-1&
M8D^RH91]T<7CI6^)R3^NRB%73((.ZA3E+DJ9; (,<'U.]L.B[W44P]E@*RLD
MT<&6[(= 3-:.>"U<\!%DN^ @OOF05KJG[T=+WT%8GRJLE*V\5(DYBR64O*J8
M!V4]]?3]L.A['8J(+C+.."4Z,HI1RD2\=X*@5I8]RU0XC^JYI3=N@-R3][TE
M[XK%8'P&&:ZDE();*A5+PN3L9/"^M[X?%GEW!F@'K1.UCFB./3BK3(FS,1"-
MJ0@4\,8:$-],V*&B-VX9W!/XO27PD"V+W$26JRR- /T<._8PEIBE$6RXGL ?
M%(%W(P,R@M!.09**1\PHL!&4<Y#@PD:5+0V5CP[['E@PP>]38Y-;*KJXSZ[_
MNM#B'-?_%6,OMS%^_E$VR;O%\WDL7-Y('C!R(A6H<10U.LJLIU8K9:Q1O97V
M@+C\R^Z@FA"$2EI:8JTWH,95%?%9:9(B,]):'B3W=0V*&5IQ8RY_ZQ1VSSN*
M]JRV9[779;74"*]MMLH$&2@FXR7%+:^4\:"-]77,#XO5K@-:D3FCN0'>JKTE
M$KL5>",-<51IFIE(6<4G3R5&M*K;&K+3,]J>T?:,]IQ^C2QS;;1PE8Q2>V%H
M)2KX'_4VJU#U_1H?%J/MU$=5V!>">F(L<T0R$8E/-!)& Z4L*L-<>/)4"3X4
M/:/M&6W/:+\ZHXW 5U-@/#FI331@67*>M;-!<^GZ!A8/B]&N0[S*15HES-[(
M'%/'*2=&,$I2X)X+)J10 JO-[)#?/ >S9[0]H^T9[<7]2Z/C6.$9F/;24FTJ
MFBIM%+6@ZWJ=>T;[H!CM.MAN3<R.@T9;45T1F;@AIL(Q*%0X:WWTAHE;"[;W
MC+9GM#VCO9C1*LDB0^]!U#(DZ[W*0&,F.?C)9=4SV@?%:+M)#X%)KJQE)'&-
M'2:!RQKC$\F<&<N35T8(3%MDC ZE$8^&V9:DB;\M'+P4_HVCCT_;K>TN <U&
MH?X;R6 T6;JRU[_#9>W6&E*2O)Y6=3B=C_":'V9I#!=_3#\>C>)BOR6USHW-
MGNGZ%N=A>\O%^;=T=A82D.7LMAD&HY=Q#(YK8F8%Y_K .C]QN87V>'#2:4XK
MS;*DTCCODQ?>).T5BZ"4&?6DO6E_UF[AT.TEXF?)?2 NPPY_<.,C=SQ_\K>-
M@S@83<B)@S_OS&"/@<"Y(9[^,%\>'+C9\?G'EO-7X;-P:C5: J^;S@H2_0#$
MD&9X%:S&G;G:]&E_Y$>+'^]Z?8/]&7+__[D<I-63IZ^1D@;3/$"F#4@Z__O?
MW-.ST.42&/T(/_8 S V96-A"\PGR ORSH7Z"BL8/G&^=Z!'['@3%*!_7'XU@
M,Y/%#Z2^[*N3374VV8BMFDN>_OGW#99S"T)W4Y8^=[,)'-7\US1[M>]FZ34\
M_!_C:?APMW)2[K9R\OT?<H?_Z_W;9]MLA[_YM/OL]_V=9V\4R+C/;S[#<_GO
M[W</WH@W?_[^ 63>./WS]^.W?\9#SZ7>?;WW^<W![H>=9W]\?OO^.=W]Y?G1
M[OL/(.-VW^_P_[P'.<C?OH_[;W_Y/>^\WCO:_>V=M$9[+@21DEOL%F2($QQ0
M4&3-C%:"!5-K/L#R4]Q&=852$Z6B&:S,**/U+@O%*%9P2$F9D$\&"92/0^32
MLR70='OD@\,T&Y1#/RU7ND1Q0L;4<+GTI9M<\3**N80ZOA%QG"U37N\G8!D'
M\.;CTI"E^G$^@/,<8;[?'(XT+):S-!A-4.N#MX;IP<$4%PE(/'"3"%KKQS1?
MI#B8P3]PO/AK\^V1F\7YUN#U%.\Z! $[2%W@S!$X@[_@6SG]\?FOK\IO[,>_
M#@>+]:(&[O!P/((WXV>+HRD)8S>?#P[28G\:!SX%MYRG[@VK75RVL@&^_M"A
MCC+"%M*3O0'PP^4,E )XW='^*.R72P!$H\48;EY,.Y?#Y_]=NO'X>' $VO&9
M"]@XJQ$J^'&$*_%+7$I[%EN#;=QAJ-$/&/A9CSJU\1$L?PY*_7@\/9K_L(G2
MUT'-#68N]%58.2UMP>\(7?\R^FN[V6__^LW38G3+<#R(W;1  @'K:. 6-7R+
M, 9\Z2+R"!N3QV4 V/OC\HT[ -5\@3 'D(W@> $I01,8 ];%0ES-=:&QPP#?
MSKQGL>\6@P, %M #H"AHZF#MU7<N9S-LC0[T-IK6'R<'>%WC$CRD("?0Z'X"
M3#_"'Q>9I:T<.SFZ/29.G3&5,UYF$)0B,<M4E$$(J:JZ6P^ELI:4]*1YRC>L
M4U1*T$(] @MDGB:7B=1G(U3=X[,U9:VL4?J=2=G=]W]\?L=H=!'T1:*\ QF+
MF?3>IHJ$!*>N'6< E8M]#^< 604K3<Q!6,UD98U)09EH*VU",B+:1AV2Y_@@
M>B#?(I Y$P  &XD*F8$B10.Q/%E"D\]9:*LRMP\.R/]P\U'H0=R &" @6<Z!
M&.HID97CQ#H:B6%&2A4-4Q7_(A#?T)?8T_$M EDI.&++)#&J2F 5R8HX&2GQ
M(N0*DV]-E1X<D'LZ[H)8)VIT$H$$*W#69S3$:N$)<S8KX[U16GX1B*ESCF,7
M(FHJZ53R5MN 'J(J8 .RW"A=[&LH73V(NR V,JD<8B! M9Y(2Q7QWG(2C<L&
M)SESX1\<B'M6?0+("CBUD0%4+FPOP1,ECAI% /(N62=L<%^F<MVE\=33<1?$
M+EN:!+8,X=RCZ:2)X6 ZV9@U-S;8P$#EFDQ/Q>#NZ(,-O\#:&[#A %CLSU(J
MOH3YZ-/@ &[8GP_@LA0'_UI.4NT%%W0X0-PJUZ$^L/4].93NCT?);-%R$.B3
MG:4#-T)B/>$VG*R=39N^0O0OP9^3E5\2?DR#6]2.R]'B"WRW0_0QCC(^J7W9
MRH/;(ECC6=IWZ(R%MW?66MQ*\')T)7>6O;&NXHUJW*YE"S$MTNP CJEXO^K3
M&0"Z[7>?W*S^G'/97-K6X+M"YON#S6J+FQ:;KPS^@L$U+UNY/^LW(M0_IIG;
M@Z<M#WR:(4I.EXOY I"A..]1HIU"3'C)"J7*Y\]_?;7V@ZY>#:QT#N]$Q^MH
M<F:L8>M4W.@K!@Y?A?T4E^/T,I\ILK<GL='/2MCW.PXK?MK=?N==E,I4BAA+
M06[3'(F/(1$0YUDF8:SSXF28\%'%[^HP$-) '7B8IT6A@R8N-;E2?&*X(2-J
M6NJ0U[#P7+SDW)!9Y^J;,-U3V39G'W:SU3:IIZ0KP:&/W>$\_=#^\B.(B,.Q
M._YA-"E'5VXZD>* ^0LG4I7*"^NOUPDN6[1.<FDZO31O;K[>*E^=2+^JOU-T
MR]#SOZ9;[ N_4^++GGK18AELDWWI@OK%]HN]=+'Z2G=>TE/ITC9IU[C4KE.]
M-[(B-_,>+^K6U+"I.\DM/I7R5%A-T1(*QV[T!%1[SAW9<.N']7V?UUWB[NF$
MW8<%B-?%7[%3^RF>K_P4 T&'7P5]KY3@?+^/[-7HT^T>V#?$7_'8\!?=:%<X
M]\MW>_4C.Y<#/YXC9;=!^[=P< _Q[&Z$CCU&WC9&?D/FRMDCE'9_*>ZYZ1(>
M$>=__4I0> S3VM99J5=A -?M1WV=@WID9:IG[?"Q%)K>,!A]K4+37V?3/%K\
M>SJ?WY?ZT2]U8#?UHSN?=IZ]'>W^\O;@Y2\OCEZ^_HV^^1SDVU^>?W[[RW\.
M=CYOP[V_L=W/_WA_LGYTY_/S(U@'?7OP1KYYOZW@?>]W/^]_>/-Z]\/;/]]\
MWGFV^W[WV1]BYY?=O/L3/5X5ZLOLO/:Q(M1:3"!+%3'P-U'44UWY2CJ9GCS5
MU5":1SC4IF="CY()W3 )N6="WX0)T143$MHKF9DG/F=*9 R46*XER8)+[772
ME4G8MU\/^6.<O=-SH4?)A6Z8?-ESH6_"A?BZ.5QP-.JLB$C:$0E0(YYRT(><
M!4A&4(@LPUKP:FB%[+E0SX4>!!?ZEIU_>B[TI5Q(KL>455Q1+4NE!_S@KB*6
M94^4D4))YXTM[7R$&$K^V,:$?P=SD/Z=YO,?+DJH FB2DI8]'8\Q/6J$_M,T
MQW8L7^"$NZ33W-K3>[U#?G1#X;ZEVVHW+5X4V".CW.Z __5T=SKIP/Y% _J>
MF5Z'F;[J>+>2 ,P(HA1%6B)3A-^2@A\A 61I<-E)4.G4T(@;>[?.YD5WV4>R
MI^X[\ ?UU/V5J7OM-K*.*NO!3$O69!SWR(BQ4A,?LU8A:%NI"E0E-A3LQO9:
M3]WWEKJ_I9^EI^ZO3-UK=TS((E2&::)8"$#=CA''#1A"V0?ILV"<.S2$ADS9
MGKH?+75_2_]%3]U?F;K7;@Y0R'*DCA(K%"=H<A'CA2/>5EQ:%DQEZ9.GJAI:
M<UN#..X+=7]7J4,7%8Q]C;2B*_'-YADW:Y/_D)GJG;D[>H9Y'88YZK@R?!#,
M">6)3K3$R VQ+D50ATP0WB60BA(8)AMJ=>.!&M>ECSN.7/4T?Z^=(#W-7X_F
MUPZ.BD5%5<B$>3!\I N:F J[NWDCJ.#")JZ?/&5:#HV]K8AT3_2/B>COS#?2
M$_WUB'[M]] B*58E1BHPB(CT)A,+[)C$)+W-''@"]4#T5 ZK2O5$WQ/]_7&9
M]$1_/:)?NT.\4@JXLB/8!I!([,SL#?Q&330BJ\HBC)[R2@VE_*[4^^\F)>39
MA<W)SG&FG-=)I\\5>23.DS^Z6-!V\BK>Z;8)VNOIKUTD>+7"@=*1HN?(U^'(
MQQU_B_"@- =-"6C*FLA*<F)HC$1XFG \0@0[^C&B3=.^I$><+T4<DP#$BD=B
M$90R9$VL9H$HJCFH8SH[@SE'H+V?+F5Y9)&.7FK<C?NMEQK?EOC7'CO.).="
M6S#>$^CQ3&7BK0*0&EV%F*GRE7N,:--+C1LB3N99"Z,,R2KC9$,!ZH;AB<1*
M>"68\P$-0#54^K3YUTN-1RLUOJ7_MB?_;TW^:Z=OY:P(46@2M)2@- 9'#+!\
MPB(SS@CMK&>/$7%Z=>-&:.,Y9=)*"\@2*B)5,/B;!2-52V,<:"-2X>QW94^7
M-_12X]%*C6\9 .BEQK<F_W740$3&>'2!F(S->YA3Q =0'[7W51*2*Q\N&=7Y
M,!&GEQHW0AOI!;6F2D0I#D9J-NC:S)1X23V8K\[F7#UY:H?\C$RR1R8UOH-<
MW"\*+&U,<;B+]G^;C4 %H$B<+G%QUVZQ^CA[5=SB^3P6K>?N:K@_NM&X+A/Y
MJ=#-*QR!M3\= P!Z675M6?6RVY]0QTBUUIFDB-&4RCOB&$TD1"]P9$]4YI+I
MIP\"2WI5^(9XDI/-K')@^N:@0:?Q%;&)5B2Q#!#/+GJ6GSR5=FBJT_5$MYM0
M<PL\^9ZW@NJ%<R^<[W'XLQ?.7Y7IKH-6U$0EN0E$2UX1Z;W&'!E&+%?612IL
M4I=,GW\06-(+YQOB2?!,"*$8T;P*1$;GB8LL$&ZMS4H*+J7%-CQV*,[HK-A+
MYUXZ]]+YT829>^G\5;GN.CA(@^#44DLJL''!=(X8)O066*^-.G+&C+]>!NO]
MQ))>.M\03[RKJBIG0 R=#&AQE2".TD2B8R9[ZYT/%1:<L2&K3G?:Z:5S+YU[
MZ?QHPOF]=/ZJ7'<=A&5@XR;G%:D,-D#BK"*.)4>4S)%9JJ/P\1%@22^=;X@G
MD3I?41J)TAEL9PFJG)..$^%T=DYH+0S@"==Z"%C32^=+:TG_5F+<\&\<?7SZ
M=_C1/NO S?9&DW:/%IAX\PENRK92=C2):;+X@?,M51Y\JY*#T<M$!Z]''"<@
MU?%X>H15GV4_\\$\+9!^%_NEPQ;0YN%RX0K/F&:<18UQ_S0K7RZ.IB2,W7P^
M.$B+_6G\884.7W8F&Y,>SSRE.J]@<Y0DG-;8'<[3#^TO/\;1_'#LCG\83<J>
MRTT_;BX!'G<23\H+ZZ]_K,? 6[O%M449VV1V-"^^?&J]8%N"GO_UUY]:?YW%
MVBVAONRI=[%6JOF#6>O].M?^!![16J](!=]R@KJ^TO3EAS7D]_7^+*4K#+7_
MAN?,5#^J_L:CZK_D(8_RX-E=H?%U0'+EPSP8Q3A.=W.8V*NV-F8'3>8Y*,W?
M&*UO=][]63[ U0EWM/M38+D; +S:2#*^U06H+7Z%)?QX.)V/$.H_S-(8P/\Q
M_8@'3OB6.6UN>#=/^( G3__"_KII.#U(9+E_!%D<BR55O7$>H?EZ!8+\JESN
ML1]ZSP5[+MASP7M$D)=SP3NU$:_DZ;W?6O1?1I/!8G^ZA$?$^7"0/H5T6'RH
M@\,TJTN?!NY@NIPLYG^]SL$_AJ*QG^ZZ_NOQ![H?9:CZ?E;7/*)0]<$?],V?
M&&K<.8;[^,MGO\'U_QCM8 CR?7R_\WF/[;[^>?_EZ_'^R1#D6]A3"35^_M<'
M>(_<??;A>.>7%T=O7N\>[/*=SR^?_0%K?*Y>_ODSCB1N:VO@>6_><9>DTY&1
MJ((@DEE!?.4925E);K-+5?"/ %$>5;3ZCE!%5BI7VGN2C(Y$VBH0HXT%,'JM
M)8#8AJ]>B75?(L[7;%G^B)J2U)K#'1+]GV69*6[#:;F]M+L\\&GV,M=FULOE
M8KX M0\.NY<-7T#PM$OP58JVPN&KVF@&!,\B\4D$(@&H+#H=LE /$%,:67 *
M87I<N0&NA*@SJZ@AVFE-9.*6.,D%J:1*VF=)O0/AP+@="O;5<HWOD73HS:#'
M80;]FF:%4=PN&^,G657;)JE]W4E]E?8LZ2HLJ:U]X+"7=\8+X9R1)$7MB)3>
M$6M#(-10Z2.W-GMZ+X&_J;GTH+\^Z%TEM<JB(CI0,%4H((%W'-473D&9\97(
M\<E3NB6^!U%TG6<T3F 4/A=X@7MA]SB%75^T_WCYH^IJZRP8G%9A2- >M'5#
M%;:7]:3BFB=*C6/V(LONH:!*[P*X*:((@)GSGA$CHR(RNT!\+"V8<L4!90"Z
MZ:LW>+B/LK1W^GU3FN^=?E^1XC\!M7]"JM]]_0=_QY(5J<J<:",#R ;AB674
M$%51$8RW*>2+)IW<5U3IO7Y? UEXY7.J6"(\.4IDJBS8V#H39RM&JQ"#=CC(
M6M"A^ J=ZN^??.@MH<=A"9WC^;DA'^L]/U^'(QTW'.G]-G\'QHN.UGNB1)8$
MHP_$"J8)-U['*'C@ZA+3YHY@W[M\;P'ZRH'8L6#.!F/ L)4NH\^7DLKQ6%F%
M/6] >6%;_%YG*'P'LY%_[0<</^XDOGX*R+?D@Z\V4[7Z&<<][GPI[O1CCGO9
M<?>Y6R\F898.TF3AQHU?OZQHNS/.Y@07V)U./J;YRL7SYVBQ#Q_]/)WE-"K7
M/QM]',4TB;_C <Q['G$]'K&1[65XI:D- J<A9R)MSL0K]/UXJX-@@C.1GCR5
M0\U.=Z[J6<+#9 E],M0#H]B-C!BIE<F<*>(JP7%^N2->&$YHHE9)F2(-E\RA
M[9.A'BCHC4Q!I\H0DUPBT@/;]H8:T.^X4I6 WS&@\U62H>XQ\[[",[XL&>K[
M%0]W&/3KO0W?EL%L)(EP)CD7VJ(VZ%"V@#9H%4#5Z"K$3)6O+HH8/UC,Z;T-
M-\>=S+,61AF25;: .Z"<&,,3B2"8E& .I!5]\E0-E7[T(VN_7]EQYSDCO;?A
MGO&(S2R3BNN4 /A8I$Y!@Y6,.,\-2<YQBIFL5FET-Z@SYEKW/.%A\H0^$/_@
M2+8;B#=5D%113V*RGDB3-,AU#$AEDP33*M,L[B7T>W_#C6&?<<J0816IF,&D
M0,J)K5PBP>LJ6BJ3]OXK)6'<(OO^#II!O9Z"PC, C0=>?7P7S:#ZF4G?['P>
MK!9P7_H+]2K\=63":)54P'>>[;VS()RS3IPHFQ6(!)6)U1S0G?-DK:&>)05F
M/AOJFZOPCVJT3?^,>UC/W(NM7FS=XV!(+[9N(+;42FR]WGX7P9*)67B")@V(
M+5$10V5%'+?"E!FY%*Q8IN70V-/EK[W<>AS/N(WQ<OTHM7Z(5#]*K1^EUJ^U
M'Z5V3]KDOQI]Z@>I?=TC[@>I]8/4'O[$DGZ$4#]"J!\A=(\(LA^DUG/!G@OV
M7/#[)LA^D-K7/N%^D%H_2*UO)7:[@4#JG.-6)4%-)9U*WI8X$LM54-3HW.2O
ML'Z0VA>'"C_OO/[ W_SY=@3O'^^\_TW![_L[K[<_[SS[_</;/W]^__*7W3&L
M69P.%>Y\>OGZ[?[;@W]]V#WXXWCWV1A^?_YIY]G.T>XOOX_?_+DCW_#_'.P^
MB]WI6$?O!/?!B"0("]AT#(N?/-45<2I39ZA1--I'@"6/K.#IV^.)XA55558D
M5Y81*1(CQ@E+1+(\YI!8Q+D$ -4AJ[ZKT01].^5O2O+?93OE;T7N=$7NTKL4
MF52$,IZ(E(83%V@FCLLL*Q.IX>D!HLEC;Z7\[1'%Z&A35H(X@"*17 &.&*%)
MY8Q)V42C*EI/3Y/?A5SH;9_'8?N<4\-U0Q[V?=5P?2MNQ%?<B&GFDLB,4&U!
M;&E04)W&Z3 A*FO!FA$\WDNX/[+*S6\/^1249L(Y@+PT8,=Z2CR+@ -)LLPR
MIUIQ;!7T%5H_WC\A=/=U!KV8NS];NX;SQBK)(N,:M#HM0[+>JPRT8)*#GUQ6
M3:X_ZX=AW7O6J%:LT?(H-#>,^. 9"$5GB&&4$U#3,WQ!697"(\"2WL5W0SP)
MUF8I6"**2\ 3&BU.3+,DEL[;F69N $^XUD-F;[^ET3V6HKV+[YN2?.^[^:H$
MOVI0M+/]CH?(*[!72 J5)%($0VQPGD3&;'8Y>UU5#Q!5>F_P;2.*I9E%L*.:
M1HF)4N(BS20FZ9.V$<PLVDQ+T_=Z0$WOYNOMG\O=/3?D8;V;[^OPH^,5/S(B
M"Q^I)M)E3R23@E@K+>&)N:0$1__?O81\[^B[,>RSYB([04DTUA(9LR:^"HDD
M[ID+54Y).[!3MNB]'NO<3TKK>TT^]"R]O@/UM^6#KSH)696S(D2A2= 23+<0
M'#'":@+2RV $WEE_R5B,AXDXO2EW([3QG#*)FI(1H2)2@<4/OUDBO);&.,ZD
M5$^>BJ'Z"D.O^P[%]T1JW'EZ5M^U_)XQB$[FGPTL '0)LQKDBK&"N& K$D,5
M@PV@ :M0!J31TWZ>GA\\3'[0YSL]*&)=9[U0EBGE52"*"T&D38D891FQU%KM
M "X5SB"YAW#OW2 WA#R+5K@0.-&<12*S=,0SX4BRWCJA;+!"?*5\IWO,MOO1
M:(\I0ZAW+WQK_K).!A&1,1Y=("9C)BUSBOB0+='>5TE(KGRXOTE#O7OAKM!&
M>D&MJ1)1BCL02X830S,E7E(O.7<VY^K)4SOD9S1+?\1RZ?N2&G>>%M*[%^X9
M@]A()3$F5<DZ8H I$!F5(8:+BF3.@C%1<3 URD@TT8]$>RP<H8^W/SB"7<?;
MP=X'T@1:53%Y(J6EQ&K)2.5]$%45C0A?YF3HLVSN.>1=)2HCHR-:94%D\I9X
M7CD274K K$/V2GRE3(M^'%H_#NW^GG<_5^9A):H\RKDRWT8BC+I-@&S@.DE)
M!$ (RZLU<<YG0L'L3\(&*JS#)D!R6%6J'RIS#P?"/-!G],/0>J%U+X36G96^
M]D+K>D*K$\D(MN*T2B3)P(AT.-.9I42$#!( F"Q-"8R82@VE["=X/@)A<8U)
M:-^:W7!D-^]N][_-#MWGCG<SF\+I_7*^&.7CVV:XC%[I"/["_EH3UNF?OZ?#
M69JGR6(^6.RGP5%3X3EP=8EGT[LY8.OFP71=X3F(RQG^@_<<PJ*F<>M$Z_*:
ML'>7!_!MJ/]&UCZ:+%WML;CPZ!JDJE40H2\ZS*=_][._/3T7+,U!2+Y5X;R[
MTYW9FTE3M6CJW-BLAJYO<1X8QW)Q_BT GT!@G<C-?I@O#V!?QZ<;=]\1$C![
M D*=G[B'(N9X<-)IX-]@&$HJC?,^>>%-TEZQ"%:BQ2SW^J;]V;KI^5XB?I;<
M!^(R[/ '-SYRQ_,G?]N$,H#X!#1.'N2Y)Y/SUV(0-7Q )YC."F+^ !PNS>J&
M_']W]V4I@_T9*D3_<SF JB=/7Y<!D=,\^ EU*2#MO__-/3T+^-<93KE!D?4L
MRC-H<F-B)5F-K/RZ^'ZJ)WV-[W+K/*;W]PWF= LJYZ8FB4'0T0(#HO/M2?RI
M<+V]- DE468>QM/Y<I9>PQO_,9Z&#W>K8*J=5L$\V%%O7K\%I7#W8/?]V_=O
M/O_^?N< %,S7X_V=7_[S?N?9GMC]<^?HS<%S!LKB./WS]^.W?\9#SZ5^\WF\
MOWL 2B%_P_'NW5]VCM^^__#IY9_/C]["/2^?!?;F\S]&;U[_)[]\]N;SR^UW
M0;EDLW<DP($329,G+F9)5$H  ):SKE1M#(#$2'$;-7A&LU/"1T&%D3I*PT15
M"=!"JJR=MW!] JW]$""QF"U3W7F_@4.9_K !B=,2JDL?)Z15#:++W[^YWES!
M%50DIZR6'"Y1P5OXV\9*&\'RDR\>#_O5U8GRQ!]&"WA=N *M_1L$Y-[FG)N;
M3+\]BYE\(UYRMNQ\#6I.X^X?C "9!H=NMC@>+*:#CPZ4G^5\,$Y[;CRHK9CY
M<' XFP)>(,.$/Q#WPMB-#N:#O\QQ+!"PYJ/]4=@?H&XUF2X&HPFRA/C7^MI9
MVEN"<C*='9<_IZ!DS09[4]#()G66Q< MXZA!ZE')I&A.?SXH@SC@#3-X-V@?
MJ+G-YN6->(-?SF%O\_G6H+NCX":X"% $XR@LROW+\0)LY$5"G2\T2SY,M>HW
M7@'[C'W>8.UE4;!6>"_H$'-<^C@.#J<HPD9N/#X>S)?^?6I6V"X>8 "0;<\]
MN@/01>"7&4C1Y6&A_>$@XZ:'G07!5MP8\\_J@WB6$)YX,>[S7XA](0T'/Q5U
M;5[FF.S@V2"X_I\[./RQ^1.,R%=I]A$N!LC^O_\QG-,??]IY57YC/P(TX<;Z
MA3F!),?-3]":Q8--$WAL*&DSIPZN85%P$@C 25S"GE'\XB;A(2= 7C194-GA
M)#H'@XM@U8]KF*<5<N3E K -?G4+?,5PD$9ED4!IF':S+&<]G;67N[T]6!R\
M8CC8![, L!\Q8S;"[40 +( ,[$"$RW1RX0H*( !6>&>K5".DYH!M<SSY*9@2
MKH$DGLEX]-_E"+9]O/5(V<H4P0H',&_Y W"3.=(8D!T>R%FGV3VD+B$<N!'0
M%W 2),H,SZR1Y<"-#XMW)20X3^='0+['-<,!4*1RSH!O!3O/^CY,:TL0[4,P
M__> :0TFI?$/+C". /(SQ&%XZ=[,'<QKM$)*B0DY!GZW/,0!.$M@>!E6,@62
M<K6Y69/"$2!?VMC+:+5-. M<(5Q24+3PMM4!E-<<[4\+OAY-@ 8 :_&S^A*D
MB=6:WT_A> 8?83F ^UN#P<_3V9G'N_FX<\XZ+&>XZ7'WU,\ZLJ+ P\N!A7I
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MZ]768!O@-9ND->M_F?.HXYEY5AHPA*),X"[^A5S[&-A ^H#XNI)_T["L51#
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MZ_468[#-/4J?#E.)E<%EX]IT_9B BW?:*+C.&!U<1EC3]E9;\_+ZO->OUGN
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MY]#[L[O^;'D[#7ULW]#GN_."WYT9MSN=D%^VMW\=[-05B(]43?SS#!\:=E>
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MN3%,+=O=':2DUY^6._N)>N+2B=>0QQS;HU6D*G_.OHJZ;A[_MGJA]>E[K&1
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MY< _HRS*LXMAP),E7&H^N16>G8<[_TK2[S 3[=?PL>+108=A]QQGAY'<3!.
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MC>M8%>-W73'*X<KU/:;K3:LY*PRL3G+)<SQF> 9Q26DNN:;# K?]>@$):<6
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MK=G<U5ZTKL'\8,]4T&IDN2 $7S2"#==CAK5G@GQ","'X[),V?9W9^I[1,ZU
M<,=C ;J4',EDIFXQIW&"[%;"\<)X:S#+!OZZ>Q;/(]XJS%L3MA";^8V3*K>2
MM[2-J ['QHD36XE#8BHQE9AZQ&R8SPUW:X-#]VOTXW#NW"TG$#L>"TIR7%M
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MM<YF_4D$7Z_VGRC+9D)5 :##IA4/^X_:A.=YL2KD?+<BO1"XAG("MQD>WB=
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MH3,=$[ (6"_>NE[OT G8"%@$+-@)26(1L(YRV;)WZ)RGA"O"E5"Q#IT-N@O
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MIQF_+G^Y&4;9=!(^7D>QF)YXZ6:Q=^3\D@P0,Y>/"U $0<\V',1%X68I/EQ
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M:J\F29:]UD9I<E<JJTF\<HJ_;=Y4T[K=-:T-QV0Z564G!+<6P0Z&4BM9E)T
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M]SR>/>L6W//.H96SE0VC=^AD(EUP&IS7']4)8 4'.)$@8!&P5A//] Z=_I.
M1< "8%F]/4O7$[ (6$]&;O;<PV4;)$P1I@X4I=8]8%W M=FY-2LKC6TKZ;#3
M(FEM.B&G=YY40F='^H'"[KN-#M=MK-(1/"X''EY@]<Z3TX_PT09\F(9!\N,P
M^'B>#J8<L?:-7[SHY10XC2,4.[*:+NJ0;4M>GR9&>_LP;C=6* Z3-.KL$#^#
M2Z=]Z'"LWIZ5<P@>%P /TV[NSB!\7 X^#,/<]XX'X>.0RI=RQ%+@/E7[EI-K
M[QM)T/;5M' GZK2C$1>7_GW8_ZU<+RJGLWIYZTPWM6!]:D4&;4U";O7G7TF.
M=[)B -9H-NEMG%31L6WV/+S[-$VR" ]^KE,^"?/HGM^4%R#$Y8C:B\6%*7W^
M2MC/DLDLW_S*2C#KF>AG&8ODJ/_$X4;#O[^(S$%HAZZI>ZXQLG7;#_M]WK?Z
M/G?[CC%T1_\V3/M%^=8XG0?PWO*K?LK#[U?A"*9X'4X>PL?LQ9O%BX)1?+5$
M^66B;23-:'2LI21ESI /$GGZ=PVRBJ?8"H84JC(4;9SRT=]?_&T[A[P7;[^)
MBX')2'L/'P3,93^_"=^NXW[[;G&NQ&2;\@;'[0Q6;I(^:M*)DFU<^BV9Y_HU
M_&F6:N_B>!9.M"]\FJ2YEL3:[TEZ)\6?H5_]W^HJZB,/T^(^Z:]\P._Z/"WN
ME!KR3BG31M$$GCY$^5B\\?6W]Z(_WD]G(9#2=.8W5N,\C.),"[4AA]_PM6&4
M#699AC=F &GX?BJY@"?H\-]AKH6C$1_ &&'4_5D6B8M'4:Q]#M-<#N5#)=%_
M*9^7?_@OO)X4BQNW7^;]]K3%"[N1&-+"2#(\T"]&=)>D>+WV-HY&H$1 5V,>
M3O+Q($RKT2)FREN^8M#C\)X7(X=9XMA'41S&@PB(7K_["Q/!3\"?HF28:>(Z
M%;S0?X0_P[#2@C^IAA^;1-_YY!$O_-9HLKY?K(DX?P*4'XJ-IOS>:);/4B[I
M$,7B+?&XSX$D6C9.9A,8!$XO'.([T,%_9O% M*DX+>BR@9-U+A9\YZ(G'/(B
MUC9OL*JO,M'C-=[RB@8[R)>/?!@)T'SAT5U_EF8<@=G:V6^]$5_-=YHFMVEX
M!Z HYIW5EQ \O8]@AY+WW^%[]]$ +\//TCC*QO*">]55G\<<5F$4IA'/F/8P
MC@9CL39NX4$:3F!YP#+($':@36BN(U9",H'^&8 VR3B\DX@W!N,TB=$J@'<
MO+C;#9EH+MME,UAD*<H'$=@#0A"(B)VF/(8U!:_P,"O64#E#6+*W0N24:QCD
M82*6X%<^F*51_JB]PW4[THR@&!L*GR$H-5&6BZ4_32/,&P"#*CKXXX^OHN'[
MCU][ !UQ<::8;B[670JB )J+4>;KZ3Y->89JXU +I_#7'_")'$6):?V$@\%%
M65S):9:$ ,=E.AO[V+I[7,S:_YT/$9[:'P+WVGMDS^>"/>_GZ2&^\&P*V.5E
M4H?WG_[YX=<K(X#=#J9U%PU:2Z^G-9)8^S.,A;HPURL0]Z#%3D22BU";SOI
MZD)P:" Z4U@#@T=-:+<@-N3F9 &MBFW[LWRAH/A7*5=P^3'--K7_[GWMO>\)
M&]"[T4S;@[4O+J9M8$ RRX5I4NZ@_QU'N)R^YK"0"H4"!PS+/(4=$28"4H(_
MH/1"\;!A[+!Y\A36OMQ\<=4$^M4P?*ST 2[V>; E4:5Z!Z)AHIEN2: _9Y-*
MO8+__#3($UA@L*:K!@5-3:-<KT471GW]RFZ*)=W3@!<?PQ2DJE'U\QFH$B%*
MM&_I[&Y:<46NY5"3XP=T5S.33X:S53I."R 7@G:9:N$,A"]F39$/'T*8>XKZ
MSUTR%.I77B@8 YZB4@%D_I\92$#<2;,""W49R(K?HJ&4H>-H,@3."/W0N\E*
M='R(LUDJ%*=R4;[")J9^\_Z/#Y_%K\;-:^!CFLU0 X19E8@S#,LI(;=&UO<
M*7)0*.CE[/)'AM(<1'\V$]B.9R@:L9?^)(R_\[R8>*%,\A^@6?$2/DN;)NZ9
ML^ET$HD=%/> ;,H'2*N:_)_3:%GW7?J@V%(G0B^5V&/:'> QNIN&A;X)6)A-
M@-8H\JM8U^O]Y5+APKO"<_1KR]TNJ:X,_VR"*JHVK--_?9%2AMGS+*3#A[BX
M9 ^<6<A , H'^!^@)U5@_O#E]ZP$,]/@OV#%1'DFY<"XR%B0B?\2#U!;F#R*
MG$8)F@.P[$'#'T4(V@S?AU?!(D* 3F9#0*4<B=1H<I2/63(I3!8I6:MT17,A
M6.DMH(H-"J.A7%#%N%T=)>) 3'(VX<44H 5T.@;E+I,?&'"4E-/P41A\(4X$
M!]E;37O4472J \^@%[A(AW\D\!?<Y*38FF.LA.0_OKW_H\*DT,OY#WXWS>>P
MN(5M-\>+$J F79F.V!_!NDY1%9_P^!9$(AKL>?A8%W1B-P7='JS/+"_L: 1R
MN;,*P1K%$K>+.]2&S5J^V:LR>V2P!?#OV"?.H5H;Q1:U9EF(,6;/GMC#&.P$
MJ584_3Z$M14'TT93? PXEK;3'0?QCLUAWX65G95K:]N$GZ&;MVS5J+-LO)X1
M("$J$X[_$ J3U(;RQRD7[%O2!$9<^%T0DFC<(O0*ZUD#*X\7K2O+&C!1 A\7
MR*)5S(%'$3I^4>)'\+@:2F'41>G")ZMN4;% %0<5BVS+"!^X^#._CY)9!ML#
MT*3VV7+LN V)(>"7JV&LF1$KYB/6]_@Q$SF*,,%(. 6K&AXG@\%L6BJI]0>@
M*G%0=4$'NIWALH-&L)\DM_*I<!U@<_A]S0:S;5@7LX#N%5H_4BFJV/* ^(F3
MO)2@:,==)2,PWT'T%F")8,S(ZCB)K^9_F::@\0JGJ=##A?X#8A*+=P]+(U#V
M4@GD1VVNFB,6JQ4'+>)Y@WHO82P )GL"/,[Z_T''+GRN-' JWZW4R^0G 7F3
M!%$N^YH)3W1-R;\0Y*D#/,QR)X 7QH^;;-)2^:FS%(3Y-,3@A$C*I[G=F7Q>
M5(N$@3;4AC/ADEQ4H:5J@JBY10$UU[*$BWXTX3\B81@\"N"BVH%]U&QRJ;9?
M#&Q4VO"EP)HKE;A[2\,:-Y4[T%O1+R+T '&X@NM>8@</8D"<"06OQ$3I%[CJ
MARAA@-+(]05 @NQ8ZSPICZ+*#93']U&:R,,S0*/8[N;(6H?#0@4HG#;0*JG4
M@>H]E&PR0KT4H+-2(P7-8C!+4Y$>=W$:0XZ+1(QD/OU2M2VUX)AS4&Y!%<:V
MI9*[)"XK[],4MOS+@;LZ>+<+NU#Z#H3Q)_6L$I)R.YR[MX;14.S?R%WA=IOU
MP=#1_F<6"GDV#/-PX8 (45IZ0H6;$^1;/DZ3V>U8G&!H93)D@<3D;@KJ9W6B
M6?9:,Q>E"^V"1*-"8#$+:VC5N5YLAO"A@10&\UUVKL%E?#*Z2OF(IWCR,@D?
MM%='GMG&0Z%-WD1^1EJ_>,OP^"+]CJ1Y+19.N0@K0Q/VAEE<.'G%,JW(&<)/
MD.)RZY!Q&D()G8A#20Q1J#L8TFE2'I5^&HWP'*:0SQ]B]%;G\.W_D@>XE0+T
MZ<-_5?J/T.+%?L)_\'00@;W*,6IA(#TBZ.\ 8. 8X<,H+:([_&!UL)J*>+RU
M<!D5!W,A[)17WZ/!=XPUE?M2+J7)':ITA<VW%*'!YP0L'>@4+K@0+FAN#A>D
MP#\*_%/C^!G/XJ2VBL$18F.I'^Z59W$H#!R[4"FK8\520]!>S9U0*!E^1;D3
MR6"/][!:[_I1R+3/,Q"QB?8E&B0U_Q(H^FD:@12,>/:::8Y1T_RKL+)D_DT8
M")Y+%D-!758+03P-A8ABF@LV7B@M3+0VUW2PX47A8*BF;BQ.W3"7IPZJ- C3
MO-@>@!#HNT!7]#!%?U]!B*U^9G$6*D0\&,9XT)S.CS +6P(-%9[EA?-\KAV*
M 9>GGSWM7UP&WDDE47C#8RY/CS&$;U.G:$F$W[D&>B4/,^A*S!</.Z4AELAC
MUFKO0P.C] H):WK5E):T?.#B]+306:4K<2D$KYL!'9]K!^4" PE8DB'8DV#L
M?4ZY*%PB C612E70RU?DI-C2@<CO<"U.TZBP]D3<1A'2\0_8;@W#O3(PU '!
M,PZS4B5<YY M';8+YNY:1TJ62%UF(<Q,^.E0 0%65Z<G@V06Y[ \7Z&Z@?37
MTIG4BZ#1:V'%E_[B+1YKB8<(C>L[?-+GP&6\?( Q'S(4HPCYZ"U$#0RK%5X%
M"R3H"4*H";SCN9)FN'J]:?T0H,]K07:HSU3C9-)NG^O2<HTD,<JH^7%6V1>0
M-,%P,@GZT6PR$E[[<, !K%?X[XJG >V_CF+_0UP1O( _:J(27Z'4/YE<%.^^
M_/95Q /B 1Z/0QDK7#+=]$JN?Z@<(MD:MK-Y7"62EVFP'8DS^&IW&<UB>42.
M)Y19OB&0I+8@MHOLK[7XZ/D\1&?9/'1[*71D'B]2'D!1W,C9XD9>@MHLCM>*
ML/!P4=Z6(9R+472(J2K(J5C]OU72\_>9C.\ P3)#MQWV,14QH>A+8?@[2'[Q
MJ[0E141($5Y284[($+'=2E3C\\(FK$X)UR-8>"AK3TIKE/^8XH%+)OV (AQ
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M+4(<8R8K29VLL!.=G\2I'HH?H%95.+7VY>V=F,Y/G70>O7C[6P49L:P63F"
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M)G-6RE$I?]I$IRQV5H<KY0G-8KL S%C:]?OX /E(>G\9RL%MI[@I-3D%&V0
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M\=WRR4Z>@IWH.BDZ2?\L19[T8I[*BIJ3Y4<Z+"\79GM!L]H)%]Q4XNNDYGW
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M&:.^V*S8K*EHA98]X#NJ93I0?K_<PBU+#_HX1T6.SR19G0#P (+>EC[!<_-
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M+ONJ>.?5!J5F:<>D9AUI_K??PF^.$3\PY:'9_%1V07+-(3ES)(_ZH@RIWHK
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M(K5VR#E#*EPKB5HU2JM'-2;J5J)(*V]DU!A%[9<[G4\9[6HSNQ<RXIK:!D>
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M$4F,?^!OV:"Y>V\-1_D%Q(PSM6 #%MPM]A(3 8A;T-_E.[0^;-#Q*3> C.P
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MDSE+[D@/L0"BC:99A#P9$OO&K9C1@UOSIZR1&6N#1_!Y7(/QQ[)06! #X\9
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M6P2+1=N^V0'(J,G1>G8]%:P;*Z!)64])5^![N#L^L;OC-KX[I$S9PMY'E(*
M4K7+0NJ SX)@P>K X-HB<Y8GJ$D3!-J, 2T57,5DN;BU!M:3?>=I<^E/J3+,
M<7D/_.2;HI>5D<<M[)Z.[PVL8H/K>K&P5H']/OK#!]C^:F$]OW=<.B_]Z$-V
M=923<,/2M<LO$D()^YJ+T-&H-S1UE**A#_].HQ=S =LC ?LNG&Y_UP>4#D<[
MOU9Z:L7O3%VK],M]F\62;4UOTF:-0LN^(ZPQS&'U)5#=WU[IKY+[=8H5EN^U
MU0])S:I""WNV11Z,,D[-I9LWV);P4I)4[9AQ^,'WG$G!$[W*>714Y/A,I:H3
M ';*X0Q,!,+W/<K%)0I3>%:B.+84G:11U)"Y>X\\<'' 1;?YUE([W],XJ*J"
MG0K+S_:PTQN'CZ8.Y]X:UID&;\O0P=B:_/GH>V!67?$-3R:V#09=20)9.M/I
MPGYI$&QIP4IL'3!%-Z[X&#_GZKM%!,\AB&R25QE(*E*M&"X?GJ\WH53JA.F3
M^;AJG8[6'_9E933,%RDE64(J>5Q!<]VD.;VORXK6OQS-E;X"9O1/0Z\ &B)'
MB1+;CHU*XG\#&CNU"ZT<1'/9LG;$^V:HR&9?>UN8;O-IYT5E9<<1-)0UP[P(
M@KJE6T:")<\O^A)Z92&Z+7K?UX]N#5V5^T.U..'63PMK.X:&LFZ,+H*@#J@L
M/%4FSFN@< W&7>@/6"CRW5JP4.5EE9;"OI)FD+4ZT.6A:994Q\O"HD$Z3\OP
MJVE]V="UFN*W*RI3GB##IBIC^]%QJ6,+SK. ];VIT)U*>Q1T4QX.RY*XT)_.
MBR5S,)"5OBK\/I>2-39\?IR4.7#+%KQ->.Q1!S1.O37FP!P,/A:Z>IOKPST]
M?.HM"921/- '1ZDD)P#2A752P2V"6XH 9JCHLC'2F\HM=.N^H[3%LEFX1LVK
M>[[D1-23D/MKO:]GV[VD,U"K]Y@?]K/3)BNMJI1OQ/NT=XC'I'C2P6:S33:]
MCYY9P6]_.$LKQ#$EKW5UT%.V&A-:T^\6[2 >_Y=,_;L&=7'!N[NS;IKTK/25
M/8I3 1]]:TD5.4_V8D%;R;X4^Z&96R_->5?>A,&24(WK;=GT0@!I:O#%:]W<
M[.Y79B/?[!F;BO'9"VU)-:ESDZI^D&ZNO]W> Z3B1J<N/! D'221L=CTCE1[
M&.[DQSY6(7P050GQ*89SV[=YP]JHNLEQJ5XHI"KA=A;W87?-J?4<4#>% (N<
M 38N#3K!NC?38-^"YITS1R#-TV8_?O(CT *.$^%/J^DVP?O>9>Y^EY(5(*:Z
M]3*)O0>'6NY[#Q A</AZ$JZQJG7,YMZLO*B<'FNYXA$,F+[.QZ=,GB<+/H8E
M.\JAR2-3#I0A;(?:6;CL]3#=JZ[RE<"J ./"2EP[B%?C4\O[/2-3^,FGZ[ '
M0>*!8.8U,_$T'3;$5-N<A<(R!^+"0&HGB1,;6'T;K9=T66);HXT \;"3T8Z\
MV2P@%S]K70QW VP"C/MI:GPKU65D^I/ DJP%\^M1TC&B)^V#<+J=Y1'7XV$(
M;\*I#(0'-8,POC+5*HL*];6$@II;NKZ_,T9.Z)J3D3',EO:^&*-JHXT*[:D3
ML#)>0CU52T^SM+6GKA?)2^UGA_@!MD ]<%,*4XC#5)9+'#P1>I,_Y]YB2A.L
M]L%#3Q/M*?DJ@0?6O>NY,Y2BXV_,I^.CM^;.*@4#5M7(2\?_#D;12OH5#DC-
MY;["+5BVD%Q)>F\R4.BC[)AG!@F^4QS+9H6>C\QG<X"3HF7[2VGA ;&F-+=[
M&R])";1H.)(TLR9XASKGNQC%^.;+%EQKHL->';9RYM)I,\M(YN4OR=+EQ]6*
MK!MT\!WMC3S_3[PX)@P -9AX@U<3]GC%+B!/V=WQ[D;I"3>YINAF<U?33"G0
M>TS2S48DFZ_?F#N<V_EE9Y(/?1CU>0LBJW+!S4Q42S9:C,6Z3:SJEO8*Q6U>
M:N]0Z0J_[=:/).F2O/?%936[6L1!?*.D3+"V>9YTC?-FB;X^>SW)C @U>R;K
MT;=M-M,)NXG).*@!DT$(Y>$<E58Y/;0*%K >X3>/Z()!'=[A9J/UW7(6=#5M
MJ9>^_=U;D'^50Y W/@+AH*0<U.1<3G^2F=R+]F"Z>WFP'B^<)6*%*[Y.$*RC
M]D#D,P+[<V&'-& (E60Z[V[*K;.9>)TO-CEX4?RF_61CS_>I^T0139^$@L-<
M&=1U6\998HGG!ALQ)9;#&_M'A)"URT=Z8-,JWP$>QY9+@ /6\,);)T)T'";(
MH9',S+PW$X?*6^D-;I+W]N=[C=_+6]F_[46GF#I3E'%L]+/E/J>/G(9$ 4KL
M28>!^]H<&5F?#B=V1LM%Z)T49^F111E8B[ZH(;^1:>"5VGT)XJV[$Z2DV$W,
MY_I+WF2O=^ZD1T0+K$"CR)'004@]\CDB"9W$O[GZQ]=/<!/[00BJA>UN"66F
MY!1^/(E\H5!,2V=B."4M;7?M9IMXHT:3J$^A?P_H%M2 -3K\7.F3Y<-73"?3
M.D.@]^BU H4L=@MQ#:X."GGD:R+M</ !9*/E3YD;#E33T .),L>HXSJ<@]QF
M+;O3SCAL*!H=:\45T]!+?[I>,=F%])2-#X(*CG/JX0*>@SY/9.?0Q)ED^<@!
MQQ;&G8QM&T="A<S]!?>&L\C7^576!XGB0+Z]M*BH,)*F['= SZ VK%WJ#1AI
MKO':P!2V!28W$G["IZ G(!MLPPGNFPV )$Q,4R+8&9867$#H>)O:J;Z%+DY.
M_!/8A=03WUL_SM$:^<ZBO*[]Z(5LLAXPGAM8%*KBC9[ Y@F),/ O#JHZP&)P
MV[(K-4B\B5-@>QX_AJ5AM5[RW0QV&F0W2OV.F=_>!<B[S!C9IR[DW9?)V_DM
MG*(,CO:4>Q..;MN'O=3W#BH'?!21O8H:7(8I4HF F'=9QWM">DKV,Y7TH6P.
M%7FD#*.] 7 MTD+H'M^(]YO]Y)Z7$7.O1SW-H#'O]/-(%'([*4@CCZDVG1&!
M<=N[.L@\]C]JS;[VDZ%SQ/BQ5>PL5X"I) *U/5#58U9^:O87KK*(&_Q-;>#K
M*<XH!?:B&W!J?[<7WHI'->9 7!/+1:8 @6!-)K@9I*P57M03/L>4>!(9_(,T
M]YY@ 9^R,,9HZW^W:0<43'"I8^VC[7+/02K@D>%;='@ =Q;41$EZ6MB?3EJ3
MCX Y NS-DX/< 5*=LQ@%W!0L=+A XQ!E)PW'!<#N&?NSV[>"VLA02;?@)V&4
M5JKQD:S:+=3LHUNCXTW%R-]9LJE&^/_ MO]D-WSHH%+GIZ)=;/9Y#"NRY2)!
M3&A-;D9XY!U>L#_@[^ZCS:)R?+Y28 ,KQ T.,]=CO(!<Y'JDB]S'2#.AS&>.
MBB<G@*OO?LVZH2>1RM1NX+TX;02467Y=X_T8Q:.3)+$4CT6+2]S'G.@>3 R@
M% "^1J+%7_+CH+?-X9ME'L-(>/@("Y\YVF0VA,_"5!;493#@.DDD#GLO4#73
M0E"N1=>_XR+1P\9CK0.(UTFY@AM'M"7OG=]9$'8K!%"':V@GBP%-HF/$6ZU
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MG,B=?5C+/OQE$GI8L*_U\Q_7LX]'@[[IX1%M._N\D7T^:A8FJ0K_R1O'G7#
MLK/XV'_6IB;LGG3+*%Y"X1.U2+WA@Z0W&BT.K_Y;EF;.@HW&(4KA8]3?]G(4
MX].WG;F<:-;50J+YY=J-"!G[8C(VL)=7?5U!.E:5?_^P?^@JEY$WB(-9:GC2
MS=RQ9\ RT9BD+WP,4CK4<\^Z%4=-T[2(J>XM'^2,'5Q]^;&PGZ.9*9JB:!U@
M'DTP3V>81]O!/ G;_)-:$OEV0%.*V+5-G)7,C!*<58BS-'$M=8>SM)+7$E-]
MCV8[=2C]WKOOW?2R#*CJID)*\M1;H6*YDU-'2E]PJJJHO;O/]V=CUBB!IS8
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M+5YIKK0F6XK1T!2@Z S+9B=@&GC\98N7^9[][W%ED&MI:+]?G89T<TY#KIV
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MP768SC'_%)9SBC-6SQ+%%%7JF%]@F:;I>N)$CL9B 98I-E 9-434&7)R0;C
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MNUHZ"TZ% K)VC7*E.-VI\_K>4,=U]\+8&+>W,A^$<S\O3I>3Z 3E%L5!2"R
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M1FF9I6XS\6] Z;KB;1YXO2,;YU*A2X:16R!H=)KF#J<?)22!P=/$\FU.DG>
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M9R57TL @F^(N=-\4F7I7UTU*=;XP^W;"/XF+Y1S2<@3(94DFL62J6U'Q1A(
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MN57GE+F#[+-JL]P? ?*;=J1:*7-8WNV<<X? ;>I '0GX/,Y3,P(<3K3>M-?
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M#.!+[1.85;O&'?<YQMJ "<?(NK%1<>7U:\<-.N59PMJ#0=8;MVG!8UYYS1T
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MWUV/>G,BT53W^\3F^7W]0MVZX+=2KV?K@B*?U.?UPOA::;[X3^WEO==?X%G
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M$G(B4RICV\7^)8I,S2]9VP)H^X84K35 VR$=FJ%=-#KGU_AC83XPI6[@;NT
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M9P(29MI]::\!XA!12)%@J<1)))C3YLA)25.;]FM%38X7J%5UF_&G(;6;]UZ
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M+QM0.QH;<9@&YKK.ZEB_-47-M%57X'IOO$[L(?DL^. %8\]5(2[3:>32$5X
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M(.V:]:ZXYO]<Y:5\LZKRA8EFJ.J$NQM:/;1_$3.&PC2FC,.0F^!/@F/(,A)
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MR'%B]8VT =UY(\.Q^ND)!"/,9(14!"4+I"EK32&)31R1($D2<!$)%3@5HO6
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MD;%CO@'Q'ICZ=J&N50<O= <?6JB-^C]MNGYI&[Q6Z^H#GN\27DXZC%W7JP]
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M5:2EG_BI,?964T!;5>UII@?ZYPE\6$P'9O.U\L!H#W[<Z@\^J9_ #MAK&ZY
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MAAAQ3)A!G^\ZZL ?A?\\6_SU>?/T-*O&$XK9V^E*S1:KC?N>G!Q\*FQ09IB
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MN1[WJNT4[&_-G(377K"(4,V@2S!$Z.:D]=,=V!L%ME:!8[-\$/NE86!G6>)
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MS-9V%<.X?8"UZ9G)CY=EJR;8&P&.K+CS'39VGZC/!( W"%06I<SSZX9IV@S
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MP6%9^B$9G C(,;4P9S+C&2.9LC1TSN0U(6-[<>[TC,Y';T2RF?U2X=,SHUV
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MN4-'E>:^44/X!.AF+ /=H*X(]>T%;8S?=>TU=,]VK6-")Z@)@K0^T$5)P[I
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MFFD0.#"QW#;]G$H"KDF1.G.4X_%E<3E^.6$YPB;/!*0T4Q ;*J H-(&4X:S
M6#EO*6J>3[0&8Z.97\UJ]6_@."/C)%5F?G*D,6UYI!&]5('G''TN0-^''^?)
M&2?@7SD>Z2LY(P*^'M,S0K1XQ02-")":4S1B;M2.'W^;SA?+Z?K'[G9OIRLU
M6ZPVRZ,I6:Q$7.1(P2(C)<269)!K+F#)"3):"J)$%",&R!P;!WXRVIC'ZIGS
M![@/W0]P0X /X[?$<+[2<>Y!:_!G+U/'(F!*REPA<@?EJ@@@3MDIYM*V51#/
MB]FS^V8\+(V>KG\6JFHRM$UL8)9)+@F&F9+.-V.ZA,QD'+(BRUFF*>-QN[U&
M:>/CH*VRP&[UC*U_:((VC&N2 =8SRQRPJA4%.TU[2!L)PB1Q9423Q('K(P*,
M/Z^2"+FHY1C7Z=?YU$Z5F*_OE5ILYKZ@NYK$.S6K8Y_&8J.S'!;,^*'-4D+!
M3.%'NA-K-#>%B"HI#1,[-DHYJ IVND8.7@U#.XQ<TF/8,\L<*0PN0-F3(Q,'
M4]IIJ6&BAQV.&@7'V2S4N*M;SJ<1T^7?Q6QCWCB.$]Y=\B'SGY?FOS=FKG[<
M?Y^N)D)E969*!@DI'2$I*_W@TP(2FA>(LXQD+*I=28#,L;'1D9Y@KRCXTZL:
M&<\. 3R,DQ+#V#,AM4(P?OA,."9II\X$R!UVW$PX$&=S9B(N;1WY]CV!/BX7
MSU-M])L??ZR,?C_?-[DY]+B96&%*(IWWHR3-(2;([:@HIS"7#$LJI9)81M:+
M!HJ.HJ !2D5]O%55G92VN@/Y RSV?8'$[;Y 7=<B.*;= \(#!+.K-E4?C\#]
MR6L.IO._]=Q^*1ZQU/'K4/%#!ZXC8;D0L8Z]0SM"^]7=I&XMYQ,,-JOJ+6XT
M4S03"I92..J27$"!&?.Y2X;8HB Y5S%NTR4A8_.3#CJ"6LE6/M)%.,/8IRM(
M/?-,-#[19-($0%+:N"AH4()H,O64"AH_VW'K5$\1N9_KHZE\6\])?YA_\KTV
MEIYMYOKWQ7RY^]77,:^^^'.;"989Y5ICJ+0J(.;80N8V5K"@RBB5(Z/"9FHG
MUVQL].(- Y5EOO_K5MTJ??A8?_!GI7S;C5GGY8S<O@VY2#W36Z+U:;_M2X5E
M/YO#SMJ]SA8R%:A7-YK)!*3(1Z^?86E,AMS>$R),'"4C+2%G"L'<:L$,RG26
M=4@\'R6Y?E;?C-[,JN3RJBOW>M^5^Z#YJAVY7H(XC"8[ M=WF#T-9AU3Q_NC
MKDMR7C$9O)%.FC[:<EOGVX8_+%;US0YG1H@QFILRAP3[L9.Y5I!GAL),XY(C
MS0UF42=T5^2,F2!F56]^M8CMXWT-TL#=77>@^M[@U>/!O([;IQ[T<M)V XFT
M.[TKLH;=[#4;?+;?N_'Q.$+09CIY-U]/US^^B._OM:.7ZF#.;R=_WU0Y*IF0
MA=:20RY0!K'F!(H2(XAH3ATU8%NBH'+CFY+&1@JULL!I"UZJ"VI]P^CA-L#-
M!)$4MIXIHC5BP201C,8%FE@9]:]?%\__R]VC9@CW0T4,%27<OO,@I!!LX(X6
MPB]HF=JSD:OJ?&S][MG]\>MT;MZOS>-JDA.*N,PQI#DK(3:*0ZEM 1D2);*V
MR%".HI)YK@@:&RT<] 25HN!/KRJH=(W<.US%-LQG2(%8W[N(5F#%9^?<0")M
M/LXU8<-FX-PP^2SGYM;GV]'#.[&<3^=?5Q_-LIHB6/6PO)>KJJ!LHAAW;* M
M9-KX1AK2^$8:#&J#''E@BHHLJE5)H[2Q$46E''CW\7,<*30C&L8,R7#JVV'8
MZNF+T.NYH-LVM^#/G;8)62((E:14T2QQ4+X(,OZ4-,(N:L<<_VFF7[^MC;Y_
M-DOQU=3.R@=;SR+]L%FOUF*NM\%0-:'&[4*0S&!)!8&X1#YU&)=0,>S^GA=8
M&137KCM*?LPS,TPSNIWZ0-3ZGW3I7AP,N*L;=K<?4QRW4F$,U1OZ/3/6'O:M
MXMN=337\H4;^PS'RB7MVMT(M*:/%:3 HP[4"YY3QVMTDC>^TF^Q$,;%291(J
MCGTQO.!0:*FAR"62UA1(DJA#\RMRQN8O;=6J>$HO9C.Q7/G^/S5G15+6-6@S
MB24JC86(</<:(>XGD7$&D<YS3MP_&,KC7B,)P!WFA;&#U^Q\KCVVO2+>SF$=
MWS"R2ZYJ\F%C-V#HU3=]E<%A-PR^Y8^F&0+VV7SUYVK;SCLT8\1:[F=]^7)7
M6I104(:A^X8@8RW&E$:=C[^X^]@X=ZO<JF4+HY?(!4:MVN+1=Z@J&(KX\-0E
MD]/&I%Y(&#80=<FXL^C3Q0_%]RD_GGJ]JX=_]_W)S%=F'R(11&!+)(6:9A9B
MX?[@RB@H46&E(0ACPX*&G83)&]LCO6_NX#:#]5GV[)![%-Y8.P3IY@>^!_QZ
MIH"MMF![U+U'<JMQ2%"J%8[A'<H3XSE0B_(;N*9I31X!34-O\I"[#-:</,*D
MX^[D,9=U'YOJD\.^F.6C/U%PO];=!2;"4%W:O( YEQABA7+(N<ZA$8P+P@I5
MY#2NA?9-F4%?_$$;:1\/4%V>-A*)KF>[#7J8 Y8&R-<8KWK(0ZST]7]5:]S/
MK-5&<'J;NGI9ZJO-7VT$H6D2:_.%[7CGN%7W!UOSG.]HLEA52=:^,Y+O)K":
M4&Q%84D!)27<^8"Y@(PJ 8W25I<YSRV)RF,,%3PV9_!8[WUK;;W5]@X\+<WC
M=/-8U3%,5ZM-]9;VJ8^1U!2\+F$,U0?:/1/5*=!UHO0.TDKS"N6][NDH*Q:M
MI,P5+'Q0 HN%Y)3'HJ]/WB?WT/OP2AM6K;.,"49A;HR!F)822E)8: A5!MF2
M"!,WSJ^]+F,CO8:NN<M#2\G^&^C>7,,P-AQH97HFR-M-=5^V^WRU_KJAF [5
M:?>F/F/IN1L*7$3WW>!;QD<2/RX7RAB]^MF9^*O;#<X^F_5Z5C6$6=TKM=SX
M?@K;Y[20N15EAB$I<\>UI="0E6X=C<YSYTDJ5F9!![*1<L?&JUOU]DP9'@2+
M ?MV4+$G"'LFP)W6P*L-*KW!D>)W8 ?O3;;K!&]XK+$GF >*.::#.RH*V0*T
MAFADS-T&BTJV,/$X.MGF\G;N=?U6^2*^F]5',=7N/3,ADLLBUQHZ'UE!G!<(
M<F$I+#G.E#1,(!'5N>9<Q-A(N^K]].1T W:Q!&NO:9R#>P'%,+^U&S8]L_'6
M%:VT UZ].S]L(YV#>=WXI'[C!3&#NH/7S3SU\AH^F:0PZ:CQ+1:,*X,I)"+W
MP3]?=8"PA45I_.A.1@V*RI^[*FELS_IIM4VG:J3X3L(I8.KYL3]%J+=VP;>P
MZ+,BZ=6: M\R^D9-4K+6O_L2Z?T).V=Y*?RT3<&LGV'@=G!2$><&6($+5EC?
M[J!57X.Q9H$<^CIV[F<067O4"9J>'_\7/0QZJ#"Z:GL_70M>IY+HJI%7.Q4D
MRCKXN#];?#OU;2_G>G4Z&V5BC<T+37/("NH>]$QCGW? '8H<NT>?R(*@N+R#
M *GCRSQX.UW5<32WQU[YX*H_>WIR=__FEJ0Z.$\4_@Y9DS#>2(7S0-&<H[2$
M#TL]G8OE#[!7_*[_"'8$7$G))T3NH'04 <0I0<5<VHZR'A:/3TOSS<Q7TV=3
M;X'<SN>#=?N@"2L--E)B:'E!(9;64U5A8"$R3')M&)8FI@%X@ZPH[V2 CM\O
M5+UV5O?9S(Q:@]^,GBHQ _^QF.FJ .-AL7Q:+*OP81Q7-2U&&$<E@KAG;GJ)
M[HM#MRK*X3G+:7QW=@+W42R;=HW1'!4 5U)N:I(W*"<%&'[*12&7M V#KMVW
M8^K6N.Y&Z6[[[KN:;?S3],MBH?^:SF831E7!C%2PS!2!F&H&&6<:,JR9EE8*
MG9&XP.AMH6/;,^VZYU2/PW1O !"5!7=@WA @;(\\UR:G4A)89(6&F%#LD]8$
MM(A+*1#22O"8UT!RY =X'WSQ,L#T-OY B>7R1]5Z]]%GX/2P'J'![;0H]Q[N
MWJ-YOT73OPA^VNL,=DI?+_ML$0,/QRAQ5#Q \,!Q\G HSB/G$=?&)T+4;M;6
MRSKRK;8C*DW)39$S!F4A$<0JIY KG$/-2LX1RS7C0>60MT6-[75PXG]&NYT!
MX#9S35K(^HZL7T7K]O3/6-C"<QC2P3=0VD(7&*,2%<*0:<A-N'&#P=(1P@PY
MSD (O"*>2O=!]RKR^<EW$OE@_UC5O/W'?&EF/O3G=EG5T"EA.,D4SB 5[BV&
M"TRA<*P*"6:2&8LT#ZM1B)8\-J+=ZP>V"H8311SBM^FV-QQ[9M_#<<_VB*-2
M'7ZPT"E?NWQW8#"<P_FY-[P'HNO$N$<Q>"OL&@@][GZ#\7LK,X_IOMT-DLY_
MW%>0',T<U(J:7)82,HR9+^"P;M]O,U@6Q/V-),K]DF#^XP718]O]7YS_^--F
M-Z+0[BQ(/0GRTJJ$[?[[P;KG=\2-29![Y8><!-F V!"3("^)'\,DR 98 B=!
M-MVA6]N5$P*]M\Y%O%?N;;NI>/2X=.[32[< 9S9' A40R=*74=@2<D,11(PR
M7!)>(!'4#3B91F-SA#^U=<_2K,]M]WAPU'NFQ)/&))><M\HN<&08.+;,#X-[
MU35KUSIFD+5[G>8R?:YAZWXTG?$.[%C37LZK]+3I#,NUKC?=;]QVWIXURZ5_
M_VZ3W8_&_OG"B4(4')6"PEQ([_,7&>2E>R%28:W&@IF<\KC9>XWRQO9^^]WG
MG&V6/LD Z*WJOB1EWZ'L1^SLO6:XPYSYA"#V_+K::0H.U2O@2-G$)2R!N"2>
MRM<L<^ )?4$ G$_K"[NL'<5\6'\S2Y]=6#]'+^:*5H<C(I.EHY$<2HL+B"6R
M4%!I(2H0X:R4!)51,S=N"1P;R53ZUNFM6ZJ)[G\8C'48P:1$L.\X<@7>0==C
M>DEX !6+3%*.N2ET4)()A>"498*OZU([ZW,&?9WNN__>N)?S;V;];>%H[=FL
MUE7>[$1GF4+(8&BUXA 7BD+N_T""<%H4VOTOCVNG'B0WYH$9IKEZK2B8S@_M
MU1<6;'P.^&HQF^IJ>[':R-543\4RFHC"5D-AS)&E!!)F'?-C9*#,M80%+K.,
M:9Q)9.)J']*MQJ#5#Z-8C;!W0_+O>\\OB)<M?#R=@2W:M=;@2.W4U=2!*/50
M8'U+\BO47 >"<;D,._3BMKO@Y?39;:Z?S;'GNW]537(D66:E@&XK["?**@-Y
ME@FH.1*VQ QI&=6<\8:\L3FH^_;'2\=#0(DG4%4*";6^>^&V/OD@16R-PRWL
M0[?$R1#M?4N\TW3OJOZX.W)@4VZ'@S!)O!UNECGP=C@(@//M<-AE\:=2ORR<
M<S?WC'6OGWWL;_5P_^G=YWNUGC!M2D$%AWDN'<4PPJ"P0D/A]N:XI'DNPD8H
M-8L9&[,<- 5BJRKXZ?>%8QE$ L?YW,!54L.+$B%H"B8@=K] 3G0&N<:BM$11
MC0+G)Z5#=A@/_P*V=Z!2UY^7)P'W]OE;&L!ZIN0CI.Y[0BK\U"L-8@,=9;5$
M+NI8ZC8@#6=-#1</=H!TVX#C4Z& 3[=L/[1>J'_X!L]&O]TLW1[SHWO/+?3?
MQ6QC/AE??:_<+K/ZU/U?8JE_7BRMF:XW[OLR*14IA;((6N0=8,0Q%)E/_\T8
MIWDFD,WVPQ&^1/0I:J]2BSW\EP%>:$<:UCMXOT5Q>_?EWAJP\N9$-CKJL'1A
M_G/?*S%028?7#]1F@-H.4!MR!RI3_,GY?B'J3U?FW($C@Q(V5>J.:MJV2QWT
M&;8Q4W?@SEHW);AEO,?_R7RKMQ#5B_@_%JLG]^-L=QK#,"UL(4O(,B4AMAA#
MYML],:,5+9DD7 8[_8V2QN;WOU06[+0-=[6:<;WMER9#JV=&NP)4P-%6)&3A
M#FHRZ ;R4=M#&.6F!L'2X*DV7S^8LQIDQK&_&G9!.Y?U9S%=5@3MYU?,%BM/
MQH<FCWF)B"E]'P)12)^;A*#$N8)9+A'E6<'+N)$YC=+&QJ!>V=JG\7[F-GE:
MS,#[N7N5;9I/,UI@'>9%)D.P9U8] N](TYXZ:P:!DM3-:Y8XJ",79/RIJQ9V
M44M*.4JZW,???Q/.SW/__5(-<=A_Z0TK::X8@9(J!;'"&G+'V1 IJT5N1(ZS
M(HI@PF6/C6ZV6D[K;:W=9C"WG-;:9BT"":@?A/NFHY<)X4?'0C^[!\"1^G\9
ML00[,QQ-5?UF^B&K> #34E>$_&&)+!Z8,UIK<8MV)/=WL:QZ$NUGJ<[73L3'
MY?11+'^\,7-CI\Y96/[8^OZ*<$PY05!C*2!&FD-!J2,[03@SA;521R5YQXD?
M&]7MM#^:^EOI?P>V%H C$^((+W)=PCBO/[1[IKTHH'O(Y6P'7%*ZBU1A4,9K
M!\\IZ;6\2\MIJZJ><OA1_/ R'[8I) ;E.=<&P5*7"&+!W4:1Y!12FUN9$\VL
MBIH\>%G,V'ALIR5XJM6,')!Z&<HP2NH.4,_4L\=FJ^$=>$B=?=.,0=J1II=%
M#3O M-'<LW&ES9]NV[K8:>KSTJHJN>GJ'V]^?'%WNO\^74V(H7F18P2Y,AIB
MZ6-%N<(0NXU<@6E9$%G&4$"#K+'QP M5@=<5>%7!GU[9P/AQ",1AU) (N)[Y
MH25F+?H-WT0C<;_AZ_(&[C=\T_#S?L.W+VD[IL&SSZY])+4\4U9 9$OJ^*'0
M4$J.(;=4:<$S9O.HJ/+QS<=&#747V^K,\]MBY@!;_?,_L1S1?]^FR,=.5CB"
M,8P-VH+3\^-?J]7#EN.2O8F''1P)&'BJP;EIY^,++GRF9<K^;O[!P^+Q<3&O
MOL,3(IBPFF!(<I)#S/,<"JV5>^EG[D$N<XR=HQ^?IG1)UDCSC_:J FW43/C2
M:S]%456*UZE'VR<=_/3_9/^*<@*>S!*LOKF/!B;<-JY V&/?&M"!4O0/4U%J
M!6N*3)B9WV!_VG3\2X*&S<%O,/4L\;[ILZTC KL>&E7]Z86A!=L7%B:D8 )+
M6.2BA%A1 27S5$(U%4P98E%0V^AHR6-S"HZ[SM35U0WC.:*#"H&K$1QG2(]Q
MWZ&'#P_OK\PQZ<'AB$8H=6 B4/K0L8HX4"Z$+R)OT'H8TXX'/_LW].K#9KU:
MB[EOI#^11%*%-86*:@,QL3F4' E8$BU+7>2\T%&3H9N$C8VC'H[\F;O:>UF!
MQ4%?\--TOOWK2(IJA#PTQ)$&R-YC' ?7Y@[4FMZ!(UV3CE6ZB4CJN4K7!0X]
M6.FFZ1<F*]V^ID,SGGU_X9JJWGU_<LSEAS=-:)GG2)(,HA);/^&M@%R4&=1Y
MJ4B&,&8,1;?BN2IN;*Q2>SN+?8?L>LQ;BPX\UP$.8Y!TL/7,(35BAY[B.]]P
MJ^S?$C?X"L,E?>^=ZR*'[[QST_R+?7=N7]6U<T*5P#+1.*<:,0H)R@G$19XY
M O$^BLX)IX+G#.7M.B54]Q\;8QP5\]=969'G*:?P!89/VH/2=^0D'(\.[0Q>
M6-U3^X):QBNU*WAAX/7V!"\_UKIMUM(GI+TU]7_?S[^81S]?9OFC/@/XM)C-
M?EXL?4E4=8J:&8XA0D1#C(R?N6@LM*7**>$:$1N52!$C?&R/_DYW\--.^[_Y
M_DU[ W9=AO[T-H"M$9'T$+4X8=S1%^0]$TMBM-OT<XJ&+75;IW %AN[N% W-
MA29/\??H.NYJGX.[33\YFPK$C41&8@9SBI&C.\HAIY1 G2E9%IDD.)?MYEW=
M$CTVLDLVB.DFYLTLUB^2?6^63D<O'27Z;[5/./+J)M)M9UZE1/RUAEYU0[[#
MT*M0\(*G7MV\X2N-O0HU]/K<J^ [Q+\'?EW,OWXQR\>W1JY_62Y6J_NY/J[.
M^"!GTZ_U<\&D)J4M"53$IP-)+:%$2$*5$58(I/V F-!W0+C8L?'_Q^5TKJ9/
M8A84'^Z"=YD97&92P!P1 3&E)>29I5 C1+$N#<F)"ADRUB/>0XT7[P7?V^_7
M?E#K^=WJE89>:^#5O@.5XL!I#EX4UX&#\KV@&_Y.[0?E@=ZG"=&.>I?&@];P
M'HVXV6#OT'@#C]^?+:Y.E6EOYNK;HUC^X^WB44SG$V0S3JCOM9CYP6F.TR'C
M7$/KN5TQ4IHBZ*T9*G!L[\L+^>-[C<&?M<Z=4^]/, \]G$Z'9.\'U%U 3)"+
M?QF9GA/R3X2^<E;^90ANI^9?N:YMC+JN'?SDO/\'\;1+U#=(*%1DD"F4.8[1
M&')F,RBTU3SCU!(55;5\4<K8B&5?*NNU!$[-V(#R)21#(\<=\>D]1'P"30_I
M=(T8)([W7I(T<&"WP=CS"&[3AR.WZ,NUIY3]Y(NJ9MCM^+<O.J-+MPUW#SXV
MQCD7?G(4HXA#7DB2::291C1H2]XH9FQ/_K&F8*=JI"]Q ]@;>\-D</7O-[1!
M*GPG$@1$$QNX.QPQ@?OME 5NB!AF/Q)DYG[_$?;IU&<V]W)5#:*8B$QII%0)
MW5N?.F^ 82AL1J' -"\LRPME$YW5[$2.CB"V4S@.^6LMVS-%H-[UM*8-EJ]_
M2@/^W.D=T7XS$-%4IS)MD!W/:<P01R^G"+4^<MG?:"1'+:>&A1^QG%W9;K]6
MW?MAL7+?9E.4I2 64LD9Q%CDD!,I(2Y,)DRF,AT6S3^[\_^' _;G*(7MOUK9
MWG?8O7Z O5;I-EEGAB;=6!WN/NAFZLRHTPW4^0>Z^DK^9F>G_K3 92X-@P7S
M";I$EY";HH!EJ54ND$&(!O6T#!,W-A\I67;%16QCO:&NB WM"7E]$V:H7,2P
MK?_3%<O7\GUB,>W@ #5!%.S\7+S)*SD^309==WH:K^HP6F?;5Z'.5WP_5[.-
M3Y+X6,]$/"[X_;+PP^3\!,7%;%:59-2AL_T>0&:EP@01WWW&YQU6+6AR#C-<
MH-)*D=D\:B!Z6O7&QNG7V]?\6XLI.^E6,<RK>[VUZ?GM<6S8OVP7Y [LC0-;
MZ\Y*X5\:>.@-&K#G;C>?)SGXZ4?VI%-Q^"D^R>&].-@GO926F1&;U7KQ:):?
M_.O%B5Y]FS[M1JQP)8M,Y@H:ABG$-B.099F!G$JJ,:%%'N9Z!\@:&T?O5 7+
M8UTC$R :H WCVD2 ]7U\L</JA9H]'&8&P)$VUZ%!WK!I#K<-/\MP"+BD'6/\
M,=?35<U/1K\3R[DCI97OK7,_JY;0Z"^+RDOU^;?>B?ULU'84P]OIS%\T,4;B
M$FL-B\QMYS$S"#):9K"0A%F$L% YBR&6[BJ-C7]^-:O5O_E9+SNK@)AKL#FV
M<UOM#\2)/_)T;"A8[2T%$&R-!>\^?HZCL@1K'L9XPZYDS\3XPABPLV;;B KL
M+=KV4SI:M(-1=[LU2\>BZ2!.2K8)U!J4D]/!>$K=">_<\CC$R7IP'J>[M9DK
M=]M?IW/S?FT>5Q.-&5$E)A!ERD*<6P$E)P6D*,\+0157-JK?RG518V-DW^-F
MNJ[FE%5<_$+KR(.4Z_C^O]5]6Y/;.);F^_P*ODU51**7! $0>)F(]*5Z:M=5
M]J1=/;%;#PI<;?;(DEM2NIWSZP<@=4M=2( "F-R([JJL3!'GG _"QP/@7#QO
M5J*@EOJJQ878/],R^]/IF36*1G0+^]&(>Q]S7=RX%S2]9I_=V/0_$2F\_M '
M[= 02^2$YI"5 #)7JDGEI=U(,@R8* @6D!(.\4TA]A>$3HY$5EK5FS8T_)G^
MH5M+'\ ]]YB184R]V3R/L3\HG*@A8@A$:8/M+PE^V8#[#BAZ@^Z[GAU8&'_E
M@LDV3Q_L=V9SOU#N>.V;>V>[4F9(491K;D!EC.N.6!5 :"E #BN-32ZITD&E
MGKJ$38UX=KHVKHO>*7J7+3JJG84C[,<XL7!+S#0[->^R1M$&N;<'Y*+6B?.!
M)&[9_2Z!XY;A]S#]K"R_SS,WU)M\=XA =8?OVU92F!#&)6/ =1FT>Q\E .6\
M I1R1HWD5:&""FY?%S4U]FBK)BZ6"[!5<'@+U0Y\_=@C#FJ)N:,%[$C+N^R@
M9^3RDIU8Q"\M>5G<^&4E.\V^6%*R^XE;@]<>ZL]?-N_-'VM]OU[KH_AH)BDI
M40ZHMCL>A%R(/RER4"EEB#98"N[5GL=;XN3(XR2\?^74!DL#'NU_<*?YX("L
M:YAW,TD2)%,3RFD8UL,.1:MTUF@=(<C_ZG=X8(Q;!%Q?*LSM'-\4$6X] 'D'
MN5T;YX7BW'K,NA[JUO?@P&@W^46KQ[E^;URAB5\7=M#F.[4^G)4H6G!-A0):
M5!H@7B) E=! F-PH710%*8/VAOTBIT;3.XVSI6GZI_#%T[^NL[DKG+)QA5.4
MM:/9 RV6&SVP1ZO'1/@Y@7'A3<S=Q\B^V^/I%,^.--_6'\Z2G&#YXQ4W%JQ?
M[+CQ7=XPG,5L^3\YM"[Y\;"'"R%I6$DU0:!DL@)(D@)P S4@*B\%DR4N\J#0
MVBMRIL9&)ZO#[^8H"%@_HHD 5V)V&834@%KFG3A$KFE^6=;(M<T[#3ZO<=[]
M\6&DL+O\_Z!735^5O4-.J*F@EA#P4F* C,61$BR )% J7FE9Y4&1F=<$38T6
M]C$TK@?DKD>D4SC[Z7?KEF1%^7-@#/U5B/WX(09PB0EBCYG5L>V:E"0TO0^)
MJ!1Q5=BH'-%G\BE)]'X^1@+EP_/TM(*PRB!H *0NU+(J2L @9T!27"J$""R%
M=SG8/F%38XN'>&E_#[<G3@[':NRSI3;%+QUZMZ1,#D?Q91,F?=&\,5WR,CQ!
MR9(/DTF5O&Q,=Z+DE6?"F%7I>O9F^W7YCT<[E%[-GQ[TM^5J,^.F4ACF!N"F
M0H04U-7MT<!H1AE&RN+K=5+4(6-J/+I3,]OKF;6*^G%"%YK=1!H)H]0[L&!X
MO!>Y!P 7_*JUEG_YO/S^O^S3K4ME?VA6?K/JN\8<9;%[&+5;XSX?';:U>G#=
MYM?KVM2R>2'\8M7SZ)*[K3MC/;AZJ7[7F_?F$_\Q0\SDK*@$,(7) 2JD!+PR
M!9 :2UZ4K##8J\!?"N6F1B;W7Y>/[KASM;?1OA7=ER-SC:;#-F]1)]%OP_=2
M4Y.8PT[-VLZ(5V?U0YFQUKPF-LH==EL3X^TO4P ?=4\:5<%1][$IH#W=^R:1
M,8SZ/ZVXTJ[6\S[/F>>%T)H"+7!I]\B4 DJ5  53%8=<(:&"DEI.!4R-@@_Z
MA='M&7!^E'D+'(EI[Z!:@G3E:W9'99TS(:,RQS433U?_U<\-#-*\7!1P?W9+
ME>8YE!@(V%1:+PP07!:@*JM25CCG%0UJ^]DC;W+KV]7VN[VLJB_:?BP0$<.Q
MS\/VRB8Y./<$)FXD9X_,<<,Y_0 XB^GT?&Q@#FR]T.]-FZ_U"Y?-T&W+:XRT
M,9HIH' A :)( D$E @2J I74Y)!Y%6[NE30U6G&*-M%!;1+;3M=AC<2OX^M'
M)U%02TPD0P$+SX#M R-N NQ5:>/FO_89?9;^VOM ^/W;:[W:M'L:O7YO?M=:
M;5UC0;$6FDB #71'0I4!5 L&"F&,@1JCW'@EBW0)F1I!'.OIOO<+W5&WPA_*
M_LNV&  EYH)GV+PWF5.R?\_A#Y+_G5H,L$:Z2WO0W^QP373DYHO.ZH59KKZV
MYU,N_XO7[CK=E4^1%[YY=QFWGN]GZPGOM'5_<>-HU^KAZ2]Q[N#ZX.RX>[OZ
MZ&AW;GW*']^U]7XVG#V/>_TU =^N >!1FLY^BU$0A6%),6"DLFRJ! ("(V7?
M3!65N&1*"J^"42%"I\:NSSI5!ES'>X/<S[,IH$O,N\_[>[9*-XT_C]0>E#GC
M#:L_,Z> =R2FC@5S$/6&XM5!Q=Y#C4;-H<8=4W7PL^'A$4V[I*?730AF4]"T
MB6A;'W7;G@G+RH)5&I1($("XPH +E -!L%2T4$(CKUM1/W%3H^M6XZQ5.6MT
MOFO#+]?A/<D]$>]F\/@X)N;N6R$,"K/P1V90Q(7'\*,%7_B;>AR'$?#4T"I2
MZX:HWO[XIA?KHS<HP:606EOFJ'+7*@U3((PD@#&10\A197\?5CGJLJ"I44BC
M9UNQ9:MI8'#[543]SMABX)1Z6[V':*=DDC/Z/B0B5WVZ(FSD2D_=)I]7=^KY
M_*VYNW]=+M4_Z_F\/24F2,F\LBX%Y9H#1$H$6$&8I0AA_8J24,6",F"NR)D:
M)1SGDNX4'78 ?PU8/VJ( %=B9AB$U V)M1=Q2)1-^US6"Z707C3X>M[LY8\/
M(X5](=S&!7EE=SG*Q0Y9WFFVN5L*FB'JHG=8!70A<I?4CP&#A6,+EFN$1556
M;+;0G]U(?BSA)]AK%;!V%1R+3[@8G+_F$N;VJNY<BC#2\ 3>CT,B@CD2I3@]
M@7"*9A_X4W.D?+]:V8_HMB;<VQY,@^DE#**H;.,I>E3R"8/CE(L"GQZ>,O)+
MO99\WL8L_F)_MY[E)5(5+@R0%98 Z8(!KI0!12$TEI42C'H?A5R5,C5?99\7
MT6JZC0[.&EW#,T?.0>T_[8@"56)2&832H 22JRC<E$)R/NKH2217#;N41G+]
MP^'W5Q\?11-;U\8JG[6&M.X%A500H"HD &*" EKD]B?)%<H9AJ12?OY'O[#I
M^1PWM-WLP;7_HBH"5B.Y%%M%]ZD4Z5#SOX>*A]Y(MT\WH!ATX>0'3,<U4\\
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MQX64K!263RH#$"_L1@$6&C!9X8H5G" 1U-5V-_#4]@D[O<(X80^3S"6M,%,
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MBVZ9(W>X\ +@O*N%WV/7:.5X!M_9G_[M7W:_L?\0=LOT;__R/U!+ P04
M" "5A 53&@$(EZ"(  "//P8 %    '-E;2TR,#(Q,#8S,%]P<F4N>&ULY+W9
MEILYDB9XWT\1DWT[EH%]J5-5?1121);.*$)JA;*J>VYXL!@D=M))%4E72/7T
M8Z#O](W+#_Y03)Y(2>YR$;9\,)@9#&;__#^^GLU^^(++U70Q_Y>_\+^RO_R
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ML+7R3I!0_4/B*(F.C(J?Y^OI^MLOTQG^=GX6<3FQ(96(19 <? #%N8+ C(>
MTC+A?=8.CT+#]HH[H4#WBX*C)-B%]M_CQVD5PGS]6SC#B?36\L(T."<*H3<2
M<(O1P)4IALX^XW@>  %W5]T)!:9W%!PAR2Z0\)KB^269L(W@?R?YX\O%^7R]
M_/9RD7&"K#"R7 J\<-6L945BR8*^],2E<.0>QP& \201.^'$]HZ3X>3<!6P^
MA*^O,XEO6J87J8I+2R@]V3U)#C+]/X)BQH)W7 /*J$MBILAX7+C\Y/([0<7U
M#I4A9-L%2%[D3"I87?[V9CI'/I$"!0;+ +.E\S)J#B%7I.N8'4N<976<Z_GH
MTCN!P_<.CF-EVBDPQ,06S4O"",5S\J$DKQZT#N"90"6<*9A#$V"(W=)7[/M#
MQGY"[0D9+^F/;Y<?%G_,)U9+I9PV8+4CCXHB*7!1,OHRYV1%"<F9X7!QL_!N
MJ.@XJSF$0'O"Q,9I>KM\MUQ\F<X33I+G+@GN@,1"?$A-/I.4%K(WW"AGO2QV
M.&!LK;X;.CK.=0XFVIX@\FZQ6H?9_SO]O'&JN;>(*DC(I6;R8R"[Q[,%SCG!
M/V)"/:#EN+/V;O#H./<YD%A'!D>U>B^6&#9T9YVY"H6#T%F"T@PAR.1!9,YT
M,9)G?=R5V.W5=@- QYG.@T4WLLKKU?GLW:?%_"HW%TN*I=+..>,4-5D+SND"
MV6HO3! YQN/4OKWB;JKO.+UYE A'5O_OF,Z7!%TNXH?I>H83)RD"*HF@FY(&
MQ84$+RA\#CEQ.L5DM-8=I?[M%7=3?\=YS:-$.++Z/RQ#+4[Z_=M97,PFC"L,
M1B@PCIP7Q1(#EU. ;()U/GJKF#A*]W>6VTWQ'2<J#Q=>)YO^YZ_I4YA_Q$TF
MWLN:+"/ %B\2G5DAU\LX#RE0S(M,1Y&/2S0]M.IN&.@X WFT*+L(!UZ>+ZNX
M+NYF*Z1)!^>K24Y*8V6AH"3/55L$;SDCM0;AB$.2V7&NP%.K[P:-[O./ XBV
M"XB\GM.GD3BF7_!56(=+MB;66CK2;( 812TEE08"\Q%2%(&YF)1)QU7*/+7Z
M;O53W2<B!Q!M%Q"I%_S+EV&-'Q?+;Y,BO42?!'!A'2'<.'*"?0"*=[-UV:6(
MQSD3#RRZ&R"ZST$>+L@N</#[69C-?CI?3>>X6DU<I* WR@B&3CY0T?AZ&$9P
MQKB2 DM!#E$K<6?1W7#0?;;Q<$%V@8.?SW#YD8Z\ORT7?ZP_O5R<?0[S;Q/.
ME,W%9HBT*HE$*V*C9"B6FQ@LES8.43WUX.*[X:+[-./Q@NT"'[]_PMGLBGJG
M&4K,$DQRG*R<B^"93A U+ZB8#B8-<3MQ>\W=T-!QSO%(,78! B+\K!;X+-(_
M?O]$<EN]/5_7!SXULIY8I4F'A0&34H)")2!6%TCY8$P.Y"?;(4#Q% V[@:3C
M[.3 8A[[AN+".?YENDIA]K\Q+*_*S'5"I=!ID$41Y8)SLG[D,A<IH_#,DR-]
MY+NC1U;>#2 =YR\'$>G(L'AQAO-<"\U_F07"LP]*2&X@"QU($DY D(J!*5XA
M0RVY/>XB\\YRNP&@XSSFX<+KY+W&#71_H>^L)E&2XR,C QUS3<!'14XR#Y"]
MLB8D+X=ZS+>U\&Y(Z#B;.81 N\+$Q5.D"R:RM4(4G\ PZT&5I"%*88$)<I!9
MYER985[YW5MZ-UQTG,H<1JA]^)O$QC+,7L\S?OU_\-N$V414\P(2Z[5-0@LA
MY0P".3I;= @WSMTQ+N;=97=[ZM=]YO(880Z&AG_^\9X0W] WCGRQ3RS-5YCI
M#ZO%;)IK=X:?PJPV'J!X"]>K\WDXSU/Z[EU^=GS7O_NG#_GZ_T">CNP1<+Z"
MCR%\GFR*YJH5>5M^F<YIU2F9DL7%J\!K//(@DK"B0*#SIC[L<(1'1?&K2I9S
M(81YLOR@A%7<P.5RT8L]B;/UZNH[&TT XY>-'?[[/M0=:GVNUGBQ6I&4KWD-
MVJ%%6:#$4JN$4H!@,\5>]4E4*I;+_%0F['!>[](Q3C>"9JBXLE(#"'W$ ^LN
M]9<AVC43B7-,@B-0')9KK4$M+E$.N'0II!@2TT_=NAV+G"URQ@70,?I]$"K'
M"+L#Q+P,JT\OYKG^]O-_GD^_A!DQLWJQ?AF6RV_3^<=_#[-SG$2F(TO*0HY:
M@,)4();@P7.>I7!1R_B4,WPX@G8BKP=$'06#16N== "T%RG5%YFK]YB06(HS
M_ W75Y?7A0MTF#+([&@;LF+ B2!JF&#)X2P)-6]CH9Z@:IQ^*^U@-9@&#D83
MA1)Q,1">WBWQ<YCF#^$KKB;2Z\02)V$HK&8<.;CZE)-K[V/2S+OP5 KG</S<
MIF*<ABSM\'*PA#NP-F_7GRALO2V2B0J.(M3ZUB:8RH%!\+X^T?*)8DV7I"YM
M,'*?EG'ZM+1#RI'2[@ O=XE/R9D2& (KS%  82*X9 4$+#H'G5#$I_HR#.0P
MC]/'I>'Y<[",#P?(8AUFPQB4SUB;2\P_OL&PPO>UJ^;;\O<5;IB:6)NMXH1Q
MQA7Y8EY8<"4X\,I'DU,MYFZ3AWB2K!X<F$$BK>&$WX&I>;=<$#OK;^]F@3;6
M/%<7_W--:9 W-O$L)NZL!9VYJ^T1%3AN#1@Z9 W7+KK2)E1_BJH>')M!<#28
MZ#N T=\6B_S'=#:;2*E#=(8TJDRXR':YFIB7SCM64E2NM(F=KBCHP9L9!!X'
MB;0#*+PF<<\_3BF@NQ &H?GGKVEV7JMUKGGRVD3M$X>D/)*59 F<]0*LXXC1
M^Y!%&YCL0ET/KLX@$!I<%1W ZY9W_]MBGB[]-^V5(7H,8'VOK(QAY+H)!EHD
MQY3UNO@VUQ$/DC-.M[L6KL[1PNX ,1?TDQR\4"41NJ/&6F*,%"Q4L".!G\O$
M4;4,H\;I;-?LHF$O<780,;V9ACB=3==37)&KM:DE_;28D=!7U>U:?[L6#5,N
MLF0=':^U*"1B!E^K!YTM0CA$"C?;^+R[4CAN'-7\RK.)HCJP0K?XVDYCJ!B5
M<F1*G:&X407-P2?O0=0N?SJIJ%ASR'5U+=H& X\#[1B%= "MNPF)*[Z^7>>V
MI,AH8P"3,NW&E.BX5K9 #!B2*-RJ^-1#A*'20=MT=0.QH[3_9&[H*%5T *PW
MB_G'#[@\>X5QO;D"_CRMYW%E[6V<33]NM'4KA^I-"M$"CS5E8;V!:(H#[IA1
M/&9$]53E^A%F;!\RQST^&\&NG:(Z0.'53?&[\*U>$U_?$:.@\%22L4^:;']@
M&CRS 1"#+LP[<D$:^?,/TC-N6K(1K@80_8@ 6N%9Y6!YCOGW, O+ZDY<?/G3
M8GZ^VC@7E]\@!FG1V>9V^?K24$O#LM:02RU""!3A. IP(6NDP,>:=.\:Y5ZQ
M['$4C)O*'!A2)U1&'S:K<O+OX:*I]Q47TL2(B6*B'%.N+7KI_(_UN9(JG@5K
M)2]/]3T^RF8]0,^XB<YV-NM8T7< H$U?%5RMMRRO+4[X'#UH)LCRVJ))1$E
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MT;N: PD>-\O0%IJGT&$'%O+-='W9/>UW7*]GF[/DNFK8:^-R9!DH$J[-:ID
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MAD%R4EKA4;M&G:.>(&KLZ1!= '$OS7Q_':-WO<1HTD/ZL,4[N=8Y:9_IG79
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MQR(U\T*UJ<UZBJJ17YX-[D@/IH$.T'0=E;XA*[QIDC.A\SC[4"QD+FD_D"#
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MPFL81D/?>8_8R]ZYJ[9-8>^O<DK;^ R/P]N_ZQ5O!@M[X3 E5=^<6E"!SNS
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M2K49NOH,8>/V,ND.GD.JL0-4WJ_MNA;<Y=O^6W=KSCO+&9AZHZ:,=.##ILR
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M@BY@LK:@K'(0/8E1;$9,!,L";]:&]_MQ[9L!9G=@'JV]#L!YSY6T4:G@"AT
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MR/X:907O%[6::/GU9XSK$]04//6Z"0H*7EWU*:H)E$O:&2? >6] "68@<!%
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M$UKD"%C(NR6?4T+4%$\;;ZWS69K\%Z]C'D^^KQ<L#V%V=W"YSB)UV5D?"O%
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M[5VV73/<>@$Y__37H=W%[(O_ E!+ P04    " "5A 53L9VU#D(%  !/&@
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M+3(P,C$P-C,P+GAS9%!+ 0(4 Q0    ( )6$!5.JPK=+_2X  (7L 0 4
M          "  ;7W @!S96TM,C R,3 V,S!?8V%L+GAM;%!+ 0(4 Q0    (
M )6$!5-5$*(&44   )&] @ 4              "  >0F P!S96TM,C R,3 V
M,S!?9&5F+GAM;%!+ 0(4 Q0    ( )6$!5-*3ZQ$2N4  *F="0 4
M      "  6=G P!S96TM,C R,3 V,S!?;&%B+GAM;%!+ 0(4 Q0    ( )6$
M!5,: 0B7H(@  (\_!@ 4              "  >-,! !S96TM,C R,3 V,S!?
M<')E+GAM;%!+ 0(4 Q0    ( )6$!5-O^A"/: @  )8N   8
M  "  ;75! !S96TM-C,P,C R,3$P<7AE>#,Q,2YH=&U02P$"% ,4    " "5
MA 53[0*-VW$(  #S+0  &               @ %3W@0 <V5M+38S,#(P,C$Q
M,'%X97@S,3(N:'1M4$L! A0#%     @ E80%4[&=M0Y"!0  3QH  !@
M         ( !^N8$ '-E;2TV,S R,#(Q,3!Q>&5X,S(Q+FAT;5!+!08
.."0 ) %8"  !R[ 0    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
